US20060211717A1 - Quinoline and quinazoline derivatives and drugs containing the same - Google Patents
Quinoline and quinazoline derivatives and drugs containing the same Download PDFInfo
- Publication number
- US20060211717A1 US20060211717A1 US11/432,407 US43240706A US2006211717A1 US 20060211717 A1 US20060211717 A1 US 20060211717A1 US 43240706 A US43240706 A US 43240706A US 2006211717 A1 US2006211717 A1 US 2006211717A1
- Authority
- US
- United States
- Prior art keywords
- optionally substituted
- halogen atom
- solution
- alkyl
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 125000002294 quinazolinyl group Chemical class N1=C(N=CC2=CC=CC=C12)* 0.000 title description 3
- 229940079593 drug Drugs 0.000 title description 2
- 239000003814 drug Substances 0.000 title description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 title 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 258
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 114
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 44
- 230000035578 autophosphorylation Effects 0.000 claims abstract description 21
- 108091008606 PDGF receptors Proteins 0.000 claims abstract description 18
- 102000011653 Platelet-Derived Growth Factor Receptors Human genes 0.000 claims abstract description 16
- 201000010099 disease Diseases 0.000 claims abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 12
- 150000003839 salts Chemical class 0.000 claims abstract description 9
- 230000001404 mediated effect Effects 0.000 claims abstract description 7
- 239000012453 solvate Substances 0.000 claims abstract description 6
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims abstract description 5
- 125000005843 halogen group Chemical group 0.000 claims description 235
- 125000000623 heterocyclic group Chemical group 0.000 claims description 123
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 104
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 83
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims description 60
- 229920006395 saturated elastomer Polymers 0.000 claims description 58
- 125000002837 carbocyclic group Chemical group 0.000 claims description 55
- -1 nitro, amino Chemical group 0.000 claims description 38
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 32
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 31
- 125000002619 bicyclic group Chemical group 0.000 claims description 30
- 229910052757 nitrogen Inorganic materials 0.000 claims description 26
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 25
- 125000004122 cyclic group Chemical group 0.000 claims description 19
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 18
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 14
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 14
- 125000000027 (C1-C10) alkoxy group Chemical group 0.000 claims description 11
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims description 11
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 11
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 claims description 9
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 9
- 210000004204 blood vessel Anatomy 0.000 claims description 8
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 8
- 230000002792 vascular Effects 0.000 claims description 8
- 125000005842 heteroatom Chemical group 0.000 claims description 7
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 7
- 239000008194 pharmaceutical composition Substances 0.000 claims description 7
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 6
- 125000001624 naphthyl group Chemical group 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 208000023589 ischemic disease Diseases 0.000 claims description 5
- 206010016654 Fibrosis Diseases 0.000 claims description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 4
- 238000011316 allogeneic transplantation Methods 0.000 claims description 3
- QELGRPPEBNRPLX-UHFFFAOYSA-N 1-[2-(diethylamino)ethyl]-3-[4-(6,7-dimethoxyquinazolin-4-yl)oxy-2-nitrophenyl]urea Chemical compound C1=C([N+]([O-])=O)C(NC(=O)NCCN(CC)CC)=CC=C1OC1=NC=NC2=CC(OC)=C(OC)C=C12 QELGRPPEBNRPLX-UHFFFAOYSA-N 0.000 claims description 2
- UNBXGEFKYCCXMS-UHFFFAOYSA-N 1-[4-(6,7-dimethoxyquinazolin-4-yl)oxy-2-nitrophenyl]-3-(2-piperidin-1-ylethyl)urea Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1[N+]([O-])=O)=CC=C1NC(=O)NCCN1CCCCC1 UNBXGEFKYCCXMS-UHFFFAOYSA-N 0.000 claims description 2
- 206010059245 Angiopathy Diseases 0.000 claims description 2
- 208000032612 Glial tumor Diseases 0.000 claims description 2
- 206010018338 Glioma Diseases 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 claims description 2
- 125000004414 alkyl thio group Chemical group 0.000 claims description 2
- 125000002947 alkylene group Chemical group 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 125000002527 bicyclic carbocyclic group Chemical group 0.000 claims description 2
- 230000004663 cell proliferation Effects 0.000 claims description 2
- 230000001684 chronic effect Effects 0.000 claims description 2
- 230000007882 cirrhosis Effects 0.000 claims description 2
- 208000019425 cirrhosis of liver Diseases 0.000 claims description 2
- 230000001419 dependent effect Effects 0.000 claims description 2
- 230000004761 fibrosis Effects 0.000 claims description 2
- 210000000056 organ Anatomy 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 208000005069 pulmonary fibrosis Diseases 0.000 claims description 2
- 125000000165 tricyclic carbocycle group Chemical group 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 abstract description 9
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 8
- 239000001257 hydrogen Substances 0.000 abstract description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract description 5
- 206010020880 Hypertrophy Diseases 0.000 abstract description 2
- 208000034827 Neointima Diseases 0.000 abstract description 2
- 230000008692 neointimal formation Effects 0.000 abstract description 2
- 150000002431 hydrogen Chemical class 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 239000000243 solution Substances 0.000 description 847
- 239000000203 mixture Substances 0.000 description 581
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 576
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 438
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 429
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 423
- 238000010992 reflux Methods 0.000 description 422
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 420
- 238000006243 chemical reaction Methods 0.000 description 284
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 282
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 275
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 145
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 143
- 238000004949 mass spectrometry Methods 0.000 description 143
- UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 description 143
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 143
- 238000005160 1H NMR spectroscopy Methods 0.000 description 141
- 238000000605 extraction Methods 0.000 description 141
- 239000012153 distilled water Substances 0.000 description 140
- 238000010438 heat treatment Methods 0.000 description 140
- 229910052938 sodium sulfate Inorganic materials 0.000 description 140
- 235000011152 sodium sulphate Nutrition 0.000 description 140
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 140
- 238000005406 washing Methods 0.000 description 140
- ZLVVYBNEDMWIRX-UHFFFAOYSA-N 4-(6,7-dimethoxyquinazolin-4-yl)oxyaniline Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC1=CC=C(N)C=C1 ZLVVYBNEDMWIRX-UHFFFAOYSA-N 0.000 description 29
- 150000003246 quinazolines Chemical class 0.000 description 29
- JWNJXRODWCORFX-UHFFFAOYSA-N 2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyaniline Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC1=CC=C(N)C(Cl)=C1 JWNJXRODWCORFX-UHFFFAOYSA-N 0.000 description 28
- ZKPSHRUKJGWIHO-UHFFFAOYSA-N 4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylaniline Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC1=CC=C(N)C(C)=C1C ZKPSHRUKJGWIHO-UHFFFAOYSA-N 0.000 description 28
- RYOSIAALQNJYKP-UHFFFAOYSA-N 4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylaniline Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC1=CC(C)=C(N)C=C1C RYOSIAALQNJYKP-UHFFFAOYSA-N 0.000 description 27
- VXEQRXJATQUJSN-UHFFFAOYSA-N 4-(6,7-dimethoxyquinolin-4-yl)oxyaniline Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC1=CC=C(N)C=C1 VXEQRXJATQUJSN-UHFFFAOYSA-N 0.000 description 27
- 230000002401 inhibitory effect Effects 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 239000002904 solvent Substances 0.000 description 15
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 13
- 239000012312 sodium hydride Substances 0.000 description 13
- 229910000104 sodium hydride Inorganic materials 0.000 description 13
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- PCSIZCXZPLZZCD-UHFFFAOYSA-N 2-quinolin-4-yloxyaniline Chemical class NC1=CC=CC=C1OC1=CC=NC2=CC=CC=C12 PCSIZCXZPLZZCD-UHFFFAOYSA-N 0.000 description 11
- 238000007796 conventional method Methods 0.000 description 11
- OEGPRYNGFWGMMV-UHFFFAOYSA-N (3,4-dimethoxyphenyl)methanol Chemical compound COC1=CC=C(CO)C=C1OC OEGPRYNGFWGMMV-UHFFFAOYSA-N 0.000 description 10
- JESIHYIJKKUWIS-UHFFFAOYSA-N 1-(4-Methylphenyl)ethanol Chemical compound CC(O)C1=CC=C(C)C=C1 JESIHYIJKKUWIS-UHFFFAOYSA-N 0.000 description 10
- 125000001424 substituent group Chemical group 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 238000004821 distillation Methods 0.000 description 9
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 8
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 239000002168 alkylating agent Substances 0.000 description 8
- 229940100198 alkylating agent Drugs 0.000 description 8
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 7
- 125000003396 thiol group Chemical group [H]S* 0.000 description 7
- 150000005653 4-chloroquinolines Chemical class 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- AUDBREYGQOXIFT-UHFFFAOYSA-N (3,5-dimethoxyphenyl)methanol Chemical compound COC1=CC(CO)=CC(OC)=C1 AUDBREYGQOXIFT-UHFFFAOYSA-N 0.000 description 5
- GEZMEIHVFSWOCA-UHFFFAOYSA-N (4-fluorophenyl)methanol Chemical compound OCC1=CC=C(F)C=C1 GEZMEIHVFSWOCA-UHFFFAOYSA-N 0.000 description 5
- AGFYZLVFPSGUIX-UHFFFAOYSA-N (4-methylphenyl)methanethiol Chemical compound CC1=CC=C(CS)C=C1 AGFYZLVFPSGUIX-UHFFFAOYSA-N 0.000 description 5
- RIRHPWCWRLZXAM-UHFFFAOYSA-N 1-(2,4,5-trifluorophenyl)ethanol Chemical compound CC(O)C1=CC(F)=C(F)C=C1F RIRHPWCWRLZXAM-UHFFFAOYSA-N 0.000 description 5
- DZLZSFZSPIUINR-UHFFFAOYSA-N 1-(2-bromophenyl)ethanol Chemical compound CC(O)C1=CC=CC=C1Br DZLZSFZSPIUINR-UHFFFAOYSA-N 0.000 description 5
- JDWJORYBUIOXEE-UHFFFAOYSA-N 1-(2-ethoxyphenyl)ethanol Chemical compound CCOC1=CC=CC=C1C(C)O JDWJORYBUIOXEE-UHFFFAOYSA-N 0.000 description 5
- SXFYVXSOEBCFLV-UHFFFAOYSA-N 1-(2-fluorophenyl)ethanol Chemical compound CC(O)C1=CC=CC=C1F SXFYVXSOEBCFLV-UHFFFAOYSA-N 0.000 description 5
- ULMJQMDYAOJNCC-UHFFFAOYSA-N 1-(3-bromophenyl)ethanol Chemical compound CC(O)C1=CC=CC(Br)=C1 ULMJQMDYAOJNCC-UHFFFAOYSA-N 0.000 description 5
- QYUQVBHGBPRDKN-UHFFFAOYSA-N 1-(3-chlorophenyl)ethanol Chemical compound CC(O)C1=CC=CC(Cl)=C1 QYUQVBHGBPRDKN-UHFFFAOYSA-N 0.000 description 5
- YESOPGLEIJQAEF-UHFFFAOYSA-N 1-(3-fluorophenyl)ethanol Chemical compound CC(O)C1=CC=CC(F)=C1 YESOPGLEIJQAEF-UHFFFAOYSA-N 0.000 description 5
- ZUBPFBWAXNCEOG-UHFFFAOYSA-N 1-(3-methoxyphenyl)ethanol Chemical compound COC1=CC=CC(C(C)O)=C1 ZUBPFBWAXNCEOG-UHFFFAOYSA-N 0.000 description 5
- PSDSORRYQPTKSV-UHFFFAOYSA-N 1-(4-fluorophenyl)ethanol Chemical compound CC(O)C1=CC=C(F)C=C1 PSDSORRYQPTKSV-UHFFFAOYSA-N 0.000 description 5
- FSQALMKHWYDIEL-UHFFFAOYSA-N 1-(4-methoxyphenyl)-2,2-dimethylpropan-1-ol Chemical compound COC1=CC=C(C(O)C(C)(C)C)C=C1 FSQALMKHWYDIEL-UHFFFAOYSA-N 0.000 description 5
- RRKDGVKNYAWWAM-UHFFFAOYSA-N 1-[(4-tert-butylphenyl)methyl]pyrrolidin-3-amine Chemical compound C1=CC(C(C)(C)C)=CC=C1CN1CC(N)CC1 RRKDGVKNYAWWAM-UHFFFAOYSA-N 0.000 description 5
- YNVXCOKNHXMBQC-UHFFFAOYSA-N 1-[3-(trifluoromethyl)phenyl]ethanol Chemical compound CC(O)C1=CC=CC(C(F)(F)F)=C1 YNVXCOKNHXMBQC-UHFFFAOYSA-N 0.000 description 5
- YDKIPCCKZKQMDT-UHFFFAOYSA-N 2-[3-(trifluoromethyl)phenyl]ethanol Chemical compound OCCC1=CC=CC(C(F)(F)F)=C1 YDKIPCCKZKQMDT-UHFFFAOYSA-N 0.000 description 5
- CSCKMYSAZZCGBM-UHFFFAOYSA-N 3-(2-chlorophenoxy)propan-1-ol Chemical compound OCCCOC1=CC=CC=C1Cl CSCKMYSAZZCGBM-UHFFFAOYSA-N 0.000 description 5
- PKEJCKFGHWWOGO-UHFFFAOYSA-N 3-(3-methoxyphenoxy)propan-1-ol Chemical compound COC1=CC=CC(OCCCO)=C1 PKEJCKFGHWWOGO-UHFFFAOYSA-N 0.000 description 5
- JMKYASWLIZQXNC-UHFFFAOYSA-N 3-(4-chloro-2-methylphenyl)sulfanylpropan-1-ol Chemical compound CC1=CC(Cl)=CC=C1SCCCO JMKYASWLIZQXNC-UHFFFAOYSA-N 0.000 description 5
- DMCGTVJRKBBDNM-UHFFFAOYSA-N 3-(4-chlorophenoxy)propan-1-ol Chemical compound OCCCOC1=CC=C(Cl)C=C1 DMCGTVJRKBBDNM-UHFFFAOYSA-N 0.000 description 5
- WMPCMSDCGYUKGU-UHFFFAOYSA-N 3-(4-methoxyphenoxy)propan-1-ol Chemical compound COC1=CC=C(OCCCO)C=C1 WMPCMSDCGYUKGU-UHFFFAOYSA-N 0.000 description 5
- KMJTYCHPLDCYPW-UHFFFAOYSA-N 3-(4-methylphenyl)sulfanylpropan-1-ol Chemical compound CC1=CC=C(SCCCO)C=C1 KMJTYCHPLDCYPW-UHFFFAOYSA-N 0.000 description 5
- OKRNRFHXBAOAJH-UHFFFAOYSA-N 3-(4-tert-butylphenyl)sulfanylpropan-1-ol Chemical compound CC(C)(C)C1=CC=C(SCCCO)C=C1 OKRNRFHXBAOAJH-UHFFFAOYSA-N 0.000 description 5
- MOOUWXDQAUXZRG-UHFFFAOYSA-N 4-(trifluoromethyl)benzyl alcohol Chemical compound OCC1=CC=C(C(F)(F)F)C=C1 MOOUWXDQAUXZRG-UHFFFAOYSA-N 0.000 description 5
- IUUULXXWNYKJSL-UHFFFAOYSA-N 4-methoxy-alpha-methylbenzyl alcohol Chemical compound COC1=CC=C(C(C)O)C=C1 IUUULXXWNYKJSL-UHFFFAOYSA-N 0.000 description 5
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 5
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 5
- 150000001408 amides Chemical class 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 239000012280 lithium aluminium hydride Substances 0.000 description 5
- 239000007800 oxidant agent Substances 0.000 description 5
- 230000001590 oxidative effect Effects 0.000 description 5
- 208000037803 restenosis Diseases 0.000 description 5
- DDUBOVLGCYUYFX-UHFFFAOYSA-N 1-(2-chlorophenyl)ethanol Chemical compound CC(O)C1=CC=CC=C1Cl DDUBOVLGCYUYFX-UHFFFAOYSA-N 0.000 description 4
- KYCQIPSCAOIEKN-UHFFFAOYSA-N 2-(4-methylphenyl)sulfanylethanol Chemical compound CC1=CC=C(SCCO)C=C1 KYCQIPSCAOIEKN-UHFFFAOYSA-N 0.000 description 4
- JLXXXNWUQYMJMM-UHFFFAOYSA-N 4-[2-(4-propan-2-ylphenoxy)ethylsulfanyl]phenol Chemical compound C1=CC(C(C)C)=CC=C1OCCSC1=CC=C(O)C=C1 JLXXXNWUQYMJMM-UHFFFAOYSA-N 0.000 description 4
- LLLHRNQLGUOJHP-UHFFFAOYSA-N 4-chloro-6,7-dimethoxyquinazoline Chemical compound C1=NC(Cl)=C2C=C(OC)C(OC)=CC2=N1 LLLHRNQLGUOJHP-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 description 4
- 239000012298 atmosphere Substances 0.000 description 4
- 239000007795 chemical reaction product Substances 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 150000002466 imines Chemical class 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 150000003248 quinolines Chemical class 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 150000003558 thiocarbamic acid derivatives Chemical class 0.000 description 4
- KJGMGILMGSVHAY-UHFFFAOYSA-N 2-quinolin-4-yloxyphenol Chemical class OC1=CC=CC=C1OC1=CC=NC2=CC=CC=C12 KJGMGILMGSVHAY-UHFFFAOYSA-N 0.000 description 3
- YKBLAXZVDXPXLW-UHFFFAOYSA-N 4-[3-(3-methoxyphenoxy)propoxy]phenol Chemical compound COC1=CC=CC(OCCCOC=2C=CC(O)=CC=2)=C1 YKBLAXZVDXPXLW-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 108091008605 VEGF receptors Proteins 0.000 description 3
- 102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 125000003342 alkenyl group Chemical group 0.000 description 3
- 125000000304 alkynyl group Chemical group 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000012286 potassium permanganate Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000000967 suction filtration Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- MQFPKXNYBYCAEG-UHFFFAOYSA-N (2-quinolin-4-yloxyphenyl) benzoate Chemical class C=1C=CC=C(OC=2C3=CC=CC=C3N=CC=2)C=1OC(=O)C1=CC=CC=C1 MQFPKXNYBYCAEG-UHFFFAOYSA-N 0.000 description 2
- GCXHGXLGOKBXAF-UHFFFAOYSA-N 1-(3-chlorophenyl)ethyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1)=CC=C1NC(=O)OC(C)C1=CC=CC(Cl)=C1 GCXHGXLGOKBXAF-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
- GPPZKNGUAZXHOA-UHFFFAOYSA-N 4-(2-nitrophenoxy)quinoline Chemical class [O-][N+](=O)C1=CC=CC=C1OC1=CC=NC2=CC=CC=C12 GPPZKNGUAZXHOA-UHFFFAOYSA-N 0.000 description 2
- VSLQZQFYIGWXNU-UHFFFAOYSA-N 4-(2-phenylmethoxyphenoxy)quinoline Chemical class C=1C=CC=C(OC=2C3=CC=CC=C3N=CC=2)C=1OCC1=CC=CC=C1 VSLQZQFYIGWXNU-UHFFFAOYSA-N 0.000 description 2
- SXJQUUPSLJTKKT-UHFFFAOYSA-N 4-amino-3-methoxyphenol Chemical compound COC1=CC(O)=CC=C1N SXJQUUPSLJTKKT-UHFFFAOYSA-N 0.000 description 2
- KMTDMTZBNYGUNX-UHFFFAOYSA-N 4-methylbenzyl alcohol Chemical compound CC1=CC=C(CO)C=C1 KMTDMTZBNYGUNX-UHFFFAOYSA-N 0.000 description 2
- VBEIMFZUDCIBQS-UHFFFAOYSA-N 6,7-dimethoxy-4-(2-methyl-4-nitrophenoxy)quinoline Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC1=CC=C([N+]([O-])=O)C=C1C VBEIMFZUDCIBQS-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical class CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 description 2
- JLCHNBRGUPQWKF-UHFFFAOYSA-J [OH-].[C+4].[OH-].[OH-].[OH-] Chemical compound [OH-].[C+4].[OH-].[OH-].[OH-] JLCHNBRGUPQWKF-UHFFFAOYSA-J 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- 150000002513 isocyanates Chemical class 0.000 description 2
- 150000002540 isothiocyanates Chemical class 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 125000005493 quinolyl group Chemical group 0.000 description 2
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- 150000003585 thioureas Chemical class 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 150000003672 ureas Chemical class 0.000 description 2
- 150000003673 urethanes Chemical class 0.000 description 2
- 210000003556 vascular endothelial cell Anatomy 0.000 description 2
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- WORWEFGASOICDT-UHFFFAOYSA-N (2,5-dimethoxyphenyl)methyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound COC1=CC=C(OC)C(COC(=O)NC=2C(=CC(OC=3C4=CC(OC)=C(OC)C=C4N=CN=3)=CC=2)Cl)=C1 WORWEFGASOICDT-UHFFFAOYSA-N 0.000 description 1
- CNWOUPXCCZHBBH-UHFFFAOYSA-N (2,5-dimethoxyphenyl)methyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound COC1=CC=C(OC)C(COC(=O)NC=2C=CC(OC=3C4=CC(OC)=C(OC)C=C4N=CN=3)=CC=2)=C1 CNWOUPXCCZHBBH-UHFFFAOYSA-N 0.000 description 1
- CZHWNVRUEXIOAN-UHFFFAOYSA-N (2,5-dimethoxyphenyl)methyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound COC1=CC=C(OC)C(COC(=O)NC=2C(=C(C)C(OC=3C4=CC(OC)=C(OC)C=C4N=CC=3)=CC=2)C)=C1 CZHWNVRUEXIOAN-UHFFFAOYSA-N 0.000 description 1
- REJJHMLWMGPSIQ-UHFFFAOYSA-N (2,5-dimethoxyphenyl)methyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamate Chemical compound COC1=CC=C(OC)C(COC(=O)NC=2C(=CC(OC=3C4=CC(OC)=C(OC)C=C4N=CC=3)=C(C)C=2)C)=C1 REJJHMLWMGPSIQ-UHFFFAOYSA-N 0.000 description 1
- AKXAWXNXGZTZSY-UHFFFAOYSA-N (2,5-dimethoxyphenyl)methyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamate Chemical compound COC1=CC=C(OC)C(COC(=O)NC=2C=CC(OC=3C4=CC(OC)=C(OC)C=C4N=CC=3)=CC=2)=C1 AKXAWXNXGZTZSY-UHFFFAOYSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- RRWXLUWLXXBVHL-UHFFFAOYSA-N (3,4-dimethoxyphenyl)methyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C1=C(OC)C(OC)=CC=C1COC(=O)NC(C(=C1)Cl)=CC=C1OC1=NC=NC2=CC(OC)=C(OC)C=C12 RRWXLUWLXXBVHL-UHFFFAOYSA-N 0.000 description 1
- ILOPWAIAXQAUPH-UHFFFAOYSA-N (3,4-dimethoxyphenyl)methyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C1=C(OC)C(OC)=CC=C1COC(=O)NC(C=C1)=CC=C1OC1=NC=NC2=CC(OC)=C(OC)C=C12 ILOPWAIAXQAUPH-UHFFFAOYSA-N 0.000 description 1
- WCYYZBFRISFFDR-UHFFFAOYSA-N (3,4-dimethoxyphenyl)methyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound C1=C(OC)C(OC)=CC=C1COC(=O)NC(C(=C1C)C)=CC=C1OC1=CC=NC2=CC(OC)=C(OC)C=C12 WCYYZBFRISFFDR-UHFFFAOYSA-N 0.000 description 1
- SGKWHYUVORQHPE-UHFFFAOYSA-N (3,4-dimethoxyphenyl)methyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamate Chemical compound C1=C(OC)C(OC)=CC=C1COC(=O)NC(C(=C1)C)=CC(C)=C1OC1=CC=NC2=CC(OC)=C(OC)C=C12 SGKWHYUVORQHPE-UHFFFAOYSA-N 0.000 description 1
- UTKAAINCXJMBIW-UHFFFAOYSA-N (3,4-dimethoxyphenyl)methyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamate Chemical compound C1=C(OC)C(OC)=CC=C1COC(=O)NC(C=C1)=CC=C1OC1=CC=NC2=CC(OC)=C(OC)C=C12 UTKAAINCXJMBIW-UHFFFAOYSA-N 0.000 description 1
- XHQBXBKVAGSNDV-UHFFFAOYSA-N (4-fluorophenyl)methyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1)=CC=C1NC(=O)OCC1=CC=C(F)C=C1 XHQBXBKVAGSNDV-UHFFFAOYSA-N 0.000 description 1
- XTBUZWKVVOSWGY-UHFFFAOYSA-N (4-fluorophenyl)methyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1C)C)=CC=C1NC(=O)OCC1=CC=C(F)C=C1 XTBUZWKVVOSWGY-UHFFFAOYSA-N 0.000 description 1
- FIZXLXXBCPKAIA-UHFFFAOYSA-N (4-fluorophenyl)methyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)C)=CC(C)=C1NC(=O)OCC1=CC=C(F)C=C1 FIZXLXXBCPKAIA-UHFFFAOYSA-N 0.000 description 1
- OJBGLNBXPHIPAY-UHFFFAOYSA-N (4-fluorophenyl)methyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(=O)OCC1=CC=C(F)C=C1 OJBGLNBXPHIPAY-UHFFFAOYSA-N 0.000 description 1
- JFAXJRJMFOACBO-UHFFFAOYSA-N (4-hydroxyphenyl) benzoate Chemical class C1=CC(O)=CC=C1OC(=O)C1=CC=CC=C1 JFAXJRJMFOACBO-UHFFFAOYSA-N 0.000 description 1
- BNSFSYCKCPJRBN-UHFFFAOYSA-N (4-methylphenyl)methyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1Cl)=CC=C1NC(=O)OCC1=CC=C(C)C=C1 BNSFSYCKCPJRBN-UHFFFAOYSA-N 0.000 description 1
- NBHKJJMTUBLCPW-UHFFFAOYSA-N (4-methylphenyl)methyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1)=CC=C1NC(=O)OCC1=CC=C(C)C=C1 NBHKJJMTUBLCPW-UHFFFAOYSA-N 0.000 description 1
- LOPKUSOPSFKKDU-UHFFFAOYSA-N (4-tert-butylphenyl)methyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1Cl)=CC=C1NC(=O)OCC1=CC=C(C(C)(C)C)C=C1 LOPKUSOPSFKKDU-UHFFFAOYSA-N 0.000 description 1
- RYJHIQNDHXDGLC-UHFFFAOYSA-N (4-tert-butylphenyl)methyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1)=CC=C1NC(=O)OCC1=CC=C(C(C)(C)C)C=C1 RYJHIQNDHXDGLC-UHFFFAOYSA-N 0.000 description 1
- SWRCRQDLMZHDKX-UHFFFAOYSA-N (4-tert-butylphenyl)methyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1C)C)=CC=C1NC(=O)OCC1=CC=C(C(C)(C)C)C=C1 SWRCRQDLMZHDKX-UHFFFAOYSA-N 0.000 description 1
- MMVKDSDRPBDCKF-UHFFFAOYSA-N (4-tert-butylphenyl)methyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)C)=CC(C)=C1NC(=O)OCC1=CC=C(C(C)(C)C)C=C1 MMVKDSDRPBDCKF-UHFFFAOYSA-N 0.000 description 1
- WJJYSHSMGROESF-UHFFFAOYSA-N (4-tert-butylphenyl)methyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(=O)OCC1=CC=C(C(C)(C)C)C=C1 WJJYSHSMGROESF-UHFFFAOYSA-N 0.000 description 1
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 description 1
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 description 1
- 125000006650 (C2-C4) alkynyl group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- SFSVWQFTASDEFA-UHFFFAOYSA-N 1-(2,4,5-trifluorophenyl)ethyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1Cl)=CC=C1NC(=O)OC(C)C1=CC(F)=C(F)C=C1F SFSVWQFTASDEFA-UHFFFAOYSA-N 0.000 description 1
- PEQJNFNQKUJCFC-UHFFFAOYSA-N 1-(2,4,5-trifluorophenyl)ethyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1)=CC=C1NC(=O)OC(C)C1=CC(F)=C(F)C=C1F PEQJNFNQKUJCFC-UHFFFAOYSA-N 0.000 description 1
- ZLJIXQZUQAMBBN-UHFFFAOYSA-N 1-(2,4,5-trifluorophenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1C)C)=CC=C1NC(=O)OC(C)C1=CC(F)=C(F)C=C1F ZLJIXQZUQAMBBN-UHFFFAOYSA-N 0.000 description 1
- SPOAGHBUINTXKP-UHFFFAOYSA-N 1-(2,4,5-trifluorophenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)C)=CC(C)=C1NC(=O)OC(C)C1=CC(F)=C(F)C=C1F SPOAGHBUINTXKP-UHFFFAOYSA-N 0.000 description 1
- DBTPKWLOFXQUFE-UHFFFAOYSA-N 1-(2,4,5-trifluorophenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(=O)OC(C)C1=CC(F)=C(F)C=C1F DBTPKWLOFXQUFE-UHFFFAOYSA-N 0.000 description 1
- HHDVZBNMTCQVPM-UHFFFAOYSA-N 1-(2-bromophenyl)ethyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1Cl)=CC=C1NC(=O)OC(C)C1=CC=CC=C1Br HHDVZBNMTCQVPM-UHFFFAOYSA-N 0.000 description 1
- UYCVVYPLYSMXOO-UHFFFAOYSA-N 1-(2-bromophenyl)ethyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1)=CC=C1NC(=O)OC(C)C1=CC=CC=C1Br UYCVVYPLYSMXOO-UHFFFAOYSA-N 0.000 description 1
- HEGMDDBICRNEGH-UHFFFAOYSA-N 1-(2-bromophenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1C)C)=CC=C1NC(=O)OC(C)C1=CC=CC=C1Br HEGMDDBICRNEGH-UHFFFAOYSA-N 0.000 description 1
- MMLDYPZGUSZMNN-UHFFFAOYSA-N 1-(2-bromophenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)C)=CC(C)=C1NC(=O)OC(C)C1=CC=CC=C1Br MMLDYPZGUSZMNN-UHFFFAOYSA-N 0.000 description 1
- KRBZTHYZCAXMRG-UHFFFAOYSA-N 1-(2-bromophenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(=O)OC(C)C1=CC=CC=C1Br KRBZTHYZCAXMRG-UHFFFAOYSA-N 0.000 description 1
- YPCHJZKHHOLURE-UHFFFAOYSA-N 1-(2-chlorophenyl)ethyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1Cl)=CC=C1NC(=O)OC(C)C1=CC=CC=C1Cl YPCHJZKHHOLURE-UHFFFAOYSA-N 0.000 description 1
- LHBQNHJFMNYBTG-UHFFFAOYSA-N 1-(2-chlorophenyl)ethyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1)=CC=C1NC(=O)OC(C)C1=CC=CC=C1Cl LHBQNHJFMNYBTG-UHFFFAOYSA-N 0.000 description 1
- SPGVTCZWPOQBIG-UHFFFAOYSA-N 1-(2-chlorophenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1C)C)=CC=C1NC(=O)OC(C)C1=CC=CC=C1Cl SPGVTCZWPOQBIG-UHFFFAOYSA-N 0.000 description 1
- WGQZNWHMFOLHSD-UHFFFAOYSA-N 1-(2-chlorophenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(=O)OC(C)C1=CC=CC=C1Cl WGQZNWHMFOLHSD-UHFFFAOYSA-N 0.000 description 1
- UTZCVEBPWWCEJJ-UHFFFAOYSA-N 1-(2-ethoxyphenyl)ethyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound CCOC1=CC=CC=C1C(C)OC(=O)NC(C(=C1)Cl)=CC=C1OC1=NC=NC2=CC(OC)=C(OC)C=C12 UTZCVEBPWWCEJJ-UHFFFAOYSA-N 0.000 description 1
- JTQMELWVZIZSFD-UHFFFAOYSA-N 1-(2-ethoxyphenyl)ethyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound CCOC1=CC=CC=C1C(C)OC(=O)NC(C=C1)=CC=C1OC1=NC=NC2=CC(OC)=C(OC)C=C12 JTQMELWVZIZSFD-UHFFFAOYSA-N 0.000 description 1
- ZQUDYYJSKCIOMI-UHFFFAOYSA-N 1-(2-ethoxyphenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound CCOC1=CC=CC=C1C(C)OC(=O)NC(C(=C1C)C)=CC=C1OC1=CC=NC2=CC(OC)=C(OC)C=C12 ZQUDYYJSKCIOMI-UHFFFAOYSA-N 0.000 description 1
- PURHUMJDYKRTTI-UHFFFAOYSA-N 1-(2-ethoxyphenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamate Chemical compound CCOC1=CC=CC=C1C(C)OC(=O)NC(C(=C1)C)=CC(C)=C1OC1=CC=NC2=CC(OC)=C(OC)C=C12 PURHUMJDYKRTTI-UHFFFAOYSA-N 0.000 description 1
- WZESNRLPIZXUCO-UHFFFAOYSA-N 1-(2-ethoxyphenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamate Chemical compound CCOC1=CC=CC=C1C(C)OC(=O)NC(C=C1)=CC=C1OC1=CC=NC2=CC(OC)=C(OC)C=C12 WZESNRLPIZXUCO-UHFFFAOYSA-N 0.000 description 1
- GTHZLCSCZCUXNU-UHFFFAOYSA-N 1-(2-fluorophenyl)ethyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1Cl)=CC=C1NC(=O)OC(C)C1=CC=CC=C1F GTHZLCSCZCUXNU-UHFFFAOYSA-N 0.000 description 1
- MDANXXLIIWWBHV-UHFFFAOYSA-N 1-(2-fluorophenyl)ethyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1)=CC=C1NC(=O)OC(C)C1=CC=CC=C1F MDANXXLIIWWBHV-UHFFFAOYSA-N 0.000 description 1
- VJHPKBCGXSJMPO-UHFFFAOYSA-N 1-(2-fluorophenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1C)C)=CC=C1NC(=O)OC(C)C1=CC=CC=C1F VJHPKBCGXSJMPO-UHFFFAOYSA-N 0.000 description 1
- ULBPHSCLRCVPDG-UHFFFAOYSA-N 1-(2-fluorophenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)C)=CC(C)=C1NC(=O)OC(C)C1=CC=CC=C1F ULBPHSCLRCVPDG-UHFFFAOYSA-N 0.000 description 1
- CPZUDWQOCAIGLP-UHFFFAOYSA-N 1-(2-fluorophenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(=O)OC(C)C1=CC=CC=C1F CPZUDWQOCAIGLP-UHFFFAOYSA-N 0.000 description 1
- CGHMXBHMOCHNOK-UHFFFAOYSA-N 1-(3-bromophenyl)ethyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1Cl)=CC=C1NC(=O)OC(C)C1=CC=CC(Br)=C1 CGHMXBHMOCHNOK-UHFFFAOYSA-N 0.000 description 1
- SQZBHCCLMIEEFZ-UHFFFAOYSA-N 1-(3-bromophenyl)ethyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1)=CC=C1NC(=O)OC(C)C1=CC=CC(Br)=C1 SQZBHCCLMIEEFZ-UHFFFAOYSA-N 0.000 description 1
- RFSPMSWRCYFVSF-UHFFFAOYSA-N 1-(3-bromophenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1C)C)=CC=C1NC(=O)OC(C)C1=CC=CC(Br)=C1 RFSPMSWRCYFVSF-UHFFFAOYSA-N 0.000 description 1
- DFXKJLYUNAJRKR-UHFFFAOYSA-N 1-(3-bromophenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)C)=CC(C)=C1NC(=O)OC(C)C1=CC=CC(Br)=C1 DFXKJLYUNAJRKR-UHFFFAOYSA-N 0.000 description 1
- QAQBADKYDQIXRJ-UHFFFAOYSA-N 1-(3-bromophenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(=O)OC(C)C1=CC=CC(Br)=C1 QAQBADKYDQIXRJ-UHFFFAOYSA-N 0.000 description 1
- KVHBBOSEVZULMH-UHFFFAOYSA-N 1-(3-chlorophenyl)ethyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1Cl)=CC=C1NC(=O)OC(C)C1=CC=CC(Cl)=C1 KVHBBOSEVZULMH-UHFFFAOYSA-N 0.000 description 1
- FXTZAMNSEDKWLJ-UHFFFAOYSA-N 1-(3-chlorophenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1C)C)=CC=C1NC(=O)OC(C)C1=CC=CC(Cl)=C1 FXTZAMNSEDKWLJ-UHFFFAOYSA-N 0.000 description 1
- JLKSIJKLWZOGSF-UHFFFAOYSA-N 1-(3-chlorophenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)C)=CC(C)=C1NC(=O)OC(C)C1=CC=CC(Cl)=C1 JLKSIJKLWZOGSF-UHFFFAOYSA-N 0.000 description 1
- ZQGUHYOKPGJESB-UHFFFAOYSA-N 1-(3-fluorophenyl)ethyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1Cl)=CC=C1NC(=O)OC(C)C1=CC=CC(F)=C1 ZQGUHYOKPGJESB-UHFFFAOYSA-N 0.000 description 1
- ACOQYHTUFHOXSZ-UHFFFAOYSA-N 1-(3-fluorophenyl)ethyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1)=CC=C1NC(=O)OC(C)C1=CC=CC(F)=C1 ACOQYHTUFHOXSZ-UHFFFAOYSA-N 0.000 description 1
- WQAYFJHJFJDELK-UHFFFAOYSA-N 1-(3-fluorophenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1C)C)=CC=C1NC(=O)OC(C)C1=CC=CC(F)=C1 WQAYFJHJFJDELK-UHFFFAOYSA-N 0.000 description 1
- NRLFFHSFQZKJNT-UHFFFAOYSA-N 1-(3-fluorophenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)C)=CC(C)=C1NC(=O)OC(C)C1=CC=CC(F)=C1 NRLFFHSFQZKJNT-UHFFFAOYSA-N 0.000 description 1
- COJDECIIQIBKOD-UHFFFAOYSA-N 1-(3-fluorophenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(=O)OC(C)C1=CC=CC(F)=C1 COJDECIIQIBKOD-UHFFFAOYSA-N 0.000 description 1
- DNXBCYPYCPXODC-UHFFFAOYSA-N 1-(3-methoxyphenyl)ethyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound COC1=CC=CC(C(C)OC(=O)NC=2C(=CC(OC=3C4=CC(OC)=C(OC)C=C4N=CN=3)=CC=2)Cl)=C1 DNXBCYPYCPXODC-UHFFFAOYSA-N 0.000 description 1
- KBYISOCKYQBYKS-UHFFFAOYSA-N 1-(3-methoxyphenyl)ethyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound COC1=CC=CC(C(C)OC(=O)NC=2C=CC(OC=3C4=CC(OC)=C(OC)C=C4N=CN=3)=CC=2)=C1 KBYISOCKYQBYKS-UHFFFAOYSA-N 0.000 description 1
- MXMBFHJCYSJZOH-UHFFFAOYSA-N 1-(3-methoxyphenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound COC1=CC=CC(C(C)OC(=O)NC=2C(=C(C)C(OC=3C4=CC(OC)=C(OC)C=C4N=CC=3)=CC=2)C)=C1 MXMBFHJCYSJZOH-UHFFFAOYSA-N 0.000 description 1
- QPDDPAMNOPJTCV-UHFFFAOYSA-N 1-(3-methoxyphenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamate Chemical compound COC1=CC=CC(C(C)OC(=O)NC=2C(=CC(OC=3C4=CC(OC)=C(OC)C=C4N=CC=3)=C(C)C=2)C)=C1 QPDDPAMNOPJTCV-UHFFFAOYSA-N 0.000 description 1
- LEIGRWGWNAIGKF-UHFFFAOYSA-N 1-(3-methoxyphenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamate Chemical compound COC1=CC=CC(C(C)OC(=O)NC=2C=CC(OC=3C4=CC(OC)=C(OC)C=C4N=CC=3)=CC=2)=C1 LEIGRWGWNAIGKF-UHFFFAOYSA-N 0.000 description 1
- LZGAQGQEHDZFCM-UHFFFAOYSA-N 1-(4-fluorophenyl)ethyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1Cl)=CC=C1NC(=O)OC(C)C1=CC=C(F)C=C1 LZGAQGQEHDZFCM-UHFFFAOYSA-N 0.000 description 1
- GYWGDLWEXKRMLS-UHFFFAOYSA-N 1-(4-fluorophenyl)ethyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1)=CC=C1NC(=O)OC(C)C1=CC=C(F)C=C1 GYWGDLWEXKRMLS-UHFFFAOYSA-N 0.000 description 1
- XREVWIWIIVWUOV-UHFFFAOYSA-N 1-(4-fluorophenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1C)C)=CC=C1NC(=O)OC(C)C1=CC=C(F)C=C1 XREVWIWIIVWUOV-UHFFFAOYSA-N 0.000 description 1
- RGVCOXURTLDGFN-UHFFFAOYSA-N 1-(4-fluorophenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)C)=CC(C)=C1NC(=O)OC(C)C1=CC=C(F)C=C1 RGVCOXURTLDGFN-UHFFFAOYSA-N 0.000 description 1
- QHHSIAOCTASYGA-UHFFFAOYSA-N 1-(4-fluorophenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(=O)OC(C)C1=CC=C(F)C=C1 QHHSIAOCTASYGA-UHFFFAOYSA-N 0.000 description 1
- LWNUAFYYTJKKSM-UHFFFAOYSA-N 1-(4-methoxyphenyl)ethyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C1=CC(OC)=CC=C1C(C)OC(=O)NC(C(=C1)Cl)=CC=C1OC1=NC=NC2=CC(OC)=C(OC)C=C12 LWNUAFYYTJKKSM-UHFFFAOYSA-N 0.000 description 1
- DJCIZPVEHSLQQN-UHFFFAOYSA-N 1-(4-methoxyphenyl)ethyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C1=CC(OC)=CC=C1C(C)OC(=O)NC(C=C1)=CC=C1OC1=NC=NC2=CC(OC)=C(OC)C=C12 DJCIZPVEHSLQQN-UHFFFAOYSA-N 0.000 description 1
- AJBCJENASKFXAX-UHFFFAOYSA-N 1-(4-methoxyphenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound C1=CC(OC)=CC=C1C(C)OC(=O)NC(C(=C1C)C)=CC=C1OC1=CC=NC2=CC(OC)=C(OC)C=C12 AJBCJENASKFXAX-UHFFFAOYSA-N 0.000 description 1
- ALYZINWBIXTZDP-UHFFFAOYSA-N 1-(4-methoxyphenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamate Chemical compound C1=CC(OC)=CC=C1C(C)OC(=O)NC(C(=C1)C)=CC(C)=C1OC1=CC=NC2=CC(OC)=C(OC)C=C12 ALYZINWBIXTZDP-UHFFFAOYSA-N 0.000 description 1
- NIUPLOCIVXBGTA-UHFFFAOYSA-N 1-(4-methoxyphenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamate Chemical compound C1=CC(OC)=CC=C1C(C)OC(=O)NC(C=C1)=CC=C1OC1=CC=NC2=CC(OC)=C(OC)C=C12 NIUPLOCIVXBGTA-UHFFFAOYSA-N 0.000 description 1
- NNIPAIFFUCAYSM-UHFFFAOYSA-N 1-(4-methylphenyl)ethyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1Cl)=CC=C1NC(=O)OC(C)C1=CC=C(C)C=C1 NNIPAIFFUCAYSM-UHFFFAOYSA-N 0.000 description 1
- QYJCMZUHPOGQGX-UHFFFAOYSA-N 1-(4-methylphenyl)ethyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1)=CC=C1NC(=O)OC(C)C1=CC=C(C)C=C1 QYJCMZUHPOGQGX-UHFFFAOYSA-N 0.000 description 1
- ACSRNRKVUWZPFU-UHFFFAOYSA-N 1-(4-methylphenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1C)C)=CC=C1NC(=O)OC(C)C1=CC=C(C)C=C1 ACSRNRKVUWZPFU-UHFFFAOYSA-N 0.000 description 1
- UIMVVASHMLQGLB-UHFFFAOYSA-N 1-(4-methylphenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)C)=CC(C)=C1NC(=O)OC(C)C1=CC=C(C)C=C1 UIMVVASHMLQGLB-UHFFFAOYSA-N 0.000 description 1
- NAECELDIABAPGH-UHFFFAOYSA-N 1-(4-methylphenyl)ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(=O)OC(C)C1=CC=C(C)C=C1 NAECELDIABAPGH-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- QQPKSKVJXXLPMB-UHFFFAOYSA-N 1-[3-(diethylamino)propyl]-1-[4-(6,7-dimethoxyquinazolin-4-yl)oxy-2-nitrophenyl]urea Chemical compound C1=C([N+]([O-])=O)C(N(C(N)=O)CCCN(CC)CC)=CC=C1OC1=NC=NC2=CC(OC)=C(OC)C=C12 QQPKSKVJXXLPMB-UHFFFAOYSA-N 0.000 description 1
- VAQCMSTUNSFTPW-UHFFFAOYSA-N 1-[3-(trifluoromethyl)phenyl]ethyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1Cl)=CC=C1NC(=O)OC(C)C1=CC=CC(C(F)(F)F)=C1 VAQCMSTUNSFTPW-UHFFFAOYSA-N 0.000 description 1
- VFZGQLMHCUZERP-UHFFFAOYSA-N 1-[3-(trifluoromethyl)phenyl]ethyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1)=CC=C1NC(=O)OC(C)C1=CC=CC(C(F)(F)F)=C1 VFZGQLMHCUZERP-UHFFFAOYSA-N 0.000 description 1
- VBKOHAASIQNYBB-UHFFFAOYSA-N 1-[3-(trifluoromethyl)phenyl]ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1C)C)=CC=C1NC(=O)OC(C)C1=CC=CC(C(F)(F)F)=C1 VBKOHAASIQNYBB-UHFFFAOYSA-N 0.000 description 1
- HQVAXIINXJQKRU-UHFFFAOYSA-N 1-[3-(trifluoromethyl)phenyl]ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)C)=CC(C)=C1NC(=O)OC(C)C1=CC=CC(C(F)(F)F)=C1 HQVAXIINXJQKRU-UHFFFAOYSA-N 0.000 description 1
- XFRSYFLJIIHAAW-UHFFFAOYSA-N 1-[3-(trifluoromethyl)phenyl]ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(=O)OC(C)C1=CC=CC(C(F)(F)F)=C1 XFRSYFLJIIHAAW-UHFFFAOYSA-N 0.000 description 1
- DAYFVANRMJHQGZ-UHFFFAOYSA-N 1-[4-(6,7-dimethoxyquinazolin-4-yl)oxy-2-nitrophenyl]-1-(3-piperidin-1-ylpropyl)urea Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1[N+]([O-])=O)=CC=C1N(C(N)=O)CCCN1CCCCC1 DAYFVANRMJHQGZ-UHFFFAOYSA-N 0.000 description 1
- XDXYPSMYEUUZFS-UHFFFAOYSA-N 1-[4-(6,7-dimethoxyquinazolin-4-yl)oxy-2-nitrophenyl]-1-(4-piperidin-1-ylbutyl)urea Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1[N+]([O-])=O)=CC=C1N(C(N)=O)CCCCN1CCCCC1 XDXYPSMYEUUZFS-UHFFFAOYSA-N 0.000 description 1
- KISPSQWFGJQUNI-UHFFFAOYSA-N 1-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]-1-(4-methylpiperazin-1-yl)urea Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1)=CC=C1N(C(N)=O)N1CCN(C)CC1 KISPSQWFGJQUNI-UHFFFAOYSA-N 0.000 description 1
- DMQYGLVSFZJRJX-UHFFFAOYSA-N 1-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-(4-methylpiperazin-1-yl)urea Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1N(C(N)=O)N1CCN(C)CC1 DMQYGLVSFZJRJX-UHFFFAOYSA-N 0.000 description 1
- IVJDRXRFNVXSAN-UHFFFAOYSA-N 1-[4-(diethylamino)butyl]-1-[4-(6,7-dimethoxyquinazolin-4-yl)oxy-2-nitrophenyl]urea Chemical compound C1=C([N+]([O-])=O)C(N(C(N)=O)CCCCN(CC)CC)=CC=C1OC1=NC=NC2=CC(OC)=C(OC)C=C12 IVJDRXRFNVXSAN-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- RCMXUPYDWURPHU-UHFFFAOYSA-N 2-[3-(trifluoromethyl)phenyl]ethyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1Cl)=CC=C1NC(=O)OCCC1=CC=CC(C(F)(F)F)=C1 RCMXUPYDWURPHU-UHFFFAOYSA-N 0.000 description 1
- ONUJCENRRQDFCG-UHFFFAOYSA-N 2-[3-(trifluoromethyl)phenyl]ethyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1)=CC=C1NC(=O)OCCC1=CC=CC(C(F)(F)F)=C1 ONUJCENRRQDFCG-UHFFFAOYSA-N 0.000 description 1
- ZFCABQQKSLROGP-UHFFFAOYSA-N 2-[3-(trifluoromethyl)phenyl]ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1C)C)=CC=C1NC(=O)OCCC1=CC=CC(C(F)(F)F)=C1 ZFCABQQKSLROGP-UHFFFAOYSA-N 0.000 description 1
- BGUQUEGXFHXYGN-UHFFFAOYSA-N 2-[3-(trifluoromethyl)phenyl]ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)C)=CC(C)=C1NC(=O)OCCC1=CC=CC(C(F)(F)F)=C1 BGUQUEGXFHXYGN-UHFFFAOYSA-N 0.000 description 1
- ODHUUFHFLQLPHL-UHFFFAOYSA-N 2-[3-(trifluoromethyl)phenyl]ethyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(=O)OCCC1=CC=CC(C(F)(F)F)=C1 ODHUUFHFLQLPHL-UHFFFAOYSA-N 0.000 description 1
- SCVJRXQHFJXZFZ-KVQBGUIXSA-N 2-amino-9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purine-6-thione Chemical class C1=2NC(N)=NC(=S)C=2N=CN1[C@H]1C[C@H](O)[C@@H](CO)O1 SCVJRXQHFJXZFZ-KVQBGUIXSA-N 0.000 description 1
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical class NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 1
- KDQPMQNHVQVVMR-UHFFFAOYSA-N 2-methyl-4-nitrophenol Chemical compound CC1=CC([N+]([O-])=O)=CC=C1O KDQPMQNHVQVVMR-UHFFFAOYSA-N 0.000 description 1
- IQUPABOKLQSFBK-UHFFFAOYSA-N 2-nitrophenol Chemical compound OC1=CC=CC=C1[N+]([O-])=O IQUPABOKLQSFBK-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- YOBWTSAFUDDPGP-UHFFFAOYSA-N 3-(2-chlorophenoxy)propyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1Cl)=CC=C1NC(=O)OCCCOC1=CC=CC=C1Cl YOBWTSAFUDDPGP-UHFFFAOYSA-N 0.000 description 1
- GEYYJKAGLHSOCQ-UHFFFAOYSA-N 3-(2-chlorophenoxy)propyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1)=CC=C1NC(=O)OCCCOC1=CC=CC=C1Cl GEYYJKAGLHSOCQ-UHFFFAOYSA-N 0.000 description 1
- TXXXWSYXMKLDKR-UHFFFAOYSA-N 3-(2-chlorophenoxy)propyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1C)C)=CC=C1NC(=O)OCCCOC1=CC=CC=C1Cl TXXXWSYXMKLDKR-UHFFFAOYSA-N 0.000 description 1
- ZVOGGFDQWJPXMJ-UHFFFAOYSA-N 3-(2-chlorophenoxy)propyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)C)=CC(C)=C1NC(=O)OCCCOC1=CC=CC=C1Cl ZVOGGFDQWJPXMJ-UHFFFAOYSA-N 0.000 description 1
- DNGWOKAVWAEFRA-UHFFFAOYSA-N 3-(2-chlorophenoxy)propyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(=O)OCCCOC1=CC=CC=C1Cl DNGWOKAVWAEFRA-UHFFFAOYSA-N 0.000 description 1
- KZBGLCHECXFWHR-UHFFFAOYSA-N 3-(3-methoxyphenoxy)propyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound COC1=CC=CC(OCCCOC(=O)NC=2C(=CC(OC=3C4=CC(OC)=C(OC)C=C4N=CN=3)=CC=2)Cl)=C1 KZBGLCHECXFWHR-UHFFFAOYSA-N 0.000 description 1
- GNFNQQDQZXMIIQ-UHFFFAOYSA-N 3-(3-methoxyphenoxy)propyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound COC1=CC=CC(OCCCOC(=O)NC=2C=CC(OC=3C4=CC(OC)=C(OC)C=C4N=CN=3)=CC=2)=C1 GNFNQQDQZXMIIQ-UHFFFAOYSA-N 0.000 description 1
- GMTMFRVOHFSVPM-UHFFFAOYSA-N 3-(3-methoxyphenoxy)propyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound COC1=CC=CC(OCCCOC(=O)NC=2C(=C(C)C(OC=3C4=CC(OC)=C(OC)C=C4N=CC=3)=CC=2)C)=C1 GMTMFRVOHFSVPM-UHFFFAOYSA-N 0.000 description 1
- LWMDODXPOMSJRH-UHFFFAOYSA-N 3-(3-methoxyphenoxy)propyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamate Chemical compound COC1=CC=CC(OCCCOC(=O)NC=2C(=CC(OC=3C4=CC(OC)=C(OC)C=C4N=CC=3)=C(C)C=2)C)=C1 LWMDODXPOMSJRH-UHFFFAOYSA-N 0.000 description 1
- MUWGKOKLAGSEAR-UHFFFAOYSA-N 3-(3-methoxyphenoxy)propyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamate Chemical compound COC1=CC=CC(OCCCOC(=O)NC=2C=CC(OC=3C4=CC(OC)=C(OC)C=C4N=CC=3)=CC=2)=C1 MUWGKOKLAGSEAR-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- OEANELZYRWTWLB-UHFFFAOYSA-N 3-(4-chloro-2-methylphenyl)sulfanylpropyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1Cl)=CC=C1NC(=O)OCCCSC1=CC=C(Cl)C=C1C OEANELZYRWTWLB-UHFFFAOYSA-N 0.000 description 1
- RBRVYDICQFLQJF-UHFFFAOYSA-N 3-(4-chloro-2-methylphenyl)sulfanylpropyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1)=CC=C1NC(=O)OCCCSC1=CC=C(Cl)C=C1C RBRVYDICQFLQJF-UHFFFAOYSA-N 0.000 description 1
- PEYJXRBTCMBWKQ-UHFFFAOYSA-N 3-(4-chloro-2-methylphenyl)sulfanylpropyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1C)C)=CC=C1NC(=O)OCCCSC1=CC=C(Cl)C=C1C PEYJXRBTCMBWKQ-UHFFFAOYSA-N 0.000 description 1
- OQUKIBOGIJFTMT-UHFFFAOYSA-N 3-(4-chloro-2-methylphenyl)sulfanylpropyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)C)=CC(C)=C1NC(=O)OCCCSC1=CC=C(Cl)C=C1C OQUKIBOGIJFTMT-UHFFFAOYSA-N 0.000 description 1
- DUOJUSGVPNCQLO-UHFFFAOYSA-N 3-(4-chloro-2-methylphenyl)sulfanylpropyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(=O)OCCCSC1=CC=C(Cl)C=C1C DUOJUSGVPNCQLO-UHFFFAOYSA-N 0.000 description 1
- INYUFAOZBPGIMI-UHFFFAOYSA-N 3-(4-chlorophenoxy)propyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1Cl)=CC=C1NC(=O)OCCCOC1=CC=C(Cl)C=C1 INYUFAOZBPGIMI-UHFFFAOYSA-N 0.000 description 1
- VOHLBVUTISUHII-UHFFFAOYSA-N 3-(4-chlorophenoxy)propyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1)=CC=C1NC(=O)OCCCOC1=CC=C(Cl)C=C1 VOHLBVUTISUHII-UHFFFAOYSA-N 0.000 description 1
- RZZFSYOINAQNGR-UHFFFAOYSA-N 3-(4-chlorophenoxy)propyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1C)C)=CC=C1NC(=O)OCCCOC1=CC=C(Cl)C=C1 RZZFSYOINAQNGR-UHFFFAOYSA-N 0.000 description 1
- XLQHXMALBOVGHE-UHFFFAOYSA-N 3-(4-chlorophenoxy)propyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)C)=CC(C)=C1NC(=O)OCCCOC1=CC=C(Cl)C=C1 XLQHXMALBOVGHE-UHFFFAOYSA-N 0.000 description 1
- IBSXPSNESPJYQL-UHFFFAOYSA-N 3-(4-chlorophenoxy)propyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(=O)OCCCOC1=CC=C(Cl)C=C1 IBSXPSNESPJYQL-UHFFFAOYSA-N 0.000 description 1
- MRKQNQKJVIHCIA-UHFFFAOYSA-N 3-(4-methoxyphenoxy)propyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C1=CC(OC)=CC=C1OCCCOC(=O)NC(C(=C1)Cl)=CC=C1OC1=NC=NC2=CC(OC)=C(OC)C=C12 MRKQNQKJVIHCIA-UHFFFAOYSA-N 0.000 description 1
- NIJPHIBDLMTORT-UHFFFAOYSA-N 3-(4-methoxyphenoxy)propyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C1=CC(OC)=CC=C1OCCCOC(=O)NC(C=C1)=CC=C1OC1=NC=NC2=CC(OC)=C(OC)C=C12 NIJPHIBDLMTORT-UHFFFAOYSA-N 0.000 description 1
- UHFXMHJLBNCSBG-UHFFFAOYSA-N 3-(4-methoxyphenoxy)propyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound C1=CC(OC)=CC=C1OCCCOC(=O)NC(C(=C1C)C)=CC=C1OC1=CC=NC2=CC(OC)=C(OC)C=C12 UHFXMHJLBNCSBG-UHFFFAOYSA-N 0.000 description 1
- GTMFYFYSHCDKOM-UHFFFAOYSA-N 3-(4-methoxyphenoxy)propyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamate Chemical compound C1=CC(OC)=CC=C1OCCCOC(=O)NC(C(=C1)C)=CC(C)=C1OC1=CC=NC2=CC(OC)=C(OC)C=C12 GTMFYFYSHCDKOM-UHFFFAOYSA-N 0.000 description 1
- BUBWMAYWDDVUAA-UHFFFAOYSA-N 3-(4-methoxyphenoxy)propyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamate Chemical compound C1=CC(OC)=CC=C1OCCCOC(=O)NC(C=C1)=CC=C1OC1=CC=NC2=CC(OC)=C(OC)C=C12 BUBWMAYWDDVUAA-UHFFFAOYSA-N 0.000 description 1
- AQPKYGHIYHIVBS-UHFFFAOYSA-N 3-(4-methylphenyl)sulfanylpropyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1Cl)=CC=C1NC(=O)OCCCSC1=CC=C(C)C=C1 AQPKYGHIYHIVBS-UHFFFAOYSA-N 0.000 description 1
- LHPLZOBUPFTJOP-UHFFFAOYSA-N 3-(4-methylphenyl)sulfanylpropyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1C)C)=CC=C1NC(=O)OCCCSC1=CC=C(C)C=C1 LHPLZOBUPFTJOP-UHFFFAOYSA-N 0.000 description 1
- GJUFYFNBQROHIO-UHFFFAOYSA-N 3-(4-tert-butylphenyl)sulfanylpropyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1Cl)=CC=C1NC(=O)OCCCSC1=CC=C(C(C)(C)C)C=C1 GJUFYFNBQROHIO-UHFFFAOYSA-N 0.000 description 1
- HETZNMHKESTNNR-UHFFFAOYSA-N 3-(4-tert-butylphenyl)sulfanylpropyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1)=CC=C1NC(=O)OCCCSC1=CC=C(C(C)(C)C)C=C1 HETZNMHKESTNNR-UHFFFAOYSA-N 0.000 description 1
- JAJRGTYNKLIMIA-UHFFFAOYSA-N 3-(4-tert-butylphenyl)sulfanylpropyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1C)C)=CC=C1NC(=O)OCCCSC1=CC=C(C(C)(C)C)C=C1 JAJRGTYNKLIMIA-UHFFFAOYSA-N 0.000 description 1
- DEKXYHDCAWJXHA-UHFFFAOYSA-N 3-(4-tert-butylphenyl)sulfanylpropyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)C)=CC(C)=C1NC(=O)OCCCSC1=CC=C(C(C)(C)C)C=C1 DEKXYHDCAWJXHA-UHFFFAOYSA-N 0.000 description 1
- IEAOAODKTCEQLH-UHFFFAOYSA-N 3-(4-tert-butylphenyl)sulfanylpropyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(=O)OCCCSC1=CC=C(C(C)(C)C)C=C1 IEAOAODKTCEQLH-UHFFFAOYSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- DCFZOECVVBSZLL-UHFFFAOYSA-N 3-chloro-4-(6,7-dimethoxyquinolin-4-yl)oxyaniline Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC1=CC=C(N)C=C1Cl DCFZOECVVBSZLL-UHFFFAOYSA-N 0.000 description 1
- MHRMSZPCHBTAJN-UHFFFAOYSA-N 4-(2-fluoro-4-nitrophenoxy)-6,7-dimethoxyquinoline Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC1=CC=C([N+]([O-])=O)C=C1F MHRMSZPCHBTAJN-UHFFFAOYSA-N 0.000 description 1
- PARAYNGFAURGJR-UHFFFAOYSA-N 4-(3-fluoro-4-nitrophenoxy)-6,7-dimethoxyquinoline Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC1=CC=C([N+]([O-])=O)C(F)=C1 PARAYNGFAURGJR-UHFFFAOYSA-N 0.000 description 1
- SJGLGHAKDFYLAW-UHFFFAOYSA-N 4-(6,7-dimethoxyquinazolin-4-yl)oxy-2-methoxyaniline Chemical compound C1=C(N)C(OC)=CC(OC=2C3=CC(OC)=C(OC)C=C3N=CN=2)=C1 SJGLGHAKDFYLAW-UHFFFAOYSA-N 0.000 description 1
- VUXAIUWBZFDCNG-UHFFFAOYSA-N 4-(6,7-dimethoxyquinazolin-4-yl)oxy-2-nitroaniline Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC1=CC=C(N)C([N+]([O-])=O)=C1 VUXAIUWBZFDCNG-UHFFFAOYSA-N 0.000 description 1
- SIDZXXQYQLBOHZ-UHFFFAOYSA-N 4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluoroaniline Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC1=CC=C(N)C=C1F SIDZXXQYQLBOHZ-UHFFFAOYSA-N 0.000 description 1
- UOZCXYMRQHMNRC-UHFFFAOYSA-N 4-(6,7-dimethoxyquinolin-4-yl)oxy-3-methylaniline Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC1=CC=C(N)C=C1C UOZCXYMRQHMNRC-UHFFFAOYSA-N 0.000 description 1
- RFJVQGMBFQGZPV-UHFFFAOYSA-N 4-amino-3-chlorophenol;hydrochloride Chemical compound Cl.NC1=CC=C(O)C=C1Cl RFJVQGMBFQGZPV-UHFFFAOYSA-N 0.000 description 1
- IQXUIDYRTHQTET-UHFFFAOYSA-N 4-amino-3-nitrophenol Chemical compound NC1=CC=C(O)C=C1[N+]([O-])=O IQXUIDYRTHQTET-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- WRVHQEYBCDPZEU-UHFFFAOYSA-N 4-chloro-6,7-dimethoxyquinoline Chemical compound C1=CC(Cl)=C2C=C(OC)C(OC)=CC2=N1 WRVHQEYBCDPZEU-UHFFFAOYSA-N 0.000 description 1
- GVRRXASZZAKBMN-UHFFFAOYSA-N 4-chloroquinazoline Chemical class C1=CC=C2C(Cl)=NC=NC2=C1 GVRRXASZZAKBMN-UHFFFAOYSA-N 0.000 description 1
- BXAVKNRWVKUTLY-UHFFFAOYSA-N 4-sulfanylphenol Chemical class OC1=CC=C(S)C=C1 BXAVKNRWVKUTLY-UHFFFAOYSA-N 0.000 description 1
- ORPHLVJBJOCHBR-UHFFFAOYSA-N 403-19-0 Chemical compound OC1=CC=C([N+]([O-])=O)C=C1F ORPHLVJBJOCHBR-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 201000000057 Coronary Stenosis Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- ZTRNUPKKYYVGTB-UHFFFAOYSA-N [2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamic acid Chemical compound COC1=C(C=C2C(=C1)C(=NC=N2)OC3=CC(=C(C=C3)NC(=O)O)Cl)OC ZTRNUPKKYYVGTB-UHFFFAOYSA-N 0.000 description 1
- LRGJFBGQFBSGLG-UHFFFAOYSA-N [4-(trifluoromethyl)phenyl]methyl n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1Cl)=CC=C1NC(=O)OCC1=CC=C(C(F)(F)F)C=C1 LRGJFBGQFBSGLG-UHFFFAOYSA-N 0.000 description 1
- BACDWWUGIWKDST-UHFFFAOYSA-N [4-(trifluoromethyl)phenyl]methyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1)=CC=C1NC(=O)OCC1=CC=C(C(F)(F)F)C=C1 BACDWWUGIWKDST-UHFFFAOYSA-N 0.000 description 1
- FKQRHKADEOOXFV-UHFFFAOYSA-N [4-(trifluoromethyl)phenyl]methyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1C)C)=CC=C1NC(=O)OCC1=CC=C(C(F)(F)F)C=C1 FKQRHKADEOOXFV-UHFFFAOYSA-N 0.000 description 1
- KVYTZACAJJVIPZ-UHFFFAOYSA-N [4-(trifluoromethyl)phenyl]methyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)C)=CC(C)=C1NC(=O)OCC1=CC=C(C(F)(F)F)C=C1 KVYTZACAJJVIPZ-UHFFFAOYSA-N 0.000 description 1
- XTMYPNIGQKCAJV-UHFFFAOYSA-N [4-(trifluoromethyl)phenyl]methyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(=O)OCC1=CC=C(C(F)(F)F)C=C1 XTMYPNIGQKCAJV-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 150000005303 alkyl halide derivatives Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000007887 coronary angioplasty Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 125000005980 hexynyl group Chemical group 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical class C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- PNTFRMMTNCZHKL-UHFFFAOYSA-N o-[(4-methylphenyl)methyl] n-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamothioate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1Cl)=CC=C1NC(=S)OCC1=CC=C(C)C=C1 PNTFRMMTNCZHKL-UHFFFAOYSA-N 0.000 description 1
- OCKCTGPFGPTFSC-UHFFFAOYSA-N o-[(4-methylphenyl)methyl] n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamothioate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1)=CC=C1NC(=S)OCC1=CC=C(C)C=C1 OCKCTGPFGPTFSC-UHFFFAOYSA-N 0.000 description 1
- QBLUHCLZXKHLKT-UHFFFAOYSA-N o-[(4-methylphenyl)methyl] n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3-dimethylphenyl]carbamothioate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1C)C)=CC=C1NC(=S)OCC1=CC=C(C)C=C1 QBLUHCLZXKHLKT-UHFFFAOYSA-N 0.000 description 1
- DXBNPYRUYPHYPE-UHFFFAOYSA-N o-[(4-methylphenyl)methyl] n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamothioate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)C)=CC(C)=C1NC(=S)OCC1=CC=C(C)C=C1 DXBNPYRUYPHYPE-UHFFFAOYSA-N 0.000 description 1
- KBTAMZGQUPKZPA-UHFFFAOYSA-N o-[(4-methylphenyl)methyl] n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamothioate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(=S)OCC1=CC=C(C)C=C1 KBTAMZGQUPKZPA-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 125000005981 pentynyl group Chemical group 0.000 description 1
- 230000010118 platelet activation Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920001289 polyvinyl ether Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- XYYXTCFEEYIHSA-UHFFFAOYSA-N propyl n-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]carbamate Chemical compound C1=CC(NC(=O)OCCC)=CC=C1OC1=NC=NC2=CC(OC)=C(OC)C=C12 XYYXTCFEEYIHSA-UHFFFAOYSA-N 0.000 description 1
- XUVZIJIVURUOPF-UHFFFAOYSA-N propyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-dimethylphenyl]carbamate Chemical compound C1=C(C)C(NC(=O)OCCC)=CC(C)=C1OC1=CC=NC2=CC(OC)=C(OC)C=C12 XUVZIJIVURUOPF-UHFFFAOYSA-N 0.000 description 1
- YKUBDZIUULYNAT-UHFFFAOYSA-N propyl n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]carbamate Chemical compound C1=CC(NC(=O)OCCC)=CC=C1OC1=CC=NC2=CC(OC)=C(OC)C=C12 YKUBDZIUULYNAT-UHFFFAOYSA-N 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 150000007660 quinolones Chemical class 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- ZWZVWGITAAIFPS-UHFFFAOYSA-N thiophosgene Chemical compound ClC(Cl)=S ZWZVWGITAAIFPS-UHFFFAOYSA-N 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 125000006168 tricyclic group Chemical group 0.000 description 1
- 210000004026 tunica intima Anatomy 0.000 description 1
- 210000004231 tunica media Anatomy 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Definitions
- the present invention relates to quinoline derivatives and quinazoline derivatives and more particularly to quinoline derivatives and quinazoline derivatives that can be used in the treatment of diseases associated with the autophosphorylation of a PDGF receptor and particularly can inhibit angiostenosis.
- PTCA percutaneous transluminal coronary angioplasty
- vascular smooth muscular cells or fibroblasts of the vascular outer membrane are activated, for example, by platelet activation caused by the tear of vascular tunica intima or media, extension stimulation, and vascular endothelial cell injury at the time of catheter therapy and consequently migrate and proliferate and excessively accumulate at injured vascular sites.
- vascular smooth muscle cells or fibroblasts activation factors have hitherto been assumed as the vascular smooth muscle cells or fibroblasts activation factors.
- PDGF platelet-derived growth factor
- PDGF-R PDGF receptor autophosphorylation inhibitory compounds
- VEGF receptor autophosphorylation inhibitory compounds which have been reported, however, the selectivity for VEGF receptors (such as KDR) and c-kit (SCF receptors) belonging to the PDGF receptor family has not been discussed.
- VEGF is one of major growth factors of vascular endothelial cells (EC), and VEGF receptor inhibitory compounds possibly inhibit the regeneration of EC in injured blood vessels to promote the formation of thrombus and to accelerate angiostenosis.
- EC vascular endothelial cells
- SCF is a growth factor involved in the upstream of hematopoietic system and the movement of intestinal tracts, and substances that inhibit receptors of SCF possibly induce hematopoietic failure and intestinal tract movement failure.
- the present inventors have now found out compounds having PDGF receptor autophosphorylation inhibitory activity.
- the present inventors have also found out compounds inhibiting angiostenosis in rat carotid balloon injury models and porcine coronary balloon injury models.
- the present inventors have further found out compounds having potent PDGF receptor autophosphorylation inhibitory activity and having low VEGF receptor autophosphorylation inhibitory activity.
- the present inventors have further found out compounds having PDGF receptor autophosphorylation inhibitory activity and having low c-kit autophosphorylation inhibitory activity.
- An object of the present invention is to provide compounds that can be used in the treatment of diseases mediated by the autophosphorylation of PDGF receptors, particularly compounds having inhibitory activity against angiostenosis.
- Another object of the present invention is to provide compounds that can be used in the treatment of diseases mediated by the autophosphorylation of PDGF receptors and have a low level of side effects attributable to c-kit autophosphorylation inhibitory activity.
- X and Z which may be the same or different, represent CH or N;
- R 1 and R 2 which may be the same or different, represent a hydrogen atom or C 1-4 alkoxy optionally substituted by a halogen atom;
- R 3 , R 4 , R 5 , and R 6 which may be the same or different, represent a hydrogen atom; a halogen atom; C 1-4 alkyl optionally substituted by a halogen atom; C 1-4 alkoxy optionally substituted by a halogen atom; nitro; amino; or morpholyl;
- A represents a group selected from the group consisting of formulae (i) to (x), wherein R 11 and R 12 , which may be the same or different, represent a hydrogen atom, C 1-4 alkyl optionally substituted by a halogen atom, or C 1-4 alkylcarbonyl optionally substituted by a halogen atom;
- R 3 , R 4 , R 1 and R 6 represent a hydrogen atom and A represents group (v) wherein u is 0 (zero) and R 19 represents phenyl optionally substituted by a halogen atom, C 1-4 alkyl, or C 1-4 alkoxy are excluded: wherein
- i is an integer of 0 to 10
- R 13 and R 14 which may be the same or different, represent a hydrogen atom; C 1-6 alkyl optionally substituted by a halogen atom; or phenyl optionally substituted by a halogen atom or C 1-4 alkyl optionally substituted by a halogen atom,
- R 13 and R 14 may form a five- to seven-membered saturated or unsaturated heterocyclic ring optionally containing one or more additional hetero-atoms together with the nitrogen atom to which they are attached, and this heterocyclic ring is optionally substituted by a halogen atom or C 1-4 alkyl optionally substituted by a halogen atom, or, R 13 or R 14 may form C 1-4 alkylene optionally substituted by a halogen atom together with R 12 ; wherein
- j is an integer of 0 to 3
- k is an integer of 0 to 3, provided that
- n is an integer of 0 to 2
- carbon atoms in the following are optionally substituted by one or more C 1-4 alkyl groups, which may be the same or different, optionally substituted by a halogen atom, and
- R 15 represents a hydrogen atom; cyclic C 3-7 alkyl optionally substituted by a halogen atom; phenyl optionally substituted by C 1-6 alkyl or a halogen atom; or C 1-4 alkoxycarbonyl; wherein
- n 0 (zero) or 1
- p is an integer of 0 to 10
- R 16 and R 17 which may be the same or different, represent a hydrogen atom; C 1-6 alkyl optionally substituted by a halogen atom; C 1-4 alkylcarbonyl optionally substituted by a halogen atom; cyclic C 3-7 alkyl optionally substituted by C 1-4 alkyl optionally substituted by a halogen atom; or phenyl optionally substituted by a halogen atom or C 1-4 alkyl optionally substituted by a halogen atom, or
- R 16 and R 17 may form a five- to seven-membered saturated or unsaturated heterocyclic ring optionally containing one or more additional hetero-atoms together with the nitrogen atom to which they are attached, this heterocyclic ring is optionally condensed with another one or two carbocyclic or heterocyclic ring to form a ten- to twelve-membered saturated or unsaturated bicyclic carbocyclic ring or heterocyclic ring or a ten- to fifteen-membered saturated or unsaturated tricyclic carbocyclic ring or heterocyclic ring, and these heterocyclic rings are optionally substituted by an oxygen atom or C 1-4 alkyl optionally substituted by a halogen atom; wherein
- r is an integer of 0 to 3
- s is an integer of 0 to 3, provided that
- t is an integer of 0 to 2
- carbon atoms in the following are optionally substituted by one or more C 1-4 alkyl groups, which may be the same or different, and
- R 18 represents a hydrogen atom; phenyl optionally substituted by a halogen atom or C 1-6 alkyl optionally substituted by a halogen atom; or C 1-4 alkoxycarbonyl optionally substituted by a halogen atom; wherein
- u 0 (zero) or 1
- R 19 represents
- phenyl which is optionally substituted by C 1-10 alkyl optionally substituted by a halogen atom; C 1-10 alkoxy optionally substituted by a halogen atom; —NR 31 R 32 wherein R 31 and R 32 , which may be the same or different, represent a hydrogen atom or C 1-4 alkyl optionally substituted by a halogen atom; phenyl optionally substituted by a halogen atom; a halogen atom; or cyano,
- cyclic C 3-7 alkyl which is optionally condensed with another carbocyclic ring or heterocyclic ring to form an eight- to twelve-membered bicyclic saturated or unsaturated carbocyclic ring or heterocyclic ring and the carbocyclic ring and the heterocyclic ring are optionally substituted by C 1-4 alkyl optionally substituted by a halogen atom; phenyl optionally substituted by a halogen atom; cyclic C 3-7 alkyl optionally substituted by a halogen atom; or a halogen atom,
- C 1-16 alkyl, (6) C 2-6 alkenyl, and (7) C 2-6 alkynyl are optionally substituted by one or more of the following groups:
- cyclic C 3-7 alkyl which is optionally condensed with another carbocyclic ring or heterocyclic ring to form an eight- to twelve-membered bicyclic saturated or unsaturated carbocyclic ring or heterocyclic ring and the carbocyclic ring and the heterocyclic ring are optionally substituted by C 1-4 alkyl optionally substituted by a halogen atom; phenyl optionally substituted by a halogen atom; or a halogen atom,
- R 20 represents
- cyclic C 3-7 alkyl which is optionally condensed with another carbocyclic ring or heterocyclic ring to form an eight- to twelve-membered bicyclic saturated or unsaturated carbocyclic ring or heterocyclic ring and the carbocyclic ring and the heterocyclic ring are optionally substituted by C 1-4 alkyl optionally substituted by a halogen atom, or a halogen atom,
- C 1-20 alkyl, (5) C 2-6 alkenyl, and (6) C 2-6 alkynyl are optionally substituted by one or more of the following groups:
- cyclic C 3-7 alkyl which is optionally condensed with another carbocyclic ring or heterocyclic ring to form an eight- to twelve-membered bicyclic saturated or unsaturated carbocyclic ring or heterocyclic ring and the carbocyclic ring and the heterocyclic ring are optionally substituted by C 1-4 alkyl optionally substituted by a halogen atom, or a halogen atom,
- v is an integer of 0 to 2
- R 21 represents
- cyclic C 3-7 alkyl which is optionally condensed with another carbocyclic ring or heterocyclic ring to form an eight- to twelve-membered bicyclic saturated or unsaturated carbocyclic ring or heterocyclic ring and the carbocyclic ring and the heterocyclic ring are optionally substituted by C 1-4 alkyl optionally substituted by a halogen atom, or a halogen atom,
- C 1-20 alkyl, (5) C 2-6 alkenyl, and (6) C 2-6 alkynyl are optionally substituted by one or more of the following groups:
- cyclic C 3-7 alkyl which is optionally condensed with another carbocyclic ring or heterocyclic ring to form an eight- to twelve-membered bicyclic saturated or unsaturated carbocyclic ring or heterocyclic ring and the carbocyclic ring and the heterocyclic ring are optionally substituted by C 1-4 alkyl optionally substituted by a halogen atom, or a halogen atom,
- w is an integer of 1 to 4,
- L represents —O—, —S( ⁇ O)y-, wherein y is an integer of 0 to 2, or —N(—R 11 )—,
- M represents —O—, —C( ⁇ O)—O—, —S( ⁇ O)z-, wherein z is an integer of 0 to 2, —N(—R 12 )—, —C( ⁇ O)—N(—R 12 )—, or —C( ⁇ O)—,
- R 22 represents a hydrogen atom; C 1-4 alkyl optionally substituted by a halogen atom; or phenyl optionally substituted by C 1-4 alkyl optionally substituted by a halogen atom, C 1-4 alkoxy optionally substituted by a halogen atom, nitro, amino, or a halogen atom,
- R 22 and R 12 may form a five- to seven-membered saturated or unsaturated heterocyclic ring optionally containing one or more additional hetero-atoms together with the nitrogen atom to which they are attached, this heterocyclic ring is optionally condensed with another carbocyclic ring or heterocyclic ring to form a ten- to twelve-membered bicyclic saturated or unsaturated heterocyclic ring, and these heterocyclic rings are optionally substituted by C 1-4 alkyl optionally substituted by a halogen atom; phenyl; benzyl; or piperidine; —OR 23 (ix) wherein R 23 represents a hydrogen atom or C 1-4 alkyl optionally substituted by a halogen atom; and —NR 24 R 25 (x) wherein R 24 and R 25 , which may be the same or different, represent a hydrogen atom or C 1-4
- the compounds according to the present invention are useful for the treatment of diseases mediated by the autophosphorylation of PDGF receptors.
- alkyl alkoxy
- alkenyl alkynyl
- C 1-6 alkyl is preferably C 1-4 alkyl.
- C 1-10 alkyl is preferably C 1-8 alkyl.
- C 1-16 alkyl is preferably C 1-13 alkyl.
- C 1-20 alkyl is preferably C 1-18 alkyl.
- C 1-6 alkoxy is preferably C 1-4 alkoxy.
- C 1-10 alkoxy is preferably C 1-8 alkoxy.
- C 2-6 alkenyl is preferably C 2-4 alkenyl.
- C 2-6 alkynyl is preferably C 2-4 alkynyl.
- C 1-6 alkyl examples include methyl, ethyl, n-propyl, isopropyl, n-butyl, i-butyl, s-butyl, t-butyl, n-pentyl, and n-hexyl.
- C 1-6 alkoxy examples include methoxy, ethoxy, n-propoxy, i-propoxy, n-butoxy, i-butoxy, s-butoxy, and t-butoxy.
- C 2-6 alkenyl examples include allyl, butenyl, pentenyl, and hexenyl.
- C 2-6 alkynyl examples include 2-propynyl, butynyl, pentynyl, and hexynyl.
- alkyl optionally substituted by means alkyl, of which one or more hydrogen atoms are substituted by one or more substituents which may be the same or different, or unsubstituted alkyl. It will be understood by a person skilled in the art that the maximum number of the substituents can be determined depending upon the number of substitutable hydrogen atoms on the alkyl group. This will apply to groups having substituents other than alkyl.
- halogen atom as used herein means a fluorine, chlorine, bromine, or iodine atom.
- the saturated or unsaturated five- to seven-membered heterocyclic ring contains one or more hetero-atoms selected from oxygen, nitrogen, and sulfur atoms.
- Examples of the saturated or unsaturated five- to seven-membered heterocyclic group include pyridyl, piperidino, piperazino, morpholino, imidazolyl, triazolyl, tetrazolyl, oxazolyl, thiazolyl, pyrrolidinyl, and pyrazolyl.
- the five- to seven-membered saturated or unsaturated heterocyclic group may be condensed with another saturated or unsaturated carbocyclic ring or heterocyclic ring to form a ten- to twelve-membered bicyclic ring or a ten- to fifteen-membered tricyclic ring.
- Condensed bicyclic groups include indanyl, quinolyl, and quinazolinyl.
- Condensed tricyclic groups include phenythiazyl, phenoxazyl, and dihydrodibenzoazepinyl.
- Cyclic C 3-7 alkyl may be condensed with another saturated or unsaturated carbocyclic ring or heterocyclic ring to form an eight- to twelve-membered bicyclic saturated or unsaturated carbocyclic ring or heterocyclic ring.
- Condensed bicyclic groups include indanyl, quinolyl, and quinazolinyl.
- i is preferably an integer of 0 to 4, more preferably 1 to 3.
- R 13 and R 14 which may be the same or different, represent C 1-4 alkyl or may form a five- to seven-membered saturated heterocyclic ring optionally substituted by C 1-4 alkyl together with the nitrogen atom, to which they are attached.
- j is preferably an integer of 1 or 2.
- k is preferably an integer of 1 or 2.
- m is preferably an integer of 1 or 2.
- An example of preferred group (ii) is a group wherein j is 1 or 2, k is 1 or 2, m is 1 or 2, and R 15 represents optionally substituted phenyl.
- p is preferably an integer of 0 to 3.
- An example of preferred group (iii) is a group wherein n is 0 (zero), p is an integer of 1 to 3, and R 16 and R 17 , which may be the same or different, represent C 1-4 alkyl or may form a five- to seven-membered saturated heterocyclic ring optionally substituted by C 1-4 alkyl or an oxygen atom together with the nitrogen atom, to which they are attached.
- Another example of preferred group (iii) is a group wherein n is 1 and p is 0 (zero).
- r is preferably an integer of 1 or 2.
- s is preferably an integer of 1 or 2.
- t is preferably an integer of 0 or 1.
- An example of preferred group (iv) is a group wherein q is 0 (zero), r is 1 or 2, s is 1 or 2, t is 1 or 2, and R 18 represents optionally substituted phenyl.
- the phenyl and phenoxy groups presented by R 19 are optionally substituted by C 6-10 alkyl or C 6-10 alkoxy, preferably C 6-8 alkyl or C 6-8 alkoxy.
- the alkyl, alkenyl, and alkynyl groups presented by R 19 are optionally substituted by phenyl, phenoxy, or phenylthio, and this phenyl, phenoxy, or phenylthio group is optionally substituted by C 6-10 alkyl or C 6-10 alkoxy, preferably C 6-8 alkyl or C 6-8 alkoxy.
- An example of preferred group (v) is a group wherein u is 1 and R 19 represents C 1-4 alkyl substituted by optionally substituted phenyl.
- An example of preferred group (vi) is a group wherein R 20 represents optionally substituted phenyl or C 1-6 alkyl optionally substituted by optionally substituted phenyl.
- w is preferably an integer of 1 to 3.
- M represents —O—, preferably, M represents —O—, —C( ⁇ O)—O—, —N(—R 12 )—, —C( ⁇ O)—N(—R 12 )—, or —C( ⁇ O)—.
- L represents —S( ⁇ O)y-, preferably, M represents —O—.
- L represents —N(—R 11 )—, preferably, M represents —O—.
- An example of preferred group (viii) is a group wherein w is an integer of 1 to 3, L represents —O—, M represents —O— or —C( ⁇ O)—O—, and R 22 represents optionally substituted phenyl.
- Examples of preferred compounds represented by formula (I) according to the present invention include the following compounds:
- R 1 and R 2 represent C 1-4 alkoxy and at least one of R 3 , R 4 , R 5 and R 6 represents a group other than a hydrogen atom;
- R 1 and R 2 represent C 1-4 alkoxy
- R 3 represents a group other than a hydrogen atom
- R 4 , R 5 , and R 6 represent a hydrogen atom
- R 1 and R 2 represent C 1-4 alkoxy
- A represents group (i), wherein i is an integer of 1 to 3
- R 13 and R 14 which may be the same or different, represent C 1-4 alkyl or may form a five- to seven-membered saturated heterocyclic ring optionally substituted by C 1-4 alkyl together with the nitrogen atom, to which they are attached and, more preferably, X represents CH or N and Z represents CH;
- R 1 and R 2 represent C 1-4 alkoxy
- R 3 , R 4 , R 5 and R 6 represent a hydrogen atom
- A represents group (i), wherein i is an integer of 1 to 3
- R 13 and R 14 which may be the same or different, represent C 1-4 alkyl or may form a five- to seven-membered saturated heterocyclic ring optionally substituted by C 1-4 alkyl together with the nitrogen atom to which they are attached and, more preferably, X represents CH or N and Z represents CH;
- R 1 and R 2 represent C 1-4 alkoxy
- R 3 represents a group other than a hydrogen atom
- R 4 , R 5 and R 6 represent a hydrogen atom
- A represents group (i) wherein i is an integer of 1 to 3
- R 13 and R 14 which may be the same or different, represent C 1-4 alkyl or may form a five- to seven-membered saturated heterocyclic ring optionally substituted by C 1-4 alkyl together with the nitrogen atom, to which they are attached, and, more preferably, X represents CH or N and Z represents CH;
- R 1 and R 2 represent C 1-4 alkoxy
- R 3 represents nitro
- R 4 , R 5 , and R 6 represent a hydrogen atom
- A represents group (i) wherein i is an integer of 1 to 3
- R 13 and R 14 which may be the same or different, represent C 1-4 alkyl or may form a five- to seven-membered saturated heterocyclic ring optionally substituted by C 1-4 alkyl together with the nitrogen atom, to which they are attached, and, more preferably, X represents CH or N and Z represents CH;
- A represents group (i) wherein i is 2, and R 13 and R 4 , which may be the same or different, represent C 2-3 alkyl or may form a six-membered saturated heterocyclic ring optionally substituted by C 1-4 alkyl together with the nitrogen atom, to which they are attached;
- R 1 and R 2 represent C 1-4 alkoxy
- A represents group (ii) wherein j is 1 or 2, k is 1 or 2, m is 1 or 2, and R 15 represents optionally substituted phenyl and, more preferably, X represents CH or N and Z represents CH;
- R 1 and R 2 represent C 1-4 alkoxy
- R 3 , R 4 , R 5 , and R 6 represent a hydrogen atom
- A represents group (ii) wherein j is 1 or 2, k is 1 or 2, m is 1 or 2, and R 15 represents optionally substituted phenyl;
- R 1 and R 2 represent C 1-4 alkoxy
- R 3 represents a group other than a hydrogen atom
- R 4 , R 5 , and R 6 represent a hydrogen atom
- A represents group (ii) wherein j is 1 or 2, k is 1 or 2, m is 1 or 2, and R 15 represents optionally substituted phenyl and, more preferably, X represents CH or N and Z represents CH;
- R 1 and R 2 represent C 1-4 alkoxy
- A represents group (iii) wherein n is 0 (zero), p is an integer of 1 to 3
- R 16 and R 17 which may be the same or different, represent C 1-4 alkyl or may form a five- to seven-membered saturated heterocyclic ring optionally substituted by C 1-4 alkyl or an oxygen atom together with the nitrogen atom, to which they are attached, and, more preferably, X represents CH or N and Z represents CH;
- R 1 and R 2 represent C 1-4 alkoxy
- R 3 , R 4 , R 5 , and R 6 represent a hydrogen atom
- A represents group (iii) wherein n is 0 (zero), p is an integer of 1 to 3
- R 16 and R 17 which may be the same or different, represent C 1-4 alkyl or may form a five- to seven-membered saturated heterocyclic ring optionally substituted by C 1-4 alkyl or an oxygen atom together with the nitrogen atom, to which they are attached, and, more preferably, X represents CH or N and Z represents CH;
- R 1 and R 2 represent C 1-4 alkoxy
- R 3 represents a group other than a hydrogen atom
- R 4 , R 5 , and R 6 represent a hydrogen atom
- A represents group (iii) wherein n is 0 (zero), p is an integer of 1 to 3
- R 16 and R 17 which may be the same or different, represent C 1-4 alkyl or may form a five- to seven-membered saturated heterocyclic ring optionally substituted by C 1-4 alkyl or an oxygen atom together with the nitrogen atom, to which they are attached, and, more preferably, X represents CH or N and Z represents CH;
- R 1 and R 2 represent C 1-4 alkoxy
- A represents group (iv) wherein q is 0 (zero), r is 1 or 2, s is 1 or 2, t is 1 or 2, and R 18 represents optionally substituted phenyl, and, more preferably, X represents CH or N and Z represents CH;
- R 1 and R 2 represent C 1-4 alkoxy
- R 3 , R 4 , R 5 and R 6 represent a hydrogen atom
- A represents group (iv) wherein q is 0 (zero), r is 1 or 2, s is 1 or 2, t is 1 or 2, and R 18 represents optionally substituted phenyl;
- R 1 and R 2 represent C 1-4 alkoxy
- R 3 represents a group other than a hydrogen atom
- R 1 , R 5 , and R 6 represent a hydrogen atom
- A represents group (iv) wherein q is 0 (zero), r is 1 or 2, s is 1 or 2, t is 1 or 2, and R 18 represents optionally substituted phenyl, and, more preferably, X represents CH or N and Z represents CH;
- R 1 and R 2 represent C 1-4 alkoxy and A represents group (v), wherein u is 1, and R 19 represents optionally substituted phenyl, or C 1-4 alkyl substituted by optionally substituted phenyl, and, more preferably, X represents CH or N and Z represents CH;
- R 1 and R 2 represent C 1-4 alkoxy
- R 3 , R 4 , R 5 , and R 6 represent a hydrogen atom
- A represents group (v) wherein u is 1, R 19 represents optionally substituted phenyl, or C 1-4 alkyl substituted by optionally substituted phenyl;
- R 1 and R 2 represent C 1-4 alkoxy
- R 5 represents a group other than a hydrogen atom
- R 3 , R 4 , and R 6 represent a hydrogen atom
- A represents group (v) wherein u is 1,
- R 19 represents optionally substituted phenyl, or C 1-4 alkyl substituted by optionally substituted phenyl, and, more preferably, X represents CH or N and Z represents CH;
- R 1 and R 2 represent C 1-4 alkoxy and A represents group (vi) wherein R 20 represents optionally substituted phenyl or C 1-6 alkyl optionally substituted by optionally substituted phenyl, and, more preferably, X represents CH or N and Z represents CH;
- R 1 and R 2 represent C 1-4 alkoxy and A represents group (vii) wherein R 21 represents optionally substituted phenyl, or C 1-6 alkyl optionally substituted by optionally substituted phenyl, and, more preferably, X represents CH or N and Z represents CH;
- R 1 and R 2 represent C 1-4 alkoxy and A represents group (viii) wherein w is an integer of 1 to 3, L represents —O—, M represents —O— or —C( ⁇ O)—O—, R 22 represents optionally substituted phenyl, and, more preferably, X represents CH or N and Z represents CH;
- R 1 and R 2 represent C 1-4 alkoxy and A represents group (viii) wherein, when L represents —O—, M represents —O—, —C( ⁇ O)—O—, —N(—R 12 )—, —C( ⁇ O)—N(—R 12 )—, or —C( ⁇ O)—; when L represents —S( ⁇ O)y-, M represents —O—; and when L represents —N(—R 11 )—, M represents —O—, and, more preferably, X represents CH or N and Z represents CH;
- R 1 and R 2 represent C 1-4 alkoxy and A represents group (iii), wherein n is 1 and p is 0 (zero), and, more preferably, X represents CH or N and Z represents CH; and
- R 1 and R 2 represent C 1-4 alkoxy
- R 3 represents morpholyl
- R 4 , R 5 , and R 6 represent a hydrogen atom
- A represents group (x), and, more preferably, X represents CH or N and Z represents CH.
- Examples of particularly preferred compounds according to the present invention include compounds described in Examples 1 to 1209.
- Examples of more preferred compounds according to the present invention are the following compounds:
- One or more enantiomeric carbon atoms, which form enantiomer configuration, may exist in the compounds represented by formula (I).
- the compounds represented by formula (I) include all enantiomers.
- Acid addition salts include: salts with inorganic acids such as hydrochloric acid, sulfuric acid, phosphoric acid, hydrobromic acid, and nitric acid; or organic acids such as maleic acid, fumaric acid, malic acid, oxalic acid, tartaric acid, succinic acid, citric acid, acetic acid, lactic acid, methanesulfonic acid, and p-toluenesulfonic acid.
- Pharmacologically acceptable solvates of the compounds represented by formula (I) include hydrates and ethanolates.
- Quinolone derivatives as an intermediate may be synthesized according to the method described, for example, in WO 97/17329.
- 4-chloroquinoline derivatives may be synthesized by a conventional method described, for example, in Org. Synth. Col., Vol. 3, 272 (1955), Acta Chim. Hung., 112, 241 (1983) or WO 98/47873.
- 4-chloroquinazoline derivatives may be synthesized by a conventional method described, for example, in J. Am. Chem. Soc., 68, 1299 (1946), J. Am. Chem. Soc., 68, 1305 (1946) or Dai-Yukikagaku, supervised by Kotake, Vol. 17, p. 150, Asakura Publishing Co., Ltd., 1967.
- 4-(Nitrophenoxy)quinoline derivatives or corresponding quinazoline derivatives may be synthesized by reacting nitrophenol with a 4-chloroquinoline derivative or a corresponding quinazoline derivative in the presence or absence of a suitable solvent.
- 4-(Aminophenoxy)quinoline derivatives or corresponding quinazoline derivatives may be synthesized by stirring a 4-(nitrophenoxy)quinoline derivative or a corresponding quinazoline derivative in a suitable solvent, for example, N,N-dimethylformamide, in the presence of a catalyst, for example, palladium hydroxide-carbon or palladium-carbon) in a hydrogen atmosphere.
- 4-(aminophenoxy)quinoline derivatives or corresponding quinazoline derivatives may be sythesized by reacting an aminophenol derivative with a 4-chloroquinoline derivative or a corresponding quinazoline derivative in the presence of a base, for example, sodium hydride.
- a substituent can be introduced into R 11 by reacting a 4-(aminophenoxy)quinoline derivative or a corresponding quinazoline derivative with an acid chloride or an acid anhydride in the presence of a base and then reducing the reaction product with lithium aluminum hydride or the like (step 1A).
- a substituent can be introduced into R 11 by reacting a 4-(aminophenoxy)quinoline derivative or a corresponding quinazoline derivative with an aldehyde or a ketone to form an imine compound and then reducing the imine compound with sodium cyanoborohydride or the like (step 1B).
- Compounds represented by formula (I) may be produced by reacting a derivative having a substituent at R 11 with an isocyanate derivative (O ⁇ C ⁇ N—R 51 wherein R 51 represents a portion of groups (i) and (ii) not having a urea portion according to a conventional method (step 2) and, if necessary, reacting the reaction product with a suitable alkylating agent (R 12 Hal) in the presence of a base, for example, sodium hydride (step 3).
- a suitable alkylating agent R 12 Hal
- R 11 and R 12 may also be introduced by reacting a urea derivative, wherein R 10 and/or R 11 represent a hydrogen atom, with a suitable alkylating agent (R 11 Hal or R 12 Hal) in the presence of a base, for example, sodium hydride (steps 5 and 7).
- a suitable alkylating agent R 11 Hal or R 12 Hal
- Urea derivatives wherein R 11 and/or R 12 represent a hydrogen atom, may be produced by reacting a 4-(aminophenoxy)quinoline derivative or a corresponding quinazoline derivative produced in scheme 1 with an isocyanate derivative according to a conventional method, or by adding triphosgene in the presence of a base, for example, triethylamine and then reacting the mixture with a suitable alkylamine (R 51 NH 2 or R 11 R 51 NH) (steps 4 and 6).
- a base for example, triethylamine
- a substituent can be introduced into R 11 by reacting a 4-(aminophenoxy)quinoline derivative or a corresponding quinazoline derivative with an acid chloride or an acid anhydride in the presence of a base and then reducing the reaction product with lithium aluminum hydride or the like (step 1A).
- a substituent can be introduced into R 11 by reacting a 4-(aminophenoxy)quinoline derivative or a corresponding quinazoline derivative with an aldehyde or a ketone to form an imine derivative and then reducing the imine derivative with sodium cyanoborohydride or the like (step 1B).
- Compounds represented by formula (I) may be produced by reacting a derivative having a substituent at R 11 with an isothiocyanate derivative, (S ⁇ C ⁇ N—R 52 wherein R 52 represents a portion of groups (iii), (iv), and (v), not having a thiourea portion according to a conventional method (step 2) and, if necessary, reacting the reaction product with a suitable alkylating agent (R 12 Hal) in the presence of a base, for example, sodium hydride (step 3).
- a suitable alkylating agent R 12 Hal
- R 11 and R 12 may also be introduced by reacting a thiourea derivative, wherein R 11 and/or R 12 represent a hydrogen atom, with a suitable alkylating agent (R 11 Hal or R 12 Hal) in the presence of a base, for example, sodium hydride (steps 5 and 7).
- a suitable alkylating agent R 11 Hal or R 12 Hal
- Thiourea derivatives wherein R 11 and/or R 12 represent a hydrogen atom, may be produced by reacting a 4-(aminophenoxy)quinoline derivative or a corresponding quinazoline derivative produced in scheme 1 with an isothiocyanate derivative (S ⁇ C ⁇ N—R 52 ) according to a conventional method, or by adding thiophosgene in the presence of a base, for example, triethylamine and then reacting the mixture with a suitable alkylamine (R 52 NH 2 or R 11 R 52 NH) (steps 4 and 6).
- a base for example, triethylamine
- Urethane derivatives wherein R 11 and/or R 12 represent a hydrogen atom, may be produced according to a conventional method by adding triphosgene to a 4-(aminophenoxy)quinoline derivative or a corresponding quinazoline derivative produced according to scheme 1 in the presence of a base, for example, triethylamine and then reacting the mixture with a suitable alcohol (R 20 OH).
- R 11 may be introduced by reacting a urethane derivative, wherein R 11 represents a hydrogen atom, with a suitable alkylating agent (R 11 Hal) in the presence of a base, for example, sodium hydride.
- R 11 may be introduced by reacting a thiocarbamate derivative, wherein R 11 represents a hydrogen atom, with a suitable alkylating agent (R 11 Hal) in the presence of a base, for example, sodium hydride.
- 4-(Alkyloxyphenoxy)quinoline derivatives or corresponding quinazoline derivatives, or 4-(acyloxyphenoxy) quinoline derivatives or corresponding quinazoline derivatives may be synthesized by reacting a 4-alkyloxyphenol derivative or a 4-acyloxyphenol derivative with a 4-chloroquinoline derivative or a corresponding quinazoline derivative in the presence or absence of a suitable solvent (scheme 6-1).
- D represents —(CH 2 )w-M-R 20 .
- 4-(Benzyloxyphenoxy)quinoline derivatives or corresponding quinazoline derivatives, or 4-(benzoyloxyphenoxy)quinoline derivatives or corresponding quinazoline derivatives may be synthesized by reacting a 4-benzyloxyphenol derivative or a 4-benzoyloxyphenol derivative with a 4-chloroquinoline derivative or a corresponding quinazoline derivative in the presence or absence of a suitable solvent (scheme 6-1).
- 4-(Hydroxyphenoxy)quinoline derivatives or corresponding quinazoline derivatives may be synthesized by deprotecting a 4-(benzyloxyphenoxy)quinoline derivative or a corresponding quinazoline derivative in a suitable solvent, for example, N,N-dimethylformamide, in the presence of a catalyst, for example, palladium hydroxide-carbon or palladium-carbon in a hydrogen atmosphere.
- a catalyst for example, palladium hydroxide-carbon or palladium-carbon in a hydrogen atmosphere.
- 4-(Hydroxyphenoxy)quinoline derivatives or corresponding quinazoline derivatives may also be synthesized by deprotecting the benzoyl group in the 4-(benzoyloxyphenoxy)quinoline derivative or corresponding quinazoline derivative under basic conditions, for example, using sodium hydroxide.
- Carboxylic acid compound (1) is produced by reacting a 4-(hydroxyphenoxy)quinoline derivative or a corresponding quinazoline derivative with a ⁇ -halogenated alkyl carboxylic acid ester under basic conditions, for example, using sodium hydride and then deprotecting the ester under basic conditions, for example, using sodium hydroxide.
- Amide derivative (2) may be produced by reacting carboxylic acid compound (1) with an amine in the presence of a coupling reagent, for example, N,N′-dicyclohexylcarbodiimide. Subsequently, reduced derivative (3) may be produced by reducing amide derivative (2) with diborane, lithium aluminum hydride or the like (scheme 6-2).
- S-Alkyl-substituted phenols may be produced by reacting a 4-hydroxythiophenol derivative with a suitable alkyl halide derivative in the presence or absence of a suitable solvent under basic conditions, for example, using potassium carbonate.
- Thio derivatives may be synthesized by reacting the S-alkyl-substituted phenol with a 4-chloroquinoline derivative or a corresponding quinazoline derivative.
- Sulfoxide derivatives may be produced by oxidizing the thio derivative with an oxidizing agent such as m-chloroperbenzoic acid.
- Sulfone derivatives may be produced by oxidizing the thio derivative with an oxidizing agent such as potassium permanganate or oxone, or by oxidizing the sulfoxide derivative with an oxidizing agent such as potassium permanganate or oxone.
- a reduced derivative may be produced by reacting a fatty acid with a 4-(aminophenoxy)quinoline derivative or a corresponding quinazoline derivative produced by a conventional method in the presence of a coupling reagent to give an amide derivative and reducing the amide derivative with diborane, lithium aluminum hydride or the like.
- R 11 may be introduced by reacting a reduced derivative, wherein R 11 represents a hydrogen atom, with a suitable alkylating agent (R 11 Hal) in the presence of a base, for example, sodium hydride.
- R 11 may be introduced by reacting an amide derivative, wherein R 11 represents a hydrogen atom, with a suitable alkylating agent (R 11 Hal) in the presence of a base, for example, sodium hydride.
- R 11 Hal alkylating agent
- a reduced derivative having a substituent at R 11 may be produced by reducing the derivative with diborane, lithium aluminum hydride or the like.
- the compounds according to the present invention inhibit, in vitro, PDGF-R autophosphorylation and the growth and migration of vascular smooth muscle cells induced by PDGF stimulation (see Pharmacological Test Examples 1 and 2).
- the autophosphorylation of PDGF receptors mediates diseases, for example, ischemic diseases involving blood vessel occlusion or angiostenosis induced by angiopathy, ischemic diseases involving blood vessel occlusion or angiostenosis induced by vascular autotransplantation or allotransplantation, and diseases involving cell proliferation and organ fibrosis induced by PDGF, for example, chronic rheumatism, PDGF-dependent tumors such as glioma, cirrhosis, pulmonary fibrosis, and occlusion of arteriovenous shunt resulting, for example, from dialysis of patients suffering from renal failure (Gordon A.
- the compounds according to the present invention have low VEGF-R inhibitory activity (Pharmacological Test Example 5). Compounds, which do not inhibit VEGF-R, are expected not to accelerate angiostenosis. Furthermore, the compounds according to the present invention inhibit, in vivo, neointima formation hypertrophy of injured blood vessels (Pharmacological Test Examples 4 and 6). Therefore, the compounds according to the present invention can be used in the treatment of diseases mediated by the autophosphorylation of PDGF receptors, particularly ischemic diseases involving blood vessel occlusion/angiostenosis induced by blood vessel injury or vascular autotransplantation or allotransplantation.
- the compounds according to the present invention have low c-kit autophosphorylation inhibitory activity.
- the c-kit autophosphorylation inhibitory activity crucially affects hematopoiesis and intestinal tract movements (Experimental Medicine, Vol. 11, No. 13, pp 42-53). Therefore, the present invention can provide compounds which do not cause any significant side effect attributable to c-kit autophosphorylation inhibitory activity.
- compositions comprising compounds of the present invention as an active ingredient can be administered to human and non-human animals orally or parenterally by administration routes, for example, intravenous administration, intramuscular administration, subcutaneous administration, rectal administration, or percutaneous administration. Therefore, the pharmaceutical composition comprising the compound according to the present invention as active ingredient may be formulated into suitable dosage forms according to the administration routes.
- oral preparations include tablets, capsules, powders, granules, and syrups
- parental preparations include injections, suppositories, tapes, and ointments.
- compositions may be prepared by conventional methods, for example, with commonly used component, such as excipients, disintegrants, binders, lubricants, colorants, and diluents.
- component such as excipients, disintegrants, binders, lubricants, colorants, and diluents.
- Excipients include, for example, lactose, glucose, corn starch, sorbit, and crystalline cellulose; disintegrants include, for example, starch, sodium alginate, gelatin powder, calcium carbonate, calcium citrate, and dextrin; binders include, for example, dimethylcellulose, polyvinyl alcohol, polyvinyl ether, methylcellulose, ethylcellulose, gum arabic, gelatin, hydroxypropylcellulose, polyvinyl pyrrolidone, carboxymethylcellulose sodium salt, and chremophore; lubricants include, for example, talc, magnesium stearate, polyethylene glycol, and hydrogenated vegetable oils.
- buffers for example, buffers, pH adjustors, stabilizers, tonicity agents, and preservatives may be added.
- the dose of the compound according to the present invention in the pharmaceutical composition may vary depending upon the dosage form. In general, however, the dose is about 0.5 to 50% by weight, preferably about 1 to 20% by weight, based on the whole composition.
- the dose may be appropriately determined depending upon, for example, the age, weight, sex, difference in diseases, and severity of condition of patients, and the active ingredient may be administered, for example, in an amount of 0.1 to 100 mg/kg, preferably 0.1 to 30 mg/kg. This dose can be administered at a time daily or divided doses of several times daily.
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated, and the residue was purified on a column using chloroform/methanol to give the title compound (108 mg, yield 51%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (48 mg, yield 28%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (62 mg, yield 49%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (70 mg, yield 56%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (43 mg, yield 36%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (43 mg, yield 33%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (38 mg, yield 34%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (77 mg, yield 64%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (88 mg, yield 79%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (52 mg, yield 48%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (77 mg, yield 69%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (62 mg, yield 44%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (62 mg, yield 44%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (80 mg, yield 48%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (60 mg, yield 48%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (52 mg, yield 41%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (77 mg, yield 69%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (80 mg, yield 55%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (71 mg, yield 51%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (60 mg, yield 37%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (58 mg, yield 44%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (75 mg, yield 66%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (61 mg, yield 52%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (58 mg, yield 53%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (82 mg, yield 56%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (82 mg, yield 56%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (68 mg, yield 49%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (130 mg, yield 76%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (88 mg, yield 69%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (91 mg, yield 72%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (91 mg, yield 72%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (105 mg, yield 65%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (88 mg, yield 66%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (78 mg, yield 56%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (69 mg, yield 55%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (109 mg, yield 69%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (101 mg, yield 72%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (71 mg, yield 42%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (55 mg, yield 36%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (73 mg, yield 55%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (70 mg, yield 48%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (53 mg, yield 42%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (66 mg, yield 52%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (59 mg, yield 46%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (100 mg, yield 64%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (68 mg, yield 47%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (98 mg, yield 69%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (81 mg, yield 49%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (101 mg, yield 76%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (79 mg, yield 56%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (69 mg, yield 46%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (80 mg, yield 48%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (53 mg, yield 39%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (77 mg, yield 49%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (61 mg, yield 46%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (68 mg, yield 48%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (51 mg, yield 32%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (48 mg, yield 35%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (89 mg, yield 64%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (60 mg, yield 36%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (49 mg, yield 31%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (94 mg, yield 72%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (59 mg, yield 47%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (45 mg, yield 35%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (90 mg, yield 65%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (74 mg, yield 54%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (74 mg, yield 54%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (58 mg, yield 42%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (89 mg, yield 54%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (60 mg, yield 35%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (51 mg, yield 33%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (88 mg, yield 55%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (61 mg, yield 44%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (79 mg, yield 52%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (60 mg, yield 45%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (98 mg, yield 69%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (78 mg, yield 55%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (63 mg, yield 46%).
- the mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (58 mg, yield 43%).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
wherein R1 and R2 represent hydrogen, alkyl or the like; R3, R4, R5, and R6 represent hydrogen, halogen, alkyl, alkoxy or the like; R11 and R12 represent hydrogen, alkyl, alkylcarbonyl or the like; and A represents any one of formulae (i) to (x), provided that compounds wherein R3, R4, R5 and R6 represent hydrogen and A represents group (v) wherein u is 0 (zero) and R19 represents phenyl optionally substituted by halogen, alkyl, or alkoxy are excluded.
Description
- 1. Field of the Invention
- The present invention relates to quinoline derivatives and quinazoline derivatives and more particularly to quinoline derivatives and quinazoline derivatives that can be used in the treatment of diseases associated with the autophosphorylation of a PDGF receptor and particularly can inhibit angiostenosis.
- 2. Background Art
- PTCA (percutaneous transluminal coronary angioplasty) is widely adopted as therapy useful for ischemic heart diseases resulting from coronary stenosis. Vascular restenosis, which is observed in a frequency of about 30% within 3 to 6 months after the operation of PTCA, however, has become a serious problem associated with long-term prognosis and medical economy. The restenosis is considered attributable to the fact that vascular smooth muscular cells or fibroblasts of the vascular outer membrane are activated, for example, by platelet activation caused by the tear of vascular tunica intima or media, extension stimulation, and vascular endothelial cell injury at the time of catheter therapy and consequently migrate and proliferate and excessively accumulate at injured vascular sites.
- Various growth factors have hitherto been assumed as the vascular smooth muscle cells or fibroblasts activation factors. In particular, since R. Ross et al. have proposed a hypothesis of a injury reaction (N. Engl. J. Med., 295, 369 (1976)), PDGF (platelet-derived growth factor) has drawn attention as one of factors causative of arteriosclerosis and has been also considered as a major factor causative of restenosis from both fundamental and clinical aspects (G. A. A. Ferns et al., Science, 253, 1129 (1991), M. G. Sirois et al., Circulation, 95, 669 (1997), and M. Ueda et al., Am. J. Pathol., 149, 831 (1996) etc.).
- PDGF-R (PDGF receptor) autophosphorylation inhibitory compounds (WO 97/17329 and The FASEB Journal, Vol. 11, pp. 1119-1126 (1997)) have been reported up to now.
- For PDGF receptor autophosphorylation inhibitory compounds which have been reported, however, the selectivity for VEGF receptors (such as KDR) and c-kit (SCF receptors) belonging to the PDGF receptor family has not been discussed.
- VEGF is one of major growth factors of vascular endothelial cells (EC), and VEGF receptor inhibitory compounds possibly inhibit the regeneration of EC in injured blood vessels to promote the formation of thrombus and to accelerate angiostenosis.
- Further, SCF is a growth factor involved in the upstream of hematopoietic system and the movement of intestinal tracts, and substances that inhibit receptors of SCF possibly induce hematopoietic failure and intestinal tract movement failure.
- For these reasons, compounds that can selectively inhibit PDGF receptors for c-kit, KDR, and the like are family are expected as anti-restenosis agents that have no significant side effect.
- Although various restenosis inhibitors have been developed up to now, any pharmaceutical compound having potent angiostenosis inhibitory activity has not yet been developed.
- The present inventors have now found out compounds having PDGF receptor autophosphorylation inhibitory activity.
- The present inventors have also found out compounds inhibiting angiostenosis in rat carotid balloon injury models and porcine coronary balloon injury models.
- The present inventors have further found out compounds having potent PDGF receptor autophosphorylation inhibitory activity and having low VEGF receptor autophosphorylation inhibitory activity.
- The present inventors have further found out compounds having PDGF receptor autophosphorylation inhibitory activity and having low c-kit autophosphorylation inhibitory activity.
- An object of the present invention is to provide compounds that can be used in the treatment of diseases mediated by the autophosphorylation of PDGF receptors, particularly compounds having inhibitory activity against angiostenosis.
- Another object of the present invention is to provide compounds that can be used in the treatment of diseases mediated by the autophosphorylation of PDGF receptors and have a low level of side effects attributable to c-kit autophosphorylation inhibitory activity.
-
- X and Z, which may be the same or different, represent CH or N;
- R1 and R2, which may be the same or different, represent a hydrogen atom or C1-4 alkoxy optionally substituted by a halogen atom;
- R3, R4, R5, and R6, which may be the same or different, represent a hydrogen atom; a halogen atom; C1-4 alkyl optionally substituted by a halogen atom; C1-4 alkoxy optionally substituted by a halogen atom; nitro; amino; or morpholyl;
- A represents a group selected from the group consisting of formulae (i) to (x), wherein R11 and R12, which may be the same or different, represent a hydrogen atom, C1-4 alkyl optionally substituted by a halogen atom, or C1-4 alkylcarbonyl optionally substituted by a halogen atom;
-
- i is an integer of 0 to 10,
- R13 and R14, which may be the same or different, represent a hydrogen atom; C1-6 alkyl optionally substituted by a halogen atom; or phenyl optionally substituted by a halogen atom or C1-4 alkyl optionally substituted by a halogen atom,
- R13 and R14 may form a five- to seven-membered saturated or unsaturated heterocyclic ring optionally containing one or more additional hetero-atoms together with the nitrogen atom to which they are attached, and this heterocyclic ring is optionally substituted by a halogen atom or C1-4 alkyl optionally substituted by a halogen atom, or, R13 or R14 may form C1-4 alkylene optionally substituted by a halogen atom together with R12;
wherein - j is an integer of 0 to 3,
- k is an integer of 0 to 3, provided that
- both j and k are not 0 (zero),
- m is an integer of 0 to 2,
-
-
- n is 0 (zero) or 1,
- p is an integer of 0 to 10, and
- R16 and R17, which may be the same or different, represent a hydrogen atom; C1-6 alkyl optionally substituted by a halogen atom; C1-4 alkylcarbonyl optionally substituted by a halogen atom; cyclic C3-7 alkyl optionally substituted by C1-4 alkyl optionally substituted by a halogen atom; or phenyl optionally substituted by a halogen atom or C1-4 alkyl optionally substituted by a halogen atom, or
- R16 and R17 may form a five- to seven-membered saturated or unsaturated heterocyclic ring optionally containing one or more additional hetero-atoms together with the nitrogen atom to which they are attached, this heterocyclic ring is optionally condensed with another one or two carbocyclic or heterocyclic ring to form a ten- to twelve-membered saturated or unsaturated bicyclic carbocyclic ring or heterocyclic ring or a ten- to fifteen-membered saturated or unsaturated tricyclic carbocyclic ring or heterocyclic ring, and these heterocyclic rings are optionally substituted by an oxygen atom or C1-4 alkyl optionally substituted by a halogen atom;
wherein - q is 0 (zero) or 1,
- r is an integer of 0 to 3,
- s is an integer of 0 to 3, provided that
- both r and s are not 0 (zero),
- t is an integer of 0 to 2,
-
-
- u is 0 (zero) or 1,
- R19 represents
- (1) phenyl which is optionally substituted by C1-10 alkyl optionally substituted by a halogen atom; C1-10 alkoxy optionally substituted by a halogen atom; —NR31R32 wherein R31 and R32, which may be the same or different, represent a hydrogen atom or C1-4 alkyl optionally substituted by a halogen atom; phenyl optionally substituted by a halogen atom; a halogen atom; or cyano,
- (2) phenoxy of which the phenyl portion is optionally substituted by C1-10 alkyl optionally substituted by a halogen atom; C1-10 alkoxy optionally substituted by a halogen atom; —NR31R32 wherein R31 and R32 are as defined above; phenyl optionally substituted by a halogen atom; a halogen atom; or cyano,
- (3) cyclic C3-7 alkyl which is optionally condensed with another carbocyclic ring or heterocyclic ring to form an eight- to twelve-membered bicyclic saturated or unsaturated carbocyclic ring or heterocyclic ring and the carbocyclic ring and the heterocyclic ring are optionally substituted by C1-4 alkyl optionally substituted by a halogen atom; phenyl optionally substituted by a halogen atom; cyclic C3-7 alkyl optionally substituted by a halogen atom; or a halogen atom,
- (4) a five- to seven-membered saturated or unsaturated heterocyclic ring which is optionally condensed with another carbocyclic or heterocyclic ring to form a ten- to twelve-membered bicyclic saturated or unsaturated heterocyclic ring optionally substituted by C1-4 alkyl optionally substituted by a halogen atom, or a halogen atom,
- (5) C1-16 alkyl,
- (6) C2-6 alkenyl, or
- (7) C2-6 alkynyl,
- wherein (5) C1-16 alkyl, (6) C2-6 alkenyl, and (7) C2-6 alkynyl are optionally substituted by one or more of the following groups:
- (a) phenyl optionally substituted by C1-10 alkyl optionally substituted by a halogen atom; C1-10 alkoxy optionally substituted by a halogen atom; —NR31R32 wherein R31 and R32 are as defined above; phenyl optionally substituted by a halogen atom; a halogen atom; or cyano,
- (b) phenoxy of which the phenyl portion is optionally substituted by C1-10 alkyl optionally substituted by a halogen atom; C1-10 alkoxy optionally substituted by a halogen atom; —NR31R32 wherein R31 and R32 are as defined above; phenyl optionally substituted by a halogen atom; a halogen atom; or cyano,
- (c) phenylthio of which the phenyl portion is optionally substituted by C1-10 alkyl optionally substituted by a halogen atom; C1-10 alkoxy optionally substituted by a halogen atom; —NR31R32 wherein R31 and R32 are as defined above; phenyl optionally substituted by a halogen atom; a halogen atom; or cyano,
- (d) —NR33R34 wherein R33 and R34 are as defined in R13 and R14,
- (e) cyclic C3-7 alkyl which is optionally condensed with another carbocyclic ring or heterocyclic ring to form an eight- to twelve-membered bicyclic saturated or unsaturated carbocyclic ring or heterocyclic ring and the carbocyclic ring and the heterocyclic ring are optionally substituted by C1-4 alkyl optionally substituted by a halogen atom; phenyl optionally substituted by a halogen atom; or a halogen atom,
- (f) a five- to seven-membered saturated or unsaturated heterocyclic ring which is optionally condensed with another carbocyclic ring or heterocyclic ring to form a ten- to twelve-membered bicyclic saturated or unsaturated heterocyclic ring optionally substituted by C1-4 alkyl optionally substituted by a halogen atom, or a halogen atom,
- (g) naphthyl,
- (h) cyano,
- (i) C1-4 alkylthio optionally substituted by a halogen atom,
- (j) a halogen atom, or
-
- R20 represents
- (1) phenyl optionally substituted by C1-6 alkyl optionally substituted by a halogen atom; C1-6 alkoxy optionally substituted by a halogen atom; —NR35R36 wherein R35 and R36, which may be the same or different, represent a hydrogen atom or C1-4 alkyl optionally substituted by a halogen atom; phenyl optionally substituted by a halogen atom; a halogen atom; or cyano,
- (2) cyclic C3-7 alkyl which is optionally condensed with another carbocyclic ring or heterocyclic ring to form an eight- to twelve-membered bicyclic saturated or unsaturated carbocyclic ring or heterocyclic ring and the carbocyclic ring and the heterocyclic ring are optionally substituted by C1-4 alkyl optionally substituted by a halogen atom, or a halogen atom,
- (3) a five- to seven-membered saturated or unsaturated heterocyclic ring which is optionally condensed with another carbocyclic ring or heterocyclic ring to form a ten- to twelve-membered bicyclic saturated or unsaturated heterocyclic ring optionally substituted by C1-4 alkyl optionally substituted by a halogen atom, or a halogen atom,
- (4) C1-20 alkyl,
- (5) C2-6 alkenyl, or
- (6) C2-6 alkynyl, and
- wherein (4) C1-20 alkyl, (5) C2-6 alkenyl, and (6) C2-6 alkynyl are optionally substituted by one or more of the following groups:
- (a) phenyl optionally substituted by C1-6 alkyl optionally substituted by a halogen atom; C1-6 alkoxy optionally substituted by a halogen atom; —NR35R36 wherein R35 and R36 are as defined above; phenyl optionally substituted by a halogen atom; a halogen atom; or cyano,
- (b) phenoxy of which the phenyl portion is optionally substituted by C1-6 alkyl optionally substituted by a halogen atom; C1-6 alkoxy optionally substituted by a halogen atom; —NR35R36 wherein R35 and R36 are as defined above; phenyl optionally substituted by a halogen atom; a halogen atom; or cyano,
- (c) phenylthio of which the phenyl portion is optionally substituted by C1-6 alkyl optionally substituted by a halogen atom; C1-6 alkoxy optionally substituted by a halogen atom; —NR35R36 wherein R35 and R36 are as defined above; phenyl optionally substituted by a halogen atom; a halogen atom; or cyano,
- (d) —NR37R38 wherein R37 and R38 are as defined in R13 and R14,
- (e) cyclic C3-7 alkyl which is optionally condensed with another carbocyclic ring or heterocyclic ring to form an eight- to twelve-membered bicyclic saturated or unsaturated carbocyclic ring or heterocyclic ring and the carbocyclic ring and the heterocyclic ring are optionally substituted by C1-4 alkyl optionally substituted by a halogen atom, or a halogen atom,
- (f) a five- to seven-membered saturated or unsaturated heterocyclic ring which is optionally condensed with another carbocyclic ring or heterocyclic ring to form a ten- to twelve-membered bicyclic saturated or unsaturated heterocyclic ring optionally substituted by C1-4 alkyl optionally substituted by a halogen atom, or a halogen atom,
- (g) naphthyl, or
-
- v is an integer of 0 to 2,
- R21 represents
- (1) phenyl optionally substituted by C1-6 alkyl optionally substituted by a halogen atom; C1-6 alkoxy optionally substituted by a halogen atom; —NR39R40 wherein R39 and R40, which may be the same or different, represent a hydrogen atom or C1-4 alkyl optionally substituted by a halogen atom; phenyl optionally substituted by a halogen atom; a halogen atom; or cyano,
- (2) cyclic C3-7 alkyl which is optionally condensed with another carbocyclic ring or heterocyclic ring to form an eight- to twelve-membered bicyclic saturated or unsaturated carbocyclic ring or heterocyclic ring and the carbocyclic ring and the heterocyclic ring are optionally substituted by C1-4 alkyl optionally substituted by a halogen atom, or a halogen atom,
- (3) a five- to seven-membered saturated or unsaturated heterocyclic ring which is optionally condensed with another carbocyclic ring or heterocyclic ring to form a ten- to twelve-membered bicyclic saturated or unsaturated heterocyclic ring optionally substituted by C1-4 alkyl optionally substituted by a halogen atom, or a halogen atom,
- (4) C1-20 alkyl,
- (5) C2-6 alkenyl, or
- (6) C2-6 alkynyl, and
- wherein (4) C1-20 alkyl, (5) C2-6 alkenyl, and (6) C2-6 alkynyl are optionally substituted by one or more of the following groups:
- (a) phenyl optionally substituted by C1-6 alkyl optionally substituted by a halogen atom; C1-6 alkoxy optionally substituted by a halogen atom; —NR39R40 wherein R39 and R40 are as defined above; phenyl optionally substituted by a halogen atom; a halogen atom; or cyano,
- (b) phenoxy of which the phenyl portion is optionally substituted by C1-6 alkyl optionally substituted by a halogen atom; C1-6 alkoxy optionally substituted by a halogen atom; —NR39R40 wherein R39 and R40 are as defined above; phenyl optionally substituted by a halogen atom; a halogen atom; or cyano,
- (c) phenylthio of which the phenyl portion is optionally substituted by C1-6 alkyl optionally substituted by a halogen atom; C1-6 alkoxy optionally substituted by a halogen atom; —NR39R40 wherein R39 and R40 are as defined above; phenyl optionally substituted by a halogen atom; a halogen atom; or cyano,
- (d) —NR41R42 wherein R41 and R42 are as defined in R13 and R14,
- (e) cyclic C3-7 alkyl which is optionally condensed with another carbocyclic ring or heterocyclic ring to form an eight- to twelve-membered bicyclic saturated or unsaturated carbocyclic ring or heterocyclic ring and the carbocyclic ring and the heterocyclic ring are optionally substituted by C1-4 alkyl optionally substituted by a halogen atom, or a halogen atom,
- (f) a five- to seven-membered saturated or unsaturated heterocyclic ring which is optionally condensed with another carbocyclic ring or heterocyclic ring to form a ten- to twelve-membered bicyclic saturated or unsaturated heterocyclic ring optionally substituted by C1-4 alkyl optionally substituted by a halogen atom, or a halogen atom,
- (g) naphthyl, or
-
- w is an integer of 1 to 4,
- L represents —O—, —S(═O)y-, wherein y is an integer of 0 to 2, or —N(—R11)—,
- M represents —O—, —C(═O)—O—, —S(═O)z-, wherein z is an integer of 0 to 2, —N(—R12)—, —C(═O)—N(—R12)—, or —C(═O)—,
- R22 represents a hydrogen atom; C1-4 alkyl optionally substituted by a halogen atom; or phenyl optionally substituted by C1-4 alkyl optionally substituted by a halogen atom, C1-4 alkoxy optionally substituted by a halogen atom, nitro, amino, or a halogen atom,
- when M represents —N(—R12)— or —C(═O)—N(—R12)—, R22 and R12 may form a five- to seven-membered saturated or unsaturated heterocyclic ring optionally containing one or more additional hetero-atoms together with the nitrogen atom to which they are attached, this heterocyclic ring is optionally condensed with another carbocyclic ring or heterocyclic ring to form a ten- to twelve-membered bicyclic saturated or unsaturated heterocyclic ring, and these heterocyclic rings are optionally substituted by C1-4 alkyl optionally substituted by a halogen atom; phenyl; benzyl; or piperidine;
—OR23 (ix)
wherein R23 represents a hydrogen atom or C1-4 alkyl optionally substituted by a halogen atom; and
—NR24R25 (x)
wherein R24 and R25, which may be the same or different, represent a hydrogen atom or C1-4 alkyl optionally substituted by a halogen atom. - The compounds according to the present invention are useful for the treatment of diseases mediated by the autophosphorylation of PDGF receptors.
- Compound
- The terms “alkyl,” “alkoxy,” “alkenyl,” and “alkynyl” as used herein as a group or a part of a group respectively mean straight chain or branched chain alkyl, alkoxy, alkenyl, and alkynyl.
- C1-6 alkyl is preferably C1-4 alkyl.
- C1-10 alkyl is preferably C1-8 alkyl.
- C1-16 alkyl is preferably C1-13 alkyl.
- C1-20 alkyl is preferably C1-18 alkyl.
- C1-6 alkoxy is preferably C1-4 alkoxy.
- C1-10 alkoxy is preferably C1-8 alkoxy.
- C2-6 alkenyl is preferably C2-4 alkenyl.
- C2-6 alkynyl is preferably C2-4 alkynyl.
- Examples of C1-6 alkyl include methyl, ethyl, n-propyl, isopropyl, n-butyl, i-butyl, s-butyl, t-butyl, n-pentyl, and n-hexyl.
- Examples of C1-6 alkoxy include methoxy, ethoxy, n-propoxy, i-propoxy, n-butoxy, i-butoxy, s-butoxy, and t-butoxy.
- Examples of C2-6 alkenyl include allyl, butenyl, pentenyl, and hexenyl.
- Examples of C2-6 alkynyl include 2-propynyl, butynyl, pentynyl, and hexynyl.
- The expression “alkyl optionally substituted by” as used herein means alkyl, of which one or more hydrogen atoms are substituted by one or more substituents which may be the same or different, or unsubstituted alkyl. It will be understood by a person skilled in the art that the maximum number of the substituents can be determined depending upon the number of substitutable hydrogen atoms on the alkyl group. This will apply to groups having substituents other than alkyl.
- The term “halogen atom” as used herein means a fluorine, chlorine, bromine, or iodine atom.
- The saturated or unsaturated five- to seven-membered heterocyclic ring contains one or more hetero-atoms selected from oxygen, nitrogen, and sulfur atoms. Examples of the saturated or unsaturated five- to seven-membered heterocyclic group include pyridyl, piperidino, piperazino, morpholino, imidazolyl, triazolyl, tetrazolyl, oxazolyl, thiazolyl, pyrrolidinyl, and pyrazolyl.
- The five- to seven-membered saturated or unsaturated heterocyclic group may be condensed with another saturated or unsaturated carbocyclic ring or heterocyclic ring to form a ten- to twelve-membered bicyclic ring or a ten- to fifteen-membered tricyclic ring. Condensed bicyclic groups include indanyl, quinolyl, and quinazolinyl. Condensed tricyclic groups include phenythiazyl, phenoxazyl, and dihydrodibenzoazepinyl.
- Cyclic C3-7 alkyl may be condensed with another saturated or unsaturated carbocyclic ring or heterocyclic ring to form an eight- to twelve-membered bicyclic saturated or unsaturated carbocyclic ring or heterocyclic ring. Condensed bicyclic groups include indanyl, quinolyl, and quinazolinyl.
- In group (i), i is preferably an integer of 0 to 4, more preferably 1 to 3.
- An example of preferred group (i) is a group wherein i is an integer of 1 to 3, R13 and R14, which may be the same or different, represent C1-4 alkyl or may form a five- to seven-membered saturated heterocyclic ring optionally substituted by C1-4 alkyl together with the nitrogen atom, to which they are attached.
- In group (ii), j is preferably an integer of 1 or 2. k is preferably an integer of 1 or 2. m is preferably an integer of 1 or 2.
- An example of preferred group (ii) is a group wherein j is 1 or 2, k is 1 or 2, m is 1 or 2, and R15 represents optionally substituted phenyl.
- In group (iii), p is preferably an integer of 0 to 3.
- An example of preferred group (iii) is a group wherein n is 0 (zero), p is an integer of 1 to 3, and R16 and R17, which may be the same or different, represent C1-4 alkyl or may form a five- to seven-membered saturated heterocyclic ring optionally substituted by C1-4 alkyl or an oxygen atom together with the nitrogen atom, to which they are attached.
- Another example of preferred group (iii) is a group wherein n is 1 and p is 0 (zero).
- In group (iv), r is preferably an integer of 1 or 2. s is preferably an integer of 1 or 2. t is preferably an integer of 0 or 1.
- An example of preferred group (iv) is a group wherein q is 0 (zero), r is 1 or 2, s is 1 or 2, t is 1 or 2, and R18 represents optionally substituted phenyl.
- In group (v), the phenyl and phenoxy groups presented by R19 are optionally substituted by C6-10 alkyl or C6-10 alkoxy, preferably C6-8 alkyl or C6-8 alkoxy.
- In group (v), the alkyl, alkenyl, and alkynyl groups presented by R19 are optionally substituted by phenyl, phenoxy, or phenylthio, and this phenyl, phenoxy, or phenylthio group is optionally substituted by C6-10 alkyl or C6-10 alkoxy, preferably C6-8 alkyl or C6-8 alkoxy.
- An example of preferred group (v) is a group wherein u is 1 and R19 represents C1-4 alkyl substituted by optionally substituted phenyl.
- An example of preferred group (vi) is a group wherein R20 represents optionally substituted phenyl or C1-6 alkyl optionally substituted by optionally substituted phenyl.
- In group (viii), w is preferably an integer of 1 to 3.
- When L represents —O—, preferably, M represents —O—, —C(═O)—O—, —N(—R12)—, —C(═O)—N(—R12)—, or —C(═O)—. When L represents —S(═O)y-, preferably, M represents —O—. When L represents —N(—R11)—, preferably, M represents —O—.
- An example of preferred group (viii) is a group wherein w is an integer of 1 to 3, L represents —O—, M represents —O— or —C(═O)—O—, and R22 represents optionally substituted phenyl.
- Examples of preferred compounds represented by formula (I) according to the present invention include the following compounds:
- compounds wherein X represents CH or N and Z represents CH;
- compounds wherein R1 and R2 represent C1-4 alkoxy and at least one of R3, R4, R5 and R6 represents a group other than a hydrogen atom;
- compounds wherein R1 and R2 represent C1-4 alkoxy, R3 represents a group other than a hydrogen atom, and R4, R5, and R6 represent a hydrogen atom;
- compounds wherein R1 and R2 represent C1-4 alkoxy, A represents group (i), wherein i is an integer of 1 to 3, and R13 and R14, which may be the same or different, represent C1-4 alkyl or may form a five- to seven-membered saturated heterocyclic ring optionally substituted by C1-4 alkyl together with the nitrogen atom, to which they are attached and, more preferably, X represents CH or N and Z represents CH;
- compounds wherein R1 and R2 represent C1-4 alkoxy, R3, R4, R5 and R6 represent a hydrogen atom, A represents group (i), wherein i is an integer of 1 to 3, and R13 and R14, which may be the same or different, represent C1-4 alkyl or may form a five- to seven-membered saturated heterocyclic ring optionally substituted by C1-4 alkyl together with the nitrogen atom to which they are attached and, more preferably, X represents CH or N and Z represents CH;
- compounds wherein R1 and R2 represent C1-4 alkoxy, R3 represents a group other than a hydrogen atom, R4, R5 and R6 represent a hydrogen atom, A represents group (i) wherein i is an integer of 1 to 3, and R13 and R14, which may be the same or different, represent C1-4 alkyl or may form a five- to seven-membered saturated heterocyclic ring optionally substituted by C1-4 alkyl together with the nitrogen atom, to which they are attached, and, more preferably, X represents CH or N and Z represents CH;
- compounds wherein R1 and R2 represent C1-4 alkoxy, R3 represents nitro, R4, R5, and R6 represent a hydrogen atom, A represents group (i) wherein i is an integer of 1 to 3, and R13 and R14, which may be the same or different, represent C1-4 alkyl or may form a five- to seven-membered saturated heterocyclic ring optionally substituted by C1-4 alkyl together with the nitrogen atom, to which they are attached, and, more preferably, X represents CH or N and Z represents CH;
- compounds wherein X represents N, Z represents CH, R1 and R2 represent C1-4 alkoxy, R3 represents nitro, R4, R5, and R6 represent a hydrogen atom, A represents group (i) wherein i is 2, and R13 and R4, which may be the same or different, represent C2-3 alkyl or may form a six-membered saturated heterocyclic ring optionally substituted by C1-4 alkyl together with the nitrogen atom, to which they are attached;
- compounds wherein R1 and R2 represent C1-4 alkoxy, A represents group (ii) wherein j is 1 or 2, k is 1 or 2, m is 1 or 2, and R15 represents optionally substituted phenyl and, more preferably, X represents CH or N and Z represents CH;
- compounds wherein R1 and R2 represent C1-4 alkoxy, R3, R4, R5, and R6 represent a hydrogen atom, A represents group (ii) wherein j is 1 or 2, k is 1 or 2, m is 1 or 2, and R15 represents optionally substituted phenyl;
- compounds wherein R1 and R2 represent C1-4 alkoxy, R3 represents a group other than a hydrogen atom, R4, R5, and R6 represent a hydrogen atom, A represents group (ii) wherein j is 1 or 2, k is 1 or 2, m is 1 or 2, and R15 represents optionally substituted phenyl and, more preferably, X represents CH or N and Z represents CH;
- compounds wherein R1 and R2 represent C1-4 alkoxy, A represents group (iii) wherein n is 0 (zero), p is an integer of 1 to 3, and R16 and R17, which may be the same or different, represent C1-4 alkyl or may form a five- to seven-membered saturated heterocyclic ring optionally substituted by C1-4 alkyl or an oxygen atom together with the nitrogen atom, to which they are attached, and, more preferably, X represents CH or N and Z represents CH;
- compounds wherein R1 and R2 represent C1-4 alkoxy, R3, R4, R5, and R6 represent a hydrogen atom, A represents group (iii) wherein n is 0 (zero), p is an integer of 1 to 3, and R16 and R17, which may be the same or different, represent C1-4 alkyl or may form a five- to seven-membered saturated heterocyclic ring optionally substituted by C1-4 alkyl or an oxygen atom together with the nitrogen atom, to which they are attached, and, more preferably, X represents CH or N and Z represents CH;
- compounds wherein R1 and R2 represent C1-4 alkoxy, R3 represents a group other than a hydrogen atom, R4, R5, and R6 represent a hydrogen atom, A represents group (iii) wherein n is 0 (zero), p is an integer of 1 to 3, and R16 and R17, which may be the same or different, represent C1-4 alkyl or may form a five- to seven-membered saturated heterocyclic ring optionally substituted by C1-4 alkyl or an oxygen atom together with the nitrogen atom, to which they are attached, and, more preferably, X represents CH or N and Z represents CH;
- compounds wherein R1 and R2 represent C1-4 alkoxy, A represents group (iv) wherein q is 0 (zero), r is 1 or 2, s is 1 or 2, t is 1 or 2, and R18 represents optionally substituted phenyl, and, more preferably, X represents CH or N and Z represents CH;
- compounds wherein R1 and R2 represent C1-4 alkoxy, R3, R4, R5 and R6 represent a hydrogen atom, and A represents group (iv) wherein q is 0 (zero), r is 1 or 2, s is 1 or 2, t is 1 or 2, and R18 represents optionally substituted phenyl;
- compounds wherein R1 and R2 represent C1-4 alkoxy, R3 represents a group other than a hydrogen atom, R1, R5, and R6 represent a hydrogen atom, and A represents group (iv) wherein q is 0 (zero), r is 1 or 2, s is 1 or 2, t is 1 or 2, and R18 represents optionally substituted phenyl, and, more preferably, X represents CH or N and Z represents CH;
- compounds wherein R1 and R2 represent C1-4 alkoxy and A represents group (v), wherein u is 1, and R19 represents optionally substituted phenyl, or C1-4 alkyl substituted by optionally substituted phenyl, and, more preferably, X represents CH or N and Z represents CH;
- compounds wherein R1 and R2 represent C1-4 alkoxy, R3, R4, R5, and R6 represent a hydrogen atom, A represents group (v) wherein u is 1, R19 represents optionally substituted phenyl, or C1-4 alkyl substituted by optionally substituted phenyl;
- compounds wherein R1 and R2 represent C1-4 alkoxy, R5 represents a group other than a hydrogen atom, R3, R4, and R6 represent a hydrogen atom, and A represents group (v) wherein u is 1, R19 represents optionally substituted phenyl, or C1-4 alkyl substituted by optionally substituted phenyl, and, more preferably, X represents CH or N and Z represents CH;
- compounds wherein R1 and R2 represent C1-4 alkoxy and A represents group (vi) wherein R20 represents optionally substituted phenyl or C1-6 alkyl optionally substituted by optionally substituted phenyl, and, more preferably, X represents CH or N and Z represents CH;
- compounds wherein R1 and R2 represent C1-4 alkoxy and A represents group (vii) wherein R21 represents optionally substituted phenyl, or C1-6 alkyl optionally substituted by optionally substituted phenyl, and, more preferably, X represents CH or N and Z represents CH;
- compounds wherein R1 and R2 represent C1-4 alkoxy and A represents group (viii) wherein w is an integer of 1 to 3, L represents —O—, M represents —O— or —C(═O)—O—, R22 represents optionally substituted phenyl, and, more preferably, X represents CH or N and Z represents CH;
- compounds wherein R1 and R2 represent C1-4 alkoxy and A represents group (viii) wherein, when L represents —O—, M represents —O—, —C(═O)—O—, —N(—R12)—, —C(═O)—N(—R12)—, or —C(═O)—; when L represents —S(═O)y-, M represents —O—; and when L represents —N(—R11)—, M represents —O—, and, more preferably, X represents CH or N and Z represents CH;
- compounds wherein R1 and R2 represent C1-4 alkoxy and A represents group (iii), wherein n is 1 and p is 0 (zero), and, more preferably, X represents CH or N and Z represents CH; and
- compounds wherein R1 and R2 represent C1-4 alkoxy, R3 represents morpholyl, R4, R5, and R6 represent a hydrogen atom, and A represents group (x), and, more preferably, X represents CH or N and Z represents CH.
- Examples of particularly preferred compounds according to the present invention include compounds described in Examples 1 to 1209.
- In addition to the compounds described in Examples 1 to 1209, the following compounds may be included in examples of particularly preferred compounds according to the present invention:
- N-{4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-2-nitrophenyl}-N-(4-piperidinobutyl)urea;
- N-{4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-2-nitrophenyl}-N-(3-piperidinopropyl)urea;
- N-[4-(diethylamino)butyl]-N-{4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-2-nitrophenyl}urea;
- N-[3-(diethylamino)propyl]-N-{4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-2-nitrophenyl}urea;
- N-{4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenyl}-N-(4-methylpiperazino)urea; and
- N-{4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N-(4-methylpiperazino)urea.
- Examples of more preferred compounds according to the present invention are the following compounds:
- N-{4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-2-nitrophenyl}-N′-(2-piperidinoethyl)urea; and
- N-[2-(diethylamino)ethyl]-N′-{4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-2-nitrophenyl}urea.
- One or more enantiomeric carbon atoms, which form enantiomer configuration, may exist in the compounds represented by formula (I). The compounds represented by formula (I) include all enantiomers.
- Pharmacologically acceptable salts of the compounds represented by formula (I) include acid addition salts. Acid addition salts include: salts with inorganic acids such as hydrochloric acid, sulfuric acid, phosphoric acid, hydrobromic acid, and nitric acid; or organic acids such as maleic acid, fumaric acid, malic acid, oxalic acid, tartaric acid, succinic acid, citric acid, acetic acid, lactic acid, methanesulfonic acid, and p-toluenesulfonic acid.
- Pharmacologically acceptable solvates of the compounds represented by formula (I) include hydrates and ethanolates.
- Production Process of Compounds
-
- Starting compounds necessary for the synthesis of the compounds according to the present invention are commercially available or can be easily produced by a conventional method.
- Quinolone derivatives as an intermediate may be synthesized according to the method described, for example, in WO 97/17329. Further, 4-chloroquinoline derivatives may be synthesized by a conventional method described, for example, in Org. Synth. Col., Vol. 3, 272 (1955), Acta Chim. Hung., 112, 241 (1983) or WO 98/47873. Further, 4-chloroquinazoline derivatives may be synthesized by a conventional method described, for example, in J. Am. Chem. Soc., 68, 1299 (1946), J. Am. Chem. Soc., 68, 1305 (1946) or Dai-Yukikagaku, supervised by Kotake, Vol. 17, p. 150, Asakura Publishing Co., Ltd., 1967.
- 4-(Nitrophenoxy)quinoline derivatives or corresponding quinazoline derivatives may be synthesized by reacting nitrophenol with a 4-chloroquinoline derivative or a corresponding quinazoline derivative in the presence or absence of a suitable solvent. 4-(Aminophenoxy)quinoline derivatives or corresponding quinazoline derivatives may be synthesized by stirring a 4-(nitrophenoxy)quinoline derivative or a corresponding quinazoline derivative in a suitable solvent, for example, N,N-dimethylformamide, in the presence of a catalyst, for example, palladium hydroxide-carbon or palladium-carbon) in a hydrogen atmosphere. Alternatively, 4-(aminophenoxy)quinoline derivatives or corresponding quinazoline derivatives may be sythesized by reacting an aminophenol derivative with a 4-chloroquinoline derivative or a corresponding quinazoline derivative in the presence of a base, for example, sodium hydride.
- A substituent can be introduced into R11 by reacting a 4-(aminophenoxy)quinoline derivative or a corresponding quinazoline derivative with an acid chloride or an acid anhydride in the presence of a base and then reducing the reaction product with lithium aluminum hydride or the like (step 1A).
- Alternatively, a substituent can be introduced into R11 by reacting a 4-(aminophenoxy)quinoline derivative or a corresponding quinazoline derivative with an aldehyde or a ketone to form an imine compound and then reducing the imine compound with sodium cyanoborohydride or the like (step 1B).
- Compounds represented by formula (I) may be produced by reacting a derivative having a substituent at R11 with an isocyanate derivative (O═C═N—R51 wherein R51 represents a portion of groups (i) and (ii) not having a urea portion according to a conventional method (step 2) and, if necessary, reacting the reaction product with a suitable alkylating agent (R12Hal) in the presence of a base, for example, sodium hydride (step 3).
- R11 and R12 may also be introduced by reacting a urea derivative, wherein R10 and/or R11 represent a hydrogen atom, with a suitable alkylating agent (R11Hal or R12Hal) in the presence of a base, for example, sodium hydride (steps 5 and 7).
- Urea derivatives, wherein R11 and/or R12 represent a hydrogen atom, may be produced by reacting a 4-(aminophenoxy)quinoline derivative or a corresponding quinazoline derivative produced in scheme 1 with an isocyanate derivative according to a conventional method, or by adding triphosgene in the presence of a base, for example, triethylamine and then reacting the mixture with a suitable alkylamine (R51NH2 or R11R51NH) (steps 4 and 6).
-
- A substituent can be introduced into R11 by reacting a 4-(aminophenoxy)quinoline derivative or a corresponding quinazoline derivative with an acid chloride or an acid anhydride in the presence of a base and then reducing the reaction product with lithium aluminum hydride or the like (step 1A).
- Alternatively, a substituent can be introduced into R11 by reacting a 4-(aminophenoxy)quinoline derivative or a corresponding quinazoline derivative with an aldehyde or a ketone to form an imine derivative and then reducing the imine derivative with sodium cyanoborohydride or the like (step 1B).
- Compounds represented by formula (I) may be produced by reacting a derivative having a substituent at R11 with an isothiocyanate derivative, (S═C═N—R52 wherein R52 represents a portion of groups (iii), (iv), and (v), not having a thiourea portion according to a conventional method (step 2) and, if necessary, reacting the reaction product with a suitable alkylating agent (R12Hal) in the presence of a base, for example, sodium hydride (step 3).
- R11 and R12 may also be introduced by reacting a thiourea derivative, wherein R11 and/or R12 represent a hydrogen atom, with a suitable alkylating agent (R11Hal or R12Hal) in the presence of a base, for example, sodium hydride (steps 5 and 7).
- Thiourea derivatives, wherein R11 and/or R12 represent a hydrogen atom, may be produced by reacting a 4-(aminophenoxy)quinoline derivative or a corresponding quinazoline derivative produced in scheme 1 with an isothiocyanate derivative (S═C═N—R52) according to a conventional method, or by adding thiophosgene in the presence of a base, for example, triethylamine and then reacting the mixture with a suitable alkylamine (R52NH2 or R11R52NH) (steps 4 and 6).
-
- Urethane derivatives, wherein R11 and/or R12 represent a hydrogen atom, may be produced according to a conventional method by adding triphosgene to a 4-(aminophenoxy)quinoline derivative or a corresponding quinazoline derivative produced according to scheme 1 in the presence of a base, for example, triethylamine and then reacting the mixture with a suitable alcohol (R20OH). R11 may be introduced by reacting a urethane derivative, wherein R11 represents a hydrogen atom, with a suitable alkylating agent (R11Hal) in the presence of a base, for example, sodium hydride.
-
- Thiocarbamate derivatives, wherein R11 and/or R12 represent a hydrogen atom (v=0), may be produced by adding triphosgene to a 4-(aminophenoxy)quinoline derivative or a corresponding quinazoline derivative produced in scheme 1 in the presence of a base, for example, triethylamine according to a conventional method and then reacting the mixture with a suitable thiol (R21SH). R11 may be introduced by reacting a thiocarbamate derivative, wherein R11 represents a hydrogen atom, with a suitable alkylating agent (R11Hal) in the presence of a base, for example, sodium hydride.
- Oxidation derivatives (v=1) may be produced by oxidizing the thiocarbamate derivative with an oxidizing agent such as m-chloroperbenzoic acid. Further, oxidation derivatives (v=2) may be produced by oxidizing a thiocarbamate derivative with an oxidizing agent such as potassium permanganate or oxone.
-
- 4-(Alkyloxyphenoxy)quinoline derivatives or corresponding quinazoline derivatives, or 4-(acyloxyphenoxy) quinoline derivatives or corresponding quinazoline derivatives may be synthesized by reacting a 4-alkyloxyphenol derivative or a 4-acyloxyphenol derivative with a 4-chloroquinoline derivative or a corresponding quinazoline derivative in the presence or absence of a suitable solvent (scheme 6-1). In the scheme, D represents —(CH2)w-M-R20.
- 4-(Benzyloxyphenoxy)quinoline derivatives or corresponding quinazoline derivatives, or 4-(benzoyloxyphenoxy)quinoline derivatives or corresponding quinazoline derivatives may be synthesized by reacting a 4-benzyloxyphenol derivative or a 4-benzoyloxyphenol derivative with a 4-chloroquinoline derivative or a corresponding quinazoline derivative in the presence or absence of a suitable solvent (scheme 6-1).
- 4-(Hydroxyphenoxy)quinoline derivatives or corresponding quinazoline derivatives may be synthesized by deprotecting a 4-(benzyloxyphenoxy)quinoline derivative or a corresponding quinazoline derivative in a suitable solvent, for example, N,N-dimethylformamide, in the presence of a catalyst, for example, palladium hydroxide-carbon or palladium-carbon in a hydrogen atmosphere. 4-(Hydroxyphenoxy)quinoline derivatives or corresponding quinazoline derivatives may also be synthesized by deprotecting the benzoyl group in the 4-(benzoyloxyphenoxy)quinoline derivative or corresponding quinazoline derivative under basic conditions, for example, using sodium hydroxide.
- Carboxylic acid compound (1) is produced by reacting a 4-(hydroxyphenoxy)quinoline derivative or a corresponding quinazoline derivative with a ω-halogenated alkyl carboxylic acid ester under basic conditions, for example, using sodium hydride and then deprotecting the ester under basic conditions, for example, using sodium hydroxide. Amide derivative (2) may be produced by reacting carboxylic acid compound (1) with an amine in the presence of a coupling reagent, for example, N,N′-dicyclohexylcarbodiimide. Subsequently, reduced derivative (3) may be produced by reducing amide derivative (2) with diborane, lithium aluminum hydride or the like (scheme 6-2).
- S-Alkyl-substituted phenols may be produced by reacting a 4-hydroxythiophenol derivative with a suitable alkyl halide derivative in the presence or absence of a suitable solvent under basic conditions, for example, using potassium carbonate. Thio derivatives may be synthesized by reacting the S-alkyl-substituted phenol with a 4-chloroquinoline derivative or a corresponding quinazoline derivative.
- Sulfoxide derivatives may be produced by oxidizing the thio derivative with an oxidizing agent such as m-chloroperbenzoic acid. Sulfone derivatives may be produced by oxidizing the thio derivative with an oxidizing agent such as potassium permanganate or oxone, or by oxidizing the sulfoxide derivative with an oxidizing agent such as potassium permanganate or oxone.
- A reduced derivative may be produced by reacting a fatty acid with a 4-(aminophenoxy)quinoline derivative or a corresponding quinazoline derivative produced by a conventional method in the presence of a coupling reagent to give an amide derivative and reducing the amide derivative with diborane, lithium aluminum hydride or the like. R11 may be introduced by reacting a reduced derivative, wherein R11 represents a hydrogen atom, with a suitable alkylating agent (R11Hal) in the presence of a base, for example, sodium hydride. Alternatively, R11 may be introduced by reacting an amide derivative, wherein R11 represents a hydrogen atom, with a suitable alkylating agent (R11Hal) in the presence of a base, for example, sodium hydride. Further, a reduced derivative having a substituent at R11 may be produced by reducing the derivative with diborane, lithium aluminum hydride or the like.
- Use of Compounds
- The compounds according to the present invention inhibit, in vitro, PDGF-R autophosphorylation and the growth and migration of vascular smooth muscle cells induced by PDGF stimulation (see Pharmacological Test Examples 1 and 2). The autophosphorylation of PDGF receptors mediates diseases, for example, ischemic diseases involving blood vessel occlusion or angiostenosis induced by angiopathy, ischemic diseases involving blood vessel occlusion or angiostenosis induced by vascular autotransplantation or allotransplantation, and diseases involving cell proliferation and organ fibrosis induced by PDGF, for example, chronic rheumatism, PDGF-dependent tumors such as glioma, cirrhosis, pulmonary fibrosis, and occlusion of arteriovenous shunt resulting, for example, from dialysis of patients suffering from renal failure (Gordon A. A. Ferns et al., Science, Vol. 253, pp 1129-1132 (1991), Martin G Sirois et al., Circulation, Vol. 95, No. 3, pp 669-675 (1997), Marukka Myllarniemi et al., The FASEB Journal, Vol. 11, pp 1119-1126 (1997), H. Ohnishi et al., Life Science, Vol. 28, pp 1641-1646 (1981), J. Gastroenterol. Vol. 32, pp 496-501 (1997), Toxicol. Appl. Pharmacol. Vol. 149, pp 120-126 (1998), and Am. J. Pathol. Vol. 148, pp 785-800 (1996)). Further, the compounds according to the present invention have low VEGF-R inhibitory activity (Pharmacological Test Example 5). Compounds, which do not inhibit VEGF-R, are expected not to accelerate angiostenosis. Furthermore, the compounds according to the present invention inhibit, in vivo, neointima formation hypertrophy of injured blood vessels (Pharmacological Test Examples 4 and 6). Therefore, the compounds according to the present invention can be used in the treatment of diseases mediated by the autophosphorylation of PDGF receptors, particularly ischemic diseases involving blood vessel occlusion/angiostenosis induced by blood vessel injury or vascular autotransplantation or allotransplantation.
- The compounds according to the present invention have low c-kit autophosphorylation inhibitory activity. The c-kit autophosphorylation inhibitory activity crucially affects hematopoiesis and intestinal tract movements (Experimental Medicine, Vol. 11, No. 13, pp 42-53). Therefore, the present invention can provide compounds which do not cause any significant side effect attributable to c-kit autophosphorylation inhibitory activity.
- Pharmaceutical compositions comprising compounds of the present invention as an active ingredient can be administered to human and non-human animals orally or parenterally by administration routes, for example, intravenous administration, intramuscular administration, subcutaneous administration, rectal administration, or percutaneous administration. Therefore, the pharmaceutical composition comprising the compound according to the present invention as active ingredient may be formulated into suitable dosage forms according to the administration routes.
- Specifically, oral preparations include tablets, capsules, powders, granules, and syrups, and parental preparations include injections, suppositories, tapes, and ointments.
- These various preparations may be prepared by conventional methods, for example, with commonly used component, such as excipients, disintegrants, binders, lubricants, colorants, and diluents.
- Excipients include, for example, lactose, glucose, corn starch, sorbit, and crystalline cellulose; disintegrants include, for example, starch, sodium alginate, gelatin powder, calcium carbonate, calcium citrate, and dextrin; binders include, for example, dimethylcellulose, polyvinyl alcohol, polyvinyl ether, methylcellulose, ethylcellulose, gum arabic, gelatin, hydroxypropylcellulose, polyvinyl pyrrolidone, carboxymethylcellulose sodium salt, and chremophore; lubricants include, for example, talc, magnesium stearate, polyethylene glycol, and hydrogenated vegetable oils.
- In preparing injections, if necessary, for example, buffers, pH adjustors, stabilizers, tonicity agents, and preservatives may be added.
- The dose of the compound according to the present invention in the pharmaceutical composition may vary depending upon the dosage form. In general, however, the dose is about 0.5 to 50% by weight, preferably about 1 to 20% by weight, based on the whole composition.
- The dose may be appropriately determined depending upon, for example, the age, weight, sex, difference in diseases, and severity of condition of patients, and the active ingredient may be administered, for example, in an amount of 0.1 to 100 mg/kg, preferably 0.1 to 30 mg/kg. This dose can be administered at a time daily or divided doses of several times daily.
- The present invention will be described in more detail with reference to the following examples, though it is not limited to these examples only.
- Sodium hydride (60 wt %, 0.20 g) was added to dimethyl sulfoxide (15 ml), and the mixture was stirred at room temperature for 10 min. 4-Amino-3-nitrophenol (0.77 g) was added thereto, and the mixture was stirred at room temperature for 10 min. Next, 4-chloro-6,7-dimethoxyquinazoline (1.12 g) was added thereto, and the mixture was stirred at 100° C. for 3 hr. Water was added to the reaction solution, followed by extraction with chloroform. The chloroform layer was then washed with a 1 N aqueous sodium hydroxide solution and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and methanol was added to the residue to prepare a suspension. The precipitated crystal was collected by suction filtration to give the title compound (1.10 g, yield 64%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 4.07 (s, 3H), 4.08 (s, 3H), 6.10-6.15 (m, 2H), 6.92 (d, J=9.0 Hz, 1H), 7.34 (s, 1H), 7.35 (dd, J=9.0 Hz, J=2.7 Hz, 1H), 7.52 (s, 1H), 8.06 (d, J=2.9 Hz, 1H), 8.62 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 343 (M++1)
- 4-Chloro-6,7-dimethoxyquinazoline (10.23 g) and 2-fluoro-4-nitrophenol (14.37 g) were suspended in monochlorobenzene (100 ml), and the suspension was heated under reflux overnight. The solvent was removed by distillation under the reduced pressure, and the residue was washed with toluene, was filtered, and was dried. The crystal thus obtained was then suspended in an aqueous sodium hydroxide solution, and the suspension was filtered, followed by drying to give 4-(3-fluoro-4-nitrophenoxy)-6,7-dimethoxyquinoline (14.2 g, yield 90%). 4-(2-Fluoro-4-nitrophenoxy)-6,7-dimethoxy-quinoline (4.57 g) was dissolved in ethyl acetate/N,N-dimethylformamide/triethylamine (100 ml/100 ml/20 ml) to prepare a solution. Palladium hydroxide (1.2 g) was added to the solution, and the mixture was stirred in a hydrogen atmosphere at room temperature overnight. After filtration through Celite, the solvent was removed by distillation under the reduced pressure. A saturated aqueous sodium hydrogencarbonate solution was added to the residue, and the mixture was extracted with chloroform. The organic layer was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure to quantitatively give 4.27 g of the title compound.
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.85 (m, 2H), 4.07 (s, 3H), 4.08 (s, 3H), 6.50-6.60 (m, 3H), 7.02-7.07 (m, 1H), 7.55-7.65 (m, 2H), 8.48 (d, J=5.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 315 (M++1)
- Sodium hydride (60 wt %, 0.72 g) was added to dimethyl sulfoxide (10 ml), and the mixture was stirred at 50° C. for 20 min. 4-Amino-3-chlorophenol hydrochloride (1.61 g) was added thereto, and the mixture was stirred at room temperature for 10 min. Next, 4-chloro-6,7-dimethoxyquinoline (1.00 g) was added thereto, and the mixture was stirred at 100° C. overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The chloroform layer was then washed with a saturated aqueous sodium hydrogencarbonate solution and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. Methanol was added to the residue, and the precipitated crystal was collected by suction filtration to give the title compound (0.80 g, yield 60%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 4.06 (s, 3H), 4.07 (s, 3H), 6.36 (d, J=5.4 Hz, 1H), 6.65 (dd, J=8.5 Hz, J=2.9 Hz, 1H), 6.76 (d, J=8.8 Hz, 1H), 7.34 (d, J=8.5 Hz, 1H), 7.51 (s, 1H), 8.46 (d, J=6.0 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 332 (M++1)
- 4-Chloro-6,7-dimethoxyquinazoline (5.00 g) and 4-nitro-2-methylphenol (6.85 g) were suspended in monochlorobenzene (25 ml) to prepare a suspension which was then heated under reflux overnight. The solvent was removed by distillation under the reduced pressure. The residue was washed with ethyl acetate, was filtered, and was dried. Next, the resultant crystal was suspended in an aqueous sodium hydroxide solution to prepare a suspension. The suspension was then filtered, followed by drying to give 6.89 g of 4-(2-methyl-4-nitrophenoxy)-6,7-dimethoxyquinoline. 4-(2-Methyl-4-nitrophenoxy)-6,7-dimethoxyquinoline (1.36 g) was dissolved in ethyl acetate/N,N-dimethylformamide/triethylamine (25 ml/25 ml/5 ml). Palladium hydroxide (0.4 g) was added to the solution, and the mixture was stirred in a hydrogen atmosphere at room temperature overnight. After filtration through Celite, the solvent was removed by distillation under the reduced pressure. A saturated aqueous sodium hydrogencarbonate solution was added to the residue, and the mixture was extracted with chloroform. The organic layer was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure to give the title compound (1.31 g, yield 91%).
- Mass spectrometry value (ESI-MS, m/z): 311 (M++1)
- Sodium hydride (60 wt %, 3.2 g) was added to dimethyl sulfoxide (50 ml), and the mixture was stirred at 50° C. for 20 min. 4-Amino-3-methoxyphenol (5.6 g) was added thereto, and the mixture was stirred at room temperature for 10 min. Next, 4-chloro-6,7-dimethoxyquinazoline (7.0 g) was added thereto, and the mixture was stirred at 100° C. overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The chloroform layer was then washed with a saturated aqueous sodium hydrogencarbonate solution and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. Methanol was added to the residue, and the precipitated crystal was collected by suction filtration to give the title compound (7.3 g, yield 72%).
- Mass spectrometry value (ESI-MS, m/z): 328 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (129 mg) was added to toluene/triethylamine=10/1 (10 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (193 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-methylbenzyl alcohol (79 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated, and the residue was purified on a column using chloroform/methanol to give the title compound (108 mg, yield 51%).
- 1H-NMR (CDCl3, 400 MHz): 8.61 (1H, s), 7.16-7.54 (10H, m), 6.70 (1H, s), 5.16 (2H, s), 4.05 (6H, s), 2.35 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 446 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)-oxy]aniline (109 mg) was added to toluene/triethylamine=10/1 (10 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (146 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. subsequently, 4-methylbenzyl alcohol (61 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (48 mg, yield 28%).
- 1H-NMR (CDCl3, 400 MHz): 8.61 (1H, s), 8.29 (1H, d, J=9.0), 7.50 (1H, s), 7.15-7.35 (8H, m), 5.18 (2H, s), 4.05 (3H, s), 4.05 (3H, s), 2.36 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 481 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (72 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (109 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-chloro-α-methylbenzyl alcohol (46 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (88 mg, yield 70%).
- 1H-NMR (CDCl3, 400 MHz): 8.44-8.50 (1H, m), 8.14 (1H, s), 7.58-7.64 (3H, m), 7.26-7.42 (4H, m), 7.15-7.19 (2H, m), 6.86 (1H, s), 6.67 (1H, d, J=6.6), 5.88 (1H, q, J=6.6), 4.16
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (75 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (100 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-chloro-α-methylbenzyl alcohol (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (62 mg, yield 49%).
- 1H-NMR (CDCl3, 400 MHz): 8.41-8.47 (1H, m), 8.15 (1H, s), 7.71-7.76 (1H, m), 7.66 (1H, s), 7.25-7.45 (4H, m), 7.01 (1H, d, J=9.2 Hz), 6.50-6.55 (2H, m), 5.87 (1H, q, J=6.5 Hz), 4.17 (3H, s), 4.11 (3H, s), 2.27 (3H, s), 2.10 (3H, s), 1.62 (3H, d, J=6.5 Hz)
- Mass spectrometry value (ESI-MS, m/z): 508 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (75 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (110 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-chloro-α-methylbenzyl alcohol (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (70 mg, yield 56%).
- 1H-NMR (CDCl3, 400 MHz): 8.37-8.44 (1H, m), 8.07 (1H, s), 7.82 (1H, bs), 7.57 (1H, s), 7.34 (1H, s), 7.20-7.26 (3H, m), 6.88 (1H, s), 6.49 (1H, d, J=6.6 Hz), 6.44 (1H, m), 5.80 (1H, q, J=6.6 Hz), 4.10 (3H, s), 4.03 (3H, s), 2.22 (3H, s), 2.04 (3H, s), 1.56 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 508 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (72 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (100 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 15 min. Subsequently, 3-chloro-α-methylbenzyl alcohol (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (71 mg, yield 57%).
- 1H-NMR (CDCl3, 400 MHz): 8.76 (1H, s), 8.07 (1H, s), 7.50-7.60 (3H, m), 7.15-7.39 (5H, m), 6.83 (1H, s), 6.75-6.78 (1H, m), 5.84 (1H, q, J=6.8 Hz), 4.16 (3H, s), 4.09 (3H, s), 1.59 (3H, d, J=6.8 Hz)
- Mass spectrometry value (ESI-MS, m/z): 481 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (72 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (105 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-chloro-α-methylbenzyl alcohol (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (43 mg, yield 36%).
- 1H-NMR (CDCl3, 400 MHz): 8.77 (1H, s), 8.33 (1H, d, J=9.0 Hz), 8.06 (1H, s), 7.55 (1H, s), 7.39 (1H, s), 7.22-7.32 (6H, m), 5.85 (1H, q, J=6.7 Hz), 4.16 (3H, s), 4.09 (3H, s), 1.61 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 415 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (72 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (108 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-fluorobenzyl alcohol (40 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (68 mg, yield 58%).
- 1H-NMR (CDCl3, 400 MHz): 8.44-8.50 (1H, m), 8.14 (1H, s), 7.63 (1H, s), 7.56-7.66 (2H, m), 7.38-7.44 (2H, m), 7.16-7.20 (2H, m), 7.05-7.11 (2H, m), 6.85 (1H, s), 6.68 (1H, s), 5.20 (2H, s), 4.17 (3H, s), 4.10 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 429 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (78 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (110 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-fluorobenzyl alcohol (40 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (77 mg, yield 62%).
- 1H-NMR (CDCl3, 400 MHz): 8.42-8.47 (1H, m), 8.16 (1H, s), 7.66 (1H, s), 6.99-7.45 (6H, m), 6.50-6.56 (2H, m), 5.20 (2H, s), 4.17 (3H, s), 4.11 (3H, s), 2.25 (3H, s), 2.10 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 477 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (82 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (111 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-fluorobenzyl alcohol (40 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (88 mg, yield 68%).
- 1H-NMR (CDCl3, 400 MHz): 8.43-8.48 (1H, m), 8.15 (1H, m), 7.91 (1H, s), 7.64 (1H, s), 6.94-7.53 (6H, m), 6.57 (1H, d, J=6.6 Hz), 6.49 (1H, s), 5.20 (2H, s), 4.17 (3H, s), 4.11 (3H, s), 2.27 (3H, s), 2.13 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 477 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (115 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 15 min. Subsequently, 4-fluorobenzyl alcohol (45 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (43 mg, yield 33%).
- 1H-NMR (CDCl3, 400 MHz): 8.64 (1H, s), 7.56 (1H, s), 7.00-7.54 (9H, m), 6.72 (1H, s), 5.19 (2H, s), 4.09 (3H, s), 4.08 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 450 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (72 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (116 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 15 min. Subsequently, 4-fluorobenzyl alcohol (45 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (38 mg, yield 34%).
- 1H-NMR (CDCl3, 400 MHz): 8.64 (1H, s), 8.30 (1H, d, J=9.3 Hz), 7.52 (1H, s), 7.40-7.45 (3H, m), 7.32-7.34 (1H, m), 7.18-7.22 (2H, m), 7.06-7.12 (2H, m), 5.21 (2H, s), 4.08 (3H, s), 4.07 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 485 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (69 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (103 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 15 min. Subsequently, 2-chloro-α-methylbenzyl alcohol (55 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (77 mg, yield 64%).
- 1H-NMR (CDCl3, 400 MHz): 8.40-8.48 (1H, m), 8.14 (1H, s), 7.15-7.64 (9H, m), 6.86 (1H, s), 6.67 (1H, d, J=6.6 Hz), 6.28 (1H, q, J=6.6 Hz), 4.16 (3H, s), 4.19 (3H, s), 1.63 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 480 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (67 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (92 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 15 min. Subsequently, 2-chloro-α-methylbenzyl alcohol (48 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (88 mg, yield 79%).
- 1H-NMR (CDCl3, 400 MHz): 8.43 (1H, d, J=6.6 Hz), 8.14 (1H, s), 7.72-7.78 (1H, m), 7.66 (1H, s), 7.25-7.54 (4H, m), 7.00 (1H, d, J=8.6 Hz), 6.50-6.57 (2H, m), 6.27 (1H, q, J=6.6 Hz), 4.17 (3H, s), 4.11 (3H, s), 2.27 (3H, s), 2.09 (3H, s), 1.63 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 508 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (62 mg) was added to toluene/triethylamine=10/1 (6 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (93 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 15 min. Subsequently, 2-chloro-α-methylbenzyl alcohol (49 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (52 mg, yield 48%).
- Mass spectrometry value (ESI-MS, m/z): 480 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (61 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (91 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 15 min. Subsequently, 2-chloro-α-methylbenzyl alcohol (57 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (77 mg, yield 69%).
- 1H-NMR (CDCl3, 400 MHz): 8.77 (1H, s), 8.36 (1H, d, J=8.8 Hz), 8.00-8.05 (1H, m), 7.16-7.57 (8H, m), 6.28 (1H, q, J=6.8 Hz), 4.17 (3H, s), 4.10 (3H, s), 1.63 (3H, d, J=6.8 Hz)
- Mass spectrometry value (ESI-MS, m/z): 515 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (78 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (117 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(2-chlorophenoxy)-1-propanol (67 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (80 mg, yield 58%).
- 1H-NMR (CDCl3, 400 MHz): 8.43 (1H, d, J=5.4 Hz), 7.61 (1H, s), 7.48 (1H, s), 7.35-7.40 (1H, m), 7.18-7.25 (2H, m), 6.87-7.05 (3H, m), 6.43 (1H, bs), 6.27 (1H, d, J=4.9 Hz), 4.46 (2H, t, J=6.2 Hz), 4.05-4.22 (2H, m), 4.07 (3H, s), 4.06 (3H, s), 2.24 (3H, s), 2.11 (3H, s), 2.10-2.22 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 538 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (71 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (97 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(2-chlorophenoxy)-1-propanol (72 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (62 mg, yield 44%).
- 1H-NMR (CDCl3, 400 MHz): 8.44 (1H, d, J=5.4 Hz), 7.50-7.80 (2H, m), 7.19-7.40 (3H, m), 6.88-6.98 (3H, m), 6.35-6.48 (2H, m), 4.65 (2H, t, J=6.2 Hz), 4.18 (2H, t, J=6.0 Hz), 4.07 (3H, s), 4.07 (3H, s), 2.10-2.30 (8H, m)
- Mass spectrometry value (ESI-MS, m/z): 538 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (77 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (115 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(2-chlorophenoxy)-1-propanol (72 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (62 mg, yield 44%).
- 1H-NMR (CDCl3, 400 MHz): 8.62-8.64 (1H, m), 7.55-7.57 (1H, m), 7.48-7.53 (2H, m), 7.35-7.40 (2H, m), 7.19-7.28 (3H, m), 6.87-6.97 (2H, m), 6.77 (1H, bs), 4.43-4.48 (2H, m), 4.14-4.20 (2H, m), 4.08 (3H, s), 4.07 (3H, s), 2.15-2.28 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 511 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (70 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (94 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(2-chlorophenoxy)-1-propanol (59 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (61 mg, yield 50%).
- 1H-NMR (CDCl3, 400 MHz): 8.63 (1H, s), 8.25-8.35 (1H, d), 7.52 (1H, s), 7.14-7.41 (6H, m), 6.88-6.98 (2H, m), 4.48 (2H, t, J=6.2 Hz), 4.18 (2H, t, J=6.2 Hz), 4.08 (3H, s), 4.07 (3H, s), 2.10-2.50 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 545 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (75 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (112 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-trifluoromethylbenzyl alcohol (67 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (77 mg, yield 57%).
- 1H-NMR (CDCl3, 400 MHz): 8.43-8.48 (1H, m), 8.14 (1H, s), 7.47-7.70 (7H, m), 7.15-7.22 (3H, m), 6.68 (1H, d, J=6.6 Hz), 5.29 (2H, s), 4.16 (3H, s), 4.10 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 499 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (77 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (105 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-trifluoromethylbenzyl alcohol (63 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (80 mg, yield 60%).
- 1H-NMR (CDCl3, 400 MHz): 8.44 (1H, d, J=6.4 Hz), 8.00-8.15 (1H, m), 7.53-7.69 (6H, m), 7.03 (1H, d, J=9.0 Hz), 6.54-6.65 (1H, m), 6.47-6.53 (1H, m), 5.29 (3H, s), 4.15 (3H, s), 4.11 (3H, s), 2.27 (3H, s), 2.11 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 528 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (77 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (105 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-trifluoromethylbenzyl alcohol (63 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (80 mg, yield 48%).
- 1H-NMR (CDCl3, 400 MHz): 8.43-8.48 (1H, m), 8.16 (1H, s), 7.50-7.95 (6H, m), 6.97 (1H, s), 6.55-6.60 (2H, m), 5.29 (2H, m), 4.17 (3H, s), 4.11 (3H, s), 2.29 (3H, s), 2.14 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 528 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (70 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (105 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-trifluoromethylbenzyl alcohol (63 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (60 mg, yield 48%).
- 1H-NMR (CDCl3, 400 MHz): 8.70 (1H, s), 7.48-7.78 (8H, m), 7.20-7.24 (2H, m), 6.94 (1H, bs), 5.28 (2H, s), 4.13 (3H, s), 4.10 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 500 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (74 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (99 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-trifluoromethylbenzyl alcohol (60 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (52 mg, yield 41%).
- 1H-NMR (CDCl3, 400 MHz): 8.62-8.65 (1H, m), 8.25-8.34 (1H, m), 7.16-7.71 (9H, m), 5.27-5.31 (2H, m), 4.05-4.08 (6H, m)
- Mass spectrometry value (ESI-MS, m/z): 535 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (61 mg) was added to toluene/triethylamine=10/1 (6 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (91 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(2-chlorophenoxy)-1-propanol (57 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (77 mg, yield 69%).
- 1H-NMR (CDCl3, 400 MHz): 8.43-8.50 (1H, m), 8.15 (1H, s), 7.64 (1H, s), 7.56-7.65 (2H, m), 6.89-7.40 (6H, m), 6.81 (1H, s), 6.68 (1H, d, J=6.4 Hz), 4.48 (2H, t, J=6.2 Hz), 4.15-4.22 (2H, m), 4.17 (3H, s), 4.10 (3H, s), 2.20-2.30 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 510 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (79 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (120 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(4-chlorophenoxy)-1-propanol (60 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (80 mg, yield 55%).
- 1H-NMR (CDCl3, 400 MHz): 8.44-8.50 (1H, m), 8.15 (1H, s), 7.63 (1H, s), 7.52-7.64 (4H, m), 6.77-6.87 (3H, m), 6.68 (1H, d, J=6.3 Hz), 4.41 (2H, t, J=6.3 Hz), 4.17 (3H, s), 4.10 (3H, s), 4.05-4.10 (2H, m), 2.15-2.22 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 510 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (115 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(4-chlorophenoxy)-1-propanol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (84 mg, yield 60%).
- 1H-NMR (CDCl3, 400 MHz): 8.41-8.48 (1H, m), 8.16 (1H, s), 7.65-7.75 (1H, m), 6.82-7.27 (7H, m), 6.43-6.58 (1H, m), 4.41 (2H, d, J=6.3 Hz), 4.17 (3H, s), 4.11 (3H, s), 4.05-4.15 (2H, m), 2.26 (3H, s), 2.10 (3H, s), 2.00-2.08 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 538 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (78 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (115 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(4-chlorophenoxy)-1-propanol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (71 mg, yield 51%).
- 1H-NMR (CDCl3, 400 MHz): 8.43-8.48 (1H, m), 8.15 (1H, s), 7.88 (1H, bs), 7.64 (1H, s), 6.82-7.26 (6H, m), 6.57 (1H, d, J=6.6 Hz), 6.43 (1H, bs), 4.12 (2H, t, J=6.6 Hz), 4.17 (3H, s), 4.11 (3H, s), 4.05-4.11 (2H, m), 2.28 (3H, s), 2.15-2.23 (2H, m), 2.12 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 538 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (78 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (120 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(4-chlorophenoxy)-1-propanol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (60 mg, yield 37%).
- 1H-NMR (CDCl3, 400 MHz): 8.79 (1H, s), 8.14 (1H, s), 7.61 (1H, s), 7.53-7.58 (2H, m), 7.16-7.26 (4H, m), 6.76-6.86 (3H, m), 4.40 (2H, t, J=6.2 Hz), 4.19 (3H, s), 4.12 (3H, s), 4.02-4.10 (2H, m), 2.15-2.21 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 511 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (75 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (121 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(4-chlorophenoxy)-1-propanol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (58 mg, yield 44%).
- 1H-NMR (CDCl3, 400 MHz): 8.70 (1H, s), 8.25-8.35 (1H, m), 7.65-7.70 (1H, m), 7.54 (1H, s), 7.15-7.35 (4H, m), 6.82-6.87 (3H, m), 4.42 (2H, t, J=6.4 Hz), 4.12 (3H, s), 4.09 (3H, s), 4.05-4.13 (2H, m), 2.17-2.25 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 545 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (73 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (110 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-methoxy-α-methylbenzyl alcohol (56 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (74 mg, yield 59%).
- 1H-NMR (CDCl3, 400 MHz): 8.44-8.48 (1H, m), 8.14 (1H, s), 7.63 (1H, s), 7.55-7.62 (2H, m), 7.33-7.38 (2H, m), 7.14-7.18 (2H, m), 6.88-6.94 (2H, m), 6.79 (1H, s), 6.67 (1H, d, J=6.4 Hz), 5.86-5.93 (1H, m), 4.16 (3H, s), 4.10 (3H, s), 3.82 (3H, s), 1.63 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 476 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (68 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (94 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-methoxy-α-methylbenzyl alcohol (48 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (75 mg, yield 66%).
- 1H-NMR (CDCl3, 400 MHz): 8.40-8.45 (1H, m), 8.15 (1H, s), 7.73-7.78 (1H, m), 7.66 (1H, s), 7.33-7.38 (2H, m), 6.98-7.02 (1H, m), 6.89-6.94 (2H, m), 6.53 (1H, d, J=6.6 Hz), 6.46 (1H, bs), 5.85-5.92 (1H, m), 4.20 (3H, s), 4.11 (3H, s), 3.82 (3H, s), 2.24 (3H, s), 2.09 (3H, s), 1.63 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 504 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (110 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-methoxy-α-methylbenzyl alcohol (56 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (80 mg, yield 60%).
- 1H-NMR (CDCl3, 400 MHz): 8.41-8.47 (1H, m), 8.15 (1H, s), 7.92 (1H, s), 7.64 (1H, s), 6.80-7.40 (5H, m), 6.55 (1H, d, J=6.6 Hz), 6.44 (1H, s), 5.85-5.92 (1H, m), 4.17 (3H, s), 4.11 (3H, s), 3.82 (3H, s), 2.26 (3H, s), 2.11 (3H, s), 1.64 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 504 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (68 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (102 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-methoxy-α-methylbenzyl alcohol (52 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (61 mg, yield 52%).
- 1H-NMR (CDCl3, 400 MHz): 8.72 (1H, s), 7.85 (1H, s like), 7.58 (1H, s), 7.48-7.55 (2H, m), 7.32-7.37 (2H, m), 7.15-7.20 (2H, m), 6.87-6.93 (2H, m), 6.72 (1H, s), 5.85-5.92 (1H, m), 4.14 (3H, s), 4.10 (3H, s), 3.81 (3H, s), 1.61 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 477 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (66 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (88 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-methoxy-α-methylbenzyl alcohol (45 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (58 mg, yield 53%).
- 1H-NMR (CDCl3, 400 MHz): 8.76 (1H, s like), 8.32-8.40 (1H, m), 6.88-8.00 (9H, m), 5.87-5.93 (1H, m), 4.16 (3H, s), 4.10 (3H, s), 3.82 (3H, s), 1.63 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 511 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (121 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-[(4-methylphenyl)sulfanyl]-1-propanol (74 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (98 mg, yield 67%).
- 1H-NMR (CDCl3, 400 MHz): 8.44-8.50 (H, m), 8.15 (1H, s), 7.64 (1H, s), 7.55-7.64 (2H, m), 7.10-7.31 (6H, m), 6.77 (1H, s), 6.69 (1H, d, J=6.6 Hz), 4.32 (2H, t, J=6.2 Hz), 4.17 (3H, s), 4.10 (3H, s), 2.97-3.03 (2H, m), 2.33 (3H, s), 1.95-2.05 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 506 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (85 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (122 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-[(4-methylphenyl)sulfanyl]-1-propanol (72 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (93 mg, yield 62%).
- 1H-NMR (CDCl3, 400 MHz): 8.40-8.48 (1H, m), 8.16 (1H, s), 7.65-7.77 (2H, m), 7.00-7.31 (5H, m), 6.55 (1H, d, J=6.4 Hz), 6.40-6.50 (1H, m), 4.29-4.40 (1H, m), 4.17 (3H, s), 4.11 (3H, s), 3.74-3.80 (1H, m), 2.95-3.05 (2H, m), 2.26-2.34 (6H, m), 2.10 (3H, s), 1.84-2.04 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 523 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (85 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (120 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-[(4-methylphenyl)sulfanyl]-1-propanol (72 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (82 mg, yield 56%).
- 1H-NMR (CDCl3, 400 MHz): 8.40-8.49 (1H, m), 8.16 (1H, s), 7.85-7.92 (1H, m), 7.64 (1H, s), 7.08-7.32 (4H, m), 6.95 (1H, s), 6.57 (1H, d, J=6.6 Hz), 6.40 (1H, s), 4.30-4.40 (2H, m), 4.17 (3H, s), 4.11 (3H, s), 2.95-3.15 (2H, m), 2.27-2.34 (6H, m), 2.13 (3H, s), 1.98-2.06 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 524 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (120 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-[(4-methylphenyl)sulfanyl]-1-propanol (74 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (82 mg, yield 56%).
- 1H-NMR (CDCl3, 400 MHz): 8.66 (1H, s), 7.57 (1H, s), 7.48-7.55 (2H, m), 7.10-7.31 (7H, m), 6.65 (1H, bs), 4.27-4.38 (2H, m), 4.10 (3H, s), 4.09 (3H, s), 2.95-3.15 (2H, m), 2.32 (3H, s), 1.95-2.05 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 507 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (125 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-[(4-methylphenyl)sulfanyl]-1-propanol (66 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (68 mg, yield 49%).
- 1H-NMR (CDCl3, 400 MHz): 8.76 (1H, s), 8.31-8.38 (1H, m), 7.91 (1H, bs), 7.56 (2H, s), 7.10-7.34 (6H, m), 4.30-4.43 (2H, m), 4.16 (3H, s), 4.11 (3H, s), 3.00 (2H, t, J=7.0 Hz), 2.32 (3H, s), 1.97-2.06 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 541 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (120 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(4-methoxyphenoxy)-1-propanol (73 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (118 mg, yield 80%).
- 1H-NMR (CDCl3, 400 MHz): 8.44-8.48 (1H, m), 8.14 (1H, s), 7.64 (1H, s), 7.57-7.64 (2H, m), 7.15-7.20 (2H, m), 6.83-6.87 (5H, m), 6.65-6.72 (1H, m), 4.17 (3H, s), 4.10 (3H, s), 4.42 (2H, t, J=6.2 Hz), 4.06 (2H, t, J=6.2 Hz), 3.77 (3H, s), 2.17 (2H, t, J=6.2 Hz)
- Mass spectrometry value (ESI-MS, m/z): 506 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (88 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (122 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(4-methoxyphenoxy)-1-propanol (74 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (128 mg, yield 83%).
- 1H-NMR (CDCl3, 400 MHz): 8.42-8.46 (1H, m), 8.16 (1H, s), 7.66-7.75 (1H, m), 7.02 (1H, d, J=8.8 Hz), 6.80-6.87 (5H, m), 6.55 (1H, d, J=6.6 Hz), 6.46 (1H, bs), 4.41 (2H, t, J=6.4 Hz), 4.17 (3H, s), 4.11 (3H, s), 4.04-4.10 (2H, m), 3.77 (3H, s), 2.26 (3H, s), 2.10 (3H, s), 2.14-2.21 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 534 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (98 mg) was added to toluene/triethylamine=10/1 (10 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (136 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(4-methoxyphenoxy)-1-propanol (83 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (130 mg, yield 76%).
- 1H-NMR (CDCl3, 400 MHz): 8.43-8.47 (1H, m), 8.15 (1H, s), 7.89 (1H, bs), 7.64 (1H, s), 6.80-6.97 (5H, m), 6.57 (1H, d, J=6.6 Hz), 6.44 (1H, s), 4.42 (2H, t, J=6.3 Hz), 4.17 (3H, s), 4.11 (3H, s), 4.06 (2H, t, J=6.3 Hz), 3.77 (3H, s), 2.28 (3H, s), 2.14-2.24 (2H, m), 2.12 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 534 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (82 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (122 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(4-methoxyphenoxy)-1-propanol (75 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (92 mg, yield 62%).
- 1H-NMR (CDCl3, 400 MHz): 8.66 (1H, s), 7.57 (1H, s), 7.40-7.54 (3H, m), 7.18-7.24 (2H, m), 6.65-6.85 (5H, m), 4.40 (2H, t, J=63 Hz), 4.09 (3H, s), 4.08 (3H, s), 4.05 (2H, t, J=6.1 Hz), 3.77 (3H, s), 2.10-2.20 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 507 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (87 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (117 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(4-methoxyphenoxy)-1-propanol (72 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (68 mg, yield 45%).
- 1H-NMR (CDCl3, 400 MHz): 8.68 (1H, s), 8.30 (1H, d, J=8.5 Hz), 7.53-7.60 (2H, m), 6.80-7.34 (7H, m), 4.42 (2H, t, J=6.4 Hz), 4.11 (3H, s), 4.08 (3H, s), 4.06 (2H, t, J=6.2 Hz), 3.77 (3H, s), 2.15-2.22 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 540 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (75 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (112 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(3-methoxyphenoxy)-1-propanol (69 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (88 mg, yield 69%).
- 1H-NMR (CDCl3, 400 MHz): 8.45-8.51 (1H, m), 8.14 (1H, s), 7.63 (1H, s), 7.54-7.64 (2H, m), 7.15-7.23 (3H, m), 6.82 (1H, s), 6.69 (1H, d, J=6.6 Hz), 6.45-6.55 (3H, m), 4.42 (2H, t, J=6.2 Hz), 4.17 (3H, s), 4.10 (3H, s), 4.09 (2H, t, J=6.1 Hz), 3.79 (3H, s), 2.15-2.22 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 506 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (85 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (116 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(3-methoxyphenoxy)-1-propanol (72 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (91 mg, yield 72%).
- 1H-NMR (CDCl3, 400 MHz): 8.43 (1H, d, J=5.4 Hz), 7.50-7.63 (2H, m), 6.28-7.24 (8H, m), 4.40 (2H, t, J=6.3 Hz), 4.07 (6H, s), 4.05-4.10 (2H, m), 3.79 (3H, s), 2.24 (3H, s), 2.15-2.23 (2H, m), 2.11 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 534 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (77 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (105 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(3-methoxyphenoxy)-1-propanol (65 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (91 mg, yield 72%).
- 1H-NMR (CDCl3, 400 MHz): 8.40-8.48 (1H, m), 8.15 (1H, s), 7.89 (1H, s), 8.63-8.68 (1H, m), 6.93-7.25 (2H, m), 6.40-6.59 (5H, m), 4.38-4.45 (2H, m), 4.17 (3H, s), 4.11 (3H, s), 4.05-4.14 (2H, m), 3.79 (3H, s), 2.15-2.25 (2H, m), 2.28 (3H, s), 2.12 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 534 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (95 mg) was added to toluene/triethylamine=10/1 (10 ml), and the mixture was then added to the solution, and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (142 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(3-methoxyphenoxy)-1-propanol (87 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (105 mg, yield 65%).
- 1H-NMR (CDCl3, 400 MHz): 8.69 (1H, s), 7.45-7.97 (3H, m), 7.13-7.21 (3H, m), 6.40-6.80 (5H, m), 4.38 (2H, t, J=6.4 Hz), 4.10 (3H, s), 4.07 (3H, s), 3.98-4.08 (2H, m), 3.77 (3H, s), 2.08-2.20 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 507 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (107 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(3-methoxyphenoxy)-1-propanol (67 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (67 mg, yield 52%).
- 1H-NMR (CDCl3, 400 MHz): 8.70 (1H, s), 8.31 (1H, d, J=9.0 Hz), 7.54 (1H, s), 7.33 (1H, d, J=2.7 Hz), 7.15-7.23 (3H, m), 6.47-6.55 (4H, m), 4.43 (2H, t, J=6.2 Hz), 4.12 (3H, s), 4.09 (3H, s), 4.08-4.13 (2H, m), 3.79 (3H, s), 2.15-2.25 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 541 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (83 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (124 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-methoxy-α-methylbenzyl alcohol (64 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (88 mg, yield 66%).
- 1H-NMR (CDCl3, 400 MHz): 8.46 (1H, dd, J=6.5 Hz), 8.14 (1H, s), 7.58-7.64 (2H, m), 7.38-7.42 (1H, m), 7.29-7.32 (1H, m), 7.14-7.18 (2H, m), 6.96-7.02 (1H, m), 6.91 (1H, d, J=8.3 Hz), 6.86 (1H, s), 6.68 (1H, d, J=6.6 Hz), 6.29 (1H, q, J=6.5 Hz), 4.16 (3H, s), 4.10 (3H, s), 3.88 (3H, s), 1.58 (3H, d, J=6.5 Hz)
- Mass spectrometry value (ESI-MS, m/z): 476 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (90 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (123 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-methoxy-α-methylbenzyl alcohol (64 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (97 mg, yield 70%).
- 1H-NMR (CDCl3, 400 MHz): 8.41-8.46 (1H, m), 8.15 (1H, s), 7.77 (1H, d, J=8.6 Hz), 7.66 (1H, s), 7.40 (1H, d, J=7.8 Hz), 7.30 (1H, d, J=7.3 Hz), 6.96-7.20 (2H, m), 6.91 (1H, d, J=8.3 Hz), 6.50-6.55 (2H, m), 6.29 (1H, q, J=6.5 Hz), 4.17 (3H, s), 4.11 (3H, s), 3.87 (3H, s), 2.27 (3H, s), 2.09 (3H, s), 1.59 (3H, d, J=6.5 Hz)
- Mass spectrometry value (ESI-MS, m/z): 504 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (90 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (123 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-methoxy-α-methylbenzyl alcohol (64 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (78 mg, yield 56%).
- 1H-NMR (CDCl3, 400 MHz): 8.41-8.48 (1H, m), 8.12 (1H, s), 7.92 (1H, s), 7.62 (1H, s), 7.26-7.42 (2H, m), 6.85-7.00 (3H, m), 6.45-6.58 (2H, m), 6.27 (1H, q, J=6.5 Hz), 4.14 (3H, s), 4.08 (3H, s), 3.86 (3H, s), 2.27 (3H, s), 2.08 (3H, s), 1.57 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 504 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (83 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (124 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-methoxy-α-methylbenzyl alcohol (64 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (76 mg, yield 58%).
- 1H-NMR (CDCl3, 400 MHz): 8.75 (1H, s), 8.00 (1H, bs), 7.16-7.62 (7H, m), 6.88-7.02 (2H, m), 6.79 (1H, bs), 6.28 (1H, q, J=6.4 Hz), 4.16 (3H, s), 4.11 (3H, s), 3.87 (3H, s), 1.58 (3H, d, J=6.4 Hz)
- Mass spectrometry value (ESI-MS, m/z): 477 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (82 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (110 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-methoxy-α-methylbenzyl alcohol (56 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (69 mg, yield 55%).
- 1H-NMR (CDCl3, 400 MHz): 8.80 (1H, s), 8.40 (1H, d, J=9.0 Hz), 8.14 (1H, s), 7.14-7.60 (5H, m), 6.97-7.03 (1H, m), 6.91 (1H, d, J=8.3 Hz), 6.30 (1H, q, J=6.5 Hz), 4.19 (3H, s), 4.12 (3H, s), 3.88 (3H, s), 1.60 (3H, d, J=6.5 Hz)
- Mass spectrometry value (ESI-MS, m/z): 511 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (90 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (137 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-methoxy-tert-butylbenzyl alcohol (75 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (109 mg, yield 69%).
- 1H-NMR (CDCl3, 400 MHz): 8.46 (1H, dd, J=6.7 Hz), 8.15 (1H, s), 7.64 (1H, s), 7.59 (2H, d, J=9.0 Hz), 7.43 (2H, d, J=9.0 Hz), 7.36 (2H, d, J=8.3 Hz), 7.18 (2H, d, J=9.0 Hz), 6.82 (1H, s), 6.68 (1H, d, J=6.7 Hz), 5.21 (2H, s), 4.17 (3H, s), 4.19 (3H, s), 1.34 (9H, s)
- Mass spectrometry value (ESI-MS, m/z): 488 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (83 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (115 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-methoxy-tert-butylbenzyl alcohol (63 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (101 mg, yield 72%).
- 1H-NMR (CDCl3, 400 MHz): 8.42-8.47 (1H, m), 8.16 (1H, s), 7.75-7.85 (1H, m), 7.67 (1H, s), 7.44 (2H, d, J=8.6 Hz), 7.38 (2H, d, J=8.3 Hz), 7.03 (1H, d, J=9.0 Hz), 6.55 (1H, d, J=6.6 Hz), 6.52 (1H, bs), 5.21 (2H, s), 4.17 (3H, s), 4.11 (3H, s), 2.25 (3H, s), 2.09 (3H, s), 1.34 (9H, s)
- Mass spectrometry value (ESI-MS, m/z): 516 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (111 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-methoxy-tert-butylbenzyl alcohol (61 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (93 mg, yield 68%).
- 1H-NMR (CDCl3, 400 MHz): 8.40-8.47 (1H, m), 8.15 (1H, s), 7.95 (1H, bs), 7.64 (1H, s), 7.36-7.46 (4H, m), 6.95 (1H, s), 6.57 (1H, d, J=6.6 Hz), 6.50 (1H, s), 5.21 (2H, s), 4.17 (3H, s), 4.11 (3H, s), 2.26 (3H, s), 2.13 (3H, s), 1.34 (9H, s)
- Mass spectrometry value (ESI-MS, m/z): 516 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (95 mg) was added to toluene/triethylamine=10/1 (10 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (144 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-methoxy-tert-butylbenzyl alcohol (79 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (71 mg, yield 42%).
- 1H-NMR (CDCl3, 400 MHz): 8.77 (1H, s), 8.07 (1H, bs), 7.61 (1H, s), 7.51-7.58 (2H, m), 7.42 (2H, d, J=8.6 Hz), 7.36 (2H, d, J=8.3 Hz), 7.19 (2H, d, J=9.0 Hz), 6.79 (1H, s), 5.20 (2H, s), 4.18 (3H, s), 4.12 (3H, s), 1.33 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 489 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (90 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (122 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-methoxy-tert-butylbenzyl alcohol (67 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (55 mg, yield 36%).
- 1H-NMR (CDCl3, 400 MHz): 8.80 (1H, s), 8.41 (1H, d, J=9.2 Hz), 8.13 (1H, s), 7.58 (1H, s), 7.36-7.46 (4H, m), 7.24-7.34 (2H, m), 7.17-7.22 (1H, m), 5.22 (2H, s), 4.19 (3H, s), 4.12 (3H, s), 1.34 (9H, s)
- Mass spectrometry value (ESI-MS, m/z): 523 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (65 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (100 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3,4-dimethoxybenzyl alcohol (55 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (70 mg, yield 60%).
- 1H-NMR (CDCl3, 400 MHz): 8.49 (1H, s), 8.14 (1H, s), 7.58-7.64 (3H, m), 7.17-7.22 (2H, m), 6.86-7.04 (4H, m), 6.69 (1H, m), 5.17 (2H, s), 4.17 (3H, s), 4.10 (3H, s), 3.92 (3H, s), 3.90 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (65 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (107 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3,4-dimethoxybenzyl alcohol (60 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (73 mg, yield 55%).
- 1H-NMR (CDCl3, 400 MHz): 8.46 (1H, dd, J=6.6 Hz), 8.15 (1H, s), 7.75-7.80 (1H, m), 7.66 (1H, s), 6.83-7.05 (4H, m), 6.55 (1H, d, J=6.4 Hz), 6.51 (1H, s), 5.17 (2H, s), 4.17 (3H, s), 4.12 (3H, s), 3.92 (3H, s), 3.91 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 520 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (89 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (124 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3,4-dimethoxybenzyl alcohol (72 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (102 mg, yield 67%).
- 1H-NMR (CDCl3, 400 MHz): 8.44-8.50 (1H, m), 8.12 (1H, s), 7.91 (1H, s), 7.62 (1H, s), 6.80-7.03 (4H, m), 6.55 (1H, d, J=6.3 Hz), 6.48 (1H, s), 5.15 (2H, s), 4.15 (3H, s), 4.08 (3H, s), 3.90 (3H, s), 3.88 (3H, s), 2.24 (3H, s), 2.11 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 519 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (83 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (147 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3,4-dimethoxybenzyl alcohol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (70 mg, yield 48%).
- 1H-NMR (CDCl3, 400 MHz): 8.79 (1H, s), 8.14 (1H, s), 7.54-7.64 (3H, m), 7.18-7.24 (2H, m), 6.79-7.01 (4H, m), 5.16 (2H, s), 4.19 (3H, s), 4.12 (3H, s), 3.92 (3H, s), 3.90 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (76 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (105 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3,4-dimethoxybenzyl alcohol (58 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (53 mg, yield 42%).
- 1H-NMR (CDCl3, 400 MHz): 8.68 (1H, s), 8.33 (1H, d, J=8.8 Hz), 7.50-7.60 (2H, m), 6.83-7.35 (6H, m), 5.18 (2H, s), 4.11 (3H, s), 4.08 (3H, s), 3.93 (3H, s), 3.90 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 527 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (75 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (120 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3,5-dimethoxybenzyl alcohol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (90 mg, yield 68%).
- 1H-NMR (CDCl3, 400 MHz): 8.47 (1H, d like, J=6.6 Hz), 8.14 (1H, s), 6.67-7.66 (10H, m), 5.27 (2H, s), 4.17 (3H, s), 4.10 (3H, s), 3.84 (3H, s), 3.79 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 491 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (85 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3,5-dimethoxybenzyl alcohol (80 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (92 mg, yield 60%).
- 1H-NMR (CDCl3, 400 MHz): 8.44 (1H, d, J=6.4 Hz), 8.05 (1H, s), 7.74-7.80 (1H, m), 7.66 (1H, s), 6.78-7.40 (4H, m), 6.50-6.58 (2H, m), 5.27 (2H, s), 4.16 (3H, s), 4.11 (3H, s), 3.85 (3H, s), 3.79 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 520 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (90 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (125 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3,5-dimethoxybenzyl alcohol (73 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (92 mg, yield 60%).
- 1H-NMR (CDCl3, 400 MHz): 8.46 (1H, d like, J=6.6 Hz), 8.15 (1H, s), 7.95 (1H, s), 7.65 (1H, s), 6.85-7.02 (4H, m), 6.58 (1H, d, J=6.6 Hz), 6.53 (2H, s), 5.28 (2H, s), 4.17 (3H, s), 4.11 (3H, s), 3.85 (3H, s), 3.80 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 519 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (72 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (120 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3,5-dimethoxybenzyl alcohol (65 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (66 mg, yield 52%).
- 1H-NMR (CDCl3, 400 MHz): 8.80 (1H, s), 8.14 (1H, s), 7.55-7.63 (3H, m), 7.16-7.22 (2H, m), 6.83-7.00 (3H, m), 5.26 (2H, s), 4.19 (3H, s), 4.12 (3H, s), 3.83 (3H, s), 3.79 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (76 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (105 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3,5-dimethoxybenzyl alcohol (60 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (59 mg, yield 46%).
- 1H-NMR (CDCl3, 400 MHz): 8.75 (1H, s), 8.39 (1H, d, J=9.3 Hz), 6.73-7.85 (8H, m), 5.28 (2H, s), 4.15 (3H, s), 4.10 (3H, s), 3.84 (3H, s), 3.80 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 527 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (72 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (120 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-[4-(tert-butyl)phenyl]sulfanyl-1-propanol (80 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (81 mg, yield 57%).
- 1H-NMR (CDCl3, 400 MHz): 8.45-8.50 (1H, m), 8.14 (1H, s), 7.64 (1H, s), 7.58-7.66 (2H, m), 7.16-7.33 (6H, m), 6.80 (1H, s), 6.69 (1H, d, J=6.6 Hz), 4.33 (2H, t, J=6.2 Hz), 4.17 (3H, s), 4.10 (3H, s), 3.01 (2H, t, J=7.2 Hz), 1.99-2.07 (2H, m), 1.31 (9H, s)
- Mass spectrometry value (ESI-MS, m/z): 548 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (78 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (121 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-[4-(tert-butyl)phenyl]sulfanyl-1-propanol (80 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (109 mg, yield 74%).
- 1H-NMR (CDCl3, 400 MHz): 8.44 (1H, d, J=5.4 Hz), 7.48-7.64 (3H, m), 7.27-7.35 (4H, m), 6.97-7.03 (1H, m), 6.38 (1H, bs), 6.28 (1H, d, J=5.4 Hz), 4.31 (2H, t, J=6.2 Hz), 4.07 (3H, s), 2.98-3.13 (2H, m), 2.25 (3H, s), 2.12 (3H, s), 1.98-2.06 (2H, m), 1.30 (9H, s)
- Mass spectrometry value (ESI-MS, m/z): 576 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (82 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (122 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-[4-(tert-butyl)phenyl]sulfanyl-1-propanol (80 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (113 mg, yield 73%).
- 1H-NMR (CDCl3, 400 MHz): 8.45-8.50 (1H, m), 8.15 (1H, s), 7.89 (1H, s), 7.65 (1H, s), 7.32 (4H, s), 6.95 (1H, s), 6.58 (1H, d, J=6.4 Hz), 6.44 (1H, s), 4.33 (2H, t, J=6.4 Hz), 4.17 (3H, s), 4.11 (3H, s), 3.02 (2H, t, J=7.1 Hz), 2.29 (3H, s), 2.13 (3H, s), 2.00-2.08 (2H, m), 1.31 (9H, s)
- Mass spectrometry value (ESI-MS, m/z): 576 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (120 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-[4-(tert-butyl)phenyl]sulfanyl-1-propanol (80 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (100 mg, yield 64%).
- 1H-NMR (CDCl3, 400 MHz): 8.73 (1H, s like), 8.52-8.60 (1H, m), 7.70-7.90 (2H, m), 6.80-7.65 (8H, m), 4.29-4.33 (2H, m), 4.10-4.16 (6H, m), 2.98-3.04 (2H, m), 1.90-2.10 (2H, m), 1.31 (9H, s)
- Mass spectrometry value (ESI-MS, m/z): 549 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (77 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (125 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-[4-(tert-butyl)phenyl]sulfanyl-1-propanol (80 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (68 mg, yield 47%).
- 1H-NMR (CDCl3, 400 MHz): 8.80 (1H, s), 8.33-8.38 (1H, m), 8.07 (1H, bs), 7.15-7.62 (8H, m), 4.35 (2H, t, J=6.2 Hz), 4.18 (3H, s), 4.12 (3H, s), 3.02 (2H, t, J=7.1 Hz), 2.00-2.08 (2H, m), 1.31 (9H, s)
- Mass spectrometry value (ESI-MS, m/z): 583 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (73 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (120 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-[4-chloro-2-methylphenyl]sulfanyl-1-propanol (80 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (98 mg, yield 69%).
- 1H-NMR (CDCl3, 400 MHz): 8.45-8.50 (3H, m), 8.15 (1H, s), 7.57-7.65 (3H, m), 7.12-7.25 (5H, m), 6.82 (1H, s), 6.69 (1H, d, J=6.6 Hz), 4.33 (2H, t, J=6.2 Hz), 4.17 (3H, s), 4.10 (3H, s), 2.99 (2H, t, J=7.2 Hz), 2.37 (3H, s), 1.95-2.08 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 540 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (82 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (120 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-[4-chloro-2-methylphenyl]sulfanyl-1-propanol (80 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (88 mg, yield 58%).
- 1H-NMR (CDCl3, 400 MHz): 8.43-8.50 (1H, m), 8.16 (1H, s), 7.66-7.76 (2H, m), 7.00-7.25 (5H, m), 6.55 (1H, d, J=6.6 Hz), 6.46 (1H, s), 4.33 (2H, t, J=6.2 Hz), 4.17 (3H, s), 4.11 (3H, s), 2.96-3.03 (2H, m), 2.37 (3H, s), 2.27 (3H, s), 2.11 (3H, s), 1.98-2.10 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 468 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (90 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (120 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-[4-chloro-2-methylphenyl]sulfanyl-1-propanol (80 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (81 mg, yield 49%).
- 1H-NMR (CDCl3, 400. MHz): 8.42-8.48 (1H, m), 8.12 (1H, s), 7.86 (1H, s), 7.62 (1H, s), 7.08-7.23 (3H, m), 6.94 (1H, s), 6.56 (1H, d, J=6.6 Hz), 6.43 (1H, s), 4.31 (2H, t, J=6.2 Hz), 4.15 (3H, s), 4.08 (3H, s), 2.97 (2H, t, J=7.2 Hz), 2.35 (3H, s), 2.26 (3H, s), 2.11 (3H, s), 1.96-2.06 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 568 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (88 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (120 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-[4-chloro-2-methylphenyl]sulfanyl-1-propanol (80 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (77 mg, yield 45%).
- 1H-NMR (CDCl3, 400 MHz): 8.73 (1H, s), 7.85 (1H, bs), 7.60 (1H, s), 7.51-7.57 (2H, m), 7.10-7.24 (5H, m), 6.74 (5H, m), 4.32 (2H, t, J=6.1 Hz), 4.15 (3H, s), 4.11 (3H, s), 2.98 (2H, t, J=7.2 Hz), 2.37 (3H, s), 1.98-2.07 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 541 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (75 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (120 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-[4-chloro-2-methylphenyl]sulfanyl-1-propanol (80 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (69 mg, yield 50%).
- 1H-NMR (CDCl3, 400 MHz): 8.66 (1H, s), 8.23-8.33 (1H, m), 7.53 (1H, s), 7.46 (1H, s), 7.34 (1H, d, J=2.7 Hz), 7.12-7.25 (5H, m), 4.34 (2H, t, J=7.1 Hz), 4.09 (3H, s), 4.08 (3H, s), 3.00 (2H, t, J=7.1 Hz), 2.37 (3H, s), 2.00-2.08 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 575 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (72 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (125 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-trifluoromethylphenethyl alcohol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (101 mg, yield 76%).
- 1H-NMR (CDCl3, 400 MHz): 8.42-8.49 (1H, m), 8.12 (1H, s), 7.61 (1H, s), 7.42-7.59 (6H, m), 7.13-7.18 (2H, m), 6.76 (1H, s), 6.66 (1H, d, J=6.6 Hz), 4.44 (2H, t, J=6.7 Hz), 4.15 (3H, s), 4.08 (3H, s), 3.07 (2H, t, J=6.7 Hz)
- Mass spectrometry value (ESI-MS, m/z): 513 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (68 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (125 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-trifluoromethylphenethyl alcohol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (88 mg, yield 73%).
- 1H-NMR (CDCl3, 400 MHz): 8.4-8.49 (1H, m), 8.16 (1H, s), 7.67 (1H, s), 7.40-7.56 (5H, m), 7.02 (1H, d, J=8.8 Hz), 6.54 (1H, d, J=6.4 Hz), 6.42 (1H, bs), 4.46 (2H, t, J=6.7 Hz), 4.17 (3H, s), 4.11 (3H, s), 3.09 (2H, t, J=6.7 Hz), 2.23 (3H, s), 2.10 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 541 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (125 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-trifluoromethylphenethyl alcohol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (79 mg, yield 56%).
- 1H-NMR (CDCl3, 400 MHz): 8.13-8.62 (2H, m), 7.26-8.00 (6H, m), 6.96 (1H, s), 6.64-6.28 (1H, m), 6.42 (1H, bs), 4.46 (2H, t, J=6.7 Hz), 4.03-4.18 (6H, m), 3.07-3.13 (3H, m), 2.23-2.30 (3H, m), 2.11 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 541 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (82 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (125 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-trifluoromethylphenethyl alcohol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (68 mg, yield 45%).
- 1H-NMR (CDCl3, 400 MHz): 8.76 (1H, s), 8.01 (1H, s), 7.60 (1H, s), 7.43-7.58 (6H, m), 7.17-7.24 (2H, m), 6.79 (1H, s), 4.44 (2H, t, J=6.7 Hz), 4.17 (3H, s), 4.11 (3H, s), 3.08 (2H, t, J=6.8 Hz)
- Mass spectrometry value (ESI-MS, m/z): 514 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (85 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (125 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-trifluoromethylphenethyl alcohol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (69 mg, yield 46%).
- 1H-NMR (CDCl3, 400 MHz): 8.79 (1H, s), 8.27-8.34 (1H, m), 8.03 (1H, s), 7.30-7.62 (6H, m), 7.24-7.23 (2H, m), 4.46 (2H, t, J=6.8 Hz), 4.18 (3H, s), 4.11 (3H, s), 3.10 (2H, t, J=6.9 Hz)
- Mass spectrometry value (ESI-MS, m/z): 549 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (74 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (115 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-trifluoromethyl-α-methylbenzyl alcohol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (81 mg, yield 59%).
- 1H-NMR (CDCl3, 400 MHz): 8.41-8.48 (1H, m), 8.11 (1H, s), 7.45-7.68 (7H, m), 7.13-7.18 (2H, m), 6.93 (1H, s), 6.65 (1H, d, J=6.6 Hz), 5.94 (1H, q, J=6.6 Hz), 4.14 (3H, s), 4.08 (3H, s), 1.63 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 513 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (72 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (110 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-trifluoromethyl-α-methylbenzyl alcohol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (90 mg, yield 68%).
- 1H-NMR (CDCl3, 400 MHz): 8.39-8.45 (1H, m), 8.13 (1H, s), 7.40-7.72 (6H, m), 6.99 (1H, d, J=9.0 Hz), 6.48-6.55 (2H, m), 5.93 (1H, 1, J=6.6 Hz), 4.15 (3H, s), 4.09 (3H, s), 2.24 (3H, s), 2.07 (3H, s), 1.63 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 542 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (76 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (110 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-trifluoromethyl-α-methylbenzyl alcohol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (78 mg, yield 58%).
- 1H-NMR (CDCl3, 400 MHz): 8.40-8.47 (1H, m), 8.12 (1H, s), 7.84 (1H, s), 7.45-7.68 (5H, m), 6.93 (1H, s), 6.47-6.57 (2H, m), 5.93 (1H, q, J=6.8 Hz), 4.14 (3H, s), 4.08 (3H, s), 2.27 (3H, s), 2.09 (3H, s), 1.63 (3H, d, J=6.8 Hz)
- Mass spectrometry value (ESI-MS, m/z): 542 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (89 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (120 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-trifluoromethyl-α-methylbenzyl alcohol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (80 mg, yield 48%).
- 1H-NMR (CDCl3, 400 MHz): 8.75 (1H, s), 8.07 (1H, s), 7.14-7.63 (8H, m), 6.95 (1H, s), 6.79 (1H, d, J=8.8 Hz), 5.93 (1H, q, J=6.6 Hz), 4.15 (3H, s), 4.09 (3H, s), 1.61 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 514 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (76 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (120 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-trifluoromethyl-α-methylbenzyl alcohol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (53 mg, yield 39%).
- 1H-NMR (CDCl3, 400 MHz): 8.76 (1H, s), 7.86 (1H, s), 7.20-7.65 (6H, m), 6.88-6.92 (2H, m), 6.72-6.77 (1H, m), 5.87-5.95 (1H, m), 4.15 (3H, s), 4.09 (3H, s), 1.60 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 549 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (87 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (130 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2,4,5-trifluoro-α-methylbenzyl alcohol (80 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (77 mg, yield 49%).
- 1H-NMR (CDCl3, 400 MHz): 8.41-8.49 (1H, m), 8.11 (1H, s), 7.56-7.64 (4H, m), 7.12-7.20 (2H, m), 6.80-6.72 (2H, m), 6.65 (1H, d, J=6.4 Hz), 6.07 (1H, q, J=6.4 Hz), 4.14 (3H, s), 4.08 (3H, s), 1.59 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 499 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (76 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (130 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2,4,5-trifluoro-α-methylbenzyl alcohol (80 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (61 mg, yield 46%).
- 1H-NMR (CDCl3, 400 MHz): 8.40-8.47 (1H, m), 8.13 (1H, s), 7.62-7.74 (2H, m), 6.82-6.72 (3H, m), 6.48-6.55 (2H, m), 6.07 (1H, q, J=6.6 Hz), 4.15 (3H, s), 4.09 (3H, s), 2.26 (3H, s), 2.08 (3H, s), 1.59 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 528 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (82 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (130 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2,4,5-trifluoro-α-methylbenzyl alcohol (80 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (68 mg, yield 48%).
- 1H-NMR (CDCl3, 400 MHz): 8.4-8.48 (1H, m), 8.11 (1H, s), 7.84 (1H, s), 7.61 (1H, s), 6.80-7.30 (3H, m), 6.52-6.57 (2H, m), 6.06 (1H, q, J=6.7 Hz), 4.14 (3H, s), 4.08 (3H, s), 2.28 (3H, s), 2.09 (3H, s), 1.59 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 527 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (89 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (130 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2,4,5-trifluoro-α-methylbenzyl alcohol (80 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (51 mg, yield 32%).
- 1H-NMR (CDCl3, 400 MHz): 8.73 (1H, s), 8.05 (1H, s), 7.58 (1H, s), 7.53-7.58 (1H, m), 6.50-7.25 (6H, m), 6.00-6.10 (1H, m), 4.15 (3H, s), 4.09 (3H, s), 1.57 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 500 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (130 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2,4,5-trifluoro-α-methylbenzyl alcohol (80 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (48 mg, yield 35%).
- 1H-NMR (CDCl3, 400 MHz): 8.72 (1H, s), 8.27 (1H, d, J=9.0 Hz), 7.99 (1H, s), 7.50 (1H, s), 6.80-7.28 (5H, m), 5.95-6.08 (1H, m), 4.11 (3H, s), 4.04 (3H, s), 1.56 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 535 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (97 mg) was added to toluene/triethylamine=10/1 (10 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (150 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-fluoro-α-methylbenzyl alcohol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (111 mg, yield 68%).
- 1H-NMR (CDCl3, 400 MHz): 8.41-8.47 (1H, m), 8.12 (1H, s), 7.55-7.62 (3H, m), 6.86-7.38 (7H, m), 6.65 (1H, d, J=6.6 Hz), 5.88 (1H, 1, J=6.6 Hz), 4.14 (3H, s), 4.08 (3H, s), 1.60 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 463 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (86 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (150 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-fluoro-α-methylbenzyl alcohol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (89 mg, yield 64%).
- 1H-NMR (CDCl3, 400 MHz): 8.38-8.44 (1H, m), 8.13 (1H, s), 7.66-7.75 (1H, m), 7.64 (1H, s), 6.95-7.36 (6H, m), 6.51 (1H, d, J=6.4 Hz), 5.87 (1H, q, J=6.6 Hz), 4.15 (3H, s), 4.09 (3H, s), 2.25 (3H, s), 2.07 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (97 mg) was added to toluene/triethylamine=10/1 (10 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (150 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-fluoro-α-methylbenzyl alcohol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (108 mg, yield 68%).
- 1H-NMR (CDCl3, 400 MHz): 8.40-8.45 (1H, m), 8.12 (1H, s), 7.87 (1H, s), 7.62 (1H, s), 6.90-7.38 (5H, m), 6.54 (1H, d, J=6.8 Hz), 6.49 (1H, s), 4.15 (3H, s), 4.08 (3H, s), 2.27 (3H, s), 2.09 (3H, s), 1.61 (3H, d, J=6.8 Hz)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (99 mg) was added to toluene/triethylamine=10/1 (10 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (150 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-fluoro-α-methylbenzyl alcohol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (60 mg, yield 36%).
- 1H-NMR (CDCl3, 400 MHz): 8.75 (1H, s), 7.98 (1H, bs), 8.47 (1H, bs), 6.48-7.60 (9H, m), 5.82-5.90 (1H, m), 4.13 (3H, s), 4.08 (3H, s), 1.58 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 464 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (98 mg) was added to toluene/triethylamine=10/1 (10 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (150 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-fluoro-α-methylbenzyl alcohol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (49 mg, yield 31%).
- 1H-NMR (CDCl3, 400 MHz): 8.78 (1H, s), 8.34 (1H, d, J=9.3 Hz), 8.13 (1H, s), 7.56 (1H, s), 6.97-7.38 (7H, m), 5.88 (1H, q, J=6.5 Hz), 4.17 (3H, s), 4.17 (3H, s), 4.10 (3H, s), 1.61 (3H, d, J=6.8 Hz)
- Mass spectrometry value (ESI-MS, m/z): 499 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (8.0 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (120 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-fluoro-α-methylbenzyl alcohol (57 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (91 mg, yield 73%).
- 1H-NMR (CDCl3, 400 MHz): 8.43-8.48 (1H, m), 8.14 (1H, s), 7.63 (1H, s), 7.57-7.61 (2H, m), 7.37-7.42 (2H, m), 7.14-7.19 (2H, m), 7.04-7.10 (2H, m), 6.86 (1H, s), 6.66 (1H, d, J=6.6 Hz), 5.90 (1H, q, J=6.6 Hz), 4.16 (3H, s), 4.10 (3H, s), 1.62 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 461 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (86 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (117 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-fluoro-α-methylbenzyl alcohol (55 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (94 mg, yield 72%).
- 1H-NMR (CDCl3, 400 MHz): 8.42-8.48 (1H, m), 8.15 (1H, s), 7.74 (1H, d, J=8.5 Hz), 7.66 (1H, s), 7.37-7.43 (2H, m), 6.98-7.10 (3H, m), 6.48-6.55 (2H, m), 5.90 (1H, q, J=6.6 Hz), 4.17 (3H, s), 4.10 (3H, s), 2.25 (3H, s), 2.09 (3H, s), 1.63 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (90 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (123 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-fluoro-α-methylbenzyl alcohol (58 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (87 mg, yield 64%).
- 1H-NMR (CDCl3, 400 MHz): 8.40-8.48 (1H, m), 8.12 (1H, s), 7.88 (1H, s), 7.61 (1H, s), 7.30-7.41 (2H, m), 7.30-7.41 (2H, m), 7.00-7.10 (2H, m), 6.91 (1H, s), 6.53 (1H, d, J=6.6 Hz), 6.45 (1H, s), 5.87 (1H, q, J=6.7 Hz), 4.14 (3H, s), 4.08 (3H, s), 2.25 (3H, s), 2.09 (3H, s), 1.61 (3H, d, J=6.7 Hz)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (120 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-fluoro-α-methylbenzyl alcohol (57 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (59 mg, yield 47%).
- 1H-NMR (CDCl3, 400 MHz): 8.77 (1H, s), 8.08 (1H, s), 7.60 (1H, s), 7.52-7.58 (2H, m), 7.36-7.41 (2H, m), 7.16-7.20 (2H, m), 7.02-7.09 (2H, m), 6.79 (1H, s), 5.89 (1H, q.J=6.6 Hz), 4.18 (3H, s), 4.11 (3H, s), 1.61 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 464 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (85 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (114 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-fluoro-α-methylbenzyl alcohol (54 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (45 mg, yield 35%).
- 1H-NMR (CDCl3, 400 MHz): 8.80 (1H, s), 8.35 (1H, d, J=9.0 Hz), 8.12 (1H, s), 7.57 (1H, s), 7.05-7.44 (7H, m), 5.90 (1H, q, J=6.6 Hz), 4.19 (3H, s), 4.11 (3H, s), 1.63 (3H, d, J=6.8 Hz)
- Mass spectrometry value (ESI-MS, m/z): 499 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (82 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-methylbenzylmercaptan (60 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (90 mg, yield 65%).
- 1H-NMR (CDCl3, 400 MHz): 8.43-8.50 (1H, m), 8.13 (1H, s), 7.55-7.72 (4H, m), 7.00-7.26 (6H, m), 6.67 (1H, d, J=6.4 Hz), 4.21 (2H, s), 4.16 (3H, s), 4.10 (3H, s), 2.33 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 462 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (90 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (145 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-methylbenzylmercaptan (60 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (87 mg, yield 60%).
- 1H-NMR (CDCl3, 400 MHz): 8.47 (1H, bs), 8.16 (1H, s), 7.58-7.70 (2H, m), 6.88-7.26 (6H, m), 6.6 (1H, bs), 4.21 (2H, s), 4.17 (3H, s), 4.11 (3H, s), 2.34 (3H, s), 2.27 (3H, s), 2.14 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 490 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (90 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (145 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-methylbenzylmercaptan (60 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (74 mg, yield 54%).
- 1H-NMR (CDCl3, 400 MHz): 8.45-8.52 (1H, m), 8.15 (1H, s), 7.80 (1H, s), 7.64 (1H, s), 6.89-7.28 (6H, m), 6.57 (1H, d, J=6.3 Hz), 4.22 (2H, s), 4.17 (3H, s), 4.11 (3H, s), 2.34 (3H, s), 2.28 (3H, s), 2.13 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 490 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (81 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-methylbenzylmercaptan (60 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (74 mg, yield 54%).
- 1H-NMR (CDCl3, 400 MHz): 8.72 (1H, s), 8.12 (1H, s), 7.50-7.67 (4H, m), 7.10-7.26 (6H, m), 4.21 (2H, s), 4.18 (3H, s), 4.12 (3H, s), 2.33 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 462 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (85 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-methylbenzylmercaptan (60 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (58 mg, yield 42%).
- 1H-NMR (CDCl3, 400 MHz): 8.81 (1H, s), 8.44 (1H, d, J=9.3 Hz), 8.13 (1H, s), 7.52-7.55 (2H, m), 7.11-7.34 (6H, m), 4.24 (2H, s), 4.19 (3H, s), 4.12 (3H, s), 2.34 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 497 (M++1)
- 4-[(6,7′-Dimethoxy-4-quinolyl)oxy]aniline (88 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (145 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-bromo-α-methylbenzyl alcohol (90 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (89 mg, yield 54%).
- 1H-NMR (CDCl3, 400 MHz): 8.44 (1H, d, J=6.7 Hz), 8.12 (1H, s), 6.90-7.61 (10H, m), 6.65 (1H, d, J=6.7 Hz), 6.20 (1H, q, J=6.4 Hz), 4.14 (3H, s), 4.08 (3H, s), 1.59 (3H, d, J=6.4 Hz)
- Mass spectrometry value (ESI-MS, m/z): 524 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (78 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (145 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-bromo-α-methylbenzyl alcohol (90 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (101 mg, yield 71%).
- 1H-NMR (CDCl3, 400 MHz): 8.43 (1H, dd, J=6.5 Hz), 8.15 (1H, s), 7.15-7.7.8 (6H, m), 7.00 (1H, d, J=8.8 Hz), 6.57 (1H, bs), 6.52 (1H, d, J=6.5 Hz), 6.21 (1H, q, J=6.5 Hz), 4.17 (3H, s), 4.11 (3H, s), 2.28 (3H, s), 2.09 (3H, s), 1.62 (3H, d, J=6.5 Hz)
- Mass spectrometry value (ESI-MS, m/z): 552 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (85 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (148 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-bromo-α-methylbenzyl alcohol (90 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (70 mg, yield 45%).
- 1H-NMR (CDCl3, 400 MHz): 8.45 (1H, dd, J=6.6 Hz), 8.14 (1H, s), 7.92 (1H, bs), 7.15-7.65 (6H, m), 6.94 (1H, s), 6.46-6.58 (2H, m), 6.22 (1H, q, J=6.6 Hz), 4.17 (3H, s), 4.10 (3H, s), 2.30 (3H, s), 2.10 (3H, s), 1.63 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 552 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (90 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (151 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-bromo-α-methylbenzyl alcohol (90 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (60 mg, yield 35%).
- 1H-NMR (CDCl3, 400 MHz): 8.75 (1H, s), 8.04 (1H, s), 7.14-7.61 (9H, m), 6.94 (1H, bs), 6.20 (1H, q, J=6.5 Hz), 4.17 (3H, s), 4.11 (3H, s), 1.60 (3H, d, J=6.5 Hz)
- Mass spectrometry value (ESI-MS, m/z): 525 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (85 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (139 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-bromo-α-methylbenzyl alcohol (90 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (51 mg, yield 33%).
- 1H-NMR (CDCl3, 400 MHz): 8.80 (1H, s), 8.38 (1H, d, J=9.3 Hz), 8.14 (1H, s), 7.16-7.60 (7H, m), 6.23 (1H, q, J=6.6 Hz), 4.19 (3H, s), 4.11 (3H, s), 1.63 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 560 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (72 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (111 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-bromo-α-methylbenzyl alcohol (75 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (79 mg, yield 584%).
- 1H-NMR (CDCl3, 400 MHz): 8.46 (1H, dd, J=6.4 Hz) 8.13 (1H, s), 7.16-7.64 (9H, m), 7.01 (1H, s), 6.68 (1H, d, J=6.4 Hz), 5.86 (1H, q, J=6.4 Hz), 4.16 (3H, s), 4.10 (3H, s), 1.61 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 524 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (68 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (120 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-bromo-α-methylbenzyl alcohol (75 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (83 mg, yield 67%).
- 1H-NMR (CDCl3, 400 MHz): 8.45 (1H, dd, J=6.6 Hz), 8.15 (1H, s like), 7.16-7.74 (7H, m), 7.02 (1H, d, J=9.0 Hz), 6.54 (1H, d, J=6.1 Hz), 5.86 (1H, q, J=6.6 Hz), 4.17 (3H, s), 4.11 (3H, s), 2.27 (3H, s), 2.10 (3H, s), 1.62 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 552 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (88 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (138 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-bromo-α-methylbenzyl alcohol (75 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (88 mg, yield 55%).
- 1H-NMR (CDCl3, 400 MHz): 8.40-8.50 (1H, m), 8.15 (1H, s like), 7.89 (1H, bs), 7.20-7.66 (5H, m), 6.95 (1H, s), 6.56 (1H, d, J=6.4 Hz), 6.50 (1H, bs), 5.86 (1H, q, J=6.6 Hz), 4.17 (3H, s), 4.10 (3H, s), 2.30 (3H, s), 2.11 (3H, s), 1.62 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 552 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (74 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (125 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-bromo-α-methylbenzyl alcohol (75 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (61 mg, yield 44%).
- 1H-NMR (CDCl3, 400 MHz): 8.76 (1H, s), 8.06 (1H, s), 7.16-7.62 (8H, m), 6.85 (1H, bs), 5.85 (1H, q, J=6.6 Hz), 4.18 (3H, s), 4.11 (3H, s), 1.65 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 525 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (76 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (119 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-bromo-α-methylbenzyl alcohol (75 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (51 mg, yield 40%).
- 1H-NMR (CDCl3, 400 MHz): 8.80 (1H, s), 8.35 (1H, d, J=9.0 Hz), 8.12 (1H, s), 7.54-7.60 (2H, m), 7.44-7.58 (1H, m), 7.15-7.36 (4H, m), 5.86 (1H, q, J=6.7 Hz), 4.19 (3H, s), 4.16 (3H, s, 1.63 (3H, d, J=6.7 Hz)
- Mass spectrometry value (ESI-MS, m/z): 560 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (77 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (117 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-fluoro-α-methylbenzyl alcohol (55 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (101 mg, yield 78%).
- Mass spectrometry value (ESI-MS, m/z): 524 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (74 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (103 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-fluoro-α-methylbenzyl alcohol (55 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (88 mg, yield 73%).
- 1H-NMR (CDCl3, 400 MHz): 8.37 (1H, dd, J=6.6 Hz), 8.08 (1H, s like), 7.67 (1H, d, J=8.1 Hz), 7.59 (1H, s), 7.37 (1H, dd, J=7.1 Hz), 7.10 (1H, dd, J=7.4 Hz), 7.01 (1H, dd, J=9.4 Hz), 6.93 (1H, d, J=8.8 Hz), 6.50 (1H, s), 6.46 (1H, d, J=6.6 Hz), 6.10 (1H, q, J=6.6 Hz), 4.10 (3H, s), 4.04 (3H, s), 2.22 (3H, s), 2.02 (3H, s), 1.59 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (71 mg) was added toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (99 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-fluoro-α-methylbenzyl alcohol (55 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (78 mg, yield 68%).
- 1H-NMR (CDCl3, 400 MHz): 8.45 (1H, dd, J=6.5 Hz), 8.15 (1H, d, J=4.2 Hz), 7.91 (1H, s), 7.64 (1H, s), 7.42-7.45 (1H, m), 7.28-7.33 (1H, m), 7.06-7.11 (1H, m), 7.15-7.20 (1H, m), 6.94 (1H, s), 6.56 (1H, d, J=6.5 Hz), 6.52 (1H, s), 6.17 (1H, q, J=6.7 Hz) 4.17 (3H, s), 4.10 (3H, s), 2.29 (3H, s), 2.11 (3H, s), 1.66 (3H, d, J=6.7 Hz)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (90 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (136 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-fluoro-α-methylbenzyl alcohol (55 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (79 mg, yield 52%).
- 1H-NMR (CDCl3, 400 MHz): 8.74 (1H, s), 8.06 (1H, s), 7.58 (1H, s), 7.54 (2H, d, J=9.0 Hz), 7.39-7.43 (1H, m), 7.23-7.32 (1H, m), 7.12-7.17 (3H, m), 7.03-7.08 (1H, m), 6.86 (1H, s), 6.14 (1H, q, J=6.6 Hz), 4.15 (3H, s), 4.09 (3H, s), 1.62 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 464 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]aniline (83 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (134 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-fluoro-α-methylbenzyl alcohol (55 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (60 mg, yield 45%).
- 1H-NMR (CDCl3, 400 MHz): 8.80 (1H, s), 8.37 (1H, d, J=9.2 Hz), 8.15 (1H, s), 7.58 (1H, s), 7.43-7.52 (1H, m), 7.32 (1H, d, J=2.7° Hz), 7.28-7.35 (1H, m), 7.15-7.20 (2H, m), 7.06-7.11 (1H, m), 6.19 (1H, q, J=6.6 Hz), 4.19 (3H, s), 4.12 (3H, s), 1.66 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI MS, m/z): 499 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (122 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-ethoxy-α-methylbenzyl alcohol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (98 mg, yield 69%).
- 1H-NMR (CDCl3, 400 MHz): 8.46 (1H, dd, J=6.5 Hz), 8.14 (1H, s like), 7.58-7.64 (3H, m), 7.38-7.42 (1H, m), 7.16-7.18 (2H, m), 6.85-7.00 (3H, m), 6.68 (1H, d, J=6.6 Hz), 6.31 (1H, q, J=6.5 Hz), 4.16 (3H, s), 4.10 (3H, s), 4.05-4.13 (2H, m), 1.59 (3H, d, J=6.5 Hz), 1.44 (3H, t, J=7.1 Hz)
- Mass spectrometry value (ESI-MS, m/z): 490 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (72 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (100 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-ethoxy-α-methylbenzyl alcohol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (71 mg, yield 58%).
- 1H-NMR (CDCl3, 400 MHz): 8.42 (1H, d, J=6.5 Hz), 8.13 (1H, s like), 7.73-7.80 (1H, m), 7.64 (1H, s), 7.10-7.40 (2H, m), 6.80-7.00 (3H, m), 6.48-6.53 (1H, m), 6.28 (1H, q, J=6.4 Hz), 4.15 (3H, s), 4.09 (3H, s), 4.02-4.10 (2H, m), 2.24 (3H, s), 2.07 (3H, s), 1.57 (3H, d, J=6.4 Hz), 1.42 (3H, t, J=6.9 Hz)
- Mass spectrometry value (ESI-MS, m/z): 518 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (83 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (115 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-ethoxy-α-methylbenzyl alcohol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (78 mg, yield 55%).
- 1H-NMR (CDCl3, 400 MHz): 8.42 (1H, dd, J=6.3 Hz), 8.13 (1H, s like), 7.93 (1H, bs), 7.38 (1H, d, J=7.6 Hz), 6.83-6.99 (4H, m), 6.53-6.58 (1H, m), 6.49 (1H, bs), 6.29 (1H, q, J=6.5 Hz), 4.15 (3H, s), 4.08 (3H, s), 4.04-4.11 (2H, m), 2.27 (3H, s), 2.08 (3H, s), 1.58 (3H, d, J=6.5 Hz), 1.43 (3H, t, J=6.9 Hz)
- Mass spectrometry value (ESI-MS, m/z): 518 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (77 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (117 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-ethoxy-α-methylbenzyl alcohol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (63 mg, yield 46%).
- 1H-NMR (CDCl3, 400 MHz): 8.74 (1H, s like), 8.05 (1H, s), 7.53-7.59 (3H, m), 7.34-7.38 (1H, m), 7.13-7.26 (3H, m), 6.82-6.98 (3H, m), 6.27 (1H, q, J=6.5 Hz), 4.15 (3H, s), 4.09 (3H, s), 4.02-4.10 (2H, m), 1.56 (3H, d, J=6.5 Hz), 1.42 (3H, t, J=7.0 Hz)
- Mass spectrometry value (ESI-MS, m/z): 491 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (80 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (109 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-ethoxy-α-methylbenzyl alcohol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (58 mg, yield 43%).
- 1H-NMR (CDCl3, 400 MHz): 8.80 (1H, s), 8.40 (1H, d, J=9.0 Hz), 8.13 (1H, s), 7.58 (1H, s), 7.14-7.45 (4H, m), 6.86-7.01 (3H, m), 6.32 (1H, q, J=6.3 Hz), 4.19 (3H, s), 4.12 (3H, s), 4.05-4.13 (2H, m), 1.61 (3H, d, J=6.3 Hz), 1.39-1.45 (3H, m)
- Mass spectrometry value (ESI-MS, m/z): 525 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (72 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (109 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-methyl-α-methylbenzyl alcohol (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (98 mg, yield 81%).
- 1H-NMR (CDCl3, 400 MHz): 8.40-8.45 (1H, m), 8.11 (1H, s), 7.61 (1H, s), 7.53-7.59 (2H, m), 7.10-7.32 (6H, m), 6.78-6.85 (1H, m), 6.65 (1H, d, J=6.6 Hz), 5.87 (1H, q, J=6.6 Hz), 4.14 (3H, s), 4.08 (3H, s), 2.34 (3H, s), 1.60 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 460 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (111 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-methyl-α-methylbenzyl alcohol (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (97 mg, yield 75%).
- 1H-NMR (CDCl3, 400 MHz): 8.40-8.45 (1H, m), 8.12 (1H, s), 7.73 (1H, d, J=8.3 Hz), 7.64 (1H, s), 7.15-7.32 (4H, m), 6.97 (1H, d, J=8.8 Hz), 6.51 (1H, d, J=6.6 Hz), 6.48 (1H, s), 5.87 (1H, q, J=6.5 Hz), 4.14 (3H, s), 4.08 (3H, s), 2.34 (3H, s), 2.22 (3H, s), 2.06 (3H, s), 1.60 (3H, d, J=6.4 Hz)
- Mass spectrometry value (ESI-MS, m/z): 488 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (111 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-methyl-α-methylbenzyl alcohol (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (88 mg, yield 68%).
- 1H-NMR (CDCl3, 400 MHz): 8.41-8.47 (1H, m), 8.12 (1H, s), 7.90 (1H, s), 7.62 (1H, s), 7.15-7.33 (4H, m), 6.91 (1H, s), 6.54 (1H, d, J=6.4 Hz), 6.45 (1H, s), 5.87 (1H, q, J=6.6 Hz), 4.14 (3H, s), 4.08 (3H, s), 2.34 (3H, s), 2.22 (3H, s), 2.08 (3H, s), 1.61 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 488 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (76 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (115 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-methyl-α-methylbenzyl alcohol (52 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (85 mg, yield 67%).
- 1H-NMR (CDCl3, 400 MHz): 8.74 (1H, s), 8.03 (1H, s), 7.43-7.60 (3H, m), 6.74-7.30 (6H, m), 6.45 (1H, bs), 5.80-5.90 (1H, m), 4.14 (3H, s), 4.09 (3H, s), 2.33 (3H, s), 1.59 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 461 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (78 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (106 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-methyl-α-methylbenzyl alcohol (48 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (61 mg, yield 49%).
- 1H-NMR (CDCl3, 400 MHz): 8.78 (1H, s), 8.35 (1H, d, J=9.0 Hz), 8.12 (1H, s), 7.55 (1H, s), 7.12-7.34 (7H, m), 5.83-5.91 (1H, m), 4.17 (3H, s), 4.09 (3H, s), 2.34 (3H, s), 1.62 (3H, d, J=6.5 Hz)
- Mass spectrometry value (ESI-MS, m/z): 405 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (78 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (118 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-[(4-methylphenyl)sulfanyl]-1-ethanol (66 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (48 mg, yield 35%).
- 1H-NMR (CDCl3, 400 MHz): 8.40-8.49 (1H, M), 8.13 (1H, s), 7.62 (1H, s), 7.55 (1H, d, J=9.0 Hz), 7.09-7.35 (6H, m), 6.75 (1H, s), 6.66 (1H, d, J=6.4 Hz), 4.33 (2H, t, J=6.4 Hz), 4.15 (3H, s), 4.08 (3H, s), 3.15 (2H, t, J=6.4 Hz), 2.31 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (72 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (100 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-[(4-methylphenyl)sulfanyl]-1-ethanol (56 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (53 mg, yield 43%).
- 1H-NMR (CDCl3, 400 MHz): 8.40-8.46 (1H, m), 8.13 (1H, s), 7.63-7.74 (2H, m), 6.98-7.36 (5H, m), 5.53 (1H, d, J=6.6 Hz), 6.43 (1H, s), 4.33 (2H, t, J=6.7 Hz), 4.15 (3H, s), 4.09 (3H, s), 3.16 (2H, t, J=6.7 Hz), 2.30 (6H, s), 2.23 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 520 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (74 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (103 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-[(4-methylphenyl)sulfanyl]-1-ethanol (58 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (51 mg, yield 40%).
- 1H-NMR (CDCl3, 400 MHz): 8.41-8.48 (1H, m), 8.13 (1H, s), 7.85 (1H, s), 7.62 (1H, s), 6.92-7.35 (5H, m), 6.55 (1H, d, J=6.1 Hz), 6.39 (1H, s), 4.33 (1H, t, J=6.7 Hz), 4.15 (3H, s), 4.08 (3H, s), 3.16 (2H, t, J=6.7 Hz), 2.31 (3H, s), 2.24 (3H, s), 2.14 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 520 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (69 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (105 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-[(4-methylphenyl)sulfanyl]-1-ethanol (59 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (29 mg, yield 24%).
- 1H-NMR (CDCl3, 400 MHz): 8.76 (1H, s), 8.10 (1H, s), 7.59 (1H, s), 7.49-7.56 (2H, m), 6.70-7.33 (7H, m), 4.32 (2H, t, J=6.7 Hz), 4.17 (3H, s), 4.10 (3H, s), 3.14 (2H, t, J=6.7 Hz), 2.31 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 493 (M++1).
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (75 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (102 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-[(4-methylphenyl)sulfanyl]-1-ethanol (57 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (57 mg, yield 30%).
- 1H-NMR (CDCl3, 400 MHz): 8.79 (1H, s), 8.32 (1H, d, J=9.3 Hz), 8.13 (1H, s), 7.56 (1H, s), 7.08-7.36 (7H, m), 4.35 (2H, t, J=6.7 Hz), 4.18 (3H, s), 4.10 (3H, s), 3.16 (2H, t, J=6.7 Hz), 2.30 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 527 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (70 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (106 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(2-fluorophenoxy)-1-propanol (60 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (60 mg, yield 55%).
- 1H-NMR (CDCl3, 400 MHz): 8.44-8.47 (1H, m), 8.11-8.13 (1H, m), 7.54-7.60 (2H, m), 7.61 (1H, s), 7.14-7.18 (2H, m), 7.01-7.08 (2H, m), 6.86-6.98 (3H, m), 4.14 (3H, s), 4.08 (3H, s), 4.11-4.20 (2H, m), 4.34-4.44 (2H, m), 2.12-2.24 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 494 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (72 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (100 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(2-fluorophenoxy)-1-propanol (57 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (78 mg, yield 63%).
- 1H-NMR (CDCl3, 400 MHz): 8.41-8.46 (1H, m), 8.13-8.14 (1H, d, J=3.9 Hz), 7.72 (1H, s like), 7.64 (1H, s) 5.94-7.09 (3H, m), 6.87-6.93 (1H, m), 6.53 (1H, d, J=6.6 Hz) 6.47 (1H, s), 4.42 (1H, J=6.2 Hz), 4.35 (1H, t, J=6.2 Hz), 4.15-4.20 (2H, m), 4.15 (3H, s), 4.09 (3H, s), 2.25 (3H, s), 2.08 (3H, s), 2.14-2.25 (2H, m)
- Mass spectrometry value (ESI-MS, m/z) 522 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (71 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (100 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(2-fluorophenoxy)-1-propanol (61 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (53 mg, yield 42%).
- 1H-NMR (CDCl3, 400 MHz): 8.45-8.49 (1H, m), 8.13 (1H, d like), 7.87 (1H, s), 7.62 (1H, s), 6.87-7.09 (4H, m), 6.56 (1H, d, J=6.3 Hz), 6.45 (1H, s), 4.42 (4H, d, J=6.2 Hz), 4.36 (1H, d, J=6.2 Hz), 4.13-4.20 (2H, m), 4.15 (3H, s), 4.08 (3H, s), 2.05-2.24 (2H, m), 2.26 (3H, s), 2.10 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 522 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (65 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (90 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(2-fluorophenoxy)-1-propanol (51 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (52 mg, yield 46%).
- 1H-NMR (CDCl3, 400 MHz): 8.74 (1H, s), 7.96 (1H, s), 7.58 (1H, s), 7.52-7.56 (1H, m), 7.16-7.21 (2H, m), 6.77-7.08 (5H, m), 4.40 (1H, t, J=6.2 Hz), 4.34 (1H, t, J=6.2 Hz), 4.07-4.19 (2H, m), 4.14 (3H, s), 4.09 (3H, s), 2.03-2.27 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 494 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2,3-dimethylaniline (65 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (90 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(2-fluorophenoxy)-1-propanol (51 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (52 mg, yield 46%).
- 1H-NMR (CDCl3, 400 MHz): 8.69 (1H, s like), 8.07 (1H, s), 7.65 (1H, bs), 7.57 (1H, s), 6.80-6.87 (1H, m), 6.89-7.04 (4H, m), 4.35 (1H, t, J=6.2 Hz), 4.28 (1H, d, J=6.2 Hz), 4.08-4.14 (2H, m), 4.12 (3H, s), 4.06 (3H, s), 2.05-2.19 (2H, m), 2.00 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 523 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (71 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (108 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. subsequently, 3-(3-fluorophenoxy)-1-propanol (61 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (88 mg, yield 69%).
- 1H-NMR (CDCl3, 400 MHz): 8.44-8.48 (1H, m), 8.12 (1H, d, J=3.7 Hz), 7.61 (1H, s), 7.57-7.61 (2H, m), 7.14-7.21 (3H, m), 6.92 (1H, d, J=9.2 Hz), 6.57-6.68 (3H, m), 4.39: (1H, t, J=6.2 Hz), 4.35 (1H, d, J=6.2 Hz), 4.12 (3H, s), 4.08 (3H, s), 4.05-4.09 (2H, m), 2.12-2.1 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 494 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (66 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (92 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(3-fluorophenoxy)-1-propanol (52 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (63 mg, yield 55%).
- 1H-NMR (CDCl3, 400 MHz): 8.41-8.45 (1H, m), 8.14 (1H, d, J=3.9 Hz), 7.72 (1H, bs), 7.64 (1H, s), 7.16-7.22 (1H, m), 7.00 (1H, dd, J=8.8 Hz, J=5.6 Hz), 6.58-6.70 (2H, m), 6.53 (1H, d, J=6.6 Hz), 6.43-6.49 (1H, m), 4.39 (1H, t, J=6.2 Hz), 4.35 (1H, t, J=6.2 Hz), 4.15 (3H, s), 4.10 (3H, s), 4.05-4.10 (2H, m), 2.25 (3H, d, J=4.9. Hz), 2.08 (3H, s, J=3.2 Hz), 2.13-2.21 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 522 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (79 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (110 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(3-fluorophenoxy)-1-propanol (62 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (74 mg, yield 54%).
- 1H-NMR (CDCl3, 400 MHz): 8.45-8.50 (1H, m), 8.12 (1H, d, J=3.7 Hz), 7.86 (1H, bs), 7.62 (1H, s), 7.16-7.25 (1H, m), 6.93 (1H, d, J=3.2 Hz), 6.54-6.70 (3H, m), 6.43-6.47 (1H, m), 4.39 (1H, t, J=6.2 Hz), 4.36 (1H, t, J=6.2 Hz), 4.14 (3H, s), 4.08 (3H, s), 4.05-4.10 (2H, m), 2.26 (3H, d, J=4.6 Hz), 2.10 (3H, d, J=5.4H), 2.13-2.22 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 522 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (82 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (124 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min.
- Subsequently, 3-(3-fluorophenoxy)-1-propanol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (59 mg, yield 46%).
- 1H-NMR (CDCl3, 400 MHz): 8.69 (1H, s), 8.01 (1H, s), 7.54 (1H, s), 7.46-7.54 (2H, m), 7.10-7.15 (3H, m), 6.76-6.85 (1H, m), 6.51-6.64 (2H, m), 4.32 (1H, t, J=6.2 Hz), 4.29 (1H, t, J=6.2 Hz), 4.10 (3H, s), 4.04 (3H, s), 3.96-4.04 (2H, m), 2.05-2.15 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 494 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2,3-dimethylaniline (68 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (94 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(3-fluorophenoxy)-1-propanol (53 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (68 mg, yield 56%).
- 1H-NMR (CDCl3, 400 MHz): 8.74 (1H, s), 8.08 (1H, s), 7.67 (1H, bs), 7.61 (1H, s), 7.14-7.23 (1H, m), 6.96-7.02 (1H, m), 6.55-6.68 (2H, m), 6.43-6.53 (1H, m), 4.30-4.38 (2H, m), 4.16 (3H, s), 4.10 (3H, s), 4.03-4.10 (2H, m), 2.22-2.25 (3H, m), 2.10-2.18 (2H, m), 2.04-2.07 (3H, m)
- Mass spectrometry value (ESI-MS, m/z) 523 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (71 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (108 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(4-fluorophenoxy)-1-propanol (61 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (81 mg, yield 64%).
- 1H-NMR (CDCl3, 400 MHz): 8.45 (1H, d, J=4.2 Hz), 8.12 (1H, d, J=3.6 Hz), 7.62 (1H, s), 7.56-7.62 (2H, m), 7.14-7.18 (2H, m), 6.94-6.98 (1H, m), 6.80-6.89 (2H, m), 6.67 (1H, d, J=6.4 Hz), 4.39 (1H, t, J=6.2 Hz), 4.36 (1H, t, J=6.2 Hz), 4.14 (3H, s), 4.08 (3H, s), 4.04 (2H, t, J=6.0 Hz), 2.12-2.20 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 494 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (66 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (92 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(4-fluorophenoxy)-1-propanol (52 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (79 mg, yield 70%).
- 1H-NMR (CDCl3, 400 MHz): 8.44 (1H, dd, J=6.2 Hz), 8.13 (1H, d, J=3.9 Hz), 7.72 (1H, bs), 7.64 (1H, s), 6.92-7.02 (3H, m), 6.81-6.85 (1H, m), 6.53 (1H, d, J 35=6.2 Hz), 6.48 (1H, d, J=5.6 Hz), 4.39 (1H, t, J=6.3 Hz), 4.35 (1H, t, J=6.3 Hz), 4.15 (3H, s), 4.09 (3H, s), 4.04 (2H, t, J=6.1 Hz), 2.25 (3H, d, J=6.3 Hz), 2.08 (3H, d, J=3.2 Hz), 2.13-2.20 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 522 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (68 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (94 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(4-fluorophenoxy)-1-propanol (54 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (68 mg, yield 58%).
- 1H-NMR (CDCl3, 400 MHz): 8.49 (1H, dd, J=6.5 Hz), 8.10 (1H, s), 7.85 (1H, bs), 7.61 (1H, s), 6.78-6.97 (4H, m), 6.56 (1H, d, J=6.3 Hz), 6.50 (1H, d, J=6.8 Hz), 4.38 (1H, t, J=6.3 Hz), 4.34 (1H, t, J=6.3 Hz), 4.13 (3H, s), 4.13 (3H, s), 4.07 (3H, s), 4.04 (2H, t, J=6.0 Hz), 2.25 (3H, d, J=5.6 Hz), 2.09 (3H, d, J=5.1 Hz)
- Mass spectrometry value (ESI-MS, m/z): 522 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (59 mg) was added to toluene/triethylamine=10/1 (6 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (89 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(4-fluorophenoxy)-1-propanol (51 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (51 mg, yield 49%).
- 1H-NMR (CDCl3, 400 MHz): 8.73 (1H, s), 7.97 (1H, s), 7.58 (1H, s), 7.53-7.57 (2H, m), 7.16-7.19 (2H, m), 6.89-6.98 (2H, m), 6.78-6.85 (2H, m), 4.37 (1H, t, J=6.3 Hz), 4.34 (1H, t, J=6.3 Hz), 4.14 (−3H, s), 4.09 (3H, s), 4.03 (2H, t, J=6.3 Hz), 2.08-2.20 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 494 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2,3-dimethylaniline (68 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (94 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(4-fluorophenoxy)-1-propanol (53 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (48 mg, yield 41%).
- 1H-NMR (CDCl3, 400 MHz): 8.71 (1H, s), 7.91 (1H, s), 7.66 (1H, bs), 7.61 (1H, s), 6.91-7.02 (3H, m), 6.78-6.84 (2H, m), 6.44 (1H, bs), 4.37 (1H, t, J=6.5 Hz), 4.33 (1H, t, J=6.5 Hz), 4.14 (3H, s), 4.10 (3H, s), 4.00-4.08 (2H, m), 2.23 (3H, d, J=6.1 Hz), 2.06 (3H, d, J=3.2 Hz), 2.10-2.20 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 523 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (72 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (109 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(2-methoxyphenoxy)-1-propanol (66 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (91 mg, yield 69%).
- 1H-NMR (CDCl3, 400 MHz): 8.47 (1H, bs), 8.12 (1H, s), 7.61 (1H, s), 7.55-7.60 (2H, m), 7.13-7.18 (2H, m), 6.85-6.95 (4H, m), 6.68 (1H, bs), 4.42 (2H, t, J=6.2 Hz), 4.12-4.20 (2H, m), 4.14 (3H, s), 4.08 (3H, s), 3.85 (3H, s), 2.17-2.26 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 506 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (70 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (97 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(2-methoxyphenoxy)-1-propanol (60 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (77 mg, yield 63%).
- 1H-NMR (CDCl3, 400 MHz): 8.43 (1H, dd, J=6.6 Hz), 8.14 (1H, d like, J=4.1 Hz), 7.72 (1H, bs), 7.64 (1H, s), 6.99 (1H, d, J=8.8 Hz), 6.86-6.96 (4H, m), 6.53 (1H, d, J=6.6 Hz), 6.47 (1H, bs), 4.41 (2H, t, J=6.3 Hz), 4.15 (3H, s), 4.15 (2H, t, J=6.2 Hz), 4.09 (3H, s), 3.85 (3H, s), 2.24 (3H, s), 2.07 (3H, s), 2.19-2.26 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 534 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (68 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (94 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(2-methoxyphenoxy)-1-propanol (60 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated The residue was purified on a column using chloroform/methanol to give the title compound (61 mg, yield 51%).
- 1H-NMR (CDCl3, 400 MHz): 8.44 (1H, d, J=6.4 Hz), 8.14 (1H, d like, J=3.9 Hz), 7.87 (1H, bs), 6.87-6.97 (5H, m), 7.62 (1H, s), 6.56 (1H, d, J=6.4 Hz), 6.43 (1H, bs), 4.42 (2H, t, J=6.2 Hz), 4.15 (3H, s), 4.15 (2H, t, J=6.2 Hz), 4.08 (3H, s), 3.85 (3H, s), 2.23 (2H, t, J=6.2 Hz), 2.26 (3H, s), 2.10 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 534 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (75 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (114 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(2-methoxyphenoxy)-1-propanol (69 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (51 mg, yield 35%).
- 1H-NMR (CDCl3, 400 MHz): 8.71 (1H, s), 8.04 (1H, s), 7.54 (1H, s), 7.46-7.53 (2H, m), 6.70-7.20 (7H, m), 4.36 (1H, t, J=6.2 Hz), 4.30 (1H, t, J=6.2 Hz), 4.12 (3H, s), 4.05 (3H, s), 4.05-4.11 (2H, m), 3.79 (3H, s), 2.10-2.20 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 507 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (70 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (106 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(3-methoxyphenoxy)-1-propanol (64 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (69 mg, yield 54%).
- 1H-NMR (CDCl3, 400 MHz): 8.45 (1H, dd, J=6.3 Hz), 8.13 (1H, d like, J=3.9 Hz), 7.62 (1H, s), 7.55-7.65 (3H, m), 7.12-7.18 (3H, m), 6.65-6.75 (1H, m), 6.43-6.52 (1H, m), 6.44-6.47 (1H, m), 4.22-4.41 (2H, m), 4.14 (3H, s), 4.08 (3H, s), 4.05-4.14 (2H, m), 3.76 (3H, s), 2.14-2.20 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 506 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (72 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (100 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(3-methoxyphenoxy)-1-propanol (61 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (83 mg, yield 66%).
- 1H-NMR (CDCl3, 400 MHz): 8.39 (1H, d like, J=6.7 Hz), 8.08 (1H, d like, J=3.4 Hz), 7.60-7.70 (1H, m), 7.59 (1H, s), 7.11 (1H, dd, J=8.2 Hz), 6.94 (1H, d, J=9.0 Hz), 6.39-6.50 (4H, m), 4.34 (2H, t, J=6.3 Hz), 4.09 (3H, s), 4.04 (3H, s), 4.01 (2H, t, J=6.2 Hz), 3.72 (3H, s), 2.19 (3H, s), 2.08-2.15 (2H, m), 2.02 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 534 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (73 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (101 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(3-methoxyphenoxy)-1-propanol (62 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (59 mg, yield 46%).
- 1H-NMR (CDCl3, 400 MHz): 8.45-8.55 (1H, m), 8.11 (1H, s), 7.86 (1H, s), 7.62 (1H, s), 7.16 (1H, dd, J=8.2 Hz), 6.92 (1H, s), 6.56 (1H, d, J=6.4 Hz), 6.40-6.52 (4H, m), 4.39 (2H, t, J=6.2 Hz), 4.14 (3H, s), 4.08 (3H, s), 4.07 (2H, t, J=6.4 Hz), 3.77 (3H, s), 2.26 (3H, s), 2.14-2.22 (2H, m), 2.10 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 534 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (75 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (114 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(3-methoxyphenoxy)-1-propanol (69 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (51 mg, yield 35%).
- 1H-NMR (CDCl3, 400 MHz): 8.71 (1H, s), 8.04 (1H, s), 7.54 (1H, s), 7.46-7.53 (2H, m), 6.70-7.20 (7H, m), 4.36 (1H, t, J=6.2 Hz), 4.30 (1H, t, J=6.2 Hz), 4.12 (3H, s), 4.05 (3H, s), 4.05-4.11 (2H, m), 3.79 (3H, s), 2.10-2.20 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 507 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (77 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (105 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-[(2,5-dimethylphenyl)sulfanyl]-1-ethanol (78 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (105 mg, yield 74%).
- 1H-NMR (CDCl3, 400 MHz): 8.43-8.48 (1H, m), 8.13 (1H, d like, J=3.9 Hz), 7.62 (1H, s), 7.56 (2H, d, J=9.0 Hz), 7.16 (2H, d, J=9.0 Hz), 7.02 (2H, d, J=9.0 Hz), 6.84 (1H, s), 6.76 (1H, s), 6.67 (1H, d, J=6.6 Hz), 4.35 (2H, t, J=6.6 Hz), 4.15 (3H, s), 4.08 (3H, s), 3.18 (2H, t, J=6.6 Hz), 2.27 (6H, s)
- Mass spectrometry value (ESI-MS, m/z): 506 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (62 mg) was added to toluene/triethylamine=10/1 (61 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (85 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 ml. Subsequently, 2-[(2,5-dimethylphenyl)sulfanyl]-1-ethanol (55 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (88 mg, yield 81%).
- 1H-NMR (CDCl3, 400 MHz): 8.44 (1H, d, J=6.6 Hz), 8.14 (1H, s, J=4.2 Hz), 7.72 (1H, bs), 7.64 (1H, s), 7.01-7.04 (2H, m), 6.99 (1H, s), 6.84 (1H, s), δ 53 (1H, d, J=6.4 Hz), 6.43 (1H, s), 3.71 (1H, t, J=6.0 Hz), 4.15 (3H, s), 4.09 (3H, s), 3.19 (2H, t, J=6.0 Hz), 2.27 (6H, s), 2.23 (3H, s), 2.08 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 534 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (68 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (97 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-[(2,5-dimethylphenyl)sulfanyl]-1-ethanol (60 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (79 mg, yield 66%).
- 1H-NMR (CDCl3, 400 MHz): 8.45 (1H, dd, J=6.6 Hz), 8.13 (1H, d, J=4.2 Hz), 7.86 (1H, s), 7.62 (1H, s), 7.02 (2H, s), 6.93 (1H, s), 6.84 (1H, s), 6.55 (1H, d, J=6.6 Hz), 6.40 (1H, s), 4.36 (1H, t, J=6.7 Hz), 4.15 (3H, s), 4.08 (3H, s), 3.20 (2H, t, J=6.7 Hz), 2.27 (6H, s), 2.24 (3H, s), 2.11 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 534 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (70 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (108 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-[(2,5-dimethylphenyl)sulfanyl]-1-ethanol (65 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (101 mg, yield 79%).
- 1H-NMR (CDCl3, 400 MHz): 8.77 (1H, s), 8.09 (1H, S), 7.59 (1H, s), 7.53 (2H, d, J=9.0 Hz), 7.17 (2H, d, J=8.8 Hz), 6.97-7.03 (2H, m), 6.72-6.85 (2H, m), 4.34 (2H, t, J=6.6 Hz), 4.16 (3H, s), 4.10 (3H, s), 3.17 (2H, t, J=6.6 Hz), 2.27 (6H, s)
- Mass spectrometry value (ESI-MS, m/z): 507 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (70 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (105 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-[(2,5-dimethylphenyl)sulfanyl]-1-propanol (78 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (48 mg, yield 37%).
- 1H-NMR (CDCl3, 400 MHz): 8.45 (1H, dd, J=6.6 Hz), 8.12 (1H, s), 7.62 (1H, s), 7.56-7.61 (2H, m), 7.15-7.61 (2H, m), 7.15-7.25 (3H, m), 6.96 (1H, s), 6.80-6.85 (1H, m), 6.67 (1H, d, J=6.4 Hz), 4.36 (1H, t, J=6.4 Hz), 4.31 (1H, t, J=6.4 Hz), 4.14 (3H, s), 4.08 (3H, s), 3.00 (2H, t, J=7.1 Hz), 2.27 (6H, s), 1.97-2.25 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 520 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (72 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (100 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-[(2,5-dimethylphenyl sulfanyl]-1-propanol (60 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (33 mg, yield 25%).
- 1H-NMR (CDCl3, 400 MHz): 8.4.0-8.46 (1H, m), 8.14 (1H, s), 7.73 (1H, bs), 7.65 (1H, s), 6.94-7.02 (3H, m), 6.82-7.02 (3H, m), 6.82 (1H, s), 6.53 (1H, d, J=6.6 Hz), 6.43-6.48 (1H, m), 4.28-4.37 (2H, m), 4.15 (3H, s), 4.09 (3H, s), 4.00 (2H, t, J=7.1 Hz), 2.27 (6H, s), 2.25 (3H, s), 2.08 (3H, s), 1.98-2.20 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 548 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (68 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (97 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-[(2,5-dimethylphenyl)sulfanyl]-1-propanol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (51 mg, yield 42%).
- 1H-NMR (CDCl3, 400 MHz): 8.41-8.45 (1H, m), δ 14 (1H, bs), 7.68 (1H, bs), 7.62 (1H, s), 6.97 (1H, s), 6.92-6.96 (1H, m), 6.82 (1H, s), 6.56 (1H, d, J=6.6 Hz), 6.40-6.45 (1H, m), 4.36 (1H, t, J=6.0 Hz), 4.32 (1H, t, J=6.0 Hz), 3.00 (2H, t, J=7.1 Hz), 2.27 (6H, s), 2.26 (3H, s), 2.14-2.20 (1H, m), 2.11 (3H, s), 1.98-2.05 (1H, m)
- Mass spectrometry value (ESI-MS, m/z): 548 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (66 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (1001 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-[(2,5-dimethylphenyl)sulfanyl]-1-propanol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (29 mg, yield 23%).
- 1H-NMR (CDCl3, 400 MHz): 8.75 (1H, s), 8.07 (1H, s), 7.59 (1H, s), 7.52-7.58 (2H, m), 6.79-7.21 (5H, m), 4.34 (1H, d, J=6.1 Hz), 4.30 (1H, d, J=6.1 Hz), 4.16 (3H, s), 4.10 (3H, s), 2.99 (2H, t, J=7.1 Hz), 2.27 (6H, s), 2.11-2.19 (1H, m), 2.15-2.03 (1H, m)
- Mass spectrometry value (ESI-MS, m/z): 521 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (111 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(2-pyridylsulfanyl)-1-propanol (63 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (18 mg, yield 13%).
- 1H-NMR (CDCl3, 400 MHz): 8.39-8.44 (2H, m), 7.90-7.95 (1H, m), 7.64-7.70 (1H, m), 7.63 (1H, s), 7.44-7.50 (1H, m), 7.15-7.20 (1H, m), 6.95-7.02 (2H, m), 6.42-6.48 (1H, m), 4.33 (2H, t, J=6.2 Hz), 4.12 (3H, s), 4.08 (3H, s), 3.29 (2H, t, J=7.1 Hz), 2.25 (3H, s), 2.09-2.15 (2H, m), 2.09 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 521 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (78 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (110 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(2-pyridylsulfanyl)-1-propanol (62 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (13 mg, yield 10%).
- 1H-NMR (CDCl3, 400 MHz): 8.75-8.79 (1H, m), 8.41-8.47 (1H, m), 8.12 (1H, s), 8.06-8.14 (1H, m), 7.99 (1H, bs), 7.81 (1H, s), 7.69 (1H, d, J=8.5 Hz), 7.63 (1H, s like), 7.52-7.58 (1H, m), 6.92 (1H, s), 6.58 (1H, d, J=6.3 Hz), 4.30 (2H, t, J=5.6 Hz), 4.14 (3H, s), 4.09 (3H, s), 3.99 (2H, t, J=7.3 Hz), 2.40 (3H, s), 2.08-2.22 (2H, m), 2.08 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 521 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (73 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (110 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(2-pyridylsulfanyl)-1-propanol (62 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (5 mg, yield 4%).
- Mass spectrometry value (ESI-MS, m/z): 494 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (88 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (70 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-methyl-4-chlorothiophenol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (108 mg, yield 70%).
- Mass spectrometry value (ESI-MS, m/z): 482 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (82 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (114 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-methyl-4-chlorothiophenol (60 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (91 mg, yield 66%).
- Mass spectrometry value (ESI-MS, m/z): 510 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (79 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (110 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-methyl-4-chlorothiophenol (58 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (71 mg, yield 53%).
- Mass spectrometry value (ESI-MS, m/z): 510 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (121 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-methyl-4-chlorothiophenol (64 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (68 mg, yield 49%).
- Mass spectrometry value (ESI-MS, m/z): 493 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (82 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (124 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-trifluoromethoxy-α-methylbenzyl alcohol (85 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (61 mg, yield 39%).
- 1H-NMR (CDCl3, 400 MHz): 8.39 (1H, dd, J=6.6 Hz), 8.07 (1H, s like), 7.50-7.56 (2H, m), 7.31-7.36 (3H, m), 7.23-7.28 (1H, m), 7.08-7.13 (2H, m), 6.82 (1H, s), 6.60 (1H, d, J=6.6 Hz), 5.85 (1H, q, J=6.6 Hz), 4.09 (3H, s), 4.02 (3H, s), 1.55 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 529 (M+1+1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (88 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (122 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-trifluoromethoxy-α-methylbenzyl alcohol (83 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (73 mg, yield 46%).
- 1H-NMR (CDCl3, 400 MHz): 8.42 (1H, dd, J=6.5 Hz), 8.13 (1H, s), 7.63-7.75 (2H, m), 6.96-7.42 (5H, m), 6.51 (2H, d, J=6.5 Hz), 5.89 (1H, q, J=6.6 Hz), 4.15 (3H, s), 4.09 (3H, s), 2.24 (3H, s), 2.07 (3H, s), 1.61 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 558 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (90 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (125 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-trifluoromethoxy-α-methylbenzyl alcohol (85 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (78 mg, yield 48%).
- 1H-NMR (CDCl3, 400 MHz): 8.43 (1H, dd, J=6.6 Hz), 8.13 (1H, s), 7.85 (1H, s), 7.62 (1H, s), 7.40 (1H, dd, J=7.8 Hz), 7.31 (1H, d, J=7.8 Hz), 7.16 (1H, d, J=8.0 Hz), 6.93 (1H, s), 6.54 (1H, d, J=6.6 Hz), 6.48 (1H, s), 5.89 (1H, q, J=6.7 Hz), 4.15 (3H, s), 4.08 (3H, s), 2.27 (3H, s), 2.09 (3H, s), 1.62 (3H, d, J=6.7 Hz)
- Mass spectrometry value (ESI-MS, m/z): 558 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (82 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (124 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-trifluoromethoxy-α-methylbenzyl alcohol (85 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (48 mg, yield 31%).
- 1H-NMR (CDCl3, 400 MHz): 8.75 (1H, s), 8.11 (1H, s), 7.53-7.59 (3H, m), 7.38 (1H, dd, J=7.9 Hz), 7.30 (1H, d, J=7.9 Hz), 7.12-7.19 (3H, m), 6.87 (1H, s), 5.89 (1H, q, J=6.6 Hz), 4.16 (3H, s), 4.10 (3H, s), 1.60 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 530 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (78 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (118 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 1-phenyl-1-butanol (59 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (78 mg, yield 58%).
- 1H-NMR (CDCl3, 400 MHz): 8.43 (1H, dd, J=6.6 Hz), 8.12 (1H, s like), 7.60 (1H, s), 7.53-7.58 (2H, m), 7.23-7.38 (4H, m), 7.12-7.15 (2H, m), 6.80 (1H, s), 6.64 (1H, d, J=6.6 Hz), 5.72-5.78 (1H, m), 4.14 (3H, s), 4.07 (3H, s), 1.75-2.03 (2H, m), 1.35-1.45 (2H, m), 0.94 (2H, d, J=7.3 Hz)
- Mass spectrometry value (ESI-MS, m/z): 474 (M+1+1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (90 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (125 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 1-phenyl-1-butanol (62 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (59 mg, yield 40%).
- 1H-NMR (CDCl31 400 MHz): 8.36 (1H, dd, J=6.5 Hz), 8.08 (1H, s), 7.67 (1H, d, J=8.8 Hz), 7.59 (1H, s) 7.24-7.34 (5H, m), 6.92 (1H, d, J=8.8 Hz), 6.42-6.47 (2H, m), 5.69 (1H, t, J=6.9 Hz), 4.10 (3H, s) 4.04 (3H, s), 2.18 (3H, s), 2.01 (3H, s), 1.70-2.00 (2H, m), 1.2-1.42 (2H, m), 0.90 (3H, t, J=7.4 Hz)
- Mass spectrometry value (ESI-MS, m/z): 502 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (89 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (126 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 1-phenyl-1-butanol (63 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (58 mg, yield 39%).
- 1H-NMR (CDCl3, 400 MHz): 8.43 (1H, dd, J=6.5 Hz), 8.12 (1H, s like), 7.89 (1H, s), 7.61 (1H, s), 7.26-7.40 (5H, m), 6.91 (1H, s), 6.53 (1H, d, J=6.5 Hz), 6.47 (1H, s), 5.71-5.76 (1H, m), 4.14 (3H, s), 4.08 (3H, s9, 2.25 (3H, s), 2.07 (3H, s), 1.75-2.05 (2H, m), 1.25-1.50 (2H, m), 0.95 (3H, t, J=7.3 Hz)
- Mass spectrometry value (ESI-MS, m/z): 502 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (76 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (115 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 1-phenyl-1-butanol (57 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (38 mg, yield 29%).
- 1H-NMR (CDCl3, 400 MHz): 8.71 (1H, s), 8.07 (1H, s), 7.54 (1H, s), 7.44-7.52 (2H, m), 7.18-7.33 (5H, m), 7.08-7.13 (2H, m), 6.73 (1H, s), 5.65-5.72 (1H, m), 4.12 (3H, s), 4.05 (3H, s), 1.65-1.95 (2H, m), 1.30-1.40 (2H, m), 0.89 (3H, t, J=7.4 Hz)
- Mass spectrometry value (ESI-MS, m/z): 475 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (83 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (40 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-dimethylaminoethanol (40 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (31 mg, yield 25%).
- 1H-NMR (CDCl3, 400 MHz): 8.41 (1H, d, J=5.4 Hz), 7.56-7.65 (2H, m), 7.43 (1H, s), 7.20-7.26 (2H, m), 6.97 (1H, d, J=8.8 Hz), 6.25 (1H, d, J=5.1 Hz), 4.34-4.41 (2H, m), 4.05 (2H, s), 4.04 (3H, s), 2.92 (2H, bs), 2.57 (6H, bs)
- Mass spectrometry value (ESI-MS, m/z): 412 (M+1+1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (111 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-dimethylaminoethanol (31 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (41 mg, yield 35%).
- 1H-NMR (CDCl3, 400 MHz): 8.41 (1H, d, =5.3 Hz), 7.59 (2H, s), 7.42 (1H, s), 6.96 (1H, d, H=8.8 Hz), 6.24 (1H, d, J=5.3 Hz), 4.30-4.38 (2H, m), 4.94 (3H, s), 4.03 (3H, s), 2.81 (2H, bs), 2.47 (6H, bs), 2.25 (3H, s), 2.09 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 441 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (85 mg) was added to toluene/triethylamine=10/1 (9 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (115 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-dimethylaminoethanol (33 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (28 mg, yield 22%).
- 1H-NMR (CDCl3, 400 MHz):
- Mass spectrometry value (ESI-MS, m/z): 441 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (74 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (112 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-dimethylaminoethanol (32 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (13 mg, yield 12%).
- 1H-NMR (CDCl3, 400 MHz): 8.42 (1H, m), 8.07 (1H, s) 7.10-7.70 (5H, m), 6.62-6.68 (1H, m), 4.47-4.52 (2H, m), 4.14 (3H, s), 4.08 (3H, s), 3.30-3.35 (2H, m), 2.94 (6H, s)
- Mass spectrometry value (ESI-MS, m/z): 413 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (130 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-dimethylaminopropanol (40 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (22 mg, yield 17%).
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (76 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (106 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-dimethylaminopropanol (40 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (29 mg, yield 25%).
- Mass spectrometry value (ESI-MS, m/z): 469 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (75 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (114 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 4-dimethylaminopropanol (43 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (18 mg, yield 15%).
- Mass spectrometry value (ESI-MS, m/z): 413 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (77 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (118 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-methyl-1-phenyl-1-propanol (39 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (78 mg, yield 59%).
- 1H-NMR (CDCl3, 400 MHz): 8.40-8.45 (1H, m), 8.10-8.13 (1H, m), 7.10-7.61 (10H, m), 6.62-6.65 (1H, m), 5.45 (1H, d, J=7.8 Hz), 4.14 (3H, s), 4.07 (3H, s), 2.00-2.25 (1H, m), 1.04 (3H, d, J=6.6 Hz), 0.83 (3H, d, J=6.8 Hz).
- Mass spectrometry value (ESI-MS, m/z): 474 (M+1+1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (111 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-methyl-1-phenyl-1-propanol (55 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (69 mg, yield 52%).
- 1H-NMR (CDCl3, 400 MHz): 8.38-8.43 (1H, m), 8.11-8.15 (1H, m), 7.00-7.80 (8H, m), 6.95-7.00 (1H, m), 6.47-6.52 (1H, m), 5.45 (1H, d, J=7.6 Hz), 4.14 (3H, s), 4.09 (3H, s), 2.23 (3H, s), 2.06 (3H, s), 2.00-2.25 (1H, m), 1.04 (3H, d, J=6.6 Hz), 0.83 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 502 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (124 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-methyl-1-phenyl-1-propanol (61 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (58 mg, yield 44%).
- 1H-NMR (CDCl3, 400 MHz): 8.39-8.44 (1H, m), 8.12-8.14 (1H, m), 7.85-7.90 (1H, s like), 7.61 (1H, s), 7.24-7.36 (5H, m), 6.91 (1H, s), 6.45-6.55 (2H, m), 5.45 (1H, d, J=7.8 Hz), 4.14 (3H, s), 4.08 (3H, s), 2.26 (3H, s), 2.10-2.22 (1H, m), 2.07 (3H, s), 1.05 (3H, d, J=6.6 Hz), 0.83 (3H, d, J=6.8 Hz)
- Mass spectrometry value (ESI-MS, m/z): 502 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (75 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (137 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-methyl-1-phenyl-1-propanol (56 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (38 mg, yield 29%).
- 1H-NMR (CDCl3, 400 MHz): 8.72 (1H, s), 8.09 (1H, s), 7.58 (1H, s), 7.55 (2H, d, J=8.8 Hz), 7.20-7.36 (5H, m), 7.13-7.16 (2H, m), 6.93 (1H, bs), 5.45 (1H, d, J=7.6 Hz), 4.15 (3H, s), 4.09 (3H, s), 2.09-2.18 (1H, m), 1.02 (3H, d, J=6.6 Hz), 0.82 (3H, d, J=6.8 Hz)
- Mass spectrometry value (ESI-MS, m/z): 475 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (78 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (120 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-dimethylamino-α-methylbenzyl alcohol (65 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (61 mg, yield 44%).
- 1H-NMR (CDCl3, 400 MHz): 8.39 (1H, d, J=5.6 Hz), 7.42-7.57 (3H, m), 7.06-7.22 (2H, m), 6.54-6.74 (5H, m), 6.42 (1H, d, J=5.6 Hz), 5.80 (1H, q, J=6.6 Hz), 4.01 (3H, s), 3.99 (3H, s), 2.90 (3H, s), 2.89 (3H, s), 1.56 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 489 (M+1+1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (83 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (120 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-dimethylamino-α-methylbenzyl alcohol (62 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (77 mg, yield 55%).
- 1H-NMR (CDCl3, 400 MHz): 8.41 (1H, d, J=5.4 Hz), 7.48-7.65 (3H, m), 7.20-7.26 (1H, m), 6.96 (1H, d, J=8.8 Hz), 6.65-6.78 (3H, m), 6.42 (1H, bs), 6.25-6.30 (1H, m), 5.85 (1H, q, J=6.6 Hz), 4.04-4.06 (6H, m), 2.95 (6H, s), 2.22 (3H, s), 2.08 (3H, s), 1.61 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z): 517 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (110 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-dimethylamino-α-methylbenzyl alcohol (60 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (58 mg, yield 43%).
- 1H-NMR (CDCl3, 400 MHz): 8.41 (1H, d, J=5.6 Hz), 7.80 (1H, bs), 7.57 (1H, s), 7.55 (1H, bs), 7.20-7.26 (1H, m), 6.89 (1H, s), 6.72-6.7.9 (2H, m), 6.65-6.70 (1H, m), 6.41 (1H, bs), 6.31 (1H, q, J=5.4 Hz), 5.85 (1H, q, J=6.6 Hz), 4.05 (3H, s), 4.05 (3H, s), 2.96 (6H, s), 2.22 (3H, s), 2.10 (3H, s), 1.62 (3H, d, J=6.6 Hz)
- Mass spectrometry value (ESI-MS, m/z) 517 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (120 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-dimethylamino-α-methylbenzyl alcohol (66 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (51 mg, yield 36%).
- 1H-NMR (CDCl3, 400 MHz): 8.54 (1H, s), 7.48 (1H, s), 7.42 (1H, d, J=7.8 Hz), 7.25 (1H, s), 7.10-7.20 (3H, m), 6.58-6.74 (5H, m), 5.80 (1H, q, J=6.5 Hz), 3.99 (3H, s), 3.99 (3H, s), 2.90 (6H, s), 1.55 (3H, d, J=6.5 Hz)
- Mass spectrometry value (ESI-MS, m/z): 490 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (60 mg) was added to toluene/triethylamine=10/1 (6 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (91 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-(2-fluorophenoxy)-1-ethanol (47 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (52 mg, yield 50%).
- 1H-NMR (CDCl3, 400 MHz): 8.43-8.49 (1H, m), 8.13 (1H, d, J=3.9 Hz), 7.62 (1H, s), 7.59 (2H, d, J=8.6 Hz), 7.17 (2H, d, J=9.0 Hz), 6.90-7.12 (5H, m), 6.68 (1H, d, J=6.1 Hz), 4.54-4.59 (2H, m), 4.28-4.33 (2H, m), 4.15 (3H, s), 4.08 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 479 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (62 mg) was added to toluene/triethylamine=10/1 (6 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (86 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-(2-fluorophenoxy)-1-ethanol (45 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (49 mg, yield 47%).
- 1H-NMR (CDCl3, 400 MHz): 8.40-8.45 (1H, t, J=6.5 Hz), 8.14 (1H, s like), 7.72 (1H, bs), 7.64 (1H, s), 6.90-7.12 (5H, m), 6.59 (1H, bs), 6.53 (1H, d, J=6.4 Hz), 4.56 (2H, t, J=4.6 Hz), 4.30 (2H, t, J=4.6 Hz), 4.15 (3H, s), 4.09 (3H, s), 2.25 (3H, s), 2.08 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 508 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (55 mg) was added to toluene/triethylamine=10/1 (6 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (76 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-(2-fluorophenoxy)-1-ethanol (40 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (61 mg, yield 66%).
- 1H-NMR (CDCl3, 400 MHz): 8.46-8.53 (1H, m), 8.11 (1H, d, J=1.7 Hz), 7.85 (1H, bs), 7.62 (1H, s), 6.85-7.12 (5H, m), 6.54-6.64 (2H, m), 4.54-4.58 (2H, m), 4.29-4.32 (2H, m), 4.14 (3H, s), 4.08 (3H, s), 2.26 (3H, s), 2.10 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 508 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene/triethylamine=10/1 (5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (76 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-(2-fluorophenoxy)-1-ethanol (40 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (38 mg, yield 44%).
- 1H-NMR (CDCl3, 400 MHz): 8.75 (1H, s), 7.99 (1H, s), 7.59 (1H, s), 7.54 (2H, d, J=8.8 Hz), 7.19 (2H, d, J=9.0 Hz), 6.85-7.12 (5H, m), 4.53-4.56 (2H, m), 4.28-4.32 (2H, m), 4.15 (3H, s), 4.09 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 480 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (62 mg) was added to toluene/triethylamine=10/1 (6 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (92 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-(3-fluorophenoxy)-1-ethanol (48 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (55 mg, yield 51%).
- 1H-NMR (CDCl3, 400 MHz): 8.43-8.49 (1H, m), 8.10-8.13 (1H, m), 7.57-7.64 (3H, m), 6.60-7.25 (7H, m), 4.52-4.57 (2H, m), 4.18-4.27 (2H, m), 4.14 (3H, s), 4.08 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 479 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (70 mg) was added to toluene/triethylamine=10/1 (7 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (97 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-(3-fluorophenoxy)-1-ethanol (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (78 mg, yield 67%).
- 1H-NMR (CDCl3, 400 MHz): 8.42-8.49 (1H, m), 8.12-8.14 (1H, m), 7.73 (1H, bs), 7.64 (1H, s), 7.21 (1H, d, J=8.0 Hz), 7.00 (1H, d, J=8.8 Hz), 6.50-6.74 (4H, m), 4.54 (2H, t, J=4.5 Hz), 4.21 (2H, t, J=4.5 Hz), 4.15 (3H, s), 4.09 (3H, s), 2.25 (3H, s), 2.08 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 508 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (56 mg) was added to toluene/triethylamine=10/1 (6 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (78 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-(3-fluorophenoxy)-1-ethanol (40 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (54 mg, yield 57%).
- 1H-NMR (CDCl3, 400 MHz): 8.40-8.50 (1H, m), 8.11 (1H, s), 8.00 (1H, s), 7.84-7.91 (1H, m), 7.60-7.67 (2H, m), 6.40-6.99 (5H, m), 4.08-4.28 (4H, m), 4.14 (3H, s), 4.09 (3H, s), 2.26 (3H, s), 2.11 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 508 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (55 mg) was added to toluene/triethylamine=10/1 (6 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (83 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 2-(3-fluorophenoxy)-1-ethanol (43 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (28 mg, yield 29%).
- 1H-NMR (CDCl3, 400 MHz): 8.75 (1H, m), 8.05 (1H, s like), 7.59 (1H, s), 7.50-7.58 (2H, m), 7.17-7.24 (2H, m), 6.60-6.73 (4H, m), 4.52-4.56 (2H, m), 4.19-4.23 (2H, m), 4.16 (3H, s), 4.10 (3H, s)
- Mass spectrometry value (ESI-MS, m/z): 480 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2,3-aniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (111 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(2-chlorophenoxy)-1-propanol (69 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (70 mg, yield 50%).
- 1H-NMR (CDCl3, 400 MHz): 8.74 (1H, d, J=1.7 Hz), 8.08 (1H, s), 7.70 (1H, bs), 7.62 (1H, s), 7.32-7.36 (1H, m), 7.17-7.22 (1H, m), 7.00 (1H, dd, J=6.8 Hz, J=9.3 Hz), 6.85-6.95 (2H, m), 6.44 (1H, bs), 4.43 (1H, t, J=6.2 Hz), 4.34 (1H, t, J=6.2 Hz), 4.10-4.20 (1H, m), 4.18 (3H, s), 4.11 (3H, s), 3.60-3.70 (1H, m), 2.23 (1H, d, J=5.9 Hz), 2.06 (1H, d, J=4.1 Hz), 2.08-2.22 (2H, m)
- Mass spectrometry value (ESI-MS, m/z): 539 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2,3-aniline (80 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (111 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(3-chlorophenoxy)-1-propanol (62 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (65 mg, yield 46%).
- 1H-NMR (CDCl3, 400 MHz): 8.75 (1H, d, J=2.7 Hz), 8.14 (1H, s), 7.70 (1H, bs), 7.62 (1H, s), 7.15-7.22 (1H, m), 6.97-7.03 (1H, m), 6.87-6.95 (1H, m), 6.76-6.82 (1H, m), 6.42 (1H, bs), 4.32-4.39 (2H, m), 4.18 (3H, s), 4.11 (3H, s), 4.03-4.08 (1H, m), 3.62-3.68 (1H, m), 2.23-2.26 (3H, m), 2.12-2.21 (2H, m), 2.05-2.07 (3H, m)
- Mass spectrometry value (ESI-MS, m/z): 539 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2,3-aniline (82 mg) was added to toluene/triethylamine=10/1 (8 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (114 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 15 min. Subsequently, 3-(4-chlorophenoxy)-1-propanol (71 mg) was added thereto, and the mixture was further stirred with heating under reflux for 2 hr. After the completion of the reaction, the reaction solution was allowed to cool to room temperature before distilled water was added thereto. The mixture was subjected to separatory extraction with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution and saturated brine. The washed solution was dried over sodium sulfate and was concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (85 mg, yield 59%).
- 1H-NMR (CDCl3, 400 MHz): 8.74 (1H, s like), 8.09 (1H, s), 7.69 (1H, bs), 7.62 (1H, s), 7.19-7.23 (2H, m), 7.97-7.02 (1H, m), 6.79-6.84 (2H, m), 6.42 (1H, bs), 4.32-4.39 (2H, m), 4.17 (3H, s), 4.11 (3H, s), 4.02-4.09 (2H, m), 2.23-2.26 (3H, m), 2.10-2.20 (2H, m), 2.05-2.07 (3H, m)
- Mass spectrometry value (ESI-MS, m/z): 539 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (150 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 10 min. Next, 3-methoxyphenol (55 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (108 mg, yield 68%)
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.29 (s, 3H), 4.07 (s, 3H), 4.09 (s, 3H), 6.54 (brs, 1H), 7.13-7.29 (m, 8H), 7.59-7.60 (m, 3H), 8.49 (d, J=5.9 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 447 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (138 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 10 min. Next, 1-propanol (28 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (120 mg, yield 87%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.95 (t, J=7.6 Hz, 3H), 1.63-1.66 (m, 2H), 2.07 (s, 3H), 2.20 (s, 3H), 4.04 (t, J=6.8 Hz, 2H), 4.05 (s, 6H), 6.67 (d, J=6.6 Hz, 1H), 7.15 (d, J=8.3 Hz, 1H), 7.37 (d, J=9.0 Hz, 1H), 7.60 (s, 1H), 7.79 (s, 1H), 8.77 (d, J=6.6 Hz, 1H), 9.06 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 411 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (151 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 10 min. Next, phenol (48 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (97 mg, yield 63%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 4.03 (s, 3H), 4.04 (s, 3H), 6.83 (d, J=6.3 Hz, 1H), 7.24-7.30 (m, 3H), 7.38-7.47 (m, 3H), 7.57 (s, 1H), 7.72-7.74 (m, 3H), 8.79 (d, J=6.6 Hz, 1H), 10.50 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 417 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (139 mg) in methylene chloride was then added to the solution, and the mixture was heated under reflux for 10 min. Next, phenol (44 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (73 mg, yield 49%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.10 (s, 3H), 2.30 (s, 3H), 4.05 (s, 6H), 6.69 (d, J=6.6 Hz, 1H), 7.15-7.28 (m, 4H), 7.42-7.48 (m, 3H), 7.61 (s, 1H), 7.79 (s, 1H), 8.76 (d, J=6.3 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 445 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, phenylmethanol (51 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (137 mg, yield 89%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.13 (s, 3H), 2.27 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 5.24 (s, 2H), 6.52 (s, 1H), 6.59 (brs, 1H), 6.95 (s, 1H), 7.26-7.45 (m, 5H), 7.64 (s, 1H), 7.93 (s, 1H), 8.14 (s, 1H), 8.51 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 459 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, phenylmethanol (51 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (120 mg, yield 78%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.10 (s, 3H), 2.26 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 5.24 (s, 2H), 6.55 (s, 2H), 7.03 (d, J=8.8 Hz, 1H), 7.37-7.43 (m, 5H), 7.67 (s, 1H), 7.76 (brs, 1H), 8.15 (s, 1H), 8.50 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 459 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (151 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, phenylmethanol (55 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (100 mg, yield 58%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 4.12 (s, 3H), 4.19 (s, 3H), 5.23 (s, 2H), 6.96 (s, 1H), 7.19 (d, J=9.0 Hz, 2H), 7.35-7.43 (m, 5H), 7.59 (d, J=8.8 Hz, 2H), 7.61 (s, 1H), 8.14 (s, 1H), 8.79 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 432 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-cyclohexanol (47 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (80 mg, yield 53%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.49-1.57 (m, 10H), 1.76-1.80 (m, 2H), 1.97-2.01 (m, 2H), 2.13 (s, 3H), 2.29 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 6.39 (s, 1H), 6.59 (d, J=9.0 Hz, 1H), 6.94 (s, 1H), 7.65 (s, 1H), 7.95 (s, 1H), 8.15 (s, 1H), 8.49 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 451 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-cyclohexanol (47 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (85 mg, yield 56%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.47-2.20 (m, 13H), 2.28 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 4.74 (brs, 1H), 6.43 (s, 1H), 6.57 (brs, 1H), 7.02 (d, J=8.8 Hz, 1H), 7.67 (s, 1H), 7.75 (brs, 1H), 8.14 (s, 1H), 8.49 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 451 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (151 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, o-cresol (55 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (116 mg, yield 80%).
- Mass spectrometry value (ESI-MS, m/z): 432 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, phenol (44 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (69 mg, yield 50%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.15 (s, 3H), 2.34 (s, 3H), 4.01 (s, 3H), 4.07 (s, 3H), 6.32 (d, J=5.4 Hz, 1H), 6.77 (brs, 1H), 6.97 (s, 1H), 7.22-7.28 (m, 3H), 7.40-7.47 (m, 3H), 7.60 (s, 1H), 7.85 (brs, 1H), 8.46 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 445 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (134 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, phenylmethanol (49 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (100 mg, yield 72%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 4.00 (s, 6H), 5.17 (s, 2H), 7.12-7.37 (m, 9H), 7.44 (s, 1H), 8.24 (d, J=8.8 Hz, 1H), 8.56 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 467 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (151 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (3-methoxyphenyl)methanol (71 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (133 mg, yield 79%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.83 (s, 3H), 4.10 (s, 3H), 4.17 (s, 3H), 5.21 (s, 2H), 6.58 (brs, 1H), 6.88-7.01 (m, 4H), 7.18 (d, J=8.8 Hz, 1H), 7.29-7.33 (m, 1H), 7.61-7.63 (m, 3H), 8.14 (s, 1H), 8.50 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 462 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (151 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (2-chlorophenyl)methanol (73 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (153 mg, yield 90%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 4.03 (s, 3H), 4.04 (s, 3H), 5.27 (s, 2H), 6.83 (d, J=6.6 Hz, 1H), 7.35 (d, J=9.0 Hz, 2H), 7.41-7.43 (m, 2H), 7.52-7.54 (m, 1H), 7.58-7.61 (m, 2H), 7.69 (d, J=8.8 Hz, 2H), 7.74 (s, 1H), 8.77 (d, J=6.6 Hz, 1H), 10.12 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z) 466 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (151 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (3-chlorophenyl)methanol (73 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (158 mg, yield 93%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 4.03 (s, 3H), 4.04 (s, 3H), 5.20 (s, 2H), 6.82 (d, J=6.6 Hz, 1H), 7.35 (d, J=9.0 Hz, 2H), 7.42-7.47 (m, 3H), 7.52 (s, 1H), 7.63 (s, 1H), 7.69 (d, J=9.0 Hz, 2H), 7.74 (s, 1H), 8.78 (d, J=6.6 Hz, 1H), 10.09 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 466 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (151 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (4-chlorophenyl)methanol (73 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (147 mg, yield 86%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 4.03 (s, 3H), 4.04 (s, 3H), 5.18 (s, 2H), 6.82 (d, J=6.6 Hz, 1H), 7.35 (d, J=9.0 Hz, 2H), 7.48 (s, 4H), 7.64 (s, 1H), 7.68 (d, J=8.8 Hz, 2H), 7.74 (s, 1H), 8.78 (d, J=6.6 Hz, 1H), 10.07 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 466 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (151 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-cyclohexanol (51 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (120 mg, yield 77%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.24-1.58 (m, 6H), 1.73-1.76 (m, 2H), 1.90-1.94 (m, 2H), 4.02 (s, 3H), 4.04 (s, 3H), 4.54 (brs, 1H), 6.79 (d, J=6.3 Hz, 1H), 7.32 (d, J=9.0 Hz, 2H), 7.55 (s, 1H), 7.67 (d, J=9.0 Hz, 2H), 7.72 (s, 1H), 8.76 (d, J=6.6 Hz, 1H), 9.82 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 423 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (151 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, phenylmethanol (55 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (130 mg, yield 82%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 4.03 (s, 3H), 4.04 (s, 3H), 5.19 (s, 2H), 6.82 (d, J=6.6 Hz, 1H), 7.30-7.46 (m, 7H), 7.62 (s, 1H), 7.69 (d, J=9.0. Hz, 2H), 7.74 (s, 1H), 8.78 (d, J=6.6 Hz, 1H), 10.04 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 431 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (2-methylphenyl)methanol (57 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (140 mg, yield 89%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.07 (s, 3H), 2.20 (s, 3H), 2.36 (s, 3H), 4.05 (s, 6H), 5.17 (s, 2H), 6.67 (d, J=6.6 Hz, 1H), 7.13-7.27 (m, 4H), 7.39 (d, J=9.0 Hz, 2H), 7.62 (s, 1H), 7.79 (s, 1H), 8.76 (d, J=6.6 Hz, 1H), 9.22 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 473 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (3-methylphenyl)methanol (57 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (140 mg, yield 89%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.07 (s, 3H), 2.20 (s, 3H), 2.33 (s, 3H), 4.05 (s, 6H), 5.12 (s, 2H), 6.65 (d, J=6.8 Hz, 1H), 7.12-7.31 (m, 5H), 7.39 (d, J=8.8 Hz, 2H), 7.60 (s, 1H), 7.78 (s, 1H), 8.75 (d, J=6.8 Hz, 1H), 9.21 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 473 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (4-methylphenyl)methanol (57 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (40 mg, yield 25%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.07 (s, 3H), 2.19 (s, 3H), 2.32 (s, 3H), 4.04 (s, 6H), 5.11 (s, 2H), 6.65 (d, J=6.3 Hz, 1H), 7.14-7.22 (m, 3H), 7.32 (d, J=8.1 Hz, 2H), 7.38 (d, J=8.8 Hz, 1H), 7.56 (s, 1H), 7.78 (s, 1H), 8.75 (d, J=6.3 Hz, 1H), 9.19 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 473 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (2-chlorophenyl)methanol (67 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (127 mg, yield 77%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.10 (s, 3H), 2.27 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 5.36 (s, 2H), 6.55-6.56 (m, 2H), 7.03 (d, J=9.0 Hz, 1H), 7.25-7.33 (m, 1H), 7.43-7.50 (m, 2H), 7.67 (s, 1H), 8.15 (s, 1H), 8.48 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 494 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (3-chlorophenyl)methanol (67 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (147 mg, yield 90%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.10 (s, 3H), 2.27 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 5.21 (s, 2H), 6.56 (d, J=6.3 Hz, 2H), 7.03 (d, J=8.5 Hz, 1H), 7.25-7.35 (m, 3H), 7.43 (s, 1H), 7.67 (s, 1H), 7.75 (brs, 1H), 8.15 (s, 1H), 8.49 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 494 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (4-chlorophenyl)methanol (67 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (103 mg, yield 63%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.10 (s, 3H), 2.26 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 5.20 (s, 2H), 6.54 (brs, 2H), 7.03 (d, J=8.8 Hz, 1H), 7.38 (s, 4H), 7.66 (s, 1H), 7.71 (brs, 1H), 8.15 (s, 1H), 8.50 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 494 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (3-methoxyphenyl)methanol (65 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (136 mg, yield 84%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.10 (s, 3H), 2.26 (s, 3H), 3.84 (s, 3H), 4.11 (s, 3H), 4.18 (s, 3H), 5.21 (s, 2H), 6.55 (brs, 2H), 6.84-7.02 (m, 4H), 7.25-7.32 (m, 1H), 7.67 (s, 1H), 7.83 (brs, 1H), 8.16 (s, 1H), 8.44 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 489 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (2-methoxyphenyl)methanol (65 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (130 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.13 (s, 3H), 2.26 (s, 3H), 3.90 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 5.31 (s, 2H), 6.51 (s, 1H), 6.58 (d, J=6.6 Hz, 1H), 6.88-7.01 (m, 3H), 7.34-7.42 (m, 2H), 7.64 (s, 1H), 7.96 (s, 1H), 8.15 (s, 1H), 8.47 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 489 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (3-methoxyphenyl)methanol (65 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (120 mg, yield 74%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.13 (s, 3H), 2.27 (s, 3H), 3.84 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 5.22 (s, 2H), 6.51 (s, 1H), 6.58 (d, J=6.3 Hz, 1H), 6.91-7.03 (m, 4H), 7.25-7.35 (m, 1H), 7.64 (s, 1H), 7.93 (s, 1H), 8.15 (s, 1H), 8.47 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 489 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (2-chlorophenyl)methanol (67 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (112 mg, yield 68%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.13 (s, 3H), 2.28 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 5.36 (s, 2H), 6.54 (s, 1H), 6.58 (d, J=6.3 Hz, 1H), 6.96 (s, 1H), 7.26-7.33 (m, 2H), 7.43-7.49 (m, 2H), 7.64 (s, 1H), 7.93 (s, 1H), 8.15 (s, 1H), 8.47 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 494 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (3-chlorophenyl)methanol (67 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (117 mg, yield 71%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.14 (s, 3H), 2.29 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 5.21 (s, 2H), 6.53 (s, 1H), 6.56 (s, 1H), 6.96 (s, 1H), 7.26-7.38 (m, 3H), 7.44 (s, 1H), 7.64 (s, 1H), 7.91 (s, 1H), 8.15 (s, 1H), 8.43 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 494 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (4-chlorophenyl)methanol (67 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (154 mg, yield 94%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.13 (s, 3H), 2.27 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 5.20 (s, 2H), 6.50 (s, 1H), 6.58 (s, 1H), 6.95 (s, 1H), 7.38 (s, 4H), 7.64 (s, 1H), 7.90 (s, 1H), 8.15 (s, 1H), 8.47 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 494 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-propanol (28 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (115 mg, yield 83%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.01 (t, J=7.3 Hz, 3H), 1.72-1.77 (m, 2H), 2.13 (s, 3H), 2.29 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 4.17 (t, J=7.8 Hz, 2H), 6.42 (s, 1H), 6.60 (brs, 1H), 6.95 (s, 1H), 7.65 (s, 1H), 7.92 (s, 1H), 8.15 (s, 1H), 8.50 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 411 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (2-methylphenyl)methanol (57 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (140 mg, yield 89%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.13 (s, 3H), 2.26 (s, 3H), 2.43 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 5.27 (s, 2H), 6.50 (s, 1H), 6.58 (brs, 1H), 6.95 (s, 1H), 7.25-7.30 (m, 3H), 7.40 (d, J=7.1 Hz, 1H), 7.64 (s, 1H), 7.94 (s, 1H), 8.15 (s, 1H), 8.50 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 473 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-naphthylmethanol (87 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (160 mg, yield 90%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.14 (s, 3H), 2.28 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 5.29 (s, 2H), 6.53 (s, 1H), 6.58 (s, 1H), 6.95 (s, 1H), 7.37-7.53 (m, 4H), 7.59-7.65 (m, 4H), 7.95 (s, 1H), 8.15 (s, 1H), 8.50 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 510 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (151 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-propanol (31 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (104 mg, yield 73%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.01 (t, J=7.6 Hz, 3H), 1.71-1.76 (m, 2H), 4.10 (s, 3H), 4.17 (s, 3H), 4.17 (t, J=8.1 Hz, 2H), 6.69 (brs, 1H), 6.81 (s, 1H), 7.18 (d, J=8.8 Hz, 2H), 7.61 (d, J=8.3 Hz, 2H), 7.64 (s, 1H), 8.14 (s, 1H), 8.50 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 383 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (151 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (2-methoxyphenyl)methanol (71 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (123 mg, yield 73%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.89 (s, 3H), 4.10 (s, 3H), 4.17 (s, 3H), 5.30 (s, 2H), 6.69 (d, J=6.3 Hz, 1H), 6.83 (s, 1H), 6.93-7.00 (m, 2H), 7.18-7.52 (m, 4H), 7.59-7.63 (m, 3H), 8.15 (s, 1H), 8.49 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 462 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (151 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (4-methoxyphenyl)methanol (71 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (140 mg, yield 83%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.83 (s, 3H), 4.10 (s, 3H), 4.17 (s, 3H), 5.17 (s, 2H), 6.68 (d, J=6.3 Hz, 1H), 6.83 (s, 1H), 6.92 (d, J=8.5 Hz, 2H), 7.17 (d, J=9.0 Hz, 2H), 7.37 (d, J=8.5 Hz, 2H), 7.59 (d, J=9.0 Hz, 2H), 7.63 (s, 1H), 8.14 (s, 1H), 8.49 (t, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 462 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (151 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (2-methylphenyl)methanol (62 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (143 mg, yield 88%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.42 (s, 3H), 4.10 (s, 3H), 4.17 (s, 3H), 5.27 (s, 2H), 6.68 (d, J=6.3 Hz, 1H), 6.87 (s, 1H), 7.17-7.28 (m, 5H), 7.38 (d, J=7.1 Hz, 1H), 7.61 (d, J=9.0 Hz, 2H), 7.63 (s, 1H), 8.14 (s, 1H), 8.49 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 446 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (151 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (3-methylphenyl)methanol (62 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (146 mg, yield 89%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.38 (s, 3H), 4.10 (s, 3H), 4.17 (s, 3H), 5.20 (s, 2H), 6.69 (brs, 1H), 6.92 (s, 1H), 7.17-7.31 (m, 6H), 7.61-7.63 (m, 3H), 8.14 (s, 1H), 8.51 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 446 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (151 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (4-methylphenyl)methanol (62 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (133 mg, yield 81%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.37 (s, 3H), 4.10 (s, 3H), 4.17 (s, 3H), 5.20 (s, 2H), 6.69 (brs, 1H), 6.92 (s, 1H), 7.16-7.33 (m, 6H), 7.60 (d, J=7.3 Hz, 2H), 7.64 (s, 1H), 8.15 (s, 1H), 8.49 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 446 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (2-methylphenyl)methanol (57 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (122 mg, yield 77%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.26 (s, 3H), 2.43 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 5.27 (s, 2H), 6.52 (s, 1H), 6.58 (d, J=6.3 Hz, 1H), 6.95 (s, 1H), 7.24-7.30 (m, 3H), 7.40 (d, J=7.1 Hz, 1H), 7.65 (s, 1H), 7.93 (s, 1H), 8.15 (s, 1H), 8.49 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 474 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (3-methylphenyl)methanol (57 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (120 mg, yield 76%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.13 (s, 3H), 2.27 (s, 3H), 2.39 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 5.21 (s, 2H), 6.53 (s, 1H), 6.58 (brs, 1H), 6.95 (s, 1H), 7.18-7.30 (m, 4H), 7.64 (s, 1H), 7.94 (s, 1H), 8.15 (s, 1H), 8.48 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 474 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (4-methylphenyl)methanol (57 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (139 mg, yield 88%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.13 (s, 3H), 2.26 (s, 3H), 2.38 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 5.20 (s, 2H), 6.49 (s, 1H), 6.58 (brs, 1H), 6.94 (s, 1H), 7.22 (d, J=7.8 Hz, 2H), 7.34 (d, J=8.1 Hz, 2H), 7.64 (s, 1H), 7.94 (s, 1H), 8.15 (s, 1H), 8.50 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 474 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (151 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-hexanol (52 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (110 mg, yield 70%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.92 (t, J=6.8 Hz, 3H), 1.33-1.35 (m, 6H), 1.67-1.72 (m, 2H), 4.10 (s, 3H), 4.17 (s, 3H), 4.20 (t, J=6.8 Hz, 2H), 6.70 (d, J=6.3 Hz, 1H), 6.79 (s, 1H), 7.18 (d, J=9.0 Hz, 2H), 7.60 (d, J=8.8 Hz, 2H), 7.64 (s, 1H), 8.14 (s, 1H), 8.51 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 426 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (151 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-butylphenol (77 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (130 mg, yield 75%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.94 (t, J=7.3 Hz, 3H), 1.34-1.40 (m, 2H), 1.51-1.63 (m, 2H), 2.63 (t, J=7.8 Hz, 2H), 4.11 (s, 3H), 4.17 (s, 3H), 6.71 (d, J=6.3 Hz, 1H), 7.09 (d, J=8.5 Hz, 2H), 7.20-7.23 (m, 4H), 7.64 (s, 1H), 7.69 (d, J=8.8 Hz, 2H), 8.15 (s, 1H), 8.52 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 474 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (151 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-hexanol (52 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (130 mg, yield 83%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.95-0.98 (m, 6H), 1.39-1.67 (m, 6H), 4.11 (s, 3H), 4.17 (s, 3H), 4.84-4.86 (m, 1H), 6.70 (d, J=6.1 Hz, 1H), 6.77 (s, 1H), 7.18 (d, J=9.0 Hz, 2H), 7.61 (d, J=8.8 Hz, 2H), 7.64 (s, 1H), 8.13 (s, 1H), 8.53 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 426 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (151 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-(tert-butyl)phenol (77 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (150 mg, yield 87%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.34 (s, 9H), 4.11 (s, 3H), 4.17 (s, 3H), 6.71 (d, J=6.1 Hz, 1H), 7.13 (d, J=8.8 Hz, 2H), 7.21-7.27 (m, 3H), 7.43 (d, J=8.8 Hz, 2H), 7.64 (s, 1H), 7.68 (d, J=8.8 Hz, 2H), 8.15 (s, 1H), 8.51 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 474 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (151 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-methoxyphenol (63 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (75 mg, yield 46%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.90 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 6.70 (brs, 1H), 6.85 (s, 1H), 6.92-7.02 (m, 4H), 7.15-7.25 (m, 3H), 7.64 (s, 1H), 7.70 (d, J=8.3 Hz, 1H), 8.14 (s, 1H), 8.52 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 448 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-hexanol (48 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (106 mg, yield 72%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.92 (t, J=7.1 Hz, 3H), 1.34-1.44 (m, 6H), 1.67-1.74 (m, 2H), 2.10 (s, 3H), 2.28 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 4.20 (t, J=6.8 Hz, 2H), 6.45 (s, 1H), 6.56 (d, J=6.6 Hz, 1H), 7.02 (d, J=9.0 Hz, 1H), 7.67 (s, 1H), 7.75 (d, J=9.3 Hz, 1H), 8.16 (s, 1H), 8.46 (t, J=6.3 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 454 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-hexanol (48 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (154 mg, yield 100%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.92 (t, J=7.1 Hz, 3H), 1.34-1.42 (m, 6H), 1.68-1.73 (m, 2H), 2.13 (s, 3H), 2.29 (s, 3H), 4.11 (s, 3H), 4.18 (S, 3H), 4.21 (t, J=6.8 Hz, 2H), 6.42 (s, 1H), 6.59 (brs, 1H), 6.95 (s, 1H), 7.65 (s, 1H), 7.92 (s, 1H), 8.15 (s, 1H), 8.47 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 454 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-phenyl-1-propanol (35 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (77 mg, yield 92%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.96 (t, J=7.6 Hz, 3H), 1.88-1.93 (m, 1H), 1.99-2.05 (m, 1H), 4.10 (s, 3H), 4.16 (s, 3H), 5.69 (t, J=7.3 Hz, 1H), 6.66 (d, J=5.6 Hz, 1H), 6.84 (s, 1H), 7.16 (d, J=8.8 Hz, 2H), 7.32-7.39 (m, 5H), 7.59 (d, J=8.8 Hz, 2H), 7.63 (s, 1H), 8.15 (d, J=4.1 Hz, 1H), 8.45-8.47 (m, 1H)
- Mass spectrometry value (ESI-MS, m/z): 460 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-phenyl-1-propanol (31 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (76 mg, yield 97%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.97 (t, J=7.5 Hz, 3H), 1.89-1.94 (m, 1H), 2.01-2.17 (m, 1H), 2.10 (s, 3H), 2.28 (s, 3H), 4.10 (s, 3H), 4.17 (s, 3H), 5.68 (t, J=7.3 Hz, 1H), 6.50 (s, 1H), 6.55 (d, J=6.3 Hz, 1H), 6.93 (s, 1H), 7.33-7.39 (m, 5H), 7.64 (s, 1H), 7.91 (s, 1H), 8.14 (s, 1H), 8.45 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 488 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-phenyl-1-propanol (31 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (52 mg, yield 66%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.96 (t, J=7.3 Hz, 3H), 1.89-1.92 (m, 1H), 1.94-2.05 (m, 1H), 2.09 (s, 3H), 2.25 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 5.69 (t, J=7.1 Hz, 1H), 6.52 (s, 1H), 6.54 (s, 1H), 6.99 (d, J=8.5 Hz, 1H), 7.32-7.39 (m, 5H), 7.66 (s, 1H), 7.73 (brs, 1H), 8.15 (s, 1H), 8.45 (t, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 488 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-penten-1-ol (22 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (77 mg, yield 100%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.80-1.83 (m, 2H), 2.16-2.20 (m, 2H), 4.10 (s, 3H), 4.17 (s, 3H), 4.23 (t, J=6.6 Hz, 2H), 5.02-5.10 (m, 2H), 5.83-5.85 (m, 1H), 6.69 (d, J=6.3 Hz, 1H), 6.76 (s, 1H), 7.18 (d, J=8.8 Hz, 2H), 7.60 (d, J=9.0 Hz, 2H), 7.64 (s, 1H), 8.15 (s, 1H), 8.48 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 410 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-penten-1-ol (20 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (71 mg, yield 100%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.81-1.85 (m, 2H), 2.13 (s, 3H), 2.18-2.20 (m, 2H), 2.29 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 4.23 (t, J=6.6 Hz, 2H), 5.02-5.11 (m, 2H), 5.81-5.88 (m, 1H), 6.42 (s, 1H), 6.58 (d, J=6.3 Hz, 1H), 6.95 (s, 1H), 7.64 (s, 1H), 7.91 (s, 1H), 8.16 (s, 1H), 8.46 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 438 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-penten-1-ol (20 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (67 mg, yield 95%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.79-1.86 (m, 2H), 2.10 (s, 3H), 2.16-2.20 (m, 2H), 2.27 (s, 3H), 4.12 (s, 3H), 4.17 (s, 3H), 4.22 (t, J=6.6 Hz, 2H), 5.02-5.10 (m, 2H), 5.81-5.88 (m, 1H), 6.44 (s, 1H), 6.56 (d, J=6.6 Hz, 1H), 7.03 (d, J=8.5 Hz, 1H), 7.67 (s, 1H), 7.76 (brs, 1H), 8.16 (d, J=4.1 Hz, 1H), 8.45 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 438 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2,6-dimethylphenol (32 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (82 mg, yield 100%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.26 (s, 6H), 4.11 (s, 3H), 4.17 (s, 3H), 6.70 (d, J=7.6 Hz, 1H), 7.10 (s, 2H), 7.22-7.26 (m, 4H), 7.65 (s, 1H), 7.71 (d, J=8.5 Hz, 2H), 8.16 (d, J=4.1 Hz, 1H), 8.48 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 446 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2,6-dimethylphenol (28 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (76 mg, yield 100%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.13 (s, 3H), 2.28 (s, 6H), 2.39 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 6.59 (d, J=5.9 Hz, 1H), 7.01 (s, 1H), 7.11 (s, 2H), 7.25-7.27 (m, 2H), 7.65 (s, 1H), 7.98 (brs, 1H), 8.16 (s, 1H), 8.47 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 474 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2,6-dimethylphenol (28 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (68 mg, yield 89%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.14 (s, 3H), 2.28 (s, 6H), 2.38 (s, 3H), 4.12 (s, 3H), 4.18 (s, 3H), 6.56 (d, J=6.8 Hz, 1H), 7.00-7.10 (m, 4H), 7.25-7.27 (m, 1H), 7.67 (s, 1H), 8.16 (s, 1H), 8.46 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 474 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-butylphenol (35 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (12 mg, yield 15%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.90-0.96 (m, 3H), 1.33-1.44 (m, 2H), 1.50-1.65 (m, 2H), 2.13 (s, 3H), 2.28 (s, 3H), 2.53 (t, J=7.8 Hz, 1H), 2.63 (t, J=8.1 Hz, 1H), 4.11 (s, 3H), 4.17 (s, 3H), 6.44 (s, 1H), 6.58 (d, J=6.3 Hz, 1H), 6.75 (d, J=8.5 Hz, 1H), 6.95 (s, 1H), 7.02 (t, J=8.5 Hz, 1H), 7.11 (d, J=8.5 Hz, 1H), 7.22 (d, J=8.8 Hz, 1H), 7.64 (s, 1H), 7.89 (brs, 1H), 8.16 (s, 1H), 8.45 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 502 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-butylphenol (35 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (44 mg, yield 55%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.94 (t, J=7.3 Hz, 3H), 1.34-1.44 (m, 2H), 1.56-1.63 (m, 2H), 2.13 (s, 3H), 2.36 (s, 3H), 2.63 (t, J=7.8 Hz, 2H), 4.12 (s, 3H), 4.17 (s, 3H), 6.57 (d, J=10.7 Hz, 1H), 7.04-7.26 (m, 6H), 7.67 (s, 1H), 7.84 (brs, 1H), 8.17 (d, J=4.4 Hz, 1H), 8.46 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 502 (M++1)
- 4-[(6,7-dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-(tert-butyl)phenol (35 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (35 mg, yield 44%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.54 (s, 9H), 2.13 (s, 3H), 2.37 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 6.59 (s, 1H), 6.77 (d, J=8.8 Hz, 1H), 6.95 (s, 1H), 7.00 (s, 1H), 7.14 (d, J=8.8 Hz, 2H), 7.43 (d, J=8.8 Hz, 2H), 7.65 (s, 1H), 7.99 (brs, 1H), 8.16 (s, 1H), 8.46 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 502 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-(tert-butyl)phenol (35 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (34 mg, yield 42%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.54 (s, 9H), 2.13 (s, 3H), 2.36 (s, 3H), 4.12 (s, 3H), 4.17 (s, 3H), 6.57 (d, J=5.6 Hz, 1H), 6.77 (d, J=8.8 Hz, 1H), 7.05 (d, J=9.3 Hz, 1H), 7.14 (d, J=8.8 Hz, 2H), 7.42 (d, J=8.8 Hz, 2H), 7.67 (s, 1H), 7.84 (brs, 1H), 8.17 (d, J=3.9 Hz, 1H), 8.45 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 502 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-hexanol (24 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (20 mg, yield 27%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.95-0.99 (m, 6H), 1.40-1.65 (m, 6H), 2.13 (s, 3H), 2.29 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 4.85 (brs, 1H), 6.41 (s, 1H), 6.57 (d, J=4.6 Hz, 1H), 6.94 (s, 1H), 7.65 (s, 1H), 7.96 (s, 1H), 8.15 (s, 1H), 8.45 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 454 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-hexanol (24 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (39 mg, yield 53%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.94-0.99 (m, 6H), 1.40-1.68 (m, 6H), 2.10 (s, 3H), 2.28 (s, 3H), 4.12 (s, 3H), 4.17 (s, 3H), 4.85 (brs, 1H), 6.55 (d, J=5.9 Hz, 1H), 7.00-7.03 (m, 1H), 7.79 (s, 1H), 8.16-8.17 (m, 1H), 8.44 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 454 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-methoxyphenol (29 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (39 mg, yield 51%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.12 (s, 3H), 2.38 (s, 3H), 3.90 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 6.60 (d, J=5.9 Hz, 1H), 6.86-7.04 (m, 4H), 7.17-7.19 (m, 1H), 7.65 (s, 1H), 7.99 (s, 1H), 8.16 (d, J=4.1 Hz, 1H), 8.47 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 476 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-methoxyphenol (29 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (31 mg, yield 41%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.13 (s, 3H), 2.37 (s, 3H), 3.89 (s, 3H), 4.12 (s, 3H), 4.17 (s, 3H), 6.57 (brs, 1H), 6.86-7.06 (m, 5H), 7.18 (d, J=6.3 Hz, 1H), 7.67 (d, J=2.0 Hz, 1H), 8.17 (d, J=3.9 Hz, 1H), 8.46 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 476 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2,6-dimethoxyphenol (40 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (80 mg, yield 92%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.87 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 6.60-6.67 (m, 4H), 7.17-7.21 (m, 2H), 7.64 (s, 1H), 7.70 (d, J=8.8 Hz, 2H), 8.15 (s, 1H), 8.49 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 478 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2,6-dimethoxyphenol (35 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (75 mg, yield 93%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.33 (s, 3H), 2.38 (s, 3H), 3.89 (s, 6H), 4.11 (s, 3H), 4.17 (s, 3H), 6.60 (brs, 1H), 6.67 (d, J=8.5 Hz, 1H), 6.98-7.19 (m, 2H), 7.65 (s, 1H), 8.04 (s, 1H), 8.15 (s, 1H), 8.48 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 506 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2,6-dimethoxyphenol (35 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (74 mg, yield 91%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.21 (s, 3H), 2.37 (s, 3H), 3.88 (s, 3H), 3.89 (s, 3H), 4.12 (s, 3H), 4.17 (s, 3H), 6.58-6.60 (m, 2H), 6.66 (d, J=8.5 Hz, 1H), 6.78-6.82 (m, 1H), 7.02-7.05 (m, 1H), 7.16-7.20 (m, 1H), 7.67 (s, 1H), 7.87 (s, 1H), 8.16 (s, 1H), 8.47 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 506 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cyclohexylmethanol (30 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (49 mg, yield 61%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.03-1.04 (m, 2H), 1.21-1.27 (m, 4H), 1.78-1.80 (m, 5H), 4.02 (d, J=6.3 Hz, 2H), 4.11 (s, 3H), 4.17 (s, 3H), 6.70 (d, J=5.9 Hz, 1H), 6.88 (s, 1H), 7.18 (d, J=8.8 Hz, 2H), 7.61 (d, J=8.5 Hz, 2H), 7.64 (s, 1H), 8.15 (d, J=4.1 Hz, 1H), 8.47 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 438 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cyclohexylmethanol (26 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (62 mg, yield 83%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.02-1.04 (m, 2H), 1.21-1.31 (m, 4H), 1.72-1.79 (m, 5H), 2.13 (s, 3H), 2.29 (s, 3H), 4.03 (d, J=6.3 Hz, 2H), 4.11 (s, 3H), 4.17 (s, 3H), 6.42 (s, 1H), 6.58 (d, J=4.9 Hz, 1H), 6.95 (s, 1H), 7.65 (s, 1H), 7.93 (s, 1H), 8.16 (d, J=4.1 Hz, 1H), 8.46 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 466 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cyclohexylmethanol (26 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (48 mg, yield 64%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.97-1.07 (m, 2H), 1.17-1.32 (m, 4H), 1.69-1.82 (m, 5H), 2.10 (s, 3H), 2.28 (s, 3H), 4.02 (d, J=6.6 Hz, 2H), 4.11 (s, 3H), 4.17 (s, 3H), 6.44 (s, 1H), 6.55 (d, J=5.4 Hz, 1H), 7.00-7.04 (m, 2H), 7.67 (s, 1H), 7.77 (brs, 1H), 8.16 (d, J=4.1 Hz, 1H), 8.44 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 466 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-cycloheptanol (30 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (68 mg, yield 85%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.47-1.79 (m, 12H), 4.10 (s, 3H), 4.17 (s, 3H), 4.90-4.96 (m, 1H), 6.70 (d, J=5.9 Hz, 1H), 6.83 (s, 1H), 7.17 (d, J=9.0 Hz, 2H), 7.60 (d, J=8.5 Hz, 2H), 7.64 (s, 1H), 8.15 (s, 1H), 8.47 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 438 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-cycloheptanol (26 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (68 mg, yield 91%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.51-1.74 (m, 12H), 2.13 (s, 3H), 2.29 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 4.96 (brs, 1H), 6.40 (s, 1H), 6.58 (d, J=6.3 Hz, 1H), 6.94 (s, 1H), 7.65 (s, 1H), 7.95 (s, 1H), 8.16 (d, J=4.1 Hz, 1H), 8.46 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 466 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-cycloheptanol (26 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (66 mg, yield 88%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.51-1.74 (m, 12H), 2.10 (s, 3H), 2.27 (s, 3H), 4.12 (s, 3H), 4.17 (s, 3H), 4.96 (brs, 1H), 6.43 (s, 1H), 6.56 (d, J=6.6 Hz, 1H), 7.02 (d, J=9.3 Hz, 1H), 7.67 (s, 1H), 7.78 (s, 1H), 8.16 (d, J=3.9 Hz, 1H), 8.45 (brs, 1H).
- Mass spectrometry value (ESI-MS, m/z): 466 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, o-cresol (25 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (62 mg, yield 84%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.13 (s, 3H), 2.31 (s, 3H), 2.39 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 6.60 (d, J=6.3 Hz, 1H), 6.85 (s, 1H), 7.00 (s, 1H), 7.14-7.27 (m, 4H), 7.65 (s, 1H), 7.98 (brs, 1H), 8.15 (d, J=3.7 Hz, 1H), 8.52 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 460 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-methoxyphenol (29 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (30 mg, yield 39%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.14 (s, 3H), 2.37 (s, 3H), 3.83 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 6.42 (s, 1H), 6.59 (brs, 1H), 6.79-6.84 (m, 3H), 7.00 (s, 1H), 7.30-7.34 (m, 1H), 7.65 (s, 1H), 7.98 (brs, 1H), 8.16 (s, 1H), 8.49 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 476 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-methoxyphenol (29 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (23 mg, yield 30%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.13 (s, 3H), 2.36 (s, 3H), 3.83 (s, 3H), 4.12 (s, 3H), 4.17 (s, 3H), 6.44-6.48 (m, 1H), 6.56-6.58 (m, 1H), 6.78-6.83 (m, 3H), 7.06 (d, J=8.8 Hz, 1H), 7.29-7.33 (m, 1H), 7.67 (s, 1H), 7.81 (brs, 1H), 8.16 (d, J=3.4 Hz, 1H), 8.50 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 476 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1,2,3,4-tetrahydro-2-naphthalenol (34 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (80 mg, yield 100%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.08-2.13 (m, 2H), 2.12 (s, 3H), 2.27 (s, 3H), 2.80-3.24 (m, 4H), 4.11 (s, 3H), 4.17 (s, 3H), 5.30 (brs, 1H), 6.43 (s, 1H), 6.57 (d, J=6.6 Hz, 1H), 6.94 (s, 1H), 7.11-7.18 (m, 4H), 7.64 (s, 1H), 7.94 (brs, 1H), 8.15 (d, J=3.9 Hz, 1H), 8.48 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 500 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1,2,3,4-tetrahydro-2-naphthalenol (34 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (55 mg, yield 69%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.08-2.13 (m, 2H), 2.09 (s, 3H), 2.25 (s, 3H), 2.92-3.23 (m, 4H), 4.11 (s, 3H), 4.17 (s, 3H), 5.29 (brs, 1H), 6.46 (s, 1H), 6.55 (d, J=6.1 Hz, 1H), 7.01 (d, J=8.8 Hz, 1H), 7.12-7.18 (m, 4H), 7.67 (s, 1H), 7.77 (brs, 1H), 8.16 (d, J=3.7 Hz, 1H), 8.48 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 500 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-phenylphenol (44 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (29 mg, yield 32%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 4.11 (s, 3H), 4.17 (s, 3H), 6.71 (s, 1H), 6.93 (d, J=8.5 Hz, 1H), 7.26-7.78 (m, 13H), 8.14 (brs, 1H), 8.53 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 494 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-phenylphenol (39 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (55 mg, yield 66%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.14 (s, 3H), 2.28 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 6.44 (s, 1H), 6.60 (brs, 1H), 6.95 (s, 1H), 7.01 (brs, 1H), 7.26-7.52 (m, 4H), 7.57-7.65 (m, 5H), 7.89 (s, 1H), 8.15 (brs, 1H), 8.48 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 522 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-phenylphenol (39 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (36 mg, yield 43%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.14 (s, 3H), 2.38 (s, 3H), 4.12 (s, 3H), 4.17 (s, 3H), 6.57-6.59 (m, 1H), 6.92-7.08 (m, 2H), 7.25-7.79 (m, 10H), 8.16-8.17 (m, 1H), 8.47-8.52 (m, 1H)
- Mass spectrometry value (ESI-MS, m/z): 522 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-phenyl-1-ethanol (32 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (42 mg, yield 51%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.03 (t, J=6.8 Hz, 2H), 4.10 (s, 3H), 4.17 (s, 3H), 4.45 (t, J=7.1 Hz, 2H), 6.69 (s, 1H), 6.78 (s, 1H), 7.16-7.36 (m, 7H), 7.52-7.64 (m, 3H), 8.15 (s, 1H), 8.49 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 446 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-phenyl-1-ethanol (28 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (76 mg, yield 100%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.12 (s, 3H), 2.26 (s, 3H), 3.04 (t, J=6.8 Hz, 2H), 4.11 (s, 3H), 4.17 (s, 3H), 4.44 (t, J=7.1 Hz, 2H), 6.40 (s, 1H), 6.59 (s, 1H), 6.95 (s, 1H), 7.26-7.36 (m, 5H), 7.64 (s, 1H), 7.86 (brs, 1H), 8.16 (s, 1H), 8.47 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 474 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-phenyl-1-ethanol (28 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (60 mg, yield 79%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ2.09 (s, 3H), 2.24 (s, 3H), 3.03 (t, J=6.8 Hz, 2H), 4.11 (s, 3H), 4.17 (s, 3H), 4.44 (t, J=7.1 Hz, 2H), 6.42 (s, 1H), 6.55 (d, J=5.9 Hz, 1H), 7.01 (d, J=8.5 Hz, 1H), 7.26-7.36 (m, 5H), 7.66 (s, 1H), 8.16 (d, J=4.1 Hz, 1H), 8.46 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 474 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-(tert-butyl)phenol (39 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (64 mg, yield 74%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.42 (s, 9H), 4.11 (s, 3H), 4.17 (s, 3H), 6.72 (brs, 1H), 7.11 (d, J=6.3 Hz, 1H), 7.22-7.26 (m, 6H), 7.43-7.45 (m, 1H), 7.65 (s, 1H), 7.71 (brs, 1H), 8.15 (brs, 1H), 8.51 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 474 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-(tert-butyl)phenol (35 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (77 mg, yield 96%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.56 (s, 9H), 2.13 (s, 3H), 2.39 (s, 3H), 4.12 (s, 3H), 4.17 (s, 3H), 6.59 (brs, 1H), 7.01 (s, 1H), 7.13 (d, J=7.8 Hz, 1H), 7.21-7.26 (m, 3H), 7.43-7.45 (m, 1H), 7.65 (s, 1H), 8.15 (s, 1H), 8.49 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 502 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-(tert-butyl)phenol (35 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (48 mg, yield 60%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.56 (s, 9H), 2.14 (s, 3H), 2.38 (s, 3H), 4.12 (s, 3H), 4.18 (s, 3H), 6.55 (brs, 1H), 7.06 (d, J=9.0 Hz, 1H), 7.14 (d, J=7.8 Hz, 1H), 7.21-7.26 (m, 4H), 7.42 (brs, 1H), 7.67 (s, 1H), 8.16 (s, 1H), 8.48 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 502 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-piperidino-1-ethanol (34 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (66 mg, yield 74%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.89-1.93 (m, 4H), 2.29-2.45 (m, 2H), 2.74-2.86 (m, 2H), 3.36 (brs, 1H), 3.70-3.73 (m, 2H), 4.10 (s, 3H), 4.16 (s, 3H), 4.56-4.58 (m, 2H), 6.72 (d, J=6.3 Hz, 1H), 7.15 (d, J=8.8 Hz, 2H), 7.65 (s, 1H), 7.74 (d, J=8.8 Hz, 2H), 8.10 (s, 1H), 8.52 (t, J=6.3 Hz, 1H), 9.60 (brs, 1H), 11.42 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 453 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-piperidino-1-ethanol (30 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (42 mg, yield 51%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.50 (brs, 2H), 1.85 (brs, 2H), 2.11 (s, 3H), 2.43 (brs, 5H), 2.78 (brs, 2H), 3.34 (brs, 2H), 3.70 (brs, 2H), 4.11 (s, 3H), 4.17 (s, 3H), 4.56 (brs, 2H), 6.61 (brs, 1H), 6.95 (s, 1H), 7.66 (s, 1H), 7.86 (s, 1H), 8.13 (s, 1H), 8.48 (brs, 1H), 11.85 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 481 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-piperidino-1-ethanol (30 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (83 mg, yield 100%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.88 (brs, 2H), 2.09 (s, 3H), 2.31-2.39 (m, 1H), 2.39 (s, 3H), 2.47-2.51 (m, 1H), 2.71-2.80 (m, 2H), 3.12-3.14 (m, 1H), 3.33 (brs, 2H), 3.69 (brs, 2H), 4.01-4.03 (m, 1H), 4.12 (s, 3H), 4.17 (s, 3H), 4.54-4.55 (m, 2H), 6.58 (d, J=6.3 Hz, 1H), 6.98 (d, J=8.8 Hz, 1H), 7.68 (s, 1H), 7.76 (d, J=9.0 Hz, 1H), 8.14 (s, 1H), 8.48-8.49 (m, 1H), 11.83 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 481 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-morpholino-1-ethanol (34 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (43 mg, yield 48%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.11 (brs, 2H)—, 3.42 (brs, 2H), 3.66 (brs, 2H), 4.01-4.19 (m, 2H), 4.10 (s, 3H), 4.16 (s, 3H), 4.46 (brs, 2H), 4.62 (brs, 2H), 6.73 (s, 1H), 7.14 (s, 1H), 7.65 (s, 1H), 7.73 (s, 2H), 8.09 (s, 1H), 8.54 (brs, 1H), 9.45 (s, 1H), 12.38 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 455 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-morpholino-1-ethanol (30 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (63 mg, yield 76%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.11 (s, 3H), 2.42 (s, 3H), 3.06 (brs, 2H), 3.41 (brs, 2H), 3.62 (brs, 2H), 4.02-4.17 (m, 2H), 4.11 (s, 3H), 4.17 (s, 3H), 4.52-4.59 (m, 4H), 6.60 (brs, 1H), 6.95 (s, 1H), 7.66 (s, 1H), 7.85 (s, 1H), 8.13 (s, 2H), 8.30 (brs, 1H), 8.50 (brs, 1H), 12.79 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 483 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-morpholino-1-ethanol (30 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (74 mg, yield 89%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.09 (s, 3H), 2.39 (s, 3H), 3.03 (brs, 2H), 3.38 (brs, 2H), 3.62 (d, J=11.7 Hz, 2H), 4.02-4.04 (m, 2H), 4.12 (s, 3H), 4.17 (s, 3H), 4.50-4.59 (m, 4H), 6.57 (d, J=6.3 Hz, 1H), 6.99 (d, J=8.8 Hz, 1H), 7.67 (s, 1H), 7.77 (d, J=9.3 Hz, 1H), 8.14 (s, 1H), 8.32 (brs, 1H), 8.48 (s, 1H), 12.87 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 483 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 6-(dimethylamino)-1-hexanol (38 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (31 mg, yield 34%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.43-1.87 (m, 8H), 2.82-3.08 (m, 8H), 4.11 (s, 3H), 4.16 (s, 3H), 4.11-4.22 (m, 2H), 6.72 (s, 1H), 7.14 (s, 2H), 7.65 (s, 1H), 7.87 (s, 2H), 8.11 (s, 1H), 8.50 (brs, 1H), 8.80 (brs, 1H), 12.00 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 469 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 6-(dimethylamino)-1-hexanol (33 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (48 mg, yield 56%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.53-1.93 (m, 8H), 2.13 (s, 3H), 2.33 (s, 3H), 2.83 (s, 6H), 3.02 (brs, 2H), 4.11 (s, 3H), 4.17 (s, 3H), 4.11-4.21 (m, 2H), 6.61 (brs, 1H), 6.95 (s, 1H), 7.65 (s, 1H), 7.85 (s, 1H), 8.14 (s, 1H), 8.49 (brs, 1H), 12.39 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 497 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 6-(dimethylamino)-1-hexanol (33 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (66 mg, yield 77%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.75-2.01 (m, 8H), 2.10 (s, 3H), 2.31 (s, 3H), 2.83 (s, 6H), 3.03 (s, 2H), 4.12 (s, 3H), 4.17 (s, 3H), 4.12-4.21 (m, 2H), 6.59 (s, 1H), 7.01 (d, J=8.1 Hz, 1H), 7.68 (s, 1H), 8.13 (s, 1H), 8.50 (brs, 1H), 12.02 (brs, 1H), 12.30 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 497 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-cyclohexanol (26 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (60 mg, yield 71%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.21-1.57 (m, 6H), 1.76 (brs, 2H), 1.94 (brs, 2H), 4.12 (s, 3H), 4.19 (s, 3H), 4.78 (brs, 1H), 6.72 (s, 1H), 7.19 (d, J=9.0 Hz, 2H), 7.57 (d, J=8.8. Hz, 2H), 7.62 (s, 1H), 8.15 (s, 1H), 8.80 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 425 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-cyclohexanol (23 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (61 mg, yield 77%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.30-1.58 (m, 6H), 1.78 (brs, 2H), 1.95 (brs, 2H), 4.12 (s, 3H), 4.20 (s, 3H), 4.79 (brs, 1H), 7.16-7.20 (m, 2H), 7.32 (s, 1H), 7.59 (s, 1H), 8.17 (s, 1H), 8.40 (d, J=9.3 Hz, 1H), 8.82 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 459 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-propanol (16 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (77 mg, yield 100%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.00 (t, J=7.3 Hz, 3H), 1.68-1.75 (m, 2H), 4.12 (s, 3H), 4.16 (t, J=6.8 Hz, 2H), 4.19 (s, 3H), 6.77 (s, 1H), 7.20 (d, J=9.0 Hz, 2H), 7.58 (d, J=8.8 Hz, 2H), 7.62 (s, 1H), 8.15 (s, 1H), 8.81 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 384 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (2-methoxyphenyl)methanol (36 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (91 mg, yield 100%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.88 (s, 3H), 4.12 (s, 3H), 4.19 (s, 3H), 5.29 (s, 2H), 6.84 (s, 1H), 6.92-7.00 (m, 2H), 7.19 (d, J=9.0 Hz, 2H), 7.33-7.40 (m, 2H), 7.57 (d, J=9.0 Hz, 2H), 7.62 (s, 1H), 8.15 (s, 1H), 8.80 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 463 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (2-methoxyphenyl)methanol (32 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (79 mg, yield 93%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.89 (s, 3H), 4.12 (s, 3H), 4.20 (s, 3H), 5.32 (s, 2H), 6.89 (s, 2H), 6.89-7.01 (m, 3H), 7.18-7.21 (m, 1H), 7.29-7.43 (m, 3H), 7.59 (s, 1H), 8.16 (s, 1H), 8.43 (d, J=9.0 Hz, 1H), 8.83 (s, 1H), 9.57 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 497 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (2-chlorophenyl)methanol (37 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (92 mg, yield 100%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 4.12 (s, 3H), 4.19 (s, 3H), 5.35 (s, 2H), 7.20 (d, J=9.0 Hz, 2H), 7.29-7.32 (m, 2H), 7.42-7.44 (m, 1H), 7.48-7.52 (m, 1H), 7.59 (d, J=8.8 Hz, 2H), 7.62 (s, 1H), 8.15 (s, 1H), 8.79 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 467 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (2-chlorophenyl)methanol (33 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (80 mg, yield 93%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 4.12 (s, 3H), 4.20 (s, 3H), 5.38 (s, 2H), 7.19-7.22 (m, 1H), 7.30-7.35 (m, 3H), 7.43-7.45 (m, 1H), 7.49-7.51 (m, 1H), 7.59 (s, 1H), 8.16 (s, 1H), 8.41 (d, J=9.0 Hz, 1H), 8.82 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 501 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (2-methylphenyl)methanol (32 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (79 mg, yield 90%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.41 (s, 3H), 4.12 (s, 3H), 4.19 (s, 3H), 5.26 (s, 2H), 6.87 (s, 1H), 7.20 (d, J=9.0 Hz, 2H), 7.22-7.30 (m, 3H), 7.37-7.39 (m, 1H), 7.58 (d, J=8.8 Hz, 2H), 7.61 (s, 1H), 8.15 (s, 1H), 8.79 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 447 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (2-methylphenyl)methanol (28 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (62 mg, yield 75%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.43 (s, 3H), 4.12 (s, 3H), 4.20 (s, 3H), 5.28 (s, 2H), 7.18-7.33 (m, 5H), 7.40 (d, J=6.8 Hz, 1H), 7.59 (s, 1H), 8.16 (s, 1H), 8.41 (d, J=9.0 Hz, 1H), 8.82 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 481 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-butanol (19 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (34 mg, yield 46%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.97 (t, J=7.3 Hz, 3H), 1.41-1.49 (m, 2H), 1.62-1.72 (m, 2H), 4.10 (s, 3H), 4.17 (s, 3H), 4.21 (t, J=6.8 Hz, 2H), 6.70 (d, J=6.3 Hz, 1H), 6.85 (s, 1H), 7.18 (d, J=8.8 Hz, 2H), 7.61 (d, J=8.8 Hz, 2H), 7.64 (s, 1H), 8.15 (s, 1H), 8.47 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 397 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy)-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-butanol (17 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (65 mg, yield 94%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.99 (t, J=7.3 Hz, 3H), 1.41-1.50 (m, 2H), 1.67-1.74 (m, 2H), 2.13 (s, 3H), 2.29 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 4.22 (t, J=6.8 Hz, 2H), 6.42 (s, 1H), 6.59 (brs, 1H), 6.95 (s, 1H), 7.65 (s, 1H), 7.92 (s, 1H), 8.16 (s, 1H), 8.46 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 426 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-butanol (17 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (60 mg, yield 87%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.98 (t, J=7.3 Hz, 3H), 1.40-1.49 (m, 2H), 1.67-1.73 (m, 2H), 2.10 (s, 3H), 2.28 (s, 3H), 4.12 (s, 3H), 4.17 (s, 3H), 4.21 (t, J=6.8. Hz, 2H), 6.46 (s, 1H), 6.56 (d, J=6.3 Hz, 1H), 7.02 (d, J=8.8 Hz, 1H), 7.67 (s, 1H), 7.76 (d, J=8.5 Hz, 1H), 8.15 (s, 1H), 8.47 (t, J=6.3 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 426 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-propanol (16 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (42 mg, yield 59%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.33 (d, J=6.3 Hz, 6H), 4.11 (s, 3H), 4.17 (s, 3H), 5.02-5.09 (m, 1H), 6.70 (d, J=6.1 Hz, 1H), 6.74 (s, 1H), 7.18 (d, J=9.0 Hz, 1H), 7.60 (d, J=8.8 Hz, 2H), 7.64 (s, 1H), 8.15 (s, 1H), 8.47 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 383 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-propanol (14 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (50 mg, yield 75%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.34 (d, J=6.3 Hz, 6H), 2.13 (s, 3H), 2.29 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 5.04-5.07 (m, 1H), 6.38 (s, 1H), 6.58 (brs, 1H), 6.95 (s, 1H), 7.65 (s, 1H), 7.95 (s, 1H), 8.15 (s, 1H), 8.46 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 412 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-octadecanol (70 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (54 mg, yield 51%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.88 (t, J=7.1 Hz, 3H), 1.20-1.45 (m, 30H), 1.68-1.72 (m, 2H), 4.10 (s, 3H), 4.17 (s, 3H), 4.20 (t, J=6.6 Hz, 2H), 6.69 (d, J=6.3 Hz, 1H), 6.77 (s, 1H), 7.18 (d, J=8.8 Hz, 2H), 7.60 (d, J=8.8 Hz, 2H), 7.64 (s, 1H), 8.15 (s, 1H), 8.47 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 594 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-octadecanol (62 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (83 mg, yield 84%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.88 (t, J=7.1 Hz, 3H), 1.26-1.42 (m, 30H), 1.67-1.73 (m, 2H), 2.13 (s, 3H), 2.29 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 4.20 (t, J=6.6 Hz, 2H), 6.42 (s, 1H), 6.59 (brs, 1H), 6.95 (s, 1H), 7.65 (s, 1H), 7.92 (s, 1H), 8.15 (s, 1H), 8.47 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 622 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-octadecanol (62 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (96 mg, yield 97%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.88 (t, J=6.8 Hz, 3H), 1.21-1.42 (m, 30H), 1.67-1.72 (m, 2H), 2.10 (s, 3H), 2.27 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 4.20 (t, J=6.8 Hz, 2H), 6.44 (s, 1H), 6.56 (d, J=6.6 Hz, 1H), 7.02 (d, J=8.5 Hz, 1H), 7.67 (s, 1H), 7.75 (brs, 1H), 8.15 (s, 1H), 8.47 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 622 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-heptanol (30 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (46 mg, yield 57%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.90-0.98 (m, 6H), 1.35-1.36 (m, 4H), 1.62-1.69 (m, 4H), 4.11 (s, 3H), 4.17 (s, 3H), 4.80-4.86 (m, 1H), 6.69 (d, J=6.3 Hz, 1H), 6.79 (s, 1H), 7.18 (d, J=8.8 Hz, 2H), 7.62 (d, J=9.0 Hz, 2H), 7.64 (s, 1H), 8.15 (s, 1H), 8.47 (t, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 440 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-heptanol (27 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (59 mg, yield 78%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.93-0.99 (m, 6H), 1.30-1.45 (m, 4H), 1.57-1.68 (m, 4H), 2.13 (s, 3H), 2.30 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 4.82-4.85 (m, 1H), 6.42 (s, 1H), 6.58 (d, J=6.3 Hz, 1H), 6.95 (s, 1H), 7.65 (s, 1H), 7.96 (s, 1H), 8.15 (s, 1H), 8.46 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 468 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-heptanol (27 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (46 mg, yield 61%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.91-0.99 (m, 6H), 1.30-1.45 (m, 4H), 1.59-1.68 (m, 4H), 2.10 (s, 3H), 2.28 (s, 3H), 4.12 (s, 3H), 4.17 (s, 3H), 4.82-4.84 (m, 1H), 6.43 (s, 1H), 6.55 (d, J=6.6 Hz, 1H), 7.02 (d, J=8.8 Hz, 1H), 7.67 (s, 1H), 7.78 (brs, 1H), 8.15 (s, 1H), 8.47 (t, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 468 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-heptanol (30 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (48 mg, yield 60%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.95 (t, J=7.3 Hz, 6H), 1.37-1.45 (m, 4H), 1.53-1.63 (m, 4H), 4.11 (s, 3H), 4.17 (s, 3H), 4.89-4.94 (m, 1H), 6.69 (d, J=6.6 Hz, 1H), 6.76 (s, 1H), 7.18 (d, J=8.8 Hz, 2H), 7.61 (d, J=8.8 Hz, 2H), 7.64 (s, 1H), 8.15 (s, 1H), 8.47 (t, J=6.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 440 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-heptanol (27 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (57 mg, yield 76%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.96 (t, J=7.3 Hz, 6H), 1.38-1.46 (m, 4H), 1.54-1.64 (m, 4H), 2.13 (s, 3H), 2.29 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 4.91-4.94 (m, 1H), 6.41 (s, 1H), 6.57 (d, J=6.3 Hz, 1H), 6.95 (s, 1H), 7.65 (s, 1H), 7.96 (s, 1H), 8.15 (s, 1H), 8.46 (t, J=6.3 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 468 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-heptanol (27 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (44 mg, yield 58%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.96 (t, J=7.1 Hz, 6H), 1.37-1.45 (m, 4H), 1.57-1.64 (m, 4H), 2.10 (s, 3H), 2.27 (s, 3H), 4.12 (s, 3H), 4.17 (s, 3H), 4.90-4.93 (m, 1H), 6.42 (s, 1H), 6.55 (d, J=6.3 Hz, 1H), 7.02 (d, J=8.8 Hz, 1H), 7.67 (s, 1H), 7.78 (brs, 1H), 8.15 (s, 1H), 8.45 (t, J=6.3 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 468 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-hexanol (27 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (69 mg, yield 82%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.91 (t, J=7.1 Hz, 3H), 1.31-1.49 (m, 6H), 1.66-1.73 (m, 2H), 4.12 (s, 3H), 4.19 (s, 3H), 4.19 (t, J=7.1 Hz, 2H), 6.79 (s, 1H), 7.20 (d, J=8.8 Hz, 2H), 7.58 (d, J=8.8 Hz, 2H), 7.62 (s, 1H), 8.15 (s, 1H), 8.79 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 427 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-hexanol (24 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (54 mg, yield 68%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.92 (t, J=7.1 Hz, 3H), 1.32-1.49 (m, 6H), 1.68-1.75 (m, 2H), 4.12 (s, 3H), 4.20 (s, 3H), 4.22 (t, J=6.8 Hz, 2H), 7.18 (d, J=2.4 Hz, 1H), 7.21 (d, J=2.7 Hz, 1H), 7.33 (d, J=2.7 Hz, 1H), 7.59 (s, 1H), 8.16 (s, 1H), 8.39 (d, J=9.0 Hz, 1H), 8.82 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 461 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-hexanol (27 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (62 mg, yield 73%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.93-0.97 (m, 6H), 1.36-1.68 (m, 6H), 4.13 (s, 3H), 4.19 (s, 3H), 4.82-4.87 (m, 1H), 6.75 (s, 1H), 7.20 (d, J=9.0 Hz, 2H), 7.59 (d, J=8.8 Hz, 2H), 7.62 (s, 1H), 8.15 (s, 1H), 8.80 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 427 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-hexanol (24 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (55 mg, yield 69%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.94-0.99 (m, 6H), 1.37-1.70 (m, 6H), 4.12 (s, 3H), 4.20 (s, 3H), 4.83-4.87 (m, 1H), 7.18 (d, J=2.7 Hz, 1H), 7.20 (d, J=2.7 Hz, 1H), 7.33 (d, J=2.7 Hz, 1H), 7.59 (s, 1H), 8.16 (s, 1H), 8.42 (d, J=9.3 Hz, 1H), 8.82 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 461 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-phenyl-1-ethanol (28 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (18 mg, yield 22%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.03 (t, J=7.1 Hz, 2H), 4.12 (s, 3H), 4.20 (s, 3H), 4.45 (t, J=7.1 Hz, 2H), 7.17 (d, J=2.4 Hz, 1H), 7.20 (d, J=2.7 Hz, 1H), 7.29-7.34 (m, 6H), 7.58 (s, 1H), 8.16 (s, 1H), 8.33 (brs, 1H), 8.82 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 481 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cyclohexylmethanol (30 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (61 mg, yield 70%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.00-1.06 (m, 2H), 1.17-1.29 (m, 3H), 1.69-1.79 (m, 6H), 4.01 (d, J=6.3 Hz, 2H), 4.12 (s, 3H), 4.19 (s, 3H), 6.80 (s, 1H), 7.19 (d, J=9.0 Hz, 2H), 7.58 (d, J=8.8 Hz, 2H), 7.62 (s, 1H), 8.15 (s, 1H), 8.79 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 439 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cyclohexylmethanol (26 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (54 mg, yield 66%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.01-1.07 (m, 2H), 1.18-1.31 (m, 3H), 1.70-1.82 (m, 6H), 4.04 (d, J=6.3 Hz, 2H), 4.12 (s, 3H), 4.20 (s, 3H), 7.18 (d, J=2.7 Hz, 1H), 7.21 (d, J=2.7 Hz, 1H), 7.33 (d, J=2.7 Hz, 1H), 7.59 (s, 1H), 8.16 (s, 1H), 8.39 (d, J=9.0 Hz, 1H), 8.82 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 473 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-cycloheptanol (30 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (62 mg, yield 72%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.49-1.77 (m, 10H), 1.97-2.04 (m, 2H), 4.12 (s, 3H), 4.19 (s, 3H), 4.92-4.99 (m, 1H), 6.74 (s, 1H), 7.19 (d, J=9.0 Hz, 2H), 7.57 (d, J=9.0 Hz, 2H), 7.62 (s, 1H), 8.15 (s, 1H), 8.79 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 439 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-cycloheptanol (26 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (60 mg, yield 73%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.42-1.79 (m, 10H), 1.80-2.04 (m, 2H), 4.12 (s, 3H), 4.20 (s, 3H), 4.95-4.99 (m, 1H), 7.14-7.20 (m, 2H), 7.32 (d, J=2.7 Hz, 1H), 7.59 (s, 1H), 8.16 (s, 1H), 8.40 (d, J=8.8 Hz, 1H), 8.82 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 473 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-butanol (19 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (46 mg, yield 58%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.97 (t, J=7.3 Hz, 3H), 1.40-1.51 (m, 2H), 1.60-1.72 (m, 2H), 4.12 (s, 3H), 4.19 (s, 3H), 4.19 (t, J=6.6 Hz, 2H), 6.77 (s, 1H), 7.20 (d, J=9.0 Hz, 2H), 7.58 (d, J=8.8 Hz, 2H), 7.62 (s, 1H), 8.14 (s, 1H), 8.80 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 398 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-butanol (17 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (50 mg, yield 66%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.98 (t, J=7.3 Hz, 3H), 1.40-1.51 (m, 2H), 1.58-1.74 (m, 2H), 4.12 (s, 3H), 4.20 (s, 3H), 4.23 (t, J=6.6 Hz, 2H), 7.19-7.25 (m, 2H), 7.33 (d, J=2.7 Hz, 1H), 7.59 (s, 1H), 8.15 (s, 1H), 8.39 (d, J=8.8 Hz, 1H), 8.82 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 433 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-phenyl-1-propanol (31 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (43 mg, yield 51%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.96 (t, J=7.3 Hz, 3H), 1.86-1.95 (m, 1H), 2.00-2.08 (m, 1H), 4.11 (s, 3H), 4.19 (s, 3H), 5.68 (t, J=7.3 Hz, 1H), 7.15-7.17 (m, 1H), 7.25-7.38 (m, 5H), 7.39 (d, J=4.6 Hz, 2H), 7.57 (s, 1H), 8.15 (s, 1H), 8.37 (d, J=9.3 Hz, 1H), 8.81 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 495 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-propanol (14 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (50 mg, yield 75%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.34 (d, J=6.3 Hz, 6H), 2.13 (s, 3H), 2.29 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 5.04-5.07 (m, 1H), 6.38 (s, 1H), 6.58 (brs, 1H), 6.95 (s, 1H), 7.65 (s, 1H), 7.95 (s, 1H), 8.15 (s, 1H), 8.46 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 412 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cycloheptylmethanol (33 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (64 mg, yield 77%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.23-1.31 (m, 2H), 1.45-1.60 (m, 6H), 1.70-1.89 (m, 5H), 4.01 (d, J=6.8 Hz, 2H), 4.10 (s, 3H), 4.17 (s, 3H), 6.70 (d, J=6.3 Hz, 1H), 6.80 (s, 1H), 7.18 (d, J=9.0 Hz, 2H), 7.61 (d, J=8.8 Hz, 2H), 7.64 (s, 1H), 8.15 (s, 1H), 8.48 (t, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 452 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cycloheptylmethanol (30 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (64 mg, yield 83%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.23-1.31 (m, 2H), 1.47-1.59 (m, 6H), 1.70-1.90 (m, 5H), 2.13 (s, 3H), 2.29 (s, 3H), 4.01 (d, J=6.8 Hz, 2H), 4.11 (s, 3H), 4.17 (s, 3H), 6.43 (s, 1H), 6.58 (d, J=6.3 Hz, 1H), 6.95 (s, 1H), 7.65 (s, 1H), 7.92 (brs, 1H), 8.15 (s, 1H), 8.48 (t, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 480 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cycloheptylmethanol (30 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (77 mg, yield 100%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.19-1.31 (m, 2H), 1.40-1.90 (m, 11H), 2.10 (s, 3H), 2.28 (s, 3H), 4.01 (d, J=6.8 Hz, 2H), 4.12 (s, 3H), 4.17 (s, 3H), 6.47 (s, 1H), 6.57 (d, J=6.1 Hz, 1H), 7.02 (d, J=9.0 Hz, 1H), 7.67 (s, 1H), 7.74 (brs, 1H), 8.14 (s, 1H), 8.50 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 480 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cycloheptylmethanol (33 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (41 mg, yield 46%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.22-1.30 (m, 2H), 1.46-1.88 (m, 11H), 4.00 (d, J=6.8 Hz, 2H), 4.12 (s, 3H), 4.19 (s, 3H), 6.78 (s, 1H), 7.20 (d, J=8.8 Hz, 2H), 7.58 (d, J=9.0 Hz, 2H), 7.62 (s, 1H), 8.15 (s, 1H), 8.79 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 453 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cycloheptylmethanol (30 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (53 mg, yield 63%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.23-1.31 (m, 2H), 1.47-1.91 (m, 11H), 4.02 (d, J=6.8 Hz, 2H), 4.12 (s, 3H), 4.20 (s, 3H), 7.19 (s, 1H), 7.21 (d, J=2.7 Hz, 1H), 7.33 (d, J=2.7 Hz, 1H), 7.59 (s, 1H), 8.15 (s, 1H), 8.39 (d, J=9.0 Hz, 1H), 8.82 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 487 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-cyclohexyl-1-ethanol (33 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (63 mg, yield 76%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.95-1.01 (m, 2H), 1.15-1.27 (m, 3H), 1.40-1.43 (m, 1H), 1.57-1.77 (m, 7H), 4.10 (s, 3H), 4.17 (s, 3H), 4.24 (t, J=6.8 Hz, 2H), 6.70 (d, J=6.3 Hz, 1H), 6.82 (s, 1H), 7.18 (d, J=8.8 Hz, 2H), 7.61 (d, J=8.8 Hz, 2H), 7.64 (s, 1H), 8.15 (s, 1H), 8.48 (t, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 452 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-cyclohexyl-1-ethanol (30 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (68 mg, yield 88%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.94-1.02 (m, 2H), 1.16-1.28 (m, 3H), 1.40-1.44 (m, 1H), 1.58-1.78 (m, 7H), 2.13 (s, 3H), 2.29 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 4.25 (t, J=6.8 Hz, 2H), 6.42 (s, 1H), 6.59 (d, J=6.6 Hz, 1H), 6.95 (s, 1H), 7.65 (s, 1H), 7.91 (s, 1H), 8.15 (s, 1H), 8.49 (t, J=6.3 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 480 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-cyclohexyl-1-ethanol (30 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (65 mg, yield 84%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.93-1.01 (m, 2H), 1.16-1.24 (m, 3H), 1.27-1.42 (m, 1H), 1.51-1.77 (m, 7H), 2.10 (s, 3H), 2.28 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 4.24 (t, J=6.8 Hz, 2H), 6.45 (s, 1H), 6.56 (d, J=6.6 Hz, 1H), 7.02 (d, J=8.8 Hz, 1H), 7.67 (s, 1H), 7.74 (brs, 1H), 8.15 (s, 1H), 8.49 (t, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 480 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-cyclohexyl-1-ethanol (33 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (48 mg, yield 54%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.95-1.01 (m, 2H), 1.15-1.27 (m, 3H), 1.41-1.77 (m, 8H), 4.12 (s, 3H), 4.19 (s, 3H), 4.23 (t, J=6.8 Hz, 2H), 6.76 (s, 1H), 7.20 (d, J=9.0 Hz, 1H), 7.58 (d, J=8.5 Hz, 1H), 7.62 (s, 1H), 8.15 (s, 1H), 8.80 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 453 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-cyclohexyl-1-ethanol (30 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (56 mg, yield 67%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.96-1.02 (m, 2H), 1.16-1.28 (m, 3H), 1.42-1.78 (m, 8H), 4.12 (s, 3H), 4.20 (s, 3H), 4.26 (t, J=6.8 Hz, 2H), 7.18 (s, 1H), 7.20 (d, J=2.7 Hz, 1H), 7.33 (d, J=2.7 Hz, 1H), 7.59 (s, 1H), 8.16 (s, 1H), 8.39 (d, J=9.0 Hz, 1H), 8.83 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 487 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-pentanol (23 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (40 mg, yield 53%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.96 (t, J=7.6 Hz, 6H), 1.62-1.71 (m, 4H), 4.10 (s, 3H), 4.17 (s, 3H), 4.75-4.79 (m, 1H), 6.70 (d, J=6.6 Hz, 1H), 6.80 (s, 1H), 7.18 (d, J=8.8 Hz, 2H), 7.62 (d, J=9.0 Hz, 2H), 7.64 (s, 1H), 8.14 (s, 1H), 8.49 (t, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 412 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-pentanol (20 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (53 mg, yield 74%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.97 (t, J=7.6 Hz, 6H), 1.59-1.70 (m, 4H), 2.13 (s, 3H), 2.30 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 4.76-4.79 (m, 1H), 6.43 (s, 1H), 6.58 (d, J=6.3 Hz, 1H), 6.95 (s, 1H), 7.65 (s, 1H), 7.96 (s, 1H), 8.14 (s, 1H), 8.46 (t, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 440 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-pentanol (20 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (62 mg, yield 87%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.97 (t, J=7.6 Hz, 6H), 1.59-1.70 (m, 4H), 2.10 (s, 3H), 2.28 (s, 3H), 4.12 (s, 3H), 4.17 (s, 3H), 4.76-4.79 (m, 1H), 6.44 (s, 1H), 6.56 (d, J=6.3 Hz, 1H), 7.02 (d, J=8.8 Hz, 1H), 7.67 (s, 1H), 7.78 (brs, 1H), 8.15 (s, 1H), 8.46 (t, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 440 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-pentanol (23 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (55 mg, yield 67%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.95 (t, J=7.6 Hz, 6H), 1.59-1.69 (m, 4H), 4.13 (s, 3H), 4.19 (s, 3H), 4.75-4.78 (m, 1H), 6.75 (s, 1H), 7.19 (d, J=9.0 Hz, 2H), 7.59 (d, J=9.0 Hz, 2H), 7.62 (s, 1H), 8.15 (s, 1H), 8.80 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 413 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-pentanol (20 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (49 mg, yield 63%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.97 (t, J=7.6 Hz, 6H), 1.58-1.69 (m, 4H), 4.12 (s, 3H), 4.20 (s, 3H), 4.77-4.80 (m, 1H), 7.18 (s, 1H), 7.33 (d, J=2.4 Hz, 1H), 7.59 (s, 1H), 8.16 (s, 1H), 8.42 (d, J=9.0 Hz, 1H), 8.82 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 447 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-cyclopentanol (22 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (40 mg, yield 53%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.60-1.94 (m, 8H), 4.10 (s, 3H), 4.17 (s, 3H), 5.23-5.24 (m, 1H), 6.69 (d, J=6.3 Hz, 1H), 6.74 (s, 1H), 7.17 (d, J=9.0 Hz, 2H), 7.60 (d, J=9.0 Hz, 2H), 7.64 (s, 1H), 8.15 (s, 1H), 8.48 (t, J=6.3 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 410 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-cyclopentanol (20 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (70 mg, yield 99%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.58-1.96 (m, 8H), 2.13 (s, 3H), 2.29 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 5.22-5.23 (m, 1H), 6.38 (s, 1H), 6.58 (d, J=6.6 Hz, 1H), 6.94 (s, 1H), 7.65 (s, 1H), 7.95 (s, 1H), 8.15 (s, 1H), 8.47 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 438 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-cyclopentanol (20 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (62 mg, yield 84%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.66-1.95 (m, 8H), 2.10 (s, 3H), 2.27 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 5.21-5.25 (m, 1H), 6.41 (s, 1H), 6.56 (d, J=6.3 Hz, 1H), 7.01 (d, J=8.8 Hz, 1H), 7.67 (s, 1H), 7.78 (d, J=8.8 Hz, 1H), 8.15 (s, 1H), 8.47 (t, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 438 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-cyclopentanol (22 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (62 mg, yield 76%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.49-1.93 (m, 8H), 4.12 (s, 3H), 4.19 (s, 3H), 5.22-5.23 (m, 1H), 6.71 (s, 1H), 7.19 (d, J=9.0 Hz, 2H), 7.57 (d, J=8.8 Hz, 2H), 7.62 (s, 1H), 8.15 (s, 1H), 8.80 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 410 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then dded thereto, and the mixture was heated under reflux for 10 min. Next, 1-cyclopentanol (20 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (62 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.49-1.99 (m, 8H), 4.12 (s, 3H), 4.20 (s, 3H), 5.23-5.27 (m, 1H), 7.13 (s, 1H), 7.19 (dd, J=2.9, 9.0 Hz, 1H), 7.32 (d, J=2.7 Hz, 1H), 7.59 (s, 1H), 8.16 (s, 1H), 8.40 (d, J=9.0 Hz, 1H), 8.82 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 445 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 5-nonanol (38 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (2 mg, yield 2%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.92 (t, J=7.1 Hz, 6H), 1.31-1.39 (m, 8H), 1.57-1.64 (m, 4H), 4.11 (s, 3H), 4.17 (s, 3H), 4.85-4.91 (m, 1H), 6.69 (d, J=6.8 Hz, 1H), 7.18 (d, J=9.0 Hz, 2H), 7.61 (d, J=8.8 Hz, 2H), 7.64 (s, 1H), 8.15 (d, J=3.9 Hz, 1H), 8.4.6 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 468 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 5-nonanol (33 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (56 mg, yield 70%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.93 (t, J=7.1 Hz, 6H), 1.37-1.39 (m, 8H), 1.61 (brs, 1H), 2.13 (s, 3H), 2.29 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 4.87-4.90 (m, 1H), 6.41 (s, 1H), 6.58 (d, J=6.6 Hz, 1H), 6.95 (s, 1H), 7.65 (s, 1H), 7.97 (s, 1H), 8.15 (d, J=3.9 Hz, 1H), 8.46 (t, J=6.3 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 496 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 5-nonanol (33 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (57 mg, yield 72%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.92 (t, J=7.1 Hz, 6H), 1.36 (brs, 8H), 1.56-1.60 (m, 4H), 2.10 (s, 3H), 2.28 (s, 3H), 4.12 (s, 3H), 4.17 (s, 3H), 4.87-4.90 (m, 1H), 6.42 (s, 1H), 6.55 (d, J=6.1 Hz, 1H), 7.02 (d, J=8.8 Hz, 1H), 7.67 (s, 1H), 7.80 (brs, 1H), 8.16 (d, J=3.9 Hz, 1H), 8.45 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 496 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 5-nonanol (38 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (40 mg, yield 44%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.90-0.93 (m, 6H), 1.34-1.35 (m, 8H), 1.59 (brs, 4H), 4.13 (s, 3H), 4.19 (s, 3H), 4.86-4.89 (m, 1H), 6.71 (s, 1H), 7.19 (d, J=9.0 Hz, 2H), 7.59 (d, J=8.8 Hz, 2H), 7.62 (s, 1H), 8.15 (s, 1H), 8.80 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 469 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 5-nonanol (33 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (42 mg, yield 49%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.92 (t, J=7.1 Hz, 6H), 1.36 (brs, 8H), 1.61 (brs, 4H), 4.13 (s, 3H), 4.20 (s, 3H), 4.88-4.91 (m, 1H), 7.17 (s, 1H), 7.20 (s, 1H), 7.33 (s, 1H), 7.59 (s, 1H), 8.17 (s, 1H), 8.43 (d, J=9.0 Hz, 1H), 8.82 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 503 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-propen-1-ol (13 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (56 mg, yield 84%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.13 (s, 3H), 2.29 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 4.71 (d, J=5.9 Hz, 2H), 5.32 (dd, J=1.2, 10.5 Hz, 1H), 5.40 (dd, J=1.5, 17.3 Hz, 1H), 5.96-6.06 (m, 1H), 6.49 (s, 1H), 6.59 (d, J=6.6 Hz, 1H), 6.96 (s, 1H), 7.65 (s, 1H), 7.91 (s, 1H), 8.16 (d, J=3.9 Hz, 1H), 8.49 (t, J=7.3 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 410 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-propen-1-ol (13 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (50 mg, yield 75%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.10 (s, 3H), 2.28 (s, 3H), 4.12 (s, 3H), 4.17 (s, 3H), 4.71 (d, J=5.9 Hz, 2H), 5.31 (d, J=10.2 Hz, 1H), 5.40 (d, J=17.3 Hz, 1H), 5.96-6.04 (m, 1H), 6.50 (s, 1H), 6.56 (d, J=6.1 Hz, 1H), 7.03 (d, J=8.8 Hz, 1H), 7.67 (s, 1H), 7.76 (s, 1H), 8.16 (d, J=3.9 Hz, 1H), 8.48 (t, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 410 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-propen-1-ol (15 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (42 mg, yield 54%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 4.13 (s, 3H), 4.19 (s, 3H), 4.70 (d, J=5.9 Hz, 2H), 5.29 (dd, J=1.2, 10.5 Hz, 1H), 5.39 (dd, J=1.5, 17.3 Hz, 1H), 5.93-6.03 (m, 1H), 6.81-6.87 (m, 1H), 7.20 (d, J=9.0 Hz, 2H), 7.59 (d, J=8.8 Hz, 2H), 7.62 (s, 1H), 8.15 (s, 1H), 8.80 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 382 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-phenyl-1-propanol (35 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (54 mg, yield 64%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.01-2.08 (m, 2H), 2.75 (t, J=8.1 Hz, 2H), 4.11 (s, 3H), 4.17 (s, 3H), −4.24 (t, J=6.6 Hz, 2H), 6.70 (d, J=6.3 Hz, 1H), 6.80 (s, 1H), 7.17-7.33 (m, 7H), 7.61 (d, J=8.8 Hz, 2H), 7.64 (s, 1H), 8.15 (d, J=3.7 Hz, 1H), 8.50 (t, J=6.8 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 460 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-phenyl-1-propanol (31 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (77 mg, yield 98%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.02-2.09 (m, 2H), 2.13 (s, 3H), 2.29 (s, 3H), 2.76 (t, J=7.8 Hz, 2H), 4.11 (s, 3H), 4.17 (s, 3H), 4.25 (t, J=6.6 Hz, 2H), 6.41 (s, 1H), 6.59 (d, J=6.3 Hz, 1H), 6.95 (s, 1H), 7.22-7.33 (m, 5H), 7.65 (s, 1H), 7.91 (s, 1H), 8.15 (d, J=3.7 Hz, 1H), 8.49 (t, J=6.8 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 488 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-phenyl-1-propanol (31 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (56 mg, yield 71%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.01-2.09 (m, 2H), 2.11 (s, 3H), 2.28 (s, 3H), 2.75 (t, J=8.1 Hz, 2H), 4.11 (s, 3H), 4.17 (s, 3H), 4.24 (t, J=6.6 Hz, 2H), 6.43 (s, 1H), 6.56 (d, J=6.6 Hz, 1H), 7.03 (d, J=8.8 Hz, 1H), 7.21-7.33 (m, 5H), 7.67 (s, 1H), 7.75 (brs, 1H), 8.16 (d, J=3.9 Hz, 1H), 8.49 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 488 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-phenyl-1-propanol (31 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (42 mg, yield 49%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.04-2.08 (m, 2H), 2.76 (t, J=8.3 Hz, 2H), 4.12 (s, 3H), 4.20 (s, 3H), 4.26 (t, J=6.6 Hz, 2H), 7.18-7.34 (m, 8H), 7.59 (s, 1H), 8.17 (s, 1H), 8.38 (d, J=8.8 Hz, 1H), 8.83 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 495 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cyclopropylmethanol (19 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (25 mg, yield 34%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.33-0.37 (m, 2H), 0.60-0.65 (m, 2H), 1.18-1.22 (m, 1H), 4.04 (d, J=7.3 Hz, 2H), 4.11 (s, 3H), 4.17 (s, 3H), 6.71 (s, 1H), 6.85 (s, 1H), 7.18 (d, J=8.5 Hz, 2H), 7.61 (d, J=8.3 Hz, 2H), 7.65 (s, 1H), 8.14 (s, 3H), 8.51 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 395 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cyclopropylmethanol (17 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (51 mg, yield 74%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.34-0.38 (m, 2H), 0.61-0.66 (m, 2H), 1.18-1.24 (m, 1H), 2.13 (s, 3H), 2.30 (s, 3H), 4.04 (d, J=7.3 Hz, 2H), 4.11 (s, 3H), 4.17 (s, 3H), 6.47 (s, 1H), 6.59 (s, 1H), 6.95 (s, 1H), 7.65 (s, 1H), 7.92 (s, 1H), 8.15 (s, 1H), 8.48 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 424 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cyclopropylmethanol (17 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (55 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.34-0.38 (m, 2H), 0.61-0.66 (m, 2H), 1.19-1.23 (m, 1H), 2.11 (s, 3H), 2.28 (s, 3H), 4.04 (d, J=7.3 Hz, 2H), 4.12 (s, 3H), 4.17 (s, 3H), 6.50 (s, 1H), 6.56 (s, 1H), 7.03 (d, J=8.8 Hz, 1H), 7.67 (s, 1H), 7.78 (s, 1H), 8.15 (s, 1H), 8.48 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 424 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cyclopropylmethanol (19 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (60 mg, yield 75%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.33-0.36 (m, 2H), 0.59-0.64 (m, 2H), 1.16-1.23 (m, 1H), 4.03 (d, J=7.6 Hz, 2H), 4.12 (s, 3H), 4.17 (s, 3H), 6.81 (s, 1H), 7.20 (d, J=9.0 Hz, 2H), 7.57 (d, J=8.5 Hz, 2H), 7.61 (s, 1H), 7.99 (s, 1H), 8.77 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 396 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cyclopropylmethanol (17 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (49 mg, yield 65%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.34-0.38 (m, 2H), 0.62-0.66 (m, 2H), 1.20-1.24 (m, 1H), 4.06 (d, J=7.3 Hz, 2H), 4.12 (s, 3H), 4.20 (s, 3H), 7.19-7.21 (m, 2H), 7.33 (s, 1H), 7.59 (s, 1H), 8.17 (s, 1H), 8.40 (d, J=8.8 Hz, 1H), 8.83 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 431 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cyclobutylmethanol (22 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (48 mg, yield 64%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.80-2.13 (m, 6H), 2.65-2.71 (m, 1H), 4.10 (s, 3H), 4.17 (s, 3H), 4.18 (d, J=6.8 Hz, 2H), 6.70 (s, 1H), 6.80 (s, 1H), 7.18 (d, J=8.8 Hz, 2H), 7.60 (d, J=8.5 Hz, 2H), 7.64 (s, 1H), 8.14 (s, 1H), 8.50 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 410 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cyclobutylmethanol (20 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (61 mg, yield 86%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.81-1.99 (m, 4H), 2.05-2.20 (m, 2H), 2.13 (s, 3H), 2.29 (s, 3H), 2.66-2.73 (m, 1H), 4.11 (s, 3H), 4.17 (s, 3H), 4.19 (d, J=7.1 Hz, 2H), 6.43 (s, 1H), 6.60 (s, 1H), 7.95 (s, 1H), 7.65 (s, 1H), 7.91 (s, 1H), 8.15 (s, 1H), 8.49 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 438 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cyclobutylmethanol (20 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (59 mg, yield 83%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.78-2.08 (m, 6H), 2.08 (s, 3H), 2.26 (s, 3H), 2.60-2.70 (m, 1H), 4.09 (s, 3H), 4.15 (s, 3H), 4.16 (d, J=6.8 Hz, 2H), 6.43 (s, 1H), 6.55 (s, 1H), 7.00 (d, J=8.5 Hz, 1H), 7.65 (s, 1H), 7.74 (brs, 1H), 8.13 (s, 1H), 8.47 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 438 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cyclobutylmethanol (22 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (55 mg, yield 67%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.80-1.99 (m, 4H), 2.07-2.14 (m, 2H), 2.64-2.71 (m, 1H), 4.12 (s, 3H), 4.17 (d, J=6.8 Hz, 2H), 4.19 (s, 3H), 6.79 (s, 1H), 7.20 (d, J=8.8 Hz, 2H), 7.58 (d, J=8.3 Hz, 2H), 7.62 (s, 1H), 8.11 (s, 1H), 8.80 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 410 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cyclobutylmethanol (20 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (46 mg, yield 59%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.81-2.01 (m, 4H), 2.09-2.17 (m, 2H), 2.66-2.74 (m, 1H), 4.12 (s, 3H), 4.20 (d, J=6.8 Hz, 2H), 4.20 (s, 3H), 7.19 (s, 1H), 7.21 (d, J=2.7 Hz, 1H), 7.33 (d, J=2.4 Hz, 1H), 7.59 (s, 1H), 8.17 (s, 1H), 8.39 (d, J=9.3 Hz, 1H), 8.83 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 445 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-cyclohexanol (23 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (58 mg, yield 74%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.29-1.58 (m, 6H), 1.74-1.81 (m, 2H), 1.95-2.00 (m, 2H), 2.12 (s, 3H), 2.29 (s, 3H), 4.13 (s, 3H), 4.20 (s, 3H), 4.76-4.77 (m, 1H), 6.38 (s, 1H), 6.95 (s, 1H), 7.62 (s, 1H), 7.93 (s, 1H), 8.16 (s, 1H), 8.79 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 453 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-cyclohexanol (23 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (50 mg, yield 64%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.21-1.57 (m, 6H), 1.73-1.79 (m, 2H), 1.94-2.00 (m, 2H), 2.08 (s, 3H), 2.27 (s, 3H), 4.14 (s, 3H), 4.20 (s, 3H), 4.70-4.80 (m, 1H), 6.40 (s, 1H), 7.01 (d, J=8.8 Hz, 1H), 7.65 (s, 1H), 7.78 (brs, 1H), 8.16 (s, 1H), 8.78 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 453 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-cyclopentanol (20 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (47 mg, yield 61%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.49-1.84 (m, 6H), 1.89-1.98 (m, 2H), 2.12 (s, 3H), 2.28 (s, 3H), 4.13 (s, 3H), 4.20 (s, 3H), 5.21-5.22 (m, 1H), 6.36 (s, 1H), 6.95 (s, 1H), 7.62 (s, 1H), 7.93 (s, 1H), 8.16 (s, 1H), 8.79 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 439 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-cyclopentanol (20 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (43 mg, yield 56%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.49-1.83 (m, 6H), 1.88-1.97 (m, 2H), 2.08 (s, 3H), 2.26 (s, 3H), 4.14 (s, 3H), 4.20 (s, 3H), 5.20-5.25 (m, 1H), 6.39 (s, 1H), 7.01 (d, J=8.8 Hz, 1H), 7.65 (s, 1H), 7.77 (brs, 1H), 8.16 (s, 1H), 8.78 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 439 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cyclopentylmethanol (26 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (42 mg, yield 54%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.22-1.84 (m, 8H), 2.25-2.29 (m, 1H), 4.10-4.17 (m, 8H), 6.69 (d, J=6.1 Hz, 1H), 6.80 (s, 1H), 7.18 (d, J=9.0 Hz, 2H), 7.61 (d, J=8.5 Hz, 2H), 7.64 (s, 1H), 8.15 (s, 1H), 8.47 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 424 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cyclopentylmethanol (23 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (62 mg, yield 85%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.31-1.68 (m, 6H), 1.78-1.86 (m, 2H), 2.13 (s, 3H), 2.20-2.30 (m, 1H), 2.29 (s, 3H), 4.10 (d, J=6.3 Hz, 2H), 4.11 (s, 3H), 4.17 (s, 3H), 6.42 (s, 1H), 6.58 (d, J=6.3 Hz, 1H), 6.95 (s, 1H), 7.65 (s, 1H), 7.91 (s, 1H), 8.16 (s, 1H), 8.46 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 452 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cyclopentylmethanol (23 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (48 mg, yield 66%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.27-1.35 (m, 2H), 1.55-1.67 (m, 4H), 1.76-1.84 (m, 2H), 2.10 (s, 3H), 2.26-2.30 (m, 1H), 2.28 (s, 3H), 4.09 (d, J=7.1 Hz, 2H), 4.12 (s, 3H), 4.18 (s, 3H), 6.44 (s, 1H), 6.56 (s, 1H), 7.03 (d, J=8.5 Hz, 1H), 7.67 (s, 1H), 7.76 (brs, 1H), 8.16 (s, 1H), 8.45 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 452 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cyclopentylmethanol (26 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (64 mg, yield 75%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.30-1.33 (m, 2H), 1.59-1.65 (m, 4H), 1.76-1.83 (m, 2H), 4.09 (d, J=7.3 Hz, 2H), 4.12 (s, 3H), 4.19 (s, 3H), 6.76 (s, 1H), 7.20 (d, J=9.0 Hz, 2H), 7.58 (d, J=8.8 Hz, 2H), 7.62 (s, 1H), 8.15 (s, 1H), 8.80 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 425 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cyclopentylmethanol (23 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (47 mg, yield 59%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.29-1.34 (m, 2H), 1.57-1.66 (m, 4H), 1.77-1.85 (m, 2H), 4.11 (d, J=7.1 Hz, 2H), 4.12 (s, 3H), 4.20 (s, 3H), 7.19 (s, 1H), 7.33 (d, J=2.7 Hz, 1H), 7.59 (s, 1H), 8.17 (s, 1H), 8.39 (d, J=9.0 Hz, 1H), 8.82 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 459 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-morpholino-1-ethanol (34 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (54 mg, yield 60%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.94-3.04 (m, 2H), 3.30-3.36 (m, 2H), 3.58-3.63 (m, 2H), 4.01-4.07 (m, 2H), 4.12 (s, 3H), 4.19 (s, 3H), 4.53-4.59 (m, 4H), 7.19 (d, J=9.0 Hz, 2H), 7.62 (s, 1H), 7.67 (d, J=9.0 Hz, 2H), 8.14 (s, 1H), 8.80 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 456 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-heptanol (30 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (53 mg, yield 61%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.95 (t, J=7.3 Hz, 6H), 1.19-1.62 (m, 8H), 4.13 (s, 3H), 4.19 (s, 3H), 4.90-4.93 (m, 1H), 6.72 (s, 1H), 7.19 (d, J=9.0 Hz, 2H), 7.58 (d, J=8.8 Hz, 2H), 7.62 (s, 1H), 8.15 (s, 1H), 8.80 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 441 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-heptanol (30 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (63 mg, yield 72%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.92-0.97 (m, 6H) 1.34-1.67 (m, 8H), 4.13 (s, 3H), 4.19 (s, 3H), 4.81-4.84 (m, 1H), 6.72 (s, 1H), 7.19 (d, J=9.0 Hz, 2H), 7.58 (d, J=9.0 Hz, 2H), 7.62 (s, 1H), 8.15 (s, 1H), 8.80 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 441 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-(tert-butyl)phenol (39 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (74 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.41 (s, 9H), 4.13 (s, 3H), 4.19 (s, 3H), 7.08-7.11 (m, 1H), 7.19-7.29 (m, 5H), 7.41-7.44 (m, 1H), 7.63 (s, 1H), 7.70 (d, J=8.5 Hz, 2H), 8.15 (s, 1H), 8.79 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 475 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-methoxyphenol (32 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (16 mg, yield 18%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.87 (s, 3H), 4.13 (s, 3H), 4.19 (s, 3H), 6.97-7.02 (m, 2H), 7.15-7.26 (m, 5H), 7.62 (s, 1H), 7.66 (d, J=8.8 Hz, 2H), 8.16 (s, 1H), 8.80 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 448 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-methyl-2-propen-1-ol (19 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (38 mg, yield 52%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.82 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 4.63 (s, 2H), 4.99 (s, 1H), 5.06 (s, 1H), 6.70 (d, J=6.3 Hz, 1H), 6.87 (s, 1H), 7.19 (d, J=9.0 Hz, 2H), 7.62 (d, J=9.0 Hz, 2H), 7.64 (s, 1H), 8.15 (s, 1H), 8.48 (t, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 395 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-methyl-2-propen-1-ol (17 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (31 mg, yield 45%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.83 (s, 3H), 2.13 (s, 3H), 2.30 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 4.64 (s, 2H), 5.00 (s, 1H), 5.06 (s, 1H), 6.59 (s, 1H), 6.96 (s, 1H), 7.65 (s, 1H), 8.16 (s, 1H), 8.46 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 424 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-methyl-2-propen-1-ol (17 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (40 mg, yield 58%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.83 (s, 3H), 2.11 (s, 3H), 2.29 (s, 3H), 4.12 (s, 3H), 4.1.7 (s, 3H), 4.63 (s, 2H), 5.00 (s, 1H), 5.06 (s, 1H), 6.56 (d, J=5.9 Hz, 1H), 7.03 (d, J=8.8 Hz, 1H), 7.67 (s, 1H), 8.16 (s, 1H), 8.46 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 424 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-methyl-2-propen-1-ol (19 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (37 mg, yield 47%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 4.13 (s, 3H), 4.19 (s, 3H), 4.62 (s, 2H), 4.98 (s, 1H), 5.05 (s, 1H), 6.87 (s, 1H), 7.21 (d, J=9.0 Hz, 2H), 7.59 (d, J=9.0 Hz, 2H), 7.62 (s, 1H), 8.15 (s, 1H), 8.80 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 396 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 5-hexyn-3-ol (26 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (30 mg, yield 39%).
- 1H-NMR (CDCl3-d1, 400 MHz): 1.01 (t, J=7.6 Hz, 3H) 1.79-1.83 (m, 2H), 2.04-2.05 (m, 1H), 2.57-2.61 (m, 2H), 4.11 (s, 3H), 4.17 (s, 3H), 4.90-4.93 (m, 1H), 6.69 (d, J=6.1 Hz, 1H), 6.83 (s, 1H), 7.19 (d, J=9.0 Hz, 2H), 7.61 (d, J=8.8 Hz, 2H), 7.64 (s, 1H), 8.15 (s, 1H), 8.47 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 422 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 5-hexyn-3-ol (23 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (52 mg, yield 72%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.01 (t, J=7.6 Hz, 3H), 1.79-1.83 (m, 2H), 2.05 (s, 1H), 2.13 (s, 3H), 2.30 (s, 3H), 2.55-2.60 (m, 2H), 4.11 (s, 3H), 4.17 (s, 3H), 4.92-4.93 (m, 1H), 6.48 (s, 1H), 6.59 (s, 1H), 6.96 (s, 1H), 7.65 (s, 1H), 7.93 (s, 1H), 8.15 (s, 1H), 8.47 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 450 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 5-hexyn-3-ol (23 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (43 mg, yield 59%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.01 (t, J=7.6 Hz, 3H), 1.79-1.81 (m, 2H), 2.04-2.05 (m, 1H), 2.11 (s, 3H), 2.29 (s, 3H), 2.57-2.61 (m, 2H), 4.12 (s, 3H), 4.17 (s, 3H), 4.90-4.93 (m, 1H), 6.50 (s, 1H), 6.56 (d, J=6.3 Hz, 1H), 7.03 (d, J=9.0 Hz, 1H), 7.67 (s, 1H), 7.75 (s, 1H), 8.16 (s, 1H), 8.45 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 450 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-heptanol (30 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (25 mg, yield 31%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.91 (t, J=7.1 Hz, 3H), 1.26-1.32 (m, 11H), 4.11 (s, 3H), 4.17 (s, 3H), 4.92-4.96 (m, 1H), 6.70 (s, 1H), 6.72 (s, 1H), 7.18 (d, J=8.5 Hz, 2H), 7.61 (d, J=8.3 Hz, 2H), 7.64 (s, 1H), 8.15 (s, 1H), 8.46 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z) 440 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-heptanol (27 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (54 mg, yield 72%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.91 (t, J=7.1 Hz, 3H), 1.31-1.32 (m, 11H), 2.13 (s, 3H), 2.29 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 4.93-4.95 (m, 1H), 6.39 (s, 1H), 6.58 (d, J=5.6 Hz, 1H), 6.95 (s, 1H), 7.65 (s, 1H), 7.96 (s, 1H), 8.15 (s, 1H), 8.45 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 468 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-heptanol (27 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (49 mg, yield 65%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.91 (t, J 6.6 Hz, 3H), 1.30-1.32 (m, 11H), 2.12 (s, 3H), 2.29 (s, 3H), 4.12 (s, 3H), 4.18 (s, 3H), 4.93-4.94 (m, 1H), 6.41 (s, 1H), 7.03 (s, 1H), 7.67 (s, 1H), 7.79 (s, 1H), 8.15 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 468 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-piperidino-1-propanol (33 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (90 mg, yield 100%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.26 (s, 4H), 1.87-1.96 (m, 2H), 2.13 (s, 3H), 2.29-2.42 (m, 2H), 2.33 (s, 3H), 2.64-2.73 (m, 2H), 3.11-3.16 (m, 2H), 3.61-3.63 (m, 2H), 4.11 (s, 3H), 4.17 (s, 3H), 4.31 (t, J=5.6 Hz, 2H), 6.59 (d, J=6.6 Hz, 1H), 6.96 (s, 1H), 7.65 (s, 1H), 7.84 (s, 1H), 8.15 (s, 1H), 8.47 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 495 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-piperidino-1-propanol (33 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (62 mg, yield 73%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.62 (brs, 8H), 2.01 (brs, 2H), 2.13 (s, 3H), 2.27 (s, 3H), 3.00 (brs, 2H), 4.06 (s, 3H), 4.07 (s, 3H), 4.29 (t, J=5.9 Hz, 2H), 6.27 (d, J=5.1 Hz, 1H), 6.99 (d, J=8.8 Hz, 1H), 7.44 (s, 1H), 7.57 (s, 1H), 7.61 (s, 1H), 8.44 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 495 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-hydroxy-1,3-isoindolinedione (42 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (11 mg, yield 12%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 4.12 (s, 3H), 4.18 (s, 3H), 6.83 (d, J=6.1 Hz, 1H), 7.39 (d, J=9.0 Hz, 2H), 7.66 (s, 1H), 7.72 (d, J=9.0 Hz, 2H), 7.85-7.87 (m, 2H), 8.00-8.02 (m, 3H), 8.19 (s, 1H), 8.52-8.53 (m, 1H)
- Mass spectrometry value (ESI-MS, m/z): 486 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-(hydroxymethyl)-1,3-isoindolinedione (41 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (48 mg, yield 57%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.13 (s, 3H), 2.25 (s, 3H), 3.10-3.11 (m, 1H), 4.10 (s, 3H), 4.17 (s, 3H), 5.87 (s, 1H), 6.50 (s, 1H), 6.55 (s, 1H), 6.94 (s, 1H), 7.64 (s, 1H), 7.81-7.83 (m, 2H), 7.96-7.98 (m, 2H), 8.15 (s, 1H), 8.46 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 529 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-(hydroxymethyl)-1,3-isoindolinedione (41 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (14 mg, yield 17%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.09 (s, 3H), 2.24 (s, 3H), 3.10-3.11 (m, 1H), 4.11 (s, 3H), 4.17 (s, 3H), 5.27 (s, 1H), 5.87 (s, 1H), 6.53 (s, 1H), 7.01-7.04 (m, 1H), 7.66-7.96 (m, 7H)
- Mass spectrometry value (ESI-MS, m/z): 529 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-(2-hydroxyethyl)-1,3-isoindolinedione (44 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (57 mg, yield 66%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.10 (s, 3H), 2.26 (s, 3H), 4.05 (t, J=5.1 Hz, 2H), 4.11 (s, 3H), 4.17 (s, 3H), 4.46 (t, J=5.4 Hz, 2H), 6.42 (s, 1H), 6.59 (d, J=6.3 Hz, 1H), 6.94 (s, 1H), 7.64 (s, 1H), 7.75-7.77 (m, 3H), 7.87-7.89 (m, 2H), 8.15 (s, 1H), 8.47 (t, J=6.3 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 543 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-(2-hydroxyethyl)-1,3-isoindolinedione (44 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (21 mg, yield 24%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.08 (s, 3H), 2.24 (s, 3H), 4.05 (t, J=5.1 Hz, 2H), 4.11 (s, 3H), 4.17 (s, 3H), 4.46 (t, J=5.4 Hz, 2H), 6.45 (s, 1H), 6.55 (s, 1H), 6.99 (d, J=8.5 Hz, 1H), 7.66 (s, 2H), 7.74-7.76 (m, 2H), 7.86-7.88 (m, 2H), 8.16 (s, 1H), 8.46 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 543 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-morpholino-1-propanol (38 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (38 mg, yield 41%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.89-1.96 (m, 2H), 2.51-2.53 (m, 6H), 3.76 (t, J=4.9 Hz, 4H), 4.05 (s, 3H), 4.06 (s, 3H), 4.27 (t, J=6.6 Hz, 2H), 6.45 (d, J=5.4 Hz, 1H), 6.74 (s, 1H), 7.15 (d, J=9.0 Hz, 2H), 7.45 (s, 1H), 7.49 (d, J=8.8 Hz, 2H), 7.56 (s, 1H), 8.48 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 469 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-morpholino-1-propanol (33 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (56 mg, yield 66%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.89-1.96 (m, 2H), 2.15 (s, 3H), 2.25 (s, 3H), 2.50 (brs, 6H), 3.75 (t, J=4.6 Hz, 4H), 4.057 (s, 3H), 4.063 (s, 3H), 4.27 (t, J=6.6 Hz, 2H), 6.30 (d, J=5.1 Hz, 1H), 6.38 (s, 1H), 6.93 (s, 1H), 7.45 (s, 1H), 7.59 (s, 1H), 7.77 (s, 1H), 8.45 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 497 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-morpholino-1-propanol (33 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (66 mg, yield 77%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.10 (s, 3H), 2.31 (s, 3H), 2.39 (brs, 2H), 2.93 (brs, 2H), 3.22 (brs, 2H), 3.53 (brs, 2H), 4.00-4.03 (m, 2H), 4.12 (s, 3H), 4.17 (s, 3H), 4.32 (brs, 4H), 6.57 (s, 1H), 7.01 (brs, 1H), 7.67 (s, 2H), 8.14 (s, 1H), 8.50 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 497 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-(4-methylpiperazino)-1-propanol (41 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (9 mg, yield 9%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.89-1.93 (m, 2H), 2.39 (s, 3H), 2.49-2.62 (m, 10H), 4.05 (s, 6H), 4.25 (t, J=6.3 Hz, 2H), 6.44 (d, J=5.4 Hz, 1H), 6.79 (s, 1H), 7.15 (d, J=8.8 Hz, 2H), 7.42 (s, 1H), 7.49 (d, J=8.5 Hz, 2H), 7.56 (s, 1H), 8.48 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 482 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-(4-methylpiperazino)-1-propanol (36 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (33 mg, yield 36%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.90-1.95 (m, 2H), 2.15 (s, 3H), 2.25 (s, 3H), 2.35 (s, 3H), 2.42-2.53 (m, 10H), 4.05 (s, 3H), 4.06 (s, 3H), 4.25 (t, J=6.3 Hz, 2H), 6.29 (d, J=5.4 Hz, 1H), 6.38 (s, 1H), 6.92 (s, 1H), 7.42 (s, 1H), 7.59 (s, 1H), 7.75 (s, 1H), 8.45 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 509 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-(diethylamino)-1-propanol (34 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (32 mg, yield 36%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.39 (t, J=7.1 Hz, 6H), 2.20-2.22 (m, 2H), 3.14-3.16 (m, 6H), 4.04 (s, 6H), 4.30 (t, J=5.6 Hz, 2H), 6.44 (d, J=5.1 Hz, 1H), 7.12 (d, J=8.8 Hz, 2H), 7.42 (s, 1H), 7.56 (s, 1H), 7.64 (d, J=8.1 Hz, 2H), 7.47 (d, J=5.1 Hz, 1H), 8.77 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 455 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-(diethylamino)-1-propanol (30 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (50 mg, yield 61%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.32 (t, J=7.1 Hz, 6H), 2.14 (s, 3H), 2.17-2.19 (m, 2H), 2.28 (s, 3H), 2.94-3.01 (m, 6H), 4.05 (s, 3H), 4.06 (s, 3H), 4.30 (t, J=5.9 Hz, 2H), 6.30 (d, J=5.4 Hz, 1H), 6.93 (s, 1H), 7.11 (s, 1H), 7.42 (s, 1H), 7.59 (s, 1H), 7.68 (s, 1H), 8.44 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 483 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-(diethylamino)-1-propanol (30 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (65 mg, yield 78%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.47 (t, J=7.1 Hz, 6H), 2.09 (s, 3H), 2.30 (s, 2H), 2.33 (s, 3H), 3.24 (brs, 6H), 4.12 (s, 3H), 4.17 (s, 3H), 4.33 (s, 2H), 6.57 (s, 1H), 7.01 (d, J=8.5 Hz, 1H), 7.67 (s, 2H), 8.15 (s, 1H), 8.46 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 483 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-(diethylamino)-1-propanol (34 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (25 mg, yield 27%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.24-1.35 (m, 6H), 2.16-2.17 (m, 2H), 3.05 (brs, 6H), 4.07 (s, 6H), 4.28 (s, 2H), 7.19 (d, J=8.5 Hz, 2H), 7.31 (s, 1H), 7.55 (S, 1H), 7.60 (d, J=8.5 Hz, 2H), 8.22 (s, 1H), 8.60 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 456 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-pyridylmethanol (25 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (75 mg, yield 94%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.12 (s, 3H), 2.50 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 5.70 (s, 2H), 6.60 (s, 1H), 6.97 (s, 1H), 7.66 (s, 1H), 7.84-7.96 (m, 4H), 8.15 (s, 1H), 8.48 (s, 2H), 9.02 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 461 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-pyridylmethanol (25 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (50 mg, yield 63%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.10 (s, 3H), 2.47 (s, 3H), 4.12 (s, 3H), 4.17 (s, 3H), 5.70 (s, 2H), 6.59 (d, J=5.9 Hz, 1H), 7.00 (d, J=9.5 Hz, 1H), 7.68 (s, 2H), 7.75-7.97 (m, 3H), 8.15 (s, 1H), 8.48 (t, J=7.1 Hz, 2H), 9.02 (d, J=4.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 461 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-pyridylmethanol (25 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (80 mg, yield 100%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.12 (s, 3H), 2.33 (s, 3H), 4.12 (s, 3H), 4.17 (s, 3H), 5.47 (s, 2H), 6.58 (d, J=6.8 Hz, 1H), 7.04 (d, J=8.8 Hz, 1H), 7.67 (s, 2H), 7.98-8.01 (m, 1H), 8.14 (s, 1H), 8.46 (d, J=8.1 Hz, 1H), 8.53 (s, 1H), 8.79 (d, J=5.4 Hz, 1H), 9.22 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 461 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-pyridylmethanol (28 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (10 mg, yield 12%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 4.046 (s, 3H), 4.049 (s, 3H), 5.24 (s, 2H), 6.45 (d, J=5.4 Hz, 1H), 7.17 (d, J=8.8 Hz, 2H), 7.23 (s, 1H), 7.30 (d, J=5.4 Hz, 2H), 7.45 (s, 1H), 7.53 (d, J=8.3 Hz, 2H), 7.56 (s, 1H), 8.48 (d, J=5.4 Hz, 1H), 8.62 (d, J=5.4 Hz, 2H)
- Mass spectrometry value (ESI-MS, m/z): 433 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-pyridylmethanol (28 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (21 mg, yield 23%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 4.069 (s, 3H), 4.073 (s, 3H), 5.25 (s, 2H), 7.22-7.27 (m, 2H), 7.32 (d, J=5.9 Hz, 2H), 7.34 (s, 1H), 7.53 (d, J=8.8 Hz, 2H), 7.55 (s, 1H), 8.63 (d, J=6.3 Hz, 3H)
- Mass spectrometry value (ESI-MS, m/z): 433 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-(diethylamino)-1-ethanol (31 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (53 mg, yield 61%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.08 (t, J=7.1 Hz, 6H), 2.65 (q, J=7.1 Hz, 4H), 2.79 (t, J=5.9 Hz, 2H), 4.04 (s, 3H), 4.05 (s, 3H), 4.28 (t, J=5.9 Hz, 2H), 6.44 (d, J=5.4 Hz, 1H), 7.13-7.15 (m, 2H), 7.25-7.28 (m, 1H), 7.42 (s, 1H), 7.50 (d, J=8.8 Hz, 2H), 7.56 (s, 1H), 8.48 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 441 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-(diethylamino)-1-ethanol (31 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (66 mg, yield 71%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.10 (t, J=7.1 Hz, 6H), 2.67 (q, J=7.1 Hz, 4H), 2.80 (t, J=5.9 Hz, 2H), 4.06 (s, 3H), 4.07 (s, 3H), 4.28 (t, J=5.9 Hz, 2H), 7.10 (s, 1H), 7.19-7.21 (m, 2H), 7.32 (s, 1H), 7.51 (d, J=8.8 Hz, 2H), 7.55 (s, 1H), 8.62 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 442 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-morpholino-3-hexanol (49 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (80 mg, yield 81%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.91-0.96 (m, 3H), 1.36-1.82 (m, 6H), 2.41-2.45 (m, 6H), 3.70-3.72 (m, 4H), 4.04 (s, 3H), 4.05 (s, 3H), 4.95-4.97 (m, 1H), 6.44 (d, J=5.1 Hz, 1H), 7.14 (d, J=8.8 Hz, 2H), 7.30 (s, 1H), 7.42 (s, 1H), 7.53 (d, J=8.5 Hz, 2H), 7.57 (s, 1H), 8.47 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 511 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 1.0 min. Next, 1-morpholino-3-hexanol (43 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (74 mg, yield 81%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.96 (t, J=7.3 Hz, 3H), 1.39-1.48 (m, 2H), 1.55-1.67 (m, 2H), 1.79-1.88 (m, 2H), 2.15 (s, 3H), 2.26 (s, 3H), 2.44-2.47 (m, 6H), 3.69-3.74 (m, 4H), 4.05 (s, 3H), 4.06 (s, 3H), 4.93-5.00 (m, 1H), 6.29 (d, J=5.1 Hz, 1H), 6.51 (s, 1H), 6.93 (s, 1H), 7.29 (s, 1H), 7.42 (s, 1H), 7.60 (s, 1H), 7.79 (s, 1H), 8.44 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 539 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-morpholino-3-hexanol (43 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (82 mg, yield 90%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.96 (t, J=7.3 Hz, 3H), 1.39-1.46 (m, 2H), 1.57-1.64 (m, 2H), 1.78-1.86 (m, 2H), 2.13 (s, 3H), 2.26 (s, 3H), 2.46 (s, 6H), 3.69-3.73 (m, 4H), 4.04 (s, 3H), 4.07 (s, 3H), 4.95-4.97 (m, 1H), 6.27 (d, J=5.4 Hz, 1H), 6.75 (s, 1H), 7.00 (d, J=8.5 Hz, 1H), 7.31 (s, 1H), 7.42 (s, 1H), 7.59 (s, 1H), 7.62 (s, 1H), 8.43 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 539 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-morpholino-3-hexanol (49 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (77 mg, yield 73%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.84-0.88 (m, 3H), 1.28-1.75 (m, 6H), 2.34-2.37 (m, 6H), 3.63-3.65 (m, 4H), 3.98 (s, 3H), 3.99 (s, 3H), 4.86-4.87 (m, 1H), 7.00 (s, 1H), 7.12 (d, J=8.8 Hz, 2H), 7.24 (s, 1H), 7.43 (d, J=8.5 Hz, 2H), 7.48 (s, 1H), 8.54 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 512 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-(diethylamino)-3-hexanol (45 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (10 mg, yield 10%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.96 (t, J=7.6 Hz, 3H), 1.28 (t, J=7.6 Hz, 6H), 1.38-1.46 (m, 2H), 1.55-1.73 (m, 4H), 2.93-2.95 (m, 6H), 4.05 (s, 6H), 4.90-4.93 (m, 1H), 6.44 (d, J=5.4 Hz, 1H), 7.14 (d, J=9.0 Hz, 2H), 7.42 (s, 1H), 7.54 (d, J=9.0 Hz, 2H), 7.56 (s, 1H), 8.47 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 497 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-(diethylamino)-3-hexanol (40 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (29 mg, yield 32%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.96 (t, J=7.3 Hz, 3H), 1.20 (t, J=7.3 Hz, 6H), 1.37-1.49 (m, 2H), 1.55-1.71 (m, 2H), 1.93-1.98 (m, 2H), 2.15 (s, 3H), 2.26 (s, 3H), 2.76-2.80 (m, 6H), 4.05 (s, 3H), 4.06 (s, 3H), 4.89-4.96 (m, 1H), 6.29 (d, J=5.4 Hz, 1H), 6.59 (s, 1H), 6.93 (s, 1H), 7.42 (s, 1H), 7.59 (s, 1H), 7.76 (s, 1H), 8.44 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 525 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-(diethylamino)-3-hexanol (40 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (30 mg, yield 34%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.96 (t, J=7.3 Hz, 3H), 1.19 (t, J=6.6 Hz, 6H), 1.41-1.45 (m, 2H), 1.60-1.68 (m, 2H), 1.95 (brs, 2H), 2.12 (s, 3H), 2.26 (s, 3H), 2.78-2.80 (m, 6H), 4.05 (s, 3H), 4.07 (s, 3H), 4.92 (brs, 1H), 6.26 (d, J=5.1 Hz, 1H), 6.65 (s, 1H), 6.99 (d, J=8.5 Hz, 1H), 7.27 (s, 1H), 7.43 (s, 1H), 7.61 (s, 1H), 8.43 (d, J=4.9 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 525 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-(diethylamino)-3-hexanol (45 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (5 mg, yield 5%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.93-1.02 (m, 3H), 1.26 (t, J=6.8 Hz, 6H), 1.37-1.45 (m, 2H), 1.54-2.03 (m, 4H), 2.90 (brs, 6H), 4.067 (s, 3H), 4.072 (s, 3H), 4.90-4.93 (m, 1H), 7.21 (d, J=8.8 Hz, 2H), 7.32 (s, 1H), 7.49-7.56 (m, 3H), 8.61 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 498 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-piperidino-3-hexanol (48 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (57 mg, yield 58%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.94 (t, J=7.3 Hz, 3H), 1.35-1.46 (m, 4H), 1.52-1.67 (m, 6H), 1.85-1.90 (m, 2H), 2.40-2.56 (m, 6H), 4.04 (s, 3H), 4.05 (s, 3H), 4.90-4.93 (m, 1H), 6.44 (d, J=5.4 Hz, 1H), 7.14 (d, J=8.8 Hz, 2H), 7.28 (s, 3H), 7.42 (s, 1H), 7.52 (d, J=8.8 Hz, 2H), 7.56 (s, 1H), 8.47 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 509 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-piperidino-3-hexanol (43 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (75 mg, yield 82%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.96 (t, J=7.3 Hz, 3H), 1.38-1.46 (m, 4H), 1.57-1.67 (m, 6H), 1.84-1.89 (m, 2H), 2.15 (s, 3H), 2.25 (s, 3H), 2.43-2.47 (m, 6H), 4.05 (s, 3H), 4.06 (s, 3H), 4.89-4.95 (m, 1H), 6.29 (d, J=5.1 Hz, 1H), 6.49 (s, 1H), 6.92 (s, 1H), 7.42 (s, 1H), 7.60 (s, 1H), 7.78 (s, 1H), 8.44 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 537 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-piperidino-3-hexanol (43 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (76 mg, yield 83%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.95 (t, J=7.1 Hz, 3H), 1.46 (brs, 4H), 1.64 (brs, 6H), 1.87-1.88 (m, 2H), 2.04 (s, 3H), 2.12 (s, 3H), 2.26 (brs, 6H), 4.05 (s, 3H), 4.07 (s, 3H), 4.92 (brs, 1H), 6.26 (d, J=4.9 Hz, 1H), 6.68 (s, 1H), 6.99 (d, J=8.8 Hz, 1H), 7.42 (s, 1H), 7.62 (s, 2H), 8.43 (d, J=4.9 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 537 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-piperidino-3-hexanol (48 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (75 mg, yield 71%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.86 (t, J=7.1 Hz, 3H), 1.30-1.33 (m, 4H), 1.39-1.57 (m, 6H), 1.77-1.80 (m, 2H), 2.34-2.41 (m, 6H), 3.99 (s, 3H), 4.00 (s, 3H), 4.82-4.83 (m, 1H), 7.12 (d, J=8.5 Hz, 2H), 7.21 (s, 1H), 7.25 (s, 1H), 7.44 (d, J=8.3 Hz, 2H), 7.48 (s, 1H), 8.54 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 510 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-(4-methylpiperazino)-3-hexanol (52 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (37 mg, yield 35%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.95 (t, J=7.1 Hz, 3H), 1.37-1.44 (m, 2H), 1.56-1.65 (m, 2H), 1.78-1.83 (m, 2H), 2.30 (s, 3H), 2.44-2.48 (m, 10H), 4.047 (s, 3H), 4.050 (s, 3H), 4.93-4.94 (m, 1H), 6.43 (d, J=5.4 Hz, 1H), 6.97 (s, 1H), 7.14 (d, J=9.0 Hz, 2H), 7.42 (s, 1H), 7.50 (d, J=8.5 Hz, 2H), 7.56 (s, 1H), 8.47 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 524 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-(4-methylpiperazino)-3-hexanol (46 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (48 mg, yield 49%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.96 (t, J=7.3 Hz, 3H), 1.39-1.46 (m, 2H), 1.58-1.64 (m, 2H), 1.82-1.85 (m, 2H), 2.15 (s, 3H), 2.25 (s, 3H), 2.31 (s, 3H), 2.48-2.50 (m, 10H), 4.05 (s, 3H), 4.07 (s, 3H), 6.29 (d, J=5.1 Hz, 1H), 6.41 (s, 1H), 6.93 (s, 1H), 7.43 (s, 1H), 7.60 (s, 1H), 7.79 (s, 1H), 8.44 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 552 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-(4-methylpiperazino)-3-hexanol (46 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (25 mg, yield 25%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.96 (t, J=7.3 Hz, 3H), 1.40-1.45 (m, 2H), 1.57-1.63 (m, 2H), 1.82-1.84 (m, 2H), 2.12 (s, 3H), 2.25 (s, 3H), 2.31 (s, 3H), 2.46-2.49 (m, 10H), 4.05 (s, 3H), 4.07 (s, 3H), 4.94 (brs, 1H), 6.25 (d, J=5.1 Hz, 1H), 6.45 (s, 1H), 6.99 (d, J=8.8 Hz, 1H), 7.43 (s, 1H), 7.62 (s, 2H), 8.43 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 552 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-(4-methylpiperazino)-3-hexanol (52 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (12 mg, yield 11%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.11 (t, J=7.1 Hz, 3H), 1.37-1.42 (m, 2H), 1.53-1.60 (m, 2H), 1.70-1.80 (m, 2H), 2.21 (s, 3H), 2.31-2.50 (m, 10H), 4.07 (s, 6H), 4.94 (brs, 1H), 6.78 (s, 1H), 7.20 (d, J=8.5 Hz, 1H), 7.32 (s, 1H), 7.50 (d, J=8.5 Hz, 2H), 7.56 (s, 1H), 8.61 (s, 2H)
- Mass spectrometry value (ESI-MS, m/z): 525 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-hydroxy-2-phenylacetonitrile (35 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (20 mg, yield 24%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 4.04 (s, 3H), 4.06 (s, 3H), 5.95 (s, 1H), 6.58 (d, J=5.1 Hz, 1H), 7.27 (s, 1H), 7.30 (d, J=9.0 Hz, 2H), 7.46-7.58 (m, 8H), 8.54 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 457 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-hydroxy-2-phenylacetonitrile (31 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (30 mg, yield 39%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.11-2.27 (m, 6H), 4.05 (s, 3H), 4.06 (s, 3H), 5.96-6.01 (m, 1H), 6.41-6.43 (m, 1H), 7.05-7.12 (m, 1H), 7.24-7.27 (m, 1H), 7.46-7.54 (m, 7H), 8.49-8.51 (m, 1H)
- Mass spectrometry value (ESI-MS, m/z): 485 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-hydroxy-2-phenylacetonitrile (31 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (30 mg, yield 39%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.10-2.26 (m, 6H), 4.06 (s, 6H), 5.98-6.02 (m, 1H), 6.36-6.38 (m, 1H), 7.08-7.12 (m, 1H), 7.20-7.27 (m, 1H), 7.46-7.57 (m, 7H), 8.47-8.49 (m, 1H)
- Mass spectrometry value (ESI-MS, m/z): 485 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-hydroxyphenyl cyanide (31 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (5 mg, yield 6%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 4.01 (s, 3H), 4.02 (s, 3H), 6.78-6.85 (m, 2H), 6.96-7.01 (m, 3H), 7.13-7.15 (m, 1H), 7.31-7.35 (m, 1H), 7.43-7.51 (m, 3H), 7.61 (s, 1H), 7.95 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 443 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-hydroxybenzonitrile (31 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (5 mg, yield 6%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 4.11 (s, 3H), 4.19 (s, 3H), 6.78 (d, J=5.6 Hz, 1H), 7.52-7.54 (m, 1H), 7.60 (s, 1H), 7.73-7.76 (m, 2H), 8.20 (s, 1H), 8.55 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 442 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml) and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-hydroxybenzonitrile (27 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (40 mg, yield 53%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.13-2.16 (m, 3H), 2.28-2.39 (m, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 6.59 (d, J=6.8 Hz, 1H), 7.03 (s, 1H), 7.15-7.19 (m, 2H), 7.52-7.57 (m, 3H), 7.65 (s, 1H), 8.12-8.13 (m, 1H), 8.45-8.47 (m, 1H)
- Mass spectrometry value (ESI-MS, m/z): 471 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml) and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 3-hydroxybenzonitrile (27 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (40 mg, yield 53%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.10-2.15 (m, 3H), 2.27-2.37 (m, 3H), 4.11 (s, 3H), 4.16 (s, 3H), 6.56 (d, J=6.6 Hz, 1H), 7.02-7.20 (m, 3H), 7.52-7.56 (m, 3H), 7.67 (s, 1H), 8.13-8.14 (m, 1H), 8.44-8.46 (m, 1H)
- Mass spectrometry value (ESI-MS, m/z): 471 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml) and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-hydroxybenzonitrile (27 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (40 mg, yield 53%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.16 (s, 3H), 2.39 (s, 3H), 4.11 (s, 3H), 4.17 (s, 3H), 6.97 (d, J=8.3 Hz, 1H), 7.03 (s, 1H), 7.38 (d, J=8.1 Hz, 2H), 7.65 (s, 1H), 7.74 (d, J=8.3 Hz, 2H), 7.91 (brs, 1H), 8.15 (s, 1H), 8.49 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 471 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml) and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-hydroxybenzonitrile (27 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (40 mg, yield 53%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.10-2.14 (m, 3H), 2.27-2.37 (m, 3H), 4.11-4.17 (m, 6H), 6.56 (d, J=6.1 Hz, 1H), 7.00 (d, J=8.8 Hz, 2H), 7.38 (d, J=8.8 Hz, 1H), 7.49 (d, J=9.0 Hz, 2H), 7.67 (s, 1H), 7.73 (d, J=8.8 Hz, 1H), 8.10-8.11 (m, 1H), 8.45-8.47 (m, 1H)
- Mass spectrometry value (ESI-MS, m/z): 471 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml) and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-methyl-3-piperidinol (30 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (23 mg, yield 27%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.69-1.88 (m, 6H), 2.37 (s, 3H), 2.54-2.57 (m, 1H), 2.72 (brs, 1H), 4.05 (s, 6H), 5.02 (s, 1H), 6.44 (d, J=5.1 Hz, 1H), 7.14 (d, J=8.8 Hz, 2H), 7.42 (s, 1H), 7.50 (d, J=8.8 Hz, 2H), 7.56 (s, 1H), 8.47 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 439 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml) and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-methyl-3-piperidinol (27 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (29 mg, yield 36%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.77 (brs, 2H), 1.97 (brs, 2H), 2.14 (s, 3H), 2.25 (s, 3H), 2.35 (s, 3H), 2.60-2.67 (m, 4H), 4.05 (s, 3H), 4.06 (s, 3H), 5.01 (d, J=4.1 Hz, 1H), 6.29 (d, J=5.1 Hz, 1H), 6.69 (s, 1H), 6.91 (s, 1H), 7.42 (s, 1H), 7.59 (s, 1H), 7.82 (s, 1H), 8.44 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 467 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml) and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-methyl-3-piperidinol (27 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (22 mg, yield 27%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.69-1.90 (m, 6H), 2.11 (s, 3H), 2.26 (s, 3H), 2.37 (s, 3H), 2.62 (brs, 2H), 4.05 (s, 3H), 4.07 (s, 3H), 5.01 (s, 1H), 6.26 (d, J=5.4 Hz, 1H), 6.99 (d, J=8.8 Hz, 1H), 7.43 (s, 1H), 7.62 (s, 2H), 8.43 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 467 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml) and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-methyl-3-piperidinol (30 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (26 mg, yield 28%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.69-1.96 (m, 6H), 2.37 (s, 3H), 2.57-2.70 (m, 2H), 4.066 (s, 3H), 4.071 (s, 3H), 5.01 (s, 1H), 7.20 (d, J=8.8 Hz, 2H), 7.32 (s, 1H), 7.51 (d, J=9.0 Hz, 2H), 7.56 (s, 1H), 8.62 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 440 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml) and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-methyl-4-piperidinol (30 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (41 mg, yield 47%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.76-1.85 (m, 2H), 2.01-2.09 (m, 4H), 2.31 (s, 3H), 2.71 (brs, 2H), 4.05 (s, 6H), 4.82 (brs, 1H), 6.44 (d, J=5.1 Hz, 1H), 6.89 (s, 1H), 7.15 (d, J=8.8 Hz, 2H), 7.42 (s, 1H), 7.49 (d, J=8.8 Hz, 2H), 7.56 (s, 1H), 8.48 (d, J=5.1 Hz, 2H)
- Mass spectrometry value (ESI-MS, m/z): 439 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml) and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-methyl-4-piperidinol (27 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (41 mg, yield 51%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.77-1.86 (m, 2H), 1.92 (brs, 2H), 2.03-2.05 (m, 2H), 2.16 (d, J=9.0 Hz, 3H), 2.26 (s, 3H), 2.32 (s, 3H), 4.05 (s, 3H), 4.06 (s, 3H), 4.80-4.82 (m, 1H), 6.29 (d, J=5.4 Hz, 1H), 6.40 (s, 1H), 6.92 (s, 1H), 7.42 (s, 1H), 7.59 (s, 1H), 7.77 (brs, 1H), 8.44 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 467 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml) and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-methyl-4-piperidinol (27 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (33 mg, yield 41%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.76-1.85 (m, 2H), 2.01 (brs, 4H), 2.12 (s, 3H), 2.26 (s, 3H), 2.31 (s, 3H), 2.72 (brs, 2H), 4.05 (s, 3H), 4.07 (s, 3H), 4.78-4.82 (m, 1H), 6.26 (d, J=5.4 Hz, 1H), 6.47 (s, 1H), 7.00 (d, J=8.8 Hz, 1H), 7.43 (s, 1H), 7.62 (s, 2H), 8.44 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 467 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml) and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-methyl-4-piperidinol (30 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (33 mg, yield 37%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.78-1.85 (m, 4H), 2.01 (brs, 2H), 2.32 (s, 3H), 2.71 (brs, 2H), 4.067 (s, 3H), 4.071 (s, 3H), 4.81 (s, 1H), 6.74 (s, 1H), 7.21 (d, J=9.0 Hz, 2H), 7.32 (s, 1H), 7.49 (d, J=8.5 Hz, 2H), 7.55 (s, 1H), 8.62 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 440 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml) and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, tetrahydro-2H-4-pyranol (27 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (60 mg, yield 83%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.73-1.78 (m, 2H), 2.01-2.03 (m, 2H), 3.55-3.61 (m, 2H), 3.94-3.98 (m, 2H), 4.055 (s, 3H), 4.060 (s, 3H), 4.90-5.05 (m, 1H), 6.46 (d, J=5.4 Hz, 1H), 6.67 (s, 1H), 7.16 (d, J=8.8 Hz, 2H), 7.50 (d, J=8.5 Hz, 2H), 7.56 (s, 1H), 8.48 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 426 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was added to toluene (5 ml) and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, tetrahydro-2H-4-pyranol (24 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (57 mg, yield 84%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.75-1.79 (m, 2H), 1.98-2.10 (m, 2H), 2.15 (s, 3H), 2.27 (s, 3H), 3.55-3.61 (m, 2H), 3.96-3.99 (m, 2H), 4.07 (s, 6H), 4.90-5.00 (m, 1H), 6.31 (d, J=4.9 Hz, 1H), 6.37 (s, 1H), 6.93 (s, 1H), 7.49 (s, 1H), 7.60 (s, 1H), 7.78 (s, 1H), 8.45 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 454 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml) and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (68 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, tetrahydro-2H-4-pyranol (24 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (23 mg, yield 34%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.72-1.81 (m, 2H), 2.01-2.06 (m, 2H), 2.13 (s, 3H), 2.26 (s, 3H), 3.55-3.60 (m, 2H), 3.94-3.99 (m, 2H), 4.071 (s, 3H), 4.073 (s, 3H), 4.95-5.00 (m, 1H), 6.30 (d, J=5.4 Hz, 1H), 6.40 (s, 1H), 7.01 (d, J=8.8 Hz, 1H), 7.52 (s, 1H), 7.62 (s, 1H), 8.44 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 454 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml) and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (77 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, tetrahydro-2H-4-pyranol (27 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (38 mg, yield 53%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.70-1.80 (m, 2H), 2.00-2.05 (m, 2H), 3.55-3.60 (m, 2H), 3.94-3.98 (m, 2H), 4.07 (s, 6H), 4.93-5.01 (m, 1H), 6.65 (s, 1H), 7.22 (d, J=8.8 Hz, 2H), 7.35 (s, 1H), 7.51 (d, J=10.5 Hz, 2H), 7.56 (s, 1H), 8.63 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 426 (M++1)
- Dimethylformamide (5 ml) was added to sodium hydride (12 mg), and cyclohexyl N-{2-chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenyl}carbamate (70 mg) was added to the mixture. Subsequently, a dimethylformamide solution (2 ml) of methyl iodide (43 mg) was added thereto, and the mixture was stirred at room temperature for 10 min. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (70 mg, yield 99%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.23-1.92 (m, 10H), 3.26 (s, 3H), 4.07 (s, 3H), 4.08 (s, 3H), 4.73 (s, 1H), 7.21-7.23 (m, 1H), 7.27 (s, 1H), 7.34 (s, 1H), 7.41 (d, J=2.7 Hz, 1H), 7.52 (s, 1H), 8.65 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 473 (M++1)
- Dimethylformamide (5 ml) was added to sodium hydride (11 mg), and cyclohexyl N-{2-chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenyl}carbamate (65 mg) was added to the mixture. Subsequently, a dimethylformamide solution (2 ml) of ethyl iodide (87 mg) was added thereto, and the mixture was stirred at room temperature for 10 min. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (60 mg, yield 88%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.20 (t, J=6.8 Hz, 3H), 1.24-1.91 (m, 10H), 3.54-3.59 (m, 1H), 3.83-3.89 (m, 1H), 4.07 (s, 3H), 4.08 (s, 3H), 4.73 (brs, 1H), 7.21-7.24 (m, 2H), 7.34 (s, 1H), 7.43 (d, J=2.7 Hz, 1H), 7.52 (s, 1H), 8.65 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 487 (M++1)
- Dimethylformamide (5 ml) was added to sodium hydride (7 mg), and cyclohexyl N-{4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenyl}carbamate (35 mg) was added to the mixture. Subsequently, a dimethylformamide solution (2 ml) of methyl iodide (47 mg) was added thereto, and the mixture was stirred at room temperature for 10 min. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (30 mg, yield 83%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.26-1.83 (m, 10H), 3.35 (s, 3H), 4.07 (s, 6H), 4.75-4.79 (m, 1H), 7.24 (d, J=8.8 Hz, 2H), 7.34-7.35 (m, 3H), 7.56 (s, 1H), 8.65 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 439 (M++1)
- Dimethylformamide (5 ml) was added to sodium hydride (7 mg), and cyclohexyl N-{4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenyl}carbamate (35 mg) was added to the mixture. Subsequently, a dimethylformamide solution (2 ml) of ethyl iodide (52 mg) was added thereto, and the mixture was stirred at room temperature for 10 min. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (35 mg, yield 93%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.23 (t, J=7.1 Hz, 3H), 1.36-1.93 (m, 10H), 3.73-3.78 (m, 1H), 3.91-3.98 (m, 1H), 4.07 (s, 6H), 4.76 (s, 1H), 7.19-7.34 (m, 4H), 7.51 (d, J=11.0 Hz, 1H), 7.56 (s, 1H), 8.64 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 453 (M++1)
- Dimethylformamide (5 ml) was added to sodium hydride (11 mg), and 2-methoxybenzyl N-{2-chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenyl}carbamate (66 mg) was added to the mixture. Subsequently, a dimethylformamide solution (2 ml) of methyl iodide (77 mg) was added thereto, and the mixture was stirred at room temperature for 10 min. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (50 mg, yield 75%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.29 (s, 3H), 3.87 (s, 3H), 4.065 (s, 3H), 4.07 (s, 3H), 4.69 (s, 2H), 6.83-6.96 (m, 4H), 7.20-7.50 (m, 5H), 8.64 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 511 (M++1)
- Dimethylformamide (5 ml) was added to sodium hydride (11 mg), and 2-methylbenzyl N-{2-chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenyl}carbamate (62 mg) was added to the mixture. Subsequently, a dimethylformamide solution (2 ml) of methyl iodide (77 mg) was added thereto, and the mixture was stirred at room temperature for 10 min. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (57 mg, yield 89%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.21 (s, 3H), 3.28 (s, 3H), 4.069 (s, 3H), 4.074 (s, 3H), 5.10-5.19 (m, 2H), 7.12-7.23 (m, 5H), 7.33-7.35 (m, 2H), 7.41 (d, J=2.4 Hz, 1H), 7.51 (s, 1H), 8.64 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 495 (M++1)
- Dimethylformamide (5 ml) was added to sodium hydride (11 mg), and 2-chlorobenzyl N-{2-chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenyl}carbamate (65 mg) was added to the mixture. Subsequently, a dimethylformamide solution (2 ml) of methyl iodide (77 mg) was added thereto, and the mixture was stirred at room temperature for 10 min. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (57 mg, yield 85%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.30 (s, 3H), 4.07 (s, 3H), 4.08 (s, 3H), 5.20-5.27 (m, 2H), 7.20-7.27 (m, 4H), 7.34-7.44 (m, 4H), 7.51 (s, 1H), 8.65 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 515 (M++1)
- Dimethylformamide (5 ml) was added to sodium hydride (11 mg), and 1-propylbutyl N-{2-chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenyl}carbamate (62 mg) was added to the mixture. Subsequently, a dimethylformamide solution (2 ml) of methyl iodide (77 mg) was added thereto, and the mixture was stirred at room temperature for 10 min. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (43 mg, yield 68%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.87 (t, J=7.1 Hz, 6H), 1.24-1.82 (s, 8H), 3.26 (s, 3H), 4.07 (s, 3H), 4.08 (s, 3H), 4.80-4.83 (m, 1H), 7.21-7.24 (m, 1H), 7.31 (s, 1H), 7.34 (s, 1H), 7.42 (s, 1H), 7.52 (s, 1H), 8.66 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 489 (M++1)
- Dimethylformamide (5 ml) was added to sodium hydride (11 mg), and cycloheptyl N-2-chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenylcarbamate (61 mg) was added to the mixture. Subsequently, a dimethylformamide solution (2 ml) of methyl iodide (77 mg) was added thereto, and the mixture was stirred at room temperature for 10 min. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (60 mg, yield 95%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.44-1.93 (m, 12H), 3.25 (s, 3H), 4.07 (s, 3H), 4.08 (s, 3H), 4.90 (brs, 1H), 7.20-7.23 (m, 1H), 7.33-7.34 (m, 2H), 7.41 (d, J=2.7 Hz, 1H), 7.52 (s, 1H), 8.65 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 487 (M++1)
- Dimethylformamide (5 ml) was added to sodium hydride (27 mg), and cycloheptylmethyl N-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenylcarbamate (153 mg) was added to the mixture. Subsequently, a dimethylformamide solution (2 ml) of methyl iodide (193 mg) was added thereto, and the mixture was stirred at room temperature for 10 min. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (100 mg, yield 63%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.15-1.81 (m, 13H), 3.42 (d, J=6.6 Hz, 3H), 3.99 (d, J=6.6 Hz, 2H), 4.05 (s, 6H), 6.44 (d, J=5.4 Hz, 1H), 7.14 (d, J=9.0 Hz, 2H), 7.43 (s, 1H), 7.49 (d, J=8.5 Hz, 2H), 7.56 (s, 1H), 8.48 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 466 (M++1)
- Dimethylformamide (5 ml) was added to sodium hydride (27 mg), and cycloheptylmethyl. N-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenylcarbamate (154 mg) was added to the mixture. Subsequently, a dimethylformamide solution (2 ml) of methyl iodide (193 mg) was added thereto, and the mixture was stirred at room temperature for 10 min. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (90 mg, yield 57%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.10-1.81 (m, 13H), 3.35 (s, 3H), 3.94 (d, J=6.6 Hz, 2H), 4.07 (s, 6H), 7.23-7.26 (m, 3H), 7.34-7.35 (m, 2H), 7.56 (s, 1H), 8.64 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 467 (M++1)
- Dimethylformamide (5 ml) was added to sodium hydride (11 mg), and 2-methoxybenzyl N-{2-chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenyl}carbamate (66 mg) was added to the mixture. Subsequently, a dimethylformamide solution (2 ml) of ethyl iodide (84 mg) was added thereto, and the mixture was stirred at room temperature for 10 min. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (63 mg, yield 93%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.22 (t, J=7.1 Hz, 3H), 3.55-3.60 (m, 1H), 3.76-3.94 (m, 1H), 3.87 (s, 3H), 4.067 (s, 3H), 4.074 (s, 3H), 5.19 (d, J=3.4 Hz, 2H), 6.81-7.09 (m, 4H), 7.21-7.40 (m, 3H), 7.43 (d, J=2.7 Hz, 1H), 7.51 (s, 1H), 8.65 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 525 (M++1)
- Dimethylformamide (5 ml) was added to sodium hydride (11 mg), and 2-methylbenzyl N-{2-chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenyl}carbamate (62 mg) was added to the mixture. Subsequently, a dimethylformamide solution (2 ml) of ethyl iodide (84 mg) was added thereto, and the mixture was stirred at room temperature for 10 min. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (53 mg, yield 79%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.20-1.23 (m, 3H), 2.21 (s, 3H), 3.56-3.59 (m, 1H), 3.90-3.92 (m, 1H), 4.069 (s, 3H), 4.073 (s, 3H), 5.13-5.18 (m, 1H), 7.12-7.36 (m, 7H), 7.43 (s, 1H), 7.51 (s, 1H), 8.64 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 509 (M++1)
- Dimethylformamide (5 ml) was added to sodium hydride (11 mg), and 2-chlorobenzyl N-{2-chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenyl}carbamate (65 mg) was added to the mixture. Subsequently, a dimethylformamide solution (2 ml) of ethyl iodide (84 mg) was added thereto, and the mixture was stirred at room temperature for 10 min. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (68 mg, yield 100%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.23 (t, J=7.1 Hz, 3H), 3.54-3.63 (m, 1H), 3.88-3.97 (m, 1H), 4.07 (s, 3H), 4.08 (s, 3H), 5.23 (s, 2H), 7.19-7.36 (m, 7H), 7.45 (d, J=2.4 Hz, 1H), 7.51 (s, 1H), 8.65 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 529 (M++1)
- Dimethylformamide (5 ml) was added to sodium hydride (11 mg), and 1-propylbutyl N-{2-chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenyl}carbamate (62 mg) was added to the mixture. Subsequently, a dimethylformamide solution (2 ml) of ethyl iodide (84 mg) was added thereto, and the mixture was stirred at room temperature for 10 min. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (49 mg, yield 75%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.85-0.88 (m, 3H), 0.93-0.97 (s, 3H), 1.18-1.70 (m, 11H), 3.47-3.53 (m, 1H), 3.88-3.91 (m, 1H), 4.07 (s, 3H), 4.08 (s, 3H), 4.78%-4.95 (m, 1H), 7.21-7.23 (m, 1H), 7.32-7.34 (m, 2H), 7.43 (s, 1H), 7.52 (s, 1H), 8.62 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 503 (M++1)
- Dimethylformamide (5 ml) was added to sodium hydride (11 mg), and cycloheptyl N-2-chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenylcarbamate (61 mg) was added to the mixture. Subsequently, a dimethylformamide solution (2 ml) of ethyl iodide (84 mg) was added thereto, and the mixture was stirred at room temperature for 10 min. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (51 mg, yield 78%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.20 (t, J=7.1 Hz, 3H), 1.29-2.03 (m, 12H), 3.53-3.58 (m, 1H), 3.83-3.88 (m, 1H), 4.07 (s, 3H), 4.08 (s, 3H), 4.89-4.98 (m, 1H), 7.21-7.23 (m, 1H), 7.27-7.34 (m, 2H), 7.43 (d, J=2.7 Hz, 1H), 7.52 (s, 1H), 8.65 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 501 (M++1)
- Dimethylformamide (5 ml) was added to sodium hydride (24 mg), and 2-methoxybenzyl N-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenylcarbamate (145 mg) was added to the mixture. Subsequently, a dimethylformamide solution (2 ml) of methyl iodide (170 mg) was added thereto, and the mixture was stirred at room temperature for 10 min. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (115 mg, yield 81%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.38 (s, 3H), 3.84 (s, 3H), 4.06 (s, 6H), 5.24 (s, 2H), 6.86-6.93 (m, 3H), 7.23-7.28 (m, 3H), 7.33 (s, 1H), 7.38 (d, J=8.8 Hz, 2H), 7.54 (s, 1H), 8.63 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 477 (M++1)
- Dimethylformamide (5 ml) was added to sodium hydride (24 mg), and 2-methylbenzyl N-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenylcarbamate (148 mg) was added to the mixture. Subsequently, a dimethylformamide solution (2 ml) of methyl iodide (170 mg) was added thereto, and the mixture was stirred at room temperature for 10 min. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (115 mg, yield 83%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.32 (s, 3H), 3.37 (s, 3H), 4.07 (s, 6H), 5.20 (s, 2H), 7.16-7.27 (m, 6H), 7.33 (s, 1H), 7.36 (d, J=6.6 Hz, 2H), 7.55 (s, 1H), 8.63 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 461 (M++1)
- Dimethylformamide (5 ml) was added to sodium hydride (16 mg), and 2-chlorobenzyl N-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenylcarbamate (107 mg) was added to the mixture. Subsequently, a dimethylformamide solution (2 ml) of methyl iodide (114 mg) was added thereto, and the mixture was stirred at room temperature for 10 min. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (75 mg, yield 78%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.39 (s, 3H), 4.07 (s, 6H), 5.29 (s, 2H), 7.24-7.41 (m, 9H), 7.55 (s, 1H), 8.64 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 481 (M++1)
- Dimethylformamide (5 ml) was added to sodium hydride (16 mg), and 1-propylbutyl N-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenylcarbamate (99 mg) was added to the mixture. Subsequently, a dimethylformamide solution (2 ml) of methyl iodide (114 mg) was added thereto, and the mixture was stirred at room temperature for 10 min. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (84 mg, yield 93%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.92 (t, J=7.3 Hz, 6H), 1.18-1.42 (m, 4H), 1.45-1.55 (m, 4H), 3.35 (s, 3H), 4.07 (s, 6H), 4.83-4.89 (m, 1H), 7.25 (d, J=8.8 Hz, 2H), 7.33 (s, 1H), 7.36 (d, J=8.5 Hz, 2H), 7.55 (s, 1H), 8.64 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 455 (M++1)
- Dimethylformamide (5 ml) was added to sodium hydride (24 mg), and cycloheptyl N-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenylcarbamate (144 mg) was added to the mixture. Subsequently, a dimethylformamide solution (2 ml) of methyl iodide (170 mg) was added thereto, and the mixture was stirred at room temperature for 10 min. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (117 mg, yield 86%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.26-1.93 (m, 12H), 3.34 (s, 3H), 4.07 (s, 6H), 4.91-4.95 (m, 1H), 7.24 (d, J=8.8 Hz, 2H), 7.33 (s, 1H), 7.36 (d, J=8.8 Hz, 2H), 7.55 (s, 1H), 8.64 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 453 (M++1)
- Dimethylformamide (5 ml) was added to sodium hydride (27 mg), and 1-ethyl-3-butynyl N-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenylcarbamate (143 mg) was added to the mixture. Subsequently, a dimethylformamide solution (2 ml) of methyl iodide (193 mg) was added thereto, and the mixture was stirred at room temperature for 10 min. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (83 mg, yield 56%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.84 (t, J=7.6 Hz, 3H), 1.64-1.65 (m, 2H), 1.93 (t, J=2.7 Hz, 2H), 2.44 (brs, 2H), 3.28 (s, 3H), 3.99 (s, 3H), 4.75-4.78 (m, 1H), 7.17 (d, J=8.8 Hz, 2H), 7.21 (s, 1H), 7.31 (d, J=8.8 Hz, 2H), 7.47 (s, 1H), 8.56 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 437 (M++1)
- Dimethylformamide (5 ml) was added to sodium hydride (27 mg), and 1-ethyl-3-butynyl N-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenylcarbamate (143 mg) was added to the mixture. Subsequently, a dimethylformamide solution (2 ml) of methyl iodide (193 mg) was added thereto, and the mixture was stirred at room temperature for 10 min. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (24 mg, yield 16%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.85-0.87 (m, 3H), 1.67-1.75 (m, 2H), 1.918-1.924 (m, 1H), 2.46 (s, 2H), 3.29 (s, 3H), 3.97 (s, 3H), 3.98 (s, 3H), 4.76-4.79 (m, 1H), 6.44 (d, J=5.4 Hz, 1H), 7.09 (d, J=9.0 Hz, 2H), 7.30 (d, J=8.5 Hz, 2H), 7.36 (s, 1H), 7.47 (s, 1H), 8.43 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 436 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-methoxyaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-cyclohexanol (47 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (120 mg, yield 85%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.26-1.95 (m, 10H), 3.88 (s, 3H), 4.07 (s, 6H), 4.68-4.77 (m, 1H), 6.79-6.80 (m, 1H), 6.84-6.87 (m, 1H), 7.17 (s, 1H), 7.32 (s, 1H), 7.55 (s, 1H), 8.19 (s, 1H), 8.63 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 455 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-methoxyaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-cycloheptanol (54 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (89 mg, yield 61%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.49-2.03 (m, 13H), 3.88 (s, 3H), 4.07 (s, 6H), 4.84-4.97 (m, 1H), 6.788-6.794 (m, 1H), 6.84-6.87 (m, 1H), 7.15 (s, 1H), 7.36 (s, 1H), 7.55 (s, 1H), 8.19 (s, 1H), 8.64 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 469 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-methoxyaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (2-chlorophenyl)methanol (67 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (147 mg, yield 96%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.86 (s, 3H), 4.06 (s, 3H), 4.07 (s, 3H), 5.34 (s, 2H), 6.80-6.81 (m, 1H), 6.85-6.88 (m, 1H), 7.27-7.35 (m, 4H), 7.40-7.42 (m, 1H), 7.48-7.51 (m, 1H), 7.55 (s, 1H), 8.21 (s, 1H), 8.63 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 497 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-methoxyaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (2-methoxyphenyl)methanol (58 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (148 mg, yield 100%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.86-3.91 (m, 8H), 4.06 (s, 3H), 4.07 (s, 3H), 6.84-7.32 (m, 6H), 7.33 (s, 1H), 7.55 (s, 1H), 8.23-8.30 (m, 1H), 8.65 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 493 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-methoxyaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 2-(2-pyridyl)-1-ethanol (58 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, and the extract was washed with water and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (110 mg, yield 75%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.20 (t, J=6.8 Hz, 2H), 3.85 (d, J=1.5 Hz, 3H), 4.07 (d, J=1.5 Hz, 6H), 4.60 (t, J=6.6 Hz, 2H), 6.78-6.89 (m, 1H), 6.84 (d, J=8.8 Hz, 1H), 7.16-7.27 (m, 3H), 7.32 (d, J=1.5 Hz, 1H), 7.54 (d, J=1.5 Hz, 1H), 7.62-7.66 (m, 1H), 8.18 (brs, 1H), 8.58 (d, J=4.9 Hz, 1H), 8.63 (d, J=1.7 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 478 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-methoxyaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 5-hexyn-3-ol (46 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (73 mg, yield 52%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.00 (t, J=7.3 Hz, 3H), 1.74-1.85 (m, 2H), 2.56-2.59 (m, 1H), 3.31-3.49 (m, 2H), 3.89 (s, 3H), 4.07 (s, 6H), 4.89-4.92 (m, 1H), 6.80 (d, J=2.4 Hz, 1H), 6.85-6.87 (m, 1H), 7.27 (s, 1H), 7.33 (s, 1H), 7.55 (s, 1H), 8.20 (brs, 1H), 8.63 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 453 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-cyclohexanol (44 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (120 mg, yield 88%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.24-1.57 (m, 6H), 1.78-1.81 (m, 2H), 1.96-2.04 (m, 2H), 4.07 (s, 6H), 4.78-4.82 (m, 1H), 7.34 (s, 1H), 7.52 (s, 1H), 7.58-7.61 (m, 1H), 8.17 (d, J=2.9 Hz, 1H), 8.61 (s, 1H), 8.73 (d, J=9.3 Hz, 1H), 9.80 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 470 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (2-chlorophenyl)methanol (63 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (74 mg, yield 50%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 4.08 (s, 6H), 5.39 (s, 2H), 7.26-7.33 (m, 2H), 7.37 (s, 1H), 7.43-7.45 (m, 1H), 7.49-7.52 (m, 2H), 7.59-7.62 (m, 1H), 8.18 (d, J=2.7 Hz, 1H), 8.61 (s, 1H), 8.74 (d, J=9.3 Hz, 1H), 9.97 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 512 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, (2-methylphenyl)methanol (54 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (130 mg, yield 91%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.42 (s, 3H), 4.06 (s, 3H), 4.07 (s, 3H), 5.29 (s, 2H), 7.17-7.41 (m, 5H), 7.51 (s, 1H), 7.58-7.61 (m, 1H), 8.16 (d, J=2.9 Hz, 1H), 8.59 (s, 1H), 8.73 (d, J=9.3 Hz, 1H), 9.90 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, cycloheptylmethanol (56 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (115 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.23-1.93 (m, 13H), 4.03 (d, J=6.8 Hz, 2H), 4.077 (s, 3H), 4.081 (s, 3H), 7.27 (s, 1H), 7.34 (s, 1H), 7.52 (s, 1H), 7.58-7.61 (m, 1H), 8.17 (d, J=2.7 Hz, 1H), 8.61 (s, 1H), 8.73 (d, J=9.3 Hz, 1H), 9.85 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 498 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-cycloheptanol (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (140 mg, yield 100%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.40-1.82 (m, 8H), 1.88-1.94 (m, 2H), 1.98-2.04 (m, 2H), 4.077 (s, 3H), 4.080 (s, 3H), 4.95-5.00 (m, 1H), 7.35 (s, 1H), 7.52 (s, 1H), 7.57-7.60 (m, 1H), 8.16 (d, J=2.7 Hz, 1H), 8.61 (s, 1H), 8.74 (d, J=9.3 Hz, 1H), 9.79 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 484 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 5-nonanol (64 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (143 mg, yield 96%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.89-0.94 (m, 6H), 1.33-1.65 (m, 12H), 4.077 (s, 3H), 4.083 (s, 3H), 4.89-4.92 (m, 1H), 7.35 (s, 1H), 7.52 (s, 1H), 7.57-7.60 (m, 1H), 8.17 (d, J=2.7 Hz, 1H), 8.60 (s, 1H), 8.76 (d, J=9.3 Hz, 1H), 9.83 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 514 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-hexanol (45 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (109 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.92 (t, J=7.1 Hz, 3H), 1.34-1.42 (m, 6H), 1.69-1.76 (m, 2H), 4.079 (s, 3H), 4.082 (s, 3H), 4.23 (t, J=6.8 Hz, 2H), 7.35 (s, 1H), 7.52 (s, 1H), 7.58-7.61 (m, 1H), 8.17 (d, J=2.9 Hz, 1H), 8.61 (s, 1H), 8.73 (d, J=9.3 Hz, 1H), 9.85 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 472 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (100 mg) was added to toluene (10 ml) and triethylamine (1 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (140 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 5-hexyn-3-ol (43 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with a 1 N aqueous hydrochloric acid solution, water, and saturated brine in that order. The extract was dried over sodium sulfate and was then concentrated. The residue was purified on a column using chloroform/methanol to give the title compound (115 mg, yield 85%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.01 (t, J=7.3 Hz, 3H), 1.77-1.87 (m, 2H), 2.04-2.05 (m, 1H), 2.58-2.60 (m, 2H), 4.079 (s, 3H), 4.083 (s, 3H), 4.91-4.96 (m, 1H), 7.35 (s, 1H), 7.52 (s, 1H), 7.59-7.62 (m, 1H), 8.18 (d, J=2.7 Hz, 1H), 8.61 (s, 1H), 8.73 (d, J=9.3 Hz, 1H), 9.87 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 467 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, N,N-diethylphenylenediamine (50 mg) was added to thereto, and the mixture was further stirred at room temperature for 14 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (5 mg, yield 5%).
- 1H-NMR (CDCl3, 400 MHz): 0.89 (m, 6H), 2.15 (s, 3H), 2.28 (s, 3H), 2.46 (m, 4H), 2.62 (m, 2H), 3.67 (m, 2H), 4.06 (s, 3H), 4.07 (s, 3H), 6.25 (m, 1H), 6.76 (br, 1H), 7.04 (d, J=8.5 Hz, 1H), 7.18 (d, J=8.6 Hz, 1H), 7.44 (s, 1H), 7.46 (br, 1H), 7.59 (s, 1H), 8.44 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 483 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 3 hr. Next, 2-piperidinylethylamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 16 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (25 mg, yield 33%).
- 1H-NMR (CDCl3, 400 MHz): 1.35-1.46 (m, 6H), 2.17 (s, 3H), 2.29 (s, 3H), 2.32-2.56 (m, 6H), 3.69 (m, 2H), 4.06 (s, 6H), 6.29 (m, 1H), 6.78 (br, 1H), 7.05 (d, J=8.3 Hz, 1H), 7.19 (d, J=8.6 Hz, 1H), 7.48 (s, 1H), 7.50 (br, 1H), 7.59 (s, 1H), 8.45 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 494 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 3 hr. Next, 4-amino-1-benzylpiperidine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 16 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (27 mg, yield 31%).
- 1H-NMR (CDCl3, 400 MHz): 1.38-2.26 (m, 10H), 2.80-2.88 (m, 4H), 3.53 (m, 2H), 4.06 (s, 3H), 4.07 (s, 3H), 5.46 (br, 1H), 6.28 (d, J=5.4 Hz, 1H), 7.03 (d, J=8.3 Hz, 1H), 7.14 (d, J=8.5 Hz, 1H), 7.28-7.33 (m, 5H), 7.45 (s, 1H), 7.47 (br, 1H), 7.58 (s, 1H), 8.49 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 556 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (52 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 5 hr. Next, 2-piperidinylethylamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 15 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (32 mg, yield 40%).
- 1H-NMR (CDCl3, 400 MHz): 1.35-1.46 (m, 6H), 2.17 (s, 3H), 2.29 (s, 3H), 2.32-2.56 (m, 6H), 3.69 (m, 2H), 4.06 (s, 6H), 6.29 (m, 1H), 6.78 (br, 1H), 7.05 (d, J=8.3 Hz, 1H), 7.19 (d, J=8.6 Hz, 1H), 7.48 (s, 1H), 7.50 (br, 1H), 7.59 (s, 1H), 8.45 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 494 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (52 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 5 hr. Next, 2-acetamidoethylamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 15 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (6 mg, yield 8%).
- 1H-NMR (CDCl3, 400 MHz): 1.94 (s, 3H), 2.17 (s, 3H), 2.25 (s, 3H), 3.44 (m, 2H), 3.78 (m, 2H), 4.07 (s, 6H), 6.20 (m, 1H), 6.67 (br, 1H), 6.78 (br, 1H), 7.07 (s, 1H), 7.18 (s, 1H), 7.41 (br, 1H), 7.54 (s, 1H), 7.59 (s, 1H), 8.47 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 468 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 5 hr. Next, N,N-diethylethylenediamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 15 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (62 mg, yield 81%).
- 1H-NMR (CDCl3, 400 MHz): 0.96 (br, 6H), 2.52 (br, 4H), 2.67 (br, 2H), 3.68 (br, 2H), 4.07 (s, 6H), 7.26-7.54 (m, 7H), 7.83 (br, 1H), 8.59 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 456 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, 2-(1-piperidinyl)ethylamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 14 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (35 mg, yield 45%).
- 1H-NMR (CDCl3, 400 MHz): 1.40-1.55 (m, 6H), 2.40-2.60 (m, 6H), 3.72 (m, 2H), 4.07 (s, 6H), 7.30-7.38 (m, 7H), 7.54 (s, 1H), 8.60 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 468 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, 4-amino-1-benzylpiperidine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 14 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (40 mg, yield 44%).
- 1H-NMR (CDCl3, 400 MHz): 1.52 (m, 2H), 2.09 (m, 2H), 2.19 (m, 2H), 2.83 (m, 2H), 3.52 (s, 2H), 4.08 (s, 6H), 4.37 (m, 1H), 6.06 (d, J=7.8 Hz, 1H), 7.28-7.35 (m, 10H), 7.53 (s, 1H), 7.80 (br, 1H), 8.63 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 530 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, N-acetylethylenediamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 14 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (13 mg, yield 17%).
- 1H-NMR (CDCl3, 400 MHz): 2.00 (s, 3H), 3.47 (m, 2H), 3.84 (m, 2H), 4.08 (s, 6H), 6.36 (br, 1H), 6.89 (br, 1H), 7.32-7.40 (m, 5H), 7.55 (s, 1H), 7.86 (br, 1H), 8.61 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 442 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 7 hr. Next, cyclohexylhydrazine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 12 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (8 mg, yield 10%).
- 1H-NMR (CDCl3, 400 MHz): 1.20-2.27 (m, 16H), 3.83 (m, 1H), 4.06 (s, 6H), 5.51 (m, 1H), 6.34 (m, 1H), 7.00 (m, 1H), 7.18 (m, 1H), 7.36 (m, 1H), 7.43 (s, 1H), 7.61 (s, 1H), 8.46 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 481 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, 1-aminopiperidine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 14 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (20 mg, yield 27%).
- 1H-NMR (CDCl3, 400 MHz): 1.20-1.88 (m, 6H), 2.15 (s, 3H), 2.26 (s, 3H), 2.51 (m, 2H), 3.23 (m, 2H), 4.06 (s, 3H), 4.07 (s, 3H), 6.33 (d, J=5.4 Hz, 1H), 6.93 (br, 1H), 7.03 (d, J=8.5 Hz, 1H), 7.47 (s, 1H), 7.57 (d, J=8.6 Hz, 1H), 7.62 (s, 1H), 8.46 (d, J=5.4 Hz, 1H), 9.00 (br, 1H)
- Mass spectrometry value (ESI-MS, m/z): 467 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 7 hr. Next, 1-aminopiperidine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 14 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (9 mg, yield 12%).
- 1H-NMR (CDCl3, 400 MHz): 1.20-1.90 (m, 6H), 2.18 (s, 3H), 2.27 (s, 3H), 2.50 (m, 2H), 3.21 (m, 2H), 4.07 (s, 6H), 6.38 (d, J=5.4 Hz, 1H), 6.86 (br, 1H), 6.98 (s, 1H), 7.49 (s, 1H), 7.59 (s, 1H), 7.79 (s, 1H), 8.47 (d, J=5.4 Hz, 1H), 9.05 (br, 1H)
- Mass spectrometry value (ESI-MS, m/z): 467 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (52 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 1.5 hr. Next, cyclohexylhydrazine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 7 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (10 mg, yield 13%).
- 1H-NMR (CDCl3, 400 MHz): 1.12-1.95 (m, 10H), 2.16 (s, 3H), 2.25 (s, 3H), 3.69 (m, 1H), 4.06 (s, 6H), 5.52 (m, 1H), 6.40 (d, J=5.4 Hz, 1H), 6.97 (m, 1H), 7.46 (s, 1H), 7.52 (s, 1H), 7.59 (s, 1H), 8.47 (d, J=5.4 Hz, 1H), 9.41 (br, 1H)
- Mass spectrometry value (ESI-MS, m/z): 436 (?)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (50 mg) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. Next, 1-aminopiperidine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 13 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (49 mg, yield 66%).
- 1H-NMR (CDCl3, 400 MHz): 1.18-1.83 (m, 6H), 2.48 (m, 2H), 3.18 (m, 2H), 4.07 (s, 3H), 4.08 (s, 3H), 6.99 (s, 1H), 7.26 (d, J=8.1 Hz, 2H), 7.34 (s, 1H), 7.56 (s, 1H), 7.76 (d, J=8.5 Hz, 2H), 7.53 (s, 1H), 8.61 (s, 1H), 9.27 (br, 1H)
- Mass spectrometry value (ESI-MS, m/z): 440 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (56 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (50 mg) was then added to the solution, and the mixture was stirred at room temperature for 7 hr. Next, 1-(3-aminopropyl)pyrrolidone (50 mg) was added thereto, and the mixture was further stirred at room temperature for 13 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (15 mg, yield 17%).
- 1H-NMR (CDCl3, 400 MHz): 1.87 (m, 2H), 2.04 (m, 2H), 2.37 (t, J=8.2 Hz, 2H), 3.30 (t, J=6.2 Hz, 2H), 3.41 (t, J=7.2 Hz, 2H), 3.64 (m, 2H), 4.07 (s, 6H), 7.31-7.42 (m, 6H), 7.55 (s, 1H), 7.79 (br, 1H), 8.62 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 482 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (56 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (50 mg) was then added to the solution, and the mixture was stirred at room temperature for 7 hr. Next, 3-(1-imidazoyl)propylamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 13 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (16 mg, yield 18%).
- 1H-NMR (CDCl3, 400 MHz): 2.29 (m, 2H), 3.69 (m, 2H), 4.06 (s, 3H), 4.07 (s, 3H), 4.38 (m, 2H), 7.20-7.57 (m, 11H), 8.58 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 465 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (56 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (50 mg) was then added to the solution, and the mixture was stirred at room temperature for 7 hr. Next, 2-(1-morpholinyl)ethylamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 13 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (9 mg, yield 10%).
- 1H-NMR (CDCl3, 400 MHz): 2.50 (m, 4H), 2.64 (m, 2H), 3.65 (m, 4H), 3.75 (m, 2H), 4.08 (s, 3H), 4.08 (s, 3H), 7.14 (br, 1H), 7.34 (m, 4H), 7.35 (s, 1H), 7.54 (s, 1H), 7.73 (br, 1H), 8.61 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 470 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (56 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (50 mg) was then added to the solution, and the mixture was stirred at room temperature for 7 hr. Next, N-ethyl-N-(o-tolyl)ethylenediamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 13 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (22 mg, yield 22%).
- 1H-NMR (CDCl3, 400 MHz): 1.11 (t, J=7.1 Hz, 3H), 2.29 (s, 2H), 3.34 (q, J=7.1H, 2H), 3.55 (t, J=6.3 Hz, 2H), 3.84 (m, 2H), 4.08 (s, 6H), 6.43 (br, 1H), 6.54-6.61 (m, 3H), 7.10 (m, 1H), 7.19 (d, J=8.8 Hz, 2H), 7.24 (d, J=8.8 Hz, 2H), 7.35 (s, 1H), 7.53 (s, 1H), 7.77 (br, 1H), 8.60 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 518 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (50 mg) was then added to the solution, and the mixture was stirred at room temperature for 5 hr. Next, N,N-dimethylethylenediamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 16 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (18 mg, yield 24%).
- 1H-NMR (CDCl3, 400 MHz): 1.83 (br, 2H), 2.26 (br, 6H), 2.55 (br, 2H), 4.07 (s, 6H), 7.29-7.30 (m, 5H), 7.34 (s, 1H), 7.54 (s, 1H), 8.62 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 428 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (50 mg) was then added to the solution, and the mixture was stirred at room temperature for 5 hr. Next, 2-(1-pyrrolidyl)ethylamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 16 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (16 mg, yield 21%).
- 1H-NMR (CDCl3, 400 MHz): 1.77 (br, 4H), 1.86 (br, 2H), 2.58 (br, 2H), 2.75 (br, 2H), 4.07 (s, 6H), 7.29-7.30 (m, 5H), 7.34 (s, 1H), 7.54 (s, 1H), 8.60 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 454 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (50 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, N,N-diethylpropylenediamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 15 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (10 mg, yield 12%).
- 1H-NMR (CDCl3, 400 MHz): 0.86 (br, 6H), 1.74 (br, 2H), 2.42 (br, 4H), 2.55 (br, 2H), 3.81 (br, 2H), 4.07 (s, 3H), 4.08 (s, 3H), 7.29 (s, 1H), 7.34 (m, 4H), 7.53 (s, 1H), 7.57 (br, 1H), 8.56 (s, 1H), 8.69 (br, 1H)
- Mass spectrometry value (ESI-MS, m/z): 470 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (50 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, N,N-diethylpropylenediamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 15 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (41 mg, yield 46%).
- 1H-NMR (CDCl3, 400 MHz): 0.87 (t, J=7.1 Hz, 6H), 1.19 (m, 8H), 1.71 (m, 2H), 2.28 (m, 4H), 2.52 (m, 2H), 3.79 (m, 2H), 4.07 (s, 3H), 4.08 (s, 3H), 7.27-7.32 (m, 4H), 7.34 (s, 1H), 7.52 (s, 1H), 7.75 (br, 1H), 8.44 (br, 1H), 8.57 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 526 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (50 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, 3-(1-morpholino)propylamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 15 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (16 mg, yield 20%).
- 1H-NMR (CDCl3, 400 MHz): 1.81 (m, 2H), 2.39 (m, 4H), 2.46 (m, 2H), 3.50 (m, 4H), 3.79 (m, 2H), 4.07 (s, 6H), 7.31-7.37 (m, 5H), 7.53 (s, 1H), 7.69 (br, 1H), 8.61 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 484 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (50 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, 3-[1-(2-methylpiperidinyl)]propylamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 15 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (30 mg, yield 36%).
- 1H-NMR (CDCl3, 400 MHz): 0.99 (d, J=6.4 Hz, 3H), 1.24-2.53 (m, 11H), 2.81 (m, 2H), 3.71 (m, 1H), 3.81 (m, 1H), 4.07 (s, 3H), 4.07 (s, 3H), 7.29-7.37 (m, 5H), 7.52 (s, 1H), 7.74 (br, 1H), 7.83 (br, 1H), 8.59 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 496 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (50 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, N,N-diisopropylethylenediamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 15 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (47 mg, yield 58%). 1H-NMR (CDCl3, 400 MHz): 0.91 (br, 12H), 2.67 (br, 2H), 2.96 (br, 2H), 3.64 (br, 2H), 4.07 (s, 3H), 4.08 (s, 3H), 7.17 (br, 1H), 7.28-7.34 (m, 4H), 7.34 (s, 1H), 7.54 (s, 1H), 7.85 (br, 1H), 8.58 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 484 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (50 mg) was then added to the solution, and the mixture was stirred at room temperature for 1 hr. Next, 1-(3-aminopropyl)-4-methylpiperazine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 6 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (6 mg, yield 7%).
- 1H-NMR (CDCl3, 400 MHz): 1.75-1.83 (m, 6H), 2.23 (s, 3H), 2.23 (m, 2H), 2.44 (m, 4H), 3.78 (br, 2H), 4.06 (s, 3H), 4.08 (s, 3H), 7.31-7.34 (m, 5H), 7.51 (s, 1H), 7.59 (br, 1H), 8.61 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 497 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (50 mg) was then added to the solution, and the mixture was stirred at room temperature for 1 hr. Next, N,N-diethylpropylenediamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 6 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (19 mg, yield 24%).
- 1H-NMR (CDCl3, 400 MHz): 1.55 (br, 2H), 1.79 (m, 2H), 2.42 (br, 4H), 2.58 (br, 2H), 3.81 (br, 2H), 4.07 (s, 3H), 4.07 (s, 3H), 7.27-7.34 (m, 4H), 7.34 (s, 1H), 7.52 (s, 1H), 7.73 (br, 1H), 8.19 (br, 1H), 8.59 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 467 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, N,N-dimethylethylenediamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 16 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (24 mg, yield 34%).
- 1H-NMR (CDCl3, 400 MHz): 2.16 (s, 3H), 2.22 (br, 6H), 2.28 (s, 3H), 2.51 (br, 2H), 3.68 (br, 2H), 4.06 (s, 3H), 4.06 (s, 3H), 6.27 (m, 1H), 6.68 (br, 1H), 7.05 (s, 1H), 7.21 (s, 1H), 7.44 (s, 1H), 7.49 (br, 1H), 7.57 (s, 1H), 8.46 (d, J=5.2 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 455 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, 1-(3-aminopropyl)imidazole (50 mg) was added thereto, and the mixture was further stirred at room temperature for 16 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (20 mg, yield 25%).
- 1H-NMR (CDCl3, 400 MHz): 2.00 (m, 2H), 2.15 (m, 2H), 2.18 (s, 3H), 2.25 (s, 3H), 3.67 (m, 2H), 4.05 (s, 3H), 4.06 (s, 3H), 5.98 (br, 1H), 6.33 (d, J=5.4 Hz, 1H), 6.93 (s, 1H), 7.04 (s, 1H), 7.05 (s, 1H), 7.17 (s, 1H), 7.43 (s, 1H), 7.50 (br, 1H), 7.54 (s, 1H), 7.74 (s, 1H), 8.47 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, N,N-dimethylethylenediamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 16 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (28 mg, yield 32%).
- 1H-NMR (CDCl3, 400 MHz): 1.07 (t, J=7.1 Hz, 3H), 2.07 (s, 3H), 2.22 (s, 3H), 2.29 (s, 3H), 3.30 (q, J=7.1 Hz, 2H), 3.51 (t, J=6.0 Hz, 2H), 3.84 (m, 2H), 4.06 (s, 3H), 4.06 (s, 3H), 6.06 (br, 1H), 6.22 (d, J=5.4 Hz, 1H), 6.53-6.68 (m, 3H), 6.99 (s, 1H), 7.02 (s, 1H), 7.09 (m, 1H), 7.45 (s, 1H), 7.52 (br, 1H), 7.54 (s, 1H), 8.43 (d, J=5.2 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 545 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, 1-(2-aminoethyl)pyrrolidine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 16 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (8 mg, yield 10%).
- 1H-NMR (CDCl3, 400 MHz): 1.72 (br, 4H), 2.16 (s, 3H), 2.27 (s, 3H), 2.54 (br, 4H), 2.73 (br, 2H), 3.72 (br, 2H), 4.06 (s, 6H), 6.28 (m, 1H), 6.77 (br, 1H), 7.04 (s, 1H), 7.19 (s, 1H), 7.43 (s, 1H), 7.56 (s, 1H), 8.46 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 481 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 7 hr. Next, N,N-dimethylethylenediamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 13 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (12 mg, yield 17%).
- 1H-NMR (CDCl3, 400 MHz): 2.16 (s, 3H), 2.19 (br, 6H), 2.28 (s, 3H), 2.48 (br, 2H), 3.66 (br, 2H), 4.06 (s, 3H), 4.07 (s, 3H), 6.22 (m, 1H), 6.56 (br, 1H), 7.04 (d, J=8.3 Hz, 1H), 7.19 (d, J=8.5 Hz, 1H), 7.44 (s, 1H), 7.60 (s, 1H), 8.45 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 455 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 7 hr. Next, 1-(3-aminopropyl)imidazole (50 mg) was added thereto, and the mixture was further stirred at room temperature for 13 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (13 mg, yield 17%).
- 1H-NMR (CDCl3, 400 MHz): 2.14 (m, 2H), 2.18 (s, 3H), 2.26 (s, 3H), 3.66 (m, 2H), 4.04 (m, 2H), 4.05 (s, 3H), 4.06 (s, 3H), 5.79 (br, 1H), 6.30 (d, J=5.4 Hz, 1H), 6.92 (s, 1H), 7.04 (s, 1H), 7.05 (d, J=8.6 Hz, 1H), 7.14 (d, J=8.6 Hz, 1H), 7.44 (s, 1H), 7.51 (br, 1H), 7.56 (s, 1H), 7.62 (s, 1H), 8.47 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 7 hr. Next, N,N-dimethylethylenediamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 13 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (4 mg, yield 4%).
- 1H-NMR (CDCl3, 400 MHz): 1.06 (t, J=7.1 Hz, 3H), 2.10 (s, 3H), 2.21 (s, 3H), 2.28 (s, 3H), 3.28 (q, J=7.1 Hz, 2H), 3.49 (t, J=6.1 Hz, 2H), 3.83 (m, 2H), 4.07 (s, 6H), 5.94 (br, 1H), 6.18 (d, J=5.1 Hz, 1H), 6.49-7.10 (m, 6H), 7.46 (s, 1H), 7.50 (br, 1H), 7.57 (s, 1H), 8.42 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 545 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, 1-(2-aminoethyl)morpholine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 16 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (23 mg, yield 29%).
- 1H-NMR (CDCl3, 400 MHz): 2.19 (s, 3H), 2.28 (s, 3H), 2.43 (br, 4H), 2.58 (m, 2H), 3.56 (m, 4H), 3.71 (m, 2H), 4.06 (s, 3H), 4.07 (s, 3H), 6.30 (d, J=5.1 Hz, 1H), 6.60 (br, 1H), 7.07 (s, 1H), 7.21 (s, 1H), 7.45 (s, 1H), 7.46 (br, 1H), 7.56 (s, 1H), 8.48 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 497 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, N,N-diethylpropylenediamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 15 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (36 mg, yield 45%).
- 1H-NMR (CDCl3, 400 MHz): 0.83 (t, J=7.1 Hz, 6H), 1.70 (m, 2H), 2.16 (s, 3H), 2.29 (s, 3H), 2.32 (m, 4H), 2.49 (m, 2H), 3.78 (m, 2H), 4.06 (s, 3H), 4.06 (s, 3H), 6.30 (d, J=5.4 Hz, 1H), 7.00 (d, J=8.5 Hz, 1H), 7.19 (d, J=8.5 Hz, 1H), 7.44 (s, 1H), 7.56 (br, 1H), 7.57 (s, 1H), 7.80 (br, 1H), 8.46 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 497 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, N,N-dibutylpropylenediamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 15 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (33 mg, yield 37%).
- 1H-NMR (CDCl3, 400 MHz): 0.89 (t, J=6.8 Hz, 6H), 1.19 (m, 8H), 1.69 (m, 2H), 2.15 (s, 3H), 2.20 (m, 4H), 2.29 (s, 3H), 2.49 (m, 2H), 3.78 (m, 2H), 4.05 (s, 3H), 4.06 (s, 3H), 6.30 (d, J=5.1 Hz, 1H), 7.01 (d, J=8.6 Hz, 1H), 7.19 (d, J=8.5 Hz, 1H), 7.44 (s, 1H), 7.48 (br, 1H), 7.56 (s, 1H), 7.79 (br, 1H), 8.46 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 552 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, 1-(3-aminopropyl)morpholine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 15 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (16 mg, yield 19%).
- 1H-NMR (CDCl3, 400 MHz): 1.78 (m, 4H), 2.19 (s, 3H), 2.29 (s, 3H), 2.36 (m, 4H), 3.45 (m, 4H), 3.78 (m, 2H), 4.06 (s, 3H), 4.06 (s, 3H), 6.33 (d, J=5.1 Hz, 1H), 6.70 (br, 1H), 7.03 (d, J=8.6 Hz, 1H), 7.19 (d, J=8.5 Hz, 1H), 7.44 (s, 1H), 7.56 (s, 1H), 8.48 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 511 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, 1-(3-aminopropyl)-2-methylpiperidine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 15 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (39 mg, yield 47%).
- 1H-NMR (CDCl3, 400 MHz): 0.94-2.20 (m, 14H), 2.17 (s, 3H), 2.29 (s, 3H), 2.76 (m, 2H), 3.68 (m, 1H), 3.85 (m, 1H), 4.05 (s, 3H), 4.06 (s, 3H), 6.34 (d, J=5.1 Hz, 1H), 7.02 (d, J=8.6 Hz, 1H), 7.20 (d, J=8.3 Hz, 1H), 7.44 (s, 1H), 7.50 (br, 1H), 7.55 (s, 1H), 8.48 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 523 (M+)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, N,N-diisopropylethylenediamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 15 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (52 mg, yield 64%).
- 1H-NMR (CDCl3, 400 MHz): 0.84 (br, 12H), 2.13 (s, 3H), 2.27 (s, 3H), 2.62 (m, 2H), 2.89 (m, 2H), 3.61 (m, 2H), 4.06 (s, 3H), 4.07 (s, 3H), 6.24 (m, 1H), 7.02 (d, J=8.5 Hz, 1H), 7.18 (d, J=8.3 Hz, 1H), 7.44 (s, 1H), 7.52 (br, 1H), 7.58 (s, 1H), 8.44 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 511 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, N,N-diethylpropylenediamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 16 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (38 mg, yield 49%).
- 1H-NMR (CDCl3, 400 MHz): 0.86 (t, J=7.2 Hz, 6H), 1.72 (m, 2H), 2.16 (s, 3H), 2.27 (s, 3H), 2.34 (m, 4H), 2.51 (m, 2H), 3.79 (m, 2H), 4.06 (s, 6H), 6.34 (d, J=5.1 Hz, 1H), 7.01 (s, 1H), 7.21 (s, 1H), 7.38 (br, 1H), 7.44 (s, 1H), 7.54 (s, 1H), 7.93 (br, 1H), 8.48 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 497 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, N,N-dibutylpropylenediamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 16 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (34 mg, yield 40%).
- 1H-NMR (CDCl3, 400 MHz): 0.90 (t, J=7.0 Hz, 6H), 1.20 (m, 8H), 1.70 (m, 2H), 2.16 (s, 3H), 2.23 (m, 4H), 2.27 (s, 3H), 2.51 (m, 2H), 3.79 (m, 2H), 4.05 (s, 3H), 4.06 (s, 3H), 6.34 (d, J=5.2 Hz, 1H), 7.02 (s, 1H), 7.20 (s, 1H), 7.30 (br, 1H), 7.44 (s, 1H), 7.54 (s, 1H), 7.88 (br, 1H), 8.48 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 553 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, 1-(3-aminopropyl)morpholine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 16 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (18 mg, yield 23%).
- 1H-NMR (CDCl3, 400 MHz): 1.78 (m, 4H), 2.19 (s, 3H), 2.27 (s, 3H), 2.36 (m, 4H), 3.45 (m, 4H), 3.79 (m, 2H), 4.05 (s, 3H), 4.06 (s, 3H), 6.37 (d, J=5.4 Hz, 1H), 6.83 (br, 1H), 7.03 (s, 1H), 7.22 (s, 1H), 7.44 (s, 1H), 7.54 (s, 1H), 8.50 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 511 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, 1-(3-aminopropyl)-2-methylpiperidine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 16 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (46 mg, yield 56%).
- 1H-NMR (CDCl3, 400 MHz): 0.90-2.20 (m, 14H), 2.17 (s, 3H), 2.27 (s, 3H), 2.79 (m, 2H), 3.68 (m, 1H), 3.88 (m, 1H), 4.04 (s, 3H), 4.06 (s, 3H), 6.39 (d, J=5.2 Hz, 1H), 7.02 (s, 1H), 7.22 (s, 1H), 7.38 (br, 1H), 7.44 (s, 1H), 7.53 (s, 1H), 8.49 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 523 (M+)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, N,N-diisopropylethylenediamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 16 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (13 mg, yield 17%).
- 1H-NMR (CDCl3, 400 MHz): 0.86 (br, 12H), 2.14 (s, 3H), 2.26 (s, 3H), 2.62 (m, 2H), 2.91 (m, 2H), 3.61 (m, 2H), 4.06 (s, 3H), 4.07 (s, 3H), 6.27 (m, 1H), 6.68 (br, 1H), 7.03 (s, 1H), 7.19 (s, 1H), 7.36 (br, 1H), 7.44 (s, 1H), 7.56 (s, 1H), 8.46 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 511 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, 1-(3-aminopropyl)-4-methylpiperazine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 16 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (20 mg, yield 24%).
- 1H-NMR (CDCl3, 400 MHz): 1.76 (m, 6H), 2.17 (s, 3H), 2.26 (m, 2H), 2.28 (s, 3H), 2.41 (m, 4H), 3.77 (m, 2H), 4.03 (s, 3H), 4.06 (s, 3H), 6.34 (d, J=5.1 Hz, 1H), 6.83 (br, 1H), 7.05 (s, 1H), 7.22 (s, 1H), 7.37 (br, 1H), 7.44 (s, 1H), 7.52 (s, 1H), 8.48 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 524 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, 1-(3-aminopropyl)-4-methylpiperazine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 16 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (10 mg, yield 11%).
- 1H-NMR (CDCl3, 400 MHz): 1.73 (m, 6H), 2.17 (s, 3H), 2.25 (m, 2H), 2.29 (s, 3H), 2.39 (m, 4H), 3.77 (m, 2H), 4.04 (s, 3H), 4.06 (s, 3H), 6.30 (d, J=5.1 Hz, 1H), 6.76 (br, 1H), 7.05 (d, J=8.6 Hz, 1H), 7.20 (d, J=8.6 Hz, 1H), 7.38 (br, 1H), 7.44 (s, 1H), 7.55 (s, 1H), 8.47 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 524 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (51 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, 1-(3-aminopropyl)pyrrolidine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 16 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (18 mg, yield 22%).
- 1H-NMR (CDCl3, 400 MHz): 1.55 (br, 4H), 1.77 (br, 2H), 2.17 (s, 3H), 2.28 (s, 3H), 2.39 (br, 4H), 2.55 (br, 2H), 3.78 (br, 2H), 4.05 (s, 3H), 4.06 (s, 3H), 6.32 (d, J=5.4 Hz, 1H), 7.00 (d, J=8.6 Hz, 1H), 7.18 (m, 1H), 7.44 (s, 1H), 7.46 (br, 1H), 7.56 (s, 1H), 8.47 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 475
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 5 hr. Next, N,N-dimethylethylenediamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 15 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (62 mg, yield 83%).
- 1H-NMR (CDCl3, 400 MHz): 2.52 (s, 6H), 2.67 (br, 2H), 3.68 (br, 2H), 4.07 (s, 6H), 7.26-7.54 (m, 7H), 7.83 (br, 1H), 8.59 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 428 (M++1)
- Chloroform (10 ml) and triethylamine (2 ml) were added to 4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (100 mg) to prepare a solution. Triphosgene (110 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. 1-Benzyl-3-aminopyrrolidine (89 mg) was then added thereto, and the mixture was stirred at room temperature for 3 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (76 mg, yield 45%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.97-2.08 (m, 1H), 2.38-2.49 (m, 1H), 2.55-2.64 (m, 1H), 2.78-2.85 (m, 1H), 3.13-3.19 (m, 1H), 3.34-3.41 (m, 1H), 3.91 (s, 1H), 3.92 (s, 1H), 4.04 (s, 6H), 4.45-4.53 (m, 1H), 6.23 (br, 1H), 6.44 (d, J=5.4 Hz, 1H), 7.07-7.11 (m, 2H), 7.35-7.47 (m, 8H), 7.56 (s, 1H), 8.46 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 499 (M++1)
- Chloroform (10 ml) and triethylamine (2 ml) were added to 4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (100 mg) to prepare a solution. Triphosgene (110 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. Ethyl 4-amino-1-piperidine (87 mg) was then added thereto, and the mixture was stirred at room temperature overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (108 mg, yield 65%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.25 (t, J=7.1 Hz, 3H), 1.32-1.45 (m, 2H), 1.93-2.02 (m, 2H), 2.92-3.05 (m, 2H), 3.83-3.94 (m, 1H), 3.98-4.06 (m, 2H), 4.07 (s, 3H), 4.08 (s, 3H), 4.09-4.16 (m, 2H), 5.57 (d, J=7.8 Hz, 1H), 6.48 (d, J=5.9 Hz, 1H), 7.05-7.10 (m, 2H), 7.50-7.55 (m, 2H), 7.58 (s, 1H), 7.59 (s, 1H), 7.74 (s, 1H), 8.36 (d, J=5.9 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 495 (M++1)
- Chloroform (10 ml) and triethylamine (2 ml) were added to 4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (100 mg) to prepare a solution. Triphosgene (110 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. 4-Amino-2,2,6,6-tetramethylpiperidine (79 mg) was then added thereto, and the mixture was stirred at room temperature overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (27 mg, yield 17%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.53-2.09 (m, 16H), 4.02 (s, 3H), 4.06 (s, 3H), 4.22-4.37 (m, 1H), 6.51 (d, J=5.6 Hz, 1H), 7.05 (d, J=8.8 Hz, 2H), 7.42 (s, 1H), 7.54-7.64 (m, 3H), 8.42 (d, J=5.9 Hz, 1H), 8.65 (br, 1H)
- Mass spectrometry value (ESI-MS, m/z): 479 (M++1)
- Chloroform (10 ml) and triethylamine (2 ml) were added to 4-[(6,7-dimethoxy-4-quinazolinyl)oxy]aniline (100 mg) to prepare a solution. Triphosgene (110 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. 4-Amino-2,2,6,6-tetramethylpiperidine (79 mg) was then added thereto, and the mixture was stirred at room temperature overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (66 mg, yield 41%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.28-2.09 (m, 16H), 4.05 (s, 3H), 4.06 (s, 3H), 4.11-4.28 (m, 1H), 7.13 (d, J=8.8 Hz, 2H), 7.29 (s, 1H), 7.46-7.55 (m, 3H), 8.57 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 480 (M++1)
- Chloroform (10 ml) and triethylamine (2 ml) were added to 4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (100 mg) to prepare a solution. Triphosgene (110 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. (3R)-(−)-1-Benzyl-3-aminopyrrolidine (89 mg) was then added thereto, and the mixture was stirred at room temperature overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (54 mg, yield 32%).
- 1H-NMR (chloroform-d, 400 MHz): δ 2.00-2.16 (m, 2H), 2.41-2.52 (m, 1H), 2.63-2.72 (m, 1H), 2.84-2.92 (m, 1H), 3.21-3.29 (m, 1H), 3.99 (s, 1H), 4.01 (s, 1H), 4.04 (s, 3H), 4.05 (s, 3H), 4.50-4.61 (m, 1H), 6.44 (d, J=5.1 Hz, 1H), 7.06-7.12 (m, 2H), 7.37-7.48 (m, 8H), 7.56 (s, 1H), 8.46 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 499 (M++1)
- Chloroform (10 ml) and triethylamine (2 ml) were added to 4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (100 mg) to prepare a solution. Triphosgene (110 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. (3S)-(+)-1-Benzyl-3-aminopyrrolidine (89 mg) was then added thereto, and the mixture was stirred at room temperature for 5 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (48 mg, yield 29%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.92-2.17 (m, 2H), 2.40-2.51 (m, 1H), 2.60-2.71 (m, 1H), 2.81-2.90 (m, 1H), 3.18-3.25 (m, 1H), 3.96 (s, 1H), 3.98 (s, 1H), 4.05 (s, 6H), 4.49-4.58 (m, 1H), 6.44 (d, J=5.1 Hz, 1H), 7.06-7.12 (m, 2H), 7.37-7.49 (m, 7H), 7.56 (s, 1H), 7.61 (s, 1H), 8.46 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 499 (M++1)
- Chloroform (10 ml) and triethylamine (2 ml) were added to 4-[(6,7-dimethoxy-4-quinazolinyl)oxy]aniline (100 mg) to prepare a solution. Triphosgene (110 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. (3R)-(−)-1-Benzyl-3-aminopyrrolidine (89 mg) was then added thereto, and the mixture was stirred at room temperature for 5 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (114 mg, yield 68%).
- 1H-NMR (chloroform-d, 400 MHz): δ 2.07-2.20 (m, 1H), 2.40-2.52 (m, 1H), 2.76-2.87 (m, 1H), 2.99-3.07 (m, 1H), 3.29-3.38 (m, 1H), 3.51-3.60 (m, 1H), 4.06 (s, 6H), 4.08 (s, 1H), 4.10 (s, 1H), 4.57-4.66 (m, 1H), 6.75-6.85 (m, 1H), 7.11-7.17 (m, 2H), 7.29-7.57 (m, 9H), 8.59 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 500 (M++1)
- Chloroform (10 ml) and triethylamine (2 ml) were added to 4-[(6,7-dimethoxy-4-quinazolinyl)oxy]aniline (100 mg) to prepare a solution. Triphosgene (110 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. (3S)-(+)-1-Benzyl-3-aminopyrrolidine (89 mg) was then added thereto, and the mixture was stirred at room temperature for 5 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (100 mg, yield 60%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.97-2.08 (m, 1H), 2.33-2.48 (m, 1H), 2.60-2.69 (m, 1H), 2.82-2.91 (m, 1H), 3.11-3.20 (m, 1H), 3.32-3.42 (m, 1H), 3.94 (s, 1H), 3.96 (s, 1H), 4.06 (s, 6H), 4.46-4.57 (m, 1H), 6.37 (br, 1H), 7.12-7.18 (m, 2H), 7.29-7.50 (m, 8H), 7.54 (s, 1H), 8.62 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 500 (M++1)
- N-(1-Benzyl-4-piperidyl)-N′-{4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}urea (100 mg) was dissolved in 1,2-dichloroethane (25 ml) to prepare a solution. 1-Chloroethyl chloroformate (0.10 ml) was then added to the solution, and the mixture was heated under reflux overnight. The solvent was removed by distillation under the reduced pressure. Methanol (20 ml) was added to the residue, followed by heating under reflux for 2 hr. The solvent was removed by distillation under the reduced pressure to give 139 mg of N-{4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N′-(4-piperidyl)urea (1).
- Acetonitrile (10 ml) was added to the compound (1) (139 mg), 2-methylbenzyl bromide (0.03 ml), and potassium carbonate (81 mg), and the mixture was stirred at room temperature overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (46 mg, yield 45%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.88-2.01 (m, 2H), 2.09-2.19 (m, 2H), 2.42 (s, 3H), 2.53-2.67 (m, 2H), 3.19-3.29 (m, 2H), 3.30-3.39 (m, 1H), 3.90 (s, 2H), 4.04 (s, 3H), 4.04 (s, 3H), 6.42 (d, J=5.4 Hz, 1H), 7.05-7.12 (m, 2H), 7.17-7.27 (m, 4H), 7.42 (s, 1H), 7.47-7.53 (m, 2H), 7.55 (s, 1H), 7.56 (s, 1H), 8.45 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 527 (M++1)
- 3-Aminopyrrolidine (500 mg) was dissolved in acetonitrile (10 ml) to prepare a solution. 2-Methylbenzyl bromide (0.78 ml) and potassium carbonate (2.40 g) were added to the solution, and the mixture was stirred at room temperature for 3 hr. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform/methanol for development to give 1-(2-methylbenzyl)-3-pyrrolidinamine (1) (604 mg, yield 55%).
- Chloroform (10 ml) and triethylamine (2 ml) were added to 4-[(6,7-dimethoxy-4-quinazolinyl)oxy]aniline (100 mg) to prepare a solution. Triphosgene (110 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. The compund (1) (96 mg) was then added thereto, and the mixture was stirred at room temperature overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (64 mg, yield 37%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.95-2.05 (m, 1H), 2.41 (s, 3H), 2.40-2.48 (m, 1H), 2.55-2.63 (m, 1H), 2.79-2.87 (m, 1H), 3.08-3.14 (m, 1H), 3.30-3.38 (m, 1H), 3.90 (s, 2H), 4.06 (s, 3H), 4.07 (s, 3H), 4.44-4.55 (m, 1H), 7.13-7.18 (m, 2H), 7.18-7.40 (m, 5H), 7.40-7.47 (m, 2H), 7.55 (s, 1H), 8.60 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 514 (M++1)
- Chloroform (13 ml) and triethylamine (2 ml) were added to 4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (100 mg) to prepare a solution. Triphosgene (96 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. 1-(2-Methylbenzyl)-3-pyrrolidinamine (83 mg) was then added thereto, and the mixture was stirred at room temperature overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (38 mg, yield 23%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.94-2.04 (m, 1H), 2.44 (s, 3H), 2.42-2.50 (m, 1H), 2.55-2.65 (m, 1H), 2.81-2.90 (m, 1H), 3.02-3.10 (m, 1H), 3.27-3.34 (m, 1H), 3.88-3.92 (m, 2H), 4.07 (s, 3H), 4.09 (s, 3H), 4.50-4.59 (m, 1H), 7.18-7.26 (m, 2H), 7.32-7.43 (m, 2H), 7.49-7.55 (m, 2H), 8.12 (d, J=2.7 Hz, 1H), 8.60 (s, 1H), 8.71-8.77 (m, 1H), 9.78 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 559 (M++1)
- Chloroform (10 ml) and triethylamine (2 ml) were added to 4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-2-methoxyaniline (100 mg) to prepare a solution. Triphosgene (99 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. 1-(2-Methylbenzyl)-3-pyrrolidinamine (87 mg) was then added thereto, and the mixture was stirred at room temperature overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (58 mg, yield 35%).
- 1H-NMR (chloroform-d, 400 MHz): δ 2.01-2.11 (m, 1H), 2.21-2.33 (m, 1H), 2.50 (s, 3H), 2.48-2.58 (m, 1H), 2.86-2.98 (m, 1H), 3.43-3.52 (m, 1H), 3.68-3.78 (m, 1H), 3.84 (s, 3H), 4.07 (s, 6H), 4.21 (s, 1H), 4.23 (s, 1H), 4.71-4.82 (m, 1H), 6.75 (d, J=2.4 Hz, 1H), 6.79 (dd, J=2.4 Hz, 8.8 Hz, 1H), 7.17-7.22 (m, 1H), 7.27-7.36 (m, 3H), 7.54 (s, 1H), 7.54-7.59 (m, 1H), 8.13 (d, J=8.8 Hz, 1H), 8.62 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 544 (M++1)
- Chloroform (10 ml) and triethylamine (2 ml) were added to 4-[(6,7-dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (100 mg) to prepare a solution. Triphosgene (101 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. 1-(2-Methylbenzyl)-3-pyrrolidinamine (88 mg) was then added thereto, and the mixture was stirred at room temperature overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (68 mg, yield 41%).
- 1H-NMR (chloroform-d, 400 MHz): δ 2.01-2.10 (m, 1H), 2.11 (s, 3H), 2.22 (s, 3H), 2.36 (s, 3H), 2.38-2.47 (m, 1H), 2.50-2.59 (m, 1H), 2.73-2.81 (m, 1H), 3.01-3.09 (m, 1H), 3.23-3.33 (m, 1H), 3.86 (s, 2H), 4.06 (s, 3H), 4.07 (s, 3H), 4.48-4.58 (m, 1H), 6.30 (d, J=5.4 Hz, 1H), 6.97 (d, J=8.8 Hz, 1H), 7.14-7.36 (m, 4H), 7.44 (s, 1H), 7.62 (s, 1H), 8.44 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 541 (M++1)
- Chloroform (10 ml) and triethylamine (2 ml) were added to 2-chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (100 mg) to prepare a solution. Triphosgene (99 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. 1-(2-Methylbenzyl)-3-pyrrolidinamine (86 mg) was then added thereto, and the mixture was stirred at room temperature overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (82 mg, yield 50%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.92-2.01 (m, 1H), 2.39-2.47 (m, 1H), 2.41 (s, 3H), 2.51-2.60 (m, 1H), 2.77-2.84 (m, 1H), 3.01-3.08 (m, 1H), 3.23-3.33 (m, 1H), 3.86 (s, 1H), 3.87 (s, 1H), 4.07 (s, 6H), 4.27-4.38 (m, 1H), 7.12-7.40 (m, 7H), 7.51 (s, 1H), 8.19 (d, J=9.0 Hz, 1H), 8.61 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 548 (M++1)
- Chloroform (10 ml) and triethylamine (2 ml) were added to 4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (100 mg) to prepare a solution. Triphosgene (110 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. 1-(2-Methylbenzyl)-3-pyrrolidinamine (96 mg) was then added thereto, and the mixture was stirred at room temperature overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (101 mg, yield 59%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.98-2.10 (m, 1H), 2.38-2.50 (m, 1H), 2.41 (s, 3H), 2.58-2.68 (m, 1H), 2.83-2.93 (m, 1H), 3.15-3.22 (m, 1H), 3.37-3.44 (m, 1H), 3.95 (s, 2H), 4.04 (s, 6H), 4.46-4.58 (m, 1H), 6.43 (d, J=5.4 Hz, 1H), 7.05-7.12 (m, 2H), 7.18-7.47 (m, 7H), 7.56 (s, 1H), 8.46 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 513 (M++1)
- Chloroform (15 ml) and triethylamine (3 ml) were added to 2-chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (200 mg) to prepare a solution. Triphosgene (198 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. (3R)-(−)-1-Benzyl-3-aminopyrrolidine (80 mg) was then added thereto, and the mixture was stirred at room temperature overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (189 mg, yield 59%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.90-2.02 (m, 1H), 2.37-2.47 (m, 1H), 2.48-2.58 (m, 1H), 2.72-2.80 (m, 1H), 2.98-3.06 (m, 1H), 3.21-3.29 (m, 1H), 3.83 (s, 1H), 3.85 (s, 1H), 4.07 (s, 6H), 4.45-4.56 (m, 1H), 7.14 (dd, J=2.7 Hz, 9.0 Hz, 1H), 7.28-7.43 (m, 7H), 7.51 (s, 1H), 8.20 (d, J=9.0 Hz, 1H), 8.61 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 534 (M++1)
- Chloroform (15 ml) and triethylamine (3 ml) were added to 2-chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (200 mg) to prepare a solution. Triphosgene (198 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. (3S)-(+)-1-Benzyl-3-aminopyrrolidine (80 mg) was then added thereto, and the mixture was stirred at room temperature overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (204 mg, yield 63%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.90-2.00 (m, 1H), 2.35-2.48 (m, 1H), 2.50-2.58 (m, 1H), 2.73-2.80 (m, 1H), 2.98-3.05 (m, 1H), 3.20-3.29 (m, 1H), 3.83 (s, 1H), 3.85 (s, 1H), 4.07 (s, 6H), 4.45-4.54 (m, 1H), 7.15 (dd, J=2.7 Hz, 9.0 Hz, 1H), 7.28-7.43 (m, 7H), 7.51 (s, 1H), 8.20 (d, J=9.0 Hz, 1H), 8.62 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 534 (M++1)
- Chloroform (27 ml) and triethylamine (4 ml) were added to 4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (200 mg) to prepare a solution. Triphosgene (192 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. (3R)-(−)-1-Benzyl-3-aminopyrrolidine (77 mg) was then added thereto, and the mixture was stirred at room temperature overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (184 mg, yield 58%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.96-2.05 (m, 1H), 2.39-2.49 (m, 1H), 2.56-2.66 (m, 1H), 2.81-2.89 (m, 1H), 3.04-3.12 (m, 1H), 3.26-3.36 (m, 1H), 3.91 (s, 2H), 4.07 (s, 6H), 4.50-4.59 (m, 1H), 7.30-7.55 (m, 7H), 8.12 (d, J=2.9 Hz, 1H), 8.60 (s, 1H), 8.73 (d, J=9.3 Hz, 1H), 9.80 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 545 (M++1)
- Chloroform (27 ml) and triethylamine (4 ml) were added to 4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (200 mg) to prepare a solution. Triphosgene (192 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. (3S)-(+)-1-Benzyl-3-aminopyrrolidine (77 mg) was then added thereto, and the mixture was stirred at room temperature overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (153 mg, yield 48%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.95-2.07 (m, 1H), 2.39-2.49 (m, 1H), 2.57-2.67 (m, 1H), 2.82-2.90 (m, 1H), 3.04-3.12 (m, 1H), 3.27-3.36 (m, 1H), 3.92 (s, 2H), 4.07 (s, 6H), 4.50-4.60 (m, 1H), 7.29-7.55 (m, 7H), 8.12 (d, J=2.9 Hz, 1H), 8.60 (s, 1H), 8.73 (d, J=9.5 Hz, 1H), 9.80 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 545 (M++1)
- 3-Aminopyrrolidine (500 mg) was dissolved in acetonitrile (10 ml) to prepare a solution. 2-Chlorobenzyl bromide (0.75 ml), potassium carbonate (2.40 g) were added to the solution, and the mixture was stirred at room temperature for one hr. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform/methanol for development to give 1-(2-chlorobenzyl)-3-pyrrolidinamine (1) (453 mg, yield 37%).
- Chloroform (10 ml) and triethylamine (2 ml) were added to 4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (100 mg) to prepare a solution. Triphosgene (110 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. The compound (1) (106 mg) was then added thereto, and the mixture was stirred at room temperature overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (76 mg, yield 42%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.93-2.03 (m, 1H), 2.39-2.49 (m, 1H), 2.58-2.69 (m, 1H), 2.84-2.92 (m, 1H), 3.11-3.18 (m, 1H), 3.32-3.40 (m, 1H), 4.05 (s, 6H), 4.45-4.53 (m, 1H), 6.44 (d, J=5.4 Hz, 1H), 7.05-7.12 (m, 2H), 7.27-7.34 (m, 2H), 7.38-7.47 (m, 4H), 7.54-7.64 (m, 2H), 8.46 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 533 (M++1)
- Chloroform (10 ml) and triethylamine (2 ml) were added to 4-[(6,7-dimethoxy-4-quinazolinyl)oxy]aniline (100 mg) to prepare a solution. Triphosgene (110 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. 1-(2-Chlorobenzyl)-3-pyrrolidinamine (106 mg) was then added thereto, and the mixture was stirred at room temperature overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (109 mg, yield 61%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.86-1.97 (m, 1H), 2.34-2.47 (m, 1H), 2.51-2.61 (m, 1H), 2.78-2.85 (m, 1H), 3.00-3.07 (m, 1H), 3.21-3.29 (m, 1H), 3.98 (s, 2H), 4.07 (s, 6H), 4.40-4.50 (m, 1H), 5.80-5.90 (m, 1H), 7.13-7.18 (m, 2H), 7.25-7.46 (m, 6H), 7.53-7.57 (m, 2H), 8.60 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 534 (M++1)
- Chloroform (13 ml) and triethylamine (2 ml) were added to 4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (100 mg) to prepare a solution. Triphosgene (96 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. 1-(2-Chlorobenzyl)-3-pyrrolidinamine (92 mg) was then added thereto, and the mixture was stirred at room temperature overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (66 mg, yield 39%).
- 1H-NMR (chloroform-d, 400 MHz): δ 2.05-2.16 (m, 1H), 2.40-2.50 (m, 1H), 2.60-2.69 (m, 1H), 2.87-2.93 (m, 1H), 3.03-3.10 (m, 1H), 3.25-3.33 (m, 1H), 4.04 (s, 2H), 4.07 (s, 6H), 4.51%-4.60 (m, 1H), 7.26-7.56 (m, 5H), 7.62-7.68 (m, 1H), 8.12 (d, J=2.7 Hz, 1H), 8.60 (s, 1H), 8.74 (d, J=9.3 Hz, 1H), 9.79 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 579 (M++1)
- 3-Aminopyrrolidine (500 mg) was dissolved in acetonitrile (10 ml) to prepare a solution. 4-(Tert-butyl)benzyl bromide (1.07 ml) and potassium carbonate (2.40 g) were added to the solution, and the mixture was stirred at room temperature for one hr. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform/methanol for development to give 1-[4-(tert-butyl)benzyl]-3-pyrrolidinamine (1) (589 mg, yield 44%).
- Chloroform (10 ml) and triethylamine (2 ml) were added to 4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (100 mg) to prepare a solution. Triphosgene (110 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. (1) (117 mg) was then added thereto, and the mixture was stirred at room temperature for 5 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (71 mg, yield 38%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.32 (s, 9H), 2.12-2.28 (m, 1H), 2.43-2.55 (m, 1H), 2.83-2.93 (m, 1H), 3.01-3.09 (m, 1H), 3.38-3.45 (m, 1H), 3.62-3.72 (m, 1H), 4.04 (s, 3H), 4.04 (s, 3H), 4.11 (s, 1H), 4.13 (s, 1H), 4.61-4.70 (m, 1H), 6.43 (d, J=5.4 Hz, 1H), 7.04-7.10 (m, 2H), 7.38-7.58 (m, 8H), 8.45 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 555 (M++1)
- Chloroform (10 ml) and triethylamine (2 ml) were added to 4-[(6,7-dimethoxy-4-quinazolinyl)oxy]aniline (100 mg) to prepare a solution. Triphosgene (110 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. 1-[4-(Tert-butyl)benzyl]-3-pyrrolidinamine (117 mg) was then added thereto, and the mixture was stirred at room temperature for 5 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (76 mg, yield 41%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.31 (s, 9H), 2.07-2.12 (m, 1H), 2.37-2.48 (m, 1H), 2.57-2.66 (m, 1H), 2.78-2.88 (m, 1H), 3.11-3.19 (m, 1H), 3.32-3.42 (m, 1H), 3.89 (s, 1H), 3.91 (s, 1H), 4.06 (s, 6H), 4.44-4.55 (m, 1H), 7.12-7.17 (m, 2H), 7.28-7.57 (m, 8H)1 8.60 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 556 (M++1)
- Chloroform (13 ml) and triethylamine (2 ml) were added to 4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (100 mg) to prepare a solution. Triphosgene (96 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. 1-[4-(Tert-butyl)benzyl]-3-pyrrolidinamine (102 mg) was then added thereto, and the mixture was stirred at room temperature overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (38 mg, yield 22%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.32 (s, 9H), 1.92-2.04 (m, 1H), 2.38-2.48 (m, 1H), 2.53-2.64 (m, 1H), 2.78-2.86 (m, 1H), 3.03-3.11 (m, 1H), 3.27-3.35 (m, 1H), 3.86 (s, 1H), 3.87 (s, 1H), 4.07 (s, 6H), 4.50-4.58 (m, 1H), 7.32-7.54 (m, 6H), 8.12 (d, J=2.9 Hz, 1H), 8.60 (s, 1H), 8.71-8.75 (m, 1H), 9.80 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 601 (M++1)
- 3-Aminopyrrolidine (500 mg) was dissolved in acetonitrile (10 ml) to prepare a solution. Cyclohexylmethyl bromide (0.81 ml), potassium carbonate (2.40 g), and tetra-n-butylammonium iodide (100 mg) were added to the solution, and the mixture was stirred at room temperature for 7 hr. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform/methanol for development to give 1-(cyclohexylmethyl)-3-pyrrolidinamine (1) (271 mg, yield 26%).
- Chloroform (10 ml) and triethylamine (2 ml) were added to 4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (100 mg) to prepare a solution. Triphosgene (110 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. The compound (1) (74 mg) was then added thereto, and the mixture was stirred at room temperature for 3 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (85 mg, yield 50%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.00-1.32 (m, 6H), 1.64-1.85 (m, 4H), 1.91-2.03 (m, 2H), 2.27-2.38 (m, 1H), 2.48-2.60 (m, 1H), 2.88-2.98 (m, 2H), 3.65-3.73 (m, 1H), 4.04 (s, 6H), 4.05 (s, 2H), 4.68-4.78 (m, 1H), 6.44 (d, J=5.4 Hz, 1H), 7.06-7.11 (m, 2H), 7.42 (s, 1H), 7.47-7.55 (m, 2H), 7.56 (s, 1H), 8.46 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 505 (M++1)
- Chloroform (10 ml) and triethylamine (2 ml) were added to 4-[(6,7-dimethoxy-4-quinazolinyl)oxy]aniline (100 mg) to prepare a solution. Triphosgene (110 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. 1-(Cyclohexylmethyl)-3-pyrrolidinamine (74 mg) was then added thereto, and the mixture was stirred at room temperature for 3 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (94 mg, yield 55%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.00-1.37 (m, 6H), 1.63-1.88 (m, 4H), 1.90-1.98 (m, 1H), 2.27-2.39 (m, 1H), 2.47-2.60 (m, 1H), 2.84-3.01 (m, 2H), 3.07-3.18 (m, 1H), 3.68-3.78 (m, 1H), 3.95-4.06 (m, 2H), 4.07 (s, 3H), 4.08 (s, 3H), 4.70-4.79 (m, 1H), 7.10-7.17 (m, 2H), 7.41 (s, 1H), 7.52 (s, 1H), 7.52-7.58 (m, 2H), 7.88 (s, 1H), 8.64 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 506 (M++1)
- Chloroform (13 ml) and triethylamine (2 ml) were added to 4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (100 mg) to prepare a solution. Triphosgene (96 mg) was added to the solution, and the mixture was stirred at room temperature for 30 min. 1-(Cyclohexylmethyl)-3-pyrrolidinamine (64 mg) was then added thereto, and the mixture was stirred at room temperature overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (34 mg, yield 21%).
- 1H-NMR (chloroform-d, 400 MHz): δ 0.94-1.34 (m, 6H), 1.61-1.81 (m, 4H), 1.87-1.99 (m, 2H), 2.06-2.20 (m, 1H), 2.40-2.52 (m, 1H), 2.61-2.73 (m, 2H), 2.83-2.93 (m, 1H), 3.28-3.40 (m, 1H), 3.52-3.63 (m, 1H), 4.07 (s, 6H), 4.57-4.68 (m, 1H), 7.33 (s, 1H), 7.51 (s, 2H), 8.12 (d, J=2.9 Hz, 1H), 8.60 (s, 1H), 8.72 (d, J=9.3 HZ, 1H), 9.82 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 551 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, N,N-diethylpropylenediamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 14 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (25 mg, yield %).
- 1H-NMR (CDCl3, 400 MHz): 1.00-1.10 (m, 6H), 1.85-2.00 (m, 2H), 2.55-2.80 (m, 6H), 3.80-3.90 (m, 2H), 4.04 (s, 3H), 4.06 (s, 3H), 6.54 (d, J=5.4 Hz, 1H), 7.19 (d, J=6.8 Hz, 1H), 7.24-7.28 (m, 2H), 7.36-7.44 (m, 2H), 7.44 (s, 1H), 7.516 (s, 1H), 8.51 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 469 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in N,N-dimethylformamide (2 ml) and triethylamine (1 ml) to prepare a solution. Thiophosgene (51 mg) was then added to the solution, and the mixture was stirred at room temperature for 6 hr. Next, N,N-diethylethylenediamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for 14 hr. Ethyl acetate was added to the reaction solution, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (25 mg, yield 33%).
- 1H-NMR (CDCl3, 400 MHz): 0.90-1.10 (m, 6H), 2.45-2.75 (m, 2H), 3.60-3.75 (m, 2H), 4.05 (s, 3H), 4.06 (s, 3H), 6.49 (s, 1H), 7.20-7.38 (m, 4H), 7.43 (s, 1H), 7.53 (s, 1H), 8.50 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 455 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (50 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-amino-1-benzylpiperidine (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to the reaction solution to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (27 mg, yield 32%).
- 1H-NMR (CDCl3, 400 MHz): 1.45-1.55 (m, 2H), 1.95-2.05 (m, 2H), 2.13-2.23 (m, 2H), 2.80-2.90 (m, 2H), 3.52 (s, 2H), 3.70-3.80 (m, 1H), 4.04 (s, 6H), 4.85-4.95 (m, 1H), 6.44 (d, J=5.4 Hz, 1H), 6.80-6.82 (m, 2H), 7.10-7.14 (m, 2H), 7.26-7.34 (m, 5H), 7.40-7.44 (m, 2H), 7.55 (s, 1H), 8.46 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 513 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (50 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-amino-1-benzylpiperidine (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to the reaction solution to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (30 mg, yield 35%).
- 1H-NMR (CDCl3, 400 MHz): 1.45-1.60 (m, 2H), 1.95-2.05 (m, 2H), 2.15-2.25 (m, 2H), 2.80-2.90 (m, 2H), 3.55 (s, 2H), 3.70-3.80 (m, 1H), 4.07 (s, 6H), 4.70-4.80 (m, 1H), 4.47 (s, 1H), 7.19 (d, J=9.2 Hz, 1H), 7.30-7.34 (m, 5H), 7.40 (d, J=8.8 Hz, 2H), −7.55 (s, 1H), 8.62 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 514 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (50 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-aminopiperidine (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to the reaction solution to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (40 mg, yield 56%).
- 1H-NMR (CDCl3, 400 MHz): 1.60-1.85 (m, 6H), 2.33-2.46 (m, 2H), 3.15-3.25 (m, 2H), 4.057 (s, 3H), 4.059 (s, 3H), 5.33 (s, 1H), 6.45 (d, J=5.4 Hz, 1H), 7.14 (d, J=9.0 Hz, 2H), 7.45 (s, 1H), 7.57-7.62 (m, 3H), 8.23 (s, 1H), 8.47 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 423 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (50 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-aminopiperidine (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to the reaction solution to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (40 mg, yield 58%).
- 1H-NMR (CDCl3, 400 MHz): 1.50-1.90 (m, 6H), 2.12 (s, 3H), 2.25 (s, 3H), 2.35-2.50 (m, 2H), 3.15-3.25 (m, 2H), 4.07 (s, 3H), 4.08 (s, 3H), 5.41 (s, 1H), 6.30 (d, J=5.6 Hz, 1H), 7.00 (d, J=8.8 Hz, 1H), 7.53 (s, 1H), 7.64 (s, 1H), 7.84 (d, J=8.8 Hz, 1H), 8.25 (s, 1H), 8.43 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 451 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-nitroaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (50 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-aminopiperidine (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to the reaction solution to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (35 mg, yield 51%).
- 1H-NMR (CDCl3, 400 MHz): 1.60-1.85 (m, 6H), 2.43-2.48 (m, 2H), 3.15-3.25 (m, 2H), 4.09 (s, 3H), 4.12 (s, 3H), 5.63 (s, 1H), 6.59 (d, J=5.6 Hz, 1H), 7.47-7.52 (m, 1H), 7.57 (s, 1H), 7.82 (m, 1H), 8.12 (d, J=2.9 Hz, 1H), 9.00 (d, J=9.3 Hz, 1H), 11.42 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 468 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-chloroaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (50 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-aminopiperidine (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to the reaction solution to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (38 mg, yield 55%).
- 1H-NMR (CDCl3, 400 MHz): 1.60-1.85 (m, 6H), 2.35-2.50 (m, 2H), 3.15-3.25 (m, 2H), 4.07 (s, 6H), 5.45-5.50 (m, 1H), 7.15-7.19 (m, 1H), 7.34-7.36 (m, 2H), 7.53 (s, 1H), 8.44-8.47 (m, 1H), 8.63 (d, J=1.2 Hz, 1H), 9.04 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 468 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-methoxyaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (50 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-aminopiperidine (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to the reaction solution to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (45 mg, yield 65%).
- 1H-NMR (CDCl3, 400 MHz): 1.60-1.85 (m, 6H), 2.30-2.45 (m, 2H), 3.10-3.20 (m, 2H), 3.91 (s, 3H), 4.07 (s, 6H), 5.30-5.40 (m, 1H), 6.79 (d, J=2.4 Hz, 1H), 6.82-6.86 (m, 1H), 7.33 (d, J=2.2 Hz, 1H), 7.57 (d, J=1.0 Hz, 1H), 8.33 (dd, J=1.2 Hz, J=8.5 Hz, 1H), 8.63 (d, J=1.5 Hz, 1H), 8.80 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 454 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (50 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-aminopiperidine (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to the reaction solution to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (50 mg, yield 73%).
- 1H-NMR (CDCl3, 400 MHz): 1.50-2.00 (m, 6H), 2.38-2.48 (m, 2H), 3.15-3.20 (m, 2H), 4.08 (s, 3H), 4.09 (s, 3H), 5.57 (s, 1H), 7.36 (s, 1H), 7.53-7.57 (m, 2H), 8.17 (d, J=2.9 Hz, 1H), 8.61 (s, 1H), 8.93 (d, J=9.3 Hz, 1H), 11.41 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 469 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methoxyaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (50 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-aminopiperidine (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to the reaction solution to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (43 mg, yield 62%).
- 1H-NMR (CDCl3, 400 MHz): 1.50-1.80 (m, 6H), 2.30-2.45 (m, 2H), 3.15-3.25 (m, 2H), 3.89 (s, 3H), 4.07 (s, 6H), 5.33 (s, 1H), 6.50 (d, J=5.6 Hz, 1H), 6.72 (d, J=2.4 Hz, 1H), 6.80 (dd, J=2.4 Hz, J=8.8 Hz, 1H), 7.52 (s, 1H), 7.59 (s, 1H), 8.32 (d, J=8.8 Hz, 1H), 8.47 (d, J=5.4 Hz, 1H), 8.80 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 453 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-methoxyaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (50 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-aminomorpholine (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to the reaction solution to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (26 mg, yield 37%).
- 1H-NMR (CDCl3, 400 MHz): 2.60-2.75 (m, 2H), 2.90-3.10 (m, 2H), 3.40-3.55 (m, 2H), 3.65-3.80 (m, 2H), 3.91 (s, 3H), 4.07 (s, 3H), 4.08 (s, 3H), 5.45 (s, 1H), 6.80 (d, J=2.7 Hz, 1H), 6.85 (dd, J=2.4 Hz, J=8.8 Hz, 1H), 7.34 (s, 1H), 7.56 (s, 1H), 8.33 (d, J=8.8 Hz, 1H), 8.63 (s, 1H), 8.73 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 456 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methoxyaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (50 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-aminohomopiperidine (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to the reaction solution to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (35 mg, yield 49%).
- 1H-NMR (CDCl3, 400 MHz): 1.50-1.90 (m, 8H), 2.85-3.00 (m, 2H), 3.05-3.20 (m, 2H), 3.90 (s, 3H), 4.07 (s, 3H), 4.08 (s, 3H), 5.66 (s, 1H), 6.75-6.90 (m, 2H), 7.32 (s, 1H), 7.57 (s, 1H), 8.35 (d, J=8.5 Hz, 1H), 8.63 (s, 1H), 8.95 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 468 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (50 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-aminomorpholine (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to the reaction solution to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (47 mg, yield 66%).
- 1H-NMR (CDCl3, 400 MHz): 2.50-2.70 (m, 2H), 2.90-3.10 (m, 2H), 3.65-3.85 (m, 2H), 3.85-4.00 (m, 2H), 4.07 (s, 3H), 4.08 (s, 3H), 5.45 (s, 1H), 7.21 (d, J=9.0 Hz, 2H), 7.33 (s, 1H), 7.56 (s, 1H), 7.60 (d, J=9.0 Hz, 2H), 8.12 (s, 1H), 8.61 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 426 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (50 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-aminohomopiperidine (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to the reaction solution to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (48 mg, yield 65%).
- 1H-NMR (CDCl3, 400 MHz): 1.55-1.85 (m, 8H), 2.85-3.00 (m, 2H), 3.05-3.20 (m, 2H), 4.07 (s, 3H), 4.08 (s, 3H), 5.67 (s, 1H), 7.19 (d, J=9.0 Hz, 2H), 7.33 (s, 1H), 7.57 (s, 1H), 7.60 (d, J=8.8 Hz, 2H), 8.33 (s, 1H), 8.62 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 438 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (50 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-aminopiperidine (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to the reaction solution to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (47 mg, yield 66%).
- 1H-NMR (CDCl3, 400 MHz): 1.50-1.80 (m, 6H), 2.30-2.45 (m, 2H), 3.10-3.20 (m, 2H), 4.07 (s, 3H), 4.08 (s, 3H), 5.40-5.50 (m, 1H), 7.19 (d, J=8.8 Hz, 2H), 7.35 (s, 1H), 7.57 (s, 1H), 7.59 (d, J=8.8 Hz, 2H), 8.25 (s, 1H), 8.62 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 424 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (50 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-amino-1-benzylpiperidine (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to the reaction solution to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (45 mg, yield 55%).
- 1H-NMR (CDCl3, 400 MHz): 2.07-2.18 (m, 4H), 2.24 (s, 3H), 2.40-2.54 (m, 1H), 2.80-2.95 (m, 1H), 3.25-3.30 (m, 1H), 3.45-3.60 (m, 2H), 4.05 (s, 3H), 4.06 (s, 3H), 4.09 (d, J=12.7 Hz, 1H), 4.14 (d, J=12.7 Hz, 1H), 4.60 (s, 1H), 6.30 (d, J=5.4 Hz, 1H), 6.90-7.00 (m, 2H), 7.10-7.54 (m, 7H), 7.61 (s, 1H), 8.63 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 527 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-chloroaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (50 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-amino-1-benzylpiperidine (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to the reaction solution to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (35 mg, yield 43%).
- 1H-NMR (CDCl3, 400 MHz): 1.73-1.80 (m, 2H), 2.25-2.40 (m, 2H), 2.56-2.63 (m, 1H), 2.71-2.76 (m, 1H), 2.98-3.00 (m, 1H), 3.62 (d, J=12.7 Hz, 1H), 3.66 (d, J=12.9 Hz, 1H), 4.07 (s, 6H), 4.30-4.40 (m, 1H), 5.30 (br, 1H), 7.14-7.18 (m, 1H), 7.30-7.33 (m, 7H), 7.52 (s, 1H), 8.17-8.22 (m, 1H), 8.63 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 534 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (50 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-amino-1-benzylpiperidine (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to the reaction solution to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (45 mg, yield 57%).
- 1H-NMR (CDCl3, 400 MHz): 1.75-1.80 (m, 2H), 2.32-2.43 (m, 2H), 2.62-2.68 (m, 1H), 2.73-2.78 (m, 1H), 2.95-3.01 (m, 1H), 3.68 (s, 2H), 4.07 (s, 3H), 4.08 (s, 3H), 4.41 (s, 1H), 5.48 (s, 1H), 7.27-7.36 (m, 6H), 7.50-7.55 (m, 2H), 8.13 (d, J=2.7 Hz, 1H), 8.60 (s, 1H), 8.77 (d, J=9.3 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 545 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methoxyaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (50 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 4-amino-1-benzylpiperidine (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to the reaction solution to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (55 mg, yield 68%).
- 1H-NMR (CDCl3, 400 MHz): 1.80-1.90 (m, 1H), 2.35-2.50 (m, 2H), 2.70-2.75 (m, 1H), 2.88-2.93 (m, 1H), 3.09-3.16 (m, 1H), 3.23-3.31 (m, 1H), 3.75 (d, J=12.9 Hz, 1H), 3.79 (d, J=12.9 Hz, 1H), 3.84 (s, 3H), 4.07 (s, 6H), 4.45-4.55 (m, 1H), 5.67 (d, J=7.6 Hz, 1H), 6.77 (d, J=2.4 Hz, 1H), 6.82 (dd, J=2.4 Hz, J=8.8 Hz, 1H), 6.92 (s, 1H), 7.30-7.40 (m, 5H), 7.55 (s, 1H), 8.63 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 530 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (50 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-aminohomopiperidine (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to the reaction solution to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (35 mg, yield 47%).
- 1H-NMR (CDCl3, 400 MHz): 1H-NMR (CDCl3, 400 MHz): 1.50-1.80 (m, 8H), 2.85-3.00 (m, 2H), 3.10-3.20 (m, 2H), 4.055 (s, 3H), 4.059 (s, 3H), 5.66 (s, 1H), 6.45 (d, J=5.4 Hz, 1H), 7.14 (d, J=6.8 Hz, 2H), 7.44 (s, 1H), 7.58 (s, 1H), 7.59 (d, J=6.8 Hz, 2H), 8.32 (s, 1H), 8.47 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 437 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (50 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-aminohomopiperidine (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to the reaction solution to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (43 mg, yield 55%).
- 1H-NMR (CDCl3, 400 MHz): 1.55-1.85 (m, 8H), 2.85-3.00 (m, 2H), 3.10-3.20 (m, 2H), 4.07 (s, 3H), 4.09 (s, 3H), 5.80 (s, 1H), 6.55 (d, J=5.6 Hz, 1H), 6.98-7.03 (m, 2H), 7.55 (s, 1H), 7.65 (s, 1H), 8.37-8.43 (m, 1H), 8.50 (d, J=5.9 Hz, 1H), 8.65-8.70 (m, 1H)
- Mass spectrometry value (ESI-MS, m/z): 491 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (50 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-aminopyrrolidine (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to the reaction solution to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (47 mg, yield 69%).
- 1H-NMR (CDCl3, 400 MHz): 1.86-2.00 (m, 4H), 2.50-2.70 (m, 2H), 2.85-3.05 (m, 2H), 4.05 (s, 3H), 4.06 (s, 3H), 6.05 (s, 1H), 6.50 (d, J=5.4 Hz, 1H), 6.95-7.05 (m, 2H), 7.45 (s, 1H), 7.53 (s, 1H), 8.30-8.35 (m, 1H), 8.45-8.55 (m, 2H)
- Mass spectrometry value (ESI-MS, m/z): 463 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (50 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, methylhydrazine (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to the reaction solution to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (47 mg, yield 76%).
- 1H-NMR (CDCl3, 400 MHz): 3.18 (s, 3H), 4.06 (s, 3H), 4.08 (s, 3H), 6.55 (d, J=8.5 Hz, 1H), 7.53 (s, 1H), 7.60 (s, 1H), 8.05 (s, 1H), 8.37 (t, J=9.3 Hz, 1H), 8.49 (d, J=5.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 423 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (50 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, phenylhydrazine (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to the reaction solution to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (47 mg, yield 66%).
- 1H-NMR (CDCl3, 400 MHz): 4.06 (s, 3H), 4.08 (s, 3H), 5.95 (s, 1H), 6.36 (s, 1H), 6.55 (d, J=5.6 Hz, 1H), 6.94-7.07 (m, 5H), 7.30-7.36 (m, 2H), 7.53 (s, 1H), 7.62 (s, 1H), 8.15-8.20 (m, 1H), 8.38 (d, J=9.0 Hz, 1H), 8.49 (d, J=5.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 485 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was added to toluene (5 ml), and triethylamine (0.5 ml), and the mixture was heated under reflux to prepare a solution. A solution of triphosgene (50 mg) in methylene chloride was then added thereto, and the mixture was heated under reflux for 10 min. Next, 1-aminopiperidine (50 mg) was added thereto, and the mixture was further stirred with heating under reflux for 3 hr. A saturated aqueous sodium bicarbonate solution was added to the reaction solution to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with water and saturated brine in that order. The organic layer was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by HPLC using chloroform/methanol for development to give the title compound (43 mg, yield 61%)
- 1H-NMR (CDCl3, 400 MHz): 1.60-1.90 (m, 6H), 2.35-2.50 (m, 2H), 3.15-3.25 (m, 2H), 4.06 (s, 3H), 4.08 (s, 3H), 5.49 (s, 1H), 6.54 (d, J=5.6 Hz, 1H), 6.96-7.03 (m, 2H), 7.55 (s, 1H), 7.61 (s, 1H), 8.35-8.40 (m, 1H), 8.50 (d, J=5.6 Hz, 1H), 8.53-8.56 (m, 1H)
- Mass spectrometry value (ESI-MS, m/z): 477 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml), and ethanol (1 ml) to prepare a solution. Commercially available 2-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was then added thereto, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (78 mg, yield 97%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.17 (s, 3H), 4.09 (s, 3H), 4.13 (s, 3H), 6.69 (d, J=5.86 Hz, 1H), 7.26-7.36 (m, 5H), 7.47-7.49 (m, 1H), 7.58 (d, J=8.05 Hz, 1H), 7.61 (s, 1H), 7.88 (bs, 1H), 7.94 (d, J=9.03 Hz, 2H), 8.52 (d, J=5.86 Hz, 1H), 8.89 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 474 (M++1)
- According to the descrition of technical literature, commercially available 2-phenylethanoyl chloride (80 mg) was dissolved in acetonitrile (20 ml). Potassium thiocyanate (300 mg) was added to the solution, and the mixture was heated at 80° C. for 2 hr. Water was added to the reaction solution, and the organic layer was extracted and was concentrated to give 2-phenylethanoyl isothiocyanate. 2-Phenylethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (66 mg, yield 85%) (Referenc: Elmore, D. T. et al., Journal of chemical Society 1956, 4458).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.84 (s, 2H), 3.94 (s, 3H), 3.95 (s, 3H), 6.50 (d, J=5.37 Hz, 1H), 7.27-7.55 (m, 9H), 8.01 (dd, J=2.07 Hz, J=12.32 Hz, 1H), 8.51 (d, J=5.37 Hz, 1H), 11.82 (s, 1H), 2.49 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- In the following examples, when carbonyl isothiocyanate is used, except for the case where the carbonyl isothiocyanate is purchasable, this compound was prepared from a fatty acid or an acid chloride by the method described in Example 615 according to the method of the literature and was used in the reaction without isolation and purification
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was dissolved in chloroform (5 ml), and triethylamine (0.5 ml) to prepare a solution. A solution of triphosgene (68 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 2-morpholino-1-ethanamine (30 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (70 mg, yield 84%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.15 (s, 3H), 2.26 (s, 3H), 2.47 (s, 4H), 2.52-2.55 (m, 2H), 3.38-3.42 (m, 2H), 3.63-3.66 (m, 4H), 4.05 (s, 3H), 4.07 (s, 3H), 5.43-5.45 (m, 1H), 6.30 (d, J=5.4 Hz, 1H), 6.49 (s, 1H), 6.97 (s, 1H), 7.43 (s, 1H), 7.47 (s, 1H), 7.59 (s, 1H), 8.45 (d, J=5.1 Hz, 1H)
- 4-[(6,7-Dimethyl-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was dissolved in chloroform (5 ml), and triethylamine (0.5 ml) to prepare a solution. A solution of triphosgene (68 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 2-morpholino-1-ethanamine (30 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (90 mg, yield 100%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.14 (s, 3H), 2.28 (s, 3H), 2.48-2.53 (m, 6H), 3.24-3.41 (m, 2H), 3.62-3.64 (m, 4H), 4.06 (s, 3H), 4.07 (s, 3H), 5.31-5.32 (m, 1H), 6.26 (d, J=5.4 Hz, 1H), 6.49 (s, 1H), 7.01 (d, J=8.5 Hz, 1H), 7.32 (d, J=8.5 Hz, 1H), 7.44 (s, 1H), 7.61 (s, 1H), 8.45 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 481 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in chloroform (5 ml), and triethylamine (0.5 ml) to prepare a solution. A solution of triphosgene (77 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 2-tetrahydro-1H-1-pyrrolyl-1-ethanamine (30 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (40 mg, yield 46%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.82-1.90 (m, 4H), 2.68-2.85 (m, 6H), 3.38-3.46 (m, 2H), 4.05 (s, 6H), 5.35 (s, 1H), 5.97 (s, 1H), 6.44 (d, J=5.4 Hz, 1H), 7.09 (d, J=8.8 Hz, 2H), 7.41 (s, 1H), 7.48 (d, J=8.8 Hz, 2H), 7.57 (s, 1H), 8.46 (d, J=5.4 Hz, 1H)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was dissolved in chloroform (5 ml), and triethylamine (0.5 ml) to prepare a solution. A solution of triphosgene (68 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 2-tetrahydro-1H-1-pyrrolyl-1-ethanamine (26 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (26 mg, yield 32%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.86 (s, 4H), 2.13 (s, 3H), 2.26 (s, 3H), 2.70-2.77 (m, 4H), 2.81 (t, J=5.6 Hz, 2H), 3.45-3.49 (m, 2H), 4.05 (s, 3H), 4.06 (s, 3H), 5.89 (s, 1H), 6.30 (d, J=5.1 Hz, 1H), 6.93 (s, 1H), 7.42 (s, 1H), 7.55 (s, 1H), 7.59 (s, 1H), 8.44 (d, J=5.1 Hz, 1H)
- 4-[(6,7-Dimethyl-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was dissolved in chloroform (5 ml), and triethylamine (0.5 ml) to prepare a solution. A solution of triphosgene (68 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 2-tetrahydro-1H-1-pyrrolyl-1-ethanamine (26 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (21 mg, yield 26%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.86 (s, 4H), 2.11 (s, 3H), 2.27 (s, 3H), 2.76 (s, 4H), 2.82 (t, J=5.6 Hz, 2H), 3.42-3.49 (m, 2H), 4.05 (s, 3H), 4.06 (s, 3H), 5.86 (s, 1H), 6.27 (d, J=5.1 Hz, 1H), 6.97 (d, J=8.8 Hz, 1H), 7.39 (d, J=8.8 Hz, 1H), 7.43 (s, 1H), 7.61 (s, 1H), 8.43 (d, J=5.1 Hz, 1H)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in chloroform (5 ml), and triethylamine (0.5 ml) to prepare a solution. A solution of triphosgene (77 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 2-tetrahydro-1H-1-pyrrolyl-1-ethanamine (30 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (8 mg, yield 9%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.86 (s, 4H), 2.72-2.92 (m, 6H), 3.39-3.45 (m, 2H), 4.06 (s, 3H), 4.07 (s, 3H), 5.42 (s, 1H), 7.16 (d, J=9.0 Hz, 2H), 7.31 (s, 1H), 7.48 (d, J=8.8 Hz, 2H), 7.56 (s, 1H), 8.61 (s, 1H)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in chloroform (5 ml), and triethylamine (0.5 ml) to prepare a solution. A solution of triphosgene (77 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-diethyl-1,2-ethanediamine (30 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (10 mg, yield 13%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.12 (t, J=7.1 Hz, 6H), 2.66-2.71 (m, 6H), 3.35-3.36 (m, 2H), 4.05 (s, 6H), 6.46 (d, J=5.4 Hz, 1H), 7.10-7.13 (m, 2H), 7.42 (s, 1H), 7.45 (d, J=9.0 Hz, 2H), 7.57 (s, 1H), 8.47 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 439 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was dissolved in chloroform (5 ml), and triethylamine (0.5 ml) to prepare a solution. A solution of triphosgene (68 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-diethyl-1,2-ethanediamine (27 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (7 mg, yield 10%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.12 (t, J=7.1 Hz, 6H), 2.13 (s, 3H), 2.27 (s, 3H), 2.70-2.77 (m, 6H), 3.43-3.45 (m, 2H), 4.05 (s, 3H), 4.06 (s, 3H), 6.30 (d, J=5.4 Hz, 1H), 6.95 (s, 1H), 7.42 (s, 1H), 7.49 (s, 1H), 7.59 (s, 1H), 8.44 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 467 (M++1)
- 4-[(6,7-Dimethyl-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was dissolved in chloroform (5 ml), and triethylamine (0.5 ml) to prepare a solution. A solution of triphosgene (68 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-diethyl-1,2-ethanediamine (27 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (8 mg, yield 11%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.03 (t, J=7.1 Hz, 6H), 2.12 (s, 3H), 2.28 (s, 3H), 2.58-2.67 (m, 6H), 3.35-3.38 (m, 2H), 4.06 (s, 3H), 4.07 (s, 3H), 6.26 (d, J=5.4 Hz, 1H), 6.98 (d, J=8.8 Hz, 1H), 7.32 (d, J=8.8 Hz, 1H), 7.43 (s, 1H), 7.61 (s, 1H), 8.43 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 467 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (50 mg) was dissolved in chloroform (5 ml), and triethylamine (0.5 ml) to prepare a solution. A solution of triphosgene (68 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-dimethyl-1,2-ethanediamine (20 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (24 mg, yield 36%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.03 (s, 3H), 2.13 (s, 3H), 2.25 (s, 3H), 2.28 (s, 3H), 2.51 (s, 2H), 3.38-3.39 (m, 2H), 4.05 (s, 3H), 4.06 (s, 3H), 5.59 (s, 1H), 6.30 (d, J=4.9 Hz, 1H), 6.94 (s, 1H), 7.42 (s, 1H), 7.55 (s, 1H), 7.59 (s, 1H), 8.44 (d, J=5.1 Hz, 1H)
- 4-[(6,7-Dimethyl-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was dissolved in chloroform (5 ml), and triethylamine (0.5 ml) to prepare a solution. A solution of triphosgene (68 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-dimethyl-1,2-ethanediamine (20 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (18 mg, yield 28%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.02 (s, 3H), 2.12 (s, 3H), 2.26 (s, 6H), 2.44-2.51 (m, 2H), 3.37-3.38 (m, 2H), 4.06 (s, 3H), 4.07 (s, 3H), 5.45 (s, 1H), 6.26 (d, J=5.1 Hz, 1H), 6.99 (d, J=8.8 Hz, 1H), 7.38 (d, J=8.3 Hz, 1H), 7.43 (s, 1H), 7.61 (s, 1H), 8.44 (d, J=5.1 Hz, 1H)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in chloroform (5 ml), and triethylamine (0.5 ml) to prepare a solution. A solution of triphosgene (77 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-dimethyl-1,2-ethanediamine (23 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (14 mg, yield 21%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.27 (s, 3H), 2.34 (s, 3H), 2.46-2.49 (m, 2H), 3.31-3.35 (m, 2H), 4.07 (s, 6H), 5.14 (s, 1H), 5.59 (s, 1H), 7.16 (d, J=8.3 Hz, 2H), 7.31 (s, 1H), 7.47 (d, J=8.5 Hz, 2H), 7.56 (s, 1H), 8.61 (s, 1H)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (100 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 2-morpholino-1-ethanamine (66 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (162 mg, yield 100%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.46-2.48 (m, 4H), 2.54 (t, J=5.9 Hz, 2H), 3.40 (q, J=5.4 Hz, 2H), 3.64 (t, J=4.6 Hz, 4H), 4.03 (s, 3H), 4.05 (s, 3H), 5.59 (s, 1H), 6.45 (d, J=5.4 Hz, 1H), 7.12 (d, J=8.8 Hz, 2H), 7.41 (s, 1H), 7.47 (d, J=8.8 Hz, 2H), 7.57 (s, 1H), 8.47 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 453 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (100 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 2-morpholino-1-ethanamine (66 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (41 mg, yield 27%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.45 (t, J=4.1 Hz, 4H), 2.51 (t, J=5.6 Hz, 2H), 3.38 (q, J=5.6 Hz, 2H), 3.63 (t, J=4.6 Hz, 4H), 4.06 (s, 3H), 4.07 (s, 3H), 5.66 (t, J=5.1 Hz, 1H), 7.17 (d, J=8.8 Hz, 2H), 7.31 (s, 1H), 7.44 (d, J=8.8 Hz, 2H), 7.55 (s, 1H), 7.64 (s, 1H), 8.60 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 454 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-methoxyaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (140 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-diethyl-1,2-ethanediamine (55 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (83 mg, yield 57%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.39 (t, J=7.3 Hz, 6H), 3.11-3.20 (m, 6H), 3.65-3.68 (m, 2H), 3.85 (s, 3H), 4.065 (s, 3H), 4.067 (s, 3H), 6.77-6.82 (m, 2H), 7.30 (s, 1H), 7.54 (s, 1H), 7.62 (s, 1H), 8.16 (d, J=8.8 Hz, 1H), 8.61 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 470 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-methoxyaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (140 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 2-morpholino-1-ethanamine (61 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (165 mg, yield 100%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.49-2.57 (m, 6H), 3.39-3.43 (m, 2H), 3.70-3.73 (m, 4H), 3.84 (s, 3H), 4.068 (s, 3H), 4.072 (s, 3H), 5.53 (s, 1H), 6.79-6.86 (m, 2H), 6.97-6.98 (m, 1H), 7.33 (s, 1H), 7.55 (s, 1H), 8.14 (d, J=8.8 Hz, 1H), 8.63 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 484 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-methoxyaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (140 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 2-tetrahydro-1H-1-pyrrolyl-1-ethanamine (54 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (26 mg, yield 18%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.16-2.19 (m, 4H), 3.08-3.14 (m, 4H), 3.31-3.34 (m, 2H), 3.70-3.74 (m, 2H), 3.87 (s, 3H), 4.065 (s, 3H), 4.068 (s, 3H), 6.76-6.81 (m, 2H), 7.31 (s, 1H), 7.36 (s, 1H), 7.55 (s, 1H), 7.59 (s, 1H), 8.19 (d, J=8.5 Hz, 1H), 8.62 (s, 1H)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-methoxyaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (140 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 3-(4-methylpiperazino)-1-propaneamine (74 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (62 mg, yield 39%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.70-1.75 (m, 2H), 2.29 (d, J=7.6 Hz, 3H), 2.41-2.52 (m, 10H), 3.24-3.46 (m, 2H), 3.84 (d, J=4.4 Hz, 3H), 4.07 (s, 6H), 6.77-6.85 (m, 3H), 7.32 (d, J=1.7 Hz, 1H), 7.55 (s, 1H), 8.18 (d, J=8.8 Hz, 1H), 8.63 (s, 1H)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (140 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 1-benzyl-4-piperidineamine (89 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (124 mg, yield 74%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.43-1.51 (m, 2H), 1.97-1.99 (m, 4H), 2.14 (s, 3H), 2.21 (s, 3H), 2.82-2.84 (m, 2H), 3.50 (s, 2H), 4.047 (s, 3H), 4.053 (s, 3H), 4.95 (d, J=7.8 Hz, 1H), 6.30 (d, J=5.4 Hz, 1H), 6.35 (s, 1H), 6.94 (s, 1H), 7.27-7.31 (m, 5H), 7.43 (s, 1H), 7.51 (s, 1H), 7.59 (s, 1H), 8.45 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 541 (M++1)
- 4-[(6,7-Dimethyl-4-quinolyl)oxy]-2,3-dimethylaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (139 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 1-benzyl-4-piperidineamine (89 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (101 mg, yield 60%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.41-1.44 (m, 2H), 1.95-1.97 (m, 4H), 2.13 (s, 3H), 2.25 (s, 3H), 2.81 (d, J=11.7 Hz, 2H), 3.4.9 (s, 2H), 3.71-3.75 (m, 1H), 4.05 (s, 3H), 4.06 (s, 3H), 6.26 (d, J=5.4 Hz, 1H), 6.99 (d, J=8.5 Hz, 1H), 7.26-7.32 (m, 7H), 7.44 (s, 1H), 7.61 (s, 1H), 8.45 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 541 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (151 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 1-benzyl-4-piperidineamine (97 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (142 mg, yield 81%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.41-1.51 (m, 2H), 1.94-1.96 (m, 2H), 2.07-2.16 (m, 2H), 2.79-2.82 (m, 2H), 3.48 (s, 2H), 3.68-3.75 (m, 1H), 4.05 (s, 6H), 5.09 (d, J=7.8 Hz, 1H), 7.07 (s, 1H), 7.16 (d, J=9.0 Hz, 2H), 7.26-7.31 (m, 5H), 7.40 (d, J=9.0 Hz, 2H), 7.54 (s, 1H), 8.59 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 514 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (134 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 1-benzyl-4-piperidineamine (85 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (185 mg, yield 100%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.40-1.55 (m, 2H), 1.93-1.99 (m, 2H), 2.12-2.17 (m, 2H), 2.81-2.83 (m, 2H), 3.49 (s, 2H), 3.70-3.74 (m, 1H), 4.05 (s, 3H), 4.06 (s, 3H), 5.74 (d, J=7.8 Hz, 1H), 7.13-7.16 (m, 1H), 7.23-7.32 (m, 7H), 7.51 (s, 1H), 8.29 (d, J=9.0 Hz, 1H), 8.61 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 548 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-nitroaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (131 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 1-benzyl-4-piperidineamine (84 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (141 mg, yield 86%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.55-1.63 (m, 2H), 1.97-2.03 (m, 4H), 2.81-2.90 (m, 2H), 3.53 (s, 2H), 3.72-3.73 (m, 1H), 4.04 (s, 3H), 4.05 (s, 3H), 5.35-5.36 (m, 1H), 6.47 (d, J=5.1 Hz, 1H), 7.26-7.50 (m, 7H), 8.01 (d, J=2.9 Hz, 1H), 8.52 (d, J=5.4 Hz, 1H), 8.77 (d, J=9.3 Hz, 1H), 9.72 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 558 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (142 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 1-benzyl-4-piperidineamine (91 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (47 mg, yield 28%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.47-1.55 (m, 2H), 1.98-2.00 (m, 2H), 2.15-2.20 (m, 2H), 2.84-2.87 (m, 2H), 3.53 (s, 2H), 3.70-3.80 (m, 1H), 4.04 (s, 3H), 4.05 (s, 3H), 4.89 (d, J=7.3 Hz, 1H), 6.40 (d, J=5.1 Hz, 1H), 6.93 (s, 1H), 7.06-7.17 (m, 2H), 7.26-7.32 (m, 5H), 7.41 (s, 1H), 7.49-7.53 (m, 1H), 7.58 (s, 1H) 8.47 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 531 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (131 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 1-benzyl-4-piperidineamine (89 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (151 mg, yield 93%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.54-1.63 (m, 2H), 2.01-2.03 (m, 2H), 2.16-2.21 (m, 2H), 2.87-2.90 (m, 2H), 3.54 (s, 2H), 3.72-3.73 (m, 1H), 4.07 (s, 3H), 4.08 (s, 3H), 4.97 (brs, 1H), 7.26-7.34 (m, 5H), 7.51-7.56 (m, 2H), 8.13 (d, J=2.9 Hz, 1H), 8.60 (s, 1H), 8.80 (d, J=9.5 Hz, 1H), 9.77 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 559 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-methoxyaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (139 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 1-benzyl-4-piperidineamine (89 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (118 mg, yield 71%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.47-1.54 (m, 2H), 1.98-2.01 (m, 2H), 2.13-2.19 (m, 2H), 2.83-2.86 (m, 2H), 3.52 (s, 2H), 3.70-3.73 (m, 1H), 3.85 (s, 3H), 4.07 (s, 6H), 4.66 (d, J=8.1 Hz, 1H), 6.71 (s, 1H), 6.78 (d, J=2.4 Hz, 1H), 6.82-6.85 (m, 1H), 7.26-7.52 (m, 5H), 7.55 (s, 1H), 8.10 (d, J=8.8 Hz, 1H), 8.63 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 544 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-methylaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (142 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 1-benzyl-4-piperidineamine (91 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (84 mg, yield 50%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.46-1.54 (m, 2H), 1.97-2.00 (m, 2H), 2.13 (s, 3H), 2.13-2.23 (m, 2H), 2.82-2.85 (m, 2H), 3.51 (s, 2H), 3.73-3.75 (m, 1H), 4.04 (s, 3H), 4.05 (s, 3H), 4.98 (d, J=7.8 Hz, 1H), 6.27 (d, J=5.4 Hz, 1H), 6.90 (s, 1H), 7.02 (d, J=8.5 Hz, 1H), 7.18-7.21 (m, 1H), 7.25-7.31 (m, 4H), 7.36 (d, J=2.4 Hz, 1H), 7.42 (s, 1H), 7.60 (s, 1H), 8.43 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 527 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methylaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (142 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 1-benzyl-4-piperidineamine (91 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (88 mg, yield 52%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.42-1.50 (m, 2H), 1.96-1.98 (m, 2H), 2.12-2.18 (m, 2H), 2.28 (s, 3H), 2.81-2.84 (m, 2H), 3.50 (s, 2H), 3.73-3.75 (m, 1H), 4.04 (s, 3H), 4.05 (s, 3H), 4.68 (d, J=7.6 Hz, 1H), 6.15 (s, 1H), 6.49 (d, J=5.4 Hz, 1H), 7.02-7.05 (m, 2H), 7.23-7.33 (m, 4H), 7.43 (s, 1H), 7.53-7.55 (m, 2H), 8.50 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 527 (M++1)
- 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (134 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 1-benzyl-4-piperidineamine (86 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (112 mg, yield 68%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.44-1.53 (m, 2H), 1.96-1.98 (m, 2H), 2.12-2.17 (m, 2H), 2.80-2.83 (m, 2H), 3.49 (s, 2H), 3.72-3.74 (m, 1H), 4.03 (s, 3H), 4.04 (s, 3H), 5.18 (d, J=7.8 Hz, 1H), 6.29 (d, J=5.4 Hz, 1H), 7.12 (d, J=8.8 Hz, 1H), 7.23-7.32 (m, 5H), 7.39-7.40 (m, 2H), 7.60 (s, 1H), 7.64 (d, J=2.4 Hz, 1H), 8.44 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 547 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (139 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-diethyl-1,2-ethanediamine (52 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (64 mg, yield 45%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.16 (t, J=7.3 Hz, 6H), 2.75-2.83 (m, 6H), 3.45-3.49 (m, 2H), 4.07 (s, 6H), 6.41 (brs, 1H), 7.14-7.17 (m, 1H), 7.28-7.32 (m, 2H), 7.51 (s, 1H), 8.20 (d, J=9.0 Hz, 1H), 8.62 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 474 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-nitroaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (131 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-diethyl-1,2-ethanediamine (51 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (65 mg, yield 46%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.16-1.20 (m, 6H), 2.77-2.86 (m, 6H), 3.48-3.52 (m, 2H), 4.05 (s, 3H), 4.06 (s, 3H), 6.48 (d, J=5.4 Hz, 1H), 7.44-7.50 (m, 3H), 8.01 (d, J=2.9 Hz, 1H), 8.53 (d, J=5.1 Hz, 1H), 8.70 (d, J=9.5 Hz, 1H), 9.79 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 484 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (131 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-diethyl-1,2-ethanediamine (51 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (107 mg, yield 76%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.10 (t, J=7.1 Hz, 6H), 2.67 (q, J=7.1 Hz, 4H), 2.72 (t, J=5.9 Hz, 2H), 3.40-3.44 (m, 2H), 4.075 (s, 3H), 4.079 (s, 3H), 6.07 (brs, 1H), 7.34 (s, 1H), 7.52 (s, 1H), 7.54 (dd, J=2.7, J=9.3 Hz, 1H), 8.13 (d, J=2.9 Hz, 1H), 8.61 (s, 1H), 8.78 (d, J=9.3 Hz, 1H), 9.82 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 485 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-methylaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (142 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-diethyl-1,2-ethanediamine (56 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (48 mg, yield 33%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.39 (t, J=7.3 Hz, 6H), 2.12 (s, 3H), 3.12-3.20 (m, 6H), 3.67-3.68 (m, 2H), 4.046 (s, 3H), 4.052 (s, 3H), 6.27 (d, J=5.4 Hz, 1H), 7.00 (d, J=8.5 Hz, 1H), 7.28 (s, 1H), 7.36-7.44 (m, 3H), 7.60 (s, 1H), 8.42 (d, J=5.4 Hz, 1H)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methylaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (142 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-diethyl-1,2-ethanediamine (56 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (49 mg, yield 34%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.32-1.36 (m, 6H), 2.35 (s, 3H), 2.99-3.14 (m, 6H), 3.62-3.66 (m, 2H), 4.04 (s, 3H), 4.05 (s, 3H), 6.49 (d, J=5.4 Hz, 1H), 6.97-7.00 (m, 2H), 7.28 (s, 1H), 7.41 (s, 1H), 7.55 (s, 1H), 7.72 (d, J=9.3 Hz, 1H), 8.47 (d, J=5.1 Hz, 1H)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (139 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-diethyl-1,2-ethanediamine (52 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (32 mg, yield 22%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.26 (t, J=7.1 Hz, 6H), 2.91-2.99 (m, 6H), 3.55-3.59 (m, 2H), 4.04 (s, 3H), 4.05 (s, 3H), 6.49 (d, J=5.1 Hz, 1H), 7.07-7.10 (m, 2H), 7.21 (d, J=2.7 Hz, 1H), 7.28 (s, 1H), 7.42 (s, 1H), 7.51 (s, 1H), 8.16 (d, J=9.0 Hz, 1H), 8.50 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 473 (M++1)
- 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (139 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-diethyl-1,2-ethanediamine (52 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (59 mg, yield 41%).
- 1H-NMR (CDCl3-d1, 400 MHz): 11.41 (brs, 6H), 3.18-3.19 (m, 6H), 3.64-3.73 (m, 2H), 4.05 (s, 6H), 6.31 (s, 1H), 7.12 (d, J=8.3 Hz, 1H), 7.42 (s, 2H), 7.60 (s, 1H), 7.81 (s, 1H), 8.46 (s, 1H), 8.88 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 473 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (131 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 2-morpholino-1-ethanamine (57 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (30 mg, yield 21%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.60-2.73 (m, 4H), 3.46-3.50 (m, 2H), 3.79-3.84 (m, 4H), 4.08 (s, 6H), 7.34 (s, 1H), 7.52-7.56 (m, 2H), 8.13 (d, J=2.7 Hz, 1H), 8.61 (s, 1H), 8.78 (d, J=9.5 Hz, 1H), 9.81 (s, 1H)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (131 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 2-tetrahydro-1H-1-pyrrolyl-1-ethanamine (50 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound 42 mg, yield 30%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.90 (s, 4H), 2.74 (s, 4H), 2.82 (t, J=5.6 Hz, 2H), 3.50 (q, J=5.4 Hz, 2H), 4.075 (s, 3H), 4.078 (s, 3H), 7.34 (s, 1H), 7.52-7.55 (m, 2H), 8.12 (d, J=2.9 Hz, 1H), 8.61 (s, 1H), 8.78 (d, J=9.3 Hz, 1H), 9.82 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 483 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (151 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-diisopropyl-1,2-ethanediamine (74 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (52 mg, yield 33%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.06 (d, J=6.3 Hz, 12H), 2.67 (t, J=4.9 Hz, 2H), 3.07-3.11 (m, 2H), 3.24-3.31 (m, 2H), 4.05 (s, 6H), 6.45 (d, J=5.4 Hz, 1H), 7.13 (d, J=8.8 Hz, 2H), 7.42-7.44 (m, 3H), 7.56 (s, 1H), 8.47 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 467 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (139 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-diisopropyl-1,2-ethanediamine (68 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (46 mg, yield 30%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.01-1.15 (m, 12H), 2.12 (s, 3H), 2.28 (s, 3H), 2.62 (brs, 2H), 3.00 (brs, 2H), 3.28 (brs, 2H), 4.06 (s, 3H), 4.07 (s, 3H), 6.25 (s, 1H), 6.99 (d, J=8.8 Hz, 1H), 7.43 (s, 1H), 7.61 (s, 1H), 8.43 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 495 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (151 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-diisopropyl-1,2-ethanediamine (74 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (58 mg, yield 37%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.12-1.15 (m, 12H), 2.74 (brs, 2H), 3.16 (brs, 2H), 3.34 (brs, 2H), 4.067 (s, 3H), 4.073 (s, 3H), 7.19 (d, J=9.0 Hz, 1H), 7.32 (s, 1H), 7.46 (d, J=9.0 Hz, 1H), 7.56 (s, 1H), 8.62 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 468 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (134 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-diisopropyl-1,2-ethanediamine (65 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (64 mg, yield 43%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.45-1.48 (m, 12H), 3.19-3.22 (m, 2H), 3.60-3.65 (m, 2H), 3.73-3.74 (m, 2H), 4.07 (s, 6H), 7.12-7.15 (m, 2H), 7.51 (s, 1H), 7.70 (s, 1H), 7.97 (s, 1H), 8.16 (d, J=9.0 Hz, 1H), 8.62 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 502 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-nitroaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (131 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-diisopropyl-1,2-ethanediamine (63 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (103 mg, yield 70%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.33-1.37 (m, 12H), 3.04-3.07 (m, 2H), 3.45-3.51 (m, 2H), 3.61 (s, 3H), 4.05 (s, 3H), 4.06 (s, 3H), 6.49 (d, J=5.1 Hz, 1H), 7.42-7.45 (m, 2H), 7.50 (s, 1H), 8.00 (d, J=2.9 Hz, 1H), 8.52 (d, J=5.4 Hz, 1H), 8.58-8.62 (m, 1H), 9.76 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 512 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (131 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-diisopropyl-1,2-ethanediamine (63 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (71 mg, yield 48%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.20-1.23 (m, 12H), 2.87 (s, 2H), 3.27-3.28 (m, 2H), 3.45-3.49 (m, 2H), 4.075 (s, 3H), 4.080 (s, 3H), 7.34 (s, 1H), 7.52 (s, 1H), 7.54 (d, J=2.9 Hz, 1H), 8.12 (d, J=2.7 Hz, 1H), 8.61 (s, 1H), 8.74 (d, J=9.3 Hz, 1H), 9.84 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 513 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-methoxyaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (139 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-diisopropyl-1,2-ethanediamine (68 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (50 mg, yield 32%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.07 (brs, 12H), 2.69 (brs, 2H), 3.10 (brs, 2H), 3.27 (brs, 2H), 3.84 (s, 3H), 4.05 (s, 3H), 4.06 (s, 3H), 6.48 (d, J=5.1 Hz, 1H), 7.72 (d, J=2.4 Hz, 1H), 6.78 (dd, J 2.7, 8.8 Hz, 1H), 7.42 (s, 1H), 7.56 (s, 1H), 8.05 (d, J=9.0 Hz, 1H), 8.48 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 497 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (151 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1-ethyl-N1-(3-methylphenyl)-1,2-ethanediamine (91 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (139 mg, yield 82%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.15 (t, J=7.1 Hz, 3H), 2.30 (s, 3H), 3.39 (q, J=7.1 Hz, 2H), 3.48 (s, 4H), 4.05 (s, 3H), 4.06 (s, 3H), 6.44 (d, J=5.4 Hz, 1H), 6.56 (d, J=7.1 Hz, 1H), 6.61 (s, 2H), 7.09-7.15 (m, 3H), 7.35 (d, J=8.8 Hz, 2H), 7.46 (s, 1H), 7.55 (s, 1H), 8.46 (d, J=5.4 Hz, 1H)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (139 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1-ethyl-N1-(3-methylphenyl)-1,2-ethanediamine (84 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (137 mg, yield 84%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.13 (t, J=7.1 Hz, 3H), 2.09 (s, 3H), 2.21 (s, 3H), 2.30 (s, 3H), 3.37 (q, J=6.8 Hz, 2H), 3.46 (s, 4H), 4.06 (s, 6H), 4.84 (s, 1H), 5.92 (s, 1H), 6.27 (d, J=5.1 Hz, 1H), 6.53-6.57 (m, 3H), 6.95 (s, 1H), 7.09-7.13 (m, 1H), 7.31 (s, 1H), 7.45 (s, 1H), 7.57 (s, 1H), 8.44 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 529 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (139 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1-ethyl-N1-(3-methylphenyl)-1,2-ethanediamine (84 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (112 mg, yield 68%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.12 (t, J=7.1 Hz, 3H), 2.10 (s, 3H), 2.24 (s, 3H), 2.30 (s, 3H), 3.35 (q, J=6.8 Hz, 2H), 3.45 (s, 4H), 4.07 (s, 6H), 6.57 (s, 1H), 6.95 (d, J=8.5 Hz, 1H), 7.60 (s, 1H), 8.43 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 529 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (151 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1-ethyl-N1-(3-methylphenyl)-1,2-ethanediamine (91 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (177 mg, yield 100%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.07-1.16 (m, 3H), 2.31 (s, 3H), 3.39-3.48 (m, 6H), 4.07 (s, 6H), 7.16-7.19 (m, 3H), 7.32-7.35 (m, 2H), 7.55 (s, 1H), 8.62 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 502 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (134 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1-ethyl-N1-(3-methylphenyl)-1,2-ethanediamine (80 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (146 mg, yield 91%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.09-1.17 (m, 3H), 2.31 (s, 3H), 3.41-3.50 (m, 6H), 4.07 (s, 6H), 6.60 (s, 1H), 7.31-7.33 (m, 2H), 7.52 (s, 1H), 8.18 (d, J=9.0 Hz, 1H), 8.63 (s, 1H)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-nitroaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (131 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1-ethyl-N1-(3-methylphenyl)-1,2-ethanediamine (78 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (101 mg, yield 64%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.17 (t, J=7.1 Hz, 3H), 2.31 (s, 3H), 3.39-3.44 (q, J=7.1 Hz, 2H), 3.52 (s, 4H), 4.05 (s, 3H), 4.07 (s, 3H), 6.49 (d, J=5.4 Hz, 1H), 6.58-6.62 (m, 2H), 7.12-7.14 (m, 1H), 7.47-7.51 (m, 3H), 8.04 (d, J=2.9 Hz, 1H), 8.53 (d, J=5.4 Hz, 1H), 8.78 (d, J=9.5 Hz, 1H), 9.68 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 546 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (131 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1-ethyl-N1-(3-methylphenyl)-1,2-ethanediamine (78 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (110 mg, yield 69%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.07-1.19 (m, 3H), 2.30-2.31 (m, 3H), 3.36-3.42 (m, 2H), 3.52 (s, 4H), 4.078 (s, 3H), 4.083 (s, 3H), 6.57-6.61 (m, 4H), 7.35 (s, 1H), 7.52-7.57 (m, 2H), 8.14 (d, J=2.9 Hz, 1H), 8.61 (s, 1H), 8.80 (d, J=9.8 Hz, 1H), 9.74 (s, 1H)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-methoxyaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (139 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1-ethyl-N1-(3-methylphenyl)-1,2-ethanediamine (84 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reactions and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (140 mg, yield 85%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.16 (t, J=7.1 Hz, 3H), 2.31 (s, 3H), 3.40 (q, J=7.1 Hz, 2H), 3.48 (s, 4H), 3.83 (s, 3H), 4.07 (s, 6H), 6.55-6.65 (m, 2H), 6.78 (d, J=2.4 Hz, 1H), 6.83 (dd, J=2.4, 8.8 Hz, 1H), 7.13 (s, 1H), 7.33 (s, 1H), 7.55 (s, 1H), 8.07 (d, J=8.5 Hz, 1H), 8.64 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 532 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (134 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1-ethyl-N1-(3-methylphenyl)-1,2-ethanediamine (80 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (100 mg, yield 62%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.16 (t, J=7.1 Hz, 3H), 2.30 (s, 3H), 3.40 (q, J=7.1 Hz, 2H), 3.50 (s, 4H), 4.045 (s, 3H), 4.054 (s, 3H), 6.49 (d, J=5.1 Hz, 1H), 6.56 (d, J=7.6 Hz, 1H), 6.60 (s, 1H), 7.04 (d, J=5.1 Hz, 1H), 7.09-7.13 (m, 1H), 7.21 (d, J=2.7 Hz, 1H), 7.43 (d, J=11.5 Hz, 2H), 7.51 (s, 1H), 8.19-8.22 (m, 1H), 8.50 (d, J=5.1 Hz, 1H), 8.57 (d, J=4.9 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 535 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methoxyaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (139 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1-ethyl-N1-(3-methylphenyl)-1,2-ethanediamine (84 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (130 mg, yield 79%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.16 (t, J=7.1 Hz, 3H), 2.30 (s, 3H), 3.40 (q, J=7.1 Hz, 2H), 3.49 (s, 4H), 3.81 (s, 3H), 4.06 (s, 6H), 6.48 (d, J=5.4 Hz, 1H), 6.55 (d, J=7.3 Hz, 1H), 6.60 (s, 1H), 6.70 (d, J=2.4 Hz, 1H), 6.79 (dd, J=2.4, 8.8 Hz, 1H), 7.11-7.15 (m, 1H), 7.45 (s, 1H), 7.56 (s, 1H), 8.10 (d, J=8.3 Hz, 1H), 8.48 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 531 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (139 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-diisopropyl-1,2-ethanediamine (68 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (63 mg, yield 41%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.00 (brs, 12H), 2.13 (s, 3H), 2.27 (s, 3H), 2.63 (brs, 2H), 3.02 (brs, 2H), 3.27 (brs, 2H), 4.06 (s, 3H), 4.07 (s, 3H), 6.29 (d, J=5.1 Hz, 1H), 6.98 (s, 1H), 7.43 (s, 1H), 7.59 (s, 1H), 8.44 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 495 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methoxyaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (139 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-diisopropyl-1,2-ethanediamine (68 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (80 mg, yield 52%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.02-1.15 (m, 12H), 3.03 (brs, 2H), 3.26 (brs, 2H), 3.48-3.50 (m, 2H), 3.86 (s, 3H), 4.07 (s, 3H), 6.79-6.84 (m, 3H), 7.32 (s, 1H), 7.55 (s, 1H), 8.07 (s, 1H), 8.63 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 498 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (151 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 2-piperidino-1-ethanamine (65 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (119 mg, yield 78%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.51-1.70 (m, 6H), 2.44-2.65 (m, 6H), 3.41-3.45 (m, 2H), 4.04 (s, 6H), 6.45 (d, J=5.4 Hz, 1H), 7.11 (d, J=8.8 Hz, 2H), 7.27 (s, 1H), 7.41 (s, 1H), 7.49 (d, J=8.8 Hz, 2H), 7.56 (s, 1H), 8.46 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 451 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (139 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 2-piperidino-1-ethanamine (60 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (123 mg, yield 83%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.57-1.63 (m, 6H) 2.14 (s, 3H), 2.27 (s, 3H), 2.50-2.59 (m, 6H), 3.40-3.44 (m, 2H), 4.05 (s, 3H), 4.06 (s, 3H), 5.80 (s, 1H), 6.31 (d, J=5.1 Hz, 1H), 6.96 (s, 1H), 7.27 (s, 1H), 7.42 (s, 1H), 7.49 (s, 1H), 7.59 (s, 1H), 8.44 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 479 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (139 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 2-piperidino-1-ethanamine (60 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (48 mg, yield 32%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.00 (brs, 6H), 2.09 (s, 3H), 2.30 (s, 3H), 3.08-3.18 (m, 6H), 3.70-3.74 (m, 2H), 4.05 (s, 3H), 4.06 (s, 3H), 6.29 (d, J=5.1 Hz, 1H), 6.94 (d, J=8.8 Hz, 1H), 7.28 (s, 1H), 7.43 (s, 1H), 7.52 (d, J=8.8 Hz, 1H), 7.62 (s, 1H), 8.42 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 479 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (151 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 2-piperidino-1-ethanamine (65 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (84 mg, yield 55%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.03 (brs, 6H), 3.09-3.18 (m, 6H), 3.66-3.76 (m, 2H), 4.060 (s, 3H), 4.063 (s, 3H), 6.73 (brs, 1H), 7.13 (d, J=8.8 Hz, 2H), 7.30 (s, 1H), 7.35 (brs, 1H), 7.54 (s, 1H), 7.59 (d, J=8.8 Hz, 2H), 8.58 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 452 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (134 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 2-piperidino-1-ethanamine (58 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (118 mg, yield 81%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.84-1.88 (m, 6H), 2.86-2.92 (m, 6H), 3.52-3.62 (m, 2H), 4.06 (s, 6H), 6.16 (brs, 1H), 6.98 (brs, 1H), 7.14 (dd, J=2.7, 9.0 Hz, 1H), 7.30 (d, J=2.7 Hz, 1H), 7.32 (s, 1H), 7.52 (s, 1H), 8.23 (d, J=9.0 Hz, 1H), 8.61 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 486 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-nitroaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (131 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 2-piperidino-1-ethanamine (56 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (58 mg, yield 40%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.69-1.82 (m, 6H), 2.59-2.81 (m, 6H), 3.49-3.50 (m, 2H), 4.05 (s, 3H), 4.06 (s, 3H), 5.95 (brs, 1H), 6.48 (d, J=5.4 Hz, 1H), 7.44 (s, 1H), 7.47 (d, J=2.9 Hz, 1H), 7.50 (s, 1H), 8.01 (d, J=2.9 Hz, 1H), 8.53 (d, J=5.1 Hz, 1H), 8.73 (d, J=9.3 Hz, 1H), 9.78 (s, 1H)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (131 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 2-piperidino-1-ethanamine (56 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (79 mg, yield 55%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.49-1.66 (m, 6H), 2.48 (brs, 4H), 2.57 (t, J=5.9 Hz, 2H), 3.43-3.45 (m, 2H), 4.077 (s, 3H), 4.082 (s, 3H), 5.82 (s, 1H), 7.34 (s, 1H), 7.52 (s, 1H) 7.54 (dd, J=2.9, 9.5 Hz, 1H), 8.14 (d, J=2.7 Hz, 1H), 8.61 (s, 1H), 8.81 (d, J=9.5 Hz, 1H), 9.81 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 497 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-methoxyaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (139 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 2-piperidino-1-ethanamine (60 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (80 mg, yield 54%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.96 (brs, 6H), 2.97-3.02 (m, 6H), 3.59-3.65 (m, 2H), 3.87 (s, 3H), 4.07 (s, 6H), 6.37 (brs, 1H), 6.77 (d, J=2.4 Hz, 1H), 6.81 (dd, J=2.4, 8.8 Hz, 1H), 7.32 (s, 1H), 7.37 (s, 1H), 7.55 (s, 1H), 8.18 (d, J=8.8 Hz, 1H), 8.63 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 482 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methoxyaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (139 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 2-piperidino-1-ethanamine (60 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (100 mg, yield 67%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 1.97-1.98 (m, 6H), 3.00-3.09 (m, 6H), 3.60-3.68 (m, 2H), 3.85 (s, 3H), 4.050 (s, 3H), 4.054 (s, 3H), 6.42 (brs, 1H), 6.48 (d, J=5.4 Hz, 1H), 6.70 (d, J=2.4 Hz, 1H), 6.76 (dd, J=2.4, 8.8 Hz, 1H), 7.42 (s, 1H), 7.48 (s, 1H), 7.57 (s, 1H), 8.14 (d, J=8.8 Hz, 1H), 8.47 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 481 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (151 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-dibutyl-1,2-ethanediamine (88 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (72 mg, yield 43%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.96 (t, J=7.6 Hz, 6H), 1.34-1.42 (m, 4H), 1.65-1.73 (m, 4H), 2.90-2.94 (m, 4H), 3.08 (brs, 2H), 3.59-3.60 (m, 2H), 4.04 (s, 6H), 6.44 (d, J=5.4 Hz, 1H), 7.10 (d, J=9.0 Hz, 2H), 7.41 (s, 1H), 7.52 (d, J=9.0 Hz, 2H), 7.56 (s, 1H), 8.46 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 495 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (139 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-dibutyl-1,2-ethanediamine (81 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (82 mg, yield 51%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.89 (t, J=7.3 Hz, 6H), 1.21-1.28 (m, 4H), 1.35-1.41 (m, 4H), 2.14 (s, 3H), 2.27 (s, 3H), 2.46 (t, J=7.6 Hz, 4H), 2.61-2.64 (m, 2H), 3.34-3.38 (m, 2H), 4.055 (s, 3H), 4.058 (s, 3H), 6.29 (d, J=5.1 Hz, 1H), 6.97 (s, 1H), 7.40 (s, 1H), 7.43 (s, 1H), 7.59 (s, 1H), 8.45 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 523 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (139 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-dibutyl-1,2-ethanediamine (81 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (80 mg, yield 49%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.86-0.93 (m, 6H), 1.12-1.47 (m, 8H), 2.13 (s, 3H), 2.29 (s, 3H), 2.40-2.49 (m, 4H), 2.57-2.62 (m, 2H), 3.24-3.36 (m, 2H), 4.055 (s, 3H), 4.063 (s, 3H), 6.26 (d, J=5.1 Hz, 1H), 6.98 (d, J=8.5 Hz, 1H), 7.30 (d, J=8.5 Hz, 1H), 7.43 (s, 1H), 7.61 (s, 1H), 8.43 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 523 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (151 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-dibutyl-1,2-ethanediamine (88 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (110 mg, yield 65%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.92 (t, J=7.3 Hz, 6H), 1.25-1.32 (m, 4H), 1.45-1.52 (m, 4H), 2.54-2.58 (m, 4H), 2.68-2.71 (m, 2H), 3.36-3.37 (m, 2H), 4.06 (s, 6H), 7.18 (d, J=8.5 Hz, 2H), 7.32 (s, 1H), 7.47 (d, J=8.5 Hz, 2H), 7.55 (s, 1H), 8.61 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 496 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (134 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-dibutyl-1,2-ethanediamine (78 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (69 mg, yield 43%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.93 (t, J=7.3 Hz, 6H), 1.28-1.33 (m, 4H), 1.40-1.46 (m, 4H), 2.47 (t, J=7.6 Hz, 4H), 2.60-2.63 (m, 2H), 3.32-3.35 (m, 2H), 4.07 (s, 6H), 7.17 (dd, J=2.7, 9.0 Hz, 1H), 7.32 (d, J=2.7 Hz, 1H), 7.33 (s, 1H), 7.52 (s, 1H), 8.19 (d, J=9.0 Hz, 1H), 8.63 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 530 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (131 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-dibutyl-1,2-ethanediamine (76 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (66 mg, yield 42%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.89-0.96 (m, 6H), 1.27-1.38 (m, 4H), 1.42-1.49 (m, 4H), 2.48 (t, J=7.3 Hz, 4H), 2.62-2.65 (m, 2H), 3.35-3.37 (m, 2H), 4.076 (s, 3H), 4.080 (s, 3H), 7.34 (s, 1H), 7.52-7.56 (m, 2H), 8.14 (d, J=2.9 Hz, 1H), 8.61 (s, 1H), 8.81 (d, J=9.3 Hz, 1H), 9.81 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 541 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-methoxyaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (139 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-dibutyl-1,2-ethanediamine (81 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (79 mg, yield 49%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.90-0.95 (m, 6H), 1.29-1.36 (m, 4H), 1.44-1.51 (m, 4H), 2.53 (t, J=7.6 Hz, 4H), 2.66-2.69 (m, 2H), 3.35-3.38 (m, 2H), 3.86 (s, 3H), 4.07 (s, 3H), 4.09 (s, 3H), 6.78 (d, J=2.4 Hz, 1H), 6.83 (dd, J=2.4, 8.8 Hz, 1H), 6.96 (brs, 1H), 7.32 (s, 1H), 7.55 (s, 1H), 8.10 (d, J=8.8 Hz, 1H), 8.63 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 526 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methoxyaniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (139 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, N1,N1-dibutyl-1,2-ethanediamine (81 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (56 mg, yield 34%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 0.90-0.95 (m, 6H), 1.28-1.37 (m, 4H), 1.46-1.54 (m, 4H), 2.56-2.60 (m, 4H), 2.72-2.74 (m, 2H), 3.35-3.43 (m, 2H), 3.84 (s, 3H), 4.05 (s, 6H), 6.48 (d, J=5.1 Hz, 1H), 6.71 (d, J=2.4 Hz, 1H), 6.78 (dd, J=2.4, 8.8 Hz, 1H), 7.42 (s, 1H), 7.57 (s, 1H), 8.09 (d, J=8.5 Hz, 1H), 8.48 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 525 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (151 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 1-benzylpiperazine (90 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (93 mg, yield 55%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.51 (t, J=4.9 Hz, 4H), 3.52 (t, J=5.1 Hz, 4H), 3.56 (s, 2H), 4.06 (s, 3H), 4.07 (s, 3H), 6.44 (s, 1H), 7.18 (d, J=8.8 Hz, 2H), 7.26-7.35 (m, 5H), 7.47 (d, J=9.0 Hz, 2H), 7.55 (s, 1H), 8.61 (s, 1H)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (100 mg) was dissolved in chloroform (10 ml) and triethylamine (1 ml) to prepare a solution. A solution of triphosgene (151 mg) in chloroform was then added to the solution, and the mixture was stirred at room temperature for 10 min. Next, 1-phenylpiperazine (83 mg) was added thereto, and the mixture was further stirred at room temperature for one hr. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by concentration. The residue was purified on a column using chloroform/methanol to give the title compound (130 mg, yield 79%)
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.27 (t, J=5.1 Hz, 4H), 3.69 (t, J=5.1 Hz, 4H), 4.066 (s, 3H), 4.072 (s, 3H), 6.50 (s, 1H), 6.90-6.97 (m, 3H), 7.20 (d, J=8.8 Hz, 2H), 7.28-7.32 (m, 2H), 7.49 (d, J=8.8 Hz, 2H), 7.56 (s, 1H), 8.62 (s, 1H)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 5-bromo-2-thiophenecarboxylic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 5-bromo-2-thiophene isothiocyanate was prepared using the resultant 5-bromo-2-thiophenecarbonyl chloride as a starting compound according to the description of the literature. 5-Bromo-2-thiophenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 18 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (58 mg, yield 65%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.26 (s, 3H), 3.94 (s, 3H), 3.96 (s, 3H), 6.53 (d, J=5.4 Hz, 1H), 7.11-7.16 (m, 1H), 7.21-7.24 (m, 1H), 7.37-7.45 (m, 2H), 7.49-7.54 (m, 1H), 7.82-7.85 (m, 1H), 8.51 (d, J=5.1 Hz, 1H), 10.04 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 559 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 5-bromo-2-thiophenecarboxylic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 5-bromo-2-thiophene isothiocyanate was prepared using the resultant 5-bromo-2-thiophenecarbonyl chloride as a starting compound according to the description of the literature. 5-Bromo-2-thiophenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 18 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (65 mg, yield 75%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.95 (s, 3H), 3.96 (s, 3H), 6.39 (d, J=5.4 Hz, 1H), 7.39-7.43 (m, 2H), 7.45-7.55 (m, 2H), 7.77-7.81 (m, 1H), 7.88 (d, J=4.1 Hz, 1H), 8.12 (d, J=2.4 Hz, 1H), 8.49 (d, J=5.1 Hz, 1H), 10.55 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 579 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 5-chloro-2-thiophenecarboxylic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 5-chloro-2-thiophene isothiocyanate was prepared using the resultant 5-chloro-2-thiophenecarbonyl chloride as a starting compound according to the description of the literature. 5-Chloro-2-thiophenecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (43 mg, yield 52%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.26 (s, 3H), 3.93 (s, 3H), 3.95 (s, 3H), 6.52 (d, J=5.1 Hz, 1H), 7.11-7.15 (m, 1H), 7.21-7.23 (m, 1H), 7.27-7.29 (m, 1H), 7.38-7.46 (m, 3H), 7.86-7.88 (m, 1H), 8.51 (d, J=5.1 Hz, 1H), 10.05-10.08 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 514 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 5-chloro-2-thiophenecarboxylic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 5-chloro-2-thiophene isothiocyanate was prepared using the resultant 5-chloro-2-thiophenecarbonyl chloride as a starting compound according to the description of the literature. 5-Chloro-2-thiophenecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (46 mg, yield 58%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.95 (s, 3H), 3.96 (s, 3H), 6.38 (d, J=5.4 Hz, 1H), 7.31 (d, J=4.1 Hz, 1H), 7.41 (s, 1H), 7.46 (s, 1H), 7.49 (s, 1H), 7.77-7.82 (m, 1H), 7.92-7.95 (m, 1H), 8.10-8.12 (m, 1H), 8.48 (d, J=5.1 Hz, 1H), 10.57 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 535 (M++1)
- 3-(Methylthio)propanoyl isothiocyanate was prepared using commercially available 3-(methylthio)propanoyl chloride (80 mg) as a starting compound according to the description of the literature. 3-(Methylthio)propanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 19 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (27 mg, yield 35%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.10 (s, 3H), 2.24 (s, 3H), 2.74-2.84 (m, 4H), 3.93 (s, 3H), 3.95 (s, 3H), 6.55 (d, J=5.4 Hz, 1H), 7.11-7.72 (m, 5H), 8.52 (d, J=5.4 Hz, 1H), 11.57-11.60 (bs, 1H), 12.10-12.13 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 472 (M++1)
- 3-(Methylthio)propanoyl isothiocyanate was prepared using commercially available 3-(methylthio)propanoyl chloride (80 mg) as a starting compound according to the description of the literature. 3-(Methylthio)propanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (14 mg, yield 18%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.10 (s, 3H), 2.71-2.84 (m, 4H), 3.94 (s, 3H), 3.96 (s, 3H), 6.41 (d, J=5.4 Hz, 1H), 7.31-7.72 (m, 5H), 8.50 (d, J=5.1 Hz, 1H), 11.63-11.66 (bs, 1H), 12.49-12.52 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2,5-dimethyl-3-furoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2,5-dimethyl-3-furancarbonyl isothiocyanate was prepared using the resultant 2,5-dimethyl-3-furancarbonyl chloride as a starting compound according to the description of the literature. 2,5-Dimethyl-3-furancarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 15 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (41 mg, yield 52%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.26 (s, 3H), 2.28 (s, 3H), 2.55 (s, 3H), 3.93 (s, 3H), 3.96 (s, 3H), 6.56 (d, J=5.1 Hz, 1H), 6.90 (s, 1H), 7.14 (dd, J=2.7, 8.8 Hz, 1H), 7.23 (d, J=2.7 Hz, 1H), 7.41 (s, 1H), 7.50 (s, 1H), 7.67 (t, J=8.7 Hz, 1H), 8.53 (d, J=5.1 Hz, 1H), 10.97-11.00 (bs, 1H), 12.33-12.36 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2,5-dimethyl-3-furoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2,5-dimethyl-3-furancarbonyl isothiocyanate was prepared using the resultant 2,5-dimethyl-3-furancarbonyl chloride as a starting compound according to the description of the literature. 2,5-Dimethyl-3-furancarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 15 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (38 mg, yield 50%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.26 (s, 3H), 2.55 (s, 3H), 3.95 (s, 3H), 3.96 (s, 3H), 6.42 (d, J=5.1 Hz, 1H), 6.89 (s, 1H), 7.43 (s, 1H), 7.49 (d, J=8.8 Hz, 1H), 7.53 (s, 1H), 7.70-7.76 (m, 1H), 8.16-8.21 (m, 1H), 8.51 (d, J=5.1 Hz, 1H), 11.03-11.05 (bs, 1H), 12.71-12.74 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 512 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(2-thienyl)acetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(2-thienyl)ethanoyl isothiocyanate was prepared using the resultant 2-(2-thienyl)ethanoyl chloride as a starting compound according to the description of the literature. 2-(2-Thienyl)ethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 15 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (18 mg, yield 23%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.23 (s, 3H), 3.81 (s, 1H), 3.95 (s, 3H), 3.98 (s, 3H), 4.08 (s, 1H), 6.63 (d, J=5.4 Hz, 1H), 6.93-7.05 (m, 3H), 7.16-7.19 (m, 1H), 7.24-7.27 (m, 1H), 7.36-7.46 (m, 3H), 7.55 (s, 1H), 7.70 (d, J=8.8 Hz, 1H), 8.60 (d, J=5.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 494 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(2-thienyl)acetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(2-thienyl)ethanoyl isothiocyanate was prepared using the resultant 2-(2-thienyl)ethanoyl chloride as a starting compound according to the description of the literature. 2-(2-Thienyl)ethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (15 mg, yield 20%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.81 (s, 1H), 4.00 (s, 3H), 4.02 (s, 3H), 4.08 (s, 1H), 6.68 (d, J=5.6 Hz, 1H), 6.93-7.05 (m, 3H), 7.37-7.40 (m, 1H), 7.44-7.47 (m, 1H), 7.49 (s, 1H), 7.58 (d, J=8.8 Hz, 1H), 7.67 (s, 1H), 7.74-7.79 (m, 1H), 8.16-8.20 (m, 1H), 8.71 (d, J=5.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 514 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(2-methylphenyl)acetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(2-methylphenyl)ethanoyl isothiocyanate was prepared using the resultant 2-(2-methylphenyl)ethanoyl chloride as a starting compound according to the description of the literature. 2-(2-Methylphenyl)ethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]-aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (45 mg, yield 57%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.30 (s, 3H), 3.89 (s, 2H), 3.96 (s, 3H), 3.98 (s, 3H), 6.51 (d, J=5.6 Hz, 1H), 7.12-7.28 (m, 5H), 7.45 (s, 1H), 7.50 (d, J=9.0 Hz, 1H), 7.58 (s, 1H), 7.70-7.75 (m, 1H), 8.58 (d, J=5.6 Hz, 1H), 11.80-11.83 (bs, 1H), 12.44-12.48 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 522 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(2-methylphenyl)acetic acid (80 mg), and the mixture was heated 100° C. for one hr. The solvent was removed by distillation, and 2-(2-methylphenyl)ethanoyl isothiocyanate was prepared using the resultant 2-(2-methylphenyl)ethanoyl chloride as a starting compound according to the description of the literature. 2-(2-Methylphenyl)ethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (36 mg, yield 43%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.30 (s, 3H), 3.88 (s, 2H), 3.97 (s, 3H), 3.99 (s, 3H), 7.14-7.36 (m, 7H), 7.39 (s, 1H), 7.56 (s, 1H), 7.70-7.75 (m, 1H), 8.55-8.57 (bs, 1H), 11.70-11.73 (bs, 1H), 12.39-12.42 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 489 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-cyclohexylacetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-cyclohexylethanoyl isothiocyanate was prepared using the resultant 2-cyclohexylethanoyl chloride as a starting compound according to the description of the literature. 2-Cyclohexylethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]-aniline (50 mg), toluene (5 ml), and ethanol (1 ml)-were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (36 mg, yield 46%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.88-1.30 (m, 5H), 1.58-1.80 (m, 6H), 2.07 (d, J=6.6 Hz, 1H), 2.37 (d, J=7.1 Hz, 1H), 3.94 (s, 3H), 3.96 (s, 3H), 6.41 (d, J=5.4 Hz, 1H), 7.42 (s, 1H), 7.47 (d, J=8.8 Hz, 1H), 7.53 (s, 1H), 7.67-7.72 (m, 1H), 8.14-8.18 (m, 1H), 8.51 (d, J=5.1 Hz, 1H), 11.53-11.56 (bs, 1H), 12.59-12.63 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 514 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-cyclohexylacetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-cyclohexylethanoyl isothiocyanate was prepared using the resultant 2-cyclohexylethanoyl chloride as a starting compound according to the description of the literature. 2-Cyclohexylethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (30 mg, yield 44%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.93-1.30 (m, 5H), 1.58-1.81 (m, 6H), 2.37 (d, J=7.1 Hz, 2H), 3.98 (s, 3H), 3.99 (s, 3H), 7.35 (d, J=8.8 Hz, 2H), 7.40 (s, 1H), 7.57 (s, 1H), 7.73 (d, J=9.0 Hz, 2H), 8.57 (s, 1H), 11.44-11.47 (bs, 1H), 12.58 (d, J=4.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 481 (M++1)
- 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was added to toluene (2 ml) and ethanol (2 ml) to prepare a solution. Benzyl isothiocyanate (48 μl) was then added to the solution, and the mixture was stirred at 80° C. for 6 hr. The reaction solution was concentrated, and ether and hexane were added to the residue. The resultant crystal was collected by filtration to give the title compound (46 mg, yield 65%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.95 (s, 3H), 3.96 (s, 3H), 4.77 (d, J=5.1 Hz, 1H), 6.42 (d, J=5.4 Hz, 1H), 7.25-7.55 (m, 9H), 7.95-8.01 (bs, 1H), 8.37-8.43 (bs, 1H), 8.51 (d, J=5.1 Hz, 1H), 9.80-9.86 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 480 (M++1)
- 4□[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (4 ml) and ethanol (6 ml) to prepare a solution. Benzyl isothiocyanate (81 μl) was added to the solution, and the mixture was stirred at 80° C. for 6 hr. The reaction solution was concentrated, and ether and hexane were added to the residue. The resultant crystal was collected by filtration to give the title compound (74 mg, yield 98%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.97 (s, 3H), 3.99 (s, 3H), 4.73-4.79 (bs, 2H), 7.24-7.56 (m, 11H), 8.18-8.25 (bs, 1H), 8.55 (s, 1H), 9.63-9.67 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 447 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(1-naphthyl)acetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(1-naphthyl)ethanoyl isothiocyanate was prepared using the resultant 2-(1-naphthyl)ethanoyl chloride as a starting compound according to the description of the literature. 2-(1-Naphthyl)ethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (67 mg, yield 78%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.94 (s, 3H), 3.96 (s, 3H), 4.36 (s, 2H), 6.45 (d, J=5.4 Hz, 1H), 7.41-8.15 (m, 12H), 8.53 (d, J=5.4 Hz, 1H), 11.97-12.00 (bs, 1H), 12.39-12.42 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 558 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(1-naphthyl)acetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(1-naphthyl)ethanoyl isothiocyanate was prepared using the resultant 2-(1-naphthyl)ethanoyl chloride as a starting compound according to the description of the literature. 2-(1-Naphthyl)ethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (24 mg, yield 27%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.92 (s, 3H), 3.95 (s, 3H), 4.08 (s, 2H), 6.68 (d, J=8.8 Hz, 1H), 7.29-8.16 (m, 13H), 8.63 (s, 1H), 10.03 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 525 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(2-naphthyl)acetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(2-naphthyl)ethanoyl isothiocyanate was prepared using the resultant 2-(2-naphthyl)ethanoyl chloride as a starting compound according to the description of the literature. 2-(2-naphthyl)ethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]-aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (25 mg, yield 29%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.74 (s, 2H), 3.98 (s, 3H), 4.00 (s, 3H), 6.62 (d, J=6.4 Hz, 1H), 7.40-7.93 (m, 11H), 8.15-8.20 (m, 1H), 8.66 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 558 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(2-naphthyl)acetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(2-naphthyl)ethanoyl isothiocyanate was prepared using the resultant 2-(2-naphthyl)ethanoyl chloride as a starting compound according to the description of the literature. 2-(2-Naphthyl)ethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (33 mg, yield 38%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.74 (s, 2H), 3.91 (s, 3H), 3.92 (s, 3H), 6.68 (d, J=8.8 Hz, 1H), 7.29-7.52 (m, 6H), 7.77-7.90 (m, 6H), 8.31 (s, 1H), 8.64-8.68 (bs, 1H), 9.96 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 525 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 3-(3,4-dimethoxyphenyl)propanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 3-(3,4-dimethoxyphenyl)propanoyl isothiocyanate was prepared using the resultant 3-(3,4-dimethoxyphenyl)propanoyl chloride as a starting compound according to the description of the literature. 3-(3,4-Dimethoxyphenyl)propanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]-aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (32 mg, yield 36%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.94 (t, J=7.3 Hz, 2H), 2.72-2.89 (m, 2H), 3.69-3.76 (m, 6H), 3.99 (d, J=5.6 Hz, 3H), 6.57 (d, J=5.6 Hz, 1H), 6.70-6.89 (m, 3H), 7.47 (s, 1H), 7.54 (d, J=8.8 Hz, 1H), 7.62 (s, 1H), 7.70-7.76 (m, 1H), 8.16-8.20 (m, 1H), 8.63 (d, J=5.6 Hz, 1H), 11.63-11.64 (bs, 1H), 12.55-12.58 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 582 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 3-(3,4-dimethoxyphenyl)propanoic acid (80 mg), and the mixtue was heated at 100° C. for one hr. The solvent was removed by distillation, and 3-(3,4-dimethoxyphenyl)propanoyl isothiocyanate was prepared using the resultant 3-(3,4-dimethoxyphenyl)propanoyl chloride as a starting compound according to the description of the literature. 3-(3,4-Dimethoxyphenyl)propanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (37 mg, yield 40%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.94 (t, J=7.3 Hz, 2H), 2.59-2.65 (m, 1H), 2.84-2.89 (m, 1H), 3.71 (s, 3H), 3.73 (s, 3H), 3.98 (d, J=5.9 Hz, 3H), 6.68-6.88 (m, 4H), 7.23 (d, J=8.5 Hz, 2H), 7.38 (s, 1H), 7.55 (s, 1H), 7.67 (d, J=8.8 Hz, 2H), 8.53 (s, 1H), 10.00 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 549 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(2-chlorophenoxy)acetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(2-chlorophenoxy)ethanoyl isothiocyanate was prepared using the resultant 2-(2-chlorophenoxy)ethanoyl chloride as a starting compound according to the description of the literature. 2-(2-Chlorophenoxy)ethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (29 mg, yield 37%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.95 (s, 3H), 3.95 (s, 3H), 4.88 (s, 2H), 6.35 (d, J=5.1 Hz, 1H), 6.95-7.13 (m, 3H), 7.26-7.67 (m, 6H), 8.05-8.07 (bs, 1H), 8.30-8.32 (bs, 1H), 8.47 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 523 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(2-chlorophenoxy)acetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(2-chlorophenoxy)ethanoyl isothiocyanate was prepared using the resultant 2-(2-chlorophenoxy)ethanoyl chloride as a starting compound according to the description of the literature. 2-(2-Chlorophenoxy)ethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (21 mg, yield 21%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 4.55 (s, 6H), 4.76 (s, 2H), 6.71 (d, J=8.5 Hz, 1H), 6.95-7.47 (m, 10H), 9.24 (s, 1H), 9.84 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 525 (M++1)
- 4-Ethoxy-1-benzenecarbonyl isothiocyanate was prepared using 4-ethoxy-1-benzenecarbonyl chloride as a starting compound according to the description of the literature. 4-Ethoxy-1-benzenecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (72 mg, yield 89%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.37 (t, J=7.1 Hz, 3H), 3.99 (s, 3H), 4.00 (s, 3H), 4.15 (q, J=7.1 Hz, 2H), 7.06 (d, J=8.8 Hz, 2H), 7.35-7.41 (m, 3H), 7.58 (s, 1H), 7.75-7.82 (m, 2H), 8.03 (d, J=8.8 Hz, 2H), 8.58 (s, 1H), 11.40 (d, J=2.9 Hz, 1H), 12.74-12.75 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 505 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2,5-dimethyl-3-furoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2,5-dimethyl-3-furancarbonyl isothiocyanate was prepared using the resultant 2,5-dimethyl-3-furancarbonyl chloride as a starting compound according to the description of the literature. 2,5-Dimethyl-3-furancarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethyl-aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (69 mg, yield 96%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.11 (s, 3H), 2.23 (s, 3H), 2.26 (s, 3H), 2.55 (s, 3H), 3.95 (s, 6H), 6.35 (d, J=5.4 Hz, 1H), 6.91 (s, 1H), 7.16 (s, 1H), 7.41 (s, 1H), 7.55-7.61 (m, 2H), 8.49 (d, J=5.1 Hz, 1H), 10.98-11.10 (bs, 1H), 11.31-11.34 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 506 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2,5-dimethyl-3-furoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2,5-dimethyl-3-furancarbonyl isothiocyanate was prepared using the resultant 2,5-dimethyl-3-furancarbonyl chloride as a starting compound according to the description of the literature. 2,5-Dimethyl-3-furancarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (77 mg, yield 95%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.26 (s, 3H), 2.55 (s, 3H), 3.98 (s, 3H), 4.00 (s, 3H), 6.89 (s, 1H), 7.34-7.41 (m, 3H), 7.58 (s, 1H), 7.73-7.81 (m, 2H), 8.58 (s, 1H), 10.93 (d, J=3.9 Hz, 1H), 12.67-12.70 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 479 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available pentanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and pentanoyl isothiocyanate was prepared using the resultant pentanoyl chloride as a starting compound according to the description of the literature. Pentanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (29 mg, yield 41%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.90 (t, J=7.6 Hz, 3H), 1.28-1.39 (m, 2H), 1.52-1.63 (m, 2H), 3.95 (s, 3H), 3.97 (s, 3H), 6.45 (d, J=5.1 Hz, 1H), 7.43 (s, 1H), 7.49 (d, J=8.8 Hz, 1H), 7.55 (s, 1H), 7.67-7.73 (m, 1H), 8.14-8.18 (m, 1H), 8.53 (d, J=5.4 Hz, 1H), 11.57 (d, J=2.7 Hz, 1H), 12.58 (d, J=4.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 474 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available pentanoic acid (80 mg) at 100° C. for one hr. The solvent was removed by distillation, and pentanoyl isothiocyanate was prepared using the resultant pentanoyl chloride as a starting compound according to the description of the literature. Pentanoyl isothiocyanate thus obtanined was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (17 mg, yield 23%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.86 (t, J=7.3 Hz, 3H), 1.23-1.40 (m, 2H), 1.50-1.64 (m, 2H), 3.12-3.19 (m, 2H), 3.97 (s, 3H), 3.99 (s, 3H), 7.21-7.25 (m, 2H), 7.38 (s, 1H), 7.55 (s, 1H), 7.66-7.70 (m, 2H), 8.53 (s, 1H), 9.97 (s, 1H).
- Mass spectrometry value (ESI-MS, m/z): 441 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 3-(4-methylphenyl)propanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 3-(4-methylphenyl)propanoyl isothiocyanate was prepared using the resultant 3-(4-methylphenyl)propanoyl chloride as a starting compound according to the description of the literature. 3-(4-Methylphenyl)propanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (90 mg, yield 99%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.25 (s, 3H), 2.47 (s, 2H), 2.76 (t, J=7.6 Hz, 2H), 3.93 (s, 3H), 3.95 (s, 3H), 6.54 (d, J=5.1 Hz, 1H), 7.04-7.16 (m, 4H), 7.30 (d, J=8.8 Hz, 2H), 7.41 (s, 1H), 7.50 (s, 1H), 7.73-7.79 (m, 2H), 8.51 (d, J=5.1 Hz, 1H), 11.51-11.54 (bs, 1H), 12.04-12.10 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 502 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 3-(4-methylphenyl)propanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 3-(4-methylphenyl)propanoyl isothiocyanate was prepared using the resultant 3-(4-methylphenyl)propanoyl chloride as a starting compound according to the description of the literature. 3-(4-Methylphenyl)propanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (54 mg, yield 63%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.25 (s, 3H), 2.47 (s, 2H), −2.62 (t, J=7.3 Hz, 2H), 3.97 (s, 3H), 3.99 (s, 3H), 6.67 (d, J=9.0 Hz, 1H), 7.04-7.39 (m, 7H), 7.55 (s, 3H), 7.64-7.68 (m, 2H), 8.53 (s, 1H), 10.00 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 503 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(2-chlorophenyl)acetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(2-chlorophenyl)ethanoyl isothiocyanate was prepared using the resultant 2-(2-chlorophenyl)ethanoyl chloride as a starting compound according to the description of the literature. 2-(2-Chlorophenyl)ethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (77 mg, yield 89%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.92 (s, 3H), 3.95 (s, 3H), 4.04 (s, 2H), 6.54 (d, J=5.1 Hz, 1H), 7.27-7.50 (m, 7H), 7.74-7.79 (m, 2H), 8.31 (s, 1H), 8.51 (d, J=5.1 Hz, 1H), 11.80-11.83 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 508 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(2-chlorophenyl)acetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(2-chlorophenyl)ethanoyl isothiocyanate was prepared using the resultant 2-(2-chlorophenyl)ethanoyl chloride as a starting compound according to the description of the literature. 2-(2-Chlorophenyl)ethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (43 mg, yield 49%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.86 (s, 2H), 3.97 (s, 3H), 3.99 (s, 3H), 7.22-7.48 (m, 8H), 7.56 (s, 1H), 7.66-7.71 (m, 2H), 8.53 (s, 1H), 10.33 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 509 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 4-phenylbutanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 4-phenylbutanoyl isothiocyanate was prepared using the resultant 4-phenylbutanoyl chloride as a starting compound according to the description of the literature. 4-Phenylbutanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (50 mg, yield 59%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.07-1.12 (m, 4H), 2.72-2.88 (m, 2H), 3.93 (s, 3H), 3.96 (s, 3H), 6.55 (d, J=5.4 Hz, 1H), 7.19-7.35 (m, 7H), 7.41 (s, 1H), 7.51 (s, 1H), 7.72-7.78 (m, 2H), 8.52 (d, J=5.1 Hz, 1H), 11.50-11.53 (bs, 1H), 12.48 (d, J=4.9 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 502 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 4-phenylbutanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 4-phenylbutanoyl isothiocyanate was prepared using the resultant 4-phenylbutanoyl chloride as a starting compound according to the description of the literature. 4-Phenylbutanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (56 mg, yield 70%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.23-1.28 (m, 4H), 2.72-2.88 (m, 2H), 3.94 (s, 3H), 3.96 (s, 3H), 6.42 (d, J=5.4 Hz, 1H), 7.18-7.35 (m, 5H), 7.43 (s, 1H), 7.47 (d, J=8.8 Hz, 1H), 7.53 (s, 1H), 7.64-7.70 (m, 1H), 8.11-8.15 (m, 1H), 8.51 (d, J=8.4 Hz, 1H), 11.58-11.61 (bs, 1H), 12.50 (d, J=4.9 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 536 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 5-phenylpentanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 4-phenylpentanoyl isothiocyanate was prepared using the resultant 4-phenylpentanoyl chloride as a starting compound according to the description of the literature. 4-Phenylpentanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (41 mg, yield 47%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.56-1.64 (m, 4H) 2.57-2.63 (m, 2H), 3.94 (s, 3H), 3.96 (s, 3H), 6.58 (d, J=5.4 Hz, 1H), 7.15-7.34 (m, 7H), 7.42 (s, 1H), 7.53 (s, 1H), 7.75-7.81 (m, 2H), 8.55 (d, J=5.4 Hz, 1H), 11.48 (d, J=2.9 Hz, 1H), 12.53 (d, J=4.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 516 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 5-phenylpentanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 4-phenylpentanoyl isothiocyanate was prepared using the resultant 4-phenylpentanoyl chloride as a starting compound according to the description of the literature. 4-Phenylpentanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (47 mg, yield 57%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.56-1.64 (m, 4H), 2.56-2.63 (m, 2H), 3.95 (s, 3H), 3.9.6 (s, 3H), 6.44 (d, J=5.4 Hz, 1H), 7.15-7.32 (m, 5H), 7.43 (s, 1H), 7.48 (d, J=8.8 Hz, 1H), 7.54 (s, 1H), 7.67-7.72 (m, 1H), 8.13-8.18 (m, 1H), 8.53 (d, J=5.4 Hz, 1H), 11.55-11.59 (bs, 1H), 12.55 (d, J=4.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 550 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(2-fluorophenyl)acetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(2-fluorophenyl)ethanoyl isothiocyanate was prepared using the resultant 2-(2-fluorophenyl)ethanoyl chloride as a starting compound according to the description of the literature. 2-(2-Fluorophenyl)ethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (55 mg, yield 66%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.76 (s, 2H), 3.93 (s, 3H), 3.95 (s, 3H), 6.46 (d, J=5.4 Hz, 1H), 7.10-7.52 (m, 8H), 7.71-7.76 (m, 2H), 8.31 (s, 1H), 8.47 (d, J=5.1 Hz, 1H), 10.36 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(2-fluorophenyl)acetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(2-fluorophenyl)ethanoyl isothiocyanate was prepared using the resultant 2-(2-fluorophenyl)ethanoyl chloride as a starting compound according to the description of the literature. 2-(2-Fluorophenyl)ethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (51 mg, yield 65%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.78 (s, 2H), 3.96 (s, 3H), 3.97 (s, 3H), 6.44 (d, J=5.6 Hz, 1H), 7.10-7.64 (m, 8H), 8.06 (d, J=2.2 Hz, 1H), 8.31 (s, 1H), 8.53 (d, J=5.6 Hz, 1H), 10.56 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 526 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 3-(2-methylphenyl)propanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 3-(2-methylphenyl)propanoyl isothiocyanate was prepared using the resultant 3-(2-methylphenyl)propanoyl chloride as a starting compound according to the description of the literature. 3-(2-Methylphenyl)propanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (14 mg, yield 16%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.31 (s, 3H), 2.73-2.93 (m, 4H), 3.94 (s, 3H), 3.96 (s, 3H), 6.57 (d, J=5.1 Hz, 1H), 7.08-7.19 (m, 4H), 7.32 (d, J=8.8 Hz, 2H), 7.42 (s, 1H), 7.52 (s, 1H), 7.74-7.81 (m, 2H), 8.53 (d, J=5.4 Hz, 1H), 11.54-11.57 (bs, 1H), 12.53 (d, J=2.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 502 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 3-(2-methylphenyl)propanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 3-(2-methylphenyl)propanoyl isothiocyanate was prepared using the resultant 3-(2-methylphenyl)propanoyl chloride as a starting compound according to the description of the literature. 3-(2-Methylphenyl)propanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (45 mg, yield 56%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.31 (s, 3H), 2.74-2.92 (m, 4H), 3.97 (s, 3H), 3.98 (s, 3H), 6.51 (d, J=5.6 Hz, 1H), 7.08-7.20 (m, 4H), 7.45 (s, 1H), 7.52 (d, J=8.8 Hz, 1H), 7.58 (s, 1H), 7.69-7.75 (m, 1H), 8.15-8.19 (m, 1H), 8.58 (d, J=5.4 Hz, 1H), 11.65 (d, J=2.4 Hz, 1H), 12.56 (d, J=4.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 536 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(2-methoxyphenyl)acetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(2-methoxyphenyl)ethanoyl isothiocyanate was prepared using the resultant 2-(2-methoxyphenyl)ethanoyl chloride as a starting compound according to the description of the literature. 2-(2-Methoxyphenyl)ethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (25 mg, yield 30%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.79 (s, 3H), 3.82 (s, 2H), 3.96 (s, 3H), 3.99 (s, 3H), 6.66 (d, J=5.9 Hz, 1H), 6.85-7.03 (m, 2H), 7.21-7.37 (m, 4H), 7.44 (s, 1H), 7.58 (s, 1H), 7.78-7.84 (m, 2H), 8.62 (d, J=5.9 Hz, 1H), 11.64-11.66 (bs, 1H), 12.47 (d, J=4.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 504 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(2-methoxyphenyl)acetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(2-methoxyphenyl)ethanoyl isothiocyanate was prepared using the resultant 2-(2-methoxyphenyl)ethanoyl chloride as a starting compound according to the description of the literature. 2-(2-Methoxyphenyl)ethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (45 mg, yield 55%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.79 (s, 3H), 3.82 (s, 2H), 3.99 (s, 3H), 4.01 (s, 3H), 6.66 (d, J=5.9 Hz, 1H), 6.85-7.03 (m, 2H), 7.22-7.32 (m, 2H), 7.49 (s, 1H), 7.56 (d, J=9.0 Hz, 1H), 7.66 (s, 1H), 7.74-7.80 (m, 1H), 8.20-8.24 (m, 1H), 8.69 (d, J=5.9 Hz, 1H), 11.75 (d, J=2.4 Hz, 1H), 12.52 (d, J=4.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 538 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(2-nitrophenyl)acetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(2-nitrophenyl)ethanoyl isothiocyanate was prepared using the resultant 2-(2-nitrophenyl)ethanoyl chloride as a starting compound according to the description of the literature. 2-(2-Nitrophenyl)ethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/methanol for development to give the title compound (7 mg, yield 8%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 4.00 (s, 3H), 4.00 (s, 3H), 4.30 (s, 2H), 6.71 (d, J=5.9 Hz, 1H), 7.33-7.84 (m, 8H), 8.08 (d, J=7.8 Hz, 1H), 8.67 (d, J=5.9 Hz, 1H), 11.84-11.88 (bs, 1H), 12.25-12.28 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 519 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(2-nitrophenyl)acetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(2-nitrophenyl)ethanoyl isothiocyanate was prepared using the resultant 2-(2-nitrophenyl)ethanoyl chloride as a starting compound according to the description of the literature. 2-(2-Nitrophenyl)ethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/methanol for development to give the title compound (8 mg, yield 10%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.94 (s, 3H), 3.96 (s, 3H), 4.30 (s, 2H), 6.41 (d, J=5.1 Hz, 1H), 7.40-7.80 (m, 7H), 8.10-8.17 (m, 2H), 8.50 (d, J=5.1 Hz, 1H), 11.91-11.94 (bs, 1H), 12.26 (d, J=4.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 553 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-phenoxyacetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-phenoxyethanoyl isothiocyanate was prepared using the resultant 2-phenoxyethanoyl chloride as a starting compound according to the description of the literature. 2-Phenoxyethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (40 mg, yield 48%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.94 (s, 3H), 3.96 (s, 3H), 4.73 (s, 2H), 6.49 (d, J=5.1 Hz, 1H), 6.88-7.05 (m, 3H), 7.24-7.36 (m, 4H), 7.40 (s, 1H), 7.53 (s, 1H), 7.80 (d, J=9.0 Hz, 2H), 8.50 (d, J=5.4 Hz, 1H), 10.25 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 490 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-phenoxyacetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-phenoxyethanoyl isothiocyanate was prepared using the resultant 2-phenoxyethanoyl chloride as a starting compound according to the description of the literature. 2-Phenoxyethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (50 mg, yield 64%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.99 (s, 3H), 4.00 (s, 3H), 4.76 (s, 2H), 6.57 (d, J=5.6 Hz, 1H), 6.88-7.05 (m, 3H), 7.26-7.37 (m, 3H), 7.46 (s, 1H), 7.51 (d, J=9.0 Hz, 1H), 7.63 (s, 1H), 7.73-7.78 (m, 1H), 8.12 (d, J=2.2 Hz, 1H), 8.61 (d, J=5.9 Hz, 1H), 10.44 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 524 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(2-methylphenoxy)acetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(2-methylphenoxy)ethanoyl isothiocyanate was prepared using the resultant 2-(2-methylphenoxy)ethanoyl chloride as a starting compound according to the description of the literature. 2-(2-Methylphenoxy)ethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (25 mg, yield 29%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.27 (s, 3H), 3.94 (s, 3H), 3.95 (s, 3H), 4.74 (s, 2H), 6.46 (d, J=5.1 Hz, 1H), 6.78-6.92 (m, 3H), 7.09-7.28 (m, 4H), 7.40 (s, 1H), 7.51 (s, 1H), 7.78 (d, J=8.8 Hz, 2H), 8.47 (d, J=5.1 Hz, 1H), 10.20 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 504 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(2-methylphenoxy)acetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(2-methylphenoxy)ethanoyl isothiocyanate was prepared using the resultant 2-(2-methylphenoxy)ethanoyl chloride as a starting compound according to the description of the literature. 2-Phenoxyethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (26 mg, yield 32%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.27 (s, 3H), 3.96 (s, 3H), 3.96 (s, 3H), 4.77 (s, 2H), 6.42 (d, J=5.4 Hz, 1H), 6.78-7.71 (m, 9H), 8.09 (d, J=2.4 Hz, 1H), 8.51 (d, J=5.4 Hz, 1H), 10.39 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 538 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-phenoxybutanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-phenoxybutanoyl isothiocyanate was prepared using the resultant 2-phenoxybutanoyl chloride as a starting compound according to the description of the literature. 2-Phenoxybutanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (35 mg, yield 40%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.05 (t, J=7.3 Hz, 3H), 1.87-2.01 (m, 2H), 3.92 (s, 3H), 3.95 (s, 3H), 4.95-5.00 (m, 1H), 6.54 (d, J=5.4 Hz, 1H), 6.88-7.02 (m, 3H), 7.25-7.37 (m, 4H), 7.41 (s, 1H), 7.49 (s, 1H), 7.73-7.80 (m, 2H), 8.52 (d, J=5.4 Hz, 1H), 11.73-11.76 (bs, 1H), 12.16 (d, J=4.9 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 518 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-phenoxybutanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-phenoxybutanoyl isothiocyanate was prepared using the resultant 2-phenoxybutanoyl chloride as a starting compound according to the description of the literature. 2-Phenoxybutanoyl isothiocyanate thus obatined was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (25 mg, yield 27%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.06 (t, J=7.6 Hz, 3H), 1.86-2.02 (m, 2H), 3.94 (s, 3H), 3.96 (s, 3H), 4.95-5.01 (m, 1H), 6.40 (d, J=5.4 Hz, 1H), 6.90-7.02 (m, 3H), 7.30-7.37 (m, 2H), 7.42 (s, 1H), 7.46 (d, J=8.8 Hz, 1H), 7.52 (s, 1H), 7.67-7.73 (m, 1H), 8.10-8.15 (m, 1H), 8.51 (d, J=5.4 Hz, 1H), 11.82-11.86 (bs, 1H), 12.17 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 552 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available (2R)-2-phenylpropanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and (2R)-2-phenylpropanoyl isothiocyanate was prepared using the resultant (2R)-2-phenylpropanoyl chloride as a starting compound according to the description of the literature. (2R)-2-Phenylpropanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (31 mg, yield 38%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.44 (d, J=7.1 Hz, 3H), 3.92 (s, 3H), 3.95 (s, 3H), 4.08-4.16 (m, 1H), 6.55 (d, J=5.4 Hz, 1H), 7.24-7.45 (m, 8H), 7.50 (s, 1H), 7.72-7.78 (m, 2H), 8.52 (d, J=5.1 Hz, 1H), 11.66-11.69 (bs, 1H), 12.41-12.44 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 488 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available (2R)-2-phenylpropanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and (2R)-2-phenylpropanoyl isothiocyanate was prepared using the resultant (2R)-2-phenylpropanoyl chloride as a starting compound according to the description of the literature. (2R)-2-Phenylpropanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (56 mg, yield 71%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.44 (d, J=6.8 Hz, 3H), 3.94 (s, 3H), 3.96 (s, 3H), 4.08-4.16 (m, 1H), 6.42 (d, J=5.4 Hz, 1H), 7.27%-7.49 (m, 7H), 7.53 (s, 1H), 7.66-7.72 (m, 1H), 8.10-8.14 (m, 1H), 8.52 (d, J=5.1 Hz, 1H), 11.75-11.78 (bs, 1H), 12.44-12.47 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 522 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-phenoxypropanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-phenoxypropanoyl isothiocyanate was prepared using the resultant 2-phenoxypropanoyl chloride as a starting compound according to the description of the literature. 2-Phenoxypropanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (14 mg, yield 16%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.58 (d, J=6.6 Hz, 3H), 3.93 (s, 3H), 3.95 (s, 3H), 4.86-4.93 (m, 1H), 6.44 (d, J=5.1 Hz, 1H), 6.96-7.01 (m, 3H), 7.21-7.35 (m, 4H), 7.39 (s, 1H), 7.50 (s, 1H), 7.75-7.80 (m, 2H), 8.46 (d, J=5.4 Hz, 1H), 10.27 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 504 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-phenoxypropanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-phenoxypropanoyl isothiocyanate was prepared using the resultant 2-phenoxypropanoyl chloride as a starting compound according to the description of the literature. 2-Phenoxypropanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (33 mg, yield 41%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.58 (d, J=6.6 Hz, 3H), 3.94 (s, 3H), 3.95 (s, 3H), 4.87-4.94 (m, 1H), 6.35 (d, J=5.1 Hz, 1H), 6.88-7.53 (m, 8H), 7.69-7.74 (m, 1H), 8.07 (d, J=2.4 Hz, 1H), 8.45 (d, J=5.4 Hz, 1H), 10.43 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 538 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-phenylbutanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-phenylbutanoyl isothiocyanate was prepared using the resultant 2-phenylbutanoyl chloride as a starting compound according to the description of the literature. 2-Phenylbutanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (41 mg, yield 48%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.86 (t, J=7.3 Hz, 3H), 1.22-1.28 (bs, 1H), 1.69-1.81 (m, 1H), 2.01-2.14 (m, 1H), 3.93 (s, 3H), 3.95 (s, 3H), 6.55 (d, J=5.4 Hz, 1H), 7.26-7.44 (m, 8H), 7.50 (s, 1H), 7.72-7.79 (m, 2H), 8.53 (d, J=5.1 Hz, 1H), 11.69-11.72 (bs, 1H), 12.44-12.48 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 502 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-phenylbutanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-phenylbutanoyl isothiocyanate was prepared using the resultant 2-phenylbutanoyl chloride as a starting compound according to the description of the literature. 2-Phenylbutanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (37 mg, yield 46%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.83-0.90 (m, 3H), 1.22-1.29 (bs, 1H), 1.69-1.81 (m, 1H), 2.01-2.14 (m, 1H), 3.94 (s, 3H), 3.95 (s, 3H), 6.40 (d, J=5.1 Hz, 1H), 7.28-7.47 (m, 7H), 7.52 (s, 1H), 7.66-7.72 (m, 1H), 8.10-8.14 (m, 1H), 8.50 (d, J=5.1 Hz, 1H), 11.77-11.80 (bs, 1H), 12.45-12.48 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 536 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2,2-dichloro-1-methyl-1-cyclopropanecarboxylic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2,2-dichloro-1-methyl-1-cyclopropanecarbonyl isothiocyanate was prepared using the resultant 2,2-dichloro-1-methyl-1-cyclopropanecarbonyl chloride as a starting compound according to the description of the literature. 2,2-Dichloro-1-methyl-1-cyclopropanecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (63 mg, yield 73%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.67 (s, 3H), 1.71 (d, J=8.1 Hz, 1H), 2.13 (d, J=7.8 Hz, 1H), 3.93 (s, 3H), 3.95 (s, 3H), 6.55 (d, J=5.1 Hz, 1H), 7.28-7.34 (m, 2H), 7.41 (s, 1H), 7.50 (s, 1H), 7.75-7.81 (bs, 2H), 8.52 (d, J=5.1 Hz, 1H), 12.11-12.20 (m, 1H)
- Mass spectrometry value (ESI-MS, m/z): 506 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2,2-dichloro-1-methyl-1-cyclopropanecarboxylic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2,2-dichloro-1-methyl-1-cyclopropanecarbonyl isothiocyanate was prepared using the resultant 2,2-dichloro-1-methyl-1-cyclopropanecarbonyl chloride as a starting compound according to the description of the literature. 2,2-Dichloro-1-methyl-1-cyclopropanecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (27 mg, yield 34%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.67 (s, 3H), 1.72 (d, J=7.8 Hz, 1H), 2.13 (d, J=7.8 Hz, 1H), 3.95 (s, 3H), 3.96 (s, 3H), 6.42 (d, J=4.4 Hz, 1H), 7.43 (s, 1H), 7.48 (d, J=8.8 Hz, 1H), 7.53 (s, 1H), 7.67-7.74 (bs, 1H), 8.13-8.18 (bs, 1H), 8.51 (d, J=5.1 Hz, 1H), 12.19-12.23 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 540 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 4-butoxybenzoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 4-butoxy-1-benzenecarbonyl isothiocyanate was prepared using the resultant 4-butoxy-1-benzenecarbonyl chloride as a starting compound according to the description of the literature. 4-Butoxy-1-benzenecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (59 mg, yield 65%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.95 (t, J=7.6 Hz, 3H), 1.40-1.52 (m, 2H), 1.69-1.78 (m, 2H), 3.94 (s, 3H), 3.96 (s, 3H), 4.06-4.12 (m, 2H), 6.56 (d, J=5.1 Hz, 1H), 7.05-7.11 (m, 2H), 7.30-7.36 (m, 2H), 7.42 (s, 1H), 7.51 (s, 1H), 7.80-7.87 (m, 2H), 8.00-8.05 (m, 2H), 8.52 (d, J=5.1 Hz, 1H), 11.40-11.43 (bs, 1H), 12.72-12.76 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 532 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 4-butoxybenzoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 4-butoxy-1-benzenecarbonyl isothiocyanate was prepared using the resultant 4-butoxy-1-benzenecarbonyl chloride as a starting compound according to the description of the literature. 4-Butoxy-1-benzenecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (55 mg, yield 65%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.92-0.99 (m, 3H), 1.40-1.52 (m, 2H), 1.69-1.79 (m, 2H), 3.95 (s, 3H), 3.96 (s, 3H), 4.06-4.12 (m, 2H), 6.43 (d, J=5.1 Hz, 1H), 7.05-7.11 (m, 2H), 7.42-7.56 (m, 3H), 7.73-7.79 (m, 1H), 8.00-8.06 (m, 2H), 8.18-8.24 (m, 1H), 8.52 (d, J=5.4 Hz, 1H), 11.50-11.54 (bs, 1H), 12.74-12.79 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 566 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 4-(pentyloxy)benzoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 4-(pentyloxy)-1-benzenecarbonyl isothiocyanate was prepared using the resultant 4-(pentyloxy)-1-benzenecarbonyl chloride as a starting compound according to the description of the literature. 4-(Pentyloxy)-1-benzenecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (61 mg, yield 65%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.88-0.94 (m, 3H), 1.31-1.46 (m, 4H), 1.71-1.80 (m, 2H), 3.94 (s, 3H), 3.96 (s, 3H), 4.08 (t, J=6.3 Hz, 2H), 6.56 (d, J=5.1 Hz, 1H), 7.04-7.10 (m, 2H), 7.30-7.36 (m, 2H), 7.42 (s, 1H), 7.51 (s, 1H), 7.80-7.87 (m, 2H), 8.00-8.05 (m, 2H), 8.52 (d, J=5.4 Hz, 1H), 11.40-11.43 (bs, 1H), 12.73-12.76 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 546 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 4-(pentyloxy)benzoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 4-(pentyloxy)-1-benzenecarbonyl isothiocyanate was prepared using the resultant 4-(pentyloxy)-1-benzenecarbonyl chloride as a starting compound according to the description of the literature. 4-(Pentyloxy)-1-benzenecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (63 mg, yield 72%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.88-0.94 (m, 3H), 1.31-1.47 (m, 4H), 1.71-1.80 (m, 2H), 3.95 (s, 3H), 3.96 (s, 3H), 4.08 (t, J=6.6 Hz, 2H), 6.43 (d, J=5.1 Hz, 1H), 7.05-7.10 (m, 2H), 7.43 (s, 1H), 7.50 (d, J=8.8 Hz, 1H), 7.54 (s, 1H), 7.72-7.79 (m, 1H), 8.00-8.05 (m, 2H), 8.18-8.24 (m, 1H), 8.51 (d, J=5.1 Hz, 1H), 11.49-11.53 (bs, 1H), 12.74-12.78 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 580 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 4-(hexyloxy)benzoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 4-(hexyloxy)-1-benzenecarbonyl isothiocyanate was prepared using the resultant 4-(hexyloxy)-1-benzenecarbonyl chloride as a starting compound according to the description of the literature. 4-(Hexyloxy)-1-benzenecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (58 mg, yield 61%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.86-0.92 (m, 3H), 1.29-1.35 (m, 4H), 1.39-1.48 (m, 2H), 1.70-1.79 (m, 2H), 3.94 (s, 3H), 3.96 (s, 3H), 4.05-4.11 (m, 2H), 6.56 (d, J=5.1 Hz, 1H), 7.04-7.10 (m, 2H), 7.30-7.36 (m, 2H), 7.42 (s, 1H), 7.51 (s, 1H), 7.80-7.87 (m, 2H), 8.00-8.05 (m, 2H), 8.52 (d, J=5.4 Hz, 1H), 11.39-11.43 (bs, 1H), 12.72-12.76 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 560 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 4-(hexyloxy)benzoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 4-(hexyloxy)-1-benzenecarbonyl isothiocyanate was prepared using the resultant 4-(hexyloxy)-1-benzenecarbonyl chloride as a starting compound according to the description of the literature. 4-(Hexyloxy)-1-benzenecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (56 mg, yield 63%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.86-0.91 (m, 3H), 1.28-1.35 (m, 4H), 1.39-1.47 (m, 2H), 1.70-1.79 (m, 2H), 3.95 (s, 3H), 3.96 (s, 3H), 4.08 (t, J=6.3 Hz, 2H), 6.43 (d, J=5.1 Hz, 1H), 7.05-7.10 (m, 2H), 7.43 (s, 1H), 7.50 (d, J=9.0 Hz, 1H), 7.54 (s, 1H), 7.72-7.78 (m, 1H), 8.00-8.05 (m, 2H), 8.18-8.25 (m, 1H), 8.51 (d, J=5.1 Hz, 1H), 11.49-11.52 (bs, 1H), 12.73-12.77 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 595 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(4-chlorophenoxy)-2-methylpropanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(4-chlorophenoxy)-2-methylpropanoyl isothiocyanate was prepared using the resultant 2-(4-chlorophenoxy)-2-methylpropanoyl chloride as a starting compound according to the description of the literature. 2-(4-Chlorophenoxy)-2-methylpropanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (39 mg, yield 41%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.56 (s, 6H), 3.93 (s, 3H), 3.96 (s, 3H), 6.56 (d, J=5.1 Hz, 1H), 7.07-7.13 (m, 2H), 7.31-7.53 (m, 6H), 7.78-7.85 (m, 2H), 8.53 (d, J=5.1 Hz, 1H), 10.54-10.57 (bs, 1H), 12.10-12.15 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 552 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(4-chlorophenoxy)-2-methylpropanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(4-chlorophenoxy)-2-methylpropanoyl isothiocyanate was prepared using the resultant 2-(4-chlorophenoxy)-2-methylpropanoyl chloride as a starting compound according to the description of the literature. 2-(4-Chlorophenoxy)-2-methylpropanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (17 mg, yield 19%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.56 (s, 6H), 3.95 (s, 3H), 3.96 (s, 3H), 6.42 (d, J=5.1 Hz, 1H), 7.07-7.12 (m, 2H), 7.38-7.55 (m, 5H), 7.71-7.78 (m, 1H), 8.13-8.19 (m, 1H), 8.52 (d, J=5.1 Hz, 1H), 10.67-10.71 (bs, 1H), 12.13-12.17 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 587 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2,2,3,3-tetramethylcyclopropanecarboxylic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2,2,3,3-tetramethyl-1-cyclopropanecarbonyl isothiocyanate was prepared using the resultant 2,2,3,3-tetramethyl-1-cyclopropanecarbonyl chloride as a starting compound according to the description of the literature. 2,2,3,3-Tetramethyl-1-cyclopropanecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (11 mg, yield 14%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.20 (s, 6H), 1.27 (s, 6H), 1.73 (s, 1H), 3.93 (s, 3H), 3.95 (s, 3H), 6.54 (d, J=5.4 Hz, 1H), 7.26-7.32 (m, 2H), 7.41 (s, 1H), 7.50 (s, 1H), 7.73-7.80 (m, 2H), 8.51 (d, J=5.1 Hz, 1H), 11.41-11.45 (bs, 1H), 12.55-12.59 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 480 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2,2,3,3-tetramethylcyclopropanecarboxylic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2,2,3,3-tetramethyl-1-cyclopropanecarbonyl isothiocyanate was prepared using the resultant 2,2,3,3-tetramethyl-1-cyclopropanecarbonyl chloride as a starting compound according to the description of the literature. 2,2,3,3-Tetramethyl-1-cyclopropanecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (17 mg, yield 21%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.21 (s, 6H), 1.27 (s, 6H), 1.71-1.75 (m, 1H), 3.95 (s, 3H), 3.96 (s, 3H), 6.41 (d, J=5.1 Hz, 1H), 7.43 (s, 1H), 7.46 (d, J=8.5 Hz, 1H), 7.53 (s, 1H), 7.66-7.72 (m, 1H), 8.12-8.18 (m, 1H), 8.51 (d, J=5.1 Hz, 1H), 11.50-11.53 (bs, 1H), 12.59 (d, J=4.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 514 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-methoxy-2-phenylacetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-methoxy-2-phenylethanoyl isothiocyanate was prepared using the resultant 2-methoxy-2-phenylethanoyl chloride as a starting compound according to the description of the literature. 2-Methoxy-2-phenylethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (25 mg, yield 30%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.40 (s, 3H), 3.93 (s, 3H), 3.94 (s, 3H), 4.54 (s, 1H), 4.87 (s, 1H), 6.43 (d, J=5.1 Hz, 1H), 7.20-7.54 (m, 9H), 7.80-7.86 (m, 2H), 8.45 (d, J=5.1 Hz, 1H), 10.20 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 503 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-methoxy-2-phenylacetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-methoxy-2-phenylethanoyl isothiocyanate was prepared using the resultant 2-methoxy-2-phenylethanoyl chloride as a starting compound according to the description of the literature. 2-Methoxy-2-phenylethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (28 mg, yield 35%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.40 (s, 3H), 3.94 (s, 3H), 3.95 (s, 3H), 4.54 (s, 1H), 4.88 (s, 1H), 6.33 (d, J=5.1 Hz, 1H), 7.28-7.55 (m, 8H), 7.77-7.83 (m, 1H), 8.11-8.16 (m, 1H), 8.44 (d, J=5.1 Hz, 1H), 10.37 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 537 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(2-chlorophenoxy)propanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(2-chlorophenoxy)propanoyl isothiocyanate was prepared using the resultant 2-(2-chlorophenoxy)propanoyl chloride as a starting compound according to the description of the literature. 2-(2-Chlorophenoxy)propanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (4 mg, yield 5%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.62 (d, J=6.6 Hz, 3H), 3.93 (s, 3H), 3.95 (s, 3H), 4.96 (q, J=6.6 Hz, 1H), 6.46 (d, J=5.1 Hz, 1H), 6.98-7.52 (m, 8H), 7.74-7.79 (m, 2H), 8.47 (d, J=5.1 Hz, 1H), 10.31 (s, 1H).
- Mass spectrometry value (ESI-MS, m/z): 537 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(2-chlorophenoxy)propanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(2-chlorophenoxy)propanoyl isothiocyanate was prepared using the resultant 2-(2-chlorophenoxy)propanoyl chloride as a starting compound according to the description of the literature. 2-(2-Chlorophenoxy)propanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (53 mg, yield 62%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.62 (d, J=6.8 Hz, 3H), 3.95 (s, 3H), 3.95 (s, 3H), 4.93-5.01 (m, 1H), 6.37 (d, J=5.4 Hz, 1H), 6.95-7.55 (m, 8H), 7.67-7.71 (m, 1H), 8.07 (s, 1H), 8.47 (d, J=5.4 Hz, 1H), 10.50 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 572 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available tetrahydro-2-furancarboxylic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and tetrahydro-2-furancarbonyl isothiocyanate was prepared using the resultant tetrahydro-2-furancarbonyl chloride as a starting compound according to the description of the literature. Tetrahydro-2-furancarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (5 mg, yield 6%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.84-1.92 (m, 2H), 1.97-2.06 (m, 1H), 2.17-2.27 (m, 1H), 3.82-3.88 (m, 1H), 3.94 (s, 3H), 3.95 (s, 3H), 3.97-4.04 (m, 1H), 4.39-4.44 (m, 1H), 6.45 (d, J=5.1 Hz, 1H), 7.21-7.26 (m, 2H), 7.40 (s, 1H), 7.52 (s, 1H), 7.84 (d, J=9.0 Hz, 2H), 8.48 (d, J=5.4 Hz, 1H), 9.83 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 454 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available tetrahydro-2-furancarboxylic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and tetrahydro-2-furancarbonyl isothiocyanate was prepared using the resultant tetrahydro-2-furancarbonyl chloride as a starting compound according to the description of the literature. Tetrahydro-2-furancarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (5 mg, yield 7%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.84-1.92 (m, 2H), 1.97-2.06 (m, 1H), 2.17-2.27 (m, 1H), 3.83-3.89 (m, 1H), 3.95 (s, 3H), 3.96 (s, 3H), 3.97-4.03 (m, 1H), 4.41-4.46 (m, 1H), 6.38 (d, J=5.4 Hz, 1H), 7.42 (s, 1H), 7.44 (s, 1H), 7.55 (s, 1H), 7.79-7.84 (m, 1H), 8.15 (d, J=2.4 Hz, 1H), 8.49 (d, J=5.4 Hz, 1H), 10.01 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 488 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 3-methoxy-1-cyclohexanecarboxylic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 3-methoxy-1-cyclohexanecarbonyl isothiocyanate was prepared using the resultant 3-methoxy-1-cyclohexanecarbonyl chloride as a starting compound according to the description of the literature. 3-Methoxy-1-cyclohexanecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (38 mg, yield 45%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.32-1.61 (m, 5H), 1.73-1.85 (m, 2H), 1.90-1.97 (m, 1H), 2.85-2.94 (m, 1H), 3.25 (s, 3H), 3.53-3.58 (bs, 1H), 3.93 (s, 3H), 3.96 (s, 3H), 6.56 (d, J=5.1 Hz, 1H), 7.30 (d, J=8.8 Hz, 2H), 7.41 (s, 1H), 7.51 (s, 1H), 7.74-7.80 (m, 2H), 8.53 (d, J=5.4 Hz, 1H), 11.48-11.51 (bs, 1H), 12.57 (d, J=4.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 496 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 3-methoxy-1-cyclohexanecarboxylic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 3-methoxy-1-cyclohexanecarbonyl isothiocyanate was prepared using the resultant 3-methoxy-1-cyclohexanecarbonyl chloride as a starting compound according to the description of the literature. 3-Methoxy-1-cyclohexanecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (31 mg, yield 39%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.33-1.61 (m, 5H), 1.73-1.85 (m, 2H), 1.90-1.97 (m, 1H), 2.85-2.94 (m, 1H), 3.25 (s, 3H), 3.53-3.57 (bs, 1H), 3.95 (s, 3H), 3.96 (s, 3H), 6.43 (d, J=5.1 Hz, 1H), 7.43 (s, 1H), 7.48 (d, J=8.8 Hz, 1H), 7.54 (s, 1H), 7.67-7.72 (m, 1H), 8.14-8.18 (m, 1H), 8.53 (d, J=5.4 Hz, 1H), 11.59 (d, J=2.9 Hz, 1H), 12.59 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 530 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-ethoxyacetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-ethoxyethanoyl isothiocyanate was prepared using the resultant 2-ethoxyethanoyl chloride as a starting compound according to the description of the literature. 2-Ethoxyethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (9 mg, yield 13%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.21 (t, J=7.1 Hz, 3H), 3.55-3.62 (m, 2H), 3.96 (s, 3H), 3.97 (s, 3H), 4.06 (s, 2H), 6.54 (d, J=5.4 Hz, 1H), 7.26 (d, J=8.8 Hz, 2H), 7.42 (s, 1H), 7.56 (s, 1H), 7.82 (d, J=9.0 Hz, 2H), 8.54 (d, J=5.6 Hz, 1H), 9.87 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-{[(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl]oxy}acetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-{([(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl]oxy}ethanoyl isothiocyanate was prepared using the resultant 2-{[(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl]oxy}ethanoyl chloride as a starting compound according to the description of the literature. 2-{[(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl]oxy}ethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (27 mg, yield 29%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.77 (d, J=6.8 Hz, 3H), 0.81-1.00 (m, 9H), 1.23-1.40 (m, 1H), 1.56-1.67 (m, 2H), 2.09-2.15 (m, 1H), 2.24-2.34 (m, 1H), 3.94 (s, 3H), 3.95 (s, 3H), 4.02-4.16 (m, 2H), 6.47 (d, J=5.4 Hz, 1H), 7.22-7.27 (m, 2H), 7.40 (s, 1H), 7.52 (s, 1H), 7.76-7.81 (m, 2H), 8.48 (d, J=5.4 Hz, 1H), 9.72 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 551 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-{[(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl]oxy}acetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-{[(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl]oxy}ethanoyl isothiocyanate was prepared using the resultant 2-{[(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl]oxy}ethanoyl chloride as a starting compound according to the description of the literature. 2-{[(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl]oxy}ethanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (17 mg, yield 19%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.77 (d, J=6.8 Hz, 3H), 0.80-1.02 (m, 9H), 1.23-1.40 (m, 1H), 1.56-1.67 (m, 2H), 2.08-2.14 (m, 1H), 2.23-2.34 (m, 1H), 3.95 (s, 3H), 3.96 (s, 3H), 4.04-4.18 (m, 2H), 6.36 (d, J=5.1 Hz, 1H), 7.41 (s, 1H), 7.43 (d, J=8.8 Hz, 1H), 7.54 (s, 1H), 7.70-7.74 (m, 1H), 8.09 (d, J=2.4 Hz, 1H), 8.48 (d, J=5.1 Hz, 1H), 9.93 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 585 (M++1)
- Chlorobenzene (7 ml) was added to 4-chloro-6,7-dimethoxyquinazoline (2.5 g) and 4-hydroxyphenyl benzoate (4.78 g), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. Methanol was added to the residue, and the precipitated crystal was collected by filtration and was washed to give the title compound (3.49 g, yield 78%).
- 1H-NMR (chloroform-d, 400 MHz): δ 4.10 (s, 3H), 4.10 (s, 3H), 7.31-7.38 (m, 4H), 7.49 (s, 1H), 7.51-7.59 (m, 3H), 7.64-7.69 (m, 1H), 8.20-8.25 (m, 2H), 8.68 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 403 (M++1)
- Methanol (5 ml) and sodium hydroxide (0.2 g) were added to 4-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenyl benzoate (500 mg), and the mixture was stirred at 0° C. for 30 min. A saturated aqueous ammonium chloride solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. Methanol was added to the residue, and the precipitated crystal was collected by filtration and was washed to give the title compound (350 mg, yield 95%).
- 1H-NMR (chloroform-d, 400 MHz): δ 4.08 (s, 3H), 4.11 (s, 3H), 6.91-6.95 (m, 2H), 7.05-7.10 (m, 2H), 7.57 (s, 1H), 7.59 (s, 1H), 8.66 (s, 1H)
- Mass spectrometry value (FD-MS, m/z): 298 (M+)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]phenol (100 mg) was dissolved in dimethylformamide (2 ml) to prepare a solution. Sodium hydride (15 mg) was added to the solution, and the mixture was stirred at 0° C. for 10 min. Methylbromoacetate (0.037 ml) was added thereto, and the mixture was further stirred at 0° C. for 30 min. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with ethyl acetate, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. Diethyl ether was added to the residue, and the precipitated crystal was collected by filtration and was washed to give the title compound (88 mg, yield 71%).
- 1H-NMR (chloroform-d, 400 MHz): δ 3.84 (s, 3H), 4.07 (s, 6H), 4.67 (s, 2H), 6.99-7.04 (m, 2H), 7.17-7.21 (m, 2H), 7.33 (s, 1H), 7.55 (s, 1H), 8.63 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 371 (M++1)
- Methyl 2-{4-[(6,7-dimethoxy-4-quinazolinyloxy)-phenol (70 mg) was dissolved in methanol (1 ml) to prepare a solution. A solution of sodium hydroxide (70 mg) in water was added to the solution, and the mixture was stirred at 0° C. for 2 hr. Concentrated hydrochloric acid was added to the reaction solution, and the precipitated crystal was collected by filtration and was washed with methanol, diethyl ether, and hexane to give the title compound (65 mg, yield 97%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.98 (s, 3H), 3.99 (s, 3H), 4.73 (s, 2H), 6.97-7.02 (m, 2H), 7.20-7.25 (m, 2H), 7.39 (s, 1H), 7.56 (s, 1H), 8.56 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 357 (M++1)
- 2-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenoxy}acetic acid (150 mg), 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (WSC.HCl) (122 mg), and 1-hydroxybenzotriazole hydrate (HOBT.H2O) (86 mg) were dissolved in chloroform (5 ml) to prepare a solution. o-Anisidine (63 mg) was then added to the solution, and the mixture was heated under reflux for 3 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The chloroform layer was washed with 1 N hydrochloric acid, water, and saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (155 mg, yield 80%).
- The compound (50 mg) thus obtained was dissolved in 10% hydrochloric acid-methanol solution (6 ml), and the solution was allowed to stand at room temperature for 15 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 49 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.88 (s, 3H), 4.04 (s, 3H), 4.05 (s, 3H), 4.77 (s, 1H), 4.86 (s, 1H), 6.80-6.83 (m, 1H), 6.93-6.97 (m, 1H), 7.09-7.42 (m, 6H), 7.64 (s, 1H), 7.75 (d, J=2.7 Hz, 1H), 8.05-8.09 (m, 1H), 8.79-8.82 (m, 1H), 9.29 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 461 (M++1)
- N1-(2-Methoxyphenyl)-2-{4-[(6,7-dimethoxy-4-quinolyl)oxy]phenoxy}acetamide (100 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A borane-tetrahydrofuran complex (1.0 M solution: 1.08 ml) was then added to the solution, and the mixture was heated under reflux for 5 hr. 1 N Hydrochloric acid was added thereto, and the mixture was further heated under reflux for 30 min. A 5% aqueous sodium hydroxide solution was added to the reaction solution, the mixture was extracted with chloroform, and the extract was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (58 mg, yield 60%).
- The resultant compound (55 mg) was dissolved in 10% hydrochloric acid-methanol solution (4 ml) to prepare a solution which was then allowed to stand at room temperature for 20 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 55 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.53 (t, J=5.4 Hz, 2H), 3.80 (s, 3H), 4.04 (s, 3H), 4.05 (s, 3H), 4.23 (t, J=5.6 Hz, 2H), 6.66-6.72 (m, 1H), 6.75-6.91 (m, 4H), 7.18 (d, J=9.0 Hz, 2H), 7.36 (d, J=9.0 Hz, 2H), 7.63 (s, 1H), 7.76 (s, 1H), 8.80 (d, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 447 (M++1)
- 2-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenoxy}acetic acid (150 mg), WSC.HCl (122 mg), and HOBT.H2O (86 mg) were dissolved in chloroform (5 ml) to prepare a solution. m-Anisidine (63 mg) was then added to the solution, and the mixture was heated under reflux for 3 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The chloroform layer was washed with 1 N hydrochloric acid, water, and saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (173 mg, yield 89%).
- The resultant compound (45 mg) was dissolved in 10% hydrochloric acid-methanol solution (4 ml) to prepare a solution which was then allowed to stand at room temperature for 15 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 42 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.74 (s, 3H), 4.04 (s, 3H), 4.05 (s, 3H), 4.77 (s, 1H), 4.80 (s, 1H), 6.67-6.70 (m, 1H), 6.80-6.83 (m, 1H), 7.13-7.40 (m, 7H), 7.62 (s, 1H), 7.75 (s, 1H), 8.80 (d, J=6.8 Hz, 1H), 10.20 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 461 (M++1)
- N1-(3-Methoxyphenyl)-2-{4-[(6,7-dimethoxy-4-quinolyl)oxy]phenoxy}acetamide (112 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A borane-tetrahydrofuran complex (1.0 M solution: 1.22 ml) was then added to the solution, and the mixture was heated under reflux for 5 hr. 1 N Hydrochloric acid was added thereto, and the mixture was further heated under reflux for 30 min. A 5% aqueous sodium hydroxide solution was added to the reaction solution, the mixture was extracted with chloroform, and the extract was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (64 mg, yield 59%).
- The resultant compound (60 mg) was dissolved in a 10% hydrochloric acid-methanol solution (4 ml) to prepare a solution which was then allowed to stand at room temperature for 20 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 58 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.59 (t, J=5.1 Hz, 2H), 3.73 (s, 3H), 4.04 (s, 6H), 4.26 (t, J=5.1 Hz, 2H), 6.53-6.70 (m, 3H), 6.80 (d, J=6.8 Hz, 1H), 7.15-7.22 (m, 3H), 7.35-7.40 (m, 2H), 7.76 (d, J=5.1 Hz, 2H), 8.81 (d, J=6.8 Hz, 1H)
- Mass spectrometry value (ESI MS, m/z): 447 (M++1)
- 2-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenoxy}acetic acid (150 mg), WSC.HCl (122 mg), and HOBT.H2O (86 mg) were dissolved in chloroform (5 ml) to prepare a solution. p-Anisidine (63 mg) was then added to the solution, and the mixture was heated under reflux for 4 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The chloroform layer was washed with 1 N hydrochloric acid, water, and saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (147 mg, yield 76%).
- The resultant compound (47 mg) was dissolved in a 10% hydrochloric acid-methanol solution (6 ml) which was then allowed to stand at room temperature for 15 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 49 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.73 (s, 3H), 4.03 (s, 3H), 4.04 (s, 3H), 4.76 (s, 2H), 6.80 (d, J=6.8 Hz, 1H), 6.90-6.92 (m, 2H), 7.12-7.40 (m, 4H), 7.55-7.63 (m, 3H), 7.74 (s, 1H), 8.79 (d, J=6.6 Hz, 1H), 10.05 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 461 (M++1)
- N1-(4-Methoxyphenyl)-2-{4-[(6,7-dimethoxy-4-quinolyl)oxy]phenoxy}acetamide (90 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A borane-tetrahydrofuran complex (1.0 M solution: 0.98 ml) was then added to the solution, and the mixture was heated under reflux for 3 hr. 1 N Hydrochloric acid was added thereto, and the mixture was further heated under reflux for 30 min. A 5% aqueous sodium hydroxide solution was added to the reaction solution, the mixture was extracted with chloroform, and the extract was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (52 mg, yield 60%).
- The resultant compound (52 mg) was dissolved in a 10% hydrochloric acid-methanol solution (4 ml) to prepare a solution which was then allowed to stand at room temperature for 20 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 42 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.54-3.62 (m, 2H), 3.70-3.74 (m, 3H), 4.04 (s, 3H), 4.04 (s, 3H), 4.21-4.26 (m, 2H), 6.81 (d, J=6.6 Hz, 1H), 6.87-6.97 (m, 2H), 7.12-7.21 (m, 2H), 7.35-7.39 (m, 2H), 7.57-7.63 (m, 2H), 7.75 (s, 2H), 8.80 (d, J=6.8 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 447 (M++1)
- 2-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenoxy}acetic acid (150 mg), WSC.HCl (122 mg), and HOBT.H2O (86 mg) were dissolved in chloroform (5 ml) to prepare a solution. o-Toluidine (0.055 ml) was then added to the solution, and the mixture was heated under reflux for 6 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (103 mg, yield 55%).
- The resultant compound (101 mg) was dissolved in a 10% hydrochloric acid-methanol solution (4 ml) to prepare a solution which was then allowed to stand at room temperature for 15 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 100 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.20 (s, 3H), 4.04 (s, 3H), 4.05 (s, 3H), 4.77 (s, 1H), 4.83 (s, 1H), 6.79-6.83 (m, 1H), 7.11-7.46 (m, 8H), 7.63-7.69 (m, 1H), 7.76 (s, 1H), 7.76 (s, 1H), 8.82 (d, J=6.6 Hz, 1H), 9.60 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 445 (M++1)
- N1-(2-Methylphenyl)-2-{4-[(6,7-dimethoxy-4-quinolyl)oxy]phenoxy}acetamide (65 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A borane-tetrahydrofuran complex (1.0 M solution: 0.74 ml) was then added to the solution, and the mixture was heated under reflux overnight. 1 N Hydrochloric acid was added thereto, and the mixture was further heated under reflux for 30 min. A 5% aqueous sodium hydroxide solution was added to the reaction solution, the mixture was extracted with chloroform, and the extract was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (29 mg, yield 46%).
- The resultant compound (29 mg) was dissolved in a 10% hydrochloric acid-methanol solution (3 ml) to prepare a solution which was then allowed to stand at room temperature for 20 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 30 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.16 (s, 3H), 3.57 (t, J=5.9 Hz, 2H), 4.04 (s, 3H), 4.05 (s, 3H), 4.25 (t, J=5.6 Hz, 2H), 6.63-6.70 (m, 1H), 6.77-6.84 (m, 2H), 7.02-7.12 (m, 2H), 7.16-7.21 (m, 2H), 7.34-7.39 (m, 2H), 7.66 (s, 1H), 7.76 (s, 1H), 8.80 (d, J=6.8 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 431 (M++1)
- 2-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenoxy}acetic acid (150 mg), WSC.HCl (122 mg), and HOBT.H2O (86 mg) were dissolved in chloroform (5 ml) to prepare a solution. m-Toluidine (0.055 ml) was then added to the solution, and the mixture was heated under reflux for 4 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The chloroform layer was washed with 1 N hydrochloric acid, water, and saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (102 mg, yield 55%).
- The resultant compound (30 mg) was dissolved in a 10% hydrochloric acid-methanol solution (3 ml) to prepare a solution which was then allowed to stand at room temperature for 20 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 27 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.29 (s, 3H), 4.03 (s, 3H), 4.05 (s, 3H), 4.76 (s, 1H), 4.79 (s, 1H), 6.78-6.83 (m, 1H), 6.89-6.93 (m, 1H), 7.01-7.51 (m, 7H), 7.61 (s, 1H), 7.75 (s, 1H), 8.79 (d, J=6.6 Hz, 1H), 10.12 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 445 (M++1)
- N1-(3-Methylphenyl)-2-{4-[(6,7-dimethoxy-4-quinolyl)oxy]phenoxy}acetamide (70 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A borane-tetrahydrofuran complex (1.0 M solution: 0.78 ml) was then added to the solution, and the mixture was heated under reflux overnight. 1 N Hydrochloric acid was added thereto, and the mixture was further heated under reflux for 30 min. A 5% aqueous sodium hydroxide solution was added to the reaction solution, the mixture was extracted with chloroform, and the extract was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (31 mg, yield 46%).
- The resultant compound (31 mg) was dissolved in a 10% hydrochloric acid-methanol solution (3 ml) to prepare a solution which was then allowed to stand at room temperature for 20 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 31 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.23 (s, 3H), 3.49-3.53 (m, 2H), 4.04 (s, 3H), 4.05 (s, 3H), 4.20 (t, J=5.1 Hz, 2H), 6.53-6.60 (m, 1H), 6.60-6.70 (m, 1H), 6.81 (s, 1H), 6.82 (s, 1H), 7.03-7.10 (m, 1H), 7.15-7.20 (m, 2H), 7.34-7.39 (m, 2H), 7.64 (s, 1H), 7.76 (s, 1H), 8.81 (d, J=6.8 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 431 (M++1)
- 2-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenoxy}acetic acid (150 mg), WSC.HCl (122 mg), and HOBT.H2O (86 mg) were dissolved in chloroform (5 ml) to prepare a solution. p-Toluidine (0.055 ml) was then added to the solution, and the mixture was heated under reflux for 3 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The chloroform layer was washed with 1 N hydrochloric acid, water, and saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (76 mg, yield 41%).
- The resultant compound (20 mg) was dissolved in a 10% hydrochloric acid-methanol solution (3 ml) to prepare a solution which was then allowed to stand at room temperature for 15 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 16 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.27 (s, 3H), 4.03 (s, 3H), 4.04 (s, 3H), 4.76 (s, 1H), 4.78 (s, 1H), 6.78-6.82 (m, 1H), 7.12-7.16 (m, 2H), 7.19-7.25 (m, 2H), 7.36-7.40 (m, 2H), 7.52-7.57 (m, 2H), 7.63 (s, 1H), 7.74 (s, 1H), 8.79 (d, J=6.6 Hz, 1H), 10.13 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 445 (M++1)
- N1-(4-Methylphenyl)-2-{4-[(6,7-dimethoxy-4-quinolyl)oxy]phenoxy}acetamide (54 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A borane-tetrahydrofuran complex (1.0 M solution: 0.60 ml) was then added to the solution, and the mixture was heated under reflux for 3 hr. 1 N Hydrochloric acid was added thereto, and the mixture was further heated under reflux for 30 min. A 5% aqueous sodium hydroxide solution was added to the reaction solution, the mixture was extracted with chloroform, and the extract was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (11 mg, yield 20%).
- The resultant compound (11 mg) was dissolved in a 10% hydrochloric acid-methanol solution (3 ml) to prepare a solution which was then allowed to stand at room temperature for 20 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 11 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.24 (s, 3H), 3.54-3.60 (m, 2H), 4.04 (s, 3H), 4.05 (s, 3H), 4.16-4.27 (m, 2H), 6.81 (d, J=6.6 Hz, 1H), 6.74-7.28 (m, 4H), 7.32-7.42 (m, 2H), 7.68-7.79 (m, 2H), 7.67 (s, 1H), 7.76 (s, 1H), 8.80 (d, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 431 (M++1)
- 2-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenoxy}acetic acid (150 mg), WSC.HCl (122 mg), and HOBT.H2O (86 mg) were dissolved in chloroform (5 ml) to prepare a solution. m-Chloroaniline (65 mg) was then added to the solution, and the mixture was heated under reflux for 3 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The chloroform layer was washed with 1 N hydrochloric acid, water, and saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (141 mg, yield 72%).
- The resultant compound (50 mg) was dissolved in a 10% hydrochloric acid-methanol solution (3 ml) to prepare a solution which was then allowed to stand at room temperature for 15 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 40 mg of a hydrochloride.
- Mass spectrometry value (ESI-MS, m/z): 465 (M++1)
- 2-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenoxy}acetic acid (150 mg), WSC.HCl (122 mg), and HOBT.H2O (86 mg) were dissolved in chloroform (5 ml) to prepare a solution. 4-Chloroaniline (65 mg) was then added to the solution, and the mixture was heated under reflux for 5 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The chloroform layer was washed with 1 N hydrochloric acid, water, and saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (156 mg, yield 79%).
- The resultant compound (49 mg) was dissolved in a 10% hydrochloric acid-methanol solution (3 ml) to prepare a solution which was then allowed to stand at room temperature for 15 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 39 mg of a hydrochloride.
- Mass spectrometry value (ESI-MS, m/z): 465 (M++1)
- p-Cresol (300 mg) was dissolved in acetone (5 ml) to prepare a solution. 1,3-Dibromopropane (0.85 ml), potassium carbonate (765 mg), and tetra-n-butylammonium iodide (102 mg) were then added to the solution, and the mixture was heated under reflux for 3 hr. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(3-bromopropyl)-4-methylbenzene (1) (466 mg, yield 74%).
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenol (100 mg) was dissolved in dimethylformamide (2 ml) to prepare a solution. Sodium hydride (16 mg) was then added to the solution, and the mixture was stirred at room temperature for 10 min. A solution of the compound (1) (85 mg) in dimethylformamide was added thereto, and the mixture was further stirred at room temperature for 4 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with ethyl acetate, followed by washing three times with saturated brine. The extract was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (142 mg, yield 95%).
- The resultant compound (138 mg) was dissolved in a 10% hydrochloric acid-methanol solution (5 ml) to prepare a solution which was then allowed to stand at room temperature for 15 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 117 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.16-2.22 (m, 2H), 2.23 (s, 3H), 4.03 (s, 3H), 4.04 (s, 3H), 4.12 (t, J=6.1 Hz, 2H), 4.20 (t, J=6.1 Hz, 2H), 6.80 (d, J=6.3 Hz, 1H), 6.83-6.88 (m, 2H), 7.09 (d, J=8.5 Hz, 2H), 7.14-7.20 (m, 2H), 7.31-7.36 (m, 2H), 7.59 (s, 1H), 7.74 (s, 1H), 8.77 (d, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 446 (M++1)
- m-Cresol (300 mg) was dissolved in acetone (5 ml) to prepare a solution. 1,3-Dibromopropane (0.85 ml), potassium carbonate (765 mg), and tetra-n-butylammonium iodide (102 mg) were then added to the solution, and the mixture was heated under reflux for 3 hr. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(3-bromopropyl)-3-methylbenzene (1) (490 mg, yield 78%).
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenol (100 mg) was dissolved in dimethylformamide (2 ml) to prepare a solution. Sodium hydride (16 mg) was then added to the solution, and the mixture was stirred at room temperature for 10 min. A solution of the compound (1) (85 mg) in dimethylformamide was added thereto, and the mixture was further stirred at room temperature for 4 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with ethyl acetate, followed by washing three times with saturated brine. The extract was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (145 mg, yield 97%).
- The resultant compound (139 mg) was dissolved in a 10% hydrochloric acid-methanol solution (5 ml) to prepare a solution which was then allowed to stand at room temperature for 15 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 103 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.16-2.24 (m, 2H), 2.28 (s, 3H), 4.03 (s, 3H), 4.04 (s, 3H), 4.14 (t, J=6.3 Hz, 2H), 4.20 (t, J=6.1 Hz, 2H), 6.74-6.81 (m, 4H), 7.14-7.20 (m, 3H), 7.32-7.37 (m, 2H), 7.58 (s, 1H), 7.74 (s, 1H), 8.77 (d, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 446 (M++1)
- o-Cresol (300 mg) was dissolved in acetone (5 ml) to prepare a solution. 1,3-Dibromopropane (0.85 ml), potassium carbonate (765 mg), and tetra-n-butylammonium iodide (102 mg) were added to the solution, and the mixture was heated under reflux for 4 hr. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(3-bromopropyl)-2-methylbenzene (1) (363 mg, yield 57%).
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenol (100 mg) was dissolved in dimethylformamide (2 ml) to prepare a solution. Sodium hydride (16 mg) was then added to the solution, and the mixture was stirred at room temperature for 10 min. A solution of the compound (1) (85 mg) in dimethylformamide was added thereto, and the mixture was further stirred at room temperature for 2 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with ethyl acetate, followed by washing three times with saturated brine. The extract was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (148 mg, yield 98%).
- The resultant compound (145 mg) was dissolved in a 10% hydrochloric acid-methanol solution (5 ml) to prepare a solution which was then allowed to stand at room temperature for 15 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 106 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.17 (s, 3H), 2.20-2.26 (m, 2H), 4.04 (s, 3H), 4.05 (s, 3H), 4.16 (t, J=6.1 Hz, 2H), 4.24 (t, J=6.1 Hz, 2H), 6.80-6.87 (m, 2H), 6.96 (d, J=7.8 Hz, 1H), 7.12-7.21 (m, 4H), 7.33-7.38 (m, 2H), 7.69 (s, 1H), 7.75 (s, 1H), 8.81 (d, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 446 (M++1)
- 3-Methoxyphenol (300 mg) was dissolved in acetone (5 ml) to prepare a solution. 1,3-Dibromopropane (0.74 ml), potassium carbonate (668 mg), and tetra-n-butylammonium iodide (89 mg) were added to the solution, and the mixture was heated under reflux for 4 hr. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(3-bromopropyl)-3-methoxybenzene (1) (440 mg, yield 74%).
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenol (100 mg) was dissolved in dimethylformamide (2 ml) to prepare a solution. Sodium hydride (16 mg) was then added to the solution, and the mixture was stirred at room temperature for 10 min. A solution of the compound (1) (91 mg) in dimethylformamide was added thereto, and the mixture was further stirred at room temperature for 2 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with ethyl acetate, followed by washing three times with saturated brine. The extract was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (147 mg, yield 95%).
- The resultant compound (143 mg) was dissolved in a 10% hydrochloric acid-methanol solution (5 ml) to prepare a solution which was then allowed to stand at room temperature for 15 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 109 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.17-2.24 (m, 2H), 3.73 (s, 3H), 4.03 (s, 3H), 4.04 (s, 3H), 4.15 (t, J=6.1 Hz, 2H), 4.20 (t, J=6.1 Hz, 2H), 6.51-6.57 (m, 3H), 6.80 (d, J=6.8 Hz, 1H), 7.15-7.21 (m, 3H), 7.32-7.37 (m, 2H), 7.64 (s, 1H), 7.74 (s, 1H), 8.77 (d, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 462 (M++1)
- 4-Methoxyphenol (300 mg) was dissolved in acetone (5 ml) to prepare a solution. 1,3-Dibromopropane (0.74 ml), potassium carbonate (668 mg), and tetra-n-butylammonium iodide (89 mg) were then added to the solution, and the mixture was heated under reflux for 7 hr. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(3-bromopropyl)-4-methoxybenzene (1) (399 mg, yield 67%).
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenol (100 mg) was dissolved in dimethylformamide (2 ml) to prepare a solution. Sodium hydride (16 mg) was then added to the solution, and the mixture was stirred at room temperature for 10 min. A solution of the compound (1) (91 mg) in dimethylformamide was added thereto, and the mixture was further stirred at room temperature for 6 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with ethyl acetate, followed by washing three times with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (150 mg, yield 97%).
- The resultant compound (141 mg) was dissolved in a 10% hydrochloric acid-methanol solution (5 ml) to prepare a solution which was then allowed to stand at room temperature for 15 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 135 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.15-2.23 (m, 2H), 3.70 (s, 3H), 4.03 (s, 3H), 4.04 (s, 3H), 4.10 (t, J=6.3 Hz, 2H), 4.20 (t, J=6.1 Hz, 2H), 6.80 (d, J=6.6 Hz, 1H), 6.84-6.93 (m, 4H), 7.15-7.20 (m, 2H), 7.32-7.37 (m, 2H), 7.64 (s, 1H), 7.74 (s, 1H), 8.77 (d, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 462 (M++1)
- Guaiacol (300 mg) was dissolved in acetone (5 ml) to prepare a solution. 1,3-Dibromopropane (0.74 ml), potassium carbonate (668 mg), and tetra-n-butylammonium iodide (89 mg) were then added to the solution, and the mixture was heated under reflux for 7 hr. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(3-bromopropyl)-2-methoxybenzene (1) (449 mg, yield 76%).
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenol (100 mg) was dissolved in dimethylformamide (2 ml) to prepare a solution. Sodium hydride (16 mg) was then added to the solution, and the mixture was stirred at room temperature for 10 min. A solution of the compound (1) (91 mg) in dimethylformamide was added thereto, and the mixture was further stirred at room temperature for 6 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with ethyl acetate, followed by washing three times with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (116 mg, yield 75%).
- The resultant compound (103 mg) was dissolved in a 10% hydrochloric acid-methanol solution (5 ml) to prepare a solution which was then allowed to stand at room temperature for 15 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 86 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.17-2.24 (m, 2H), 3.76 (s, 3H), 4.03 (s, 3H), 4.04 (s, 3H), 4.14 (t, J=6.1 Hz, 2H), 4.21 (t, J=6.1 Hz, 2H), 6.79 (d, J=6.6 Hz, 1H), 6.86-7.03 (m, 4H), 7.15-7.20 (m, 2H), 7.32-7.37 (m, 2H), 7.66 (s, 1H), 7.74 (s, 1H), 8.76 (d, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 462 (M++1)
- o-Fluorophenol (400 mg) was dissolved in acetone (5 ml) to prepare a solution. 1,3-Dibromopropane (1.09 ml), potassium carbonate (985 mg), and tetra-n-butylammonium iodide (132 mg) were then added to the solution, and the mixture was heated under reflux for 3 hr. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(3-bromopropyl)-2-fluorobenzene (1) (750 mg, yield 91%).
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenol (100 mg) was dissolved in dimethylformamide (2 ml) to prepare a solution. Sodium hydride (16 mg) was then added to the solution, and the mixture was stirred at room temperature for 10 min. A solution of the compound (1) (86 mg) in dimethylformamide was added thereto, and the mixture was further stirred at room temperature for 5 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with ethyl acetate, followed by washing three times with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (131 mg, yield 78%).
- The resultant compound (128 mg) was dissolved in a 10% hydrochloric acid-methanol solution (5 ml) to prepare a solution which was then allowed to stand at room temperature for 15 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 116 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.21-2.27 (m, 2H), 4.03 (s, 3H), 4.04 (s, 3H), 4.19-4.27 (m, 4H), 6.81 (d, J=6.6 Hz, 1H), 6.92-6.98 (m, 1H), 7.11-7.25 (m, 5H), 7.33-7.37 (m, 2H), 7.63-7.69 (m, 1H), 7.75 (s, 1H), 8.78 (d, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 450 (M++1)
- 3-Fluorophenol (400 mg) was dissolved in acetone (5 ml) to prepare a solution. 1,3-Dibromopropane (1.09 ml), potassium carbonate (985 mg), and tetra-n-butylammonium iodide (132 mg) were then added to the solution, and the mixture was heated under reflux for 3 hr. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(3-bromopropyl)-3-fluorobenzene (1) (808 mg, yield 97%).
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenol (100 mg) was dissolved in dimethylformamide (2 ml) to prepare a solution. Sodium hydride (16 mg) was then added to the solution, and the mixture was stirred at room temperature for 10 min. A solution of the compound (1) (86 mg) in dimethylformamide was added thereto, and the mixture was further stirred at room temperature for 5 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with ethyl acetate, followed by washing three times with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (128 mg, yield 84%).
- The resultant compound (123 mg) was dissolved in a 10% hydrochloric acid-methanol solution (5 ml) to prepare a solution which was then allowed to stand at room temperature for 15 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 109 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.18-2.25 (m, 2H), 4.04 (s, 3H), 4.05 (s, 3H), 4.17-4.22 (m, 4H), 6.74-6.88 (m, 4H), 7.15-7.20 (m, 2H), 7.29-7.38 (m, 3H), 7.61-7.73 (m, 1H), 7.76 (s, 1H), 8.79 (d, J=6.8 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 450 (M++1)
- 4-Fluorophenol (400 mg) was dissolved in acetone (5 ml) to prepare a solution. 1,3-Dibromopropane (1.09 ml), potassium carbonate (985 mg), and tetra-n-butylammonium iodide (132 mg) were then added to the solution, and the mixture was heated under reflux overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(3-bromopropyl)-4-fluorobenzene (1) (713 mg, yield 86%).
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenol (100 mg) was dissolved in dimethylformamide (2 ml) to prepare a solution. Sodium hydride (16 mg) was then added to the solution, and the mixture was stirred at room temperature for 10 min. A solution of the compound (1) (86 mg) in dimethylformamide was added thereto, and the mixture was further stirred at room temperature for 4 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with ethyl acetate, followed by washing three times with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (91 mg, yield 60%).
- The resultant compound (85 mg) was dissolved in a 10% hydrochloric acid-methanol solution (5 ml) to prepare a solution which was then allowed to stand at room temperature for 15 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 90 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.16-2.24 (m, 2H), 4.04 (s, 3H), 4.05 (s, 3H), 4.14 (t, J=6.1 Hz, 2H), 4.20 (t, J=6.1 Hz, 2H), 6.82 (d, J=6.6 Hz, 1H), 6.95-7.01 (m, 2H), 7.09-7.20 (m, 4H), 7.33-7.37 (m, 2H), 7.67 (s, 1H), 7.75 (s, 1H), 8.79 (d, J=6.8 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 450 (M++1)
- 2,6-Dimethylphenol (400 mg) was dissolved in acetone (5 ml) to prepare a solution. 1,3-Dibromopropane (1.00 ml), potassium carbonate (903 mg), and tetra-n-butylammonium iodide (121 mg) were then added to the solution, and the mixture was heated under reflux overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(3-bromopropyl)-2,6-dimethylbenzene (1) (637 mg, yield 81%).
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenol (100 mg) was dissolved in dimethylformamide (2 ml) to prepare a solution. Sodium hydride (16 mg) was then added to the solution, and the mixture was stirred at room temperature for 10 min. A solution of the compound (1) (90 mg) in dimethylformamide was added thereto, and the mixture was further stirred at room temperature for 4 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with ethyl acetate, followed by washing three times with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (137 mg, yield 88%).
- The resultant compound (116 mg) was dissolved in a 10% hydrochloric acid-methanol solution (5 ml) to prepare a solution which was then allowed to stand at room temperature for 15 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 75 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.21 (s, 6H), 2.22 (t, J=6.1 Hz, 2H), 3.92 (t, J=6.1 Hz, 2H), 4.04 (s, 3H), 4.04 (s, 3H), 4.29 (t, J=6.1 Hz, 2H), 6.80 (d, J=6.6 Hz, 1H), 6.89-6.94 (m, 1H), 7.01 (s, 1H), 7.03 (s, 1H), 7.17-7.22 (m, 2H), 7.34-7.39 (m, 2H), 7.70 (s, 1H), 7.75 (s, 1H), 8.80 (d, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 460 (M++1)
- 2-{4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]phenoxy}-acetic acid (150 mg), WSC.HCl (122 mg), and HOBT.H2O (86 mg) were dissolved in chloroform (5 ml) to prepare a solution. m-Anisidine (63 mg) was then added to the solution, and the mixture was stirred at room temperature for 4 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The chloroform layer was washed with 1 N hydrochloric acid, water, and saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (29 mg, yield 15%).
- 1H-NMR (chloroform-d, 400 MHz): δ 3.84 (s, 3H), 4.08 (s, 3H), 4.08 (s, 3H), 4.65 (s, 2H), 6.71-6.75 (m, 1H), 7.07-7.13 (m, 3H), 7.24-7.28 (m, 2H), 7.35 (t, J=2.2 Hz, 1H), 7.40 (s, 1H), 7.56 (s, 1H), 8.25 (s, 1H), 8.64 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 462 (M++1)
- 2-{4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]phenoxy}-acetic acid (150 mg), WSC.HCl (122 mg), and HOBT.H2O (86 mg) were dissolved in chloroform (5 ml) to prepare a solution. 3-Methoxybenzylamine (70 mg) was then added to the solution, and the mixture was stirred at room temperature overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The chloroform layer was washed with 1 N hydrochloric acid, water, and saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (31 mg, yield 16%).
- 1H-NMR (chloroform-d, 400 MHz): δ 3.81 (s, 3H), 4.07 (s, 6H), 4.54 (s, 1H), 4.56 (s, 1H), 4.60 (s, 2H), 6.82-6.93 (m, 3H), 6.99-7.05 (m, 2H), 7.19-7.23 (m, 2H), 7.27-7.31 (m, 1H), 7.35 (s, 1H), 7.55 (s, 1H), 8.62 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 476 (M++1)
- 2-{4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]phenoxy}-acetic acid (100 mg), WSC.HCl (81 mg), and HOBT.H2O (57 mg) were dissolved in chloroform (3 ml) to prepare a solution. 1,2,3,4-Tetrahydro-isoquinoline (45 mg) was then added to the solution, and the mixture was stirred at room temperature overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (39 mg, yield 30%).
- 1H-NMR (chloroform-d, 400 MHz): δ 2.88-2.98 (m, 2H), 3.80-3.90 (m, 2H), 4.07 (s, 3H), 4.07 (s, 3H), 4.76 (s, 1H), 4.78 (s, 1H), 4.80 (s, 2H), 7.04-7.24 (m, 8H), 7.35 (s, 1H), 7.55 (s, 1H), 8.63 (d, J=3.7 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 472 (M++1)
- 2-{4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]phenoxy}-acetic acid (100 mg), WSC.HCl (81 mg), and HOBT.H2O (57 mg) were dissolved in chloroform (3 ml) to prepare a solution. 4-Phenylpiperidine (54 mg) was then added to the solution, and the mixture was stirred at room temperature overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (42 mg, yield 30%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.61-1.73 (m, 2H), 1.90-2.00 (m, 2H), 2.68-2.83 (m, 2H), 3.16-3.26 (m, 1H), 4.08 (s, 3H), 4.14 (s, 3H), 4.08-4.20 (m, 2H), 4.76 (s, 1H), 4.77 (s, 1H), 7.06-7.12 (m, 2H), 7.17-7.34 (m, 7H), 7.39 (s, 1H), 7.56 (s, 1H), 8.63 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 500 (M++1)
- 2-{4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]phenoxy}-acetic acid (100 mg), WSC.HCl (81 mg), and HOBT.H2O (57 mg) were dissolved in chloroform (3 ml) to prepare a solution. 4-Benzylpiperidine (59 mg) was then added to the solution, and the mixture was stirred at room temperature overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (36 mg, yield 25%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.15-1.30 (m, 2H), 1.73 (d, J=13.7 Hz, 2H), 1.76-1.88 (m, 1H), 2.53-2.66 (m, 3H), 2.98-3.09 (m, 1H), 3.94-4.02 (m, 1H), 4.09 (s, 3H), 4.12 (s, 3H), 4.54-4.62 (m, 1H), 4.71 (s, 2H), 7.03-7.10 (m, 2H), 7.12-7.24 (m, 5H), 7.25-7.33 (m, 2H), 7.58 (s, 1H), 7.63 (s, 1H), 8.69 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 514 (M++1)
- 2-{4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]phenoxy}-acetic acid (100 mg), WSC.HCl (81 mg), and HOBT.H2O (57 mg) were dissolved in chloroform (3 ml) to prepare a solution. 4-Piperidinopiperidine (57 mg) was then added to the solution, and the mixture was stirred at room temperature overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (34 mg, yield 24%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.42-2.08 (m, 10H), 2.58-2.90 (m, 5H), 3.05-3.15 (m, 1H), 4.07 (s, 6H), 4.12-4.20 (m, 1H), 4.65-4.72 (m, 1H), 4.71 (s, 1H), 4.73 (s, 1H), 7.02-7.08 (m, 2H), 7.16-7.22 (m, 2H), 7.32 (s, 1H), 7.55 (s, 1H), 8.61 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 507 (M++1)
- 2-{4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]phenoxy}-acetic acid (100 mg), WSC.HCl (81 mg), and HOBT.H2O (57 mg) were dissolved in chloroform (3 ml) to prepare a solution. Piperidine (29 mg) was then added to the solution, and the mixture was stirred at room temperature for 3 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (31 mg, yield 26%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.54-1.90 (m, 6H), 3.49-3.61 (m, 4H), 4.07 (s, 3H), 4.08 (s, 3H), 4.71 (s, 2H), 7.04-7.09 (m, 2H), 7.16-7.20 (m, 2H), 7.40 (s, 1H), 7.56 (s, 1H), 8.64 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 424 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]phenol (100 mg) was dissolved in dimethylformamide (2 ml) to prepare a solution. Sodium hydride (27 mg) was then added to the solution, and the mixture was stirred at room temperature for 10 min. 2-(Diethylamino)ethyl bromide hydrobromide (88 mg) was added to the solution, and the mixture was stirred at room temperature for 2 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with ethyl acetate. The extract was washed with saturated brine and was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (30 mg, yield 23%).
- 1H-NMR (chloroform-d, 400 MHz): δ 1.20-1.44 (m, 6H), 2.80-3.15 (m, 4H), 3.15-3.30 (m, 2H), 4.07 (s, 3H), 4.07 (s, 3H), 4.27-4.45 (m, 2H), 6.98-7.03 (m, 2H), 7.16-7.20 (m, 2H), 7.32 (s, 1H), 7.56 (s, 1H), 8.62 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 398 (M++1)
- 4-Fluorophenol (1 g) was dissolved in acetone (10 ml) to prepare a solution. 1,3-Dibromopropane (2.72 ml), potassium carbonate (2.46 g), and tetra-n-butylammonium iodide (329 mg) were then added to the solution, and the mixture was heated under reflux overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(3-bromopropyl)-4-fluorobenzene (1) (1.89 g, yield 91%).
- 4-Hydroxyphenyl benzoate (300 mg) was dissolved in dimethylformamide (2 ml) to prepare a solution. Sodium hydride (84 mg) was then added to the solution, and the mixture was stirred at room temperature for 10 min. A solution of the compound (1) (650 mg) in dimethylformamide was added thereto, and the mixture was further stirred at room temperature for one hr. A saturated aqueous ammonium chloride solution was added to the reaction solution, and the mixture was extracted with ethyl acetate, followed by washing three times with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give 4-[3-(4-fluorophenoxy)propoxy]phenyl benzoate (2) (412 mg, yield 81%).
- The compound (2) (412 mg) was dissolved in methanol (3 ml) to prepare a solution. Sodium hydroxide (60 mg) was added to the solution, and the mixture was stirred at room temperature for 3 hr. A saturated aqueous ammonium chloride solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by chromatography on silica gel using hexane/acetone for development to give 4-[3-(4-fluorophenoxy)propoxy]phenol (3) (229 mg, yield 78%).
- Chlorobenzene (0.4 ml) was added to the compound (3) (225 mg) and 4-chloro-6,7-dimethoxyquinazoline (275 mg), and the mixture was stirred at 140° C. overnigh. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (117 mg, yield 31%).
- 1H-NMR (chloroform-d, 400 MHz): δ 2.24-2.31 (m, 2H), 4.07 (s, 6H), 4.14 (t, J=6.1 Hz, 2H), 4.19 (t, J=6.1 Hz, 2H), 6.83-6.88 (m, 2H), 6.94-7.03 (m, 4H), 7.14-7.19 (m, 2H), 7.33 (s, 1H), 7.56 (s, 1H), 8.63 (s, 1H)
- Mass spectrometry value (FD-MS, m/z): 450 (M+)
- 3-Methoxyphenol (1 g) was dissolved in acetone (10 ml) to prepare a solution. 1,3-Dibromopropane (2.45 ml), potassium carbonate (2.22 g), and tetra-n-butylammonium iodide (297 mg) were then added to the solution, and the mixture was heated under reflux overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(3-bromopropyl)-3-methoxybenzene (1) (1.79 g, yield 91%).
- 4-Hydroxyphenyl benzoate (300 mg) was dissolved in dimethylformamide (2 ml) to prepare a solution. Sodium hydride (84 mg) was then added to the solution, and the mixture was stirred at room temperature for 10 min. A solution of the compound (1) (686 mg) in dimethylformamide was added thereto, and the mixture was further stirred at room temperature for one hr. A saturated aqueous ammonium chloride solution was added to the reaction solution, and the mixture was extracted with ethyl acetate, followed by washing three times with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give 4-[3-(3-methoxyphenoxy)propoxy]-phenyl benzoate (2) (252 mg, yield 48%).
- The compound (2) (252 mg) was dissolved in methanol (2 ml) to prepare a solution. Sodium hydroxide (60 mg) was then added to the solution, and the mixture was stirred at room temperature for 3 hr. A saturated aqueous ammonium chloride solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give 4-[3-(3-methoxyphenoxy)propoxy]phenol (3) (146 mg, yield 80%).
- Chlorobenzene (0.4 ml) was added to the compound (3) (143 mg) and 4-chloro-6,7-dimethoxyquinazoline (167 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (118 mg, yield 50%).
- 1H-NMR (chloroform-d, 400 MHz): δ 2.24-2.32 (m, 2H), 3.80 (s, 3H), 4.07 (s, 6H), 4.15-4.22 (m, 4H), 6.48-6.55 (m, 3H), 6.98-7.03 (m, 2H), 7.14-7.21 (m, 3H), 7.35 (s, 1H), 7.56 (s, 1H), 8.63 (s, 1H)
- Mass spectrometry value (FD-MS, m/z): 462 (M+)
- 2-Methoxyphenol (750 mg) was dissolved in acetonitrile (8 ml) to prepare a solution. 1,3-Dibromopropane (0.92 ml) and potassium carbonate (1.25 g) were then added to the solution, and the mixture was heated under reflux overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(3-bromopropyl)-2-methoxybenzene (1).
- 4-Hydroxyphenyl benzoate (650 mg) was dissolved in dimethylformamide (6 ml) to prepare a solution. Sodium hydride (97 mg) was then added to the solution, and the mixture was stirred at room temperature for 10 min. A solution of the compound (1) (1.12 g) in dimethylformamide was added thereto, and the mixture was further stirred at room temperature for one hr. A saturated aqueous ammonium chloride solution was added to the reaction solution, and the mixture was extracted with ethyl acetate, followed by washing three times with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give 4-[3-(2-methoxyphenoxy)propoxy]-phenyl benzoate (2) (1.15 g, yield 50%).
- The compound (2) (1.15 g) was dissolved in methanol (10 ml) to prepare a solution. Sodium hydroxide (20 mg) was added to the solution, and the mixture was stirred at room temperature for 3 hr. A saturated aqueous ammonium chloride solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give 4-[3-(2-methoxyphenoxy)propoxy]phenol (3) (0.55 g, yield 66%).
- Chlorobenzene (0.4 ml) was added to the compound (3) (205 mg) and 4-chloro-6,7-dimethoxyquinazoline (252 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (128 mg, yield 37%).
- 1H-NMR (chloroform-d, 400 MHz): δ 2.30-2.38 (m, 2H), 3.87 (s, 3H), 4.08 (s, 3H), 4.09 (s, 3H), 4.21-4.26 (m, 4H), 6.88-6.96 (m, 4H), 6.99-7.03 (m, 2H), 7.13-7.17 (m, 2H), 7.47 (s, 1H), 7.57 (s, 1H), 8.66 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 463 (M++1)
- The resultant compound (125 mg) was dissolved in a 10% hydrochloric acid-methanol solution (6 ml) to prepare a solution which was then allowed to stand at room temperature for 15 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 61 mg of a hydrochloride.
- Dimethyl sulfoxide (25 ml) was added to potassium hydroxide (2.18 g), and the mixture was stirred. A solution of indole (3 g) in dimethyl sulfoxide was added drowise thereto, and the mixture was stirred at room temperature for 10 min. 3-Bromo-1-propanol (2.31 ml) was added thereto, and the mixture was stirred at room temperature for 5 hr. Water was added to the reaction solution, and the mixture was extrated with ethyl acetate, followed by washing three times with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give 1-(3-bromopropyl)-1H-indole (1) (3.78 g, yield 84%).
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]phenol (100 mg), the compound (1) (59 mg), and triphenylphosphine (106 mg) were dissolved in tetrahydrofuran (3 ml) to prepare a solution. Diethyl azodicarboxylate (0.063 ml) was then added to the solution, and the mixture was stirred at room temperature for 3 hr. The solvent was removed by distillation under the reduced pressure. Water was added to the residue, and the mixture was extracted with ethyl acetate, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using hexane/acetone for development. Diethyl ether was added to the purification product, and the precipitated crystal was collected by filtration and was washed to give the title compound (3 mg, yield 2%).
- Mass spectrometry value (FD-MS, m/z): 455 (M+)
- 3-Methoxyphenol (0.6 g) was dissolved in acetone (2 ml) to prepare a solution. 1-Bromo-2-chloroethane (0.60 ml), potassium carbonate (1.00 g), and tetra-n-butylammonium iodide (180 mg) were then added to the solution, and the mixture was heated under reflux overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(2-chloroethoxy)-3-methoxybenzene (1) (348 mg, yield 39%).
- The compound (1) (206 mg) was dissolved in acetone (1 ml) to prepare a solution. 4-Hydroxythiophenol (160 mg) and potassium carbonate (168 mg) were then added to the solution, and the mixture was stirred at room temperature overnight. 1 N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform for development to give 4-{[2-(3-methoxyphenoxy)ethyl]sulfanyl}phenol (2) (116 mg, yield 38%).
- Chlorobenzene (0.2 ml) was added to the compound (2) (105 mg) and 4-chloro-6,7-dimethoxyquinoline (170 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (26 mg, yield 15%).
- The resultant compound (20 mg) was dissolved in a 10% hydrochloric acid-methanol solution (3 ml) to prepare a solution which was then allowed to stand at room temperature for 15 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 17 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.41 (t, J=6.3 Hz, 2H), 3.72 (s, 3H), 4.01 (s, 3H), 4.03 (s, 3H), 4.19 (t, J=6.3 Hz, 2H), 6.44-6.55 (m, 3H), 6.85 (d, J=6.6 Hz, 1H), 7.18 (t, J=8.1 Hz, 1H), 7.36-7.41 (m, 2H), 7.60 (s, 1H), 7.61-7.65 (m, 2H), 7.72 (s, 1H), 8.77 (d, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 464 (M++1)
- 4-Methoxyphenol (0.6 g) was dissolved in acetone (2 ml) to prepare a solution. 1-Bromo-2-chloroethane (0.60 ml), potassium carbonate (1.00 g), and tetra-n-butylammonium iodide (180 mg) were then added to the solution, and the mixture was heated under reflux overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(2-chloroethoxy)-4-methoxybenzene (1) (246 mg, yield 27%).
- The compound (1) (226 mg) was dissolved in acetone (2 ml) to prepare a solution. 4-Hydroxythiophenol (170 mg) and potassium carbonate (184 mg) were then added to the solution, and the mixture was stirred at room temperature overnight. 1 N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform for development to give 4-{[2-(4-methoxyphenoxy)ethyl]sulfanyl}phenol (2) (114 mg, yield 34%).
- Chlorobenzene (0.3 ml) was added to the compound (2) (102 mg) and 4-chloro-6,7-dimethoxyquinoline (165 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (80 mg, yield 47%).
- The resultant compound (66 mg) was dissolved in a 10% hydrochloric acid-methanol solution (6 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 51 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.39-3.42 (m, 2H), 3.68 (s, 3H), 4.00 (s, 3H), 4.03 (s, 3H), 4.13 (t, J=6.1 Hz, 2H), 6.81-6.84 (m, 1H), 6.85 (s, 2H), 6.85 (s, 2H), 7.33-7.39 (m, 2H), 7.53 (s, 1H), 7.57-7.63 (m, 2H), 7.70 (s, 1H), 8.75 (d, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 464 (M++1)
- p-Cresol (0.6 g) was dissolved in acetone (2 ml) to prepare a solution. 1-Bromo-2-chloroethane (0.69 ml), potassium carbonate (1.15 g), and tetra-n-butylammonium iodide (205 mg) were then added to the solution, and the mixture was heated under reflux overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(2-chloroethoxy)-4-methylbenzene (1) (348 mg, yield 37%).
- The compound (1) (326 mg) was dissolved in acetone (2 ml) to prepare a solution. 4-Hydroxythiophenol (265 mg) and potassium carbonate (290 mg) were then added to the solution, and the mixture was stirred at room temperature overnight. 1 N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform for development to give 4-{[2-(4-methylphenoxy)ethyl]sulfanyl}phenol (2) (185 mg, yield 37%).
- Chlorobenzene (0.5 ml) was added to the compound (2) (170 mg) and 4-chloro-6,7-dimethoxyquinoline (292 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (124 mg, yield 42%).
- The resultant compound (124 mg) was dissolved in a 10% hydrochloric acid-methanol solution (4 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 105 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.21 (s, 3H), 3.39-3.42 (m, 2H), 4.01 (s, 3H), 4.03 (s, 3H), 4.15 (t, J=6.1 Hz, 2H), 6.77-6.83 (m, 2H), 6.86 (d, J=6.6 Hz, 1H), 7.04-7.10 (m, 2H), 7.34-7.40 (m, 2H), 7.56 (s, 1H), 7.57-7.64 (m, 2H), 7.72 (s, 1H), 8.77 (d, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 4.48 (M++1)
- 2-Isopropylphenol (1 g) was dissolved in acetone (3 ml) to prepare a solution. 1-Bromo-2-chloroethane (0.92 ml), potassium carbonate (1.52 g), and tetra-n-butylammonium iodide (271 mg) were then added to the solution, and the mixture was heated under reflux overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(2-chloroethoxy)-2-isopropylbenzene (1) (480 mg, yield 33%).
- The compound (1) (438 mg) was dissolved in acetone (3 ml) to prepare a solution. 4-Hydroxythiophenol (306 mg) and potassium carbonate (335 mg) were then added to the solution, and the mixture was stirred at room temperature overnight. 1 N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform for development to give 4-{[2-(2-isopropylphenoxy)ethyl]sulfanyl}phenol (2) (288 mg, yield 46%).
- Chlorobenzene (0.5 ml) was added to the compound (2) (252 mg) and 4-chloro-6,7-dimethoxyquinoline (390 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (183 mg, yield 44%).
- The resultant compound (123 mg) was dissolved in a 10% hydrochloric acid-methanol solution (4 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 91 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.16 (s, 3H), 1.18 (s, 3H), 3.19-3.26 (m, 1H), 3.48 (t, J=6.1 Hz, 2H), 4.02 (s, 3H), 4.04 (s, 3H), 4.22 (t, J=6.1 Hz, 2H), 6.85 (d, J=6.4 Hz, 1H), 6.89-6.95 (m, 2H), 7.10-7.22 (m, 2H), 7.35-7.41 (m, 2H), 7.59-7.65 (m, 3H), 7.72 (s, 1H), 8.78 (d, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 476 (M++1)
- 4-Isopropylphenol (1 g) was dissolved in acetone (3 ml) to prepare a solution. 1-Bromo-2-chloroethane (0.92 ml), potassium carbonate (1.52 g), and tetra-n-butylammonium iodide (271 mg) were then added to the solution, and the mixture was heated under reflux overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(2-chloroethoxy)-4-isopropylbenzene (1) (616 mg, yield 42%).
- The compound (1) (590 mg) was dissolved in acetone (4 ml) to prepare a solution. 4-Hydroxythiophenol (412 mg) and potassium carbonate (452 mg) were then added to the solution, and the mixture was stirred at room temperature overnight. 1 N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform for development to give 4-{[2-(4-isopropylphenoxy)-ethyl]sulfanyl}phenol (2) (441 mg, yield 52%).
- Chlorobenzene (0.8 ml) was added to the compound (2) (394 mg) and 4-chloro-6,7-dimethoxyquinoline (610 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (289 mg, yield 44%).
- The resultant compound (217 mg) was dissolved in a 10% hydrochloric acid-methanol solution (4 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 195 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.16 (s, 3H), 1.17 (s, 3H), 2.78-2.87 (m, 1H), 3.43 (t, J=6.3 Hz, 2H), 4.03 (s, 3H), 4.05 (s, 3H), 4.18 (t, J=6.3 Hz, 2H), 6.82-6.87 (m, 2H), 6.89 (d, J=6.6 Hz, 1H), 7.12-7.17 (m, 2H), 7.38-7.43 (m, 2H), 7.61-7.66 (m, 2H), 7.69 (s, 1H), 7.74 (s, 1H), 8.80 (d, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 476 (M++1)
- o-Cresol (0.6 g) was dissolved in acetone (2 ml) to prepare a solution. 1-Bromo-2-chloroethane (0.69 ml), potassium carbonate (1.15 g), and tetra-n-butylammonium iodide (205 mg) were then added to the solution, and the mixture was heated under reflux overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(2-chloroethoxy)-2-methylbenzene (1) (345 mg, yield 36%).
- The compound (1) (322 mg) was dissolved in acetone (2 ml) to prepare a solution. 4-Hydroxythiophenol (262 mg) and potassium carbonate (286 mg) were then added to the solution, and the mixture was stirred at room temperature overnight. 1 N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform for development to give 4-{[2-(2-methylphenoxy)ethyl]-sulfanyl}phenol (2) (231 mg, yield 47%).
- Chlorobenzene (0.3 ml) was added to the compound (2) (204 mg) and 4-chloro-6,7-dimethoxyquinoline (350 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (139 mg, yield 40%).
- The resultant compound (103 mg) was dissolved in a 10% hydrochloric acid-methanol solution (4 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 26 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.13 (s, 3H), 3.47 (t, J=6.1 Hz, 2H), 4.02 (s, 3H), 4.04 (s, 3H), 4.22 (t, J=5.9 Hz, 2H), 6.81-6.94 (m, 3H), 7.11-7.17 (m, 2H), 7.35-7.40 (m, 2H), 7.59 (s, 1H), 7.60-7.66 (m, 2H), 7.72 (s, 1H), 8.78 (d, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 448 (M++1)
- p-Chlorophenol (0.6 g) was dissolved in acetone (2 ml) to prepare a solution. 1-Bromo-2-chloroethane (0.58 ml), potassium carbonate (967 mg), and tetra-n-butylammonium iodide (173 mg) were then added to the solution, and the mixture was heated under reflux overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-chloro-4-(2-chloroethoxy)-benzene (1) (338 mg, yield 38%).
- The compound (1) (338 mg) was dissolved in acetone (3 ml) to prepare a solution. 4-Hydroxythiophenol (246 mg) and potassium carbonate (270 mg) were then added to the solution, and the mixture was stirred at room temperature overnight. 1 N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform for development to give 4-{[2-(4-chlorophenoxy)ethyl]sulfanyl}phenol (2) (265 mg, yield 53%).
- Chlorobenzene (0.4 ml) was added to the compound (2) (215 mg) and 4-chloro-6,7-dimethoxyquinoline (343 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (5 mg, yield 1%).
- The resultant compound (5 mg) was dissolved in a 10% hydrochloric acid-methanol solution (2 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 6 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.44 (t, J=6.3 Hz, 2H), 4.02 (s, 3H), 4.04 (s, 3H), 4.21 (t, J=6.1 Hz, 2H), 6.85 (d, J=6.3 Hz, 1H), 6.93-6.99 (m, 2H), 7.30-7.35 (m, 2H), 7.38 (s, 1H), 7.40 (s, 1H), 7.60-7.65 (m, 3H), 7.72 (s, 1H), 8.78 (d, J=6.6 Hz, 1H)
- 2-Chlorophenol (0.6 g) was dissolved in acetone (2 ml) to prepare a solution. 1-Bromo-2-chloroethane (0.58 ml), potassium carbonate (967 mg), and tetra-n-butylammonium iodide (173 mg) were then added to the solution, and the mixture was heated under reflux overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-chloro-2-(2-chloroethoxy)-benzene (1) (429 mg, yield 48%).
- The compound (1) (412 mg) was dissolved in acetone (4 ml) to prepare a solution. 4-Hydroxythiophenol (300 mg) and potassium carbonate (328 mg) were then added to the solution, and the mixture was stirred at room temperature overnight. 1 N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform for development to give 4-{[2-(2-chlorophenoxy)ethyl]sulfanyl}phenol (2) (449 mg, yield 74%).
- Chlorobenzene (0.4 ml) was added to the compound (2) (320 mg) and 4-chloro-6,7-dimethoxyquinoline (510 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (2 mg, yield 0.3%).
- The resultant compound (2 mg) was dissolved in a 10% hydrochloric acid-methanol solution (2 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 2 mg of a hydrochloride.
- Mass spectrometry value (ESI-MS, m/z): 468 (M++1)
- 3-Chlorophenol (0.6 g) was dissolved in acetone (2 ml) to prepare a solution. 1-Bromo-2-chloroethane (0.58 ml), potassium carbonate (967 mg), and tetra-n-butylammonium iodide (173 mg) were then added to the solution, and the mixture was heated under reflux overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-chloro-3-(2-chloroethoxy)-benzene (1) (400 mg, yield 45%).
- The compound (1) (387 mg) was dissolved in acetone (4 ml) to prepare a solution. 4-Hydroxythiophenol (281 mg) and potassium carbonate (308 mg) were then added to the solution, and the mixture was stirred at room temperature overnight. 1 N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by chromatography on silica gel using chloroform for development to give 4-{[2-(3-chlorophenoxy)ethyl]sulfanyl}phenol (2) (322 mg, yield 57%).
- Chlorobenzene (0.4 ml) was added to the compound (2) (206 mg) and 4-chloro-6,7-dimethoxyquinoline (328 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (105 mg, yield 31%).
- The resultant compound (93 mg) was dissolved in a 10% hydrochloric acid-methanol solution (4 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 81 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.43 (t, J=6.3 Hz, 2H), 4.02 (s, 3H), 4.04 (s, 3H), 4.24 (t, J=6.1 Hz, 2H), 6.83-7.03 (m, 4H), 7.28-7.41 (m, 3H), 7.60-7.65 (m, 3H), 7.72 (s, 1H), 8.78 (d, J=6.3 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 468 (M++1)
- 3-Fluorophenol (0.6 g) was dissolved in acetone (2 ml) to prepare a solution. 1-Bromo-2-chloroethane (0.67 ml), potassium carbonate (1.11 g), and tetra-n-butylammonium iodide (198 mg) were then added to the solution, and the mixture was heated under reflux overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(2-2-5 chloroethoxy)-3-fluorobenzene (1) (407 mg, yield 44%).
- The compound (1) (395 mg) was dissolved in acetone (4 ml) to prepare a solution. 4-Hydroxythiophenol (314 mg) and potassium carbonate (344 mg) were then added to the solution, and the mixture was stirred at room temperature overnight. 1N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by chromatography on silica gel using chloroform for development to give 4-{[2-(3-fluorophenoxy)ethyl]sulfanyl}phenol (2) (323 mg, yield 54%).
- Chlorobenzene (0.4 ml) was added to the compound (2) (230 mg) and 4-chloro-6,7-dimethoxyquinoline (390 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (137 mg, yield 35%).
- The resultant compound (110 mg) was dissolved in a 10% hydrochloric acid-methanol solution (4 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 93 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.44 (t, J=6.3 Hz, 2H), 4.03 (s, 3H), 4.04 (s, 3H), 4.23 (t, J=6.1 Hz, 2H), 6.74-6.84 (m, 3H), 6.86 (d, J=6.6 Hz, 1H), 7.27-7.41 (m, 3H), 7.61-7.66 (m, 3H), 7.73 (s, 1H), 8.78 (d, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 452 (M++1)
- o-Fluorophenol (0.6 g) was dissolved in acetone (2 ml) to prepare a solution. 1-Bromo-2-chloroethane (0.67 ml), potassium carbonate (1.11 g), and tetra-n-butylammonium iodide (198 mg) were then added to the solution, and the mixture was heated under reflux overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(2-chloroethoxy)-2-fluorobenzene (1) (406 mg, yield 44%).
- The compound (1) (387 mg) was dissolved in acetone (2 ml) to prepare a solution. 4-Hydroxythiophenol (308 mg) and potassium carbonate (338 mg) were then added to the solution, and the mixture was stirred at room temperature overnight. 1 N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform for development to give 4-{[2-(2-fluorophenoxy)ethyl]sulfanyl}phenol (2) (244 mg, yield 42%).
- Chlorobenzene (0.4 ml) was added to the compound (2) (191 mg) and 4-chloro-6,7-dimethoxyquinoline (324 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (132 mg, yield 40%).
- The resultant compound (106 mg) was dissolved in a 10% hydrochloric acid-methanol solution (3 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 105 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.48 (t, J=6.6 Hz, 2H), 4.04 (s, 3H), 4.05 (s, 3H), 4.29 (t, J=6.3 Hz, 2H), 6.89 (d, J=6.6 Hz, 1H), 6.93-7.00 (m, 1H), 7.09-7.25 (m, 3H), 7.37-7.43 (m, 2H), 7.62-7.69 (m, 3H), 7.75 (s, 1H), 8.82 (d, J=6.8 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 452 (M++1)
- m-Cresol (0.6 g) was dissolved in acetone (3 ml) to prepare a solution. 1-Bromo-2-chloroethane (0.69 ml), potassium carbonate (1.15 g), and tetra-n-butylammonium iodide (205 mg) were then added to the solution, and the mixture was heated under reflux overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(2-chloroethoxy)-3-methylbenzene (1) (349 mg, yield 37%).
- The compound (1) (337 mg) was dissolved in acetone (3 ml) to prepare a solution. 4-Hydroxythiophenol (275 mg) and potassium carbonate (301 mg) were then added to the solution, and the mixture was stirred at room temperature overnight. 1 N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform for development to give 4-{[2-(3-methylphenoxy)ethyl]sulfanyl}phenol (2) (188 mg, yield 36%).
- Chlorobenzene (0.3 ml) was added to the compound (2) (160 mg) and 4-chloro-6,7-dimethoxyquinoline (276 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate, and the solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (129 mg, yield 47%).
- The resultant compound (102 mg) was dissolved in a 10% hydrochloric acid-methanol solution (3 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 68 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.27 (s, 3H), 3.43 (t, J=6.3 Hz, 2H), 4.02 (s, 3H), 4.04 (s, 3H), 4.19 (t, J=6.3 Hz, 2H), 6.69-6.78 (m, 3H), 6.84-6.88 (m, 1H), 7.16 (t, J=7.8 Hz, 1H), 7.36-7.41 (m, 2H), 7.59-7.65 (m, 3H), 7.72 (s, 1H), 8.78 (d, J=6.3 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 448 (M++1)
- 4-Fluorophenol (0.6 g) was dissolved in acetone (3 ml) to prepare a solution. 1-Bromo-2-chloroethane (0.69 ml), potassium carbonate (1.11 g), and tetra-n-butylammonium iodide (198 mg) were then added to the solution, and the mixture was heated under reflux overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(2-chloroethoxy)-4-fluorobenzene (1) (352 mg, yield 38%).
- The compound (1) (342 mg) was dissolved in acetone (4 ml) to prepare a solution. 4-Hydroxythiophenol (273 mg) and potassium carbonate (299 mg) were then added to the solution, and the mixture was stirred at room temperature overnight. 1 N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform for development to give 4-{[2-(4-fluorophenoxy)ethyl]sulfanyl}phenol (2) (233 mg, yield 45%).
- Chlorobenzene (0.4 ml) was added to the compound (2) (211 mg) and 4-chloro-6,7-dimethoxyquinoline (357 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (181 mg, yield 50%).
- The resultant compound (106 mg) was dissolved in a 10% hydrochloric acid-methanol solution (3 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 101 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.43 (t, J=6.6 Hz, 2H), 4.03 (s, 3H), 4.05 (s, 3H), 4.19 (t, J=6.1 Hz, 2H), 6.88 (d, J=6.8 Hz, 1H), 6.92-6.97 (m, 2H), 7.08-7.14 (m, 2H), 7.37-7.42 (m, 2H), 7.60-7.68 (m, 3H), 7.74 (s, 1H), 8.81 (d, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 452 (M++1)
- 2,4-Dichlorophenol (0.6 g) was dissolved in acetone (3 ml) to prepare a solution. 1-Bromo-2-chloroethane (0.46 ml), potassium carbonate (763 mg), and tetra-n-butylammonium iodide (136 mg) were then added to the solution, and the mixture was heated under reflux overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 2,4-dichloro-1-(2-chloroethoxy)benzene (1) (475 mg, yield 57%).
- The compound (1) (462 mg) was dissolved in acetone (4 ml) to prepare a solution. 4-Hydroxythiophenol (285 mg) and potassium carbonate (312 mg) were then added to the solution, and the mixture was stirred at room temperature overnight. 1 N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform for development to give 4-{[2-(2,4-dichlorophenoxy)ethyl]sulfanyl}phenol (2) (342 mg, yield 53%).
- Chlorobenzene (0.3 ml) was added to the compound (2) (230 mg) and 4-chloro-6,7-dimethoxyquinoline (326 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (185 mg, yield 51%).
- The resultant compound (103 mg) was dissolved in a 10% hydrochloric acid-methanol solution (10 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 83 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.48 (t, J=6.8 Hz, 2H), 4.03 (s, 3H), 4.05 (s, 3H), 4.31 (t, J=6.1 Hz, 2H), 6.85-6.90 (m, 1H), 7.17-7.22 (m, 1H), 7.34-7.42 (m, 3H), 7.56-7.67 (m, 4H), 7.74 (s, 1H), 8.78-8.83 (m, 1H)
- Mass spectrometry value (ESI-MS, m/z): 502 (M++1)
- 2,4-Dimethylphenol (0.6 g) was dissolved in acetone (3 ml) to prepare a solution. 1-Bromo-2-chloroethane (0.61 ml), potassium carbonate (1.02 g), and tetra-n-butylammonium iodide (183 mg) were then added to the solution, and the mixture was heated under reflux overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(2-chloroethoxy)-2,4-dimethylbenzene (1) (231 mg, yield 26%).
- The compound (1) (224 mg) was dissolved in acetone (2 ml) to prepare a solution. 4-Hydroxythiophenol (168 mg) and potassium carbonate (184 mg) were then added to the solution, and the mixture was stirred at room temperature overnight. 1 N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform for development to give 4-{[2-(2,4-dimethylphenoxy)ethyl]sulfanyl}phenol (2) (124 mg, yield 38%).
- Chlorobenzene (0.3 ml) was added to the compound (2) (112 mg) and 4-chloro-6,7-dimethoxyquinoline (182 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (68 mg, yield 36%).
- The resultant compound (51 mg) was dissolved in a 10% hydrochloric acid-methanol solution (3 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 35 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.08 (s, 3H), 2.18 (s, 3H), 3.40-3.45 (m, 2H), 4.01 (s, 3H), 4.03 (s, 3H), 4.16 (t, J=6.1 Hz, 2H), 6.75-6.95 (m, 4H), 7.33-7.40 (m, 2H), 7.56 (s, 1H), 7.57-7.64 (m, 2H), 7.71 (s, 1H), 8.77 (d, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 462 (M++1)
- 3,4-Dimethylphenol (0.6 g) was dissolved in acetone (3 ml) to prepare a solution. 1-Bromo-2-chloroethane (0.61 ml), potassium carbonate (1.02 g), and tetra-n-butylammonium iodide (183 mg) were then added to the solution, and the mixture was heated under reflux overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(2-chloroethoxy)-3,4-dimethylbenzene (1) (286 mg, yield 32%).
- The compound (1) (279 mg) was dissolved in acetone (2 ml) to prepare a solution. 4-Hydroxythiophenol (210 mg) and potassium carbonate (230 mg) were then added to the solution, and the mixture was stirred at room temperature overnight. 1 N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform for development to give 4-{[2-(3,4-dimethylphenoxy)ethyl]sulfanyl}phenol (2) (190 mg, yield 46%).
- Chlorobenzene (0.3 ml) was added to the compound (2) (138 mg) and 4-chloro-6,7-dimethoxyquinoline (226 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (122 mg, yield 52%).
- The resultant compound (68 mg) was dissolved in a 10% hydrochloric acid-methanol solution (3 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 34 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.13 (s, 3H), 2.18 (s, 3H), 3.40 (t, J=6.3 Hz, 2H), 4.02 (s, 3H), 4.04 (s, 3H), 4.15 (t, J=6.3 Hz, 2H), 6.61-6.74 (m, 2H), 6.87 (d, J=6.6 Hz, 1H), 7.02 (d, J=8.1 Hz, 1H), 7.38 (d, J=8.8 Hz, 2H), 7.54-7.66 (m, 3H), 7.72 (s, 1H), 8.78 (d, J=6.3 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 462 (M++1)
- 2,6-Dimethylphenol (1 g) was dissolved in acetone (4 ml) to prepare a solution. 1-Bromo-2-chloroethane (1.02 ml), potassium carbonate (1.70 g), and tetra-n-butylammonium iodide (303 mg) were then added to the solution, and the mixture was heated under reflux overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(2-chloroethoxy)-2,6-dimethylbenzene (1) (513 mg, yield 34%).
- The compound (1) (513 mg) was dissolved in acetone (4 ml) to prepare a solution. 4-Hydroxythiophenol (386 mg) and potassium carbonate (423 mg) were then added to the solution, and the mixture was stirred at room temperature overnight. 1 N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform for development to give 4-{[2-(2,6-dimethylphenoxy)ethyl]sulfanyl}phenol (2) (319 mg, yield 42%).
- Chlorobenzene (0.5 ml) was added to the compound (2) (281 mg) and 4-chloro-6,7-dimethoxyquinoline (456 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (29 mg, yield 6%).
- The resultant compound (29 mg) was dissolved in a 10% hydrochloric acid-methanol solution (3 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 25 mg of a hydrochloride.
- 1H-NMR (chloroform-d, 400 MHz): δ 2.29 (s, 3H), 2.34 (s, 3H), 3.41 (s, 1H), 3.95-4.30 (m, 9H), 6.85-8.30 (m, 11H)
- Mass spectrometry value (ESI-MS, m/z): 462 (M++1)
- 4-(4-{[2-(4-Fluorophenoxy)ethyl]sulfanyl}phenoxy)-6,7-dimethoxyquinoline (20 mg) was dissolved in acetic acid (0.5 ml) to prepare a solution. Potassium permanganate (35 mg) was added to the solution, and the mixture was stirred at room temperature for 2 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development to give the title compound (16 mg, yield 76%).
- The resultant compound (16 mg) was dissolved in a 10% hydrochloric acid-methanol solution (2 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 17 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.91 (t, J=5.6 Hz, 2H), 3.99 (s, 3H), 4.03 (s, 3H), 4.30 (t, J=5.4 Hz, 2H), 6.74-6.81 (m, 2H), 6.92 (d, J=6.3 Hz, 1H), 7.04-7.13 (m, 2H), 7.57 (s, 1H), 7.59-7.66 (m, 2H), 7.68 (s, 1H), 8.06-8.13 (m, 2H), 8.81 (d, J=6.3 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 484 (M++1)
- 6,7-Dimethoxy-4-(4-{[2-3-methoxyphenoxy)ethyl]-sulfanyl}phenoxy)quinoline (20 mg) was dissolved in acetic acid (0.5 ml) to prepare a solution. Potassium permanganate (34 mg) was added to the solution, and the mixture was stirred at room temperature for 2 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development to give the title compound (9 mg, yield 40%).
- The resultant compound (9 mg) was dissolved in a 10% hydrochloric acid-methanol solution (2 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 9 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.70 (s, 3H), 3.91 (t, J=5.6 Hz, 2H), 4.01 (s, 3H), 4.04 (s, 3H), 4.31 (t, J=5.6 Hz, 2H), 6.23 (t, J=2.4 Hz, 1H), 6.32-6.37 (m, 1H), 6.50-6.55 (m, 1H), 6.93 (d, J=6.1 Hz, 1H), 7.16 (t, J=8.3 Hz, 1H), 7.57-7.69 (m, 4H), 8.07-8.13 (m, 2H), 8.80 (d, J=6.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 496 (M++1)
- 4-(4-{[2-(2,4-Dichlorophenoxy)ethyl]sulfanyl}-phenoxy)-6,7-dimethoxyquinoline (20 mg) was dissolved in acetic acid (0.5 ml) to prepare a solution. Potassium permanganate (32 mg) was added to the solution, and the mixture was stirred at room temperature for 2 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development to give the title compound (15 mg, yield 69%).
- The resultant compound (15 mg) was dissolved in a 10% hydrochloric acid-methanol solution (2 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 15 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.94-4.07 (m, 8H), 4.42 (t, J=5.4 Hz, 2H), 6.91 (d, J=6.3 Hz, 1H), 7.19 (d, J=9.0 Hz, 1H), 7.33-7.37 (m, 1H), 7.52-7.67 (m, 5H), 7.97-8.03 (m, 2H), 8.80 (d, J=6.3 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 533 (M++1)
- 4-(4-{[2-(3-Chlorophenoxy)ethyl]sulfanyl}phenoxy)-6,7-dimethoxyquinoline (20 mg) was dissolved in acetic acid (0.5 ml) to prepare a solution. Potassium permanganate (31 mg) was added to the solution, and the mixture was stirred at room temperature for 2 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development to give the title compound (10 mg, yield 50%).
- The resultant compound (10 mg) was dissolved in a 10% hydrochloric acid-methanol solution (4 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 10 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.92 (t, J=5.4 Hz, 2H), 3.99 (s, 3H), 4.03 (s, 3H), 4.35 (t, J=5.6 Hz, 2H), 6.70-6.76 (m, 1H), 6.78 (t, J=2.0 Hz, 1H), 6.94 (d, J=6.3 Hz, 1H), 6.97-7.03 (m, 1H), 7.28 (t, J=8.3 Hz, 1H), 7.58 (s, 1H), 7.60-7.67 (m, 2H), 7.68 (s, 1H), 8.06-8.13 (m, 2H), 8.81 (d, J=6.3 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 500 (M++1)
- 4-(4-{[2-(3,4-Dimethylphenoxy)ethyl]sulfanyl}-phenoxy)-6,7-dimethoxyquinoline (19 mg) was dissolved in acetic acid (0.5 ml) to prepare a solution. Potassium permanganate (33 mg) was added to the solution, and the mixture was stirred at room temperature for 2 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development to give the title compound (4 mg, yield 17%).
- The resultant compound (4 mg) was dissolved in a 10% hydrochloric acid-methanol solution (2 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 4 mg of a hydrochloride.
- Mass spectrometry value (ESI-MS, m/z): 494 (M++1)
- 6,7-Dimethoxy-4-(4-{[2-(4-methylphenoxy)ethyl]-sulfanyl}phenoxy)quinoline (20 mg) was dissolved in acetic acid (0.5 ml) to prepare a solution. Potassium permanganate (32 mg) was added to the solution, and the mixture was stirred at room temperature for 3 hr. Thereafter, water was further added thereto, and the mixture was stirred at room temperature for 5 min. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development to give the title compound (1 mg, yield 4%).
- The resultant compound (1 mg) was dissolved in a 10% hydrochloric acid-methanol solution (2 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 1 mg of a hydrochloride.
- Mass spectrometry value (ESI-MS, m/z): 480 (M++1)
- 4-(4-{[2-(4-Isopropylphenoxy)ethyl]sulfanyl}-phenoxy)-6,7-dimethoxyquinoline (22 mg) was dissolved in acetic acid (0.5 ml) to prepare a solution. Potassium permanganate (34 mg) was added to the solution, and the mixture was stirred at room temperature for 3 hr. Thereafter, water was further added thereto, and the mixture was stirred at room temperature for 10 min. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development to give the title compound (2 mg, yield 8%).
- The resultant compound (2 mg) was dissolved in a 10% hydrochloric acid-methanol solution (2 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 2 mg of a hydrochloride.
- Mass spectrometry value (ESI-MS, m/z): 508 (M++1)
- 4-(4-{[2-(2-Isopropylphenoxy)ethyl]sulfanyl}-phenoxy)-6,7-dimethoxyquinoline (12 mg) was dissolved in acetic acid (0.5 ml) to prepare a solution. Potassium permanganate (19 mg) was added to the solution, and the mixture was stirred at room temperature for 2 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development to give the title compound (7 mg, yield 57%).
- The resultant compound (7 mg) was dissolved in a 10% hydrochloric acid-methanol solution (4 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 7 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.04 (s, 3H), 1.06 (s, 3H), 2.70-2.80 (m, 1H), 3.91-4.06 (m, 8H), 4.32 (t, J=5.4 Hz, 2H), 6.87-6.98 (m, 3H), 7.09-7.18 (m, 2H), 7.54-7.66 (m, 4H), 8.09-8.17 (m, 2H), 8.78 (d, J=6.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 508 (M++1)
- 4-(4-{[2-(2-Fluorophenoxy)ethyl]sulfanyl}-phenoxy)-6,7-dimethoxyquinoline (20 mg) was dissolved in acetic acid (0.5 ml) to prepare a solution. Potassium permanganate (33 mg) was added to the solution, and the mixture was stirred at room temperature for 2 hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/acetone for development to give the title compound (7 mg, yield 37%).
- The resultant compound (7 mg) was dissolved in a 10% hydrochloric acid-methanol solution (4 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 7 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.93-4.04 (m, 8H), 4.41 (t, J=5.4 Hz, 2H), 6.87-7.23 (m, 5H), 7.56-7.64 (m, 3H), 7.67 (s, 1H), 8.11 (d, J=8.5 Hz, 2H), 8.84 (d, J=6.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 484 (M++1)
- Nitric acid (0.5 ml) was added to 6,7-dimethoxy-4-(4-{[2-(3-methoxyphenoxy)ethyl]sulfanyl}phenoxy)-quinoline (20 mg), and the mixture was stirred at 0° C. for 30 min. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (14 mg, yield 60%).
- The resultant compound (14 mg) was dissolved in a 10% hydrochloric acid-methanol solution (2 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 15 mg of a hydrochloride.
- Mass spectrometry value (ESI-MS, m/z): 541 (M++1)
- Nitric acid (0.5 ml) was added to 4-(4-{[2-(4-Fluorophenoxy)ethyl]sulfanyl}phenoxy)-6,7-dimethoxyquinoline (20 mg), and the mixture was stirred at 0° C. for 30 min. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (13 mg, yield 58%).
- The resultant compound (13 mg) was dissolved in a 10% hydrochloric acid-methanol solution (2 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 14 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.50-3.58 (m, 2H), 4.03 (s, 3H), 4.05 (s, 3H), 4.53 (t, J=4.9 Hz, 2H), 6.93-6.97 (m, 1H), 7.47-7.65 (m, 5H), 7.73 (s, 1H), 7.87-7.94 (m, 3H), 8.80 (d, J=6.3 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 513 (M++1)
- Nitric acid (0.5 ml) was added to 4-(4-{[2-(2,4-dichlorophenoxy)ethyl]sulfanyl}phenoxy)-6,7-dimethoxyquinoline (20 mg), and the mixture was stirred at 0° C. for one hr. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by thin-layer chromatography using chloroform/methanol for development to give the title compound (19 mg, yield 92%).
- The resultant compound (19 mg) was dissolved in a 10% hydrochloric acid-methanol solution (2 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 19 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.50-3.62 (m, 2H), 4.02 (s, 3H), 4.05 (s, 3H), 4.39-4.49 (m, 2H), 6.91 (d, J=6.3 Hz, 1H), 7.26 (d, J=9.0 Hz, 1H), 7.37-7.43 (m, 1H), 7.57-7.64 (m, 4H), 7.72 (s, 1H), 7.90-7.97 (m, 2H), 8.81 (d, J=6.3 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 518 (M++1)
- m-Cresol (0.6 g) was dissolved in acetonitrile (2 ml) to prepare a solution. 1,3-Dibromopropane (1.13 ml), potassium carbonate (2.30 g), and tetra-n-butylammonium iodide (205 mg) were then added to the solution, and the mixture was heated under reflux for 3 hr. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(3-bromopropoxy)-3-methylbenzene (1) (831 mg, yield 65%).
- The compound (1) (1.07 g) was dissolved in acetone (5 ml) to prepare a solution. 4-Hydroxythiophenol (647 mg) and potassium carbonate (709 mg) were then added to the solution, and the mixture was stirred at room temperature for 2 hr. 1 N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform for development to give 4-{[3-(3-methylphenoxy)propyl]sulfanyl}phenol (2) (1.00 g, yield 78%).
- Chlorobenzene (0.4 ml) was added to the compound (2) (200 mg) and 4-chloro-6,7-dimethoxyquinoline (326 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (134 mg, yield 37%).
- The resultant compound (110 mg) was dissolved in a 10% hydrochloric acid-methanol solution (4 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 103 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.05 (t, J=6.8 Hz, 2H), 2.27 (s, 3H), 3.19 (t, J=7.3 Hz, 2H), 4.04 (s, 3H), 4.05 (s, 3H), 4.08 (t, J=6.1 Hz, 2H), 6.70-6.77 (m, 3H), 6.88 (d, J=6.6 Hz, 1H), 7.16 (t, J=8.3 Hz, 1H), 7.37-7.42 (m, 2H), 7.55-7.61 (m, 2H), 7.69 (s, 1H), 7.75 (s, 1H), 8.80 (d, J=6.6 Hz, 1H)
- o-Fluorophenol (0.6 g) was dissolved in acetonitrile (2 ml) to prepare a solution. 1,3-Dibromopropane (1.09 ml), potassium carbonate (2.22 g), and tetra-n-butylammonium iodide (198 mg) were then added to the solution, and the mixture was heated under reflux for one hr. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(3-bromopropoxy)-3-methylbenzene (1) (930 mg, yield 75%).
- The compound (1) (1.10 g) was dissolved in acetone (5 ml) to prepare a solution. 4-Hydroxythiophenol (657 mg) and potassium carbonate (720 mg) were then added to the solution, and the mixture was stirred at room temperature for 2 hr. 1 N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform for development to give 4-{[3-(2-fluorophenoxy)propyl]sulfanyl}phenol (2) (853 mg, yield 65%).
- Chlorobenzene (0.4 ml) was added to the compound (2) (200 mg) and 4-chloro-6,7-dimethoxyquinoline (322 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (167 mg, yield 50%).
- The resultant compound (139 mg) was dissolved in a 10% hydrochloric acid-methanol solution (8 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 132 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.04-2.13 (m, 2H), 3.20 (t, J=7.1 Hz, 2H), 4.04 (s, 3H), 4.05 (s, 3H), 4.18 (t, J=6.1 Hz, 2H), 6.87 (d, J=6.6 Hz, 1H), 6.91-6.98 (m, 1H), 7.10-7.24 (m, 3H), 7.36-7.42 (m, 2H), 7.59-7.63 (m, 2H), 7.69 (s, 1H), 7.74 (s, 1H), 8.80 (d, J=6.6 Hz, 1H)
- o-Fluorophenol (1.0 g) was dissolved in acetonitrile (3 ml) to prepare a solution. 1,4′-Dibromobutane (2.13 ml), potassium carbonate (3.70 g), and tetra-n-butylammonium iodide (330 mg) were then added to the solution, and the mixture was heated under reflux for one hr. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(4-bromobutoxy)-2-fluorobenzene (1) (1.57 g, yield 71%).
- The compound (1) (1.55 g) was dissolved in acetone (4 ml) to prepare a solution. 4-Hydroxythiophenol (873 mg) and potassium carbonate (956 mg) were then added to the solution, and the mixture was stirred at room temperature for 2 hr. 1 N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform for development to give 4-{[4-(2-fluorophenoxy)butyl]sulfanyl}phenol (2) (1.66 g, yield 90%).
- Chlorobenzene (0.4 ml) was added to the compound (2) (200 mg) and 4-chloro-6,7-dimethoxyquinoline (306 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (156 mg, yield 47%).
- The resultant compound (99 mg) was dissolved in a 10% hydrochloric acid-methanol solution (4 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 69 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.73-1.95 (m, 4H), 3.12 (t, J=7.3 Hz, 2H), 4.03 (s, 3H), 4.04 (s, 3H), 4.09 (t, J=6.1 Hz, 2H), 6.86 (d, J=6.6 Hz, 1H), 6.88-6.97 (m, 1H), 7.08-7.23 (m, 3H), 7.34-7.39 (m, 2H), 7.52-7.57 (m, 2H), 7.61 (s, 1H), 7.73 (s, 1H), 8.78 (d, J=6.3 Hz, 1H)
- m-Cresol (1 g) was dissolved in acetonitrile (3 ml) to prepare a solution. 1,4-Dibromobutane (2.21 ml), potassium carbonate (3.84 g), and tetra-n-butylammonium iodide (342 mg) were then added to the solution, and the mixture was heated under reflux for one hr. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(4-bromobutoxy)-3-methylbenzene (1).
- The compound (1) was dissolved in acetone (4 ml) to prepare a solution. 4-Hydroxythiophenol (2.07 g) and potassium carbonate (2.27 g) were then added to the solution, and the mixture was stirred at room temperature for 6 hr. 1 N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform for development to give 4-{[4-(3-methylphenoxy)butyl]sulfanyl}phenol (2) (1.04 g, yield 39%).
- Chlorobenzene (0.4 ml) was added to the compound (2) (200 mg) and 4-chloro-6,7-dimethoxyquinoline (309 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (139 mg, yield 42%).
- The resultant compound (115 mg) was dissolved in a 10% hydrochloric acid-methanol solution (6 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 85 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.72-1.91 (m, 4H), 2.26 (s, 3H), 3.11 (t, J=7.1 Hz, 2H), 3.98 (t, J=6.3 Hz, 2H), 4.03 (s, 3H), 4.04 (s, 3H), 6.68-6.76 (m, 3H), 6.86 (d, J=6.6 Hz, 1H), 7.11-7.17 (m, 1H), 7.33-7.39 (m, 2H), 7.52-7.57 (m, 2H), 7.60 (s, 1H), 7.73 (s, 1H), 8.78 (d, J=6.6 Hz, 1H)
- o-Fluorophenol (0.6 g) was dissolved in acetonitrile (2 ml) to prepare a solution. 1,3-Dibromopropane (1.09 ml), potassium carbonate (2.22 g), and tetra-n-butylammonium iodide (198 mg) were then added to the solution, and the mixture was heated under reflux for one hr. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(3-bromopropoxy)-2-fluorobenzene (1) (930 mg, yield 75%).
- The compound (1) (1.10 g) was dissolved in acetone (5 ml) to prepare a solution. 4′-Hydroxythiophenol (657 mg) and potassium carbonate (720 mg) were then added to the solution, and the mixture was stirred at room temperature for 2 hr. 1 N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform for development to give 4-{[3-(2-fluorophenoxy)propyl]sulfanyl}phenol (2) (0.85 g, yield 65%).
- Chlorobenzene (0.3 ml) was added to the compound (2) (100 mg) and 4-chloro-6,7-dimethoxyquinazoline (163 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (65 mg, yield 39%).
- The resultant compound (60 mg) was dissolved in a 10% hydrochloric acid-methanol solution (8 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 36 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.01-2.10 (m, 2H), 3.16 (t, J=7.3 Hz, 2H), 3.99 (s, 3H), 4.00 (s, 3H), 4.13-4.23 (m, 2H), 6.90-6.93 (m, 1H), 7.09-7.51 (m, 8H), 7.58 (s, 1H), 8.65 (s, 1H)
- m-Cresol (0.6 g) was dissolved in acetonitrile (2 ml) to prepare a solution. 1,3-Dibromopropane (1.13 ml), potassium carbonate (2.30 g), and tetra-n-butylammonium iodide (205 mg) were then added to the solution, and the mixture was heated under reflux for 3 hr. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(3-bromopropoxy)-3-methylbenzene (1) (831 mg, yield 65%).
- The compound (1) (1.07 g) was dissolved in acetone (5 ml) to prepare a solution. 4-Hydroxythiophenol (647 mg), potassium carbonate (709 mg) were then added to the solution, and the mixture was stirred at room temperature for 2 hr. 1 N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform for development to give 4-{[3-(3-methylphenoxy)propyl]sulfanyl}phenol (2) (1.00 g, yield 78%).
- Chlorobenzene (0.3 ml) was added to the compound (2) (100 mg) and 4-chloro-6,7-dimethoxyquinazoline (165 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (82 mg, yield 49%).
- The resultant compound (70 mg) was dissolved in a 10% hydrochloric acid-methanol solution (3 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 12 mg of a hydrochloride.
- Mass spectrometry value (ESI-MS, m/z): 463 (M++1)
- m-Cresol (1 g) was dissolved in acetonitrile (3 ml) to prepare a solution. 1,4-Dibromobutane (2.21 ml), potassium carbonate (3.84 g), and tetra-n-butylammonium iodide (342 mg) were then added to the solution, and the mixture was heated under reflux for one hr. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(4-bromobutoxy)-3-methylbenzene (1).
- The compound (1) was dissolved in acetone (4 ml) to prepare a solution. 4-Hydroxythiophenol (2.07 g) and potassium carbonate (2.27 g) were then added to the solution, and the mixture was stirred at room temperature for 6 hr. 1 N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform for development to give 4-{[4-(3-methylphenoxy)butyl]-sulfanyl}phenol (2) (1.04 g, yield 39%).
- Chlorobenzene (0.4 ml) was added to the compound (2) (100 mg) and 4-chloro-6,7-dimethoxyquinazoline (156 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (110 mg, yield 66%).
- The resultant compound (95 mg) was dissolved in a 10% hydrochloric acid-methanol solution (8 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 60 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.71-1.91 (m, 4H), 2.26 (s, 3H), 3.07 (t, J=7.1 Hz, 2H), 3.93-4.04 (m, 8H), 6.68-6.76 (m, 3H), 7.14 (t, J=8.1 Hz, 1H), 7.25-7.31 (m, 2H), 7.38-7.48 (m, 3H), 7.59 (s, 1H), 8.64 (s, 1H)
- o-Fluorophenol (1.0 g) was dissolved in acetonitrile (3 ml) to prepare a solution. 1,4-Dibromobutane (2.13 ml), potassium carbonate (3.70 g), and tetra-n-butylammonium iodide (330 mg) were then added to the solution, and the mixture was heated under reflux for one hr. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(4-bromobutoxy)-2-fluorobenzene (1) (1.57 g, yield 71%).
- The compound (1) (1.55 g) was dissolved in acetone (4 ml) to prepare a solution. 4-Hydroxythiophenol (873 mg) and potassium carbonate (956 mg) were then added to the solution, and the mixture was stirred at room temperature for 2 hr. 1 N HCl was added to reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform for development to give 4-{[3-(2-fluorophenoxy)butyl]sulfanyl}phenol (2) (1.66 g, yield 90%).
- Chlorobenzene (0.4 ml) was added to the compound (2) (100 mg) and 4-chloro-6,7-dimethoxyquinazoline (154 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (117 mg, yield 73%).
- The resultant compound (96 mg) was dissolved in a 10% hydrochloric acid-methanol solution (6 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Ethyl acetate was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 81 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.73-1.94 (m, 4H), 3.09 (t, J=7.3 Hz, 2H), 3.99 (s, 3H), 4.01 (s, 3H), 4.08 (t, J=6.3 Hz, 2H), 6.87-6.96 (m, 1H), 7.07-7.22 (m, 3H), 7.27-7.32 (m, 2H), 7.43-7.48 (m, 3H), 7.61 (s, 1H), 8.71 (s, 1H)
- o-Fluorophenol (0.6 g) was dissolved in acetone (2 ml) to prepare a solution. 1-Bromo-2-chloroethane (0.69 ml), potassium carbonate (1.11 g), and tetra-n-butylammonium iodide (198 mg) were then added to the solution, and the mixture was heated under reflux overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(2-chloroethoxy)-2-fluorobenzene (1) (438 mg, yield 47%).
- The compound (1) (432 mg) was dissolved in acetone (3 ml) to prepare a solution. 4-Hydroxythiophenol (343 mg) and potassium carbonate (376 mg) were then added to the solution, and the mixture was stirred at room temperature overnight. 1 N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform for development to give 4-{[2-(2-fluorophenoxy)ethyl]sulfanyl}phenol (2) (345 mg, yield 53%).
- Chlorobenzene (0.4 ml) was added to the compound (2) (100 mg) and 4-chloro-6,7-dimethoxyquinazoline (171 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (110 mg, yield 64%).
- The resultant compound (90 mg) was dissolved in a 10% hydrochloric acid-methanol solution (6 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 60 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.42 (t, J=6.6 Hz, 2H), 3.98 (s, 3H), 4.00 (s, 3H), 4.26 (t, J=6.3 Hz, 2H), 6.92-6.99 (m, 1H), 7.08-7.62 (m, 9H), 8.65 (s, 1H)
- m-Cresol (0.6 g) was dissolved in acetone (2 ml) to prepare a solution. 1-Bromo-2-chloroethane (0.69 ml), potassium carbonate (1.15 g), and tetra-n-butylammonium iodide (205 mg) were then added to the solution, and the mixture was heated under reflux overnight. Water was added to the reaction solution, and the mixture was extracted with chloroform. The extract was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure, and the residue was purified by chromatography on silica gel using hexane/ethyl acetate for development to give 1-(2-chloroethoxy)-3-methylbenzene (1) (347 mg, yield 37%).
- The compound (1) (341 mg) was dissolved in acetone (3 ml) to prepare a solution. 4-Hydroxythiophenol (278 mg) and potassium carbonate (304 mg) were then added to the solution, and the mixture was stirred at room temperature overnight. 1 N HCl was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using chloroform for development to give 4-{[2-(3-methylphenoxy)ethyl]sulfanyl}phenol (2) (243 mg, yield 47%).
- Chlorobenzene (0.4 ml) was added to the compound (2) (100 mg) and 4-chloro-6,7-dimethoxyquinazoline (174 mg), and the mixture was stirred at 140° C. overnight. A saturated aqueous sodium hydrogencarbonate solution was added to the reaction solution, and the mixture was extracted with chloroform, followed by washing with saturated brine. The extract was then dried over anhydrous sodium sulfate. The solvent was removed by distillation under the reduced pressure. The residue was purified by chromatography on silica gel using hexane/acetone for development to give the title compound (86 mg, yield 50%).
- The resultant compound (72 mg) was dissolved in a 10% hydrochloric acid-methanol solution (6 ml) to prepare a solution which was then allowed to stand at room temperature for 10 min. The solvent was removed by distillation under the reduced pressure. Diethyl ether was then added to the residue, and the precipitated crystal was collected by filtration and was washed to give 52 mg of a hydrochloride.
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.27 (s, 3H), 3.38 (t, J=6.3 Hz, 2H), 3.98 (s, 3H), 4.00 (s, 3H), 4.17 (t, J=6.3 Hz, 2H), 6.68-6.78 (m, 3H), 7.12-7.18 (m, 1H), 7.27-7.34 (m, 2H), 7.41 (s, 1H), 7.50-7.56 (m, 2H), 7.58 (s, 1H), 8.62 (s, 1H)
- Sodium hydride (60 mg) was dissolved in dimethylformamide (3 ml) to prepare a solution. A dimethylformamide solution (5 ml) of 2,4-dichlorophenol (245 mg) was then added to the solution, and the mixture was stirred at room temperature for 10 min. Subsequently, a dimethylformamide solution (5 ml) of bromomethylacetate (344 mg) was added thereto, and the mixture was further stirred at room temperature for 90 min. Water was added to stop the reaction, and the reaction solution was extracted with ethyl acetate, followed by washing with water and saturated brine. The extract was then dried over sodium sulfate. After the concentration of the extract, a 5% aqueous sodium hydroxide solution (10 ml) was added thereto, and the mixture was stirred at 80° C. for 10 hr. Subsequently, the solution was acidified by the addition of 1 N hydrochloric acid. The resultant white precipitate was collected by filtration and was dried to give 2-(2,4-dichlorophenoxy)acetic acid (310 mg, yield 94%).
- 2-(2,4-Dichlorophenoxy)acetic acid (310 mg) was added to chloroform (5 ml), and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (403 mg), 1-hydroxybenzotriazole monohydrate (284 mg), and 4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (498 mg) were added thereto. The mixture was then stirred with heating under reflux for 2 hr. A saturated aqueous sodium hydrogencarbonate solution was added to stop the reaction, and the reaction solution was extracted with chloroform, followed by washing with a saturated aqueous sodium hydrogencarbonate solution, 1 N hydrochloric acid, water, and saturated brine. The extract was then dried over sodium sulfate. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give N1-{4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-2-(2,4-dichlorophenoxy)acetamide (500 mg, yield 72%).
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-2-(2,4-dichlorophenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (156 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.76 (t, J=5.4 Hz, 2H), 4.11 (s, 3H), 4.14 (s, 3H), 4.47 (t, J=5.4 Hz, 2H), 6.81 (d, J=6.6 Hz, 1H), 7.08 (d, J=8.8 Hz, 1H), 7.23-7.27 (m, 3H), 7.38 (d, J=2.7 Hz, 1H), 7.54 (d, J=8.8 Hz, 2H), 7.69-7.70 (m, 1H), 8.01 (s, 1H), 8.65 (d, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 486 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-2-(2-methylphenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.11 (s, 3H), 3.88 (brs, 2H), 4.06 (s, 3H), 4.10 (s, 3H), 4.40 (brs, 2H), 6.72-6.76 (m, 3H), 6.96-7.01 (m, 2H), 7.28-7.32 (m, 2H), 7.53 (s, 1H), 7.88 (s, 1H), 7.96 (brs, 2H), 8.72 (brs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 431 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-2-(2-methoxyphenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- Mass spectrometry value (ESI-MS, m/z): 447 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-2-(2,6-dichlorophenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (156 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.59 (brs, 2H), 4.04 (s, 3H), 4.05 (s, 3H), 4.29 (t, J=5.4 Hz, 2H), 4.54 (brs, 1H), 6.43 (d, J=5.4 Hz, 1H), 6.76 (d, J=9.0 Hz, 2H), 6.98-7.05 (m, 3H), 7.27-7.31 (m, 3H), 7.41 (s, 1H), 7.59 (s, 1H), 8.46 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 486 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-2-(2,6-dimethylphenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.29 (s, 6H), 3.55-3.56 (m, 2H), 3.99-4.02 (m, 2H), 4.03 (s, 3H), 4.04 (s, 3H), 4.38 (brs, 1H), 6.42 (d, J=5.4 Hz, 1H), 6.76 (d, J=8.8 Hz, 2H), 6.92-7.05 (m, 5H), 7.42 (s, 1H), 7.60 (s, 1H), 8.46 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 445 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-2-(2,6-dimethoxyphenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.37-3.39 (m, 2H), 3.85 (s, 3H), 3.88 (s, 3H), 4.039 (s, 3H), 4.044 (s, 3H), 4.28 (t, J=5.1 Hz, 2H), 5.01 (brs, 1H), 6.43 (d, J=5.4 Hz, 1H), 6.57-6.61 (m, 2H), 6.72 (d, J=8.8 Hz, 1H), 7.00-7.04 (m, 3H), 7.41 (s, 1H), 7.60 (s, 1H), 8.45 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 477 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-2-(2,6-difluorophenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- Mass spectrometry value (ESI-MS, m/z): 453 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-2-(3,5-dimethylphenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- Mass spectrometry value (ESI-MS, m/z): 445 (M++1)
- N1-(4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-2-(4-chlorophenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- Mass spectrometry value (ESI-MS, m/z): 452 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-2-(3-chlorophenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- Mass spectrometry value (ESI-MS, m/z): 452 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-2-(2-ethylphenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- Mass spectrometry value (ESI-MS, m/z): 445 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]phenyl}-2-(2-methylphenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.26 (s, 3H), 3.58 (t, J=5.1 Hz, 2H), 4.06 (s, 3H), 4.07 (s, 3H), 4.21 (t, J=5.4 Hz, 3H), 6.75-6.91 (m, 4H), 7.08-7.18 (m, 4H), 7.31 (s, 1H), 7.57 (s, 1H), 8.63 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 432 (M++1)
- N1-(4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-2-(4-methoxyphenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.52 (t, J=4.9 Hz, 2H), 3.77 (s, 3H), 4.04 (s, 3H), 4.05 (s, 3H), 4.15 (t, J=5.1 Hz, 2H), 6.74 (d, J=8.8 Hz, 2H), 6.83-6.89 (m, 4H), 7.03 (d, J=8.8 Hz, 2H), 7.41 (s, 1H), 7.59 (s, 1H), 8.45 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 447 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-2-(4-ethylphenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- Mass spectrometry value (ESI-MS, m/z): 445 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-2-(2,5-dichlorophenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- Mass spectrometry value (ESI-MS, m/z): 486 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-2-(4-fluorophenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 4.03 (s, 3H), 4.04 (s, 3H), 4.14 (t, J=5.4 Hz, 2H), 6.82-6.84 (m, 3H), 6.97-7.01 (m, 2H), 7.11-7.16 (m, 4H), 7.62 (s, 1H), 7.74 (s, 1H), 8.78 (d, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 435 (M++1)
- Dimethylformamide (240 ml) was added to sodium hydride (1.96 g), and N1-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl-2-(4-fluorophenoxy)acetamide (11 g) was added thereto. Subsequently, a dimethylformamide solution (10 ml) of methyl iodide (7 g) was added thereto, and the mixture was stirred at room temperature for 2 hr. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and saturated brine in that order. The extract was then dried over sodium sulfate and was then concentrated, and the residue was purified on a column using hexane/acetone to give N1-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl-N1-methyl-2-(4-fluorophenoxy)acetamide (7.1 g, yield 63%).
- N1-4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl-N1-methyl-2-(4-fluorophenoxy)acetamide (7.1 g) was dissolved in tetrahydrofuran (250 ml) to prepare a solution. A 1 M solution (46 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (3.2 g, yield 40%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.10 (s, 3H), 3.78 (t, J=5.9 Hz, 2H), 4.07 (s, 3H), 4.08 (s, 3H), 4.14 (t, J=5.9 Hz, 2H), 6.51 (d, J=5.6 Hz, 1H), 6.82-6.85 (m, 4H), 6.94-7.00 (m, 2H), 7.06-7.08 (m, 2H), 7.61 (s, 1H), 7.64 (s, 1H), 8.45 (d, J=5.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 449 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-2-(2-chlorophenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- Mass spectrometry value (ESI-MS, m/z): 452 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-2-phenoxyacetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- Mass spectrometry value (ESI-MS, m/z): 417 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-2-(4-methylphenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- Mass spectrometry value (ESI-MS, m/z): 431 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-2-(3-methylphenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- Mass spectrometry value (ESI-MS, m/z): 431 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-2-(2-hydroxyphenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 4.02 (s, 3H), 4.03 (s, 3H), 4.12 (t, J=5.4 Hz, 2H), 6.71-6.95 (m, 7H), 7.15-7.17 (m, 2H), 7.62 (s, 1H), 7.73 (s, 1H), 8.77 (d, J=6.6 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 433 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]phenyl}-2-phenoxyacetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.56 (t, J=5.1 Hz, 2H), 4.07 (s, 6H), 4.21 (t, J=4.9 Hz, 2H), 6.76 (d, J=8.8 Hz, 2H), 6.93-7.00 (m, 3H), 7.09 (d, J=8.8 Hz, 2H), 7.28-7.33 (m, 2H), 7.39 (s, 1H), 7.57 (s, 1H), 8.65 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 418 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]phenyl}-2-(2-hydroxyphenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 3.60 (t, J=5.4 Hz, 2H), 4.06 (s, 3H), 4.07 (s, 3H), 4.28 (t, J=5.4 Hz, 2H), 6.78 (d, J=8.8 Hz, 2H), 6.87-6.94 (m, 4H), 7.10 (d, J=9.0 Hz, 2H), 7.32 (s, 1H), 7.57 (s, 1H), 8.63 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 434 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-methylphenyl}-2-phenoxyacetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- Mass spectrometry value (ESI-MS, m/z): 434 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-methylphenyl}-2-(2-methylphenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.02 (s, 3H), 2.19 (s, 3H), 3.50 (t, J=4.9 Hz, 2H), 3.96 (s, 3H), 3.98 (s, 3H), 4.12 (t, J=4.9 Hz, 2H), 6.23 (d, J=5.1 Hz, 1H), 6.50-6.54 (m, 2H), 6.76-6.89 (m, 3H), 7.07-7.10 (m, 2H), 7.34 (s, 1H), 7.55 (s, 1H), 8.35-8.36 (m, 1H)
- Mass spectrometry value (ESI-MS, m/z): 445 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-methylphenyl}-2-(2-chlorophenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.10 (s, 3H), 3.60 (t, J=4.9 Hz, 2H), 4.04 (s, 3H), 4.06 (s, 3H), 4.26 (t, J=5.1 Hz, 2H), 6.31 (d, J=5.4 Hz, 1H), 6.59-6.65 (m, 2H), 6.91-6.97 (m, 3H), 7.20-7.22 (m, 1H), 7.38-7.40 (m, 1H), 7.42 (s, 1H), 7.63 (s, 1H), 8.43 (d, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 466 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-methylphenyl}-2-(3-methylphenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.10 (s, 3H), 2.34 (s, 3H), 3.54 (t, J=4.9 Hz, 2H), 4.04 (s, 3H), 4.06 (s, 3H), 4.18 (t, J=5.1 Hz, 2H), 6.30 (d, J=5.4 Hz, 1H), 6.56-6.61 (m, 2H), 6.74-6.81 (m, 3H), 6.95 (d, J=8.3 Hz, 1H), 7.18 (t, J=7.6 Hz, 1H), 7.42 (s, 1H), 7.63 (s, 1H), 8.43 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 445 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-methylphenyl}-2-(4-methylphenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): 2.10 (s, 3H), 2.30 (s, 3H), 3.53 (t, J=4.9 Hz, 2H), 4.04 (s, 3H), 4.06 (s, 3H), 4.17 (t, J=5.1 Hz, 2H), 6.30 (d, J=5.1 Hz, 1H), 6.56-6.61 (m, 2H), 6.83-6.96 (m, 3H), 7.10 (d, J=8.5 Hz, 2H), 7.42 (s, 1H), 7.63 (s, 1H), 8.43 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 445 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-methylphenyl}-2-(2-methoxyphenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.10 (s, 3H), 3.55 (t, J=4.9 Hz, 2H), 3.89 (s, 3H), 4.04 (s, 3H), 4.06 (s, 3H), 4.25 (t, J=4.9 Hz, 2H), 6.29-6.31 (m, 1H), 6.57-6.61 (m, 1H), 6.89-7.11 (m, 6H), 7.43-7.44 (m, 1H), 7.61-7.65 (m, 1H), 8.44 (t, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 460 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-methylphenyl}-2-(2,6-dimethylphenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.11 (s, 3H), 2.30 (s, 6H), 3.55 (t, J=5.1 Hz, 2H), 4.02 (t, J=4.9 Hz, 2H), 4.05 (s, 3H), 4.07 (s, 3H), 6.30 (d, J=5.4 Hz, 1H), 6.60-6.64 (m, 2H), 6.94-6.98 (m, 2H), 7.02-7.04 (m, 2H), 7.43 (s, 1H), 7.63 (s, 1H), 8.44 (t, J=5.1 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 459 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-methylphenyl}-2-(2,6-dimethoxyphenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (156 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.10 (s, 3H), 3.38 (brs, 2H), 3.89 (s, 6H), 4.05 (s, 3H), 4.06 (s, 3H), 4.27 (t, J=5.1 Hz, 2H), 4.94 (brs, 1H), 6.31 (d, J=5.1 Hz, 1H), 6.56-6.61 (m, 4H), 6.94 (d, J=8.5 Hz, 1H), 7.02 (t, J=8.3 Hz, 1H), 7.43 (s, 1H), 7.64 (s, 1H), 8.44 (t, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 491 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-methylphenyl}-2-(2,6-difluorophenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.10 (s, 3H), 3.50 (brs, 2H), 4.05 (s, 3H), 4.06 (s, 3H), 4.37 (t, J=5.1 Hz, 2H), 6.31 (d, J=5.4 Hz, 1H), 6.57-6.63 (m, 2H), 6.89-6.99 (m, 4H), 7.43 (s, 1H), 7.63 (s, 1H), 8.44 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 467 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylphenyl}-2-(2,6-dimethoxyphenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (156 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.10 (s, 3H), 2.24 (s, 3H), 3.44 (t, J=4.4 Hz, 2H), 3.87 (s, 6H), 4.05 (s, 3H), 4.07 (s, 3H), 4.32 (t, J=4.6 Hz, 2H), 4.72 (brs, 1H), 6.27 (d, J=5.4 Hz, 1H), 6.58-6.62 (m, 3H), 6.91 (d, J=8.8 Hz, 1H), 7.03 (t, J=8.5 Hz, 1H), 7.43 (s, 1H), 7.66 (s, 1H), 8.42 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 505 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-3-phenoxypropaneamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted With chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.30-2.33 (m, 2H), 3.91 (s, 3H), 3.98 (s, 3H), 4.00 (t, J=5.6 Hz, 2H), 4.34 (t, J=7.1 Hz, 2H), 6.21 (d, J=7.6 Hz, 1H), 6.86-7.01 (m, 7H), 7.27-7.32 (m, 3H), 7.47 (d, J=7.6 Hz, 1H), 7.83 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 431 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylphenyl}-3-phenoxypropaneamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 8.0%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.08 (s, 3H), 2.14 (s, 3H), 2.17-2.23 (m, 2H), 3.43 (t, J=6.3 Hz, 2H), 4.04 (s, 3H), 4.06 (s, 3H), 4.16 (t, J=5.9 Hz, 2H), 6.29 (d, J=5.4 Hz, 1H), 6.54 (s, 1H), 6.82 (s, 1H), 6.93-6.97 (m, 3H), 7.28-7.32 (m, 2H), 7.43 (s, 1H), 7.62 (s, 1H), 8.42 (d, J=5.4 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 459 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylphenyl}-3-phenoxypropaneamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mxitue was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solutions and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- 1H-NMR (CDCl3-d1, 400 MHz): δ 2.07 (s, 3H), 2.14 (s, 3H), 2.17-2.30 (m, 2H), 3.42 (t, J=6.3 Hz, 2H), 4.05 (s, 3H), 4.06 (s, 3H), 4.17 (t, J=5.9 Hz, 2H), 6.26 (d, J=5.4 Hz, 1H), 6.59 (d, J=8.5 Hz, 1H), 6.90-6.97 (m, 3H), 7.28-7.43 (m, 3H), 7.65 (s, 1H), 8.41 (d, J=5.4 Hz, 1H), 8.58 (d, J=4.9 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 459 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-3-(2-methylphenoxy)propaneamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- Mass spectrometry value (ESI-MS, m/z): 445 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylphenyl}-3-(2-methylphenoxy)propaneamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- Mass spectrometry value (ESI-MS, m/z): 473 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylphenyl}-3-(2-methylphenoxy)propaneamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- Mass spectrometry value (ESI-MS, m/z): 473 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-3-(2-chlorophenoxy)propaneamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- Mass spectrometry value (ESI-MS, m/z): 466 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylphenyl}-3-(2-chlorophenoxy)propaneamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (156 mg, yield 80%).
- Mass spectrometry value (ESI-MS, m/z): 494 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylphenyl}-3-(2-chlorophenoxy)propaneamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (156 mg, yield 80%).
- Mass spectrometry value (ESI-MS, m/z): 494 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylphenyl}-2-(2,6-dimethylphenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- Mass spectrometry value (ESI-MS, m/z): 473 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylphenyl}-2-(2,6-dimethylphenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (155 mg, yield 80%).
- Mass spectrometry value (ESI-MS, m/z): 473 (M++1)
- N1-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,5-dimethylphenyl}-2-(2,6-dimethoxyphenoxy)acetamide (200 mg) was dissolved in tetrahydrofuran (10 ml) to prepare a solution. A 1 M solution (1.3 ml) of a borane-tetrahydrofuran complex in tetrahydrofuran was then added to the solution, and the mixture was stirred with heating under reflux for 2 hr. The reaction solution was cooled to 0° C. and was adjusted to pH=1 by the addition of 1 N hydrochloric acid, followed by stirring with heating under reflux for 30 min. The reaction solution was cooled to 0° C., was adjusted to pH=12 by the addition of a 1 N aqueous sodium hydroxide solution, and was extracted with chloroform. After the concentration of the extract, the residue was purified on a column using chloroform/methanol to give the title compound (156 mg, yield 80%).
- Mass spectrometry value (ESI-MS, m/z): 505 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolveed in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (78 mg, yield 94%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.02 (s, 6H), 6.54 (d, J=5.12 Hz, 1H), 7.22 (d, J=8.78 Hz, 2H), 7.33-7.77 (m, 5H), 7.81 (t, J=3.42 Hz, 1H), 7.83-7.95 (m, 3H), 8.02 (d, J=8.76 Hz, 1H), 8.49 (d, J=5.12 Hz, 1H), 9.42 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 460 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 2-chloro-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (83 mg, yield 100%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.07 (s, 6H), 6.57 (d, J=5.37 Hz, 1H), 7.23-7.29 (m, 3H), 7.44-7.47 (m, 2H), 7.53-7.54 (m, 3H), 7.79-7.86 (m, 3H), 8.53 (d, J=5.37 Hz, 1H), 9.23 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 494 (M++1)
- 2-Fluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2-fluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-fluoro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (75 mg, yield 93%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.06 (s, 6H), 6.57 (d, J=5.37 Hz, 1H), 7.23-7.29 (m, 5H), 7.39 (m, 1H), 7.44 (s, 1H), 7.54 (s, 1H), 7.64-7.67 (m, 1H), 7.83 (d, J=9.03 Hz, 2H), 8.13 (m, 1H), 8.53 (d, J=5.37 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 478 (M++1)
- 2-Bromo-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2-bromo-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml). A solution of 2-bromo-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (85 mg, yield 93%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.93 (s, 3H), δ 3.95 (s, 3H), 6.56 (d, J=5.12 Hz, 1H), 7.32 (d, J=8.30 Hz, 2H), 7.41 (d, J=5.61 Hz, 2H), 7.44-7.52 (m, 3H), 7.62 (t, J=7.19 Hz, 1H), 7.72 (d, J=7.81 Hz, 1H), 7.84 (d, J=8.78 Hz, 2H), 8.31 (s, 1H), 8.52 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 539 (M++1)
- 2-Methoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2-methoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-methoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (83 mg, yield 96%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.11 (s, 3H), 4.13 (s, 3H), 4.17 (s, 3H), 6.77 (d, J=6.01 Hz, 1H), 7.19 (t, J=7.69 Hz, 1H), 7.26-7.29 (m, 6H), 7.61-7.65 (m, 2H), 7.99 (d, J=8.78 Hz, 1H), 8.13 (s, 1H), 8.24 (dd, J=1.83 Hz, J=7.93 Hz, 1H), 8.51 (m, 1H)
- Mass spectrometry value (ESI-MS, m/z): 490 (M++1)
- 2-(Trifluoromethyl)-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2-(trifluoromethyl)-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-(trifluoromethyl)-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (83 mg, yield 95%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.93 (s, 3H), 3.95 (s, 3H), 6.56 (d, J=5.12 Hz, 1H), 7.32 (d, J=8.78 Hz, 2H), 7.40 (s, 1H), 7.49 (s, 1H), 7.75-7.86 (m, 6H), 8.51 (d, J=5.12 Hz, 1H), 12.13 (s, 1H), 12.33 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 528 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (76 mg, yield 80%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.04 (s, 3H), 4.06 (s, 3H), 6.64 (d, J=5.12 Hz, 1H), 7.04-7.07 (m, 2H), 7.26 (s, 2H), 7.45 (s, 1H), 7.48 (s, 1H), 7.57 (t, J=7.69 Hz, 1H), 7.68 (t, J=7.44 Hz, 1H), 7.93 (d, J=7.39 Hz, 2H), 8.46 (t, J=8.79 Hz, 1H), 8.57 (d, J=5.12 Hz, 1H), 9.22 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 478 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 2-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (66 mg, yield 85%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.58 (s, 3H), 4.08 (s, 3H), 4.12 (s, 3H), 6.72 (d, J=5.61 Hz, 1H), 7.08-7.12 (m, 2H), 7.26-7.36 (m, 3H), 7.47-7.59 (m, 3H), 7.82 (bs, 1H), 8.56 (d, J=5.85 Hz, 1H), 8.60 (m, 1H), 8.93 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 2-chloro-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (63 mg, yield 80%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.04 (s, 3H), 4.06 (s, 3H), 6.64 (d, J=5.37 Hz, 1H), 7.04-7.08 (m, 2H), 7.27 (s, 1H), 7.43-7.47 (m, 3H), 7.53-7.55 (m, 2H), 7.83 (d, J=7.32 Hz, 1H), 8.48 (t, J=8.90 Hz, 1H), 8.57 (d, J=5.37 Hz, 1H), 9.39 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 512 (M++1)
- 2-Fluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2-fluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-fluoro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (63 mg, yield 80%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.11 (s, 3H), 4.17 (s, 3H), 6.84 (d, J=6.59 Hz, 1H), 7.06-7.15 (m, 3H), 7.33-7.40 (m, 3H), 7.58-7.68 (m, 1H), 8.13 (bs, 2H), 8.58 (d, J=6.59 Hz, 1H), 8.73 (bs, 1H), 10.00 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 496 (M++1)
- 2-Bromo-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2-bromo-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-bromo-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (73 mg, yield 83%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.92 (s, 3H), 3.96 (s, 3H), 6.67 (d, J=5.12 Hz, 1H), 7.16 (d, J=8.78 Hz, 1H), 7.37-7.52 (m, 5H), 7.62 (d, J=7.07 Hz, 1H), 7.72 (d, J=7.56 Hz, 1H), 8.11 (t, J=8.53 Hz, 1H), 8.55 (d, J=5.12 Hz, 1H), 12.20 (s, 1H), 12.26 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 557 (M++1)
- 2-Iodo-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2-iodo-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-iodo-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (86 mg, yield 90%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.93 (s, 3H), 3.96 (s, 3H), 6.66 (d, J=5.21 Hz, 1H), 7.14 (d, J=7.56 Hz, 1H), 7.26 (t, J=5.61 Hz, 1H), 7.34-7.53 (m, 5H), 7.93 (d, J=8.35 Hz, 1H), 8.16 (m, 1H), 8.54 (d, J=5.21 Hz, 1H), 12.14 (bs, 1H), 12.32 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 604 (M++1)
- 2-Methoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2-methoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-methoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (56 mg, yield 70%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.93 (s, 3H), 3.96 (s, 3H), 4.03 (s, 3H), 6.67 (d, J=5.37 Hz, 1H), 7.11-7.47 (m, 4H), 7.58 (m, 1H), 7.68 (m, 1H), 7.78 (m, 1H), 7.93 (d, J=6.34 Hz, 1H), 8.14 (m, 1H), 8.56 (d, J=5.37 Hz, 1H), 11.39 (s, 1H), 12.44 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 508 (M++1)
- 2-(Trifluoromethyl)-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2-(trifluoromethyl)-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-(trifluoromethyl)-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (69 mg, yield 80%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.93 (s, 3H), 3.96 (s, 3H), 6.67 (d, J=5.12 Hz, 1H), 7.13 (m, 1H), 7.42-7.47 (m, 3H), 7.69-7.85 (m, 4H), 8.12 (m, 1H), 8.56 (d, J=5.12 Hz, 1H), 12.17 (s, 1H), 12.31 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 546 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (64 mg, yield 85%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.09 (s, 3H), 4.10 (s, 3H), 6.59 (d, J=5.85 Hz, 1H), 7.27 (s, 1H), 7.34 (t, J=8.54 Hz, 1H), 7.54-7.61 (m, 4H), 7.68-7.72 (m, 2H), 7.92 (d, J=7.80 Hz, 2H), 8.01 (d, J=11.47 Hz, 1H), 8.53 (d, J=5.85 Hz, 1H), 9.13 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 478 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 2-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (55 mg, yield 70%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.58 (s, 3H), 4.11 (s, 3H), 4.16 (s, 3H), 6.71 (d, J=6.34 Hz, 1H), 7.36 (s, 1H), 7.37-7.40 (m, 3H), 7.50 (t, J=7.81 Hz, 1H), 7.57-7.64 (m, 3H), 8.06 (bs, 1H), 8.17 (d, J=9.50 Hz, 1H), 8.54 (d, J=6.34 Hz, 1H), 8.88 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 2-chloro-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (61 mg, yield 75%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.06 (s, 3H), 4.07 (s, 3H), 6.48 (d, J=5.12 Hz, 1H), 7.26 (s, 1H), 7.31 (t, J=8.42 Hz, 1H), 7.44-7.58 (m, 6H), 7.79 (d, J=7.56 Hz, 1H), 8.03 (d, J=11.47 Hz, 1H), 8.53 (d, J=5.12 Hz, 1H), 9.33 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 512 (M++1)
- 2-Bromo-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2-bromo-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-bromo-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (73 mg, yield 83%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.96 (s, 6H), 6.51 (d, J=5.12 Hz, 1H), 7.42-7.53 (m, 7H), 7.59-7.63 (m, 2H), 7.72 (d, J=7.80 Hz, 1H), 8.10 (d, J=8.10 Hz, 1H), 8.51 (d, J=8.51 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 557 (M++1)
- 2-Iodo-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2-iodo-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-iodo-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (86 mg, yield 90%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.25 (s, 6H), 6.50 (d, J=4.64 Hz, 1H), 7.11 (t, J=1.71 Hz, 1H), 7.24-7.52 (m, 6H), 7.61 (d, J=9.03 Hz, 1H), 7.84 (d, J=8.05 Hz, 1H), 7.93 (d, J=8.05 Hz, 1H), 8.14 (d, J=12.2 Hz, 1H), 8.49 (d, J=5.12 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 604 (M++1)
- 2-Methoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2-methoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-methoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (65 mg, yield 80%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 4.03 (s, 9H), 6.95 (d, J=6.01 Hz, 1H), 7.18 (t, J=7.56 Hz, 1H), 7.31 (d, J=8.54 Hz, 1H), 7.53 (s, 1H), 7.63-7.75 (m, 4H), 7.93 (d, J=6.34 Hz, 1H), 8.21 (d, J=12.4 Hz, 1H), 8.83 (d, J=6.59 Hz, 1H), 11.35 (s, 1H), 12.72 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 508 (M++1)
- 2-(Trifluoromethyl)-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2-(trifluoromethyl)-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-(trifluoromethyl)-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (63 mg, yield 73%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.96 (s, 3H), 3.97 (s, 3H), 6.53 (d, J=6.34 Hz, 1H), 7.43 (s, 1H), 7.52 (t, J=9.15 Hz, 2H), 7.62-7.64 (m, 1H), 7.75-7.84 (m, 3H), 7.87-7.88 (m, 1H), 8.09 (d, J=14.6 Hz, 1H), 8.52 (d, J=5.37 Hz, 1H), 12.23 (bs, 1H), 12.37 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 546 (M++1)
- 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (63 mg, yield 85%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.03 (s, 3H), 4.07 (s, 3H), 6.45 (d, J=5.37 Hz, 1H), 7.26 (s, 2H), 7.29 (d, J=8.78 Hz, 1H), 7.56-7.60 (m, 3H), 7.69 (t, J=7.44 Hz, 1H), 7.74 (dd, J=2.68 Hz, J=8.78 Hz, 1H), 7.92 (d, J=7.08 Hz, 2H), 8.11 (s, 1H), 8.57 (bs, 1H), 9.17 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 494 (M++1)
- 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 2-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (69 mg, yield 90%).
- 1H-NMR (CDCl3, 400 MHz): δ 3.51 (s, 3H), 4.06 (s, 3H), 4.07 (s, 3H), 6.42 (d, J=5.37 Hz, 1H), 7.28-7.36 (m, 4H), 7.47-7.59 (m, 4H), 7.75 (dd, J=2.44 Hz, 8.78 Hz, 1H), 8.11 (d, J=2.44 Hz, 1H), 8.50 (d, J=5.37 Hz, 1H), 8.92 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 509 (M++1)
- 3-Chloro-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 2-chloro-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (79 mg, yield 90%).
- 1H-NMR (CDCl3, 400 MHz): δ 3.95 (s, 3H), 3.96 (s, 3H), 6.43 (d, J=5.12 Hz, 1H), 7.43-7.59 (m, 5H), 7.64 (d, J=7.81 Hz, 1H), 7.76 (d, J=11.22 Hz, 1H), 8.19 (bs, 1H), 8.52 (d, 1H, J=5.37 Hz), 12.12 (bs, 1H), 12.38 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 530 (M++1)
- 2-Fluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2-fluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-fluoro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (66 mg, yield 86%).
- 1H-NMR (CDCl3, 400 MHz): δ 3.95 (s, 3H), 3.96 (s, 3H), 6.43 (d, J=5.12 Hz, 1H), 7.34-7.39 (m, 2H), 7.43 (s, 1H), 7.51 (t, J=9.15 Hz, 2H), 7.56-7.69 (m, 3H), 8.17 (bs, 1H), 8.52 (d, J=5.37 Hz, 1H), 11.79 (bs, 1H), 12.43 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 512 (M++1)
- 2-Bromo-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2-bromo-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-bromo-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (61 mg, yield 70%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.95 (s, 3H), 3.96 (s, 3H), 6.43 (d, J=5.12 Hz, 1H), 7.32-7.53 (m, 5H), 7.60 (d, J=5.86 Hz, 1H), 7.72-7.76 (m, 2H), 8.20 (bs, 1H), 8.51 (d, J=5.12 Hz, 1H), 12.12 (s, 1H), 12.39 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 573 (M++1)
- 2-Methoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2-methoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-methoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (67 mg, yield 85%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.95 (s, 3H), 3.96 (s, 3H), 4.03 (s, 3H), 6.43 (d, J=5.37 Hz, 1H), 7.19 (t, J=7.32 Hz, 1H), 7.31 (d, J=8.05 Hz, 1H), 7.43 (s, 1H), 7.49-7.54 (m, 3H), 7.68 (t, J=8.78 Hz, 1H), 7.78 (dd, J=2.68 Hz, J=9.03 Hz, 1H), 7.93 (d, J=9.76 Hz, 1H), 8.52 (d, J=5.13 Hz, 1H), 11.33 (bs, 1H), 2.59 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 525 (M++1)
- 2-(Trifluoromethyl)-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2-(trifluoromethyl)-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-(trifluoromethyl)-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (61 mg, yield 85%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.95 (s, 3H), 3.96 (s, 3H), 6.42 (d, J=5.02 Hz, 1H), 7.42 (s, 1H), 7.48 (d, J=8.78 Hz, 1H), 7.53 (s, 1H), 7.75-7.87 (m, 6H), 8.19 (bs, 1H), 8.50 (d, J=5.12 Hz, 1H), 12.21 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 562 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-nitroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 2-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (66 mg, yield 80%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.36 (s, 3H), 3.93 (s, 3H), 3.94 (s, 3H), 6.52 (d, J=5.37 Hz, 1H), 7.15-7.22 (m, 3H), 7.28-7.39 (m, 3H), 7.42 (dd, J=2.81 Hz, 9.15 Hz, 1H), 7.50 (s, 1H), 7.54 (s, 1H), 7.66 (bs, 1H), 7.81 (s, 1H), 8.46 (d, J=5.12 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 519 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (69 mg, yield 89%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.09 (s, 3H), 4.11 (s, 3H), 7.23-7.34 (m, 4H), 7.55-7.59 (m, 4H), 7.68 (t, J=7.56 Hz, 1H), 7.88-7.93 (m, 3H), 8.69 (s, 1H), 9.12 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 461 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 2-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (72 mg, yield 90%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.50 (s, 3H), 3.98 (s, 3H), 3.99 (s, 3H), 7.29-7.38 (m, 7H), 7.42-7.46 (m, 1H), 7.52 (d, J=7.81. Hz, 1H), 7.57 (s, 1H), 7.80-7.82 (m, J=8.78 Hz, 2H), 8.56 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 475 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 2-chloro-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (79 mg, yield 95%).
- 1H-NMR (CDCl31 400 MHz): δ 3.98 (s, 3H), 3.99 (s, 3H), 7.37-7.40 (m, 3H), 7.45-7.49 (m, 1H), 7.53-7.58 (m, 3H), 7.65 (d, J=7.81 Hz, 1H), 7.79 (d, J=8.54 Hz, 2H), 8.58 (s, 1H), 12.04 (bs, 1H), 12.35 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 495 (M++1)
- 2-Methoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2-methoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-methoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (74 mg, yield 90%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.97 (s, 3H), 4.03 (s, 3H), 4.05 (s, 3H), 6.81 (d, J=6.34 Hz, 1H), 7.11-7.12 (m, 1H), 7.17-7.23 (m, 2H), 7.31 (d, J=8.54 Hz, 1H), 7.53-7.80 (m, 3H), 7.88 (dd, J=2.56 Hz, 8.91 Hz, 1H), 7.81 (d, J=7.81 Hz, 1H), 8.30 (s, 1H), 8.81 (d, J=6.34 Hz, 1H), 11.4 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 491 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 3-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (77 mg, yield 96%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.48 (s, 3H), 4.08 (s, 3H), 4.11 (s, 3H), 6.65 (d, J=5.85 Hz, 1H), 7.23-7.29 (m, 2H), 7.43-7.58 (m, 3H), 7.61 (s, 1H), 7.72 (t, J=8.66 Hz, 3H), 7.89 (d, J=8.78 Hz, 2H), 8.51 (d, J=5.85 Hz, 1H), 9.13 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 474 (M++1)
- 3-Fluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3-fluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-fluoro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (70 mg, yield 87%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.05 (s, 3H), 4.06 (s, 3H), 6.57 (d, J=5.12 Hz, 1H), 7.24-7.26 (m, 3H), 7.35-7.40 (m, 1H), 7.44 (s, 1H), 7.54-7.59 (m, 2H), 7.64-7.68 (m, 2H), 7.80-7.84 (m, 2H), 8.53 (d, J=5.12 Hz, 1H), 9.09 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 478 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 3-chloro-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (77 mg, yield 93%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.05 (s, 3H), 4.06 (s, 3H), 6.58 (d, J=5.37 Hz, 1H), 7.24-7.92 (m, 11H), 8.52 (d, J=5.37 Hz, 1H), 9.13 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 494 (M++1)
- 3-Methoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3-methoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-methoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (70 mg, yield 80%).
- 1H-NMR (CDCl3, 400 MHz): δ 3.90 (s, 3H), 4.05 (s, 3H), 4.06 (s, 3H), 6.57 (d, J=5.37 Hz, 1H), 7.13-7.16 (m, 2H), 7.23-7.26 (m, 2H), 7.37-7.49 (m, 4H), 7.54 (s, 1H), 7.81-7.84 (m, 2H), 8.53 (d, J=5.37 Hz, 1H), 9.13 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 490 (M++1)
- 3-(Trifluoromethyl)-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3-(trifluoromethyl)-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-(trifluoromethyl)-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (67 mg, yield 75%).
- 1H-NMR (CDCl3, 400 MHz): δ 3.94 (s, 3H), 3.96 (s, 3H), 6.59 (d, J=5.37 Hz, 1H), 7.35 (d, J=8.78 Hz, 2H), 7.43 (s, 1H), 7.53 (s, 1H), 7.78-7.85 (m, 3H), 8.04 (d, J=8.05 Hz, 1H), 8.26 (d, J=8.05 Hz, 1H), 8.35 (s, 1H), 8.55 (d, J=5.37 Hz, 1H), 11.79 (s, 1H), 12.49 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 528 (M++1)
- 3-Bromo-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3-bromo-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-bromo-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (67 mg, yield 74%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.05 (s, 3H), 4.06 (s, 3H), 6.66 (d, J=5.12 Hz, 1H), 7.24-7.26 (m, 3H), 7.44-7.47 (m, 2H), 7.53 (s, 1H), 7.80-7.84 (m, 4H), 8.07 (bs, 1H), 8.53 (d, J=5.12 Hz, 1H), 9.03 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 539 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 3-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (68 mg, yield 87%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.47 (s, 3H), 4.04 (s, 3H), 4.06 (s, 3H), 6.64 (d, J=5.12 Hz, 1H), 7.03-7.07 (m, 2H), 7.26 (s, 2H), 7.42-7.49 (in, 3H), 7.07-7.73 (m, 2H), 8.46 (t, J=8.90 Hz, 1H), 8.57 (d, J=5.12 Hz, 1H), 9.18 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- 3-Fluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3-fluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-fluoro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (71 mg, yield 90%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.93 (s, 3H), 3.96 (s, 3H), 6.67 (d, J=5.37 Hz, 1H), 7.38-7.73 (m, 6H), 7.84-7.86 (m, 1H), 8.05 (m, 2H), 8.29 (s, 1H), 8.56 (d, J=5.12 Hz, 1H), 11.9 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 496 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 3-chloro-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (76 mg, yield 93%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.04 (s, 3H), 4.06 (s, 3H), 6.63 (d, J=5.13 Hz, 1H), 6.65-7.07 (m, 2H), 7.26-7.27 (m, 1H), 7.45-7.53 (m, 3H), 7.65 (d, J=8.05 Hz, 1H), 7.80 (d, J=8.78 Hz, 1H), 7.94 (s, 1H), 8.44 (t, J=7.93 Hz, 1H), 8.57 (d, J=5.13 Hz, 1H), 9.17 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 512 (M++1)
- 3-Methoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3-methoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-methoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (73 mg, yield 90%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.86 (s, 3H), 3.93 (s, 3H), 3.96 (s, 3H), 6.66 (d, J=5.12 Hz, 1H), 7.16 (d, J=7.32 Hz, 1H), 7.22-7.24 (m, 1H), 7.38-7.48 (m, 4H), 7.57-7.60 (m, 2H), 8.08 (t, J=8.91 Hz, 1H), 8.56 (d, J=5.12 Hz, 1H), 11.82 (bs, 1H), 12.55 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 508 (M++1)
- 3-Bromo-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3-bromo-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-bromo-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (85 mg, yield 96%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.93 (s, 3H), 3.96 (s, 3H), 6.66 (d, J=4.88 Hz, 1H), 7.15 (d, J=9.51 Hz, 1H), 7.36-7.39 (m, 2H), 7.41 (s, 1H), 7.46 (s, 1H), 7.51 (t, J=7.81 Hz, 1H), 7.86 (d, J=7.81 Hz, 1H), 7.98 (d, J=7.56 Hz, 1H), 8.07 (m, 1H), 8.19 (s, 1H), 8.70 (d, J=5.12 Hz, 1H), 11.98 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 557 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 3-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (64 mg, yield 82%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.48 (s, 3H), 4.06 (s, 3H), 4.07 (s, 3H), 6.49 (d, J=4.39 Hz, 1H), 7.26 (s, 1H), 7.30 (t, J=8.54 Hz, 1H), 7.44-7.52 (m, 4H), 7.58 (s, 1H), 7.69-7.12 (m, 2H), 8.03 (dd, J=2.44 Hz, 11.71 Hz, 1H), 8.53 (d, J=5.37 Hz, 1H), 9.13 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- 3-Fluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3-fluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-fluoro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (65 mg, yield 83%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.10 (s, 3H), 4.15 (s, 3H), 6.68 (d, J=6.01 Hz, 1H), 7.27 (m, 2H), 7.35-7.42 (m, 2H), 7.57-7.69 (m, 4H), 7.98 (bs, 1H), 8.12 (m, 1H), 8.54 (d, J=6.34 Hz, 1H), 9.11 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 496 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 3-chloro-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (73 mg, yield 90%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.09 (s, 3H), 4.11 (s, 3H), 6.60 (d, J=5.61 Hz, 1H), 7.26 (s, 1H), 7.35 (t, J=8.54 Hz, 1H), 7.51-7.56 (m, 2H), 7.61 (s, 1H), 7.65-7.68 (m, 1H), 7.77-7.79 (m, 2H), 7.91-7.92 (m, 1H), 8.08 (dd, J=2.68 Hz, 11.47 Hz, 1H), 8.53 (d, J=5.61 Hz, 1H), 9.08 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 512 (M++1).
- 3-Methoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3-methoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-methoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (73 mg, yield 90%).
- 1H-NMR (CDCl3, 400 MHz): δ 3.99 (s, 3H), 4.13 (s, 3H), 4.17 (s, 3H), 6.87 (d, J=5.61 Hz, 1H), 7.18 (dd, J=2.44 Hz, 8.29 Hz, 1H), 7.31-7.46 (m, 2H), 7.55-7.62 (m, 4H), 7.71 (s, 1H), 7.84 (s, 1H), 8.23 (dd, J=2.44 Hz, 11.95 Hz, 1H), 8.67 (d, J=6.59 Hz, 1H), 11.00 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 508 (M++1)
- 3-(Trifluoromethyl)-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3-(trifluoromethyl)-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-(trifluoromethyl)-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (77 mg, yield 89%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.96 (s, 6H), 6.54 (d, J=5.37 Hz, 1H), 7.43 (s, 1H), 7.53-7.60 (m, 4H), 7.80 (t, J=8.05 Hz, 1H), 8.02-8.10 (m, 2H), 8.26 (d, J=7.81 Hz, 1H), 8.35 (s, 1H), 8.53 (d, J=4.88 Hz, 1H), 12.03 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 546 (M++1)
- 3-Bromo-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3-bromo-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-bromo-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (79 mg, yield 90%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.96 (s, 6H), 6.51 (d, J=5.37 Hz, 1H), 7.41 (s, 1H), 7.48-7.60 (m, 5H), 7.86 (d, J=7.56 Hz, 1H), 7.97 (d, J=8.05 Hz, 1H), 8.08 (d, J=12.44 Hz, 1H), 8.18 (s, 1H), 8.50 (d, J=5.37 Hz, 1H), 11.84 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 557 (M++1)
- 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 3-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (71 mg, yield 92%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.48 (s, 3H), 4.07 (s, 6H), 6.44 (d, J=5.61 Hz, 1H), 7.26 (s, 3H), 7.29 (d, J=8.78 Hz, 1H), 7.43-7.50 (m, 2H), 7.59 (s, 1H), 7.69-7.74 (m, 3H), 8.11 (d, J=2.44 Hz, 1H), 9.14 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 509 (M++1)
- 3-Fluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3-fluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-fluoro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (64 mg, yield 83%).
- 1H-NMR (CDCl3, 400 MHz): δ 3.95 (s, 3H), 3.96 (s, 3H), 6.43 (d, J=5.12 Hz, 1H), 7.43 (s, 3H), 7.49-7.54 (m, 2H), 7.59-7.62 (m, 1H), 7.75 (d, J=8.78 Hz, 1H), 7.82-7.86 (m, 1H), 8.18 (bs, 1H), 8.51 (d, J=5.12 Hz, 1H), 11.79 (bs, 1H), 12.43 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 512 (M++1)
- 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 3-chloro-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (77 mg, yield 97%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.06 (s, 3H), 4.07 (s, 3H), 6.46 (d, J=5.37 Hz, 1H), 7.29-7.32 (m, 4H), 7.52 (t, J=7.93 Hz, 1H), 7.61 (s, 1H), 7.64-7.66 (m, 1H), 7.71 (dd, J=2.68 Hz, 8.78 Hz, 1H), 7.87 (d, J=7.81 Hz, 1H), 8.00 (s, 1H), 8.07 (d, J=2.44 Hz, 1H), 8.51 (d, J=5.37 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 529 (M++1)
- 3-Methoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3-methoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-methoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (65 mg, yield 82%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.86 (s, 3H), 3.95 (s, 3H), 3.96 (s, 3H), 6.41 (d, J=5.12 Hz, 1H), 7.22 (d, J=8.54 Hz, 1H), 7.41-7.60 (m, 8H), 7.74 (d, J=8.78 Hz, 1H), 8.12 (bs, 1H), 8.50 (d, J=5.37 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 525 (M++1)
- 3-(Trifluoromethyl)-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3-(trifluoromethyl)-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]-aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-(trifluoromethyl)-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (75 mg, yield 88%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.95 (s, 3H), 3.96 (s, 3H), 6.43 (d, J=5.37 Hz, 1H), 7.42 (s, 1H), 7.49-7.53 (m, 2H), 7.74 (d, J=9.27 Hz, 1H), 7.80 (t, J=8.05 Hz, 1H), 8.03 (d, J=7.56 Hz, 1H), 8.18 (s, 1H), 8.26 (d, J=5.37 Hz, 1H), 8.35 (s, 1H), 8.51 (d, J=5.37 Hz, 1H), 12.04 (s, 1H), 12.52 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 562 (M++1)
- 3-Bromo-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3-bromo-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-bromo-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (81 mg, yield 93%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 4.05 (s, 3H), 4.06 (s, 3H), 6.85 (d, J=6.34 Hz, 1H), 7.50-7.54 (m, 2H), 7.66 (d, J=8.78 Hz, 1H), 7.76 (s, 1H), 7.85-7.89 (m, 2H), 7.98 (d, J=7.80 Hz, 1H), 8.19 (s, 1H), 8.28 (s, 1H), 8.84 (d, J=6.34 Hz, 1H), 11.8 (s, 1H), 12.56 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 573 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-nitroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 3-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (69 mg, yield 91%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.47 (s, 3H), 4.04 (s, 3H), 4.07 (s, 3H), 6.67 (d, J=5.37 Hz, 1H), 7.26 (s, 2H), 7.43-7.51 (m, 4H), 7.73 (d, J=7.32 Hz, 1H), 7.77 (s, 1H), 7.94 (d, J=2.68 Hz, 1H), 8.52 (d, J=9.03 Hz, 1H), 8.61 (d, J=5.12 Hz, 1H), 9.24 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 519 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 3-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (76 mg, yield 95%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.47 (s, 3H), 4.12 (s, 3H), 4.17 (s, 3H), 7.26-7.34 (m, 5H), 7.45-7.47 (m, 1H), 7.61 (s, 1H), 7.71 (m, 2H), 7.93 (d, J=9.03 Hz, 2H), 8.77 (s, 1H), 9.10 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 475 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 3-chloro-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (80 mg, yield 96%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.08 (s, 6H), 7.29 (s, 2H), 7.33 (d, J=8.78 Hz, 1H), 7.41 (s, 1H), 7.50 (t, J=7.81 Hz, 1H), 7.57 (s, 1H), 7.63 (d, J=7.32 Hz, 1H), 7.83-7.86 (m, 3H), 7.98 (s, 1H), 8.65 (s, 1H), 9.71 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 495 (M++1)
- 3-Methoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3-methoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-methoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (67 mg, yield 81%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.87 (s, 3H), 3.98 (s, 3H), 3.99 (s, 3H), 7.21-7.23 (m, 1H), 7.28-7.39 (m, 3H), 7.46 (t, J=7.93 Hz, 1H), 7.56-7.60 (m, 3H), 7.79 (d, J=8.78 Hz, 2H), 8.56 (s, 1H), 11.59 (s, 1H), 12.66 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 491 (M++1)
- 3-(Trifluoromethyl)-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3-(trifluoromethyl)-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-(trifluoromethyl)-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (75 mg, yield 85%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.97 (s, 3H), 3.99 (s, 3H), 7.38-7.44 (m, 3H), 7.58 (s, 1H), 7.78-7.82 (m, 3H), 8.04 (d, J=8.05 Hz, 1H), 8.26 (d, J=7.81 Hz, 1H), 8.36 (s, 1H), 8.56 (s, 1H), 11.97 (s, 1H), 12.95 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 529 (M++1)
- 3-Bromo-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3-bromo-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-bromo-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (6.1 mg, yield 70%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.98 (s, 3H), 3.99 (s, 3H), 7.37-7.40 (m, 3H), 7.52 (t, J=7.93 Hz, 1H), 7.58 (s, 1H), 7.78 (d, J=8.78 Hz, 2H), 7.87 (d, J=7.08 Hz, 1H), 7.97 (d, J=7.81 Hz, 1H), 8.18 (s, 1H), 8.58 (s, 1H), 11.89 (bs, 1H), 12.48 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 540 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 4-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (70 mg, yield 89%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.48 (s, 3H), 4.09 (s, 3H), 4.15 (s, 3H), 6.72 (d, J=6.34 Hz, 1H), 7.23-7.29 (m, 3H), 7.37 (d, J=7.81 Hz, 2H), 7.62 (s, 1H), 7.82 (d, J=8.05 Hz, 2H), 7.94 (d, J=9.03 Hz, 2H), 7.98 (s, 1H), 8.51 (d, J=5.12 Hz, 1H), 9.12 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 474 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 4-chloro-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (77 mg, yield 92%).
- 1H-NMR (CDCl31 400 MHz): δ 4.06 (s, 3H), 4.07 (s, 3H), 6.59 (d, J=5.37 Hz, 1H), 7.24-7.30 (m, 3H), 7.46-7.56 (m, 4H), 7.76-7.88 (m, 4H), 8.53 (d, J=5.37 Hz, 1H), 9.08 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 494 (M++1)
- 4-Fluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-fluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-fluoro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (69 mg, yield 85%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.05 (s, 3H), 4.06 (s, 3H), 6.57 (d, J=5.12 Hz, 1H), 7.24-7.26 (m, 5H), 7.44 (s, 1H), 7.54 (s, 1H), 7.80-7.83 (m, 2H), 7.95 (m, 2H), 8.53 (d, J=5.37 Hz, 1H), 9.09 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 478 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 4-nitro-1-benzenecarbonyl isothiocyanate (30 mg) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (80 mg, yield 94%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.06 (s, 3H), 4.08 (s, 3H), 6.59 (d, J=5.37 Hz, 1H), 7.24-7.30 (m, 5H), 7.50 (s, 1H), 7.54 (s, 1H), 7.82-7.85 (m, 2H), 8.01-8.12 (m, 2H), 8.41-8.43 (m, 2H), 8.53 (d, J=5.37 Hz, 1H), 9.16 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 507 (M++1)
- 4-Methoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-methoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-methoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (67 mg, yield
- 1H-NMR (CDCl3, 400 MHz): δ 3.92 (s, 3H), 4.05 (s, 3H), 4.06 (s, 3H), 6.57 (d, J=5.37 Hz, 1H), 7.02-7.04 (m, 2H), 7.23-7.26 (m, 3H), 7.44 (s, 1H), 7.54 (s, 1H), 7.77-7.85 (m, 2H), 7.88-7.90 (m, 2H), 8.53 (d, J=5.37 Hz, 1H), 9.07 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 490 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 4-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (77 mg, yield 98%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.47 (s, 3H), 4.04 (s, 3H), 4.06 (s, 3H), 6.64 (d, J=5.37 Hz, 1H), 7.04-7.07 (m, 2H), 7.26 (s, 1H), 7.36 (d, J=8.54 Hz, 2H), 7.46 (d, J=11.95 Hz, 2H), 7.83 (d, J=8.29 Hz, 2H), 8.46 (t, J=8.90 Hz, 1H), 8.56 (d, J=5.12 Hz, 1H), 9.18 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 4-chloro-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (77 mg, yield 94%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.04 (s, 3H), 4.06 (s, 3H), 6.64 (d, J=5.12 Hz, 1H), 7.04-7.07 (m, 2H), 7.26 (s, 1H), 7.45-7.46 (m, 2H), 7.54-7.56 (m, 2H), 7.87-7.89 (m, 2H), 8.39 (t, J=8.78 Hz, 1H), 8.57 (d, J=5.37 Hz, 1H), 9.17 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 512 (M++1)
- 4-Fluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-fluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-fluoro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (65 mg, yield 83%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.93 (s, 3H), 3.96 (s, 3H), 6.62 (d, J=5.37 Hz, 1H), 7.17 (d, J=11.2 Hz, 1H), 7.36-7.47 (m, 5H), 8.05-8.11 (m, 3H), 8.56 (d, J=5.12 Hz, 1H), 11.88 (s, 1H), 12.48 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 496 (M++1)
- 4-Iodo-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-iodo-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-iodo-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (92 mg, yield 96%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.96 (s, 3H), 4.03 (s, 3H), 6.67 (d, J=4.88 Hz, 1H), 7.17 (d, J=8.29 Hz, 2H), 7.39-7.47 (m, 2H), 7.77 (d, J=8.05 Hz, 2H), 7.94 (d, J=8.29 Hz, 2H), 8.06 (t, J=8.54 Hz, 1H), 8.56 (d, J=5.12 Hz, 1H), 11.90 (s, 1H), 12.44 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 604 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 4-nitro-1-benzenecarbonyl isothiocyanate (30 mg) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (75 mg, yield 90%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.04 (s, 3H), 4.06 (s, 3H), 6.64 (dd, J=3.42 Hz, J=5.12 Hz, 1H), 7.05-7.08 (m, 2H), 7.25-7.26 (m, 2H), 7.45 (dd, J=3.17 Hz, 6.59 Hz, 2H), 8.12 (dd, J=2.93 Hz, 8.66 Hz, 2H), 8.39-8.45 (m, 3H), 8.57 (dd, J=3.42 Hz, J=5.12 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 523 (M++1)
- 4-Methoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-methoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-methoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (71 mg, yield 88%).
- 1H-NMR (CDCl3, 400 MHz): δ 3.92 (s, 3H), 4.04 (s, 3H), 4.02 (s, 3H), 6.64 (d, J=5.12 Hz, 1H), 7.02-7.06 (m, 4H), 7.26 (s, 1H), 7.46 (d, J=12.06 Hz, 2H), 7.90 (d, J=9.03 Hz, 2H), 8.46 (t, J=9.03 Hz, 1H), 8.56 (d, J=5.12 Hz, 1H), 9.14 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 508 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 4-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (77 mg, yield 98%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.46 (s, 3H), 4.09 (s, 3H), 4.10 (s, 3H), 6.57 (d, J=5.37 Hz, 1H)/7.26-7.38 (m, 4H), 7.54 (d, J=8.54 Hz, 1H), 7.59 (s, 1H), 7.68 (s, 1H), 7.81 (d, J=8.29 Hz, 2H), 8.08 (dd, J=2.47 Hz, J=11.47 Hz, 1H), 8.53 (d, J=5.61 Hz, 1H), 9.09 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 4-chloro-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (78 mg, yield 96%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.06 (s, 3H), 4.07 (s, 3H), 6.49 (d, J=5.12 Hz, 1H), 7.26 (s, 1H), 7.31 (t, J=8.66 Hz, 1H), 7.44 (s, 1H), 7.50 (d, J=8.78 Hz, 1H), 7.55-7.57 (m, 3H), 7.86-7.88 (m, 2H), 8.00 (dd, J=2.44 Hz, J=11.47 Hz, 1H), 8.52 (d, J=5.12 Hz, 1H), 9.11 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 512 (M++1)
- 4-Fluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-fluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-fluoro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (68 mg, yield 86%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.11 (s, 3H), 4.15 (s, 3H), 6.68 (d, J=6.34 Hz, 1H), 7.25-7.29 (m, 3H), 7.37 (t, J=8.54 Hz, 1H), 7.58 (d, J=9.76 Hz, 1H), 7.63 (s, 1H), 7.95-7.98 (m, 3H), 8.12 (dd, J=2.56 Hz, J=11.59 Hz, 1H), 8.54 (d, J=6.01 Hz, 1H), 9.09 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 496 (M++1)
- 4-Bromo-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-bromo-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-bromo-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (81 mg, yield 91%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.96 (s, 6H), 6.52 (d, J=5.37 Hz, 1H), 7.42 (s, 1H), 7.49-7.59 (m, 3H), 7.76 (d, J=8.54 Hz, 2H), 7.94 (d, J=8.54 Hz, 2H), 8.08 (d, J=11.95 Hz, 1H), 8.51 (d, J=5.12 Hz, 1H), 11.79 (s, 1H), 12.61 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 557 (M++1)
- 4-Iodo-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-iodo-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-iodo-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (84 mg, yield 88%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.96 (s, 5H), 6.52 (d, J=5.37 Hz, 1H), 7.42-7.61 (m, 5H), 7.77 (d, J=7.07 Hz, 2H), 7.85 (d, J=8.29 Hz, 2H), 8.11 (d, J=8.54 Hz, 3H), 8.51 (d, J=5.37 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 604 (M++1)
- 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 4-nitro-1-benzenecarbonyl isothiocyanate (30 mg) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (79 mg, yield 96%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.11 (s, 3H), 4.17 (s, 3H), 6.75 (m, 1H), 7.29 (s, 2H), 7.40 (t, J=8.54 Hz, 1H), 7.57 (m, 1H), 7.65 (s, 1H), 7.94 (s, 1H), 8.10 (d, J=11.47 Hz, 1H), 8.18-8.21 (m, 2H), 8.40-8.43 (m, 2H), 8.62 (d, J=6.34 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 523 (M++1)
- 4-Methoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-methoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-methoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (70 mg, yield 87%).
- 1H-NMR (CDCl3, 400 MHz): δ 3.87 (s, 3H), 3.96 (s, 6H), 6.52 (d, J=5.12 Hz, 1H), 7.09 (d, J=8.78 Hz, 2H), 7.43 (s, 1H), 7.49-7.54 (m, 2H), 7.61 (d, J=8.78 Hz, 1H), 8.03-8.11 (m, 3H), 8.52 (d, J=5.37 Hz, 1H), 11.52 (bs, 1H), 12.82 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 523 (M++1)
- Mass spectrometry value (ESI-MS, m/z): 508 (M++1)
- 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 4-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (76 mg, yield 99%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.47 (s, 3H), 4.07 (s, 6H), 6.43 (d, J=5.37 Hz, 1H), 7.26 (s, 2H), 7.29 (d, J=8.78 Hz, 2H), 7.37 (d, J=8.05 Hz, 2H), 7.59 (s, 1H), 7.73 (dd, J=2.44 Hz, J=8.78 Hz, 1H), 7.81 (d, J=8.29 Hz, 2H), 8.10 (d, J=2.44 Hz, 1H), 9.13 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 509 (M++1)
- 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 4-chloro-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (74 mg, yield 93%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.04 (s, 3H), 4.07 (s, 3H), 6.44 (d, J=5.37 Hz, 1H), 7.29-7.32 (m, 3H), 7.54-7.60 (m, 4H), 7.71 (dd, J=2.68 Hz, J=8.78 Hz, 1H), 7.93-7.95 (m, 2H), 8.07 (d, J=2.44 Hz, 1H), 8.53 (d, J=5.34 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 529 (M++1)
- 4-Fluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-fluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-fluoro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (67 mg, yield 87%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.06 (s, 3H), 4.07 (s, 3H), 6.42 (d, J=5.37 Hz, 1H), 7.05-7.29 (m, 4H), 7.45 (s, 1H), 7.58 (s, 1H), 7.71 (dd, J=2.44 Hz, J=8.78. Hz, 1H), 7.94-7.98 (m, 2H), 8.08 (d, J=2.44 Hz, 1H), 8.52 (d, J=5.37 Hz, 1H), 9.12 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 512 (M++1)
- 4-Bromo-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-bromo-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-bromo-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (80 mg, yield 83%).
- 1H-NMR (CDCl3, 400 MHz): δ 3.95 (s, 3H), 3.96 (s, 3H), 6.43 (d, J=5.12 Hz, 1H), 7.43 (s, 1H), 7.51 (d, J=8.54 Hz, 1H), 7.54 (s, 1H), 7.65-7.85 (m, 3H), 7.93 (d, J=8.54 Hz, 2H), 8.31 (bs, 1H), 8.51 (d, J=5.12 Hz, 1H), 11.81 (bs, 1H), 12.53 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 573 (M++1)
- 4-Iodo-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-iodo-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-iodo-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (94 mg, yield 90%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.95 (s, 3H), 3.96 (s, 3H), 6.43 (d, J=5.12 Hz, 1H), 7.43 (s, 1H), 7.49-7.54 (m, 2H), 7.66 (d, J=8.05 Hz, 1H), 7.75-7.77 (m, 2H), 7.89-7.96 (m, 2H), 8.18 (s, 1H), 8.51 (d, J=5.37 Hz, 1H), 11.77 (s, 1H), 12.54 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 620 (M++1)
- 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 4-nitro-1-benzenecarbonyl isothiocyanate (30 mg) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (78 mg, yield 95%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.08 (s, 6H), 6.45 (d, J=5.37 Hz, 1H), 7.31-7.33 (m, 3H), 7.46 (s, 1H), 7.61 (s, 1H)7.69-7.72 (m, 1H), 8.07 (d, J=2.44 Hz, 1H), 8.19-8.21 (m, 2H), 8.39-8.42 (m, 2H), 8.48 (d, J=5.37 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 539 (M++1)
- 4-Methoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-methoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-methoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (68 mg, yield 86%).
- 1H-NMR (CDCl3, 400 MHz): δ 3.92 (s, 3H), 4.08 (s, 6H), 6.47 (d, J=5.61 Hz, 1H), 7.04-7.05 (m, 2H), 7.31-7.34 (m, 3H), 7.52 (bs, 1H), 7.62 (s, 1H), 7.73 (dd, J=2.44 Hz, 8.78 Hz, 1H), 7.97 (d, J=9.03 Hz, 2H), 8.09 (d, J=2.68 Hz, 1H), 8.50 (d, J=5.38 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 524 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 4-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (73 mg, yield 92%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.47 (s, 3H), 4.09 (s, 3H), 4.12 (s, 3H), 7.26-7.37 (m, 5H), 7.58-7.62 (m, 2H), 7.81 (d, J=8.29 Hz, 2H), 7.89 (d, J=8.93 Hz, 2H), 8.69 (s, 1H), 9.09 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 475 (M++1)
- 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 4-chloro-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (82 mg, yield 98%).
- 1H-NMR (CDCl3, 400 MHz): δ 3.98 (s, 3H), 3.99 (s, 3H), 7.36-7.40 (m, 3H), 7.58-7.63 (m, 3H), 7.78 (d, J=8.54 Hz, 2H), 8.01 (d, J=8.29 Hz, 2H), 8.58 (s, 1H), 11.71 (bs, 1H), 1.2.50 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 495 (M++1)
- 4-Fluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-fluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-fluoro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (64 mg, yield 80%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.98 (s, 3H), 3.99 (s, 3H), 7.36-7.40 (m, 5H), 7.57 (s, 1H), 7.79 (d, J=8.78 Hz, 2H), 8.07-8.11 (m, 2H), 8.57 (s, 1H), 11.65 (s, 1H), 12.58 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 479 (M++1)
- 4-Nitro-1-benzenecarbonyl isothiocyanate (30 mg) was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (74 mg, yield 87%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.11 (s, 3H), 4.14 (s, 3H), 7.26 (s, 1H), 7.34 (d, J=8.78 Hz, 2H), 7.59 (s, 1H), 7.72 (bs, 1H), 7.89 (d, J=8.78 Hz, 2H), 8.12 (d, J=8.78 Hz, 2H), 8.42 (d, J=8.41 Hz, 2H), 8.72 (s, 1H), 9.19 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 506 (M++1)
- 4-Methoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-methoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-methoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (71 mg, yield 86%).
- 1H-NMR (CDCl3, 400 MHz): δ 3.95 (s, 3H), 4.09 (s, 3H), 4.12 (s, 3H), 7.03 (d, J=9.03 Hz, 2H), 7.26-7.33 (m, 3H), 7.58-7.63 (m, 2H), 7.89 (d, J=9.03 Hz, 4H), 8.69 (s, 1H), 9.05 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 491 (M++1)
- 1,3-Benzodioxole-5-carbonyl isothiocyanate was prepared using commercially available 1,3-benzodioxole-5-carbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 1,3-benzodioxole-5-carbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (68 mg, yield 86%).
- 1H-NMR (CDCl3, 400 MHz): δ 3.93 (s, 3H), 3.95 (s, 3H), 6.15 (s, 2H), 6.56 (d, J=5.37 Hz, 1H), 7.08 (d, J=8.29 Hz, 1H), 7.32 (d, J=8.78 Hz, 2H), 7.41 (s, 1H), 7.51 (s, 1H), 7.52 (s, 1H), 7.67 (d, J=8.30 Hz, 1H), 7.82 (d, J=8.54 Hz, 2H), 8.52 (d, J=5.37 Hz, 1H), 11.39 (bs, 1H), 12.65 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 504 (M++1)
- 4-Ethoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-ethoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-ethoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (76 mg, yield 92%).
- Mass spectrometry value (ESI-MS, m/z): 554 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 4-phenylbenzoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 4-phenyl-1-benzenecarbonyl isothiocyanate was prepared using the resultant 4-phenyl-1-benzenecarbonyl chloride as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-phenyl-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (76 mg, yield 92%).
- Mass spectrometry value (ESI-MS, m/z): 554 (M++1)
- 4-Ethoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-ethoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-ethoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (72 mg, yield 89%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.38 (t, J=6.95 Hz, 3H), 3.95 (s, 3H), 3.96 (s, 3H), 4.14 (dd, J=7.08 Hz, 13.93 Hz, 2H), 6.41 (d, J=5.12 Hz, 1H), 7.05 (d, J=8.78 Hz, 2H), 7.42 (s, 1H), 7.47 (d, J=8.78 Hz, 1H), 7.53 (s, 2H), 7.26-7.75 (m, 1H), 8.02 (d, J=8.78 Hz, 2H), 8.19 (bs, 1H), 8.50 (d, J=5.37 Hz, 1H), 11.51 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 539 (M++1)
- 4-Ethyl-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-ethyl-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-ethyl-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (69 mg, yield 87%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.21-1.24 (m, 3H), 2.69-2.72 (m, 2H), 3.93 (s, 3H), 3.96 (s, 3H), 6.65 (m, 1H), 7.14 (m, 1H), 7.38-7.47 (m, 7H), 7.95-7.97 (m, 2H), 8.11 (m, 1H), 8.55-8.56 (m, 1H)
- Mass spectrometry value (ESI-MS, m/z): 506 (M++1)
- 4-Propyl-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-propyl-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-propyl-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (74 mg, yield 90%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.92 (t, J=7.08 Hz, 3H), 1.63-1.65 (m, 2H), 2.66 (m, 2H), 3.93 (s, 3H), 3.96 (s, 3H), 6.67 (m, 1H), 7.17 (m, 1H), 7.36-7.47 (m, 5H), 7.95 (d, J=8.05 Hz, 2H), 8.09 (m, 1H), 8.31 (s, 1H), 8.55 (d, J=5.37 Hz, 1H), 11.71 (s, 1H), 12.59 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 520 (M++1)
- 4-Butyl-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-butyl-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-butyl-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (68 mg, yield 80%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.92 (t, J=7.44 Hz, 3H), 1.30-1.36 (m, 2H), 1.58-1.62 (m, 2H), 2.68 (t, J=7.69 Hz, 3H), 3.93 (s, 3H), 3.96 (s, 3H), 6.57 (d, J=5.12 Hz, 1H), 7.16 (d, J=9.27 Hz, 1H), 7.36-7.47 (m, 5H), 7.95 (d, J=8.29 Hz, 2H), 8.11 (t, J=9.03 Hz, 1H), 8.29 (s, 1H), 8.55 (d, J=5.37 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 534 (M++1)
- 4-(Chloromethyl)-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-(chloromethyl)-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-(chloromethyl)-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (68 mg, yield 80%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.96 (s, 3H), 3.99 (s, 3H), 4.44-4.45 (m, 2H), 6.76 (d, J=5.61 Hz, 1H), 7.22 (d, J=5.61 Hz, 1H), 7.46-7.60 (m, 4H), 7.93-7.95 (m, 1H), 8.03-8.05 (m, 1H), 8.14 (m, 1H), 8.34 (s, 1H), 8.65 (d, J=5.61 Hz, 1H), 11.88 (s, 1H)7 12.55 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 526 (M++1)
- 4-Ethyl-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-ethyl-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-ethyl-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (68 mg, yield 84%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.23 (t, J=7.50 Hz, 3H), 2.71 (dd, J=7.56 Hz, J=15.13 Hz, 2H), 3.96 (s, 6H), 6.51 (d, J=4.88 Hz, 1H), 7.39 (d, J=8.29 Hz, 2H), 7.42 (s, 1H), 7.50 (t, J=8.90 Hz, 1H), 7.54 (s, 1H), 7.61 (d, J=9.27 Hz, 1H), 7.95 (d, J=8.05 Hz, 2H), 8.10 (d, J=10.25 Hz, 1H), 8.51 (d, J=5.37 Hz, 1H), 11.40 (s, 1H), 12.50 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 506 (M++1)
- 4-Propyl-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-propyl-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-propyl-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (71 mg, yield 86%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.89-0.93 (m, 3H), 1.63-1.65 (m, 2H), 2.66 (m, 2H), 3.96 (s, 6H), 6.52 (m, 1H), 7.37-7.61 (m, 6H), 7.95 (d, J=6.83 Hz, 2H), 8.11 (m, 1H), 8.51 (d, J=5.12 Hz, 1H), 11.59 (s, 1H), 12.76 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 520 (M++1)
- 4-Butyl-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-butyl-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-butyl-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (66 mg, yield 78%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.92 (t, J=7.20 Hz, 3H), 1.32-1.36 (m, 2H), 1.58-1.62 (m, 2H), 2.68 (t, J=7.32 Hz, 2H), 3.96 (s, 6H), 6.51 (d, J=5.37 Hz, 1H), 7.36-7.59 (m, 7H), 7.94 (d, J=8.05 Hz, 2H), 8.10 (d, J=12.9 Hz, 1H), 8.30 (s, 1H), 8.51 (d, J=5.37 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 534 (M++1)
- 4-(Chloromethyl)-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-(chloromethyl)-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-(chloromethyl)-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (68 mg, yield 81%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 4.02 (s, 6H), 4.45 (s, 2H), 6.84 (m, 1H), 7.54-7.70 (m, 6H), 8.03 (d, J=6.83 Hz, 2H), 8.19 (m, 2H), 8.74 (m, 1H), 11.75 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 526 (M++1)
- 4-Propyl-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-propyl-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-propyl-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (47 mg, yield 58%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.92-0.96 (m, 3H), 1.64-1.69 (m, 2H), 2.65-2.69 (m, 2H), 4.03 (s, 3H), 4.05 (s, 3H), 6.76 (bs, 1H), 7.34-7.36 (m, 3H), 7.70-7.72 (m, 1H), 7.81-7.83 (m, 1H), 7.96-8.01 (m, 3H), 8.23 (s, 1H), 8.28 (s, 1H), 11.08 (s, 1H), 11.57 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 537 (M++1)
- 4-(Chloromethyl)-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-(chloromethyl)-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-(chloromethyl)-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (77 mg, yield 90%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.98 (s, 3H), 3.99 (s, 3H), 4.44 (d, J=5.86 Hz, 2H), 7.36-7.39 (m, 2H), 7.54-7.59 (m, 4H), 7.78-7.81 (m, 2H), 7.94 (d, J=8.29 Hz, 2H), 8.03 (d, J=8.29 Hz, 2H), 8.57 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 509 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2,4-dimethylbenzoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2,4-dimethyl-1-benzenecarbonyl isothiocyanate was prepared using the resultant 2,4-dimethyl-1-benzenecarbonyl chloride as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2,4-dimethyl-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (77 mg, yield 93%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.45 (s, 3H), 2.49 (s, 3H), 3.94 (s, 3H), 3.96 (s, 3H), 6.51-6.57 (m, 1H), 7.08-7.11 (m, 1H), 7.25-7.50 (m, 7H), 7.83-7.84 (m, 2H), 8.46-8.51 (m, 1H), 11.59 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 488 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2,5-dimethylbenzoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2,5-dimethyl-1-benzenecarbonyl isothiocyanate was prepared using the resultant 2,5-dimethyl-1-benzenecarbonyl chloride as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2,5-dimethyl-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (75 mg, yield 91%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.33 (s, 3H), 2.39 (s, 3H), 3.93 (s, 3H), 3.96 (s, 3H), 6.56 (d, J=5.37 Hz, 1H), 7.18-7.36 (m, 7H), 7.39 (s, 1H), 7.50 (s, 1H), 7.83-7.86 (m, 2H), 8.51 (d, J=5.12 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 488 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2,3-dimethylbenzoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2,3-dimethyl-1-benzenecarbonyl isothiocyanate was prepared using the resultant 2,3-dimethyl-1-benzenecarbonyl chloride as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml), and a solution of 2,3-dimethyl-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (81 mg, yield 98%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.31 (s, 6H), 3.95 (s, 3H), 3.96 (s, 3H), 6.42 (d, J=5.36 Hz, 1H), 7.19 (t, J=7.40 Hz, 1H), 7.29-7.34 (m, 4H), 7.41 (s, 1H), 7.48 (d, J=8.78 Hz, 1H), 7.53 (s, 1H), 7.44-7.78 (m, 1H), 8.22-8.24 (m, 1H), 1.1.82 (s, 1H), 12.63 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 488 (M++1)
- 2,4-Difluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,4-difluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2,4-Difluoro-1-benzenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (69 mg, yield 82%).
- 1H-NMR (CDCl3, 400 MHz): δ 3.92 (s, 3H), 3.94 (s, 3H), 6.55 (d, J=5.12 Hz, 1H), 7.22-7.27 (m, 2H), 7.32 (d, J=9.08 Hz, 2H), 7.40-7.47 (m, 2H), 7.49 (s, 1H), 7.79-7.83 (m, 1H), 8.51 (d, J=5.12 Hz, 1H), 11.76 (s, 1H), 12.30 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 496 (M++1)
- 2,6-Difluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,6-difluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2,6-Difluoro-1-benzenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (62 mg, yield 74%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.93 (s, 3H), 3.94 (s, 3H), 6.44 (d, J=5.12 Hz, 1H), 6.84-6.87 (m, 1H), 7.02-7.25 (m, 4H), 7.37-7.49 (m, 2H), 7.59-7.63 (m, 2H), 7.80 (bs, 1H), 8.09 (bs, 1H), 8.45 (d, J=5.37 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 496 (M++1)
- 2,4-Dichloro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,4-dichloro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2,4-Dichloro-1-benzenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (70 mg, yield 78%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.05 (s, 3H), 4.06 (s, 3H), 6.57 (d, J=5.37 Hz, 1H), 7.26 (s, 1H), 7.35 (dd, J=2.19 Hz, J=8.42 Hz, 1H), 7.44-7.46 (m, 2H), 7.54-7.56 (m, 2H), 7.76-7.84 (m, 4H), 8.53 (d, J=5.37 Hz, 1H), 9.29 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 529 (M++1)
- 3,5-Dichloro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3,5-dichloro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3,5-Dichloro-1-benzenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (73 mg, yield 79%).
- Mass spectrometry value (ESI-MS, m/z): 529 (M++1)
- 3,5-Dimethoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3,5-dimethoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3,4-Dimethoxy-1-benzenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (70 mg, yield 80%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.79 (s, 3H), 3.82 (s, 3H), 3.93 (s, 6H), 5.11 (bs, 1H), 6.37 (d, J=5.12 Hz, 1H), 6.66 (d, J=8.54 Hz, 2H), 6.91 (d, J=8.54 Hz, 2H), 7.03 (d, J=8.05 Hz, 1H), 7.35 (s, 1H), 7.43 (s, 1H), 7.49 (s, 1H), 7.55 (d, J=8.78 Hz, 1H), 8.29 (s, 1H), 8.41 (d, J=5.37 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 520 (M++1)
- 2,4-Dichloro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,4-dichloro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2,4-Dichloro-1-benzenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (78 mg, yield 90%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.11 (s, 3H), 4.17 (s, 3H), 6.79 (d, J=6.34 Hz, 1H), 7.21-7.17 (m, 1H), 7.26 (s, 1H), 7.34 (d, J=10.25 Hz, 1H), 7.45-7.47 (m, 2H), 7.57 (d, J=1.95 Hz, 1H), 7.60 (s, 1H), 7.79 (d, J=8.29 Hz, 1H), 7.83 (d, J=8.29 Hz, 1H), 8.54 (d, J=6.34 Hz, 1H), 9.44 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 547 (M++1)
- 2,6-Dichloro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,6-dichloro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2,6-Dichloro-1-benzenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (71 mg, yield 82%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.07 (s, 3H), 4.10 (s, 3H), 6.69 (d, J=5.86 Hz, 1H), 7.08-7.12 (m, 2H), 7.26-7.44 (m, 5H), 7.53 (s, 1H), 7.72 (bs, 1H), 8.55 (d, J=5.85 Hz, 1H), 8.89 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 547 (M++1)
- 2,4-Difluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,4-difluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2,4-Difluoro-1-benzenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (66 mg, yield 81%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.11 (s, 3H), 4.14 (s, 3H), 6.74 (d, J=5.86 Hz, 1H), 6.89-6.99 (m, 1H), 7.00-7.09 (m, 1H), 7.12-7.16 (m, 1H), 7.37-7.42 (m, 2H), 7.58 (d, J=7.56 Hz, 1H), 7.67 (s, 1H), 7.72 (s, 1H), 8.05-8.14 (m, 2H), 8.58 (d, J=6.10 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 514 (M++1)
- 2,4-Dichloro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,4-dichloro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2,4-Dichloro-1-benzenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (64 mg, yield 74%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.14 (s, 3H), 4.18 (s, 3H), 6.91 (d, J=6.83 Hz, 1H), 7.36 (dd, J=2.07 Hz, 8.42 Hz, 1H), 7.42-7.46 (m, 4H), 7.56-7.65 (m, 2H), 7.72 (s, 1H), 7.86 (s, 1H), 8.21 (dd, J=2.44 Hz, J=11.71 Hz, 1H), 8.66 (d, J=6.59 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 547 (M++1)
- 3,5-Dichloro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3,5-dichloro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3,5-Dichloro-1-benzenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (73 mg, yield 84%).
- 1H-NMR (CDCl3, 400 MHz): δ 3.96 (s, 3H), 3.97 (s, 3H), 6.52 (d, J=5.12 Hz, 1H), 7.43 (s, 2H), 7.51-7.55 (m, 2H), 7.59 (m, 1H), 7.95 (s, 1H), 8.00 (s, 1H), 8.05-8.78 (m, 1H), 8.53 (d, J=5.37 Hz, 1H), 11.93 (bs, 1H), 12.42 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 547 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2,4-dimethylbenzoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2,4-dimethyl-1-benzenecarbonyl isothiocyanate was prepared using the resultant 2,4-dimethyl-1-benzenecarbonyl chloride as a starting compound according to the description of the literature. 2,4-Dimethyl-1-benzenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (75 mg, yield 97%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.34 (s, 3H), 2.42 (s, 3H), 3.95 (s, 3H), 3.96 (s, 3H), 6.42-6.44 (m, 1H), 7.10-7.13 (m, 2H), 7.41-7.53 (m, 5H), 7.73 (m, 1H), 8.22 (m, 1H), 8.50 (m, 1H), 11.96 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 5.23 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2,5-dimethylbenzoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2,4-dimethyl-1-benzenecarbonyl isothiocyanate was prepared using the resultant 2,5-dimethyl-1-benzenecarbonyl chloride as a starting compound according to the description of the literature. 2,5-Dimethyl-1-benzenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (74 mg, yield 94%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.33 (s, 3H), 2.39 (s, 3H), 3.97 (s, 3H), 3.98 (s, 3H), 6.48 (d, J=5.37 Hz, 1H), 7.14-7.27 (m, 2H), 7.35 (s, 1H), 7.43 (s, 1H), 7.50 (d, J=8.78 Hz, 1H), 7.56 (s, 1H), 7.76 (m, 1H), 8.22-8.24 (m, 1H), 8.55 (d, J=5.37 Hz, 1H), 11.77 (s, H), 12.64 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 523 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2,3-dimethylbenzoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2,3-dimethyl-1-benzenecarbonyl isothiocyanate was prepared using the resultant 2,3-dimethyl-1-benzenecarbonyl chloride as a starting compound according to the description of the literature. 2,3-Dimethyl-1-benzenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (76 mg, yield 96%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.29 (s, 6H), 3.94 (s, 3H), 3.96 (s, 3H), 6.57 (d, J=5.12 Hz, 1H), 7.20 (t, J=7.45 Hz, 1H), 7.30-7.34 (m, 4H), 7.41 (s, 1H), 7.51 (s, 1H), 7.85-7.87 (m, 3H), 8.53 (d, J=5.12 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 523 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 3,5-dimethylbenzoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 3,5-dimethyl-1-benzenecarbonyl isothiocyanate was prepared using the resultant 3,5-dimethyl-1-benzenecarbonyl chloride as a starting compound according to the description of the literature. 3,5-Dimethyl-1-benzenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (77 mg, yield 97%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.36 (s, 6H), 3.94 (s, 3H), 3.96 (s, 3H), 6.62 (d, J=5.12 Hz, 1H), 7.31-7.32 (m, 2H), 7.41 (s, 1H), 7.52 (s, 1H), 7.64 (s, 2H), 7.84 (m, 2H), 8.53 (d, J=5.37 Hz, 1H), 11.47 (s, 1H), 12.67 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 523 (M++1)
- 2,6-Difluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,6-difluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2,6-Difluoro-1-benzenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (59 mg, yield 74%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.94 (s, 3H), 3.96 (s, 3H), 6.57 (d, J=4.64 Hz, 1H), 7.11-7.51 (m, 4H), 7.62-7.64 (m, 1H), 7.80-7.83 (m, 2H), 8.08 (m, 1H), 8.52 (d, J=5.12 Hz, 1H), 12.16 (s, 1H), 12.28 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 530 (M++1)
- 2,4-Difluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,4-difluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2,4-Difluoro-1-benzenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (77 mg, yield 92%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.06 (s, 3H), 4.09 (s, 3H), 6.62 (d, J=5.61 Hz, 1H), 6.99-7.05 (m, 1H), 7.10-7.14 (m, 1H), 7.25-7.27 (m, 2H), 7.56 (s, 1H), 7.63 (s, 1H), 7.86 (d, J=8.78 Hz, 2H), 8.15-8.21 (m, 1H), 8.52 (d, J=5.61. Hz, 1H), 9.61 (d, J=14.64 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 497 (M++1)
- 2-Phenylethanoyl isothiocyanate was prepared using commercially available 2-phenylethanoyl chloride (80 mg) as a starting compound according to the description of the literature. 2-Phenylethanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (64 mg, yield 80%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.82 (s, 2H), 3.96 (s, 3H), 3.98 (s, 3H), 6.51 (d, J=6.01 Hz, 1H), 7.25-7.35 (m, 7H), 7.44 (s, 1H), 7.48 (d, J=8.78 Hz, 1H), 7.51 (s, 1H), 7.69 (m, 1H), 8.14-8.16 (m, 1H), 8.57 (bs, 1H), 11.81 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 474 (M++1)
- 2-Cyclohexylethanoyl isothiocyanate was prepared using commercially available 2-cyclohexylethanoyl chloride (80 mg) as a starting compound according to the description of the literature. 2-Cyclohexylethanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (73 mg, yield 90%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.86-1.00 (m, 2H), 1.19-1.25 (m, 6H), 1.69 (m, 3H), 2.37 (d, J=6.83 Hz, 2H), 3.96 (s, 3H), 3.99 (s, 3H), 6.67 (m, 1H), 7.34-7.36 (m, 2H), 7.44 (s, 1H), 7.59 (s, 1H), 7.81-7.84 (m, 2H), 8.63 (m, 1H), 11.48 (s, 1H), 12.41 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 480 (M++1)
- 2-Phenylethanoyl isothiocyanate was prepared using commercially available 2-phenylethanoyl chloride (80 mg) as a starting compound according to the description of the literature. 2-Phenylethanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (65 mg, yield 83%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.83 (s, 2H), 3.92 (s, 3H), 3.95 (s, 3H), 6.64 (d, J=5.12 Hz, 1H), 7.13 (d, J=9.51 Hz, 1H), 7.29-7.36 (m, 6H), 7.41 (s, 1H), 7.46 (s, 1H), 8.05 (t, J=8.66 Hz, 1H), 8.55 (d, J=5.12 Hz, 1H), 11.89 (s, 1H), 12.26 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 3-(2-methoxyphenyl)propanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 3-(2-methoxyphenyl)propanoyl isothiocyanate was prepared using the resultant 3-(2-methoxyphenyl)propanoyl chloride as a starting compound according to the description of the literature. 3-(2-Methoxyphenyl)propanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (60 mg, yield 74%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.71-2.75 (m, 2H), 2.85-2.89 (m, 2H), 3.81 (s, 3H), 3.94 (s, 3H), 3.96 (s, 3H), 6.55 (d, J=5.12 Hz, 1H), 6.87 (t, J=7.44 Hz, 1H), 6.95 (d, J=8.29 Hz, 1H), 7.16-7.22 (m, 2H), 7.28 (d, J=8.54 Hz, 2H), 7.39 (s, 1H), 7.49 (s, 1H), 7.76-7.79 (m, 2H), 8.50 (d, J=6.04 Hz, 1H), 11.49 (s, 1H), 12.59 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 518 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 3-phenylpropanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 3-phenylpropanoyl isothiocyanate was prepared using the resultant 3-phenylpropanoyl chloride as a starting compound according to the description of the literature. 3-Phenylpropanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (60 mg, yield 74%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.81-2.91 (m, 2H), 2.99-3.03 (m, 2H), 4.07 (s, 3H), 4.09 (s, 3H), 6.76 (d, J=6.01 Hz, 1H), 7.06-7.11 (m, 2H), 7.21-7.32 (m, 3H), 7.56 (s, 3H), 7.73 (bs, 1H), 8.48 (m, 1H), 8.59 (d, J=5.86 Hz, 1H), 11.49 (s, 1H), 12.74 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 506 (M++1)
- 3-Cyclopentylpropanoyl isothiocyanate was prepared using commercially available 3-cyclopentylpropanoyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Cyclopentylpropanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy)-2-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (63 mg, yield 80%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.13-1.25 (m, 4H), 1.50-1.61 (m, 7H), 1.75 (m, 2H), 3.92 (s, 3H), 3.95 (s, 3H), 6.60 (d, J=5.12 Hz, 1H), 7.34 (d, J=11.22 Hz, 1H), 7.28 (m, 1H), 7.32-7.35 (m, 1H), 7.41 (s, 1H), 7.45 (s, 1H), 8.11 (m, 1H), 8.53 (d, J=5.12 Hz, 1H), 11.63 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 498 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 3-phenylpropanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 3-phenylpropanoyl isothiocyanate was prepared using the resultant 3-phenylpropanoyl chloride as a starting compound according to the description of the literature. 3-Phenylpropanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (57 mg, yield 71%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.79-2.84 (m, 2H), 2.89-2.94 (m, 2H), 4.02 (s, 3H), 4.03 (S, 3H), 6.88 (bs, 1H), 7.21-7.33 (m, 6H), 7.59-7.61 (m, 3H), 7.72 (s, 1H), 8.13 (d, J=13.17 Hz, 1H), 11.65 (s, 1H), 12.67 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 506 (M++1)
- 3-Cyclopentylpropanoyl isothiocyanate was prepared using commercially available 3-cyclopentylpropanoyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Cyclopentylpropanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (69 mg, yield 88%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.11 (m, 2H), 1.49-1.62 (m, 7H), 1.75-1.91 (m, 4H), 3.95 (s, 3H), 3.96 (s, 3H), 6.52 (d, J=5.37 Hz, 1H), 7.43 (s, 1H), 7.47-7.56 (m, 3H), 8.05 (d, J=4.39 Hz, 1H), 8.52 (d, J=5.12 Hz, 1H), 11.58 (s, 1H), 12.66 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 498 (M++1)
- 3-Cyclopentylpropanoyl isothiocyanate was prepared using commercially available 3-cyclopentylpropanoyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Cyclopentylpropanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (68 mg, yield 88%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.07 (m, 4H), 1.48-1.71 (m, 9H), 4.05 (s, 3H), 4.07 (s, 3H), 6.88 (d, J=6.83 Hz, 1H), 7.55 (s, 1H), 7.65 (d, J=9.03 Hz, 1H), 7.78-7.81 (m, 2H), 8.26-8.28 (m, 1H), 8.87 (d, J=6.59 Hz, 1H), 11.61 (s, 1H), 12.66 (s, 1H).
- Mass spectrometry value (ESI-MS, m/z): 515 (M++1)
- 2-(Benzyloxy)ethanoyl isothiocyanate was prepared using commercially available 2-(benzyloxy)ethanoyl chloride (80 mg) as a starting compound according to the description of the literature. 2-(Benzyloxy)ethanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (38 mg, yield 43%).
- Mass spectrometry value (ESI-MS, m/z): 522 (M++1)
- 2-(Benzyloxy)ethanoyl isothiocyanate was prepared using commercially available 2-(benzyloxy)ethanoyl chloride (80 mg) as a starting compound according to the description of the literature. 2-(Benzyloxy)ethanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (33 mg, yield 40%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.96 (s, 6H), 4.13 (s, 2H), 4.64 (s, 2H), 6.48 (d, J=5.37 Hz, 2H), 7.32-7.45 (m, 6H), 7.54 (m, 2H), 7.90-7.94 (m, 2H), 8.50 (d, J=5.12 Hz, 1H), 10.15 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 522 (M++1)
- 2-Furancarbonyl isothiocyanate was prepared using commercially available 2-furancarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2-Furancarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (40 mg, yield 53%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.94 (s, 3H), 3.96 (s, 3H), 6.56 (d, J=5.12 Hz, 1H), 6.73-6.77 (m, 2H), 7.32 (d, J=8.78 Hz, 1H), 7.41 (s, 1H), 7.51-7.52 (m, 2H), 7.79 (d, J=8.78 Hz, 1H), 7.86 (m, 1H), 8.01 (s, 2H), 8.08 (s, 1H), 8.51 (d, J=4.88, 1H)
- Mass spectrometry value (ESI-MS, m/z): 450 (M++1)
- 3-Thiophenecarbonyl isothiocyanate was prepared using commercially available 3-thiophenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Thiophenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (45 mg, yield 68%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.93 (s, 3H), 3.95 (s, 3H), 6.55 (d, J=5.37 Hz, 1H), 7.26 (t, J=4.27 Hz, 1H), 7.31 (d, J=9.03 Hz, 2H), 7.41 (s, 1H), 7.50 (s, 1H), 7.81 (d, J=9.03 Hz, 2H), 8.05 (d, J=4.88 Hz, 1H), 8.41 (d, J=3.90 Hz, 1H), 8.51 (d, J=5.12 Hz, 1H), 11.65 (s, 1H), 12.49 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 466 (M++1)
- 2-Furancarbonyl isothiocyanate was prepared using commercially available 2-furancarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2-Furancarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (47 mg, yield 68%).
- Mass spectrometry value (ESI-MS, m/z): 468 (M++1)
- 3-Thiophenecarbonyl isothiocyanate was prepared using commercially available 3-thiophenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Thiophenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (45 mg, yield 58%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.93 (s, 3H), 3.96 (s, 3H), 6.67 (d, J=5.12 Hz, 1H), 7.15-7.18 (m, 1H), 7.26-7.28 (m, 2H), 7.39-7.43 (m, 2H), 7.48 (s, 1H), 7.99-8.08 (m, 2H), 8.42 (d, J=3.42 Hz, 1H), 8.57 (d, J=5.12 Hz, 1H), 10.01 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 484 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2,5-dimethyl-3-furoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2,5-dimethyl-3-furancarbonyl isothiocyanate was prepared using the resultant 2,5-dimethyl-3-furancarbonyl chloride as a starting compound according to the description of the literature. 2,5-Dimethyl-3-furancarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (38 mg, yield 48%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.26 (s, 3H), 2.55 (s, 3H), 3.92 (s, 3H), 3.95 (s, 3H), 6.65 (d, J=5.37 Hz, 1H), 6.89 (s, 1H), 7.13-7.14 (m, 1H), 7.34-7.37 (m, 1H), 7.41 (s, 1H), 7.46 (s, 1H), 8.05-8.07 (m, 1H), 8.54 (d, J=5.15 Hz, 1H), 11.13 (s, 1H), 12.61 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 496 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 3-methyl-2-thiophenecarboxylic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 3-methyl-2-thiophenecarbonyl isothiocyanate was prepared using the resultant 3-methyl-2-thiophenecarbonyl chloride as a starting compound according to the description of the literature. 3-Methyl-2-thiophenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (42 mg, yield 53%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.51 (s, 3H), 3.92 (s, 3H), 3.96 (s, 3H), 6.66 (d, J=5.12 Hz, 1H), 7.09 (d, J=4.88 Hz, 1H), 7.14-7.16 (m, 1H), 7.38 (dd, J=2.56 Hz, 11.01 Hz, 1H), 7.42 (s, 1H), 7.46 (s, 1H), 7.86 (d, J=4.88 Hz, 1H), 8.07 (t, J=8.54 Hz, 1H), 8.55 (d, J=5.37 Hz, 1H), 11.25 (s, 1H), 12.22 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 498 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2,5-dimethyl-3-furoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2,5-dimethyl-3-furancarbonyl isothiocyanate was prepared using the resultant 2,5-dimethyl-3-furancarbonyl chloride as a starting compound according to the description of the literature. 2,5-Dimethyl-3-furancarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (51 mg, yield 64%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.26 (s, 3H), 2.55 (s, 3H), 3.96 (s, 6H), 6.51 (d, J=5.37 Hz, 1H), 6.87 (s, 1H), 7.42 (s, 1H), 7.47-7.59 (m, 3H), 8.07 (d, J=10.25 Hz, 1H), 8.51 (d, J=5.12 Hz, 1H), 11.02 (s, 1H), 12.81 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 496 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 5-methyl-2-thiophenecarboxylic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 5-methyl-2-thiophenecarbonyl isothiocyanate was prepared using the resultant 5-methyl-2-thiophenecarbonyl chloride as a starting compound according to the description of the literature. 5-Methyl-2-thiophenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (49 mg, yield 62%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.58 (s, 3H), 4.07 (s, 3H), 4.09 (s, 3H), 6.62 (d, J=5.61 Hz, 1H), 7.25-7.27 (m, 1H), 7.32-7.35 (m, 1H), 7.46-7.50 (m, 1H), 7.57-7.58 (m, 2H), 7.63 (s, 1H), 7.88-7.90 (m, 2H), 8.53 (d, J=5.61 Hz, 1H), 8.86 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 498 (M++1)
- (Diethylamino)methanoyl isothiocyanate was prepared using commercially available N,N-diethylcarbamic chloride (80 mg) as a starting compound according to the description of the literature. (Diethylamino)methanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (42 mg, yield 55%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.26-1.29 (m, 6H), 3.93 (s, 3H), 3.95 (s, 3H), 4.22-4.24 (m, 4H), 6.54 (d, J=5.12 Hz, 1H), 7.11 (m, 2H), 7.29-7.31 (m, 2H), 7.41 (s, 1H), 7.50 (s, 1H), 7.73 (m, 2H), 8.52 (d, J=5.12 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 455 (M++1)
- [Di(2-chloroethyl)amino]methanoyl isothiocyanate was prepared using commercially available N,N-di(2-chloroethyl)carbamic chloride (80 mg) as a starting compound according to the description of the literature. [Di(2-chloroethyl)amino]methanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (48 mg, yield 55%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.57-3.62 (m, 4H), 3.80-3.82 (m, 2H), 3.95 (s, 3H), 3.97 (s, 3H), 4.11-4.13 (m, 2H), 7.55 (m, 1H), 7.29-7.31 (m, 2H), 7.42 (s, 1H), 7.55 (s, 1H), 7.73-7.75 (m, 3H), 8.57 (d, J=5.37 Hz, 1H), 12.25 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 524 (M++1)
- (Diisopropylamino)methanoyl isothiocyanate was prepared using commercially available N,N-diisopropylcarbamic chloride (80 mg) as a starting compound according to the description of the literature. (Diisopropylamino)methanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (50 mg, yield 62%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.19 (d, J=6.10 Hz, 2H), 1.27 (d, J=6.83 Hz, 12H), 3.94 (s, 3H), 3.96 (s, 3H), 6.39 (d, J=5.12 Hz, 1H), 7.42-7.46 (m, 4H), 7.53 (s, 2H), 7.64 (m, 1H), 8.13 (m, 1H), 8.49 (d, J=4.88 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 483 (M++1)
- 1-Pyrrolidinecarbonyl isothiocyanate was prepared using commercially available 1-pyrrolidinecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 1-Pyrrolidinecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (48 mg, yield 63%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.85 (m, 8H), 3.92 (s, 3H), 3.94 (s, 3H), 6.52 (d, J=4.88 Hz, 1H), 7.27 (d, J=7.81 Hz, 2H), 7.39 (s, 1H), 7.49 (s, 1H), 7.75 (m, 2H), 8.49 (d, J=5.13 Hz, 1H), 9.59 (s, 1H), 12.80 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 453 (M++1)
- 4-Morpholinecarbonyl isothiocyanate was prepared using commercially available 4-morpholinecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-Morpholinecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (49 mg, yield 62%).
- 1H-NMR (CDCl3, 400 MHz): δ 3.53-3.55 (m, 4H), 3.74-3.78 (m, 4H), 4.05 (s, 3H), 4.07 (s, 3H), 6.58 (d, J=5.61 Hz, 1H), 7.21 (d, J=8.78 Hz, 2H), 7.26 (s, 1H), 7.54 (d, J=4.88 Hz, 2H), 7.76 (d, J=9.03 Hz, 2H), 7.98 (bs, 1H), 8.51 (d, J=5.37 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 469 (M++1)
- (Methylanilino)methanoyl isothiocyanate was prepared using commercially available N-methyl-N-phenylcarbamic chloride (80 mg) as a starting compound according to the description of the literature. (Methylanilino)methanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (52 mg, yield 63%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.57 (bs, 3H), 3.93 (s, 3H), 3.94 (s, 3H), 6.43 (d, J=5.37 Hz, 1H), 7.13-7.16 (m, 2H), 7.26-7.28 (m, 1H), 7.34-7.45 (m, 6H), 7.51 (s, 1H), 7.57 (d, J=9.03 Hz, 2H), 8.31 (s, 1H), 8.46 (d, J=5.37 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 489 (M++1)
- 10,11-Dihydro-5H-dibenzo(b,f)azepine-5-carbonyl isothiocyanate was prepared using commercially available 10,11-dihydro-5H-dibenzo(b,f)azepine-5-carbonyl chloride (80 mg) as a starting compound according to the description of the literature. 10,11-Dihydro-5H-dibenzo(b,f)azepine-5-carbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (61 mg, yield 65%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.86 (m, 2H), 1.25 (m, 2H), 3.94 (s, 3H), 3.95 (s, 3H), 6.49 (d, J=5.37 Hz, 1H), 7.35-7.56 (m, 12H), 8.02 (m, 1H), 8.49-8.51 (m, 2H), 12.36 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 595 (M++1)
- (Diethylamino)methanoyl isothiocyanate was prepared using commercially available N,N-diethylcarbamic chloride (80 mg) as a starting compound according to the description of the literature. (Diethylamino)methanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (52 mg, yield 38%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.29 (t, J=7.19 Hz, 6H), 3.95 (s, 6H), 4.23-4.25 (m, 4H), 6.39 (d, J=5.12 Hz, 1H), 7.41 (s, 1H), 7.45 (d, J=8.78 Hz, 1H), 7.52 (s, 1H), 7.65 (m, 2H), 8.09 (m, 1H), 8.49 (d, J=5.61 Hz, 1H), 11.37 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 489 (M++1)
- [Di(2-chloroethyl)amino]methanoyl isothiocyanate was prepared using commercially available N,N-di(2-chloroethyl)carbamic chloride (80 mg) as a starting compound according to the description of the literature. [Di(2-chloroethyl)amino]methanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (51 mg, yield 60%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.55-3.63 (m, 4H), 3.81-3.84 (m, 2H), 3.95 (s, 6H), 4.11-4.15 (m, 2H), 6.41 (d, J=5.12 Hz, 1H), 7.40-7.44 (m, 3H), 7.52 (s, 1H), 7.61-7.63 (m, 1H), 8.09-8.12 (m, 1H), 8.49 (d, J=5.12 Hz, 1H), 12.29 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 558 (M++1)
- (Diisopropylamino)methanoyl isothiocyanate was prepared using commercially available N,N-diisopropylcarbamic chloride (80 mg) as a starting compound according to the description of the literature. (Diisopropylamino)methanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (49 mg, yield 63%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.18 (d, J=6.01 Hz, 2H), 1.27 (d, J=6.83 Hz, 12H), 3.93 (s, 3H), 3.95 (s, 3H), 6.53 (d, J=5.12 Hz, 1H), 7.28 (d, J=8.78 Hz, 2H), 7.41 (s, 1H), 7.50 (s, 1H), 7.73-7.75 (m, 3H), 8.51 (d, J=5.12 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 518 (M++1)
- 1-Pyrrolidinecarbonyl isothiocyanate was prepared using commercially available 1-pyrrolidinecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 1-Pyrrolidinecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (52 mg, yield 70%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.85-1.99 (m, 8H), 3.95 (s, 6H), 6.41 (d, J=5.37 Hz, 1H), 7.42 (s, 1H), 7.46 (d, J=8.54 Hz, 1H), 7.53 (s, 1H), 7.64-7.66 (m, 2H), 8.17-8.19 (m, 2H), 8.50 (d, J=5.37 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 487 (M++1)
- 4-Morpholinecarbonyl isothiocyanate was prepared using commercially available 4-morpholinecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-Morpholinecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (40 mg, yield 52%).
- 1H-NMR (CDCl3, 400 MHz): δ 3.53-3.56 (m, 4H), 3.75-3.77 (m, 4H), 4.08 (s, 3H), 4.10 (s, 3H), 5.77 (bs, 1H), 6.49 (d, J=5.61 Hz, 1H), 7.26-7.29 (m, 1H), 7.63 (s, 1H), 7.68-7.70 (m, 2H), 8.01 (s, 1H), 8.04 (d, J=2.44 Hz, 1H), 8.52 (d, J=5.85 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 503 (M++1)
- (Methylanilino)methanoyl isothiocyanate was prepared using commercially available N-methyl-N-phenylcarbamic chloride (80 mg) as a starting compound according to the description of the literature. (Methylanilino)methanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (56 mg, yield 71%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.57 (bs, 3H), 3.94 (s, 6H), 6.32 (d, J=5.12 Hz, 1H), 7.28-7.44 (m, 8H), 7.52-7.58 (m, 2H), 7.56 (s, 1H), 8.46-8.48 (m, 2H)
- Mass spectrometry value (ESI-MS, m/z): 524 (M++1)
- 10,11-Dihydro-5H-dibenzo(b,f)azepine-5-carbonyl isothiocyanate was prepared using commercially available 10,11-dihydro-5H-dibenzo(b,f)-azepine-5-carbonyl chloride (80 mg) as a starting compound according to the description of the literature. 10,11-Dihydro-5H-dibenzo(b,f)azepine-5-carbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]-aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (46 mg, yield 50%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.86 (m, 2H), 1.25 (m, 2H), 3.94 (s, 3H), 3.95 (s, 3H), 6.39 (d, J=5.12 Hz, 1H), 7.35 (m, 6H), 7.41 (s, 1H), 7.45 (d, J=8.78 Hz, 1H), 7.51 (s, 1H), 7.56-7.57 (m, 2H), 7.68 (dd, J=2.44 Hz, 9.03 Hz, 1H), 8.14 (s, 1H), 8.49 (d, J=5.12 Hz, 1H), 8.53 (s, 1H), 12.29 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 612 (M++1)
- 2-Phenyl-1-cyclopropanecarbonyl isothiocyanate was prepared using commercially available 2-phenyl-1-cyclopropanecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2-Phenyl-1-cyclopropanecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (53 mg, yield 63%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.09 (m, 1H), 1.52 (m, 2H), 1.59 (m, 2H), 3.94 (s, 3H), 3.96 (s, 3H), 6.59 (d, J=5.37 Hz, 1H), 7.19-7.32 (m, 5H), 7.41 (m, 2H), 7.52 (m, 2H), 7.78-7.80 (m, 3H), 8.54 (m, 1H)
- Mass spectrometry value (ESI-MS, m/z): 500 (M++1)
- 1-Cyclopropanecarbonyl isothiocyanate was prepared using commercially available 1-cyclopropanecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 1-Cyclopropanecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (46 mg, yield 66%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.96-0.99 (m, 4H), 2.08-2.13 (m, 2H), 3.95 (s, 6H), 6.72 (d, J=5.12 Hz, 1H), 7.41 (s, 1H), 7.45-7.52 (m, 2H), 8.04 (d, J=11.95 Hz, 1H), 8.50 (d, J=5.12 Hz, 1H), 11.89 (s, 1H), 12.64 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 442 (M++1)
- 2-Phenyl-1-cyclopropanecarbonyl isothiocyanate was prepared using commercially available 2-phenyl-1-cyclopropanecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2-Phenyl-1-cyclopropanecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (51 mg, yield 62%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.08-1.25 (m, 1H), 1.53 (m, 2H), 1.59-1.62 (m, 2H), 3.95 (s, 6H), 6.49 (d, J=5.12 Hz, 1H), 7.19-7.55 (m, 8H), 8.05 (d, J=10.00 Hz, 1H), 8.50 (d, J=5.37 Hz, 1H), 11.88 (s, 1H), 12.62 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 518 (M++1)
- 1-Cyclopropanecarbonyl isothiocyanate was prepared using commercially available 1-cyclopropanecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 1-Cyclopropanecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (36 mg, yield 52%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.93-0.99 (m, 4H), 2.12 (m, 2H), 3.94 (s, 3H), 3.96 (s, 3H), 6.41 (d, J=5.37 Hz, 1H), 7.33 (d, J=11.95 Hz, 1H), 7.41 (s, 1H), 7.45 (d, J=8.78 Hz, 1H), 7.52 (s, 1H), 7.64-7.67 (m, 1H), 8.14 (s, 1H), 8.49 (d, J=5.37 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 458 (M++1)
- 2-Phenyl-1-cyclopropanecarbonyl isothiocyanate was prepared using commercially available 2-phenyl-1-cyclopropanecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2-Phenyl-1-cyclopropanecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (48 mg, yield 60%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.09-1.11 (m, 1H), 1.53 (m, 2H), 1.60 (m, 2H), 3.94 (s, 3H), 3.96 (s, 3H), 6.40 (d, J=5.37 Hz, 1H), 7.16-7.34 (m, 5H), 7.41 (s, 1H), 7.45 (d, J=8.78 Hz, 1H), 7.52 (s, 1H), 7.67 (dd, J=2.32 Hz, 8.91 Hz, 1H), 8.14 (d, J=2.44 Hz, 1H), 8.49 (d, J=5.12 Hz, 1H), 11.88 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 535 (M++1)
- 2-Phenyl-1-cyclopropanecarbonyl isothiocyanate was prepared using commercially available 2-phenyl-1-cyclopropanecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2-Phenyl-1-cyclopropanecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (50 mg, yield 60%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.93-0.97 (m, 1H), 1.31 (m, 1H), 1.52-1.60 (m, 2H), 3.98 (s, 6H), 6.55 (d, J=5.61 Hz, 1H), 7.18-7.33 (m, 5H), 7.45 (s, 1H), 7.56 (d, J=8.54 Hz, 1H), 7.59 (s, 1H), 7.69 (m, 1H), 8.17-8.19 (m, 1H), 8.60 (d, J=5.91 Hz, 1H), 11.88 (s, 1H), 12.59 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 501 (M++1)
- 1-Cyclopentanecarbonyl isothiocyanate was prepared using commercially available 1-cyclopentanecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 1-Cyclopentanecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (43 mg, yield 57%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.85-0.88 (m, 1H), 1.08-1.11 (m, 1H), 1.24 (bs, 1H), 1.57-1.91 (m, 6H), 3.93 (s, 3H), 3.95 (s, 3H), 6.54 (d, J=5.37 Hz, 1H), 7.19 (d, J=8.78 Hz, 1H), 7.29 (d, J=8.78 Hz, 2H), 7.39 (d, J=7.81 Hz, 1H), 7.50 (d, J=5.61 Hz, 1H), 7.73-7.78 (m, 3H), 8.51 (d, J=5.37 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 452 (M++1)
- 1-Cyclohexanecarbonyl isothiocyanate was prepared using commercially available 1-cyclohexanecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 1-Cyclohexanecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (60 mg, yield 47%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.21-1.38 (m, 6H), 1.66-1.85 (m, 5H), 3.92 (s, 3H), 3.95 (s, 3H), 6.54 (d, J=5.12 Hz, 1H), 7.28 (d, J=9.03 Hz, 3H), 7.39 (s, 1H), 7.49 (s, 1H), 7.76 (d, J=8.78 Hz, 1H), 8.50 (d, J=5.12 Hz, 1H), 11.41 (bs, 1H), 12.56 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 466 (M++1)
- 1-Cyclopentanecarbonyl isothiocyanate was prepared using commercially available 1-cyclopentanecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 1-Cyclopentanecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (35 mg, yield 47%).
- 1H-NMR (CDCl3, 400 MHz): δ 0.879 (m, 1H), 1.08 (m, 1H), 1.17 (m, 1H), 1.63-1.97 (m, 6H), 4.07 (s, 3H), 4.09 (s, 3H), 6.86 (d, J=6.01 Hz, 1H), 7.16 (dd, J=9.52 Hz, 22.93 Hz, 1H), 7.63 (s, 1H), 7.69 (s, 2H), 8.56 (m, 1H), 8.68 (d, J=6.34 Hz, 1H), 11.47 (bs, 1H), 12.88 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 470 (M++1)
- 1-Cyclohexanecarbonyl isothiocyanate was prepared using commercially available 1-cyclohexanecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 1-Cyclohexanecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (47 mg, yield 61%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.21-1.39 (m, 6H), 1.66-1.90 (m, 5H), 3.92 (s, 3H), 3.95 (s, 3H), 6.64 (d, J=5.12 Hz, 1H), 7.12 (d, J=8.78 Hz, 1H), 7.35 (dd, J=2.55 Hz, 11.10 Hz, 1H), 7.41 (s, 1H), 7.45 (s, 1H), 8.09 (t, J=8.79 Hz, 1H), 8.53 (d, J=5.37 Hz, 1H), 11.57 (s, 1H), 12.42 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 484 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 3-ethoxypropanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 3-ethoxypropanoyl isothiocyanate was prepared using the resultant 3-ethoxypropanoyl chloride as a starting compound according to the description of the literature. 3-Ethoxypropanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (55 mg, yield 72%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.92-0.95 (m, 3H), 2.74 (m, 2H), 3.44-3.46 (m, 2H), 3.64-3.65 (m, 2H), 3.95 (s, 3H), 3.96 (s, 3H), 6.44 (d, J=5.37 Hz, 1H), 7.43 (s, 1H), 7.49 (d, J=8.78 Hz, 2H), 7.54 (s, 1H), 7.70 (m, 1H), 8.16 (m, 1H), 8.53 (d, J=5.12 Hz, 1H), 11.71 (s, 1H), 12.32 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 456 (M++1)
- 4-Chlorobutanoyl isothiocyanate was prepared using commercially available 4-chlorobutanoyl chloride (80 mg) as a starting compound according to the description of the literature. 4-Chlorobutanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (51 mg, yield 67%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.02-2.05 (m, 2H), 2.63-2.67 (m, 2H), 3.67-3.70 (m, 2H), 3.93 (s, 3H), 3.96 (s, 3H), 6.66 (d, J=5.37 Hz, 1H), 7.14 (d, J=6.59 Hz, 1H), 7.36-7.38 (m, 1H), 7.42 (s, 1H), 7.47 (s, 1H), 8.08 (t, J=8.78 Hz, 1H), 8.56 (d, J=5.37 Hz, 1H), 11.71 (s, 1H), 12.32 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 479 (M++1)
- 3-(Methylsulfanyl)propanoyl isothiocyanate was prepared using commercially available 3-(methylsulfanyl)propanoyl chloride (80 mg) as a starting compound according to the description of the literature. 3-(Methylsulfanyl)propanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (43 mg, yield 57%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.74-2.76 (m, 2H), 2.79-2.81 (m, 2H), 3.17 (s, 3H), 3.92 (s, 3H), 3.96 (s, 3H), 6.65 (d, J=5.12 Hz, 1H), 7.14 (d, J=9.27 Hz, 1H), 7.35-7.38 (m, 1H), 7.42 (s, 1H), 7.46 (s, 1H), 8.08 (t, J=8.90 Hz, 1H), 8.55 (d, J=5.12 Hz, 1H), 11.71 (s, 1H), 12.34 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 476 (M++1)
- 4-Chlorobutanoyl isothiocyanate was prepared using commercially available 4-chlorobutanoyl chloride (80 mg) as a starting compound according to the description of the literature. 4-Chlorobutanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-3-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (41 mg, yield 54%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.02-2.06 (m, 2H), 2.63-2.67 (m, 2H), 3.68-3.71 (m, 2H), 3.97 (s, 3H), 3.98 (s, 3H), 6.63 (d, J=5.61 Hz, 1H), 7.44-7.59 (m, 6H), 8.07 (d, J=11.95 Hz, 1H), 8.59 (d, J=5.61 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 478 (M++1)
- 3-(Methylsulfanyl)propanoyl isothiocyanate was prepared using commercially available 3-(methylsulfanyl)propanoyl chloride (80 mg) as a starting compound according to the description of the literature. 3-(Methylsulfanyl)propanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-3-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (38 mg, yield 50%).
- 1H-NMR (DMSO-d6, 400 MHz): 2.54 (s, 3H), 2.74-2.81 (m, 4H), 3.95 (s, 6H), 6.51 (d, J=5.12 Hz, 1H), 7.41 (s, 1H), 7.48-7.53 (m, 3H), 8.04 (d, J=10.49 Hz, H), 8.50 (d, J=5.12 Hz, 1H), 11.64 (s, 1H), 12.59 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 476 (M++1)
- 3,4-Dimethoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3,4-dimethoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3,4-dimethoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (54 mg, yield 63%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.79 (s, 3H), 3.81 (s, 3H), 3.96 (s, 3H), 5.47 (bs, 1H), 6.38 (bs, 1H), 6.44-6.47 (m, 1H), 6.54 (dd, J=2.52 Hz, J=14.79 Hz, 1H), 7.02-7.08 (m, 3H), 7.37 (s, 1H), 7.43 (s, 2H), 7.49 (s, 1H), 7.53-7.57 (m, 2H), 8.46 (d, J=5.12 Hz, 1H), 12.64 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 538 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 3-ethoxypropanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 3-ethoxypropanoyl isothiocyanate was prepared using the resultant 3-ethoxypropanoyl chloride as a starting compound according to the description of the literature. 3-Ethoxypropanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (46 mg, yield 62%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.06-1.13 (m, 3H), 2.72-2.75 (m, 2H), 3.44-3.47 (m, 2H), 3.64-3.67 (m, 2H), 3.95 (s, 3H), 3.97 (s, 3H), 6.63 (d, J=5.37 Hz, 1H), 7.29 (d, J=8.54 Hz, 2H), 7.44 (s, 1H), 7.56 (s, 1H), 7.78-7.82 (m, 2H), 8.59 (d, J=5.61 Hz, 1H), 11.51 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 490 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available dodecanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and dodecanoyl isothiocyanate was prepared using the resultant dodecanoyl chloride as a starting compound according to the description of the literature. Dodecanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (58 mg, yield 60%).
- 1H-NMR (CDCl3, 400 MHz): δ 0.87-0.89 (m, 3H), 1.27 (m, 14H), 1.71-1.72 (m, 2H), 2.39-2.43 (m, 2H), 3.49 (s, 2H), 4.06 (s, 3H), 4.08 (s, 3H), 6.59 (d, J=5.61 Hz, 1H), 7.21-7.26 (m, 4H), 7.55 (s, 1H), 7.59 (s, 1H), 7.79 (d, J=8.98 Hz, 1H), 8.52 (d, J=5.61 Hz, 1H), 8.66 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 538 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available tetradecanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and tetradecanoyl isothiocyanate was prepared using the resultant tetradecanoyl chloride as a starting compound according to the description of the literature. Tetradecanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (58 mg, yield 60%).
- 1H-NMR (CDCl3, 400 MHz): δ 0.87-0.90 (m, 3H), 1.27 (m, 20H), 1.73 (m, 2H), 2.40-2.44 (m, 2H), 4.08 (s, 3H), 4.12 (s, 3H), 5.29 (s, 1H), 6.65 (d, J=6.09 Hz, 1H), 7.23-7.26 (m, 2H), 7.58 (s, 1H), 7.83-7.85 (m, 3H), 8.52 (d, J=6.09 Hz, 1H), 8.63 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 566 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-methylhexanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-methylhexanoyl isothiocyanate was prepared using the resultant 2-methylhexanoyl chloride as a starting compound according to the description of the literature. 2-Methylhexanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (54 mg, yield 68%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.86-0.89 (m, 4H), 1.10 (d, J=6.83 Hz, 3H), 1.27-1.32 (m, 5H), 2.74-2.76 (m, 1H), 3.94 (s, 3H), 3.96 (s, 3H), 6.58 (d, J=5.97 Hz, 1H), 7.31 (d, J=8.78 Hz, 2H), 7.42 (s, 1H), 7.52 (s, 1H), 7.78-7.82 (m, 3H), 8.55 (d, J=5.37 Hz, 1H), 11.50 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 468 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available dodecanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and dodecanoyl isothiocyanate was prepared using the resultant dodecanoyl chloride as a starting compound according to the description of the literature. Dodecanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (60 mg, yield 68%).
- 1H-NMR (CDCl3, 400 MHz): δ 0.86-0.89 (m, 6H), 1.26-1.27 (m, 6H), 1.56-1.64 (m, 11H), 4.09 (s, 3H), 4.17 (s, 3H), 6.78 (d, J=6.34 Hz, 1H), 7.08-7.13 (m, 2H), 7.26 (s, 1H), 7.59 (s, 1H), 8.12 (bs, 1H), 8.56 (d, J=6.34 Hz, 1H), 8.62 (m, 1H), 8.79 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 556 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available tetradecanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and tetradecanoyl isothiocyanate was prepared using the resultant tetradecanoyl chloride as a starting compound according to the description of the literature. Tetradecanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (58 mg, yield 63%).
- 1H-NMR (CDCl3, 400 MHz): δ 0.86-0.89 (m, 3H), 1.27 (m, 18H), 2.49 (m, 2H), 2.58-2.59 (m, 4H), 4.11 (s, 3H), 4.17 (s, 3H), 6.38 (m, 1H), 7.08-7.11 (m, 2H), 7.35 (s, 3H), 7.61-7.63 (m, 2H), 8.17 (m, 1H)
- Mass spectrometry value (ESI-MS, m/z): 584 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-methylhexanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-methylhexanoyl isothiocyanate was prepared using the resultant 2-methylhexanoyl chloride as a starting compound according to the description of the literature. 2-Methylhexanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (44 mg, yield 58%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.84-0.94 (m, 5H), 1.03-1.11 (m, 4H), 1.25-1.59 (m, 4H), 3.94 (s, 3H), 3.96 (s, 3H), 6.42 (d, J=5.37 Hz, 1H), 7.42 (s, 1H), 7.47 (d, J=8.78 Hz, 1H), 7.53 (s, 1H), 7.70-7.73 (m, 1H), 8.17-8.19 (m, 1H), 8.51 (d, J=5.12 Hz, 1H), 11.58 (s, 1H), 12.62 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 503 (M++1)
- Commercially available 2-chloro-1-benzenecarbonyl isothiocyanate (50 μl) was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (68 mg, yield 85%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.18 (s, 3H), 2.35 (s, 3H), 4.07 (s, 6H), 6.35 (d, J=5.37 Hz, 1H), 7.07 (d, J=8.54 Hz, 1H), 7.26 (s, 1H), 7.44-7.49 (m, 2H), 7.52-7.57 (m, 3H), 7.61 (s, 1H), 7.68 (d, J=7.32 Hz, 1H), 8.48 (d, J=5.37 Hz, 1H), 9.41 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 523 (M++1)
- Commercially available 3-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (64 mg, yield 83%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.24 (s, 3H), 2.34 (s, 3H), 2.47 (s, 3H), 4.07 (s, 6H), 6.35 (d, J=5.37 Hz, 1H), 7.06 (d, J=8.54 Hz, 1H), 7.26 (s, 1H), 7.43-7.49 (m, 3H), 7.55 (d, J=8.78 Hz, 1H), 7.61 (s, 1H), 7.71-7.74 (m, 2H), 8.48 (d, J=5.12 Hz, 1H), 9.23 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 502 (M++1)
- Commercially available 4-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (60 mg, yield 78%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.18 (s, 3H), 2.33 (s, 3H), 2.47 (s, 3H), 4.07 (s, 6H), 6.35 (d, J=5.37 Hz, 1H), 7.26 (s, 2H), 7.37 (d, J=7.81 Hz, 2H), 7.44 (s, 1H), 7.54 (d, J=8.78 Hz, 1H), 7.61 (s, 1H), 7.83 (d, J=8.29 Hz, 2H), 8.48 (d, J=5.37 Hz, 1H), 9.22 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 502 (M++1)
- Commercially available 4-nitro-1-benzenecarbonyl isothiocyanate (30 mg) was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (62 mg, yield 75%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.42 (s, 3H), 2.34 (s, 3H), 4.07 (s, 6H), 6.35 (d, J=5.12 Hz, 1H), 7.07 (d, J=8.54 Hz, 1H), 7.27 (s, 2H), 7.44 (s, 1H), 7.52 (d, J=8.54 Hz, 1H), 7.61 (s, 1H), 8.17 (d, J=9.03 Hz, 2H), 8.42 (d, J=9.03 Hz, 2H), 8.48 (d, J=5.12 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 533 (M++1)
- Commercially available 4-chloro-1-benzenecarbonyl isothiocyanate (50 μl) was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (55 mg, yield 68%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.19 (s, 3H), 2.33 (s, 3H), 4.06 (s, 6H), 6.35 (d, J=5.12 Hz, 1H), 7.06 (d, J=8.54 Hz, 1H), 7.26 (s, 1H), 7.44 (s, 1H), 7.51-7.56 (m, 3H), 7.61 (s, 1H), 7.89 (d, J=11.22 Hz, 2H), 8.48 (d, J=5.37 Hz, 1H), 9.22 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 523 (M++1)
- Commercially available 3-chloro-1-benzenecarbonyl isothiocyanate (50 μl) was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (70 mg, yield 87%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.19 (s, 3H), 2.33 (s, 3H), 4.07 (s, 6H), 6.35 (d, J=5.37 Hz, 1H), 7.06 (d, J=8.54 Hz, 1H), 7.26 (s, 1H), 7.44 (s, 1H), 7.49-7.54 (m, 2H), 7.61 (s, 1H), 7.65 (d, J=9.03 Hz, 1H), 7.80 (d, J=10.49 Hz, 1H), 7.95 (s, 1H), 8.48 (d, J=5.12 Hz, 1H), 9.24 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 523 (M++1)
- Comercially available 1-benzenecarbonyl isothiocyanate (50 μl) was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (50 mg, yield 67%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.19 (s, 3H), 2.34 (s, 3H), 4.07 (s, 6H), 6.35 (d, J=5.37 Hz, 1H), 7.06 (d, J=8.54 Hz, 1H), 7.26 (s, 1H), 7.44 (s, 1H), 7.49-7.61 (m, 4H), 7.67-7.70 (m, 1H), 7.94 (d, J=8.54 Hz, 2H), 8.48 (d, J=5.37 Hz, 1H), 9.27 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 488 (M++1)
- Commercially available 2-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (61 mg, yield 79%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.19 (s, 3H), 2.35 (s, 3H), 2.59 (s, 3H), 4.07 (s, 6H), 6.35 (d, J=5.37 Hz, 1H), 7.07 (d, J=8.78 Hz, 1H), 7.26 (s, 1H), 7.33-7.36 (m, 2H), 7.45-7.49 (m, 2H), 7.55-7.61 (m, 3H), 8.48 (d, J=5.12 Hz, 1H), 8.96 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 502 (M++1)
- 2,4-Dichloro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,4-dichloro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2,4-Dichloro-1-benzenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (60 mg, yield 69%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.19 (s, 3H), 2.37 (s, 3H), 3.35 (s, 6H), 6.70 (d, J=6.59 Hz, 1H), 7.11 (d, J=8.54 Hz, 1H), 7.34 (dd, J=1.95, 8.29 Hz, 1H), 7.45-7.48 (m, 2H), 7.56-7.72 (m, 5H), 8.54 (d, J=6.31 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 557 (M++1)
- 4-Methoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-methoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-Methoxy-1-benzenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (55 mg, yield 69%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.09 (s, 3H), 2.22 (s, 3H), 3.86 (s, 3H), 3.95 (s, 6H), 6.29 (d, J=5.37 Hz, 1H), 7.06-7.12 (m, 3H), 7.40-7.46 (m, 2H), 7.57 (s, 1H), 8.05 (d, J=9.03 Hz, 2H), 8.47 (d, J=5.37 Hz, 1H), 11.47 (bs, 1H), 3.95 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 518 (M++1)
- 2,4-Difluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,4-difluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2,4-Difluoro-1-benzenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (60 mg, yield 74%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.17 (s, 3H), 2.34 (s, 3H), 4.09 (s, 3H), 4.11 (s, 3H), 6.49 (d, J=6.59 Hz, 1H), 6.87-6.93 (m, 2H), 6.99-7.15 (m, 2H), 7.26-7.30 (m, 1H), 7.57-7.64 (m, 2H), 8.09-8.17 (m, 2H), 8.49 (d, J=6.58 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 524 (M++1)
- Commercially available 4-chloro-1-benzenecarbonyl isothiocyanate (50 μl) was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (46 mg, yield 56%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.29 (s, 3H), 4.04 (s, 3H), 4.06 (s, 3H), 6.59 (d, J=5.37 Hz, 1H), 7.09-7.12 (m, 2H), 7.26 (s, 1H), 7.44 (s, 1H), 7.53-7.58 (m, 3H), 7.83-7.89 (m, 3H), 8.53 (d, J=5.37 Hz, 1H), 9.19 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 509 (M++1)
- Commercially available 2-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (46 mg, yield 59%).
- 1H-NMR (CDCl31 400 MHz): δ 2.41 (s, 3H), 2.58 (s, 3H), 4.05 (s, 3H), 4.06 (s, 3H), 6.59 (d, J=5.37 Hz, 1H), 7.09-7.12 (m, 3H), 7.26 (s, 1H), 7.34-7.35 (m, 1H), 7.44 (s, 1H), 7.48 (t, J=7.56 Hz, 1H), 7.53 (s, 1H), 7.59 (d, J=7.81 Hz, 1H), 7.84 (d, J=8.54 Hz, 1H), 8.53 (d, J=5.12 Hz, 1H), 8.95 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 488 (M++1)
- 3-Fluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3-fluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Fluoro-1-benzenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (64 mg, yield 81%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.39 (s, 3H), 4.05 (s, 3H), 4.06 (s, 3H), 6.59 (d, J=5.37 Hz, 1H), 7.09-7.12 (m, 2H), 7.26 (s, 1H), 7.36-7.41 (m, 1H), 7.44 (s, 1H), 7.53-7.59 (m, 2H), 7.66-7.71 (m, 2H), 7.84 (d, J=8.29 Hz, 1H), 8.54 (d, J=5.12 Hz, 1H), 9.19 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- Commercially available 4-nitro-1-benzenecarbonyl isothiocyanate (30 mg) was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (41 mg, yield 49%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.39 (s, 3H), 4.05 (s, 3H), 4.06 (s, 3H), 6.59 (d, J=5.37 Hz, 1H), 7.11-7.13 (m, 2H), 7.26 (s, 2H), 7.44 (s, 1H), 7.52 (s, 1H), 7.83 (d, J=8.54 Hz, 1H), 8.13 (d, J=9.03 Hz, 2H), 8.42 (d, J=8.78 Hz, 2H), 8.54 (d, J=5.37 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 519 (M++1)
- 4-Fluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-fluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-Fluoro-1-benzenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (35 mg, yield 44%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.39 (s, 3H), 4.05 (s, 3H), 4.06 (s, 3H), 6.59 (d, J=5.37 Hz, 1H), 7.09-7.12 (m, 2H), 7.23-7.28 (m, 3H), 7.44 (s, 1H), 7.53 (s, 1H), 7.84 (d, J=8.29 Hz, 1H), 7.96-7.99 (m, 2H), 8.53 (d, J=5.37 Hz, 1H), 9.19 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- 2-Fluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2-fluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2-Fluoro-1-benzenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (41 mg, yield 52%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.39 (s, 3H), 4.05 (s, 3H), 4.06 (s, 3H), 6.59 (d, J=5.37 Hz, 1H), 7.09-7.12 (m, 2H), 7.24-7.29 (m, 3H), 7.39 (t, J=7.68 Hz, 1H), 7.44 (s, 1H), 7.53 (s, 1H), 7.64-7.69 (m, 1H), 7.86 (d, J=8.29 Hz, 1H), 8.12-8.16 (m, 1H), 8.53 (d, J=5.12 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 492 (M++1)
- 4-Methoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-methoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-Methoxy-1-benzenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (37 mg, yield 45%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.40 (s, 3H), 3.92 (s, 6H), 4.05 (s, 3H), 7.03-7.11 (m, 4H), 7.26 (s, 5H), 7.56 (s, 1H), 7.90-7.92 (m, 3H)
- Mass spectrometry value (ESI-MS, m/z): 504 (M++1)
- Commercially available 4-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (44 mg, yield 56%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.39 (s, 3H), 2.47 (s, 3H), 4.05 (s, 3H), 4.06 (s, 3H), 6.59 (d, J=5.37 Hz, 1H), 7.08-7.12 (m, 2H), 7.26 (s, 1H), 7.36 (d, J=7.81 Hz, 2H), 7.44 (s, 1H), 7.53 (s, 1H), 7.81-7.86 (m, 3H), 8.53 (d, J=5.12 Hz, 1H), 9.19 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 488 (M++1)
- Commercially available 2-chloro-1-benzenecarbonyl isothiocyanate (50 μl) was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (47 mg, yield 57%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.41 (s, 3H), 4.05 (s, 3H), 4.06 (s, 3H), 6.59 (d, J=5.12 Hz, 1H), 7.09-7.12 (m, 2H), 7.26 (s, 2H), 7.44-7.48 (m, 2H), 7.53-7.54 (m, 2H), 7.82 (d, J=7.08 Hz, 1H), 7.88 (d, J=8.54 Hz, 1H), 8.54 (d, J=5.12 Hz, 1H), 9.38 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 508 (M++1)
- Commercially available 3-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (32 mg, yield 40%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.39 (s, 3H), 2.47 (s, 3H), 4.05 (s, 3H), 4.06 (s, 3H), 6.59 (d, J=5.37 Hz, 1H), 7.09-7.12 (m, 2H), 7.26 (s, 1H), 7.44-7.49 (m, 3H), 7.53 (s, 1H), 7.71-7.74 (m, 2H), 7.87 (d, J=8.29 Hz, 1H), 8.53 (d, J=5.37 Hz, 1H), 9.21 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 488 (M++1)
- Commercially available 1-benzenecarbonyl isothiocyanate (50 μl) was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (44 mg, yield 58%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.39 (s, 3H), 4.05 (s, 3H), 4.06 (s, 3H), 6.59 (d, J=5.37 Hz, 1H), 7.09-7.12 (m, 3H), 7.25 (s, 1H), 7.44 (s, 1H), 7.53 (s, 1H), 7.58 (t, J=7.08 Hz, 2H), 7.68 (t, J=7.32 Hz, 1H), 7.86 (d, J=8.29 Hz, 2H), 7.94 (d, J=8.54 Hz, 1H), 9.23 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 474 (M++1)
- Commercially available 3-chloro-1-benzenecarbonyl isothiocyanate (50 μl) was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-methylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (41 mg, yield 50%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.39 (s, 3H), 4.05 (s, 3H), 4.06 (s, 3H), 6.59 (d, J=5.12 Hz, 1H), 7.09-7.12 (m, 2H), 7.27 (s, 1H), 7.44 (s, 1H), 7.49-7.54 (m, 2H), 7.65 (d, J=8.05 Hz, 1H), 7.79 (d, J=8.29 Hz, 1H), 7.85 (d, J=8.54 Hz, 1H), 7.95 (s, 1H), 8.53 (d, J=5.37 Hz, 1H), 9.19 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 508 (M++1)
- Commercially available 2-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was dissolved in ethanol (1 ml) to prepare a solution. 2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (40 mg, yield 52%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.64 (s, 3H), 3.92 (s, 3H), 3.93 (s, 3H), 6.60 (d, J=5.12 Hz, 1H), 7.19-7.21 (m, 2H), 7.34 (m, 2H), 7.41-7.47 (m, 3H), 7.52 (m, 2H), 8.16-8.20 (m, 1H), 8.52-8.53 (m, 2H)
- Mass spectrometry value (ESI-MS, m/z): 508 (M++1)
- Commercially available 4-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was dissolved in ethanol (1 ml) to prepare a solution. 2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (38 mg, yield 49%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.41 (s, 3H), 3.94 (s, 3H), 3.97 (s, 3H), 6.69 (d, J=5.37 Hz, 1H), 7.33-7.37 (m, 4H), 7.44 (s, 1H), 7.54 (s, 1H), 7.60 (d, J=2.68 Hz, 1H), 7.94 (d, J=8.29 Hz, 1H), 8.14 (d, J=9.03 Hz, 1H), 8.59 (d, J=5.37 Hz, 1H), 11.74 (s, 1H), 12.75 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 509 (M++1)
- 2-Methoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2-methoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2-Methoxy-1-benzenecarbonyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (36 mg, yield 45%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.95 (s, 3H), 3.96 (s, 3H), 4.04 (s, 3H), 6.42 (d, J=5.12 Hz, 1H), 7.18 (t, J=7.69 Hz, 1H), 7.30 (d, J=8.54 Hz, 1H), 7.41 (s, 1H), 7.48 (d, J=8.76 Hz, 1H), 7.52 (s, 1H), 7.68 (t, J=6.96 Hz, 1H), 7.76 (dd, J=2.56, 8.90 Hz, 1H), 7.94 (d, J=7.81 Hz, 1H), 8.20 (d, J=2.44 Hz, 1H), 8.49 (d, J=5.12 Hz, 1H), 11.29 (s, 1H), 12.62 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 525 (M++1)
- Commercially available 2-chloro-1-benzenecarbonyl isothiocyanate (50 μl) was dissolved in ethanol (1 ml) to prepare a solution. 2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (38 mg, yield 48%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.93 (s, 3H), 4.05 (s, 3H), 6.67 (d, J=5.12 Hz, 1H), 7.20 (d, J=7.81 Hz, 1H), 7.32-7.36 (m, 2H), 7.43 (s, 1H), 7.47 (s, 1H), 7.54-7.66 (m, 2H), 7.67 (d, J=6.59 Hz, 1H), 8.13 (d, J=8.78 Hz, 1H), 8.58 (d, J=5.12 Hz, 1H), 12.23 (s, 1H), 12.36 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 529 (M++1)
- 2-Phenylethanoyl isothiocyanate was prepared using commercially available 2-phenylethanoyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-phenylethanoyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (44 mg, yield 58%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.08 (s, 3H), 2.15 (s, 3H), 3.85 (s, 2H), 3.94 (s, 3H), 3.95 (s, 3H), 6.28 (d, J=5.12 Hz, 1H), 7.08 (d, J=8.54 Hz, 1H), 7.27-7.41 (m, 7H), 7.57 (s, 1H), 8.47 (d, J=5.37 Hz, 1H), 11.75 (bs, 1H), 12.01 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 502 (M++1)
- 3-Cyclopentylpropanoyl isothiocyanate was prepared using commercially available 3-cyclopentylpropanoyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Cyclopentylpropanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (32 mg, yield 41%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.11 (m, 2H), 1.49-1.61 (m, 7H), 1.63-1.79 (m, 4H), 3.92 (s, 3H), 3.93 (s, 3H), 6.65 (d, J=5.37 Hz, 1H), 7.31 (d, J=11.71 Hz, 1H), 7.47 (s, 1H), 7.48 (s, 1H), 7.58 (d, J=2.68 Hz, 1H), 8.12 (d, J=8.78 Hz, 1H), 8.56 (d, J=6.83 Hz, 1H), 11.67 (s, 1H), 12.53 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 515 (M++1)
- Commercially available 1-benzenecarbonyl isothiocyanate (50 μl) was dissolved in ethanol (1 ml) to prepare a solution. 2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (36 mg, yield 48%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.92 (s, 3H), 3.96 (s, 3H), 6.66 (d, J=5.37 Hz, 1H), 7.32 (d, J=8.78 Hz, 1H), 7.42 (s, 1H), 7.48 (s, 1H), 7.53-7.57 (m, 3H), 7.66-7.68 (m, 1H), 8.02 (d, J=8.54 Hz, 2H), 8.13 (d, J=9.03 Hz, 1H), 8.56 (d, J=5.37 Hz, 1H), 11.38 (s, 1H), 12.70 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 495 (M++1)
- Commercially available 4-nitro-1-benzenecarbonyl isothiocyanate (30 mg) was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-methylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (79 mg, yield 94%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.17 (s, 3H), 3.96 (s, 6H), 6.36 (d, J=5.12 Hz, 1H), 7.41 (s, 1H), 7.57 (s, 2H), 7.72 (bs, 2H), 8.19 (d, J=8.78 Hz, 2H), 8.29 (s, 1H), 8.36 (d, J=8.54 Hz, 2H), 8.48 (d, J=5.12 Hz, 2H)
- Mass spectrometry value (ESI-MS, m/z): 519 (M++1)
- Commercially available 1-benzenecarbonyl isothiocyanate (50 μl) was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-methylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (61 mg, yield 80%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.24 (s, 3H), 4.09 (s, 3H), 4.12 (s, 3H), 6.58 (d, J=6.09 Hz, 1H), 7.26 (s, 1H), 7.56-7.81 (m, 8H), 7.93 (d, J=7.32 Hz, 2H), 8.49 (d, J=5.86 Hz, 1H), 9.14 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 474 (M++1)
- Commercially available 3-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-methylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (65 mg, yield 83%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.17 (s, 3H), 2.41 (s, 3H), 3.96 (s, 6H), 6.37 (d, J=4.88 Hz, 1H), 7.33 (d, J=9.02 Hz, 1H), 7.41-7.48 (m, 4H), 7.56 (s, 1H), 7.72-7.85 (m, 3H), 8.48 (d, J=5.37 Hz, 1H), 11.53 (s, 1H), 12.67 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 488 (M++1)
- Commercially available 4-chloro-1-benzenecarbonyl isothiocyanate (50 μl) was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-methylaniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (52 mg, yield 64%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.24 (s, 3H), 4.08 (s, 3H), 4.09 (s, 3H), 6.44 (d, J=5.37 Hz, 1H), 7.17 (d, J=8.54 Hz, 1H), 7.26 (s, 1H), 7.55 (d, J=8.29 Hz, 3H), 7.62 (d, J=7.81 Hz, 3H), 7.71 (d, J=7.81 Hz, 1H), 7.87 (d, J=8.54 Hz, 1H), 8.49 (d, J=5.61 Hz, 1H), 9.11 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 508 (M++1)
- 2,6-Dichloro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,6-dichloro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2,6-dichloro-1-benzenecarbonyl in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (55 mg, yield 63%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.95 (s, 3H), 3.96 (s, 3H), 6.52 (d, J=5.12 Hz, 1H), 7.38-7.79 (m, 7H), 8.07-8.10 (m, 1H), 8.52 (d, J=5.12 Hz, 1H), 12.30 (bs, 1H), 12.43 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 547 (M++1)
- 2,4-Dimethoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,4-dimethoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2,4-dimethoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (45 mg, yield 53%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.87 (s, 3H), 3.90 (s, 3H), 3.96 (s, 3H), 4.06 (s, 3H), 6.52 (d, J=6.34 Hz, 1H), 6.79-6.81 (m, 2H), 7.43 (s, 2H), 7.50-7.55 (m, 1H), 7.64 (d, J=11.22 Hz, 1H), 7.99 (d, J=9.03 Hz, 1H), 8.11 (d, J=14.64 Hz, 1H), 8.52 (d, J=5.12 Hz, 1H), 11.09 (bs, 1H), 12.76 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 538 (M++1)
- 2,4-Dichloro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,4-dichloro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2,4-dichloro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (53 mg, yield 62%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.95 (s, 3H), 3.96 (s, 3H), 6.43 (d, J=5.12 Hz, 1H), 7.43-8.17 (m, 7H), 8.17 (bs, 1H), 8.52 (d, J=5.12 Hz, 1H), 12.13 (bs, 1H), 12.28 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 563 (M++1)
- 2,6-Dichloro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,6-dichloro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2,6-dichloro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (40 mg, yield 47%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.95 (s, 3H), 3.96 (s, 3H), 6.43 (d, J=5.37 Hz, 1H), 7.43 (s, 1H), 7.47-7.61 (m, 5H), 7.77-7.98 (m, 1H), 8.18-8.20 (m, 1H), 8.52 (d, J=5.12 Hz, 1H), 12.24 (bs, 1H), 12.43 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 563 (M++1)
- 3,5-Dichloro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3,5-dichloro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3,5-dichloro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (55 mg, yield 63%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.95 (s, 3H), 3.96 (s, 3H), 6.42 (d, J=4.64 Hz, 1H), 7.42 (s, 1H), 7.49 (d, J=8.78 Hz, 1H), 7.53 (s, 1H), 7.72-8.00 (m, 6H), 8.16 (bs, 1H), 8.50 (d, J=5.12 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 563 (M++1)
- 2,4-Dimethoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,4-dimethoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2,4-dimethoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (53 mg, yield 63%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.90 (s, 3H), 3.95 (s, 3H), 3.96 (s, 3H), 4.06 (s, 3H), 6.43 (d, J=5.12 Hz, 1H), 6.73-6.81 (m, 2H), 7.43 (s, 1H), 7.49-7.53 (m, 3H), 7.78 (dd, J=2.44 Hz, J=8.78 Hz, 1H), 8.12 (bs, 1H), 8.51 (d, J=5.12 Hz, 1H), 11.09 (bs, 1H), 12.69 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 555 (M++1)
- 2,6-Dichloro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,6-dichloro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2,6-dichloro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (57 mg, yield 64%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 4.09 (s, 3H), 4.13 (s, 3H), 6.69 (d, J=6.09 Hz, 1H), 7.11-7.44 (m, 6H), 7.62 (s, 1H), 7.79-7.98 (m, 3H), 8.52 (d, J=6.34 Hz, 1H), 8.81 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 529 (M++1)
- 2,4-Dimethoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,4-dimethoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2,4-dimethoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (42 mg, yield 48%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.90 (s, 3H), 3.93 (s, 3H), 3.95 (s, 3H), 4.06 (s, 3H), 6.56 (d, J=5.37 Hz, 1H), 6.79-6.81 (m, 2H), 7.33 (d, J=9.03 Hz, 2H), 7.41 (s, 1H), 7.50 (s, 1H), 7.84 (d, J=8.78 Hz, 2H), 8.01 (d, J=9.03 Hz, 1H), 8.52 (d, J=5.12 Hz, 1H), 11.05 (bs, 1H), 12.67 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 520 (M++1)
- 3,4-Dichloro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3,4-dichloro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3,4-dichloro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (56 mg, yield 63%).
- 1H-NMR (CDCl3, 400 MHz): δ 4.05 (s, 3H), 4.06 (s, 3H), 6.62 (d, J=5.37 Hz, 1H), 7.24 (s, 1H), 7.26 (s, 1H), 7.61-7.68 (m, 6H), 7.73 (m, 1H), 7.81 (d, J=9.03 Hz, 1H), 8.04 (d, J=1.95 Hz, 1H), 8.54 (d, J=5.12 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 529 (M++1)
- 2,4-Difluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,4-difluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2,4-difluoro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (56 mg, yield 68%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.93 (s, 3H), 3.96 (s, 3H), 6.66 (d, J=5.12 Hz, 1H), 7.13-7.84 (m, 7H), 8.04 (m, 1H), 8.56 (d, J=5.12 Hz, 1H), 11.95 (s, 1H), 12.18 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 514 (M++1)
- 3,5-Dichloro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3,5-dichloro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3,5-dichloro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (51 mg, yield 64%).
- Mass spectrometry value (ESI-MS, m/z): 547 (M++1)
- 2,4-Dimethoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,4-dimethoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2,4-dimethoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (54 mg, yield 67%).
- Mass spectrometry value (ESI-MS, m/z): 538 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 4-cyclohexylbenzoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 4-cyclohexyl-1-benzenecarbonyl isothiocyanate was prepared using the resultant 4-cyclohexyl-1-benzenecarbonyl chloride as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-cyclohexyl-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (44 mg, yield 48%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.31-1.83 (m, 11H), 3.93 (s, 3H), 3.95 (s, 3H), 6.56 (d, J=5.12 Hz, 1H), 7.31 (d, J=8.54 Hz, 3H), 7.39 (d, J=6.83 Hz, 4H), 7.49 (s, 1H), 7.83 (m, 3H), 7.95 (d, J=8.05 Hz, 3H), 8.50 (d, J=5.12 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 542 (M++1)
- 4-Phenyl-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-phenyl-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-phenyl-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (41 mg, yield 47%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.93 (s, 3H), 3.96 (s, 3H), 6.67 (d, J=5.12 Hz, 1H), 7.19 (m, 1H), 7.43-7.53 (m, 7H), 7.78 (d, J=7.81 Hz, 2H), 7.86 (d, J=8.19 Hz, 2H), 8.11-8.13 (m, 2H), 8.56 (d, J=5.37 Hz, 1H), 11.87 (s, 1H), 12.57 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 554 (M++1)
- 1,3-Benzodioxole-5-carbonyl isothiocyanate was prepared using commercially available 1,3-benzodioxole-5-carbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 1,3-benzodioxole-5-carbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (47 mg, yield 58%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.95 (s, 3H), 3.96 (s, 3H), 6.18 (s, 2H), 6.42 (d, J=5.12 Hz, 1H), 7.08 (d, J=8.48 Hz, 1H), 7.43 (s, 1H), 7.50 (d, J=8.78 Hz, 1H), 7.54 (s, 1H), 7.57 (s, 1H), 7.67 (d, J=8.29 Hz, 1H), 7.74 (d, J=9.03 Hz, 1H), 8.19 (bs, 1H), 8.51 (d, J=5.12 Hz, 1H), 11.49 (bs, 1H), 12.67 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 538 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 4-cyclohexylbenzoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 4-cyclohexyl-1-benzenecarbonyl isothiocyanate was prepared using the resultant 4-cyclohexyl-1-benzenecarbonyl chloride as a starting compound according to the description of the literature. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-cyclohexyl-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (47 mg, yield 54%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.31-1.83 (m, 11H), 3.95 (s, 6H), 6.41 (d, J=4.88 Hz, 1H), 7.39 (d, J=9.27 Hz, 4H), 7.47 (d, J=8.54 Hz, 1H), 7.73 (m, 1H), 7.95 (d, J=7.56 Hz, 2H), 8.21 (m, 1H), 8.49 (d, J=5.61 Hz, 1H), 11.54 (s, 1H), 12.74 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 577 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 4-octylbenzoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 4-octyl-1-benzenecarbonyl isothiocyanate was prepared using the resultant 4-octyl-1-benzenecarbonyl chloride as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-octyl-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (47 mg, yield 54%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.83-0.88 (m, 4H), 1.25-1.28 (m, 7H), 1.58-1.60 (m, 3H), 2.60-2.69 (m, 3H), 3.91 (s, 3H), 3.96 (s, 3H), 6.57 (d, J=5.12 Hz, 1H), 7.25 (d, J=8.05 Hz, 1H), 7.32-7.42 (m, 4H), 7.51 (s, 1H), 7.58 (s, 1H), 7.78 (d, J=8.05 Hz, 1H), 7.84-7.86 (m, 2H), 7.94 (d, J=8.05 Hz, 2H), 8.53 (d, J=5.37 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 572 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) was added to commercially available 3,5-dimethylbenzoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 3,5-dimethyl-1-benzenecarbonyl isothiocyanate was prepared using the resultant 3,5-dimethyl-1-benzenecarbonyl chloride as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3,5-dimethyl-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (39 mg, yield 47%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.37 (s, 6H), 3.95 (s, 3H), 3.96 (s, 3H), 6.41 (d, J=5.37 Hz, 1H), 7.29 (s, 1H), 7.41 (s, 1H), 7.47 (d, J=8.78 Hz, 1H), 7.53 (s, 1H), 7.63 (s, 2H), 7.71-7.74 (m, 2H), 8.19-8.20 (m, 1H), 8.50 (d, J=5.37 Hz, 1H), 11.54 (s, 1H), 12.72 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 488 (M++1)
- Commercially available 1,2,3,4-tetrahydroisoquinoline (50 mg) was dissolved in chloroform (10 ml), and triphosgene (111 mg) was added to the solution. The mixture was stirred at room temperature for 2 hr. The solvent was removed by distillation to give 1,2,3,4-tetrahydro-2-isoquinolinecarbonyl chloride. 1,2,3,4-Tetrahydro-2-isoquinolinecarbonyl isothiocyanate was prepared using this compound as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 1,2,3,4-tetrahydro-2-isoquinolinecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (78 mg, yield 94%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.81-2.89 (m, 4H), 3.92 (s, 3H), 3.94 (s, 3H), 4.87 (m, 2H), 6.52 (d, J=5.12 Hz, 1H), 7.13-7.28 (m, 4H), 7.39-7.49 (m, 4H), 7.73 (d, J=8.29 Hz, 2H), 8.49 (d, J=5.12 Hz, 1H), 10.18 (bs, 1H), 12.51 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 515 (M++1)
- 3-Cyclopentylpropanoyl isothiocyanate was prepared using commercially available 3-cyclopentylpropanoyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-cyclopentylpropanoyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (46 mg, yield 57%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.11 (m, 1H), 1.50-1.76 (m, 8H), 2.32-2.33 (m, 2H), 2.67-2.68 (m, 2H), 3.95 (s, 3H), 3.98 (s, 3H), 6.51 (d, J=4.39 Hz, 1H), 6.79 (d, J=2.68 Hz, 1H), 7.39-7.52 (m, 4H), 8.04 (d, J=12.20 Hz, 1H), 8.52 (d, J=5.37 Hz, 1H), 11.58 (bs, 1H), 12.65 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 480 (M++1)
- 3-Cyclopentylpropanoyl isothiocyanate was prepared using commercially available 3-cyclopentylpropanoyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-cyclopentylpropanoyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (37 mg, yield 46%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.28-1.32 (m, 1H), 1.48-1.63 (m, 5H), 1.73-1.79 (m, 3H), 2.32-2.33 (m, 2H), 2.67-2.68 (m, 2H), 3.98 (s, 3H), 3.99 (s, 3H), 7.34-7.39 (m, 3H), 7.58 (s, 2H), 7.71-7.75 (m, 2H), 8.57 (s, 2H), 11.48 (bs, 1H), 12.54 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 481 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 3-(2-methylphenyl)-propanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 3-(2-methylphenyl)propanoyl isothiocyanate was prepared using the resultant 3-(2-methylphenyl)propanoyl chloride as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-(2-methylphenyl)propanoyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (48 mg, yield 57%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.32 (s, 3H), 2.59-2.63 (m, 2H), 2.89-2.94 (m, 2H), 3.93 (s, 3H), 3.99 (s, 3H), 7.09-7.24 (m, 7H), 7.38 (s, 1H), 7.55 (s, 1H), 7.67 (d, J=8.78 Hz, 2H); 8.53 (s, 1H), 10.03 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 503 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 3-(2-methylphenyl)-propanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 3-(2-methylphenyl)propanoyl isothiocyanate was prepared using the resultant 3-(2-methylphenyl)propanoyl chloride as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-(2-methylphenyl)propanoyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (45 mg, yield 54%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.33 (s, 3H), 2.75-2.79 (m, 2H), 2.87-2.91 (m, 2H), 3.95 (s, 3H), 3.96 (s, 3H), 6.51 (d, J=5.12 Hz, 1H), 7.11-7.16 (m, 5H), 7.42 (s, 1H), 7.48-7.57 (m, 2H), 8.04 (d, J=14.63 Hz, 1H), 8.51 (d, J=5.37 Hz, 1H), 11.64 (s, 1H), 12.62 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 520 (M++1)
- 3-(Methylsulphenyl)propanoyl isothiocyanate was prepared using commercially available 3-(methylsulphenyl)propanoyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-(methylsulphenyl)propanoyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (41 mg, yield 56%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.05 (s, 3H), 2.73-2.82 (m, 4H), 4.02 (s, 3H), 4.04 (s, 3H), 6.84 (m, 1H), 7.35 (d, J=7.32 Hz, 1H), 7.45 (d, J=7.32 Hz, 1H), 7.53 (s, 1H), 7.73 (s, 1H), 7.86-7.90 (m, 4H), 8.79 (d, J=5.13 Hz, 1H)
- Mass spectrometry value (ESI-MS, m/z): 458 (M++1)
- 4-(Chloromethyl)-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-(chloromethyl)-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-(chloromethyl)-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (54 mg, yield 63%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.98 (s, 3H), 4.00 (s, 3H), 4.44 (s, 2H), 6.72 (d, J=5.86 Hz, 1H), 7.40 (d, J=8.54 Hz, 2H), 7.47 (s, 1H), 7.58-7.63 (m, 3H), 7.88-7.89 (m, 2H), 8.03 (d, J=8.29 Hz, 2H), 8.67 (d, J=5.61 Hz, 1H), 11.68 (bs, 1H), 12.62 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 508 (M++1)
- 4-(Chloromethyl)-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-(chloromethyl)-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]-aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-(chloromethyl)-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (52 mg, yield 63%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.99 (s, 3H), 4.00 (s, 3H), 4.45 (s, 2H), 6.62 (d, J=5.85 Hz, 1H), 7.48 (s, 1H), 7.57-7.65 (m, 4H), 7.82 (m, 1H), 8.03 (d, J=7.47 Hz, 2H), 8.25 (m, 1H), 8.66 (d, J=5.86 Hz, 1H), 11.77 (bs, 1H), 12.62 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 543 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(2-methylphenoxy)-acetic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(2-methylphenoxy)ethanoyl isothiocyanate was prepared using the resultant 2-(2-methylphenoxy)ethanoyl chloride as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-(2-methylphenoxy)ethanoyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (37 mg, yield 44%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.22 (s, 3H), 3.96 (s, 3H), 3.98 (s, 3H), 4.44 (s, 2H), 6.62 (d, J=8.78 Hz, 2H), 6.80-6.93 (m, 5H), 7.11-7.16 (m, 2H), 7.35 (s, 1H), 7.39 (bs, 1H), 7.52 (s, 1H), 8.51 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 505 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 4-phenylbutanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 4-phenylbutanoyl isothiocyanate was prepared using the resultant 4-phenylbutanoyl chloride as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-phenylbutanoyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (37 mg, yield 45%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.85-1.93 (m, 3H), 2.59-2.68 (m, 3H), 3.98 (s, 3H), 3.99 (s, 3H), 6.76 (d, J=8.78 Hz, 1H), 7.19-7.36 (m, 6H), 7.39 (s, 1H), 7.57 (s, 1H), 7.73 (d, J=8.78 Hz, 2H), 8.57 (s, 1H), 11.49 (s, 1H), 12.51 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 503 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 4-phenylbutanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 4-phenylbutanoyl isothiocyanate was prepared using the resultant 4-phenylbutanoyl chloride as a starting compound according to the description of the literature. N-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-N-ethylamine (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-phenylbutanoyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (45 mg, yield 56%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.15-1.19 (m, 3H), 1.52 (m, 2H), 2.04-2.09 (m, 2H), 2.21-2.33 (m, 2H), 3.85 (s, 3H), 3.94 (s, 3H), 4.21 (bs, 1H), 6.40 (d, J=5.12 Hz, 1H), 7.08-7.40 (m, 12H), 8.33 (d, J=4.88 Hz, 1H), 10.48 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 530 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 3-(2-methoxyphenyl)propanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 3-(2-methoxyphenyl)propanoyl isothiocyanate was prepared using the resultant 4-phenylbutanoyl chloride as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-(2-methoxyphenyl)propanoyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (37 mg, yield 43%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.73-2.77 (m, 2H), 2.85-2.89 (m, 2H), 3.92 (s, 3H), 3.98 (s, 3H), 3.99 (s, 3H), 6.87-6.91 (m, 2H), 6.97 (d, J=8.29 Hz, 1H), 7.17-7.23 (m, 1H), 7.36 (d, J=8.78 Hz, 2H), 7.39 (s, 1H), 7.57 (s, 1H), 7.73 (d, J=8.78 Hz, 2H), 8.57 (s, 1H), 11.51 (bs, 1H), 12.52 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 519 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 3-(2-methoxyphenyl)propanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 3-(2-methoxyphenyl)propanoyl isothiocyanate was prepared using the resultant 4-phenylbutanoyl chloride as a starting compound according to the description of the literature. N-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-N-ethylamine (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-(2-methoxyphenyl)propanoyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (44 mg, yield 52%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.19-1.18 (m, 3H), 2.32 (m, 2H), 2.52-2.54 (m, 2H), 3.72 (s, 3H), 3.93 (s, 3H), 3.97 (s, 3H), 6.51 (d, J=5.37 Hz, 1H), 6.82-6.85 (m, 1H), 6.91 (d, J=7.56 Hz, 1H), 6.95-6.99 (m, 1H), 7.00-7.19 (m, 7H), 7.42 (s, 1H), 7.53 (s, 1H), 8.42 (bs, 1H), 10.49 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 546 (M++1)
- 2-Phenyl-1-cyclopropanecarbonyl isothiocyanate was prepared using commercially available 2-phenyl-1-cyclopropanecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. N-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-N-ethylamine (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-phenyl-1-cyclopropanecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (43 mg, yield 53%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.60-1.19 (m, 3H), 1.23 (m, 2H), 1.91 (m, 2H), 1.91 (bs, 2H), 3.91 (s, 3H), 3.95 (s, 3H), 4.21 (m, 2H), 6.46 (d, J=5.12 Hz, 1H), 7.03 (d, J=7.56 Hz, 2H), 7.15-7.33 (m, 5H), 7.42 (s, 1H), 7.50 (s, 1H), 8.45 (d, J=5.37 Hz, 1H), 10.78 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 528 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(2-chlorophenoxy)-propanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(2-chlorophenoxy)propanoyl isothiocyanate was prepared using the resultant 2-(2-chlorophenoxy)propanoyl chloride as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-(2-chlorophenoxy)propanoyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (45 mg, yield 50%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.61 (d, J=6.59 Hz, 3H), 3.93 (s, 3H), 3.98 (s, 3H), 5.21-5.22 (m, 1H), 6.99-7.05 (m, 2H), 7.32-7.35 (m, 3H), 7.38 (s, 1H), 7.47 (d, J=8.05 Hz, 1H), 7.70-7.74 (m, 3H), 8.55 (s, 1H), 11.65 (bs, 1H), 12.09 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 540 (M++1)
- 1,3-Benzodioxole-5-carbonyl isothiocyanate was prepared using commercially available 1,3-benzodioxole-5-carbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-3-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 1,3-benzodioxole-5-carbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (62 mg, yield 75%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.95 (s, 3H), 3.96 (s, 3H), 6.18 (s, 2H), 6.52 (d, J=4.88 Hz, 1H), 7.09 (d, J=8.30 Hz, 1H), 7.43 (s, 1H), 7.49-7.61 (m, 4H), 7.67 (d, J=1.87 Hz, J=7.29 Hz, 1H), 8.08 (d, J=11.22 Hz, 1H), 8.52 (d, J=5.16 Hz, 1H), 11.49 (bs, 1H), 12.72 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 522 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 5-methyl-2-thiophenecarboxylic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 5-methyl-2-thiophenecarbonyl isothiocyanate was prepared using the resultant 5-methyl-2-thiophenecarbonyl chloride as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 5-methyl-2-thiophenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (42 mg, yield 52%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.51 (s, 3H), 4.01 (s, 6H), 6.78-6.82 (m, 1H), 6.96 (s, 1H), 6.99 (s, 1H), 7.53-7.65 (m, 3H), 7.91 (d, J=3.42 Hz, 1H), 8.14 (d, J=10.98 Hz, 1H), 8.24 (d, J=3.42 Hz, 1H), 8.71 (d, J=5.86 Hz, 1H), 11.66 (bs, 1H), 12.62 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 480 (M++1)
- 2-Phenylethanoyl isothiocyanate was prepared using commercially available 2-phenylethanoyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-phenylethanoyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (41 mg, yield 53%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.88 (s, 2H), 3.94 (s, 3H), 3.96 (s, 3H), 6.41 (d, J=5.12 Hz, 1H), 7.29-7.36 (m, 5H), 7.42 (s, 1H), 7.46 (d, J=8.78 Hz, 1H), 7.52 (s, 1H), 7.66-7.69 (m, 1H), 8.11-8.14 (m, 1H), 8.51 (d, J=5.12 Hz, 1H), 11.82 (s, 1H), 12.44 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 508 (M++1)
- 2-Phenylethanoyl isothiocyanate was prepared using commercially available 2-phenylethanoyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-phenylethanoyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (38 mg, yield 48%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.66 (s, 2H), 3.97 (s, 3H), 3.99 (s, 3H), 7.23-7.34 (m, 10H), 7.55 (s, 1H), 7.69 (d, J=9.03 Hz, 1H), 8.53 (s, 1H), 10.28 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 475 (M++1)
- 2-Phenylethanoyl isothiocyanate was prepared using commercially available 2-phenylethanoyl chloride (80 mg) as a starting compound according to the description of the literature. N-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]phenyl}-N-ethylamine (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-phenylethanoyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (38 mg, yield 48%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.13-1.19 (m, 3H), 3.44 (bs, 2H), 3.94 (s, 3H), 3.96 (s, 3H), 4.19 (bs, 2H), 6.55 (d, J=5.37 Hz, 1H), 7.06-7.11 (m, 3H), 7.19-7.34 (m, 6H), 7.42 (s, 1H), 7.47 (s, 1H), 8.53 (d, J=5.12 Hz, 1H), 10.74 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 502 (M++1)
- 3-Fluoro4-nitrophenol (300 mg), morpholine (800 μl), and calcium carbonate (50 mg) were added to dimethylformamide (3 ml), and the mixture was heated at 130° C. for 12 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give 3-morpholino-4-nitrophenol (400 mg, yield 94%). The resultant 3-morpholino-4-nitrophenol (400 mg) was added to dimethylformamide (3 ml). Palladium hydroxid-carbon (110 mg) and hydrogen were added thereto, and the mixture was stirred at room temperature for 4 hr. The reaction solution was filtered through Celite, and the filtrate was concentrated. The residue was then purified by chromatography on silica gel using chloroform/acetone for development to give 4-amino-3-morpholinophenol (296 mg, yield 85%). The resultant 4-amino-3-morpholinophenol (296 mg), 4-chloro-6,7-dimethoxyquinazoline (479 mg), and n-tetraethylammonium bromide (244 mg) were dissolved in ethyl methyl ketone (10 ml) to prepare a solution. A solution (10 ml) of sodium hydroxide (479 mg) in water was added to the solution, and the mixture was sitrred at 80° C. for 4 hr. Water was added to the reaction solution, and the organic layer was extracted and was concentrated. The residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (396 mg, yield 68%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.59-3.61 (m, 4H), 3.76-3.81 (m, 4H), 3.92 (s, 3H), 3.93 (s, 3H), 7.16 (s, 2H), 7.23 (s, 2H), 8.52 (s, 2H)
- Mass spectrometry value (ESI-MS, m/z): 383 (M++1)
- N-{4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]phenyl}-2-morpholinoaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 2-methyl-1-benzenecarbonyl isothiocyanate (50 μl) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (65 mg, yield 89%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.50 (s, 3H), 2.88-2.91 (m, 4H), 3.79-3.81 (m, 4H), 3.98 (s, 3H), 3.99 (s, 3H), 7.14 (d, J=11.22 Hz, 1H), 7.18 (s, 1H), 7.33 (d, J=9.76 Hz, 2H), 7.40 (s, 1H), 7.45 (t, J=7.40 Hz, 1H), 7.54 (d, J=7.56 Hz, 1H), 7.57 (s, 1H), 7.59 (s, 1H), 8.67 (d, J=12.93 Hz, 1H), 11.76 (s, 1H), 13.09 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 560 (M++1)
- 3-Pyridinecarbonyl isothiocyanate was prepared using commercially available 3-pyridinecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-pyridinecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (83 mg, yield 64%).
- 1H-NMR (CDCl3, 400 MHz): δ 3.95 (s, 3H), 4.06 (s, 3H), 6.57 (d, J=5.12 Hz, 1H), 7.24-7.27 (m, 3H), 7.45 (s, 1H), 7.51-7.54 (m, 2H), 7.82 (d, J=6.83 Hz, 2H), 8.21-8.24 (m, 1H), 8.53 (d, J=5.12 Hz, 1H), 8.89-8.91 (m, 1H), 9.18 (d, J=2.44 Hz, 1H), 9.22 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 461 (M++1)
- Commercially available 4-bromomethylbenzoic acid (300 mg) was dissolved in acetonitrile (10 ml). Potassium carbonate (30 mg) and morpholine (130 μl) were added to the solution, and the mixture was stirred at room temperature for one hr. The reaction layer was subjected to separation with chloroform and a saturated aqueous sodium hydrogencarbonate solution. The organic layer was then concentrated to give methyl 4-(morpholinomethyl)benzoate. Methanol (1 ml), water (150 μl), and potassium hydroxide (15 mg) were added to the residue, and the mixture was heated at 60° C. for one hr. After the completion of the reaction, the solvent was removed by distillation to give 4-(morpholinomethyl)benzoic acid. Toluene (20 ml) and thionyl chloride (1 ml) were added to the residule, and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 4-(morpholinomethyl)-1-benzenecarbonyl isothiocyanate was prepared using the resultant 4-(morpholinomethyl)-1-benzenecarbonyl chloride as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-(morpholinomethyl)-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (74 mg, yield 78%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.47 (s, 4H), 3.59 (s, 2H), 3.72-3.75 (m, 4H), 4.07 (s, 3H), 4.08 (s, 3H), 7.27 (s, 2H), 7.32-7.34 (m, 3H), 7.53-7.56 (m, 3H), 7.85-7.88 (m, 4H), 8.64 (s, 1H), 9.12 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 559 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 6-methylnicotinic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 6-methyl-3-pyridinecarbonyl isothiocyanate was prepared using the resultant 6-methyl-3-pyridinecarbonyl chloride as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 6-methyl-3-pyridinecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (71 mg, yield 89%).
- 1H-NMR (CDCl3, 400 MHz): δ 2.58 (s, 3H), 3.97 (s, 3H), 3.99 (s, 3H), 7.37-7.40 (m, 3H), 7.46 (d, J=8.29 Hz, 1H), 7.58 (s, 1H), 7.79 (d, J=8.78 Hz, 2H), 8.26 (dd, J=2.44 Hz, J=8.05 Hz, 1H), 8.59 (s, 1H), 9.00 (d, J=2.19 Hz, 1H), 11.82 (bs, 1H), 12.52 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 476 (M++1)
- 4-Pyridinecarbonyl isothiocyanate was prepared using commercially available 4-pyridinecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-pyridinecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (73 mg, yield 94%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.98 (s, 3H), 3.99 (s, 3H), 7.37-7.40 (m, 3H), 7.58 (s, 1H), 7.79 (d, J=8.78 Hz, 2H), 7.87 (d, J=6.09 Hz, 2H), 8.58 (s, 1H), 8.79 (d, J=6.09 Hz, 2H), 11.89 (bs, 1H), 12.34 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 462 (M++1)
- 2-Pyridinecarbonyl isothiocyanate was prepared using commercially available 2-pyridinecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-pyridinecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (69 mg, yield 90%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.98 (s, 3H), 3.99 (s, 3H), 7.39-7.42 (m, 3H), 7.58 (s, 1H), 7.81-7.84 (m, 3H), 8.16-8.20 (m, 1H), 8.28 (d, J=7.56 Hz, 1H), 8.58 (s, 1H), 8.82 (d, J=4.64 Hz, 1H), 10.85 (bs, 1H), 12.18 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 462 (M++1)
- 2-(Trifluoromethyl)-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2-(trifluoromethyl)-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-(trifluoromethyl)-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (49 mg, yield 56%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.99 (s, 3H), 4.02 (s, 3H), 7.38-7.40 (m, 2H), 7.59 (s, 1H), 7.76-7.88 (m, 7H), 8.58 (s, 1H), 12.14 (bs, 1H), 12.29 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 529 (M++1)
- 3,5-Dichloro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3,5-dichloro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3,5-dichloro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (40 mg, yield 45%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.98 (s, 3H), 3.99 (s, 3H), 7.37-7.40 (m, 4H), 7.58 (s, 1H), 7.67 (bs, 1H), 7.76-7.81 (m, 1H), 7.88 (s, 1H), 7.94 (s, 1H), 8.00 (s, 1H), 8.17 (bs, 1H), 8.58 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 530 (M++1)
- 3,5-Dichloro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3,5-dichloro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3,5-dichloro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (40 mg, yield 47%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.93 (s, 3H), 3.96 (s, 3H), 6.66 (d, J=4.88 Hz, 1H), 7.43 (s, 1H), 7.48 (s, 1H), 7.61 (s, 1H), 7.67 (s, 1H), 7.79 (s, 1H), 7.94-8.17 (m, 3H), 8.57 (d, J=5.12 Hz, 1H), 12.09 (bs, 1H), 12.42 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 563 (M++1)
- 2-Fluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2-fluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-fluoro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (68 mg, yield 86%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.95 (s, 3H), 3.96 (s, 3H), 6.52 (d, J=4.88 Hz, 1H), 7.35-7.40 (m, 2H), 7.43 (s, 1H), 7.50-7.55 (m, 2H), 7.61-7.73 (m, 2H), 7.75 (t, J=5.85 Hz, 1H), 8.07 (d, J=11.95 Hz, 1H), 8.52 (d, J=5.37 Hz, 1H), 11.85 (s, 1H), 12.43 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 496 (M++1)
- 2-Fluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2-fluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-fluoro-1-benzenecarbonyl isothiocyanate (50 μl) in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (43 mg, yield 53%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.98 (s, 3H), 3.99 (s, 3H), 7.34-7.40 (m, 5H), 7.58 (s, 1H), 7.60-7.79 (m, 4H), 8.58 (s, 1H), 11.74 (s, 1H), 12.32 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 479 (M++1)
- 2,6-Dichloro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,6-dichloro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2,6-dichloro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (56 mg, yield 63%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.98 (s, 3H), 3.99 (s, 3H), 7.39 (d, J=10.73 Hz, 3H), 7.47-7.61 (m, 4H), 7.79 (d, J=8.78 Hz, 2H), 8.59 (s, 1H), 12.22 (bs, 1H), 12.35 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 530 (M++1)
- 3-Fluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3-fluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-fluoro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (50 mg, yield 58%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.92 (s, 3H), 3.93 (s, 3H), 6.66 (d, J=5.12 Hz, 1H), 7.20 (s, 1H), 7.32-7.36 (m, 1H), 7.43 (s, 1H), 7.48 (s, 1H), 7.60-7.62 (m, 2H), 7.86 (d, J=9.03 Hz, 1H), 8.56 (d, J=5.12 Hz, 1H), 11.95 (bs, 1H), 12.55 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 512 (M++1)
- 3-Fluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3-fluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-fluoro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (60 mg, yield 75%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.98 (s, 3H), 3.99 (s, 3H), 7.37-7.40 (m, 3H), 7.52-7.55 (m, 1H), 7.58-7.61 (m, 2H), 7.78-7.86 (m, 4H), 8.58 (s, 1H), 12.05 (bs, 1H), 12.43 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 479 (M++1)
- 3-Bromo-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3-bromo-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3-bromo-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (56 mg, yield 58%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.46 (s, 3H), 3.92 (s, 3H), 6.61 (d, J=5.37 Hz, 1H), 7.19-7.22 (m, 1H), 7.32-7.36 (m, 1H), 7.48 (s, 1H), 7.52 (t, J=7.93 Hz, 1H), 7.61 (d, J=2.68 Hz, 1H), 7.88 (d, J=8.05 Hz, 1H), 7.99 (d, J=8.05 Hz, 1H), 8.09 (d, J=9.06 Hz, 1H), 8.21 (s, 1H), 8.56 (d, J=5.12 Hz, 1H), 12.02 (bs, 1H), 12.53 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 573 (M++1)
- 4-Bromo-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-bromo-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-bromo-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (57 mg, yield 63%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.93 (s, 3H), 3.96 (s, 3H), 6.55 (d, J=5.12 Hz, 1H), 7.33 (d, J=8.78 Hz, 2H), 7.41 (s, 1H), 7.51 (s, 1H), 7.77 (d, J=8.78 Hz, 2H), 7.82 (d, J=8.78 Hz, 2H), 7.93 (d, J=8.54 Hz, 2H), 8.52 (d, J=5.37 Hz, 1H), 11.65 (bs, 1H), 12.47 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 539 (M++1)
- 4-Bromo-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-bromo-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-bromo-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (46 mg, yield 53%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.92 (s, 3H), 3.93 (s, 3H), 6.66 (d, J=5.12 Hz, 1H), 7.20 (s, 1H), 7.32-7.36 (m, 1H), 7.43 (s, 1H), 7.48 (s, 1H), 7.60 (d, J=2.68 Hz, 1H), 7.78 (d, J=8.78 Hz, 1H), 7.95 (d, J=8.78 Hz, 1H), 8.56 (d, J=5.12 Hz, 1H), 11.96 (bs, 1H), 12.57 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 573 (M++1)
- 4-Bromo-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-bromo-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-bromo-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (53 mg, yield 58%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.98 (s, 3H), 3.99 (s, 3H), 7.37-7.40 (m, 3H), 7.58 (s, 1H), 7.76-7.92 (m, 4H), 7.94 (d, J=6.59 Hz, 2H), 8.58 (s, 1H), 11.72 (bs, 1H), 12.52 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 541 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 4-(bromomethyl)benzoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-[4-(bromomethyl)phenyl]ethanoyl isothiocyanate was prepared using the resultant 4-(bromomethyl)-1-benzenecarbonyl chloride as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-[4-(bromomethyl)phenyl]-ethanoyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (50 mg, yield 52%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.85 (s, 2H), 3.92 (s, 3H), 3.95 (s, 3H), 4.36 (s, 2H), 6.55 (d, J=5.12 Hz, 1H), 7.29 (d, J=9.03 Hz, 2H), 7.30-7.41 (m, 5H), 7.49 (s, 1H), 7.75 (d, J=8.78 Hz, 2H), 8.29 (d, J=5.37 Hz, 1H), 11.75 (bs, 1H), 12.39 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 567 (M++1)
- 5-Chloropentanoyl isothiocyanate was prepared using commercially available 5-chloropentanoyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 5-chloropentanoyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (46 mg, yield 58%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.49-2.55 (m, 6H), 3.36-3.69 (m, 2H), 3.93 (s, 3H), 3.96 (s, 3H), 7.34-7.39 (m, 3H), 7.58 (s, 1H), 7.73 (d, J=9.03 Hz, 2H), 8.58 (s, 1H), 11.49 (s, 1H), 12.50 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 475 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(2-thienyl)acetic acid (40 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(2-thienyl)ethanoyl isothiocyanate was prepared using the resultant 2-(2-thienyl)ethanoyl chloride as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-(2-thienyl)ethanoyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (44 mg, yield 54%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.96 (s, 3H), 3.98 (s, 3H), 4.07 (s, 2H), 6.64 (d, J=5.61 Hz, 1H), 6.96-7.03 (m, 6H), 7.33-7.38 (m, 1H), 7.45 (s, 1H), 7.78 (d, J=9.03 Hz, 1H), 8.61 (d, J=5.37 Hz, 1H), 11.75 (bs, 1H), 12.34 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 480 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-(2-thienyl) acetic acid (40 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-(2-thienyl)ethanoyl isothiocyanate was prepared using the resultant 2-(2-thienyl)ethanoyl chloride as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-(2-thienyl)ethanoyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (46 mg, yield 57%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.79 (s, 6H), 3.98 (d, J=6.34 Hz, 2H), 6.68 (d, J=9.03 Hz, 2H), 6.96-7.00 (m, 3H), 7.34-7.39 (m, 5H), 9.19 (s, 1H), 9.92 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 481 (M++1)
- 4-Methoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 4-methoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-methoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (36 mg, yield 46%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.92 (s, 9H), 7.09 (d, J=8.78 Hz, 1H), 7.19-7.22 (m, 3H), 7.31-7.36 (m, 2H), 7.43 (s, 1H), 7.48 (s, 1H), 8.06 (d, J=8.78 Hz, 1H), 8.12 (d, J=9.03 Hz, 1H), 8.53-8.57 (m, 1H), 11.52 (bs, 1H), 12.55 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 525 (M++1)
- 2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. Commercially available 4-chloro-1-benzenecarbonyl isothiocyanate was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (49 mg, yield 61%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.92 (s, 3H), 3.93 (s, 3H), 6.66 (d, J=5.12 Hz, 1H), 7.19-7.21 (m, 2H), 7.32-7.36 (m, 1H), 7.43 (s, 1H), 7.47 (s, 1H), 7.48 (s, 1H), 7.63 (d, J=8.78 Hz, 1H), 8.03 (d, J=8.78 Hz, 2H), 8.57 (d, J=5.12 Hz, 1H), 11.96 (bs, 1H), 12.57 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 529 (M++1)
- 2,4-Dimethoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,4-dimethoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2,4-dimethoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (51 mg, yield 58%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.90 (s, 3H), 3.98 (s, 3H), 3.99 (s, 3H), 4.07 (s, 3H), 6.79-6.81 (m, 2H), 7.37-7.40 (m, 3H), 7.58 (s, 1H), 7.79-7.81 (m, 2H), 8.00 (d, J=9.03 Hz, 1H), 8.58 (s, 1H), 11.01 (bs, 1H), 12.68 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 521 (M++1)
- 2,4-Dimethoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,4-dimethoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2-Chloro-4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2,4-dimethoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (40 mg, yield 48%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.93 (s, 3H), 3.96 (s, 3H), 4.05 (s, 3H), 4.06 (s, 3H), 6.66 (d, J=5.12 Hz, 1H), 6.78-6.81 (m, 2H), 7.36 (s, 1H), 7.43 (s, 1H), 7.48 (s, 1H), 7.61 (s, 1H), 8.01 (d, J=8.54 Hz, 1H), 8.19 (d, J=9.03 Hz, 1H), 8.56 (d, J=5.12 Hz, 1H), 11.18 (bs, 1H), 12.67 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 555 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 5-ethoxy-5-oxopentanoic acid (40 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and ethyl 5-isothiocyanat-5-oxopentanoate was prepared using the resultant ethyl 5-chloro-5-oxopentanoate as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of ethyl 5-isothiocyanat-5-oxopentanoate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (39 mg, yield 47%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.16-1.22 (m, 3H), 1.78-1.91 (m, 2H), 2.32-2.47 (m, 2H), 2.48-2.54 (m, 2H), 3.92 (s, 3H), 3.95 (s, 3H), 4.03-4.09 (m, 2H), 6.76 (d, J=8.78 Hz, 1H), 7.29-7.39 (m, 4H), 7.52 (s, 1H), 7.73 (d, J=5.37 Hz, 1H), 11.49 (s, 1H), 12.47 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 499 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 4-ethoxy-5-oxobutanoic acid (40 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and ethyl 4-isothiocyanat-4-oxobutanoate was prepared using the resultant ethyl 4-chloro-4-oxobutanoate as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of ethyl 4-isothiocyanat-4-oxobutanoate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (38 mg, yield 47%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.16-1.24 (m, 3H), 2.51-2.63 (m, 2H), 2.73-2.78 (m, 2H), 3.92 (s, 3H), 3.95 (s, 3H), 4.02-4.11 (m, 2H), 7.29-7.39 (m, 3H), 7.57 (s, 1H), 7.70-7.74 (m, 2H), 8.62 (s, 1H), 11.60 (s, 1H), 12.38 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 485 (M++1)
- 1-Cyclohexanecarbonyl isothiocyanate was prepared using commercially available 1-cyclohexanecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 1-Cyclohexanecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (44 mg, yield 58%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.16-1.41 (m, 6H), 1.66-1.85 (m, 4H), 2.55-2.61 (m, 1H), 3.94 (s, 3H), 3.95 (s, 3H), 6.41 (d, J=5.1 Hz, 1H), 7.42 (s, 1H), 7.46 (d, J=8.8 Hz, 1H), 7.52 (s, 1H), 7.68 (dd, J=2.2 Hz, 8.5 Hz, 1H), 8.15 (d, J=2.2 Hz, 1H), 8.50 (d, J=5.1 Hz, 1H), 11.51 (s, 1H), 12.59 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 500 (M++1)
- 1-Cyclohexanecarbonyl isothiocyanate was prepared using commercially available 1-cyclohexanecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 1-Cyclohexanecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (48 mg, yield 62%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.16-1.45 (m, 6H), 1.66-1.86 (m, 4H), 2.55-2.61 (m, 1H), 3.98 (s, 3H), 3.99 (s, 3H), 7.34 (d, J=15.6 Hz, 2H), 7.39 (s, 1H), 7.56 (s, 1H), 7.73 (d, J=9.0 Hz, 2H), 8.56 (s, 1H), 11.41 (s, 1H), 12.55 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 467 (M++1)
- 1-Cyclopropanecarbonyl isothiocyanate was prepared using commercially available 1-cyclopropanecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 1-Cyclopropanecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (51 mg, yield. 71%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.95-0.99 (m, 4H), 2.10-2.14 (m, 1H), 3.98 (s, 3H), 3.99 (s, 3H), 7.34 (d, J=9.0 Hz, 2H), 7.39 (s, 1H), 7.56 (s, 1H), 7.71 (d, J=8.8 Hz, 2H), 8.56 (s, 1H), 11.81 (s, 1H), 12.53 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z)
- 1-Cyclopentanecarbonyl isothiocyanate was prepared using commercially available 1-cyclopentanecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 1-Cyclopentanecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (38 mg, yield 52%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.56-1.76 (m, 6H), 1.88-1.90 (m, 2H), 2.97-3.03 (m, 1H), 3.94 (s, 3H), 3.96 (s, 3H), 6.40 (d, J=5.1 Hz, 1H), 7.42 (s, 1H), 7.46 (d, J=8.8 Hz, 1H), 7.52 (s, 1H), 7.68 (dd, J=2.7 Hz, 8.8 Hz, 1H), 8.15 (d, J=2.4 Hz, 1H), 8.50 (d, J=5.4 Hz, 1H), 11.56 (s, 1H), 12.60 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 486 (M++1)
- 1-Cyclopentanecarbonyl isothiocyanate was prepared using commercially available 1-cyclopentanecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 1-Cyclopentanecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by thin-layer chromatography using chloroform/acetone for development to give the title compound (24 mg, yield 31%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.55-1.90 (m, 8H), 2.99-3.03 (m, 1H), 3.98 (s, 3H), 3.99 (s, 3H), 7.34 (d, J=8.8 Hz, 2H), 7.39 (s, 1H), 7.57 (s, 1H), 7.73 (d, J=8.8 Hz, 2H), 8.56 (s, 1H), 11.47 (s, 1H), 12.56 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 453 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 3-(3-methylphenyl)propanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 3-(3-methylphenyl)propanoyl isothiocyanate was prepared using the resultant 3-(3-methylphenyl)propanoyl chloride as a starting compound according to the description of the literature. 3-(3-Methylphenyl)propanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (31 mg, yield 38%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.29 (s, 3H), 2.77-2.89 (m, 4H), 3.94 (s, 3H), 3.96 (s, 3H), 6.41 (d, J=5.4 Hz, 1H), 7.01-7.08 (m, 3H), 7.19 (t, J=7.6 Hz, 1H), 7.42 (s, 1H), 7.47 (d, J=8.8 Hz, 1H), 7.53 (s, 1H), 7.67 (dd, J=2.4 Hz, 8.5 Hz, 1H), 8.13 (d, J=2.7 Hz, 1H), 8.50 (d, J=5.1 Hz, 1H), 11.62 (s, 1H), 12.53 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 537 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 3-(3-methylphenyl)propanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 3-(3-methylphenyl)propanoyl isothiocyanate was prepared using the resultant 3-(3-methylphenyl)propanoyl chloride as a starting compound according to the description of the literature. 3-(3-Methylphenyl)propanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by thin-layer chromatography using chloroform/acetone for development to give the title compound (32 mg, yield 38%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.29 (S, 3H), 2.77-2.87 (m, 4H), 3.98 (s, 3H), 3.99 (s, 3H), 7.01-7.08 (m, 3H), 7.19 (t, J=7.6 Hz, 1H), 7.34 (d, J=8.8 Hz, 2H), 7.39 (s, 1H), 7.57 (s, 1H), 7.72 (d, J=8.8 Hz, 2H), 8.56 (s, 1H), 11.52 (s, 1H), 12.50 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 503 (M++1)
- 4-Chlorobutanoyl isothiocyanate was prepared using commercially available 4-chlorobutanoyl chloride (80 mg) as a starting compound according to the description of the literature. 4-Chlorobutanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by thin-layer chromatography using chloroform/acetone for development to give the title compound (30 mg, yield 38%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.04 (t, J=6.8 Hz, 2H), 2.65 (t, J=7.3 Hz, 2H), 3.70 (t, J=6.6 Hz, 2H), 3.98 (s, 3H), 3.99 (s, 3H), 7.35 (d, J=8.8 Hz, 2H), 7.39 (s, 1H), 7.57 (s, 1H), 7.72 (d, J=8.8 Hz, 2H), 8.56 (s, 1H), 11.55 (s, 1H), 12.45 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 461 (M++1)
- 2,2-Dimethylpropanoyl isothiocyanate was prepared using commercially available 2,2-dimethylpropanoyl chloride (80 mg) as a starting compound according to the description of the literature. 2,2-Dimethylpropanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by thin-layer chromatography using chloroform/acetone for development to give the title compound (31 mg, yield 43%).
- 1H-NMR (DMSO-d6, 400 MHz): 1.27 (s, 9H), 3.94 (s, 3H), 3.96 (s, 3H), 6.41 (d, J=5.1 Hz, 1H), 7.42 (s, 1H), 7.47 (d, J=8.8 Hz, 1H), 7.52 (s, 1H), 7.68 (dd, J=2.4 Hz, 8.8 Hz, 1H), 8.12 (s, 1H), 8.51 (d, J=5.1 Hz, 1H), 10.78 (s, 1H), 12.50 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 474 (M++1)
- 2,2-Dimethylpropanoyl isothiocyanate was prepared using commercially available 2,2-dimethylpropanoyl chloride (80 mg) as a starting compound according to the description of the literature. 2,2-Dimethylpropanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by thin-layer chromatography using chloroform/acetone for development to give the title compound (43 mg, yield 58%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.28 (s, 9H), 3.98 (s, 3H), 3.99 (s, 3H), 7.35 (d, J=8.8 Hz, 2H), 7.39 (s, 1H), 7.57 (s, 1H), 7.72 (d, J=8.5 Hz, 2H), 8.57 (s, 1H), 10.66 (s, 1H), 12.59 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z) 441 (M++1)
- Hexanoyl isothiocyanate was prepared using commercially available hexanoyl chloride (80 mg) as a starting compound according to the description of the literature. Hexanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by thin-layer chromatography using chloroform/acetone for development to give the title compound (10 mg, yield 13%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.84-0.91 (m, 3H), 1.22-1.32 (m, 4H), 1.45-1.64 (m, 2H), 2.18 (t, J=7.3 Hz, 2H), 3.98 (s, 3H), 3.99 (s, 3H), 7.33-7.37 (m, 2H), 7.39 (s, 1H), 7.57 (s, 1H), 7.70-7.75 (m, 2H), 8.56 (s, 1H), 11.45 (s, 1H), 12.59 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 455 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-methyl-1-cyclopropanecarboxylic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-methyl-1-cyclopropanecarbonyl isothiocyanate was prepared using the resultant 2-methyl-1-cyclopropanecarbonyl chloride as a starting compound according to the description of the literature. 2-Methyl-1-cyclopropanecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]-aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (40 mg, yield 56%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.84-0.89 (m, 1H), 1.08-1.38 (m, 5H), 1.87-1.91 (m, 1H), 3.94 (s, 3H), 3.95 (s, 3H), 6.40 (d, J=5.1 Hz, 1H), 7.42 (s, 1H), 7.46 (d, J=8.8 Hz, 1H), 7.52 (s, 1H), 7.66 (dd, J=2.7 Hz, 8.8 Hz, 1H), 8.13 (d, J=2.4 Hz, 1H), 8.49 (d, J=5.4 Hz, 1H), 11.82 (s, 1H), 12.58 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 472 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-methyl-1-cyclopropanecarboxylic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-methyl-1-cyclopropanecarbonyl isothiocyanate was prepared using the resultant 2-methyl-1-cyclopropanecarbonyl chloride as a starting compound according to the description of the literature. 2-Methyl-1-cyclopropanecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (13 mg, yield 18%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.84-0.88 (m, 1H), 1.09-1.24 (m, 5H), 1.88-1.90 (m, 1H), 3.98 (s, 3H), 3.99 (s, 3H), 7.33 (d, J=9.0 Hz, 2H), 7.39 (s, 1H), 7.56 (s, 1H), 7.71 (d, J=9.0 Hz, 2H), 8.56 (s, 1H), 11.73 (s, 1H), 12.54 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 439 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 1-methyl-1-cyclohexanecarboxylic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 1-methyl-1-cyclohexanecarbonyl isothiocyanate was prepared using the resultant 1-methyl-1-cyclohexanecarbonyl chloride as a starting compound according to the description of the literature. 1-Methyl-1-cyclohexanecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (38 mg, yield 49%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.26 (s, 3H), 1.35-1.52 (m, 8H), 2.06-2.09 (m, 2H), 3.94 (s, 3H), 3.96 (s, 3H), 6.41 (d, J=5.1 Hz, 1H), 7.42 (s, 1H), 7.47 (d, J=8.8 Hz, 1H), 7.52 (s, 1H), 7.68-7.72 (m, 1H), 8.15 (s, 1H), 8.50 (d, J=5.1 Hz, 1H), 10.66 (s, 1H), 12.65 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 515 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 1-methyl-1-cyclohexanecarboxylic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 1-methyl-1-cyclohexanecarbonyl isothiocyanate was prepared using the resultant 1-methyl-1-cyclohexanecarbonyl chloride as a starting compound according to the description of the literature. 1-Methyl-1-cyclohexanecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (31 mg, yield 38%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.26 (s, 3H), 1.38-1.52 (m, 8H), 2.05-2.11 (m, 2H), 3.98 (s, 3H), 3.99 (s, 3H), 7.35 (d, J=8.8 Hz, 2H), 7.39 (s, 1H), 7.57 (s, 1H), 7.74 (d, J=8.8 Hz, 2H), 8.57 (s, 1H), 10.54 (s, 1H), 12.62 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 481 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 1-phenyl-1-cyclopropanecarboxylic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 1-phenyl-1-cyclopropanecarbonyl isothiocyanate was prepared using the resultant 1-phenyl-1-cyclopropanecarbonyl chloride as a starting compound according to the description of the literature. 1-Phenyl-1-cyclopropanecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by thin-layer chromatography using chloroform/acetone for development to give the title compound (24 mg, yield 30%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.34 (s, 2H), 1.63 (s, 2H), 3.94 (s, 3H), 3.95 (s, 3H), 6.40 (d, J=5.1 Hz, 1H), 7.42-7.55 (m, 7H), 7.66 (d, J=8.5 Hz, 1H), 8.07 (s, 1H), 8.50 (d, J=5.1 Hz, 1H), 9.22 (s, 1H), 12.28 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 534 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 1-phenyl-1-cyclopropanecarboxylic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 1-phenyl-1-cyclopropanecarbonyl isothiocyanate was prepared using the resultant 1-phenyl-1-cyclopropanecarbonyl chloride as a starting compound according to the description of the literature. 1-Phenyl-1-cyclopropanecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by thin-layer chromatography using chloroform/acetone for development to give the title compound (58 mg, yield 69%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 1.34 (s, 2H), 1.64 (s, 2H), 3.97 (s, 3H), 3.99 (s, 3H), 7.32-7.55 (m, 8H), 7.69 (d, J=7.3 Hz, 2H), 8.55 (s, 1H), 9.00 (s, 1H), 12.25 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 501 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 4-propyl-1-cyclohexanecarboxylic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 4-propyl-1-cyclohexanecarbonyl isothiocyanate was prepared using the resultant 4-propyl-1-cyclohexanecarbonyl chloride as a starting compound according to the description of the literature. 4-Propyl-1-cyclohexanecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by thin-layer chromatography using chloroform/acetone for development to give the title compound (51 mg, yield 63%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.85-0.94 (m, 5H), 1.07-1.44 (m, 7H), 1.77-1.89 (m, 4H), 2.66-2.70 (m, 1H), 3.95 (s, 3H), 3.96 (s, 3H), 6.41 (d, J=5.1 Hz, 1H), 7.43 (s, 1H), 7.47 (d, J=8.8 Hz, 1H), 7.53 (s, 1H), 7.67-7.73 (m, 1H), 8.14-8.19 (m, 1H), 8.49-8.53 (m, 1H), 11.53 (s, 1H), 12.58 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 542 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 4-propyl-1-cyclohexanecarboxylic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 4-propyl-1-cyclohexanecarbonyl isothiocyanate was prepared using the resultant 4-propyl-1-cyclohexanecarbonyl chloride as a starting compound according to the description of the literature. 4-Propyl-1-cyclohexanecarbonyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by thin-layer chromatography using chloroform/acetone for development to give the title compound (59 mg, yield 69%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.85-0.91 (m, 5H), 1.15-1.41 (m, 7H), 1.78-1.89 (m, 4H), 2.66-2.69 (m, 1H), 3.98 (s, 3H), 3.99 (s, 3H), 7.35 (d, J=6.6 Hz, 2H), 7.40 (s, 1H), 7.57 (s, 1H), 7.71-7.77 (m, 2H), 8.57 (s, 1H), 11.43 (s, 1H), 12.55 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 509 (M++1)
- 4-Chlorobutanoyl isothiocyanate was prepared using commercially available 4-chlorobutanoyl chloride (80 mg) as a starting compound according to the description of the literature. 4-Chlorobutanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (35 mg, yield 48%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.00-2.08 (m, 2H), 2.66 (t, J=7.1 Hz, 2H), 3.71 (t, J=6.6 Hz, 2H), 3.99 (s, 3H), 4.00 (s, 3H), 6.60-6.65 (m, 1H), 7.51 (s, 1H), 7.56 (d, J=8.8 Hz, 1H), 7.64 (s, 1H), 7.73-7.78 (m, 1H), 8.18-8.23 (m, 1H), 8.67 (d, J=5.6 Hz, 1H), 11.67 (s, 1H), 12.50 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 495 (M++1)
- 3-Chloropropanoyl isothiocyanate was prepared using commercially available 3-chloropropanoyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Chloropropanoyl isothiocyanate thus obtained was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (38 mg, yield 50%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.04 (t, J=4.6 Hz, 2H), 3.88 (t, J=3.7 Hz, 2H), 3.99 (s, 3H), 4.00 (s, 3H), 7.37 (d, J=6.6 Hz, 2H), 7.40 (s, 1H), 7.58 (s, 1H), 7.73 (d, J=6.3 Hz, 2H), 8.57 (s, 1H), 11.65 (s, 1H), 12.39 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 447 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 2-methylpentanoic acid (80 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 2-methylpentanoyl isothiocyanate was prepared using the resultant 2-methylpentanoyl chloride as a starting compound according to the description of the literature. The resultant 2-methylpentanoyl isothiocyanate was dissolved in ethanol (1 ml) to prepare a solution. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (69 mg, yield 94%).
- 1H-NMR (chloroform-d, 400 MHz): δ 0.85-1.80 (m, 10H), 2.37-2.53 (m, 1H), 4.09 (s, 3H), 4.11 (s, 3H), 6.49 (d, J=5.9 Hz, 1H), 7.31 (d, J=5.1 Hz, 1H), 7.61 (s, 1H), 7.72 (dd, J=2.4 Hz, 8.8 Hz, 1H), 7.76 (s, 1H), 8.08 (d, J=2.4 Hz, 1H), 8.66 (s, 1H), 12.66 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 488 (M++1)
- 2-Methylpentanoyl isothiocyanate prepared according to the method 2 was dissolved in ethanol (1 ml) to prepare a solution. 4-[(6,7-Dimethoxy-4-quinazolinyl)-oxy]aniline (50 mg), toluene (5 ml), and ethanol (1 ml) were added to the solution, and the mixture was stirred at room temperature for 16 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (44 mg, yield 57%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.87-0.92 (m, 3H), 1.09-1.13 (m, 3H), 1.26-1.65 (m, 4H), 2.74-2.81 (m, 1H), 3.98 (s, 3H), 4.00 (s, 3H), 7.34-7.38 (m, 2H), 7.40 (s, 1H), 7.57 (s, 1H), 7.72-7.78 (m, 2H), 8.57 (s, 1H), 11.51 (s, 1H), 12.59 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 455 (M++1)
- 2,4-Difluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,4-difluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2,4-difluoro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (42 mg, yield 53%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.93 (s, 3H), 3.96 (s, 3H), 6.66 (d, J=5.12 Hz, 1H), 7.16-7.36 (m, 5H), 7.61 (s, 1H), 7.82-7.83 (m, 1H), 8.10 (d, J=9.03 Hz, 1H), 8.56 (d, J=5.12 Hz, 1H), 11.98 (bs, 1H), 12.33 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 530 (M++1)
- 3,4-Dimethoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3,4-dimethoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3,4-dimethoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (57 mg, yield 65%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.79 (s, 3H), 3.83 (s, 3H), 3.96 (s, 3H), 3.99 (s, 3H), 6.62 (d, J=15.61 Hz, 2H), 6.92 (d, J=15.61 Hz, 2H), 7.04 (d, J=8.54 Hz, 1H), 7.38 (s, 1H), 7.44 (s, 1H), 7.52 (s, 1H), 7.56 (dd, J=2.19 Hz, J=8.30 Hz, 1H), 8.56 (s, 1H), 11.88 (bs, 1H), 12.50 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 521 (M++1)
- 3,4-Dimethoxy-1-benzenecarbonyl isothiocyanate was prepared using commercially available 3,4-dimethoxy-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 3,4-dimethoxy-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (49 mg, yield 58%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.79 (s, 3H), 3.83 (s, 3H), 3.93 (s, 3H), 3.94 (s, 3H), 5.46 (bs, 1H), 6.29 (d, J=15.37 Hz, 1H), 6.62-6.43 (m, 1H), 6.79 (s, 1H), 7.03-7.10 (m, 2H), 7.38 (s, 1H), 7.52 (s, 1H), 7.55-7.58 (m, 2H), 8.44 (d, J=5.12 Hz, 1H), 12.63 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 555 (M++1)
- 2-Phenylethanoyl isothiocyanate was prepared using commercially available 2-phenylethanoyl chloride (80 mg) as a starting compound according to the description of the literature. 2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-phenylethanoyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (48 mg, yield 62%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.85 (s, 3H), 3.93 (s, 3H), 3.95 (s, 3H), 6.64 (d, J=5.08 Hz, 1H), 7.27-7.39 (m, 5H), 7.42 (s, 1H), 7.49 (s, 1H), 7.57 (s, 1H), 8.10 (d, J=8.78 Hz, 1H), 8.55 (d, J=5.38 Hz, 1H), 11.91 (bs, 1H), 12.39 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 508 (M++1)
- 2-Phenylethanoyl isothiocyanate was prepared using commercially available 2-phenylethanoyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2,3-dimethylaniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2-phenylethanoyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (44 mg, yield 58%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 2.08 (s, 3H), 2.15 (s, 3H), 3.85 (s, 2H), 3.94 (s, 3H), 3.95 (s, 3H), 6.28 (d, J=5.12 Hz, 1H), 7.08 (d, J=8.54 Hz, 1H), 7.27-7.41 (m, 7H), 7.57 (s, 1H), 8.47 (d, J=5.37 Hz, 1H), 11.75 (bs, 1H), 12.01 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 502 (M++1)
- 2,4-Dichloro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,4-dichloro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2,4-dichloro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (65 mg, yield 73%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.97 (s, 3H), 3.99 (s, 3H), 7.38 (d, J=11.22 Hz, 3H), 7.55-7.58 (m, 2H), 7.69 (d, J=8.29 Hz, 1H), 7.76-7.78 (m, 3H), 8.57 (s, 1H), 12.04 (bs, 1H), 12.26 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 530 (M++1)
- 2,4-Difluoro-1-benzenecarbonyl isothiocyanate was prepared using commercially available 2,4-difluoro-1-benzenecarbonyl chloride (80 mg) as a starting compound according to the description of the literature. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 2,4-difluoro-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (50 mg, yield 63%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 3.95 (s, 3H), 3.96 (s, 3H), 6.43 (d, J=5.37 Hz, 1H), 7.24-7.29 (m, 1H), 7.43-7.55 (m, 3H), 7.75 (dd, J=2.44 Hz, J=8.78 Hz, 1H), 7.79-7.90 (m, 2H), 8.16 (bs, 1H), 8.52 (d, J=5.12 Hz, 1H), 11.86 (bs, 1H), 12.32 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 530 (M++1)
- Toluene (20 ml) and thionyl chloride (1 ml) were added to commercially available 4-octylbenzoic acid (40 mg), and the mixture was heated at 100° C. for one hr. The solvent was removed by distillation, and 4-octyl-1-benzenecarbonyl isothiocyanate was prepared using the resultant 4-octyl-1-benzenecarbonyl chloride as a starting compound according to the description of the literature. 3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]-aniline (50 mg) was dissolved in toluene (5 ml) and ethanol (1 ml) to prepare a solution. A solution of 4-octyl-1-benzenecarbonyl isothiocyanate in ethanol (1 ml) was then added to the solution, and the mixture was stirred at room temperature for 2 hr. The reaction solution was concentrated, and the residue was purified by chromatography on silica gel using chloroform/acetone for development to give the title compound (53 mg, yield 58%).
- 1H-NMR (DMSO-d6, 400 MHz): δ 0.84-0.87 (m, 4H), 1.60 (m, 2H), 2.09 (s, 2H), 2.50 (s, 7H), 2.65-2.69 (m, 2H), 3.94 (s, 3H), 5.46 (bs, 1H), 6.29 (d, J=15.37 Hz, 1H), 6.42 (d, J=5.12 Hz, 1H), 7.36-7.54 (m, 6H), 7.74-7.76 (m, 1H), 7.94 (d, J=8.05 Hz, 2H), 8.19 (bs, 1H), 8.51 (d, J=5.12 Hz, 1H), 11.61 (bs, 1H), 12.70 (bs, 1H)
- Mass spectrometry value (ESI-MS, m/z): 607 (M++1)
- Piperidine (357 mg) was dissolved in acetonitrile (20 ml) to prepare a solution. Potassium carbonate (97 mg) was then added to the solution. 2-(4-Bromobutyl)-1,3-isoindolinedione (1 g) was further added thereto, and the mixture was stirred with heating under reflux for 10 hr. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and brine. The extract was then dried over sodium sulfate, was filtered, and was concentrated to give 850 mg of a mixture containing 2-(4-piperidinobutyl)-1,3-isoindolinedione. The mixture containing 2-(4-piperidinobutyl)-1,3-isoindolinedione (850 mg) thus obtained was dissolved in ethyl alcohol (10 ml) to prepare a solution. Hydrazine monohydrate (0.75 ml) was then added to the solution, and the mixture was stirred at room temperature for one hr. This solution was concentrated to give 980 mg of a mixture containing 4-piperidinobutylamine. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (100 mg) was dissolved in chloroform (10 ml) to prepare a solution. Triethylamine (1 ml) was then added to the solution, and a solution of triphosgene (131 mg) in chloroform (5 ml) was further added thereto. The mixture was stirred at room temperature for 10 min. A solution of the mixture containing 4-piperidinobutylamine (69 mg) in chloroform (5 ml) was then added thereto, and the mixture was stirred at room temperature for 30 min. Water was added to stop the reaction, the reaction solution was then extracted with chloroform, and the extract was dried over sodium sulfate. The extract was filtered and concentrated. The powder thus obtained was then filtered and washed with diethyl ether to give N-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-2-nitrophenyl-N′-(4-piperidinobutyl)-urea (104 mg, yield 68%).
- 1H-NMR (CDCl3, 400 MHz): δ 1.54 (brs, 2H), 1.65-1.79 (m, 8H), 2.52-2.61 (m, 6H), 3.35 (t, J=5.9 Hz, 2H), 4.075 (s, 3H), 4.080 (s, 3H), 7.00 (brs, 1H), 7.34 (s, 1H), 7.51-7.54 (m, 2H), 8.12 (d, J=2.7 Hz, 1H), 8.61 (s, 1H), 8.76 (d, J=9.5 Hz, 1H), 9.73 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 525 (M++1)
- Piperidine (357 mg) was dissolved in acetonitrile (20 ml) to prepare a solution. Potassium carbonate (97 mg) was then added to the solution. Further, 2-(3-bromopropyl)-1,3-isoindolinedione (1 g) was added thereto, and the mixture was stirred with heating under reflux for 10 hr. Water was added to stop the reaction, and the reaction solution was then extracted with ethyl acetate, followed by washing with water and brine. The extract was then dried over sodium sulfate, was filtered, and was concentrated to give 850 mg of a mixture containing 2-(3-piperidinopropyl)-1,3-isoindolinedione. The mixture containing 2-(3-piperidinopropyl)-1,3-isoindolinedione (850 mg) thus obtained was dissolved in ethyl alcohol (10 ml) to prepare a solution. Hydrazine monohydrate (0.75 ml) was then added to the solution, and the mixture was stirred at room temperature for one hr. This solution was concentrated to give 980 mg of a mixture containing 3-piperidinobutylamine. 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-nitroaniline (100 mg) was dissolved in chloroform (10 ml) to prepare a solution. Triethylamine (1 ml) was then added to the solution. A solution of triphosgene (131 mg) in chloroform (5 ml) was further added to the solution, and the mixture was stirred at room temperature for 10 min. A solution of the mixture containing 3-piperidinopropylamine (69 mg) in chloroform (5 ml) was then added thereto, and the mixture was stirred at room temperature for 30 min. Water was added to stop the reaction, and the reaction solution was then extracted with chloroform, followed by washing with sodium sulfate. The extract was then filtered and was concentrated to give a powder. The powder was then filtered and was washed with diethyl ether to give N-4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-2-nitrophenyl-N′-(3-piperidinopropyl)-urea (104 mg, yield 68%).
- 1H-NMR (CDCl3, 400 MHz): δ 1.55 (brs, 2H), 1.65-1.80 (m, 6H), 2.50-2.62 (m, 6H), 3.37 (t, J=5.9 Hz, 2H), 4.075 (s, 3H), 4.080 (s, 3H), 7.05 (brs, 1H), 7.35 (s, 1H), 7.50-7.55 (m, 2H), 8.10 (d, J=2.7 Hz, 1H), 8.60 (s, 1H), 8.78 (d, J=9.5 Hz, 1H), 9.75 (s, 1H)
- Mass spectrometry value (ESI-MS, m/z): 511 (M++1)
- G-292 human osteosarcoma cells (Dainippon Pharmaceutical Co. Ltd.) were cultured in a DMEM medium (Dainippon Pharmaceutical Co. Ltd.) containing 10% FBS within an incubator containing 5% carbon dioxide until 80% confluent, and the cells were planted at 3×104 cells per well in 96-well flat-bottom plates in the same medium containing 0.1% FBS. After cultivation at 37° C. overnight, a solution of a test compound in dimethyl sulfoxide was added to each well, and a reaction was allowed to proceed at 37° C. for one hr.
- After the reaction of the test compound, PDGF-AA (Upstate) was added to 50 ng/ml, and the cells were stimulated at 37° C. for 5 min. Thereafter, the cells were solubilized and shaken at room temperature for 20 min.
- This solubilized cell solution was transferred to a 96-well plate coated with aniti-phosphotyrosine antibody PY-20, and a reaction was allowed to proceed at 4° C. overnight. Anti-PDGF-Ra (c-20) (Santa Cruz) was added as a primary antibody, and a reaction was allowed to proceed for one hr. GAR (Anti-rabbit Ig, horseradish peroxidase, Amersham) was then added as a secondary antibody, and a reaction was allowed to proceed for one hr. Color development was carried out using a color development kit for peroxidase (Sumitomo Bakelite Co., Ltd.), and the absorbance was measured at 450 nm. The phosphorylation of PDGF-Ra in the presence of the test compound was measured by presuming a phosphorylation degree of the receptor in the presence of a ligand to be 100% and a phosphorylation degree of PDGF-Ra in the absence of a ligand to be 0%, and IC50 was then determined.
- Vascular smooth muscle cells (passage 5 to 10) collected from rat thoracic aorta by the explant method were planted at 8×103 cells per well in 96-well plates, subject to a serum starvation state, and 24 hr after the plantation then assayed.
- A test compund was added, and the mixture was incubated at 37° C. for one hr. Thereafter, PDGF-BB was added to 50 ng/ml, and the mixture was incubated for 5 min, followed by washing with cold PBS. Lysate buffer (20 μl/well) was then added, SDS buffer (20 ml/well) was added thereto, and 2 μl of the mixture was then spotted on a PDVF membrane.
- Treatment was carried out with anti-mouse IgG which had been labelled with peroxidase after treatment with an anti-phosphotyrosine antibody, followed by development in an ECL color development kit (Amersham). Thereafter, the color intensity was quantitatively determined by image analysis.
- The inhibitory activity IC50 of the test compound was calculated by presuming a color intensity with the addition of PDGF and without the addition of the test compound to be 0% inhibition and a color intensity without the test compound and PDGF to be 100% inhibition.
- MO7e (human megakaryocytic leukemia cell line) which had been arrested for 20 hr was seeded into 96 well plates at an amount of 2×105 per well. A solution of a test compound in DMSO was added, and a reaction was then allowed to proceed for one hr. Thereafter, the cells were stimulated by 50 ng/ml of h-SCF for 5 min, followed by replacement with lysate buffer to solubilize the cells.
- Next, the solubilized cell sap was transferred to a 96-well plate with an anti-phosphotyrosine antibody (PY-20) previously immobilized thereon, and a reaction was allowed to proceed. Thereafter, the cells were reacted with an anti-c-kit antibody (c-19, Santa Cruz) as a primary antibody and were labelled with GAR (anti-rabbit IgG, horseradish peroxidase, Amersham) as a secondary antibody. Color development was then carried out in a peroxidase color development kit (Sumitomo Bakelite Co., Ltd.), and the absorbance was measured at a wavelength of 450 nm.
- The c-kit autophosphorylation inhibitory activity of the test compound was measured by presuming c-kit autophosphorylation activity with the addition of DMSO in the absence of h-SCF to be 100% inhibition and c-kit autophosphorylation activity with the addition of DMSO in the presence of h-SCF to be 0% inhibition, and IC50 was then determined.
- The results of Pharmacological Test Examples 1 to 3 were as follows. Values within parentheses indicates IC50 (nM). Figures within parenthesess in >100 ( ) in PDGF(E) indicate inhibition (%) at 100 nM. Figures within parentheses in >1000 ( ) and −( ) indicate inhibition (%) at 1000 nM. Figures within parentheses in −( ) of c-kit indicate inhibition (%) at 1000 nM. The symbol > indicates that the inhibition at an indicated concentration is not more than 50%. The symbols < and << indicate that the inhibition at an indicated concentration is not less than 50%.
Example No. PDGF (E) PDGF (D) c-kit 1 <10 52 2 17 422 3 <10 173 4 <10 133 5 24 336 6 <10 175 7 12 616 8 <<10 62 9 <10 45 10 11 106 11 <<10 36 12 11 389 13 <10 135 14 12 209 15 21 −(48) 16 <10 495 17 <10 57 18 22 93 19 <<10 41 20 <<10 109 21 <10 135 22 <10 186 23 <10 475 24 <<10 129 25 <10 566 26 <<10 44 27 <<10 76 28 <10 118 29 27 121 30 <10 <30 31 <10 221 32 16 227 33 23 362 34 >100 (45) 800 35 <10 342 36 >100 (34) −(19) 37 <<10 <30 38 <10 33 39 <10 56 40 <<10 55 41 <10 185 42 <10 73 43 <10 158 44 19 328 45 <10 91 46 22 388 47 <10 178 48 <10 162 49 <10 185 50 <10 50 51 14 270 52 <10 273 53 <10 480 54 15 473 55 <10 288 56 11 774 57 11 393 58 12 499 59 57 −(33) 60 <10 261 61 10 −(32) 62 13 70 63 16 211 64 90 429 65 <10 103 66 50 353 67 <10 342 68 13 294 69 53 755 70 <10 451 71 38 −(34) 72 36 387 73 28 235 74 100 1000 75 25 1000 76 >100 (37) −(14) 77 <10 99 78 16 129 79 18 123 80 12 137 81 12 408 82 10 176 83 16 253 84 27 399 85 <10 163 86 13 842 87 <10 607 88 19 −(45) 89 14 −(35) 90 <10 621 91 14 −(20) 92 <10 677 93 17 601 94 31 −(31) 95 16 962 96 38 −(13) 97 <10 254 98 <10 152 99 21 394 100 14 815 101 12 −(27) 102 <10 217 103 15 200 104 25 590 105 <10 252 106 12 1000 107 372 108 180 109 412 110 110 111 750 112 16 214 113 18 402 114 65 602 115 <10 387 116 31 1000 117 26 759 118 33 746 119 >100 −(31) 120 13 505 121 48 −(17) 122 11 821 123 <10 207 124 42 −(39) 125 <10 671 126 19 −(10) 127 16 283 128 26 375 129 64 732 130 <10 714 131 38 −(40) 132 26 301 133 26 206 134 >100 (49) 944 135 18 475 136 43 −(7) 137 <10 233 138 17 74 139 57 80 140 <10 234 141 36 −(26) 142 <10 <30 143 <10 <30 144 18 49 145 <10 <30 146 11 32 147 11 <30 148 <10 <30 149 19 49 150 <10 38 151 12 32 152 <10 <30 153 <10 <30 154 40 61 155 14 41 156 >100 (48) 33 157 <10 35 158 12 107 159 52 147 160 16 52 161 <10 178 162 16 162 163 <10 185 164 12 50 165 49 149 166 34 145 167 45 370 168 15 52 169 <10 31 170 <10 34 171 22 83 172 17 74 173 <<10 37 174 <10 70 175 <<10 45 176 20 <30 177 19 <30 178 >100 179 70 180 63 181 >100 182 >100 183 35 706 184 38 369 185 46 186 63 187 <10 561 188 100 189 57 190 >100 191 84 503 192 56 193 57 194 91 715 195 66 196 49 197 93 198 21 1000 199 35 807 200 31 329 201 >100 202 10 610 203 25 169 204 28 79 205 78 206 13 80 207 31 55 208 18 53 209 >100 210 16 95 211 17 43 212 28 70 213 21 61 214 >30 (6) 47 215 8 <30 216 <3 19 217 29 39 218 88 123 219 27 <30 220 47 77 221 84 109 222 45 101 223 7 101 224 >100 147 225 86 453 226 11 72 227 7 194 228 10 71 229 18 47 230 8 111 231 1 86 232 11 42 233 8 52 234 10 46 235 <3 57 236 4 47 237 6 42 238 10 36 239 9 183 240 17 248 241 12 232 242 21 192 243 20 190 244 27 69 245 16 408 246 58 243 247 3 40 248 11 147 249 4 57 250 4 184 251 6 185 252 6 111 253 17 514 254 >100 (27) 396 255 >100 (36) 309 256 <3 15 257 6 22 258 3 178 259 34 184 260 6 180 261 4 44 262 7 83 263 10 329 264 42 486 265 35 122 266 6 34 267 23 35 268 6 34 269 17 −(48) 270 65 471 271 22 130 272 61 297 273 23 107 274 25 399 275 16 103 276 16 413 277 10 53 278 53 289 279 <10 <30 280 <10 370 281 >100 (49) 268 282 34 48 283 <10 121 284 <10 269 285 <10 85 286 <10 54 287 13 228 288 <10 162 289 <10 328 290 47 281 291 26 124 292 14 262 293 <10 145 294 15 109 295 >100 (45) 178 296 61 109 297 <<10 41 298 <10 119 299 <<10 53 300 <10 −(43) 301 43 −(39) 302 12 202 303 11 188 304 63 401 305 11 221 306 11 72 307 >100 (49) 165 308 20 101 309 10 285 310 67 607 311 <10 329 312 <<10 29 313 <10 330 314 44 32 315 <10 82 316 10 −(40) 317 <<10 136 318 10 418 319 <<10 98 320 <10 596 321 <<10 37 322 <10 60 323 <<10 <30 324 12 64 325 <10 46 326 >100 (31) −(18) 327 >100 (30) −(6) 328 >100 (22) −(10) 329 <10 253 330 12 467 331 <10 377 332 <<10 259 333 12 712 334 <10 484 335 <<10 <30 336 14 109 337 <10 198 338 25 956 339 38 197 340 <10 107 341 32 519 342 <<10 <30 343 <10 232 344 <10 <30 345 30 123 346 41 −(37) 347 77 228 348 <10 90 349 12 309 350 <10 238 351 <10 64 352 <10 195 353 <10 80 354 15 384 355 24 252 356 <10 66 357 <10 116 358 <10 366 359 28 274 360 16 189 361 <10 278 362 42 −(26) 363 <10 72 364 29 98 365 <10 47 366 27 66 367 55 207 368 64 426 369 >100 −(36) 370 74 585 371 <10 541 372 −(14) 373 43 71 374 <10 <30 375 74 144 376 <10 41 377 21 151 378 14 92 379 11 624 380 <10 45 381 66 382 <10 28 383 74 90 384 >100 (37) 385 <10 87 386 20 105 387 <10 31 388 12 60 389 51 390 33 400 391 13 129 392 >100 (38) 432 393 82 90 394 <10 133 395 19 226 396 19 86 397 <10 77 398 33 462 399 63 327 400 <10 671 401 <10 586 403 14 93 404 <10 81 405 46 126 406 <10 <30 407 26 68 408 <10 192 409 26 392 410 12 79 411 17 43 412 81 122 413 39 50 414 >100 (27) 415 24 98 416 >100 (49) 417 >100 (42) 418 26 401 419 >100 (47) 420 16 77 421 <10 34 422 <10 119 423 <10 102 424 47 224 425 >100 (5) 464 426 22 272 427 >100 (13) 364 428 64 158 429 54 603 430 76 182 431 17 43 432 13 <30 433 11 <30 434 20 <30 435 33 445 436 >100 (46) 878 437 48 250 438 >100 (41) 414 439 52 224 440 47 351 441 70 1000 442 >100 (32) −(28) 443 15 627 444 21 972 445 >100 (11) 941 446 >100 (39) −(40) 447 >100 (11) 553 448 >100 (39) −(25) 449 >100 (26) 747 450 >100 (13) −(46) 451 >100 (25) 613 452 >100 (31) −(37) 453 >100 (1) 454 >100 (23) 455 77 456 >100 (21) 457 >100 (29) 458 >100 (18) 459 47 <30 460 >100 (15) 461 60 462 52 575 463 91 432 464 55 201 465 56 1000 466 >100 (16) 467 >100 (8) 468 >100 (20) 469 >100 (0) −(28) 470 26 128 471 >100 (28) 237 472 31 67 473 >100 (30) 259 474 46 −(6) 475 15 −(24) 476 <10 172 477 59 248 478 17 −(28) 479 13 −(17) 480 10 −(22) 481 16 −(3) 482 24 −(5) 483 20 <30 484 12 75 485 >100 (35) 486 >100 (36) 487 >100 (31) 488 98 489 58 637 490 21 261 491 24 315 492 20 321 493 39 1000 494 16 125 495 65 496 45 −(32) 497 <10 82 498 <10 140 499 <10 98 500 14 199 501 11 56 502 −(23) 503 87 −(36) 504 46 −(42) 505 53 −(25) 506 74 369 507 44 787 508 −(28) 509 26 164 510 >100 (3) −(17) 511 19 663 512 29 1000 513 >100 (28) 720 514 >100 (31) −(29) 515 >100 (32) −(21) 516 50 −(27) 517 38 −(33) 518 >100 (17) 519 >100 (22) 520 >100 (43) 521 >100 522 >100 523 >100 524 >100 (21) −(21) 525 79 −(41) 526 >100 (46) 731 527 65 875 528 33 343 529 >100 (38) −(8) 530 >100 (45) −(34) 531 −(31) 532 >100 (44) 752 533 64 623 534 51 −(35) 535 32 −(27) 536 −(7) 537 >100 (34) −(34) 538 >100 (22) 768 539 >100 (45) 415 540 48 447 541 70 794 542 >100 (45) 442 543 54 328 544 <10 216 545 70 254 546 54 −(44) 547 >100 (33) −(41) 548 46 268 549 62 681 550 77 536 551 >100 (19) 1000 552 >100 (10) −(28) 553 >100 (40) 320 554 >100 (14) 555 >100 (29) −(39) 556 >100 (13) −(28) 557 >100 (33) 634 558 73 724 559 36 711 560 12 107 561 <10 54 562 80 −(27) 563 54 406 564 39 291 565 46 170 566 17 276 567 21 118 568 >100 (28) −(31) 569 12 168 570 23 173 571 32 556 572 64 262 573 39 348 574 45 147 575 27 664 576 36 151 577 14 328 578 18 104 579 22 145 580 14 84 581 14 180 582 >100 (20) −(29) 583 >100 (17) −(18) 584 >100 (13) −(13) 585 >100 (32) 1000 586 63 734 587 67 −(16) 588 36 1000 589 28 487 590 54 296 591 33 117 592 23 472 593 51 1000 594 >100 (39) −(10) 595 46 −(0) 596 63 719 597 >100 (27) −(8) 598 19 423 600 <10 208 602 11 180 603 >100 (42) 864 604 73 322 605 31 394 606 18 263 607 29 554 608 <10 201 609 45 610 380 611 95 1073 612 10 173 613 56 −(29) 614 <10 434 615 17 125 616 36 224 617 <10 172 618 <10 948 619 >100 (49) −(44) 620 <10 519 621 30 −(30) 622 11 355 623 90 632 624 34 436 625 >100 (31) 596 626 49 339 627 65 774 628 <10 81 629 <10 481 630 36 −(23) 631 39 186 632 36 223 633 58 −(28) 634 >100 (40) −(13) 635 >100 (25) −(23) 636 33 106 637 52 375 638 >100 (43) −(16) 639 >100 (29) −(12) 640 35 254 641 28 293 642 >100 (20) −(8) 643 >100 (40) −(2) 644 >100 (17) −(14) 645 23 −(32) 646 11 −(0) 647 13 712 648 16 937 649 39 1000 650 32 420 651 40 808 652 43 115 653 23 581 654 19 698 655 43 −(43) 656 19 −(32) 657 40 −(27) 658 19 389 659 19 1000 660 25 835 661 <10 75 662 23 296 663 <10 202 664 <10 97 665 11 122 666 10 134 667 <10 100 668 <10 144 669 23 134 670 15 82 671 64 −(22) 672 53 −(9) 673 15 426 674 >100 (43) 854 675 46 442 676 26 632 677 47 730 678 <10 164 679 <10 337 680 35 570 681 30 270 682 >100 (30) −(32) 683 >100 (40) −(26) 684 52 549 685 22 −(41) 686 38 −(19) 687 26 −(34) 688 34 −(19) 689 >100 (42) 571 690 >100 (10) −(11) 691 >100 (10) −(18) 692 >100 (35) >1000 (20) 693 56 >1000 (46) 694 >100 (12) −(37) 695 >100 (10) −(37) 696 >100 (37) −(35) 697 <<10 211 698 >100 (34) −(29) 699 13 −(29) 700 >100 (30) −(0) 701 <10 459 702 <10 495 703 <<10 375 704 16 177 705 <10 147 706 <10 227 707 17 209 708 51 348 709 19 −(19) 710 >100 (33) −(30) 711 >100 (34) −(17) 712 83 713 67 89 714 16 248 716 11 −(19) 717 >100 (8) 718 <10 −(19) 719 14 431 720 42 30 721 36 −(20) 722 <10 85 723 17 380 724 <10 116 725 <10 413 726 37 624 727 52 728 100 729 30 302 730 34 634 731 17 259 732 48 733 29 186 734 29 216 735 15 1000 736 72 737 <10 523 738 11 269 739 <10 234 740 23 335 741 49 742 92 743 10 548 744 40 745 53 746 >100 (31) 747 35 759 748 85 749 12 −(41) 750 17 −(43) 751 70 −(23) 752 >100 (37) 753 >100 (28) −(9) 754 >100 (7) 755 >100 (3) 757 >100 (45) 758 >100 (18) 759 26 323 760 83 −(48) 761 >100 (37) −(44) 762 >100 763 13 −(39) 764 14 −(19) 765 21 937 766 >100 (45) 772 >100 (13) 550 773 >100 774 >100 (17) 775 >100 (22) 776 17 386 777 11 11 778 6 84 779 <10 107 780 6 48 781 47 135 782 14 365 783 42 451 784 6 80 785 19 71 786 5 46 787 16 37 788 11 122 789 13 154 790 <3 107 791 3 208 792 6 301 793 6 335 794 14 192 795 5 336 796 15 394 797 27 403 798 <10 439 799 14 1000 800 <10 30 801 13 70 802 <10 −(42) 803 13 −(20) 804 37 −(20) 805 >100 (14) −(35) 806 −(35) 807 >100 (20) −(20) 808 <10 61 809 <10 73 810 18 269 811 17 −(20) 812 12 326 813 23 402 814 47 405 815 74 180 816 73 123 817 53 195 818 43 205 819 48 212 820 44 187 821 39 184 822 17 451 823 11 236 824 14 268 825 58 333 826 53 170 827 38 175 828 829 −(30) −(10) 830 −(23) −(10) 831 −(50) −(19) 832 −(35) −(21) 833 452 −(26) 834 −(23) −(1) 835 161 668 836 90 −(39) 837 −(10) −(19) 838 590 −(23) 839 −(24) −(30) 840 812 −(14) 841 28 118 842 18 127 843 43 263 844 80 450 845 >100 453 846 >100 −(33) 847 >100 −(9) 848 943 849 65 760 850 65 278 851 41 75 852 20 179 853 9 102 854 40 313 855 39 399 856 25 255 857 7 195 858 17 102 859 8 130 860 11 75 861 39 132 862 47 933 863 6 31 864 23 32 865 12 121 866 7 126 867 11 191 868 26 70 869 23 80 870 17 48 871 16 43 872 7 32 873 35 69 874 >100 151 875 40 115 876 40 242 877 43 219 878 19 65 879 20 48 880 16 149 881 >30 (29) 346 882 23 −(36) 883 >30 (30) 521 884 44 −(30) 885 <3 420 886 >100 (47) −(27) 887 50 −(20) 888 12 385 889 >100 (30) −(28) 890 95 −(39) 891 7 280 892 >100 (25) −(30) 893 52 640 894 >100 (49) −(23) 895 >100 (33) −(20) 896 96 −(31) 897 8 938 898 5 637 899 62 1000 900 10 372 901 65 −(27) 902 15 299 903 22 −(34) 904 4 −(46) 905 5 −(40) 906 47 −(29) 907 <10 572 908 9 757 909 145 −(32) 910 72 −(38) 911 9 498 912 8 497 913 8 563 914 <10 299 915 9 240 916 42 −(16) 917 132 546 918 18 552 919 73 −(11) 920 12 448 921 71 −(42) 922 12 365 923 50 −(25) 924 23 440 925 35 430 926 18 −(31) 927 5 623 928 5 289 929 94 −(21) 930 <10 184 931 23 516 932 15 208 933 18 493 934 55 143 935 59 166 936 17 427 937 69 819 938 31 532 939 15 220 940 31 292 941 12 145 942 11 335 943 19 136 944 8 140 945 25 131 946 13 142 947 39 375 948 104 830 949 51 250 950 17 224 951 50 124 952 <10 317 953 143 −(32) 954 4 131 955 12 251 956 10 326 957 10 136 958 17 194 959 <10 300 960 13 629 961 32 740 962 19 −(35) 963 59 701 964 35 −(46) 965 51 −(24) 966 25 233 967 20 −(15) 968 86 −(27) 969 48 −(19) 970 16 300 971 15 523 972 7 532 973 30 −(0) 974 49 −(34) 975 26 290 976 14 788 977 37 824 978 36 −(22) 979 29 −(25) 980 70 811 981 100 −(47) 982 96 −(18) 983 40 −(39) 984 27 −(30) 985 22 −(31) 986 <30 264 987 117 −(32) 988 24 −(33) 989 14 425 990 20 481 991 19 −(20) 992 56 766 993 52 −(35) 994 27 −(47) 995 87 −(23) 996 53 −(27) 997 9 264 998 25 591 999 29 −(45) 1000 3 771 1001 <10 −(34) 1002 <10 −(16) 1003 24 628 1004 10 877 1005 28 674 1006 29 181 1007 >30 616 1008 51 357 1009 21 243 1010 >30 78 1011 44 −(20) 1012 58 −(24) 1013 61 −(22) 1014 62 −(30) 1015 62 195 1016 48 1017 48 1018 10 320 1019 22 187 1020 35 −(11) 1021 53 −(38) 1022 28 202 1023 22 116 1024 11 141 1025 15 194 1026 44 652 1027 36 161 1028 <<10 545 1029 5 126 1030 14 337 1031 10 254 1032 <10 321 1033 67 177 1034 27 378 1035 >30 −(17) 1036 57 −(29) 1037 59 558 1038 80 597 1039 26 556 1040 <<10 414 1041 12 98 1042 39 107 1043 27 449 1044 <10 136 1045 17 193 1046 38 202 1047 >100 −(7) 1048 <10 250 1049 44 1050 23 579 1051 14 418 1052 21 408 1053 30 178 1054 27 −(19) 1055 16 312 1056 34 932 1057 24 447 1058 8 −(21) 1059 >100 550 1060 39 −(30) 1061 20 136 1062 15 233 1063 27 491 1064 12 279 1065 19 566 1066 32 279 1067 70 449 1068 14 124 1069 13 189 1070 391 1071 >100 (17) −(0) 1072 −(34) −(18) 1073 −(23) −(20) 1074 <10 289 1075 −(17) −(31) 1076 204 −(7) 1077 48 379 1078 371 −(32) 1079 196 −(25) 1080 775 −(0) 1081 −(50) −(47) 1082 573 −(15) 1083 382 −(30) 1084 306 −(30) 1085 165 −(25) 1086 −(48) −(19) 1087 566 495 1088 265 −(23) 1089 264 −(28) 1090 562 −(30) 1091 605 −(39) 1092 −(15) −(10) 1093 621 −(32) 1094 746 −(18) 1095 −(20) −(25) 1096 −(30) −(3) 1097 687 −(8) 1098 70 −(41) 1099 18 552 1100 553 −(18) 1101 >100 (37) −(26) 1102 >100 (38) −(11) 1103 >100 (25) −(3) 1104 77 −(23) 1105 >100 (31) −(1) 1106 >100 (30) −(0) 1107 >100 (46) −(24) 1108 135 962 1109 12 353 1110 16 113 1111 46 405 1112 124 −(19) 1113 785 785 1114 118 674 1115 241 −(10) 1116 156 878 1117 185 −(31) 1118 106 −(0) 1119 334 −(27) 1120 207 778 1121 7 <30 1122 >100 (48) −(26) 1123 −(43) 961 1124 >100 (22) 1125 >100 (22) −(8) 1126 >100 (70) −(35) 1127 >100 (8) 1128 >100 (47) −(17) 1129 >100 (48) 1130 <10 547 1131 51 192 1132 <10 146 1133 <10 42 1134 169 1135 <10 239 1136 14 639 1137 28 −(38) 1138 1139 12 783 1140 >100 (22) 1141 <10 416 1142 80 1143 >100 (32) 1144 28 −(30) 1145 548 1146 23 552 1147 10 105 1148 <10 42 1149 43 150 1150 51 192 1151 <10 146 1152 <10 1000 1153 43 −(13) 1154 49 −(21) 1155 17 −(31) 1156 >100 (35) −(28) 1157 <10 1158 46 1159 >100 1160 <10 1161 <10 1162 13 1163 >100 1164 <10 1165 >100 1166 <10 1167 >100 1168 <10 1169 37 1170 <10 1171 13 1172 34 1173 >100 1174 >100 1175 37 1176 >100 1177 17 1178 78 1179 14 327 1180 <<10 480 1181 35 −(26) 1182 <10 206 1183 <10 427 1184 55 1185 13 −(26) 1186 <<10 405 1187 24 1000 1188 76 1189 26 73 1190 24 240 1191 31 193 1192 19 672 1193 <10 −(18) 1194 56 1000 1195 21 530 1196 >100 700 1197 25 219 1198 <10 247 1199 42 1000 1200 25 716 1201 <10 450 1202 50 −(15) 1203 <10 1000 1204 18 434 1206 −(27) 1207 −(16) 1208 −(22) - Wistar male rats (330 to 370 mg) were anesthetized with pentobarbital anesthesia, the right femoral region was incised from the rats, a Fogaty 2F catheter was inserted through the right femoral artery and was led to the left carotid artery, and abrasion was made three times with an expansion diameter of 2.5 mm.
- The test compound was suspended in 1% cremophore, and the suspension was orally administered at 0.4 ml/100 g B.W. twice a day through an oral probe for rats for 2 weeks from the day before an operation. On the second week after the operation, the rats were sacrificed by either. The left carotid artery was removed and was fixed in buffered formalin. Sliced preparations embedded in paraffin were stained with HE and were subjected to image analysis for the measurement of the neointima area (I) and media area (M) in the section of injured blood vessel. I/M was calculated as an index for the evaluation of drug efficacy.
- The results were as follows.
in vivo (dose: 30 mg/kg) Example No I/M ratio, inhibition (%) 223 41 287 37 408 50 421 42 516 32 567 24* 590 86 614 92 615 43 622 38 647 32* 679 54* 687 17*
(*dose: 10 mg/kg)
- NIH 3T3 cells (Sawano A et al., Cell Growth & Differentiation, 7, 213-221 (1996)) prepared by transfection of human KDR were cultured in a DMEM medium containing 10% FBS (GIBCO BRL) within a 5% carbon dioxide incubator until 50 to 70% confluent. The harvested cells were inoculated into wells of a collagen-type one-coat 96-well flat-bottom plate, each containing the same medium, in an amount of 1.5×104 per well, followed by cultivation at 37° C. overnight. The medium was then replaced by a DMEM medium containing 0.1% FBS. A solution of a test compound in dimethyl sulfoxide was added to each well, and the cultivation was carried out at 37° C. for additional one hr. A human recombinant vascular endothelial growth factor (hereinafter abbreviated to “VEGF”) was added to a concentration of 100 ng/ml, and the stimulation of cells was carried out at 37° C. for 2 min. The medium was removed, the cells were washed with phosphate buffered saline (pH 7.4), and 50 μl of a solubilization buffer (20 mM HEPES (pH 7.4), 150 mM NaCl, 0.2% Triton X-100, 10% glycerol, 5 mM sodium orthovanadylate, 5 mM disodium ethylenediaminetetraacetate, and 2 mM Na4P2O7) was then added thereto. The mixture was shaken at 4° C. for 2 hr to prepare a cell extract.
- An anti-phospho-tyrosine antibody (PY20; Transduction Laboratories) was immobilized on a microplate for ELISA (Maxisorp; NUNC), and the whole quantity of the cell extract was transferred to the wells, and the immobilized antibody was reacted with the phosphorylated protein at 4° C. overnight. After washing, an anti-KDR antibody (Santa Cruz) was allowed to react at room temperature for one hr, and, further, after washing, a peroxidase-labeled anti-rabbit Ig antibody (Amersham) was allowed to react at room temperature for one hr. After washing, a chromophoric substrate for peroxidase (Sumitomo Bakelite Co., Ltd.) was added thereto and was allowed to react at room temperature. After a suitable level of color development, a reaction termination solution was added to stop the reaction, and the absorbance at 450 nm was measured with a microplate reader. The KDR phosphorylation activity for each well was determined by presuming the absorbance with the addition of VEGF and without the addition of the medicament to be 100% KDR phosphorylation activity and the absorbance without the medicament and VEGF to be 0% KDR phosphorylation activity.
- The concentration of the test compound was varied on several levels, the inhibition (%) of KDR phosphorylation was determined for each case, and the concentration of the test compound necessary for inhibiting 50% of KDR phosphorylation (IC50) was calculated.
- The results were as follows.
Example No. IC50 (nM) 223 38 287 >1000 408 108 421 692 516 >1000 567 >1000 590 >1000 614 47 615 37 622 >1000 647 599 679 323 687 176 - Edible shoats (24 to 31 kg) were anesthetized with telazol and xylazine, a balloon catheter was inserted through the femoral artery, and the descending branch in front of the heart on the left and the right rotator branch were injured under vasographing.
- For 28 days from the operation, the compound of Example 679 was orally administered as a gelatin capsule at a dose 10 mg/kg twice a day. Further, only a gelatin capsule was administered as a control. In the test, each group consisted of 6 shoats.
- On the 28th day from the operation, the shoats were sacrificed with pentobarbital and were perfused with buffered formalin, and the heart was then removed. Paraffin embedded preparations of the injured blood vessel portion were sliced and stained with HE, followed by image analysis to measure the intima area (IA), media area (MA), and vessel area (VA), and the fissure length (FL) and vessel perimeter (VP) of the inner elastic plate.
- IA/MA and (IA/VA)/(FL/VP) were calculated as an index for the evaluation of drug efficacy.
- The results were as follows.
(IA/VA)/(FL/VP) Dose (mg/kg) IA/MA inhibition(%) inhibition (%) Control — — 10 36 (p < 0.05) 47 (p < 0.001) -
Claims (33)
—OR23 (ix)
—NR24R25 (x)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/432,407 US20060211717A1 (en) | 1999-12-24 | 2006-05-12 | Quinoline and quinazoline derivatives and drugs containing the same |
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11/377486 | 1999-12-24 | ||
JP37748699 | 1999-12-24 | ||
JP37449499 | 1999-12-28 | ||
JP11374494 | 1999-12-28 | ||
JP2000177790 | 2000-06-14 | ||
JP2000/177790 | 2000-06-14 | ||
PCT/JP2000/009157 WO2001047890A1 (en) | 1999-12-24 | 2000-12-22 | Quinoline and quinazoline derivatives and drugs containing the same |
US10/168,392 US7135466B2 (en) | 1999-12-24 | 2000-12-22 | Quinoline and quinazoline derivatives and drugs containing the same |
US11/432,407 US20060211717A1 (en) | 1999-12-24 | 2006-05-12 | Quinoline and quinazoline derivatives and drugs containing the same |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2000/009157 Division WO2001047890A1 (en) | 1999-12-24 | 2000-12-22 | Quinoline and quinazoline derivatives and drugs containing the same |
US10/168,392 Division US7135466B2 (en) | 1999-12-24 | 2000-12-22 | Quinoline and quinazoline derivatives and drugs containing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
US20060211717A1 true US20060211717A1 (en) | 2006-09-21 |
Family
ID=27341845
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/168,392 Expired - Fee Related US7135466B2 (en) | 1999-12-24 | 2000-12-22 | Quinoline and quinazoline derivatives and drugs containing the same |
US11/432,407 Abandoned US20060211717A1 (en) | 1999-12-24 | 2006-05-12 | Quinoline and quinazoline derivatives and drugs containing the same |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/168,392 Expired - Fee Related US7135466B2 (en) | 1999-12-24 | 2000-12-22 | Quinoline and quinazoline derivatives and drugs containing the same |
Country Status (6)
Country | Link |
---|---|
US (2) | US7135466B2 (en) |
EP (1) | EP1243582A4 (en) |
AU (1) | AU2223201A (en) |
HK (1) | HK1049839A1 (en) |
TW (1) | TWI281915B (en) |
WO (1) | WO2001047890A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7704990B2 (en) | 2005-08-25 | 2010-04-27 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
US7718644B2 (en) | 2004-01-22 | 2010-05-18 | The Trustees Of Columbia University In The City Of New York | Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof |
US7879840B2 (en) | 2005-08-25 | 2011-02-01 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
US20110105747A1 (en) * | 2001-06-22 | 2011-05-05 | Kirin Beer Kabushiki Kaisha | Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same |
US8022058B2 (en) | 2000-05-10 | 2011-09-20 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
US8710045B2 (en) | 2004-01-22 | 2014-04-29 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the ryanodine receptors |
CN107827734A (en) * | 2017-11-23 | 2018-03-23 | 中山奕安泰医药科技有限公司 | A kind of synthesis technique of 2 phenoxy group propionyl chloride |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6797823B1 (en) * | 1999-01-22 | 2004-09-28 | Kirin Beer Kabushiki Kaisha | Quinoline derivatives and quinazoline derivatives |
EP1777218B1 (en) * | 2000-10-20 | 2008-12-31 | Eisai R&D Management Co., Ltd. | Process for the preparation of 4-phenoxy quinoline derivatives |
TWI324154B (en) | 2001-04-27 | 2010-05-01 | Kyowa Hakko Kirin Co Ltd | |
EP1535910A4 (en) * | 2002-05-01 | 2007-03-14 | Kirin Brewery | Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of macrophage colony stimulating factor receptor |
CA2491191C (en) | 2002-07-15 | 2014-02-04 | Exelixis, Inc. | Receptor-type kinase modulators and methods of use |
PT1559715E (en) * | 2002-10-21 | 2007-10-24 | Kirin Pharma Kk | N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-n`-(5-methyl-3-isoxazolyl)urea salt in crystalline form |
EP1566379A4 (en) * | 2002-10-29 | 2005-11-09 | Kirin Brewery | QUINOLINE DERIVATIVES AND QUINAZOLINE DERIVATIVES INHIBITING AUTOPHOSPHORYLATION OF Flt3 AND MEDICINAL COMPOSITIONS CONTAINING THE SAME |
OA12961A (en) | 2002-11-19 | 2006-10-13 | Achillion Pharmaceuticals Inc | Substituted aryl thioureas and related compounds, inhibitors of viral replication. |
JPWO2004080462A1 (en) * | 2003-03-10 | 2006-06-08 | エーザイ株式会社 | c-Kit kinase inhibitor |
ES2466818T3 (en) | 2003-09-26 | 2014-06-11 | Exelixis, Inc. | C-Met modulators and methods of use |
JP4303726B2 (en) | 2003-11-11 | 2009-07-29 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | Urea derivative and method for producing the same |
NZ547009A (en) | 2003-12-23 | 2009-09-25 | Pfizer | Novel quinoline derivatives |
US7459562B2 (en) | 2004-04-23 | 2008-12-02 | Bristol-Myers Squibb Company | Monocyclic heterocycles as kinase inhibitors |
TW200538453A (en) | 2004-04-26 | 2005-12-01 | Bristol Myers Squibb Co | Bicyclic heterocycles as kinase inhibitors |
TW200600492A (en) * | 2004-05-18 | 2006-01-01 | Achillion Pharmaceuticals Inc | Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
US7432373B2 (en) | 2004-06-28 | 2008-10-07 | Bristol-Meyers Squibb Company | Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors |
US7439246B2 (en) | 2004-06-28 | 2008-10-21 | Bristol-Myers Squibb Company | Fused heterocyclic kinase inhibitors |
US7173031B2 (en) | 2004-06-28 | 2007-02-06 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
AU2005270068B2 (en) * | 2004-07-02 | 2012-04-19 | Exelixis, Inc. | C-Met modulators and method of use |
KR20070053205A (en) | 2004-09-17 | 2007-05-23 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | Medicinal composition |
US20100105031A1 (en) * | 2005-08-01 | 2010-04-29 | Esai R & D Management Co., Ltd. | Method for prediction of the efficacy of vascularization inhibitor |
EP1925676A4 (en) | 2005-08-02 | 2010-11-10 | Eisai R&D Man Co Ltd | Method for assay on the effect of vascularization inhibitor |
CA2620594C (en) * | 2005-09-01 | 2012-08-21 | Eisai R&D Management Co., Ltd. | Pharmaceutical composition having improved disintegratability |
EP3061834B1 (en) | 2005-10-21 | 2020-01-08 | The Regents of the University of California | Shp-2 gene mutations in melanoma |
WO2007052849A1 (en) | 2005-11-07 | 2007-05-10 | Eisai R & D Management Co., Ltd. | USE OF COMBINATION OF ANTI-ANGIOGENIC SUBSTANCE AND c-kit KINASE INHIBITOR |
US20090247576A1 (en) * | 2005-11-22 | 2009-10-01 | Eisai R & D Management Co., Ltd. | Anti-tumor agent for multiple myeloma |
CN101443009A (en) | 2006-05-18 | 2009-05-27 | 卫材R&D管理有限公司 | Antitumor agent for thyroid cancer |
WO2008001956A1 (en) * | 2006-06-29 | 2008-01-03 | Eisai R & D Management Co., Ltd. | Therapeutic agent for liver fibrosis |
US8865737B2 (en) | 2006-08-28 | 2014-10-21 | Eisai R&D Management Co., Ltd. | Antitumor agent for undifferentiated gastric cancer |
KR101445892B1 (en) | 2007-01-29 | 2014-09-29 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | Composition for treatment of undifferentiated-type of gastric cancer |
CN101848895B (en) | 2007-11-09 | 2013-10-23 | 卫材R&D管理有限公司 | Combination of anti-angiogenic substance and anti-tumor platinum complex |
MX2010008187A (en) * | 2008-01-29 | 2010-08-10 | Eisai R&D Man Co Ltd | Combined use of angiogenesis inhibitor and taxane. |
SG10201608813PA (en) | 2008-03-17 | 2016-12-29 | Ambit Biosciences Corp | Quinazoline derivatives as raf kinase modulators and methods of use thereof |
WO2009125597A1 (en) | 2008-04-10 | 2009-10-15 | 大鵬薬品工業株式会社 | Acylthiourea compound or salt thereof, and use of the compound or the salt |
NZ594594A (en) | 2009-01-16 | 2013-11-29 | Exelixis Inc | Malate salt of n-(4-{ [6,7-bis(methyloxy)quinolin-4-yl]oxy} phenyl)-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer |
KR101106050B1 (en) | 2009-03-25 | 2012-01-18 | 한국과학기술연구원 | Aminoquinoline derivatives, preparation method thereof and pharmaceutical composition comprising the same |
UA108618C2 (en) | 2009-08-07 | 2015-05-25 | APPLICATION OF C-MET-MODULATORS IN COMBINATION WITH THEMOSOLOMID AND / OR RADIATION THERAPY FOR CANCER TREATMENT | |
EP2586443B1 (en) | 2010-06-25 | 2016-03-16 | Eisai R&D Management Co., Ltd. | Antitumor agent using compounds having kinase inhibitory effect in combination |
US20130225581A1 (en) | 2010-07-16 | 2013-08-29 | Kyowa Hakko Kirin Co., Ltd | Nitrogen-containing aromatic heterocyclic derivative |
KR101762999B1 (en) | 2011-04-18 | 2017-07-28 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | Therapeutic agent for tumor |
WO2012166899A2 (en) | 2011-06-03 | 2012-12-06 | Eisai R&D Management Co., Ltd. | Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds |
WO2013180128A1 (en) * | 2012-05-28 | 2013-12-05 | 協和発酵キリン株式会社 | 4-[4-(5-membered aromatic heterocyclic carbonyl ureide)phenyloxy]quinoline derivative |
CN102977014B (en) * | 2012-11-05 | 2015-01-07 | 沈阳药科大学 | New quinoline compounds and uses thereof |
JPWO2014098176A1 (en) | 2012-12-21 | 2017-01-12 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | Amorphous quinoline derivative and method for producing the same |
RU2658601C2 (en) | 2013-05-14 | 2018-06-21 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds |
CN104277034B (en) * | 2013-07-02 | 2017-07-04 | 湖南化工研究院 | N‑(Alkoxy aryl)Fragrant phenoxy carboxylic acyloxy aminated compounds and preparation method and application |
CN104277033B (en) * | 2013-07-02 | 2017-03-08 | 湖南化工研究院 | N (aryl alkyl) virtue phenoxy carboxylic acyloxy aminated compoundss and preparation method and application |
MX2017001980A (en) | 2014-08-28 | 2017-05-04 | Eisai R&D Man Co Ltd | High-purity quinoline derivative and method for manufacturing same. |
KR20170122734A (en) | 2015-02-25 | 2017-11-06 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | A method for inhibiting the quinoline derivative |
KR20240064733A (en) | 2015-03-04 | 2024-05-13 | 머크 샤프 앤드 돔 코포레이션 | Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer |
WO2016204193A1 (en) | 2015-06-16 | 2016-12-22 | 株式会社PRISM Pharma | Anticancer agent |
AU2016333987A1 (en) | 2015-10-05 | 2018-05-10 | Ny State Psychiatric Institute | Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies |
EP3548007A4 (en) | 2016-12-01 | 2020-08-12 | Ignyta, Inc. | Methods for the treatment of cancer |
MA47516A (en) | 2017-02-15 | 2021-03-31 | Taiho Pharmaceutical Co Ltd | PHARMACEUTICAL COMPOSITION |
JP7290631B2 (en) | 2017-10-04 | 2023-06-13 | バイエル・アクチエンゲゼルシヤフト | Derivatives of heterocyclic compounds as pesticides |
CN108409654B (en) * | 2018-02-12 | 2020-11-27 | 三峡大学 | Tetrahydroisoquinoline-2-radical aryloxy phenoxyalkyl ketone compound with antineoplastic activity and pharmaceutical application thereof |
CN109336828B (en) * | 2018-11-30 | 2022-04-26 | 雅安职业技术学院 | Quinazoline derivative and preparation method and application thereof |
CN111303024B (en) * | 2018-12-12 | 2023-03-28 | 安徽中科拓苒药物科学研究有限公司 | Quinoline-structured pan-KIT kinase inhibitor and application thereof |
CN109776432B (en) * | 2019-03-21 | 2020-07-24 | 广州六顺生物科技股份有限公司 | Multi-target kinase inhibitor, pharmaceutical composition, preparation method and application of multi-target kinase inhibitor |
CN116763787A (en) * | 2022-03-08 | 2023-09-19 | 安徽中科拓苒药物科学研究有限公司 | New application of quinoline compound |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4675047A (en) * | 1980-07-01 | 1987-06-23 | Alexander Serban | Substituted phenylamine- and phenyloxy-quinazolines as herbicides |
US4914098A (en) * | 1986-08-15 | 1990-04-03 | Ciba-Geigy Corporation | Substituted thioureas, isothioureas and carbodiimides and their use as pesticides |
US5480883A (en) * | 1991-05-10 | 1996-01-02 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
US20040229876A1 (en) * | 2001-04-27 | 2004-11-18 | Kirin Beer Kabushiki Kaisha | Quinoline derivatives and quinazoline derivatives having azolyl group |
US20050049264A1 (en) * | 2001-10-17 | 2005-03-03 | Kirin Beer Kabushiki Kaisha | Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors |
US7425564B2 (en) * | 2001-06-22 | 2008-09-16 | Kirin Beer Kabushiki Kaisha | Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus prolifertor receptor and medicinal composition containing the same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3101544A1 (en) * | 1981-01-20 | 1982-08-19 | Hoechst Ag, 6000 Frankfurt | Quinolinoxyphenoxypropionic acid derivatives, their preparation, and their use as herbicides |
DE69622183D1 (en) * | 1995-11-07 | 2002-08-08 | Kirin Brewery | CHINOLINE DERIVATIVES AND CHINAZOLE DERIVATIVES, WHICH INHIBIT THE AUTOPHOSPHORYLATION OF THE GROWTH FACTOR RECEPTOR DERIVING FROM BLOOD PLATPLES AND THEIR PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
JP4194678B2 (en) * | 1997-11-28 | 2008-12-10 | キリンファーマ株式会社 | Quinoline derivative and pharmaceutical composition containing the same |
US6797823B1 (en) * | 1999-01-22 | 2004-09-28 | Kirin Beer Kabushiki Kaisha | Quinoline derivatives and quinazoline derivatives |
EE200200149A (en) | 1999-09-21 | 2003-04-15 | Astrazeneca Ab | Quinazoline compounds and pharmaceutical compositions containing them |
-
2000
- 2000-12-22 TW TWQUINOLINEA patent/TWI281915B/en active
- 2000-12-22 AU AU22232/01A patent/AU2223201A/en not_active Abandoned
- 2000-12-22 EP EP00985844A patent/EP1243582A4/en not_active Withdrawn
- 2000-12-22 WO PCT/JP2000/009157 patent/WO2001047890A1/en active Application Filing
- 2000-12-22 US US10/168,392 patent/US7135466B2/en not_active Expired - Fee Related
-
2003
- 2003-03-21 HK HK03102092.0A patent/HK1049839A1/en unknown
-
2006
- 2006-05-12 US US11/432,407 patent/US20060211717A1/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4675047A (en) * | 1980-07-01 | 1987-06-23 | Alexander Serban | Substituted phenylamine- and phenyloxy-quinazolines as herbicides |
US4914098A (en) * | 1986-08-15 | 1990-04-03 | Ciba-Geigy Corporation | Substituted thioureas, isothioureas and carbodiimides and their use as pesticides |
US5480883A (en) * | 1991-05-10 | 1996-01-02 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
US20040229876A1 (en) * | 2001-04-27 | 2004-11-18 | Kirin Beer Kabushiki Kaisha | Quinoline derivatives and quinazoline derivatives having azolyl group |
US6821987B2 (en) * | 2001-04-27 | 2004-11-23 | Kirin Beer Kabushiki Kaisha | Quinoline derivatives and quinazoline derivatives having azolyl group |
US7425564B2 (en) * | 2001-06-22 | 2008-09-16 | Kirin Beer Kabushiki Kaisha | Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus prolifertor receptor and medicinal composition containing the same |
US20050049264A1 (en) * | 2001-10-17 | 2005-03-03 | Kirin Beer Kabushiki Kaisha | Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8022058B2 (en) | 2000-05-10 | 2011-09-20 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
US20110105747A1 (en) * | 2001-06-22 | 2011-05-05 | Kirin Beer Kabushiki Kaisha | Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same |
US8324245B2 (en) | 2001-06-22 | 2012-12-04 | Kyowa Hakko Kirin Co., Ltd. | Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same |
US7718644B2 (en) | 2004-01-22 | 2010-05-18 | The Trustees Of Columbia University In The City Of New York | Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof |
US8710045B2 (en) | 2004-01-22 | 2014-04-29 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the ryanodine receptors |
US7704990B2 (en) | 2005-08-25 | 2010-04-27 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
US7879840B2 (en) | 2005-08-25 | 2011-02-01 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
CN107827734A (en) * | 2017-11-23 | 2018-03-23 | 中山奕安泰医药科技有限公司 | A kind of synthesis technique of 2 phenoxy group propionyl chloride |
Also Published As
Publication number | Publication date |
---|---|
TWI281915B (en) | 2007-06-01 |
AU2223201A (en) | 2001-07-09 |
US20040132727A1 (en) | 2004-07-08 |
HK1049839A1 (en) | 2003-05-30 |
EP1243582A1 (en) | 2002-09-25 |
WO2001047890A1 (en) | 2001-07-05 |
EP1243582A4 (en) | 2003-06-04 |
US7135466B2 (en) | 2006-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20060211717A1 (en) | Quinoline and quinazoline derivatives and drugs containing the same | |
US6130235A (en) | Compounds and methods to treat cardiac failure and other disorders | |
US6417218B1 (en) | Substituted imidazoles, their preparation and use | |
RU2274639C2 (en) | Derivatives of substituted triazoldiamine, pharmaceutical composition based on thereof and method for its preparing | |
US20030073699A1 (en) | Compounds and methods to treat cardiac failure and other disorders | |
KR101421785B1 (en) | Piperazine compound capable of inhibiting prostaglandin d synthase | |
JP4975745B2 (en) | Substituted imidazole compounds as KSP inhibitors | |
US20040102437A1 (en) | Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same | |
WO2015043515A1 (en) | Quinazoline derivative and preparation method therefor | |
EP2258366A2 (en) | Quinoline derivatives and quinazoline derivatives capable of inhibiting autophosphorylation of hepatocyte growth factor receptors, and pharmaceutical composition comprising the same | |
JP2010509280A (en) | 1,2,4-triazole derivatives as sigma receptor inhibitors | |
US5385914A (en) | Cardiotonic carbostyril agents for treating heart ailments | |
JP4664673B2 (en) | Aminobenzothiazole compounds having NOS inhibitory activity | |
US20130040988A1 (en) | 3-amino-pyridine derivatives for the treatment of metabolic disorders | |
JP2010536713A (en) | Quinolone compounds and pharmaceutical compositions | |
JP5819397B2 (en) | TRPV4 antagonist | |
US5324728A (en) | Naphthoic acid derivative | |
US20080261926A1 (en) | Pharmaceutical Calcimimetics | |
CN112778318A (en) | Pyrimidopyrazole derivatives for inhibiting xanthine oxidase activity, and preparation method and application thereof | |
US7102007B2 (en) | Dihydroindole and tetrahydroquinoline derivatives | |
EP3315495A1 (en) | N,n' -diarylurea, n,n' -diarylthiourea and n,n' -diarylguanidino compounds for use in treatment and prevention of inflammatory disease | |
JP5769504B2 (en) | Medicine | |
JP2011016742A (en) | Cyclic amino compound, or salt thereof | |
US11207296B2 (en) | XPA inhibitor compounds and their use | |
WO1998047877A1 (en) | 2-benzoyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide derivatives and their use as inhibitors of hepatic production of apob-100 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: KIRIN PHARMA KABUSHIKI KAISHA, JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KIRIN HOLDINGS KABUSHIKI KAISHA;REEL/FRAME:021138/0257 Effective date: 20080208 Owner name: KIRIN PHARMA KABUSHIKI KAISHA,JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KIRIN HOLDINGS KABUSHIKI KAISHA;REEL/FRAME:021138/0257 Effective date: 20080208 |
|
AS | Assignment |
Owner name: KIRIN HOLDINGS KABUSHIKI KAISHA, JAPAN Free format text: CHANGE OF NAME;ASSIGNOR:KIRIN BEER KABUSHIKI KAISHA;REEL/FRAME:021147/0855 Effective date: 20071120 Owner name: KIRIN HOLDINGS KABUSHIKI KAISHA,JAPAN Free format text: CHANGE OF NAME;ASSIGNOR:KIRIN BEER KABUSHIKI KAISHA;REEL/FRAME:021147/0855 Effective date: 20071120 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |